No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 3nrqB, 0.7445, 2.31, 0.080, 149, 100, CRYSTAL STRUCTURE OF COPPER-RECONSTITUTED FETP FROM UROPATHOGENIC ESCHERICHIA COLI STRAIN F11
2, 5i0yA, 0.7444, 2.35, 0.080, 150, 100, COPPER-BOUND E46Q VARIANT OF UROPATHOGENIC ESCHERICHIA COLI STRAIN F11 FETP
3, 5i0yB, 0.7399, 2.35, 0.080, 158, 100, COPPER-BOUND E46Q VARIANT OF UROPATHOGENIC ESCHERICHIA COLI STRAIN F11 FETP
4, 3nrqA, 0.7396, 2.38, 0.080, 150, 100, CRYSTAL STRUCTURE OF COPPER-RECONSTITUTED FETP FROM UROPATHOGENIC ESCHERICHIA COLI STRAIN F11
5, 5i0xA, 0.7392, 2.49, 0.069, 153, 101, COPPER-BOUND M90I VARIANT OF UROPATHOGENIC ESCHERICHIA COLI STRAIN F11 FETP
6, 3nrpC, 0.7379, 2.42, 0.080, 151, 100, CRYSTAL STRUCTURE OF  AS ISOLATED  UROPATHOGENIC E. COLI STRAIN F11 FETP RECOMBINANTLY EXPRESSED IN THE PERIPLASM OF E. COLI BL21(DE3)
7, 3nrpB, 0.7370, 2.42, 0.080, 151, 100, CRYSTAL STRUCTURE OF  AS ISOLATED  UROPATHOGENIC E. COLI STRAIN F11 FETP RECOMBINANTLY EXPRESSED IN THE PERIPLASM OF E. COLI BL21(DE3)
8, 5i0xB, 0.7369, 2.46, 0.059, 158, 101, COPPER-BOUND M90I VARIANT OF UROPATHOGENIC ESCHERICHIA COLI STRAIN F11 FETP
9, 4nwnN, 0.7369, 2.47, 0.079, 157, 101, COMPUTATIONALLY DESIGNED TWO-COMPONENT SELF-ASSEMBLING TETRAHEDRAL CAGE T32-28
10, 3lzoA, 0.7369, 2.48, 0.099, 159, 101, CRYSTAL STRUCTURE ANALYSIS OF THE COPPER-RECONSTITUTED P19 PROTEIN FROM CAMPYLOBACTER JEJUNI AT 1.65 A AT PH 10.0
11, 4nwnD, 0.7361, 2.45, 0.079, 157, 101, COMPUTATIONALLY DESIGNED TWO-COMPONENT SELF-ASSEMBLING TETRAHEDRAL CAGE T32-28
12, 5i0vB, 0.7360, 2.46, 0.099, 157, 101, IRON AND COPPER-BOUND P19 FROM CAMPYLOBACTER JEJUNI UNDER OXIDIZING CONDITIONS
13, 3nrpA, 0.7352, 2.44, 0.080, 152, 100, CRYSTAL STRUCTURE OF  AS ISOLATED  UROPATHOGENIC E. COLI STRAIN F11 FETP RECOMBINANTLY EXPRESSED IN THE PERIPLASM OF E. COLI BL21(DE3)
14, 3lznA, 0.7352, 2.47, 0.099, 158, 101, CRYSTAL STRUCTURE ANALYSIS OF THE APO P19 PROTEIN FROM CAMPYLOBACTER JEJUNI AT 1.59 A AT PH 9
15, 3nrpD, 0.7351, 2.42, 0.080, 151, 100, CRYSTAL STRUCTURE OF  AS ISOLATED  UROPATHOGENIC E. COLI STRAIN F11 FETP RECOMBINANTLY EXPRESSED IN THE PERIPLASM OF E. COLI BL21(DE3)
16, 3lzpB, 0.7348, 2.46, 0.099, 158, 101, CRYSTAL STRUCTURE ANALYSIS OF THE  AS-ISOLATED  P19 PROTEIN FROM CAMPYLOBACTER JEJUNI AT 1.65 A AT PH 9.0
17, 5i0wA, 0.7339, 2.59, 0.098, 159, 102, IRON AND COPPER-BOUND P19 FROM CAMPYLOBACTER JEJUNI UNDER REDUCING CONDITIONS
18, 5i0vA, 0.7339, 2.59, 0.098, 159, 102, IRON AND COPPER-BOUND P19 FROM CAMPYLOBACTER JEJUNI UNDER OXIDIZING CONDITIONS
19, 4nwnH, 0.7335, 2.50, 0.079, 157, 101, COMPUTATIONALLY DESIGNED TWO-COMPONENT SELF-ASSEMBLING TETRAHEDRAL CAGE T32-28
20, 5i0wB, 0.7333, 2.47, 0.099, 157, 101, IRON AND COPPER-BOUND P19 FROM CAMPYLOBACTER JEJUNI UNDER REDUCING CONDITIONS
21, 4nwnV, 0.7333, 2.49, 0.079, 157, 101, COMPUTATIONALLY DESIGNED TWO-COMPONENT SELF-ASSEMBLING TETRAHEDRAL CAGE T32-28
22, 4nwnB, 0.7330, 2.51, 0.079, 157, 101, COMPUTATIONALLY DESIGNED TWO-COMPONENT SELF-ASSEMBLING TETRAHEDRAL CAGE T32-28
23, 3lzrA, 0.7328, 2.49, 0.099, 158, 101, CRYSTAL STRUCTURE ANALYSIS OF MANGANESE TREATED P19 PROTEIN FROM CAMPYLOBACTER JEJUNI AT 2.73 A AT PH 9 AND MANGANESE PEAK WAVELENGTH (1.893 A)
24, 3lzlA, 0.7327, 2.49, 0.099, 157, 101, CRYSTAL STRUCTURE ANALYSIS OF THE AS-SOLATED P19 PROTEIN FROM CAMPYLOBACTER JEJUNI AT 1.45 A AT PH 9.0
25, 4nwnP, 0.7326, 2.49, 0.079, 157, 101, COMPUTATIONALLY DESIGNED TWO-COMPONENT SELF-ASSEMBLING TETRAHEDRAL CAGE T32-28
26, 3lzrB, 0.7325, 2.53, 0.119, 158, 101, CRYSTAL STRUCTURE ANALYSIS OF MANGANESE TREATED P19 PROTEIN FROM CAMPYLOBACTER JEJUNI AT 2.73 A AT PH 9 AND MANGANESE PEAK WAVELENGTH (1.893 A)
27, 4nwnR, 0.7324, 2.50, 0.079, 157, 101, COMPUTATIONALLY DESIGNED TWO-COMPONENT SELF-ASSEMBLING TETRAHEDRAL CAGE T32-28
28, 3lzqB, 0.7322, 2.50, 0.099, 159, 101, CRYSTAL STRUCTURE ANALYSIS OF MANGANESE TREATED P19 PROTEIN FROM CAMPYLOBACTER JEJUNI AT 1.41 A AT PH 9
29, 3lzqA, 0.7321, 2.49, 0.099, 157, 101, CRYSTAL STRUCTURE ANALYSIS OF MANGANESE TREATED P19 PROTEIN FROM CAMPYLOBACTER JEJUNI AT 1.41 A AT PH 9
30, 4nwnF, 0.7317, 2.50, 0.079, 157, 101, COMPUTATIONALLY DESIGNED TWO-COMPONENT SELF-ASSEMBLING TETRAHEDRAL CAGE T32-28
31, 4nwnX, 0.7315, 2.49, 0.079, 157, 101, COMPUTATIONALLY DESIGNED TWO-COMPONENT SELF-ASSEMBLING TETRAHEDRAL CAGE T32-28
32, 4nwnL, 0.7315, 2.51, 0.079, 157, 101, COMPUTATIONALLY DESIGNED TWO-COMPONENT SELF-ASSEMBLING TETRAHEDRAL CAGE T32-28
33, 3uc2C, 0.7312, 2.30, 0.093, 123, 97, CRYSTAL STRUCTURE OF A DUF4426 FAMILY PROTEIN (PA0388) FROM PSEUDOMONAS AERUGINOSA PAO1 AT 2.09 A RESOLUTION
34, 3lzlB, 0.7308, 2.50, 0.099, 158, 101, CRYSTAL STRUCTURE ANALYSIS OF THE AS-SOLATED P19 PROTEIN FROM CAMPYLOBACTER JEJUNI AT 1.45 A AT PH 9.0
35, 3lzoB, 0.7307, 2.51, 0.099, 159, 101, CRYSTAL STRUCTURE ANALYSIS OF THE COPPER-RECONSTITUTED P19 PROTEIN FROM CAMPYLOBACTER JEJUNI AT 1.65 A AT PH 10.0
36, 4nwnT, 0.7290, 2.52, 0.079, 157, 101, COMPUTATIONALLY DESIGNED TWO-COMPONENT SELF-ASSEMBLING TETRAHEDRAL CAGE T32-28
37, 4nwnJ, 0.7284, 2.52, 0.079, 157, 101, COMPUTATIONALLY DESIGNED TWO-COMPONENT SELF-ASSEMBLING TETRAHEDRAL CAGE T32-28
38, 3uc2A, 0.7279, 2.26, 0.083, 123, 96, CRYSTAL STRUCTURE OF A DUF4426 FAMILY PROTEIN (PA0388) FROM PSEUDOMONAS AERUGINOSA PAO1 AT 2.09 A RESOLUTION
39, 3lzpA, 0.7268, 2.51, 0.099, 159, 101, CRYSTAL STRUCTURE ANALYSIS OF THE  AS-ISOLATED  P19 PROTEIN FROM CAMPYLOBACTER JEJUNI AT 1.65 A AT PH 9.0
40, 3lznB, 0.7254, 2.56, 0.119, 158, 101, CRYSTAL STRUCTURE ANALYSIS OF THE APO P19 PROTEIN FROM CAMPYLOBACTER JEJUNI AT 1.59 A AT PH 9
41, 3uc2B, 0.7157, 2.49, 0.083, 125, 96, CRYSTAL STRUCTURE OF A DUF4426 FAMILY PROTEIN (PA0388) FROM PSEUDOMONAS AERUGINOSA PAO1 AT 2.09 A RESOLUTION
42, 3uc2D, 0.6997, 2.30, 0.086, 109, 93, CRYSTAL STRUCTURE OF A DUF4426 FAMILY PROTEIN (PA0388) FROM PSEUDOMONAS AERUGINOSA PAO1 AT 2.09 A RESOLUTION
43, 2ivfC, 0.6761, 2.69, 0.021, 214, 97, ETHYLBENZENE DEHYDROGENASE FROM AROMATOLEUM AROMATICUM
44, 4kh9B, 0.6749, 3.12, 0.082, 357, 98, CRYSTAL STRUCTURE OF A DUF4785 FAMILY PROTEIN (LPG0956) FROM LEGIONELLA PNEUMOPHILA SUBSP. PNEUMOPHILA STR. PHILADELPHIA 1 AT 2.00 A RESOLUTION
45, 4kh9A, 0.6719, 3.24, 0.071, 358, 98, CRYSTAL STRUCTURE OF A DUF4785 FAMILY PROTEIN (LPG0956) FROM LEGIONELLA PNEUMOPHILA SUBSP. PNEUMOPHILA STR. PHILADELPHIA 1 AT 2.00 A RESOLUTION
46, 2m83A, 0.6529, 3.06, 0.074, 139, 95, SOLUTION STRUCTURE OF THE CARBOHYDRATE BINDING MODULE OF THE MUSCLE GLYCOGEN-TARGETING SUBUNIT OF PROTEIN PHOSPHATASE-1
47, 4lm8A, 0.6511, 2.88, 0.129, 626, 93, CRYSTAL STRUCTURE OF THE OUTER MEMBRANE DECAHEME CYTOCHROME MTRC
48, 4lmhC, 0.6494, 2.76, 0.053, 692, 95, CRYSTAL STRUCTURE OF THE OUTER MEMBRANE DECAHEME CYTOCHROME OMCA
49, 2b39B, 0.6491, 2.91, 0.097, 1610, 93, STRUCTURE OF MAMMALIAN C3 WITH AN INTACT THIOESTER AT 3A RESOLUTION
50, 5uv8A, 0.6482, 2.75, 0.054, 259, 92, INTERLEUKIN-3 RECEPTOR COMPLEX
51, 6h6fD, 0.6475, 2.85, 0.064, 2454, 94, struct.pdbx_descriptor               TcdA1; TcdB2;TccC3  
52, 5lkhD, 0.6474, 2.69, 0.087, 948, 92, CRYO-EM STRUCTURE OF THE TC TOXIN TCDA1 IN ITS PORE STATE (OBTAINED BY FLEXIBLE FITTING)
53, 5lkhC, 0.6474, 2.69, 0.087, 948, 92, CRYO-EM STRUCTURE OF THE TC TOXIN TCDA1 IN ITS PORE STATE (OBTAINED BY FLEXIBLE FITTING)
54, 5lkhE, 0.6473, 2.69, 0.087, 948, 92, CRYO-EM STRUCTURE OF THE TC TOXIN TCDA1 IN ITS PORE STATE (OBTAINED BY FLEXIBLE FITTING)
55, 5lkhB, 0.6473, 2.69, 0.087, 948, 92, CRYO-EM STRUCTURE OF THE TC TOXIN TCDA1 IN ITS PORE STATE (OBTAINED BY FLEXIBLE FITTING)
56, 5lkhA, 0.6473, 2.69, 0.087, 948, 92, CRYO-EM STRUCTURE OF THE TC TOXIN TCDA1 IN ITS PORE STATE (OBTAINED BY FLEXIBLE FITTING)
57, 2b39A, 0.6470, 2.92, 0.097, 1610, 93, STRUCTURE OF MAMMALIAN C3 WITH AN INTACT THIOESTER AT 3A RESOLUTION
58, 6h6eD, 0.6467, 2.86, 0.085, 2417, 94, struct.pdbx_descriptor               TcdA1; TcdB2;TccC3  
59, 6h6eC, 0.6463, 2.79, 0.065, 2417, 93, struct.pdbx_descriptor               TcdA1; TcdB2;TccC3  
60, 2winA, 0.6462, 2.72, 0.066, 638, 91, C3 CONVERTASE (C3BBB) STABILIZED BY SCIN
61, 2winG, 0.6459, 2.72, 0.066, 638, 91, C3 CONVERTASE (C3BBB) STABILIZED BY SCIN
62, 2winE, 0.6459, 2.71, 0.066, 638, 91, C3 CONVERTASE (C3BBB) STABILIZED BY SCIN
63, 2winC, 0.6459, 2.72, 0.066, 638, 91, C3 CONVERTASE (C3BBB) STABILIZED BY SCIN
64, 6h6eE, 0.6457, 2.87, 0.074, 2417, 94, struct.pdbx_descriptor               TcdA1; TcdB2;TccC3  
65, 3tp4B, 0.6456, 3.09, 0.097, 455, 93, CRYSTAL STRUCTURE OF ENGINEERED PROTEIN AT THE RESOLUTION 1.98A NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET OR128
66, 6h6eB, 0.6453, 2.82, 0.085, 2417, 94, struct.pdbx_descriptor               TcdA1; TcdB2;TccC3  
67, 4d7vA, 0.6447, 3.56, 0.126, 227, 103, THE STRUCTURE OF THE CATALYTIC DOMAIN OF NCLPMO9C FROM THE FILAMENTOUS FUNGUS NEUROSPORA CRASSA
68, 3qt2A, 0.6446, 2.98, 0.065, 307, 92, STRUCTURE OF A CYTOKINE LIGAND-RECEPTOR COMPLEX
69, 6h6fA, 0.6442, 2.88, 0.074, 2454, 94, struct.pdbx_descriptor               TcdA1; TcdB2;TccC3  
70, 4d7uA, 0.6440, 3.53, 0.118, 227, 102, THE STRUCTURE OF THE CATALYTIC DOMAIN OF NCLPMO9C FROM THE FILAMENTOUS FUNGUS NEUROSPORA CRASSA
71, 6h6eA, 0.6432, 2.82, 0.085, 2417, 94, struct.pdbx_descriptor               TcdA1; TcdB2;TccC3  
72, 2a73A, 0.6426, 2.74, 0.055, 635, 91, HUMAN COMPLEMENT COMPONENT C3
73, 6ehgA, 0.6425, 2.73, 0.066, 638, 91, COMPLEMENT COMPONENT C3B IN COMPLEX WITH A NANOBODY
74, 1jz4A, 0.6421, 2.91, 0.074, 1011, 95, E. COLI (LACZ) BETA-GALACTOSIDASE-TRAPPED 2-DEOXY- GALACTOSYL-ENZYME INTERMEDIATE (LOW BIS-TRIS)
75, 6h6fB, 0.6419, 2.86, 0.085, 2454, 94, struct.pdbx_descriptor               TcdA1; TcdB2;TccC3  
76, 6h6fC, 0.6413, 2.89, 0.064, 2454, 94, struct.pdbx_descriptor               TcdA1; TcdB2;TccC3  
77, 6h6fE, 0.6412, 2.89, 0.064, 2454, 94, struct.pdbx_descriptor               TcdA1; TcdB2;TccC3  
78, 5a1yV, 0.6412, 3.34, 0.031, 824, 97, THE STRUCTURE OF THE COPI COAT LINKAGE IV
79, 5a1yE, 0.6412, 3.34, 0.031, 824, 97, THE STRUCTURE OF THE COPI COAT LINKAGE IV
80, 5a1xM, 0.6412, 3.34, 0.031, 824, 97, THE STRUCTURE OF THE COPI COAT LINKAGE III
81, 5a1vV, 0.6412, 3.34, 0.031, 824, 97, THE STRUCTURE OF THE COPI COAT LINKAGE I
82, 5a1vM, 0.6412, 3.34, 0.031, 824, 97, THE STRUCTURE OF THE COPI COAT LINKAGE I
83, 5a1vE, 0.6412, 3.34, 0.031, 824, 97, THE STRUCTURE OF THE COPI COAT LINKAGE I
84, 5a1uE, 0.6412, 3.34, 0.031, 824, 97, THE STRUCTURE OF THE COPI COAT TRIAD
85, 3j7hD, 0.6410, 2.97, 0.031, 1022, 97, STRUCTURE OF BETA-GALACTOSIDASE AT 3.2-A RESOLUTION OBTAINED BY CRYO- ELECTRON MICROSCOPY
86, 3j7hC, 0.6410, 2.97, 0.031, 1022, 97, STRUCTURE OF BETA-GALACTOSIDASE AT 3.2-A RESOLUTION OBTAINED BY CRYO- ELECTRON MICROSCOPY
87, 3j7hB, 0.6410, 2.97, 0.031, 1022, 97, STRUCTURE OF BETA-GALACTOSIDASE AT 3.2-A RESOLUTION OBTAINED BY CRYO- ELECTRON MICROSCOPY
88, 3j7hA, 0.6410, 2.97, 0.031, 1022, 97, STRUCTURE OF BETA-GALACTOSIDASE AT 3.2-A RESOLUTION OBTAINED BY CRYO- ELECTRON MICROSCOPY
89, 3i3bB, 0.6407, 2.91, 0.084, 1011, 95, E.COLI (LACZ) BETA-GALACTOSIDASE (M542A) IN COMPLEX WITH D- GALACTOPYRANOSYL-1-ON
90, 4d7vB, 0.6404, 3.38, 0.109, 224, 101, THE STRUCTURE OF THE CATALYTIC DOMAIN OF NCLPMO9C FROM THE FILAMENTOUS FUNGUS NEUROSPORA CRASSA
91, 4d7uB, 0.6403, 3.52, 0.118, 227, 102, THE STRUCTURE OF THE CATALYTIC DOMAIN OF NCLPMO9C FROM THE FILAMENTOUS FUNGUS NEUROSPORA CRASSA
92, 1jz8B, 0.6399, 2.91, 0.084, 1011, 95, E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH ALLOLACTOSE
93, 3va2C, 0.6390, 2.99, 0.065, 307, 92, CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-5 IN COMPLEX WITH ITS ALPHA RECEPTOR
94, 5fohA, 0.6386, 3.51, 0.089, 218, 101, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF NCLPMO9A
95, 6h41A, 0.6385, 2.91, 0.087, 309, 92, STRUCTURE OF THE COMPLEX OF THE IL-5 INHIBITORY PEPTIDE AF17121 BOUND TO THE IL-5 RECEPTOR IL-5RALPHA 
96, 3iaqC, 0.6384, 2.92, 0.084, 1011, 95, E. COLI (LACZ) BETA-GALACTOSIDASE (E416V)
97, 3muy3, 0.6383, 2.92, 0.084, 1011, 95, E. COLI (LACZ) BETA-GALACTOSIDASE (R599A)
98, 5fo7A, 0.6373, 2.89, 0.054, 637, 92, CRYSTAL STRUCTURE OF HUMAN COMPLEMENT C3B AT 2.8 ANGSTROM RESOLUTION
99, 2qkiD, 0.6370, 2.85, 0.065, 632, 92, HUMAN C3C IN COMPLEX WITH THE INHIBITOR COMPSTATIN
100, 1jywD, 0.6370, 2.97, 0.084, 1011, 95, E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH PNPG
101, 6dg5B, 0.6367, 2.63, 0.090, 206, 89, STRUCTURE OF A DE NOVO DESIGNED INTERLEUKIN-2/INTERLEUKIN-15 MIMETIC COMPLEX WITH IL-2RB AND IL-2RG 
102, 1jynD, 0.6366, 2.95, 0.084, 1011, 95, E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH LACTOSE
103, 3vd3C, 0.6365, 3.13, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (N460D)
104, 3i3eD, 0.6364, 2.97, 0.084, 1011, 95, E. COLI (LACZ) BETA-GALACTOSIDASE (M542A)
105, 5hcdB, 0.6362, 2.93, 0.108, 647, 93, TERNARY COMPLEX OF HUMAN COMPLEMENT C5 WITH ORNITHODOROS MOUBATA OMCI AND RHIPICEPHALUS MICROPLUS RACI2
106, 3dypC, 0.6360, 3.08, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (H418N)
107, 1jynA, 0.6360, 3.11, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH LACTOSE
108, 1dp0D, 0.6360, 2.96, 0.084, 1011, 95, E. COLI BETA-GALACTOSIDASE AT 1.7 ANGSTROM
109, 5i5kB, 0.6359, 2.92, 0.108, 1634, 93, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH ECULIZUMAB
110, 3i3bA, 0.6359, 3.12, 0.072, 1011, 97, E.COLI (LACZ) BETA-GALACTOSIDASE (M542A) IN COMPLEX WITH D- GALACTOPYRANOSYL-1-ON
111, 1px4D, 0.6359, 2.95, 0.084, 1011, 95, E. COLI (LACZ) BETA-GALACTOSIDASE (G794A) WITH IPTG BOUND
112, 1jz4B, 0.6359, 3.10, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE-TRAPPED 2-DEOXY- GALACTOSYL-ENZYME INTERMEDIATE (LOW BIS-TRIS)
113, 3vd7B, 0.6358, 3.10, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (N460S) IN COMPLEX WITH GALACTOTETRAZOLE
114, 1jz4C, 0.6356, 3.09, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE-TRAPPED 2-DEOXY- GALACTOSYL-ENZYME INTERMEDIATE (LOW BIS-TRIS)
115, 5tkhB, 0.6355, 3.56, 0.127, 223, 102, NEUROSPORA CRASSA POLYSACCHARIDE MONOOXYGENASE 2 ASCORBATE TREATED
116, 5tkgA, 0.6355, 3.56, 0.118, 223, 102, NEUROSPORA CRASSA POLYSACCHARIDE MONOOXYGENASE 2 RESTING STATE
117, 1jz2C, 0.6355, 3.10, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE-TRAPPED 2-F-GALACTOSYL- ENZYME INTERMEDIATE (ORTHORHOMBIC)
118, 3muz3, 0.6352, 3.12, 0.072, 1011, 97, E.COLI (LACZ) BETA-GALACTOSIDASE (R599A) IN COMPLEX WITH IPTG
119, 4l18E, 0.6351, 3.21, 0.126, 141, 95, CRYSTAL STRUCTURE OF RUNX1 AND ETS1 BOUND TO TCR ALPHA PROMOTER (CRYSTAL FORM 3)
120, 3dymB, 0.6351, 3.09, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (H418E)
121, 5i5kA, 0.6348, 2.95, 0.118, 1632, 93, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH ECULIZUMAB
122, 1px4C, 0.6348, 3.09, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (G794A) WITH IPTG BOUND
123, 1px3C, 0.6346, 3.10, 0.072, 1007, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (G794A)
124, 1jz3C, 0.6346, 3.10, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE-TRAPPED 2-DEOXY- GALACTOSYL ENZYME INTERMEDIATE
125, 3iapC, 0.6345, 3.11, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (E416Q)
126, 3dyoC, 0.6345, 3.12, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (H418N) IN COMPLEX WITH IPTG
127, 5tkfD, 0.6344, 3.58, 0.127, 223, 102, NEUROSPORA CRASSA POLYSACCHARIDE MONOOXYGENASE 2 HIGH MANNOSYLATION
128, 5hceB, 0.6344, 2.93, 0.108, 647, 93, TERNARY COMPLEX OF HUMAN COMPLEMENT C5 WITH ORNITHODOROS MOUBATA OMCI AND RHIPICEPHALUS APPENDICULATUS RACI1
129, 3vd7A, 0.6344, 3.10, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (N460S) IN COMPLEX WITH GALACTOTETRAZOLE
130, 1jz5B, 0.6344, 3.11, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH D-GALCTOPYRANOSYL-1- ON
131, 3ucpA, 0.6343, 2.91, 0.106, 800, 94, OUTER MEMBRANE ENDECAHEME CYTOCHROME UNDA FROM SHEWANELLA SP. HRCR-6
132, 3i3eC, 0.6342, 3.10, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (M542A)
133, 3iapB, 0.6340, 3.12, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (E416Q)
134, 3dypB, 0.6340, 3.11, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (H418N)
135, 3dyoB, 0.6340, 3.13, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (H418N) IN COMPLEX WITH IPTG
136, 1jyxB, 0.6340, 3.13, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH IPTG
137, 3vd5A, 0.6339, 3.13, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (N460S)
138, 1jyvB, 0.6339, 3.11, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH ONPG
139, 3vd3B, 0.6338, 3.14, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (N460D)
140, 3t2oC, 0.6338, 3.11, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (S796D)
141, 1jynC, 0.6338, 3.10, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH LACTOSE
142, 6drvD, 0.6337, 2.99, 0.042, 1024, 96, BETA-GALACTOSIDASE 
143, 6drvC, 0.6337, 2.99, 0.042, 1024, 96, BETA-GALACTOSIDASE 
144, 6drvB, 0.6337, 2.99, 0.042, 1024, 96, BETA-GALACTOSIDASE 
145, 6drvA, 0.6337, 2.99, 0.042, 1024, 96, BETA-GALACTOSIDASE 
146, 1jz3B, 0.6337, 3.11, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE-TRAPPED 2-DEOXY- GALACTOSYL ENZYME INTERMEDIATE
147, 3muz2, 0.6336, 3.14, 0.072, 1011, 97, E.COLI (LACZ) BETA-GALACTOSIDASE (R599A) IN COMPLEX WITH IPTG
148, 1jz2A, 0.6336, 3.14, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE-TRAPPED 2-F-GALACTOSYL- ENZYME INTERMEDIATE (ORTHORHOMBIC)
149, 1jywB, 0.6336, 3.12, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH PNPG
150, 5tkfB, 0.6335, 3.45, 0.109, 223, 101, NEUROSPORA CRASSA POLYSACCHARIDE MONOOXYGENASE 2 HIGH MANNOSYLATION
151, 4v40N, 0.6335, 3.14, 0.093, 1021, 97, 
152, 1jynB, 0.6335, 3.11, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH LACTOSE
153, 4eirA, 0.6334, 3.45, 0.109, 222, 101, STRUCTURAL BASIS FOR SUBSTRATE TARGETING AND CATALYSIS BY FUNGAL POLYSACCHARIDE MONOOXYGENASES (PMO-2)
154, 3dyoD, 0.6334, 3.14, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (H418N) IN COMPLEX WITH IPTG
155, 3i3eB, 0.6333, 3.12, 0.072, 1010, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (M542A)
156, 1px3B, 0.6333, 3.11, 0.072, 1009, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (G794A)
157, 3t2oB, 0.6332, 3.12, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (S796D)
158, 1px4B, 0.6332, 3.12, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (G794A) WITH IPTG BOUND
159, 1jz6B, 0.6331, 3.12, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH GALACTO- TETRAZOLE
160, 3czjB, 0.6330, 3.14, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (N460T) IN COMPLEX WITH D- GALCTOPYRANOSYL-1-ONE
161, 3muz4, 0.6329, 3.15, 0.072, 1011, 97, E.COLI (LACZ) BETA-GALACTOSIDASE (R599A) IN COMPLEX WITH IPTG
162, 3muy2, 0.6329, 3.13, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (R599A)
163, 3czjC, 0.6329, 3.12, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (N460T) IN COMPLEX WITH D- GALCTOPYRANOSYL-1-ONE
164, 3i3dB, 0.6328, 3.13, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (M542A) IN COMPLEX WITH IPTG
165, 3i3bC, 0.6328, 3.11, 0.072, 1011, 97, E.COLI (LACZ) BETA-GALACTOSIDASE (M542A) IN COMPLEX WITH D- GALACTOPYRANOSYL-1-ON
166, 3mv12, 0.6327, 3.13, 0.072, 1011, 97, E.COLI (LACZ) BETA-GALACTOSIDASE (R599A) IN COMPLEX WITH GUANIDINIUM
167, 4l18A, 0.6326, 3.07, 0.128, 142, 94, CRYSTAL STRUCTURE OF RUNX1 AND ETS1 BOUND TO TCR ALPHA PROMOTER (CRYSTAL FORM 3)
168, 3ufkA, 0.6326, 2.92, 0.106, 800, 94, CRYSTAL STRUCTURE OF UNDA COMPLEXED WITH IRON NITRILOTRIACETATE
169, 3mv03, 0.6326, 3.12, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (R599A) IN COMPLEX WITH D- GALCTOPYRANOSYL-1-ONE
170, 4u59A, 0.6324, 3.49, 0.103, 1537, 97, CRYSTAL STRUCTURE OF SALMONELLA ALPHA-2-MACROGLOBULIN REACTED WITH METHYLAMINE
171, 4fxkA, 0.6323, 2.89, 0.088, 651, 91, HUMAN COMPLEMENT C4
172, 5hccB, 0.6322, 3.00, 0.118, 647, 93, TERNARY COMPLEX OF HUMAN COMPLEMENT C5 WITH ORNITHODOROS MOUBATA OMCI AND DERMACENTOR ANDERSONI RACI3.
173, 4u4jA, 0.6321, 3.56, 0.102, 1538, 98, CRYSTAL STRUCTURE OF SALMONELLA ALPHA-2-MACROGLOBULIN MUTANT Y1175G
174, 3e1f4, 0.6321, 3.13, 0.072, 1011, 97, E.COLI (LACZ) BETA-GALACTOSIDASE (H418E) IN COMPLEX WITH GALACTOSE
175, 3e1f1, 0.6321, 3.13, 0.072, 1011, 97, E.COLI (LACZ) BETA-GALACTOSIDASE (H418E) IN COMPLEX WITH GALACTOSE
176, 1jz4D, 0.6321, 3.14, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE-TRAPPED 2-DEOXY- GALACTOSYL-ENZYME INTERMEDIATE (LOW BIS-TRIS)
177, 1jyxD, 0.6321, 3.16, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH IPTG
178, 1i8uA, 0.6321, 3.21, 0.091, 189, 99, FAMILY 9 CARBOHYDRATE-BINDING MODULE FROM THERMOTOGA MARITIMA XYLANASE 10A
179, 3e1f2, 0.6320, 3.13, 0.072, 1011, 97, E.COLI (LACZ) BETA-GALACTOSIDASE (H418E) IN COMPLEX WITH GALACTOSE
180, 3e1f3, 0.6319, 3.13, 0.072, 1011, 97, E.COLI (LACZ) BETA-GALACTOSIDASE (H418E) IN COMPLEX WITH GALACTOSE
181, 4v40F, 0.6317, 3.16, 0.093, 1021, 97, 
182, 1pzdA, 0.6315, 3.32, 0.031, 271, 97, STRUCTURAL IDENTIFICATION OF A CONSERVED APPENDAGE DOMAIN IN THE CARBOXYL-TERMINUS OF THE COPI GAMMA-SUBUNIT.
183, 1jz8C, 0.6313, 3.15, 0.093, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH ALLOLACTOSE
184, 4v45M, 0.6311, 3.05, 0.042, 1018, 96, 
185, 4v45K, 0.6311, 3.05, 0.042, 1018, 96, 
186, 4v45H, 0.6311, 3.05, 0.042, 1018, 96, 
187, 4v45G, 0.6311, 3.05, 0.042, 1018, 96, 
188, 4v45C, 0.6311, 3.05, 0.042, 1018, 96, 
189, 4v45B, 0.6311, 3.05, 0.042, 1018, 96, 
190, 4v45A, 0.6311, 3.05, 0.042, 1018, 96, 
191, 1jyvC, 0.6311, 3.15, 0.093, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH ONPG
192, 1i8aA, 0.6311, 3.21, 0.091, 189, 99, FAMILY 9 CARBOHYDRATE-BINDING MODULE FROM THERMOTOGA MARITIMA XYLANASE 10A WITH GLUCOSE
193, 4v45P, 0.6310, 3.05, 0.042, 1018, 96, 
194, 4v45O, 0.6310, 3.05, 0.042, 1018, 96, 
195, 4v45N, 0.6310, 3.05, 0.042, 1018, 96, 
196, 4v45L, 0.6310, 3.05, 0.042, 1018, 96, 
197, 4v45J, 0.6310, 3.05, 0.042, 1018, 96, 
198, 4v45I, 0.6310, 3.05, 0.042, 1018, 96, 
199, 4v45F, 0.6310, 3.05, 0.042, 1018, 96, 
200, 4v45E, 0.6310, 3.05, 0.042, 1018, 96, 
201, 4v45D, 0.6310, 3.05, 0.042, 1018, 96, 
202, 4v41P, 0.6310, 3.05, 0.042, 1018, 96, 
203, 4v41O, 0.6310, 3.05, 0.042, 1018, 96, 
204, 4v41N, 0.6310, 3.05, 0.042, 1018, 96, 
205, 4v41M, 0.6310, 3.05, 0.042, 1018, 96, 
206, 4v41L, 0.6310, 3.05, 0.042, 1018, 96, 
207, 4v41K, 0.6310, 3.05, 0.042, 1018, 96, 
208, 4v41J, 0.6310, 3.05, 0.042, 1018, 96, 
209, 4v41I, 0.6310, 3.05, 0.042, 1018, 96, 
210, 4v41H, 0.6310, 3.05, 0.042, 1018, 96, 
211, 4v41G, 0.6310, 3.05, 0.042, 1018, 96, 
212, 4v41F, 0.6310, 3.05, 0.042, 1018, 96, 
213, 4v41E, 0.6310, 3.05, 0.042, 1018, 96, 
214, 4v41D, 0.6310, 3.05, 0.042, 1018, 96, 
215, 4v41C, 0.6310, 3.05, 0.042, 1018, 96, 
216, 4v41B, 0.6310, 3.05, 0.042, 1018, 96, 
217, 4v41A, 0.6310, 3.05, 0.042, 1018, 96, 
218, 4eirB, 0.6310, 3.62, 0.127, 222, 102, STRUCTURAL BASIS FOR SUBSTRATE TARGETING AND CATALYSIS BY FUNGAL POLYSACCHARIDE MONOOXYGENASES (PMO-2)
219, 4e0sA, 0.6310, 2.79, 0.099, 1552, 91, CRYSTAL STRUCTURE OF C5B-6
220, 3dymC, 0.6310, 3.14, 0.093, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (H418E)
221, 1px3A, 0.6310, 3.24, 0.052, 1010, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (G794A)
222, 1jz8A, 0.6310, 3.26, 0.052, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH ALLOLACTOSE
223, 1dp0C, 0.6310, 3.15, 0.093, 1011, 97, E. COLI BETA-GALACTOSIDASE AT 1.7 ANGSTROM
224, 6i2xC, 0.6309, 3.03, 0.108, 648, 93, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH SMALL MOLECULE INHIBITOR AND CVF 
225, 5tkiB, 0.6309, 3.46, 0.109, 223, 101, NEUROSPORA CRASSA POLYSACCHARIDE MONOOXYGENASE 2 RESTING STATE JOINT X-RAY/NEUTRON REFINEMENT
226, 5a1aD, 0.6309, 3.19, 0.052, 1022, 97, 2.2 A RESOLUTION CRYO-EM STRUCTURE OF BETA-GALACTOSIDASE IN COMPLEX WITH A CELL-PERMEANT INHIBITOR
227, 5a1aC, 0.6309, 3.19, 0.052, 1022, 97, 2.2 A RESOLUTION CRYO-EM STRUCTURE OF BETA-GALACTOSIDASE IN COMPLEX WITH A CELL-PERMEANT INHIBITOR
228, 5a1aB, 0.6309, 3.19, 0.052, 1022, 97, 2.2 A RESOLUTION CRYO-EM STRUCTURE OF BETA-GALACTOSIDASE IN COMPLEX WITH A CELL-PERMEANT INHIBITOR
229, 5a1aA, 0.6309, 3.19, 0.052, 1022, 97, 2.2 A RESOLUTION CRYO-EM STRUCTURE OF BETA-GALACTOSIDASE IN COMPLEX WITH A CELL-PERMEANT INHIBITOR
230, 1jywC, 0.6309, 3.16, 0.093, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH PNPG
231, 5nltC, 0.6307, 3.60, 0.059, 225, 102, CVAA9A
232, 4v40P, 0.6307, 3.07, 0.042, 1021, 96, 
233, 3t2oD, 0.6307, 3.16, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (S796D)
234, 3i3eA, 0.6307, 3.26, 0.052, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (M542A)
235, 1px4A, 0.6307, 3.27, 0.052, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (G794A) WITH IPTG BOUND
236, 6cvmD, 0.6306, 3.20, 0.052, 1021, 97, ATOMIC RESOLUTION CRYO-EM STRUCTURE OF BETA-GALACTOSIDASE 
237, 6cvmC, 0.6306, 3.20, 0.052, 1021, 97, ATOMIC RESOLUTION CRYO-EM STRUCTURE OF BETA-GALACTOSIDASE 
238, 6cvmB, 0.6306, 3.20, 0.052, 1021, 97, ATOMIC RESOLUTION CRYO-EM STRUCTURE OF BETA-GALACTOSIDASE 
239, 6cvmA, 0.6306, 3.20, 0.052, 1021, 97, ATOMIC RESOLUTION CRYO-EM STRUCTURE OF BETA-GALACTOSIDASE 
240, 3dypA, 0.6306, 3.26, 0.052, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (H418N)
241, 5tkfA, 0.6305, 3.47, 0.109, 223, 101, NEUROSPORA CRASSA POLYSACCHARIDE MONOOXYGENASE 2 HIGH MANNOSYLATION
242, 4v44P, 0.6305, 3.03, 0.042, 1018, 96, 
243, 4v44O, 0.6305, 3.03, 0.042, 1018, 96, 
244, 4v44N, 0.6305, 3.03, 0.042, 1018, 96, 
245, 4v44M, 0.6305, 3.03, 0.042, 1018, 96, 
246, 4v44L, 0.6305, 3.03, 0.042, 1018, 96, 
247, 4v44K, 0.6305, 3.03, 0.042, 1018, 96, 
248, 4v44J, 0.6305, 3.03, 0.042, 1018, 96, 
249, 4v44I, 0.6305, 3.03, 0.042, 1018, 96, 
250, 4v44H, 0.6305, 3.03, 0.042, 1018, 96, 
251, 4v44G, 0.6305, 3.03, 0.042, 1018, 96, 
252, 4v44F, 0.6305, 3.03, 0.042, 1018, 96, 
253, 4v44E, 0.6305, 3.03, 0.042, 1018, 96, 
254, 4v44D, 0.6305, 3.03, 0.042, 1018, 96, 
255, 4v44C, 0.6305, 3.03, 0.042, 1018, 96, 
256, 4v44B, 0.6305, 3.03, 0.042, 1018, 96, 
257, 4v44A, 0.6305, 3.03, 0.042, 1018, 96, 
258, 4v40H, 0.6305, 3.06, 0.042, 1021, 96, 
259, 4v40A, 0.6305, 3.03, 0.042, 1021, 96, 
260, 1dp0A, 0.6305, 3.27, 0.052, 1011, 97, E. COLI BETA-GALACTOSIDASE AT 1.7 ANGSTROM
261, 3vd7C, 0.6304, 3.22, 0.092, 1011, 98, E. COLI (LACZ) BETA-GALACTOSIDASE (N460S) IN COMPLEX WITH GALACTOTETRAZOLE
262, 1jz3A, 0.6304, 3.27, 0.052, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE-TRAPPED 2-DEOXY- GALACTOSYL ENZYME INTERMEDIATE
263, 1jz2B, 0.6304, 3.17, 0.093, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE-TRAPPED 2-F-GALACTOSYL- ENZYME INTERMEDIATE (ORTHORHOMBIC)
264, 3mv14, 0.6303, 3.16, 0.072, 1011, 97, E.COLI (LACZ) BETA-GALACTOSIDASE (R599A) IN COMPLEX WITH GUANIDINIUM
265, 1jz6A, 0.6302, 3.19, 0.093, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH GALACTO- TETRAZOLE
266, 1jz5C, 0.6302, 3.14, 0.093, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH D-GALCTOPYRANOSYL-1- ON
267, 1dp0B, 0.6302, 3.18, 0.093, 1011, 97, E. COLI BETA-GALACTOSIDASE AT 1.7 ANGSTROM
268, 3muy4, 0.6301, 3.16, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (R599A)
269, 1jywA, 0.6299, 3.26, 0.052, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH PNPG
270, 5tkfC, 0.6298, 3.48, 0.109, 223, 101, NEUROSPORA CRASSA POLYSACCHARIDE MONOOXYGENASE 2 HIGH MANNOSYLATION
271, 1jz5A, 0.6298, 3.15, 0.052, 1011, 96, E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH D-GALCTOPYRANOSYL-1- ON
272, 1jyvA, 0.6298, 3.27, 0.052, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH ONPG
273, 3tp4A, 0.6297, 2.90, 0.112, 452, 89, CRYSTAL STRUCTURE OF ENGINEERED PROTEIN AT THE RESOLUTION 1.98A NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET OR128
274, 3iaqA, 0.6297, 3.27, 0.052, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (E416V)
275, 3i3dC, 0.6296, 3.19, 0.093, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (M542A) IN COMPLEX WITH IPTG
276, 3dymA, 0.6296, 3.25, 0.052, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (H418E)
277, 1jyxA, 0.6296, 3.25, 0.093, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH IPTG
278, 1f4hD, 0.6296, 3.07, 0.042, 1021, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (ORTHORHOMBIC)
279, 5tkiA, 0.6295, 3.48, 0.109, 223, 101, NEUROSPORA CRASSA POLYSACCHARIDE MONOOXYGENASE 2 RESTING STATE JOINT X-RAY/NEUTRON REFINEMENT
280, 5tkhA, 0.6295, 3.62, 0.127, 223, 102, NEUROSPORA CRASSA POLYSACCHARIDE MONOOXYGENASE 2 ASCORBATE TREATED
281, 4jzjC, 0.6295, 2.85, 0.054, 250, 92, CRYSTAL STRUCTURE OF RECEPTOR-FAB COMPLEX
282, 5tkgB, 0.6293, 3.63, 0.118, 223, 102, NEUROSPORA CRASSA POLYSACCHARIDE MONOOXYGENASE 2 RESTING STATE
283, 4v40M, 0.6292, 3.04, 0.042, 1021, 96, 
284, 3mv01, 0.6291, 3.21, 0.093, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (R599A) IN COMPLEX WITH D- GALCTOPYRANOSYL-1-ONE
285, 4v40J, 0.6290, 3.07, 0.042, 1021, 96, 
286, 4v40D, 0.6290, 3.08, 0.042, 1021, 96, 
287, 4l0yA, 0.6290, 3.44, 0.146, 128, 96, CRYSTAL STRUCTURE OF RUNX1 AND ETS1 BOUND TO TCR ALPHA PROMOTER (CRYSTAL FORM 1)
288, 3t2oA, 0.6290, 3.15, 0.052, 1011, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (S796D)
289, 3wu1A, 0.6289, 3.36, 0.137, 123, 95, CRYSTAL STRUCTURE OF THE ETS1-RUNX1-DNA TERNARY COMPLEX
290, 3iaqD, 0.6288, 3.16, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (E416V)
291, 3muy1, 0.6287, 3.27, 0.052, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (R599A)
292, 1f4hC, 0.6286, 3.05, 0.042, 1021, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (ORTHORHOMBIC)
293, 5nltF, 0.6285, 3.61, 0.059, 223, 102, CVAA9A
294, 4v40E, 0.6284, 3.08, 0.042, 1021, 96, 
295, 1i82A, 0.6282, 3.08, 0.112, 189, 98, FAMILY 9 CARBOHYDRATE-BINDING MODULE FROM THERMOTOGA MARITIMA XYLANASE 10A WITH CELLOBIOSE
296, 5nltE, 0.6280, 3.62, 0.069, 225, 102, CVAA9A
297, 3vd7D, 0.6280, 3.22, 0.093, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (N460S) IN COMPLEX WITH GALACTOTETRAZOLE
298, 4duvA, 0.6278, 3.09, 0.041, 1019, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (G974A) 2-DEOXY-GALACTOSYL-ENZYME AND BIS-TRIS COMPLEX
299, 4v40I, 0.6277, 3.06, 0.042, 1021, 96, 
300, 5nltA, 0.6276, 3.49, 0.059, 223, 101, CVAA9A
301, 4v40K, 0.6276, 3.08, 0.042, 1021, 96, 
302, 4v40B, 0.6276, 3.05, 0.042, 1021, 96, 
303, 3prxA, 0.6273, 2.80, 0.077, 1626, 91, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH CVF AND SSL7
304, 1jyvD, 0.6273, 3.23, 0.093, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH ONPG
305, 4v40L, 0.6272, 3.26, 0.052, 1021, 97, 
306, 3prxC, 0.6272, 2.80, 0.077, 1626, 91, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH CVF AND SSL7
307, 3iapD, 0.6272, 3.23, 0.093, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (E416Q)
308, 3pvmA, 0.6270, 2.87, 0.109, 1627, 92, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH CVF
309, 3dyoA, 0.6270, 3.12, 0.041, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (H418N) IN COMPLEX WITH IPTG
310, 5nltB, 0.6269, 3.50, 0.059, 226, 101, CVAA9A
311, 4jzjD, 0.6269, 3.05, 0.075, 251, 93, CRYSTAL STRUCTURE OF RECEPTOR-FAB COMPLEX
312, 4ckdD, 0.6269, 3.08, 0.041, 1021, 97, MODEL OF COMPLEX BETWEEN THE E.COLI ENZYME BETA-GALACTOSIDASE AND FOUR SINGLE CHAIN FV ANTIBODY DOMAINS SCFV13R4.
313, 4ckdC, 0.6269, 3.08, 0.041, 1021, 97, MODEL OF COMPLEX BETWEEN THE E.COLI ENZYME BETA-GALACTOSIDASE AND FOUR SINGLE CHAIN FV ANTIBODY DOMAINS SCFV13R4.
314, 4ckdB, 0.6269, 3.07, 0.041, 1021, 97, MODEL OF COMPLEX BETWEEN THE E.COLI ENZYME BETA-GALACTOSIDASE AND FOUR SINGLE CHAIN FV ANTIBODY DOMAINS SCFV13R4.
315, 4ckdA, 0.6269, 3.08, 0.041, 1021, 97, MODEL OF COMPLEX BETWEEN THE E.COLI ENZYME BETA-GALACTOSIDASE AND FOUR SINGLE CHAIN FV ANTIBODY DOMAINS SCFV13R4.
316, 1f4aD, 0.6269, 3.08, 0.041, 1021, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (NCS CONSTRAINED MONOMER- ORTHORHOMBIC)
317, 1f4aC, 0.6269, 3.08, 0.041, 1021, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (NCS CONSTRAINED MONOMER- ORTHORHOMBIC)
318, 1f4aB, 0.6269, 3.08, 0.041, 1021, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (NCS CONSTRAINED MONOMER- ORTHORHOMBIC)
319, 1f4aA, 0.6269, 3.08, 0.041, 1021, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (NCS CONSTRAINED MONOMER- ORTHORHOMBIC)
320, 3mv02, 0.6268, 3.24, 0.052, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (R599A) IN COMPLEX WITH D- GALCTOPYRANOSYL-1-ONE
321, 3pvmC, 0.6267, 2.87, 0.109, 1627, 92, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH CVF
322, 3i3dA, 0.6267, 3.10, 0.041, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (M542A) IN COMPLEX WITH IPTG
323, 3dypD, 0.6267, 3.22, 0.093, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (H418N)
324, 4v40O, 0.6265, 3.10, 0.041, 1021, 97, 
325, 5nltD, 0.6262, 3.58, 0.069, 223, 102, CVAA9A
326, 1n26A, 0.6262, 2.67, 0.057, 299, 87, CRYSTAL STRUCTURE OF THE EXTRA-CELLULAR DOMAINS OF HUMAN INTERLEUKIN-6 RECEPTOR ALPHA CHAIN
327, 1hn1A, 0.6262, 3.08, 0.042, 1011, 96, E. COLI (LAC Z) BETA-GALACTOSIDASE (ORTHORHOMBIC)
328, 3czjA, 0.6261, 3.13, 0.041, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (N460T) IN COMPLEX WITH D- GALCTOPYRANOSYL-1-ONE
329, 1jz6C, 0.6260, 3.16, 0.103, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH GALACTO- TETRAZOLE
330, 3muz1, 0.6259, 3.22, 0.103, 1011, 97, E.COLI (LACZ) BETA-GALACTOSIDASE (R599A) IN COMPLEX WITH IPTG
331, 3iapA, 0.6259, 3.13, 0.041, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (E416Q)
332, 3i3dD, 0.6259, 3.11, 0.094, 1011, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (M542A) IN COMPLEX WITH IPTG
333, 1jz7A, 0.6259, 3.22, 0.052, 1010, 96, E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH GALACTOSE
334, 3vd5C, 0.6258, 3.10, 0.041, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (N460S)
335, 1jyxC, 0.6258, 3.10, 0.041, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH IPTG
336, 3mv13, 0.6257, 3.25, 0.052, 1011, 97, E.COLI (LACZ) BETA-GALACTOSIDASE (R599A) IN COMPLEX WITH GUANIDINIUM
337, 1jz2D, 0.6256, 3.21, 0.103, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE-TRAPPED 2-F-GALACTOSYL- ENZYME INTERMEDIATE (ORTHORHOMBIC)
338, 1hn1D, 0.6255, 3.24, 0.052, 1011, 97, E. COLI (LAC Z) BETA-GALACTOSIDASE (ORTHORHOMBIC)
339, 5uv8G, 0.6254, 2.79, 0.056, 265, 90, INTERLEUKIN-3 RECEPTOR COMPLEX
340, 4v40C, 0.6254, 3.11, 0.041, 1021, 97, 
341, 1jz8D, 0.6254, 3.28, 0.052, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH ALLOLACTOSE
342, 1f4hB, 0.6253, 3.12, 0.041, 1021, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (ORTHORHOMBIC)
343, 4duvC, 0.6250, 3.10, 0.041, 1018, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (G974A) 2-DEOXY-GALACTOSYL-ENZYME AND BIS-TRIS COMPLEX
344, 3vd3A, 0.6248, 3.26, 0.052, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (N460D)
345, 3i3bD, 0.6248, 3.26, 0.052, 1011, 97, E.COLI (LACZ) BETA-GALACTOSIDASE (M542A) IN COMPLEX WITH D- GALACTOPYRANOSYL-1-ON
346, 3mv11, 0.6247, 3.13, 0.041, 1011, 97, E.COLI (LACZ) BETA-GALACTOSIDASE (R599A) IN COMPLEX WITH GUANIDINIUM
347, 3iaqB, 0.6246, 3.10, 0.041, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (E416V)
348, 2icfA, 0.6246, 3.18, 0.095, 642, 95, CRIG BOUND TO C3B
349, 4fxgD, 0.6245, 2.86, 0.110, 651, 91, COMPLEMENT C4 IN COMPLEX WITH MASP-2
350, 3mv04, 0.6245, 3.27, 0.052, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (R599A) IN COMPLEX WITH D- GALCTOPYRANOSYL-1-ONE
351, 4l0zA, 0.6244, 3.36, 0.137, 147, 95, CRYSTAL STRUCTURE OF RUNX1 AND ETS1 BOUND TO TCR ALPHA PROMOTER (CRYSTAL FORM 2)
352, 3dtdE, 0.6244, 3.46, 0.081, 143, 99, CRYSTAL STRUCTURE OF INVASION ASSOCIATED PROTEIN B FROM BARTONELLA HENSELAE
353, 4duvB, 0.6241, 3.11, 0.041, 1018, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (G974A) 2-DEOXY-GALACTOSYL-ENZYME AND BIS-TRIS COMPLEX
354, 3vd5B, 0.6241, 3.11, 0.041, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (N460S)
355, 3tgxK, 0.6240, 2.69, 0.159, 209, 88, IL-21:IL21R COMPLEX
356, 3dtdB, 0.6240, 3.46, 0.081, 146, 99, CRYSTAL STRUCTURE OF INVASION ASSOCIATED PROTEIN B FROM BARTONELLA HENSELAE
357, 1hn1C, 0.6238, 3.10, 0.041, 1011, 97, E. COLI (LAC Z) BETA-GALACTOSIDASE (ORTHORHOMBIC)
358, 1hn1B, 0.6238, 3.09, 0.041, 1011, 97, E. COLI (LAC Z) BETA-GALACTOSIDASE (ORTHORHOMBIC)
359, 1f4hA, 0.6238, 3.12, 0.041, 1021, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (ORTHORHOMBIC)
360, 4v40G, 0.6234, 3.08, 0.042, 1021, 96, 
361, 4fxgA, 0.6234, 2.86, 0.110, 651, 91, COMPLEMENT C4 IN COMPLEX WITH MASP-2
362, 3dtdJ, 0.6234, 3.44, 0.081, 145, 99, CRYSTAL STRUCTURE OF INVASION ASSOCIATED PROTEIN B FROM BARTONELLA HENSELAE
363, 3tgxO, 0.6231, 2.70, 0.159, 208, 88, IL-21:IL21R COMPLEX
364, 3tgxM, 0.6231, 2.70, 0.159, 208, 88, IL-21:IL21R COMPLEX
365, 2vzsA, 0.6231, 3.74, 0.109, 857, 101, CHITOSAN PRODUCT COMPLEX OF AMYCOLATOPSIS ORIENTALIS EXO- CHITOSANASE CSXA
366, 1px3D, 0.6231, 3.22, 0.103, 1008, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (G794A)
367, 3dtdD, 0.6230, 3.49, 0.081, 145, 99, CRYSTAL STRUCTURE OF INVASION ASSOCIATED PROTEIN B FROM BARTONELLA HENSELAE
368, 3tgxI, 0.6229, 2.71, 0.159, 209, 88, IL-21:IL21R COMPLEX
369, 4duvD, 0.6228, 3.13, 0.041, 1018, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (G974A) 2-DEOXY-GALACTOSYL-ENZYME AND BIS-TRIS COMPLEX
370, 3dymD, 0.6228, 3.14, 0.041, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (H418E)
371, 3dtdK, 0.6228, 3.46, 0.081, 145, 99, CRYSTAL STRUCTURE OF INVASION ASSOCIATED PROTEIN B FROM BARTONELLA HENSELAE
372, 1jz7C, 0.6228, 3.18, 0.052, 1010, 96, E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH GALACTOSE
373, 3czjD, 0.6227, 3.15, 0.041, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (N460T) IN COMPLEX WITH D- GALCTOPYRANOSYL-1-ONE
374, 1jz5D, 0.6227, 3.14, 0.041, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH D-GALCTOPYRANOSYL-1- ON
375, 1jibA, 0.6226, 2.53, 0.058, 585, 86, COMPLEX OF ALPHA-AMYLASE II (TVA II) FROM THERMOACTINOMYCES VULGARIS R-47 WITH MALTOTETRAOSE BASED ON A CRYSTAL SOAKED WITH MALTOHEXAOSE.
376, 1vb9A, 0.6225, 2.55, 0.058, 585, 86, CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA- AMYLASE II (TVA II) COMPLEXED WITH TRANSGLYCOSYLATED PRODUCT
377, 3vd3D, 0.6224, 3.20, 0.052, 1011, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (N460D)
378, 2x09A, 0.6224, 3.73, 0.109, 850, 101, INHIBITION OF THE EXO-BETA-D-GLUCOSAMINIDASE CSXA BY A GLUCOSAMINE-CONFIGURED CASTANOSPERMINE AND AN AMINO- AUSTRALINE ANALOGUE
379, 2x05B, 0.6224, 3.73, 0.109, 851, 101, INHIBITION OF THE EXO-BETA-D-GLUCOSAMINIDASE CSXA BY A GLUCOSAMINE-CONFIGURED CASTANOSPERMINE AND AN AMINO- AUSTRALINE ANALOGUE
380, 4uytA, 0.6223, 3.23, 0.084, 177, 95, X-RAY STRUCTURE OF THE N-TERMINAL DOMAIN OF THE FLOCCULIN FLO11 FROM SACCHAROMYCES CEREVISIAE
381, 3tgxC, 0.6223, 2.71, 0.159, 209, 88, IL-21:IL21R COMPLEX
382, 3dtdI, 0.6223, 3.47, 0.081, 145, 99, CRYSTAL STRUCTURE OF INVASION ASSOCIATED PROTEIN B FROM BARTONELLA HENSELAE
383, 1jz3D, 0.6223, 3.14, 0.041, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE-TRAPPED 2-DEOXY- GALACTOSYL ENZYME INTERMEDIATE
384, 2iceD, 0.6222, 3.31, 0.095, 630, 95, CRIG BOUND TO C3C
385, 2vzuA, 0.6221, 3.74, 0.109, 850, 101, COMPLEX OF AMYCOLATOPSIS ORIENTALIS EXO-CHITOSANASE CSXA D469A WITH PNP-BETA-D-GLUCOSAMINE
386, 2x05A, 0.6220, 3.74, 0.109, 851, 101, INHIBITION OF THE EXO-BETA-D-GLUCOSAMINIDASE CSXA BY A GLUCOSAMINE-CONFIGURED CASTANOSPERMINE AND AN AMINO- AUSTRALINE ANALOGUE
387, 2iceA, 0.6220, 3.31, 0.095, 642, 95, CRIG BOUND TO C3C
388, 1vb9B, 0.6220, 2.49, 0.058, 585, 86, CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA- AMYLASE II (TVA II) COMPLEXED WITH TRANSGLYCOSYLATED PRODUCT
389, 2vzoB, 0.6219, 3.74, 0.109, 848, 101, CRYSTAL STRUCTURE OF AMYCOLATOPSIS ORIENTALIS EXO- CHITOSANASE CSXA
390, 3dtdF, 0.6218, 3.49, 0.081, 142, 99, CRYSTAL STRUCTURE OF INVASION ASSOCIATED PROTEIN B FROM BARTONELLA HENSELAE
391, 2vztA, 0.6218, 3.74, 0.109, 850, 101, COMPLEX OF AMYCOLATOPSIS ORIENTALIS EXO-CHITOSANASE CSXA E541A WITH PNP-BETA-D-GLUCOSAMINE
392, 2vzsB, 0.6218, 3.73, 0.109, 857, 101, CHITOSAN PRODUCT COMPLEX OF AMYCOLATOPSIS ORIENTALIS EXO- CHITOSANASE CSXA
393, 3tgxG, 0.6217, 2.71, 0.159, 209, 88, IL-21:IL21R COMPLEX
394, 3dtdL, 0.6217, 3.49, 0.081, 145, 99, CRYSTAL STRUCTURE OF INVASION ASSOCIATED PROTEIN B FROM BARTONELLA HENSELAE
395, 2wiiA, 0.6216, 3.32, 0.094, 640, 96, COMPLEMENT C3B IN COMPLEX WITH FACTOR H DOMAINS 1-4
396, 2vzuB, 0.6216, 3.74, 0.109, 850, 101, COMPLEX OF AMYCOLATOPSIS ORIENTALIS EXO-CHITOSANASE CSXA D469A WITH PNP-BETA-D-GLUCOSAMINE
397, 2d2oB, 0.6216, 2.49, 0.058, 585, 86, STRUCTURE OF A COMPLEX OF THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE 2 WITH MALTOHEXAOSE DEMONSTRATES THE IMPORTANT ROLE OF AROMATIC RESIDUES AT THE REDUCING END OF THE SUBSTRATE BINDING CLEFT
398, 3tgxE, 0.6215, 2.71, 0.159, 207, 88, IL-21:IL21R COMPLEX
399, 3tgxA, 0.6215, 2.72, 0.159, 208, 88, IL-21:IL21R COMPLEX
400, 4lp8A, 0.6213, 3.39, 0.105, 283, 95, A NOVEL OPEN-STATE CRYSTAL STRUCTURE OF THE PROKARYOTIC INWARD RECTIFIER KIRBAC3.1
401, 2vzoA, 0.6213, 3.74, 0.109, 850, 101, CRYSTAL STRUCTURE OF AMYCOLATOPSIS ORIENTALIS EXO- CHITOSANASE CSXA
402, 3dtdA, 0.6212, 3.49, 0.081, 142, 99, CRYSTAL STRUCTURE OF INVASION ASSOCIATED PROTEIN B FROM BARTONELLA HENSELAE
403, 2vztB, 0.6212, 3.74, 0.109, 850, 101, COMPLEX OF AMYCOLATOPSIS ORIENTALIS EXO-CHITOSANASE CSXA E541A WITH PNP-BETA-D-GLUCOSAMINE
404, 1xl4A, 0.6210, 3.38, 0.095, 289, 95, INTERMEDIATE GATING STRUCTURE 1 OF THE INWARDLY RECTIFYING K+ CHANNEL KIRBAC3.1
405, 5fobA, 0.6209, 3.18, 0.096, 642, 94, CRYSTAL STRUCTURE OF HUMAN COMPLEMENT C3B IN COMPLEX WITH SMALLPOX INHIBITOR OF COMPLEMENT (SPICE)
406, 3dtdH, 0.6209, 3.50, 0.081, 146, 99, CRYSTAL STRUCTURE OF INVASION ASSOCIATED PROTEIN B FROM BARTONELLA HENSELAE
407, 5i0fB, 0.6208, 2.78, 0.070, 729, 86, CYCLOALTERNAN-DEGRADING ENZYME FROM TRUEPERELLA PYOGENES IN COMPLEX WITH COVALENT INTERMEDIATE
408, 4uyrA, 0.6208, 3.25, 0.084, 188, 95, X-RAY STRUCTURE OF THE N-TERMINAL DOMAIN OF THE FLOCCULIN FLO11 FROM SACCHAROMYCES CEREVISIAE
409, 4lnvC, 0.6208, 2.96, 0.044, 1276, 90, CRYSTAL STRUCTURE OF TEP1S
410, 4lnvA, 0.6208, 2.96, 0.044, 1276, 90, CRYSTAL STRUCTURE OF TEP1S
411, 1e50G, 0.6208, 3.38, 0.149, 119, 94, AML1/CBF COMPLEX
412, 2wljA, 0.6207, 3.38, 0.095, 282, 95, POTASSIUM CHANNEL FROM MAGNETOSPIRILLUM MAGNETOTACTICUM
413, 3vd5D, 0.6206, 3.16, 0.041, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (N460S)
414, 2x09B, 0.6206, 3.74, 0.109, 850, 101, INHIBITION OF THE EXO-BETA-D-GLUCOSAMINIDASE CSXA BY A GLUCOSAMINE-CONFIGURED CASTANOSPERMINE AND AN AMINO- AUSTRALINE ANALOGUE
415, 2wliA, 0.6206, 3.40, 0.095, 283, 95, POTASSIUM CHANNEL FROM MAGNETOSPIRILLUM MAGNETOTACTICUM
416, 1g1yB, 0.6205, 2.55, 0.058, 585, 86, CRYSTAL STRUCTURE OF ALPHA-AMYLASE II (TVAII) FROM THERMOACTINOMYCES VULGARIS R-47 AND BETA-CYCLODEXTRIN COMPLEX
417, 1jf6B, 0.6204, 2.50, 0.058, 585, 86, CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA- AMYLASE MUTANT F286Y
418, 6byiA, 0.6202, 2.80, 0.045, 859, 88, CRYSTAL STRUCTURE OF THE ACID-BASE MUTANT (E477A) OF THE GH2 EXO-BETA- MANNANASE FROM XANTHOMONAS AXONOPODIS PV. CITRI 
419, 6byiB, 0.6201, 2.81, 0.045, 859, 88, CRYSTAL STRUCTURE OF THE ACID-BASE MUTANT (E477A) OF THE GH2 EXO-BETA- MANNANASE FROM XANTHOMONAS AXONOPODIS PV. CITRI 
420, 5acfA, 0.6200, 3.70, 0.078, 234, 102, X-RAY STRUCTURE OF LPMO
421, 3dtdG, 0.6200, 3.48, 0.081, 143, 99, CRYSTAL STRUCTURE OF INVASION ASSOCIATED PROTEIN B FROM BARTONELLA HENSELAE
422, 2xwjG, 0.6200, 3.50, 0.093, 640, 97, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTOR B
423, 2xwjC, 0.6200, 3.50, 0.093, 640, 97, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTOR B
424, 2xwjA, 0.6200, 3.50, 0.093, 640, 97, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTOR B
425, 1jz6D, 0.6200, 3.15, 0.041, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH GALACTO- TETRAZOLE
426, 2xwjE, 0.6199, 3.50, 0.093, 640, 97, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTOR B
427, 3wtvA, 0.6198, 3.13, 0.130, 118, 92, CRYSTAL STRUCTURE OF THE COMPLEX COMPRISED OF ETS1(V170G) RUNX1 CBFBETA AND THE TCRALPHA GENE ENHANCER DNA
428, 5acgA, 0.6197, 3.70, 0.078, 234, 102, X-RAY STRUCTURE OF LPMO
429, 3dtdC, 0.6197, 3.50, 0.081, 147, 99, CRYSTAL STRUCTURE OF INVASION ASSOCIATED PROTEIN B FROM BARTONELLA HENSELAE
430, 1wzmB, 0.6197, 2.52, 0.058, 585, 86, THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE II (TVA II) MUTATNT R469K
431, 3wttA, 0.6196, 3.13, 0.130, 119, 92, CRYSTAL STRUCTURE OF THE COMPLEX COMPRISED OF PHOSPHORYLATED ETS1 RUNX1 CBFBETA AND THE TCRALPHA GENE ENHANCER DNA
432, 1jz7B, 0.6196, 3.06, 0.042, 1010, 96, E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH GALACTOSE
433, 1e50C, 0.6195, 3.33, 0.138, 125, 94, AML1/CBF COMPLEX
434, 2vzvA, 0.6194, 3.77, 0.099, 857, 101, SUBSTRATE COMPLEX OF AMYCOLATOPSIS ORIENTALIS EXO- CHITOSANASE CSXA E541A WITH CHITOSAN
435, 1r4xA, 0.6194, 3.31, 0.032, 273, 95, CRYSTAL STRUCTURE ANALYS OF THE GAMMA-COPI APPENDAGE DOMAIN
436, 5nlrA, 0.6193, 3.69, 0.078, 234, 102, AUXILIARY ACTIVITY 9
437, 5n04A, 0.6193, 3.69, 0.078, 234, 102, X-RAY CRYSTAL STRUCTURE OF AN LPMO
438, 2f08A, 0.6193, 3.21, 0.095, 129, 95, CRYSTAL STRUCTURE OF A MAJOR HOUSE DUST MITE ALLERGEN DERF 2 2
439, 2d2oA, 0.6193, 2.50, 0.058, 585, 86, STRUCTURE OF A COMPLEX OF THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE 2 WITH MALTOHEXAOSE DEMONSTRATES THE IMPORTANT ROLE OF AROMATIC RESIDUES AT THE REDUCING END OF THE SUBSTRATE BINDING CLEFT
440, 1e50A, 0.6193, 3.25, 0.149, 115, 94, AML1/CBF COMPLEX
441, 1vfoB, 0.6192, 2.51, 0.058, 585, 86, CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA- AMYLASE 2/BETA-CYCLODEXTRIN COMPLEX
442, 6enyC, 0.6191, 3.14, 0.042, 364, 95, STRUCTURE OF THE HUMAN PLC EDITING MODULE
443, 2vzvB, 0.6191, 3.73, 0.099, 857, 101, SUBSTRATE COMPLEX OF AMYCOLATOPSIS ORIENTALIS EXO- CHITOSANASE CSXA E541A WITH CHITOSAN
444, 1bvzA, 0.6190, 2.49, 0.070, 585, 86, ALPHA-AMYLASE II (TVAII) FROM THERMOACTINOMYCES VULGARIS R- 47
445, 6nfqB, 0.6189, 2.62, 0.082, 97, 85, COPC FROM PSEUDOMONAS FLUORESCENS 
446, 5m6wG, 0.6189, 3.39, 0.094, 645, 96, PROPERDIN IN COMPLEX WITH ALTERNATIVE PATHWAY C3 CONVERTASE
447, 3wtuA, 0.6188, 3.16, 0.130, 118, 92, CRYSTAL STRUCTURE OF THE COMPLEX COMPRISED OF ETS1 (V170A) RUNX1 CBFBETA AND THE TCRALPHA GENE ENHANCER DNA
448, 5fo9D, 0.6187, 3.30, 0.095, 642, 95, CRYSTAL STRUCTURE OF HUMAN COMPLEMENT C3B IN COMPLEX WITH CR1 (CCP15-17)
449, 3l5nA, 0.6187, 3.45, 0.112, 634, 98, STAPHYLOCOCCAL COMPLEMENT INHIBITOR (SCIN) IN COMPLEX WITH HUMAN COMPLEMENT COMPONENT C3B
450, 3a6oB, 0.6187, 2.52, 0.058, 585, 86, CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA- AMYLASE 2/ACARBOSE COMPLEX
451, 5acjA, 0.6186, 3.71, 0.078, 234, 102, X-RAY STRUCTURE OF LPMO
452, 3wtsA, 0.6186, 3.16, 0.130, 119, 92, CRYSTAL STRUCTURE OF THE COMPLEX COMPRISED OF ETS1 RUNX1 CBFBETA AND THE TCRALPHA GENE ENHANCER DNA
453, 5foaA, 0.6185, 3.35, 0.094, 642, 96, CRYSTAL STRUCTURE OF HUMAN COMPLEMENT C3B IN COMPLEX WITH DAF (CCP2-4)
454, 4uysA, 0.6185, 3.29, 0.084, 177, 95, X-RAY STRUCTURE OF THE N-TERMINAL DOMAIN OF THE FLOCCULIN FLO11 FROM SACCHAROMYCES CEREVISIAE
455, 3a6oA, 0.6185, 2.59, 0.058, 585, 86, CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA- AMYLASE 2/ACARBOSE COMPLEX
456, 1jl8A, 0.6184, 2.50, 0.058, 585, 86, COMPLEX OF ALPHA-AMYLASE II (TVA II) FROM THERMOACTINOMYCES VULGARIS R-47 WITH BETA-CYCLODEXTRIN BASED ON A CO- CRYSTALLIZATION WITH METHYL BETA-CYCLODEXTRIN
457, 1bvzB, 0.6184, 2.50, 0.058, 585, 86, ALPHA-AMYLASE II (TVAII) FROM THERMOACTINOMYCES VULGARIS R- 47
458, 5n05A, 0.6183, 3.62, 0.059, 234, 102, X-RAY CRYSTAL STRUCTURE OF AN LPMO
459, 5achA, 0.6182, 3.63, 0.059, 234, 102, X-RAY STRUCTURE OF LPMO
460, 1jibB, 0.6181, 2.51, 0.058, 585, 86, COMPLEX OF ALPHA-AMYLASE II (TVA II) FROM THERMOACTINOMYCES VULGARIS R-47 WITH MALTOTETRAOSE BASED ON A CRYSTAL SOAKED WITH MALTOHEXAOSE.
461, 1h9dA, 0.6181, 3.10, 0.141, 125, 92, AML1/CBF-BETA/DNA COMPLEX
462, 2wlnE, 0.6180, 3.42, 0.105, 283, 95, POTASSIUM CHANNEL FROM MAGNETOSPIRILLUM MAGNETOTACTICUM
463, 2wlnC, 0.6180, 3.42, 0.105, 283, 95, POTASSIUM CHANNEL FROM MAGNETOSPIRILLUM MAGNETOTACTICUM
464, 1xl6A, 0.6180, 3.45, 0.095, 291, 95, INTERMEDIATE GATING STRUCTURE 2 OF THE INWARDLY RECTIFYING K+ CHANNEL KIRBAC3.1
465, 1wzmA, 0.6180, 2.50, 0.058, 585, 86, THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE II (TVA II) MUTATNT R469K
466, 5nkwA, 0.6179, 3.63, 0.059, 234, 102, X-RAY CRYSTAL STRUCTURE OF AN AA9 LPMO
467, 5nlqA, 0.6178, 3.64, 0.059, 234, 102, AUXILIARY ACTIVITY 9
468, 5foaC, 0.6178, 3.25, 0.095, 642, 95, CRYSTAL STRUCTURE OF HUMAN COMPLEMENT C3B IN COMPLEX WITH DAF (CCP2-4)
469, 2x6bA, 0.6178, 3.42, 0.084, 287, 95, POTASSIUM CHANNEL FROM MAGNETOSPIRILLUM MAGNETOTACTICUM
470, 2x6aA, 0.6178, 3.40, 0.105, 274, 95, POTASSIUM CHANNEL FROM MAGNETOSPIRILLUM MAGNETOTACTICUM
471, 2wlnG, 0.6178, 3.42, 0.105, 283, 95, POTASSIUM CHANNEL FROM MAGNETOSPIRILLUM MAGNETOTACTICUM
472, 2wlnD, 0.6178, 3.43, 0.105, 283, 95, POTASSIUM CHANNEL FROM MAGNETOSPIRILLUM MAGNETOTACTICUM
473, 2wlhA, 0.6178, 3.41, 0.105, 283, 95, POTASSIUM CHANNEL FROM MAGNETOSPIRILLUM MAGNETOTACTICUM
474, 1wzkA, 0.6178, 2.50, 0.058, 585, 86, THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE II (TVA II) MUTATNT D465N
475, 1ji2B, 0.6178, 2.53, 0.058, 585, 86, IMPROVED X-RAY STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA- AMYLASE 2
476, 5nlpA, 0.6177, 3.64, 0.059, 234, 102, AUXILIARY ACTIVITY 9
477, 2wloA, 0.6177, 3.41, 0.105, 283, 95, POTASSIUM CHANNEL FROM MAGNETOSPIRILLUM MAGNETOTACTICUM
478, 2wlnH, 0.6177, 3.42, 0.105, 283, 95, POTASSIUM CHANNEL FROM MAGNETOSPIRILLUM MAGNETOTACTICUM
479, 1vfoA, 0.6176, 2.50, 0.058, 585, 86, CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA- AMYLASE 2/BETA-CYCLODEXTRIN COMPLEX
480, 1jf5B, 0.6176, 2.53, 0.058, 585, 86, CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA- AMYLASE 2 MUTANT F286A
481, 1hjcA, 0.6176, 3.07, 0.130, 118, 92, CRYSTAL STRUCTURE OF RUNX-1/AML1/CBFALPHA RUNT DOMAIN BOUND TO A DNA FRAGMENT FROM THE CSF-1R PROMOTER
482, 3wtxA, 0.6175, 3.17, 0.130, 118, 92, CRYSTAL STRUCTURE OF THE COMPLEX COMPRISED OF ETS1(Y329A) RUNX1 CBFBETA AND THE TCRALPHA GENE ENHANCER DNA
483, 1hjbF, 0.6175, 3.11, 0.130, 120, 92, CRYSTAL STRUCTURE OF RUNX-1/AML1/CBFALPHA RUNT DOMAIN AND C/EBPBETA BZIP DIMERIC   BOUND TO A DNA FRAGMENT FROM THE CSF-1R PROMOTER
484, 5nlnA, 0.6174, 3.65, 0.059, 234, 102, AUXILIARY ACTIVITY 9
485, 5aciA, 0.6174, 3.64, 0.059, 234, 102, X-RAY STRUCTURE OF LPMO
486, 4aefA, 0.6174, 3.02, 0.090, 636, 89, THE CRYSTAL STRUCTURE OF THERMOSTABLE AMYLASE FROM THE PYROCOCCUS
487, 5o32A, 0.6173, 3.26, 0.095, 640, 95, THE STRUCTURE OF COMPLEMENT COMPLEX
488, 2wlnB, 0.6172, 3.43, 0.095, 283, 95, POTASSIUM CHANNEL FROM MAGNETOSPIRILLUM MAGNETOTACTICUM
489, 1wzlB, 0.6172, 2.54, 0.058, 585, 86, THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE II (TVA II) MUTATNT R469L
490, 1jz7D, 0.6172, 3.10, 0.042, 1010, 96, E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH GALACTOSE
491, 4aefB, 0.6171, 3.03, 0.090, 636, 89, THE CRYSTAL STRUCTURE OF THERMOSTABLE AMYLASE FROM THE PYROCOCCUS
492, 3wtyA, 0.6171, 3.18, 0.130, 118, 92, CRYSTAL STRUCTURE OF THE COMPLEX COMPRISED OF ETS1(G333P) RUNX1 CBFBETA AND THE TCRALPHA GENE ENHANCER DNA
493, 3wtuF, 0.6171, 3.19, 0.129, 118, 93, CRYSTAL STRUCTURE OF THE COMPLEX COMPRISED OF ETS1 (V170A) RUNX1 CBFBETA AND THE TCRALPHA GENE ENHANCER DNA
494, 3nmsA, 0.6171, 3.53, 0.110, 641, 100, STAPHYLOCOCCAL COMPLEMENT INHIBITOR (SCIN) IN COMPLEX WITH HUMAN COMPLEMENT C3C
495, 2x6cA, 0.6171, 3.47, 0.095, 264, 95, POTASSIUM CHANNEL FROM MAGNETOSPIRILLUM MAGNETOTACTICUM
496, 2a74A, 0.6171, 3.19, 0.105, 630, 95, HUMAN COMPLEMENT COMPONENT C3C
497, 3l3oD, 0.6170, 3.53, 0.110, 639, 100, STAPHYLOCOCCAL COMPLEMENT INHIBITOR (SCIN) IN COMPLEX WITH HUMAN COMPLEMENT COMPONENT C3C
498, 3l3oA, 0.6170, 3.53, 0.110, 639, 100, STAPHYLOCOCCAL COMPLEMENT INHIBITOR (SCIN) IN COMPLEX WITH HUMAN COMPLEMENT COMPONENT C3C
499, 1vfmA, 0.6170, 2.51, 0.058, 585, 86, CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA- AMYLASE 2/ALPHA-CYCLODEXTRIN COMPLEX
500, 2wlmC, 0.6169, 3.44, 0.105, 279, 95, POTASSIUM CHANNEL FROM MAGNETOSPIRILLUM MAGNETOTACTICUM
501, 3wtwA, 0.6168, 3.18, 0.130, 118, 92, CRYSTAL STRUCTURE OF THE COMPLEX COMPRISED OF ETS1(K167A) RUNX1 CBFBETA AND THE TCRALPHA GENE ENHANCER DNA
502, 3wtvF, 0.6168, 3.20, 0.129, 118, 93, CRYSTAL STRUCTURE OF THE COMPLEX COMPRISED OF ETS1(V170G) RUNX1 CBFBETA AND THE TCRALPHA GENE ENHANCER DNA
503, 3ohxD, 0.6168, 3.54, 0.110, 641, 100, MOLECULAR BASIS FOR COMPLEMENT RECOGNITION AND INHIBITION DETERMINED BY CRYSTALLOGRAPHIC STUDIES OF THE STAPHYLOCOCCAL COMPLEMENT INHIBITOR (SCIN) BOUND TO C3C AND C3B
504, 3ohxA, 0.6168, 3.54, 0.110, 641, 100, MOLECULAR BASIS FOR COMPLEMENT RECOGNITION AND INHIBITION DETERMINED BY CRYSTALLOGRAPHIC STUDIES OF THE STAPHYLOCOCCAL COMPLEMENT INHIBITOR (SCIN) BOUND TO C3C AND C3B
505, 1vfuB, 0.6168, 2.51, 0.058, 585, 86, CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 AMYLASE 2/GAMMA-CYCLODEXTRIN COMPLEX
506, 1jl8B, 0.6168, 2.53, 0.058, 585, 86, COMPLEX OF ALPHA-AMYLASE II (TVA II) FROM THERMOACTINOMYCES VULGARIS R-47 WITH BETA-CYCLODEXTRIN BASED ON A CO- CRYSTALLIZATION WITH METHYL BETA-CYCLODEXTRIN
507, 5f7sA, 0.6167, 2.95, 0.058, 701, 86, CYCLOALTERNAN-DEGRADING ENZYME FROM TRUEPERELLA PYOGENES
508, 1e50E, 0.6167, 3.23, 0.129, 119, 93, AML1/CBF COMPLEX
509, 4u48A, 0.6166, 3.48, 0.105, 1516, 95, CRYSTAL STRUCTURE OF SALMONELLA ALPHA-2-MACROGLOBULIN
510, 3wtwF, 0.6166, 3.21, 0.129, 119, 93, CRYSTAL STRUCTURE OF THE COMPLEX COMPRISED OF ETS1(K167A) RUNX1 CBFBETA AND THE TCRALPHA GENE ENHANCER DNA
511, 3wtsF, 0.6166, 3.21, 0.129, 118, 93, CRYSTAL STRUCTURE OF THE COMPLEX COMPRISED OF ETS1 RUNX1 CBFBETA AND THE TCRALPHA GENE ENHANCER DNA
512, 1wzlA, 0.6166, 2.55, 0.057, 585, 87, THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE II (TVA II) MUTATNT R469L
513, 5nloA, 0.6165, 3.65, 0.059, 234, 102, AUXILIARY ACTIVITY 9
514, 3hrzA, 0.6165, 3.66, 0.079, 614, 101, COBRA VENOM FACTOR (CVF) IN COMPLEX WITH HUMAN FACTOR B
515, 2wlnA, 0.6165, 3.45, 0.084, 283, 95, POTASSIUM CHANNEL FROM MAGNETOSPIRILLUM MAGNETOTACTICUM
516, 2wlkA, 0.6165, 3.45, 0.095, 289, 95, STRUCTURE OF THE ATP-SENSITIVE INWARD RECTIFIER POTASSIUM CHANNEL FROM MAGNETOSPIRILLUM MAGNETOTACTICUM
517, 3cu7B, 0.6164, 2.89, 0.109, 1481, 92, HUMAN COMPLEMENT COMPONENT 5
518, 3cu7A, 0.6164, 2.89, 0.109, 1625, 92, HUMAN COMPLEMENT COMPONENT 5
519, 1ji2A, 0.6164, 2.55, 0.057, 585, 87, IMPROVED X-RAY STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA- AMYLASE 2
520, 4jpqA, 0.6163, 3.31, 0.031, 214, 97, CRYSTAL STRUCTURE OF A PUTATIVE CARBOHYDRATE-BINDING PROTEIN (BACUNI_03838) FROM BACTEROIDES UNIFORMIS ATCC 8492 AT 2.70 A RESOLUTION
521, 3hs0A, 0.6163, 3.09, 0.064, 613, 94, COBRA VENOM FACTOR (CVF) IN COMPLEX WITH HUMAN FACTOR B
522, 2i07A, 0.6163, 3.26, 0.095, 630, 95, HUMAN COMPLEMENT COMPONENT C3B
523, 5nlsA, 0.6162, 3.66, 0.059, 234, 102, AUXILIARY ACTIVITY 9
524, 2a7bA, 0.6161, 3.31, 0.094, 120, 96, ON THE ROUTINE USE OF SOFT X-RAYS IN MACROMOLECULAR CRYSTALLOGRAPHY PART III- THE OPTIMAL DATA COLLECTION WAVELENGTH
525, 1jf6A, 0.6161, 2.53, 0.058, 585, 86, CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA- AMYLASE MUTANT F286Y
526, 4jpqB, 0.6160, 3.31, 0.031, 213, 97, CRYSTAL STRUCTURE OF A PUTATIVE CARBOHYDRATE-BINDING PROTEIN (BACUNI_03838) FROM BACTEROIDES UNIFORMIS ATCC 8492 AT 2.70 A RESOLUTION
527, 5t99B, 0.6159, 3.55, 0.074, 756, 94, CRYSTAL STRUCTURE OF BUGH2AWT IN COMPLEX WITH GALACTOISOFAGOMINE
528, 3wtyF, 0.6158, 3.21, 0.129, 118, 93, CRYSTAL STRUCTURE OF THE COMPLEX COMPRISED OF ETS1(G333P) RUNX1 CBFBETA AND THE TCRALPHA GENE ENHANCER DNA
529, 3hs0F, 0.6158, 3.45, 0.071, 617, 98, COBRA VENOM FACTOR (CVF) IN COMPLEX WITH HUMAN FACTOR B
530, 2wlkB, 0.6158, 3.46, 0.095, 289, 95, STRUCTURE OF THE ATP-SENSITIVE INWARD RECTIFIER POTASSIUM CHANNEL FROM MAGNETOSPIRILLUM MAGNETOTACTICUM
531, 1vfmB, 0.6158, 2.53, 0.058, 585, 86, CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA- AMYLASE 2/ALPHA-CYCLODEXTRIN COMPLEX
532, 5t98B, 0.6157, 3.49, 0.074, 755, 94, CRYSTAL STRUCTURE OF BUGH2AWT
533, 2wlmB, 0.6156, 3.43, 0.084, 279, 95, POTASSIUM CHANNEL FROM MAGNETOSPIRILLUM MAGNETOTACTICUM
534, 3wttF, 0.6154, 3.22, 0.129, 118, 93, CRYSTAL STRUCTURE OF THE COMPLEX COMPRISED OF PHOSPHORYLATED ETS1 RUNX1 CBFBETA AND THE TCRALPHA GENE ENHANCER DNA
535, 2wlmD, 0.6154, 3.43, 0.084, 279, 95, POTASSIUM CHANNEL FROM MAGNETOSPIRILLUM MAGNETOTACTICUM
536, 1h9dC, 0.6154, 3.21, 0.151, 125, 93, AML1/CBF-BETA/DNA COMPLEX
537, 3besR, 0.6152, 2.83, 0.043, 250, 92, STRUCTURE OF A POXVIRUS IFNGBP/IFNG COMPLEX
538, 3syqA, 0.6151, 3.07, 0.085, 292, 94, CRYSTAL STRUCTURE OF THE G PROTEIN-GATED INWARD RECTIFIER K+ CHANNEL GIRK2 (KIR3.2) R201A MUTANT IN COMPLEX WITH PIP2
539, 4uj6A, 0.6150, 2.59, 0.034, 711, 88, STRUCTURE OF SURFACE LAYER PROTEIN SBSC DOMAINS 1-6
540, 4n6rB, 0.6150, 3.38, 0.061, 198, 99, CRYSTAL STRUCTURE OF VOSA-VELB-COMPLEX
541, 1jf5A, 0.6150, 2.57, 0.057, 585, 87, CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA- AMYLASE 2 MUTANT F286A
542, 3prxB, 0.6149, 3.33, 0.073, 1215, 96, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH CVF AND SSL7
543, 1xl6B, 0.6149, 3.46, 0.095, 291, 95, INTERMEDIATE GATING STRUCTURE 2 OF THE INWARDLY RECTIFYING K+ CHANNEL KIRBAC3.1
544, 3prxD, 0.6148, 3.49, 0.062, 1215, 97, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH CVF AND SSL7
545, 2xwbC, 0.6148, 3.57, 0.110, 640, 100, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTORS B AND D
546, 2xwbA, 0.6148, 3.57, 0.110, 640, 100, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTORS B AND D
547, 3wtxF, 0.6147, 3.22, 0.129, 118, 93, CRYSTAL STRUCTURE OF THE COMPLEX COMPRISED OF ETS1(Y329A) RUNX1 CBFBETA AND THE TCRALPHA GENE ENHANCER DNA
548, 5fo9A, 0.6146, 3.46, 0.112, 642, 98, CRYSTAL STRUCTURE OF HUMAN COMPLEMENT C3B IN COMPLEX WITH CR1 (CCP15-17)
549, 3zrsA, 0.6145, 3.45, 0.095, 280, 95, X-RAY CRYSTAL STRUCTURE OF A KIRBAC POTASSIUM CHANNEL HIGHLIGHTS A MECHANISM OF CHANNEL OPENING AT THE BUNDLE-CROSSING GATE.
550, 1vfuA, 0.6144, 2.56, 0.058, 585, 86, CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 AMYLASE 2/GAMMA-CYCLODEXTRIN COMPLEX
551, 5t99A, 0.6142, 3.57, 0.074, 757, 94, CRYSTAL STRUCTURE OF BUGH2AWT IN COMPLEX WITH GALACTOISOFAGOMINE
552, 5o35A, 0.6141, 3.61, 0.111, 642, 99, STRUCTURE OF COMPLEMENT PROTEINS COMPLEX
553, 2wlnF, 0.6141, 3.48, 0.084, 283, 95, POTASSIUM CHANNEL FROM MAGNETOSPIRILLUM MAGNETOTACTICUM
554, 3ufhA, 0.6139, 2.83, 0.141, 800, 92, CRYSTAL STRUCTURE OF UNDA WITH IRON CITRATE BOUND
555, 1g1yA, 0.6138, 2.58, 0.057, 585, 87, CRYSTAL STRUCTURE OF ALPHA-AMYLASE II (TVAII) FROM THERMOACTINOMYCES VULGARIS R-47 AND BETA-CYCLODEXTRIN COMPLEX
556, 3bpoB, 0.6136, 2.95, 0.101, 198, 89, CRYSTAL STRUCTURE OF THE IL13-IL4R-IL13RA TERNARY COMPLEX
557, 1wzkB, 0.6135, 2.59, 0.057, 585, 87, THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE II (TVA II) MUTATNT D465N
558, 3sypA, 0.6134, 3.10, 0.085, 305, 94, CRYSTAL STRUCTURE OF THE G PROTEIN-GATED INWARD RECTIFIER K+ CHANNEL GIRK2 (KIR3.2) R201A MUTANT
559, 1p9mC, 0.6134, 2.60, 0.034, 201, 87, CRYSTAL STRUCTURE OF THE HEXAMERIC HUMAN IL-6/IL-6 ALPHA RECEPTOR/GP130 COMPLEX
560, 3pvmD, 0.6131, 3.54, 0.079, 1225, 101, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH CVF
561, 3pvmB, 0.6131, 3.54, 0.079, 1225, 101, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH CVF
562, 2x2yA, 0.6131, 3.22, 0.125, 450, 88, CELLULOMONAS FIMI ENDO-BETA-14-MANNANASE DOUBLE MUTANT
563, 1io4C, 0.6131, 3.19, 0.130, 120, 92, CRYSTAL STRUCTURE OF RUNX-1/AML1/CBFALPHA RUNT DOMAIN- CBFBETA CORE DOMAIN HETERODIMER AND C/EBPBETA BZIP HOMODIMER BOUND TO A DNA FRAGMENT FROM THE CSF-1R PROMOTER
564, 1hjcD, 0.6127, 3.24, 0.130, 118, 92, CRYSTAL STRUCTURE OF RUNX-1/AML1/CBFALPHA RUNT DOMAIN BOUND TO A DNA FRAGMENT FROM THE CSF-1R PROMOTER
565, 4cvuA, 0.6126, 3.80, 0.071, 913, 99, STRUCTURE OF FUNGAL BETA-MANNOSIDASE FROM GLYCOSIDE HYDROLASE FAMILY 2 OF TRICHODERMA HARZIANUM
566, 1gyvA, 0.6126, 3.34, 0.094, 120, 96, GAMMA-ADAPTIN APPENDAGE DOMAIN FROM CLATHRIN ADAPTOR AP1 L762E MUTANT
567, 5t7aA, 0.6125, 2.61, 0.080, 93, 87, CRYSTAL STRUCTURE OF BR DERIVATIVE BHCBM56
568, 5kukA, 0.6124, 3.26, 0.074, 326, 95, CRYSTAL STRUCTURE OF INWARD RECTIFIER KIR2.2 K62W MUTANT
569, 4nzdB, 0.6124, 2.78, 0.161, 208, 87, INTERLEUKIN 21 RECEPTOR
570, 5fo8A, 0.6121, 3.52, 0.112, 639, 98, CRYSTAL STRUCTURE OF HUMAN COMPLEMENT C3B IN COMPLEX WITH MCP (CCP1-4)
571, 1hjbC, 0.6121, 3.15, 0.130, 120, 92, CRYSTAL STRUCTURE OF RUNX-1/AML1/CBFALPHA RUNT DOMAIN AND C/EBPBETA BZIP DIMERIC   BOUND TO A DNA FRAGMENT FROM THE CSF-1R PROMOTER
572, 3syqB, 0.6118, 3.10, 0.074, 293, 94, CRYSTAL STRUCTURE OF THE G PROTEIN-GATED INWARD RECTIFIER K+ CHANNEL GIRK2 (KIR3.2) R201A MUTANT IN COMPLEX WITH PIP2
573, 2eefA, 0.6118, 3.64, 0.071, 156, 98, SOLUTION STRUCTURE OF THE CBM_21 DOMAIN FROM HUMAN PROTEIN PHOSPHATASE 1 REGULATORY (INHIBITOR) SUBUNIT 3B
574, 5nzvQ, 0.6116, 3.24, 0.031, 560, 96, THE STRUCTURE OF THE COPI COAT LINKAGE IV
575, 5nzvK, 0.6116, 3.24, 0.031, 560, 96, THE STRUCTURE OF THE COPI COAT LINKAGE IV
576, 5nzuK, 0.6116, 3.24, 0.031, 560, 96, THE STRUCTURE OF THE COPI COAT LINKAGE II
577, 5nztK, 0.6116, 3.24, 0.031, 560, 96, THE STRUCTURE OF THE COPI COAT LINKAGE I
578, 5nzsK, 0.6116, 3.24, 0.031, 560, 96, THE STRUCTURE OF THE COPI COAT LEAF IN COMPLEX WITH THE ARFGAP2 UNCOATING FACTOR
579, 5nzrK, 0.6116, 3.24, 0.031, 560, 96, THE STRUCTURE OF THE COPI COAT LEAF
580, 5o32E, 0.6114, 3.53, 0.112, 640, 98, THE STRUCTURE OF COMPLEMENT COMPLEX
581, 5f7sB, 0.6114, 2.94, 0.059, 702, 85, CYCLOALTERNAN-DEGRADING ENZYME FROM TRUEPERELLA PYOGENES
582, 5wuaD, 0.6113, 3.24, 0.084, 323, 95, STRUCTURE OF A PANCREATIC ATP-SENSITIVE POTASSIUM CHANNEL
583, 5wuaB, 0.6113, 3.24, 0.084, 323, 95, STRUCTURE OF A PANCREATIC ATP-SENSITIVE POTASSIUM CHANNEL
584, 5wuaA, 0.6113, 3.24, 0.084, 323, 95, STRUCTURE OF A PANCREATIC ATP-SENSITIVE POTASSIUM CHANNEL
585, 2f08C, 0.6113, 3.15, 0.096, 129, 94, CRYSTAL STRUCTURE OF A MAJOR HOUSE DUST MITE ALLERGEN DERF 2 2
586, 6nfqC, 0.6112, 2.52, 0.084, 96, 83, COPC FROM PSEUDOMONAS FLUORESCENS 
587, 5wuaC, 0.6110, 3.23, 0.084, 323, 95, STRUCTURE OF A PANCREATIC ATP-SENSITIVE POTASSIUM CHANNEL
588, 5icuA, 0.6110, 2.88, 0.034, 102, 87, THE CRYSTAL STRUCTURE OF COPC FROM METHYLOSINUS TRICHOSPORIUM OB3B
589, 2ra1A, 0.6109, 2.65, 0.034, 412, 88, CRYSTAL STRUCTURE OF THE N-TERMINAL PART OF THE BACTERIAL S-LAYER PROTEIN SBSC
590, 1p4uA, 0.6108, 3.22, 0.146, 145, 96, CRYSTAL STRUCTURE OF GGA3 GAE DOMAIN IN COMPLEX WITH RABAPTIN-5 PEPTIDE
591, 3bplB, 0.6106, 2.90, 0.091, 202, 88, CRYSTAL STRUCTURE OF THE IL4-IL4R-COMMON GAMMA TERNARY COMPLEX
592, 1gyuA, 0.6104, 3.36, 0.094, 120, 96, GAMMA-ADAPTIN APPENDAGE DOMAIN FROM CLATHRIN ADAPTOR AP1
593, 2f08D, 0.6102, 3.16, 0.096, 129, 94, CRYSTAL STRUCTURE OF A MAJOR HOUSE DUST MITE ALLERGEN DERF 2 2
594, 2f08B, 0.6101, 3.16, 0.096, 129, 94, CRYSTAL STRUCTURE OF A MAJOR HOUSE DUST MITE ALLERGEN DERF 2 2
595, 1na8A, 0.6101, 3.45, 0.134, 151, 97, CRYSTAL STRUCTURE OF ADP-RIBOSYLATION FACTOR BINDING PROTEIN GGA1
596, 6nfsA, 0.6099, 2.55, 0.083, 97, 84, COPC FROM PSEUDOMONAS FLUORESCENS 
597, 6i2xB, 0.6099, 3.60, 0.079, 951, 101, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH SMALL MOLECULE INHIBITOR AND CVF 
598, 5t7aB, 0.6099, 2.46, 0.070, 92, 86, CRYSTAL STRUCTURE OF BR DERIVATIVE BHCBM56
599, 2wliB, 0.6099, 3.29, 0.098, 263, 92, POTASSIUM CHANNEL FROM MAGNETOSPIRILLUM MAGNETOTACTICUM
600, 1cmoA, 0.6099, 3.37, 0.094, 127, 96, IMMUNOGLOBULIN MOTIF DNA-RECOGNITION AND HETERODIMERIZATION FOR THE PEBP2/CBF RUNT-DOMAIN
601, 6dpsE, 0.6098, 3.17, 0.114, 121, 88, CRYSTAL STRUCTURE OF NEISSERIA MENINGITIDIS DSBD N-TERMINAL DOMAIN IN THE OXIDISED FORM 
602, 5fv5A, 0.6097, 3.28, 0.033, 177, 92, KPFLO11 PRESENTS A NOVEL MEMBER OF THE FLO11 FAMILY WITH A UNIQUE RECOGNITION PATTERN FOR HOMOPHILIC INTERACTIONS
603, 2j6wB, 0.6097, 3.61, 0.135, 124, 96, R164N MUTANT OF THE RUNX1 RUNT DOMAIN
604, 1fg9C, 0.6097, 3.04, 0.099, 210, 91, 3:1 COMPLEX OF INTERFERON-GAMMA RECEPTOR WITH INTERFERON- GAMMA DIMER
605, 6jb1G, 0.6096, 3.27, 0.063, 327, 95, STRUCTURE OF PANCREATIC ATP-SENSITIVE POTASSIUM CHANNEL BOUND WITH REPAGLINIDE AND ATPGAMMAS AT 3.3A RESOLUTION 
606, 6jb1E, 0.6096, 3.27, 0.063, 327, 95, STRUCTURE OF PANCREATIC ATP-SENSITIVE POTASSIUM CHANNEL BOUND WITH REPAGLINIDE AND ATPGAMMAS AT 3.3A RESOLUTION 
607, 6jb1C, 0.6096, 3.27, 0.063, 327, 95, STRUCTURE OF PANCREATIC ATP-SENSITIVE POTASSIUM CHANNEL BOUND WITH REPAGLINIDE AND ATPGAMMAS AT 3.3A RESOLUTION 
608, 6jb1A, 0.6096, 3.27, 0.063, 327, 95, STRUCTURE OF PANCREATIC ATP-SENSITIVE POTASSIUM CHANNEL BOUND WITH REPAGLINIDE AND ATPGAMMAS AT 3.3A RESOLUTION 
609, 6gvkA, 0.6096, 3.70, 0.102, 201, 98, SECOND PAIR OF FIBRONECTIN TYPE III DOMAINS OF INTEGRIN BETA4 (T1663R MUTANT) BOUND TO THE BULLOUS PEMPHIGOID ANTIGEN BP230 (BPAG1E) 
610, 6baaD, 0.6095, 3.29, 0.074, 321, 95, CRYO-EM STRUCTURE OF THE PANCREATIC BETA-CELL KATP CHANNEL BOUND TO ATP AND GLIBENCLAMIDE
611, 6baaC, 0.6095, 3.29, 0.074, 321, 95, CRYO-EM STRUCTURE OF THE PANCREATIC BETA-CELL KATP CHANNEL BOUND TO ATP AND GLIBENCLAMIDE
612, 6baaB, 0.6095, 3.29, 0.074, 321, 95, CRYO-EM STRUCTURE OF THE PANCREATIC BETA-CELL KATP CHANNEL BOUND TO ATP AND GLIBENCLAMIDE
613, 6baaA, 0.6095, 3.29, 0.074, 321, 95, CRYO-EM STRUCTURE OF THE PANCREATIC BETA-CELL KATP CHANNEL BOUND TO ATP AND GLIBENCLAMIDE
614, 5e4eB, 0.6095, 2.72, 0.093, 183, 86, ENGINEERED INTERLEUKIN-13 BOUND TO RECEPTOR
615, 3sphA, 0.6093, 3.26, 0.063, 332, 95, INWARD RECTIFIER POTASSIUM CHANNEL KIR2.2 I223L MUTANT IN COMPLEX WITH PIP2
616, 3di2D, 0.6093, 3.10, 0.046, 196, 87, CRYSTAL STRUCTURE OF THE COMPLEX OF HUMAN INTERLEUKIN-7 WITH UNGLYCOSYLATED HUMAN INTERLEUKIN-7 RECEPTOR ALPHA ECTODOMAIN
617, 4uicA, 0.6092, 2.64, 0.034, 710, 88, CRYSTAL STRUCTURE OF THE S-LAYER PROTEIN RSBSC(31-844)
618, 3up1A, 0.6091, 2.92, 0.047, 201, 86, CRYSTAL STRUCTURE OF THE UNLIGANDED HUMAN INTERLEUKIN-7 RECEPTOR EXTRACELLULAR DOMAIN
619, 2qksA, 0.6091, 3.32, 0.053, 302, 95, CRYSTAL STRUCTURE OF A KIR3.1-PROKARYOTIC KIR CHANNEL CHIMERA
620, 5kumA, 0.6089, 3.12, 0.074, 326, 94, CRYSTAL STRUCTURE OF INWARD RECTIFIER KIR2.2 K62W MUTANT IN COMPLEX WITH PIP2
621, 5i0gB, 0.6089, 2.96, 0.068, 730, 88, CYCLOALTERNAN-DEGRADING ENZYME FROM TRUEPERELLA PYOGENES IN COMPLEX WITH CYCLOALTERNAN
622, 5i0eB, 0.6089, 2.75, 0.071, 703, 84, CYCLOALTERNAN-DEGRADING ENZYME FROM TRUEPERELLA PYOGENES IN COMPLEX WITH ISOMALTOSE
623, 5hzvA, 0.6088, 2.88, 0.100, 598, 90, CRYSTAL STRUCTURE OF THE ZONA PELLUCIDA MODULE OF HUMAN ENDOGLIN/CD105
624, 2qksB, 0.6088, 3.30, 0.043, 294, 94, CRYSTAL STRUCTURE OF A KIR3.1-PROKARYOTIC KIR CHANNEL CHIMERA
625, 1o75B, 0.6088, 2.77, 0.121, 402, 91, TP47 THE 47-KILODALTON LIPOPROTEIN OF TREPONEMA PALLIDUM
626, 5fv6B, 0.6085, 3.34, 0.033, 177, 92, KPFLO11 PRESENTS A NOVEL MEMBER OF THE FLO11 FAMILY WITH A UNIQUE RECOGNITION PATTERN FOR HOMOPHILIC INTERACTIONS
627, 3zy7B, 0.6083, 3.40, 0.104, 116, 96, CRYSTAL STRUCTURE OF COMPUTATIONALLY REDESIGNED GAMMA- ADAPTIN APPENDAGE DOMAIN FORMING A SYMMETRIC HOMODIMER
628, 3frpA, 0.6083, 3.63, 0.070, 602, 100, CRYSTAL STRUCTURE OF COBRA VENOM FACTOR A CO-FACTOR FOR C3- AND C5 CONVERTASE CVFBB
629, 5nztG, 0.6081, 3.33, 0.031, 798, 96, THE STRUCTURE OF THE COPI COAT LINKAGE I
630, 5nzsG, 0.6081, 3.33, 0.031, 798, 96, THE STRUCTURE OF THE COPI COAT LEAF IN COMPLEX WITH THE ARFGAP2 UNCOATING FACTOR
631, 5nzrG, 0.6081, 3.33, 0.031, 798, 96, THE STRUCTURE OF THE COPI COAT LEAF
632, 5nzvG, 0.6080, 3.33, 0.031, 798, 96, THE STRUCTURE OF THE COPI COAT LINKAGE IV
633, 5nzuG, 0.6080, 3.33, 0.031, 798, 96, THE STRUCTURE OF THE COPI COAT LINKAGE II
634, 1eaoB, 0.6078, 3.39, 0.128, 124, 94, THE RUNX1 RUNT DOMAIN AT 1.4A RESOLUTION: A STRUCTURAL SWITCH AND SPECIFICALLY BOUND CHLORIDE IONS MODULATE DNA BINDING
635, 6gq8D, 0.6076, 2.76, 0.092, 109, 87, SUPEROXIDE REDUCTASE FROM NANOARCHAEUM EQUITANS 
636, 1j7vR, 0.6075, 2.92, 0.045, 205, 89, HUMAN IL-10 / IL-10R1 COMPLEX
637, 4bv1A, 0.6074, 2.56, 0.093, 109, 86, SUPEROXIDE REDUCTASE (NEELAREDOXIN) FROM NANOARCHAEUM EQUITANS
638, 3doiA, 0.6074, 3.05, 0.099, 375, 91, CRYSTAL STRUCTURE OF A THERMOSTABLE ESTERASE COMPLEX WITH PARAOXON
639, 3di2B, 0.6074, 2.97, 0.047, 195, 86, CRYSTAL STRUCTURE OF THE COMPLEX OF HUMAN INTERLEUKIN-7 WITH UNGLYCOSYLATED HUMAN INTERLEUKIN-7 RECEPTOR ALPHA ECTODOMAIN
640, 1e50Q, 0.6074, 3.06, 0.146, 110, 89, AML1/CBF COMPLEX
641, 5fv6A, 0.6073, 3.36, 0.033, 168, 92, KPFLO11 PRESENTS A NOVEL MEMBER OF THE FLO11 FAMILY WITH A UNIQUE RECOGNITION PATTERN FOR HOMOPHILIC INTERACTIONS
642, 1wrfA, 0.6073, 3.19, 0.106, 129, 94, REFINED SOLUTION STRUCTURE OF DER F 2 THE MAJOR MITE ALLERGEN FROM DERMATOPHAGOIDES FARINAE
643, 3doiB, 0.6072, 2.91, 0.100, 373, 90, CRYSTAL STRUCTURE OF A THERMOSTABLE ESTERASE COMPLEX WITH PARAOXON
644, 1iarB, 0.6072, 3.04, 0.112, 188, 89, INTERLEUKIN-4 / RECEPTOR ALPHA CHAIN COMPLEX
645, 5ywbG, 0.6071, 3.27, 0.074, 325, 95, STRUCTURE OF PANCREATIC ATP-SENSITIVE POTASSIUM CHANNEL BOUND WITH MG- ADP (CTD CLASS2 AT 5.2A) 
646, 5ywbE, 0.6071, 3.27, 0.074, 325, 95, STRUCTURE OF PANCREATIC ATP-SENSITIVE POTASSIUM CHANNEL BOUND WITH MG- ADP (CTD CLASS2 AT 5.2A) 
647, 5ywbC, 0.6071, 3.27, 0.074, 325, 95, STRUCTURE OF PANCREATIC ATP-SENSITIVE POTASSIUM CHANNEL BOUND WITH MG- ADP (CTD CLASS2 AT 5.2A) 
648, 5ywbA, 0.6071, 3.27, 0.074, 325, 95, STRUCTURE OF PANCREATIC ATP-SENSITIVE POTASSIUM CHANNEL BOUND WITH MG- ADP (CTD CLASS2 AT 5.2A) 
649, 4wrnB, 0.6071, 3.87, 0.040, 663, 101, CRYSTAL STRUCTURE OF THE POLYMERIZATION REGION OF HUMAN UROMODULIN/TAMM-HORSFALL PROTEIN
650, 5ywaG, 0.6070, 3.34, 0.074, 325, 95, STRUCTURE OF PANCREATIC ATP-SENSITIVE POTASSIUM CHANNEL BOUND WITH ATPGAMMAS (CTD CLASS 2 AT 6.1A) 
651, 5ywaE, 0.6070, 3.34, 0.074, 325, 95, STRUCTURE OF PANCREATIC ATP-SENSITIVE POTASSIUM CHANNEL BOUND WITH ATPGAMMAS (CTD CLASS 2 AT 6.1A) 
652, 5ywaC, 0.6070, 3.34, 0.074, 325, 95, STRUCTURE OF PANCREATIC ATP-SENSITIVE POTASSIUM CHANNEL BOUND WITH ATPGAMMAS (CTD CLASS 2 AT 6.1A) 
653, 5ywaA, 0.6070, 3.34, 0.074, 325, 95, STRUCTURE OF PANCREATIC ATP-SENSITIVE POTASSIUM CHANNEL BOUND WITH ATPGAMMAS (CTD CLASS 2 AT 6.1A) 
654, 5ykgG, 0.6070, 3.34, 0.074, 325, 95, STRUCTURE OF PANCREATIC ATP-SENSITIVE POTASSIUM CHANNEL BOUND WITH GLIBENCLAMIDE AND ATPGAMMAS (CLASS2 AT 4.57A) 
655, 5ykgE, 0.6070, 3.34, 0.074, 325, 95, STRUCTURE OF PANCREATIC ATP-SENSITIVE POTASSIUM CHANNEL BOUND WITH GLIBENCLAMIDE AND ATPGAMMAS (CLASS2 AT 4.57A) 
656, 5ykgC, 0.6070, 3.34, 0.074, 325, 95, STRUCTURE OF PANCREATIC ATP-SENSITIVE POTASSIUM CHANNEL BOUND WITH GLIBENCLAMIDE AND ATPGAMMAS (CLASS2 AT 4.57A) 
657, 5ykgA, 0.6070, 3.34, 0.074, 325, 95, STRUCTURE OF PANCREATIC ATP-SENSITIVE POTASSIUM CHANNEL BOUND WITH GLIBENCLAMIDE AND ATPGAMMAS (CLASS2 AT 4.57A) 
658, 2vtcA, 0.6069, 3.51, 0.020, 228, 98, THE STRUCTURE OF A GLYCOSIDE HYDROLASE FAMILY 61 MEMBER CEL61B FROM THE HYPOCREA JECORINA.
659, 6gq8A, 0.6068, 2.57, 0.093, 109, 86, SUPEROXIDE REDUCTASE FROM NANOARCHAEUM EQUITANS 
660, 4eq2A, 0.6068, 3.12, 0.099, 206, 91, CRYSTAL STRUCTURE ANALYSIS OF CHICKEN INTERFERON GAMMA RECEPTOR ALPHA CHAIN
661, 3dohA, 0.6068, 3.07, 0.099, 375, 91, CRYSTAL STRUCTURE OF A THERMOSTABLE ESTERASE
662, 3sycA, 0.6067, 3.11, 0.085, 310, 94, CRYSTAL STRUCTURE OF THE G PROTEIN-GATED INWARD RECTIFIER K+ CHANNEL GIRK2 (KIR3.2) D228N MUTANT
663, 4bv1D, 0.6065, 2.76, 0.092, 109, 87, SUPEROXIDE REDUCTASE (NEELAREDOXIN) FROM NANOARCHAEUM EQUITANS
664, 3zy7A, 0.6065, 3.26, 0.105, 116, 95, CRYSTAL STRUCTURE OF COMPUTATIONALLY REDESIGNED GAMMA- ADAPTIN APPENDAGE DOMAIN FORMING A SYMMETRIC HOMODIMER
665, 1e50R, 0.6065, 3.07, 0.146, 110, 89, AML1/CBF COMPLEX
666, 6c3pD, 0.6063, 3.32, 0.063, 328, 95, CRYO-EM STRUCTURE OF HUMAN KATP BOUND TO ATP AND ADP IN PROPELLER FORM
667, 6c3pC, 0.6063, 3.32, 0.063, 328, 95, CRYO-EM STRUCTURE OF HUMAN KATP BOUND TO ATP AND ADP IN PROPELLER FORM
668, 6c3pB, 0.6063, 3.32, 0.063, 328, 95, CRYO-EM STRUCTURE OF HUMAN KATP BOUND TO ATP AND ADP IN PROPELLER FORM
669, 6c3pA, 0.6063, 3.32, 0.063, 328, 95, CRYO-EM STRUCTURE OF HUMAN KATP BOUND TO ATP AND ADP IN PROPELLER FORM
670, 4kfmA, 0.6063, 3.28, 0.095, 328, 95, CRYSTAL STRUCTURE OF THE G PROTEIN-GATED INWARD RECTIFIER K+ CHANNEL GIRK2 (KIR3.2) IN COMPLEX WITH THE BETA-GAMMA G PROTEIN SUBUNITS
671, 3syaA, 0.6063, 3.26, 0.095, 328, 95, CRYSTAL STRUCTURE OF THE G PROTEIN-GATED INWARD RECTIFIER K+ CHANNEL GIRK2 (KIR3.2) IN COMPLEX WITH SODIUM AND PIP2
672, 2wloB, 0.6063, 3.35, 0.087, 272, 92, POTASSIUM CHANNEL FROM MAGNETOSPIRILLUM MAGNETOTACTICUM
673, 1b9kA, 0.6063, 3.49, 0.117, 237, 94, ALPHA-ADAPTIN APPENDAGE DOMAIN FROM CLATHRIN ADAPTOR AP2
674, 6dnvB, 0.6062, 3.01, 0.115, 125, 87, CRYSTAL STRUCTURE OF NEISSERIA MENINGITIDIS DSBD N-TERMINAL DOMAIN IN THE REDUCED FORM 
675, 6gq8B, 0.6061, 2.57, 0.093, 109, 86, SUPEROXIDE REDUCTASE FROM NANOARCHAEUM EQUITANS 
676, 5yw9G, 0.6061, 3.29, 0.074, 325, 95, STRUCTURE OF PANCREATIC ATP-SENSITIVE POTASSIUM CHANNEL BOUND WITH ATPGAMMAS (CLASS1 5.0A) 
677, 5yw9E, 0.6061, 3.29, 0.074, 325, 95, STRUCTURE OF PANCREATIC ATP-SENSITIVE POTASSIUM CHANNEL BOUND WITH ATPGAMMAS (CLASS1 5.0A) 
678, 5yw9C, 0.6061, 3.29, 0.074, 325, 95, STRUCTURE OF PANCREATIC ATP-SENSITIVE POTASSIUM CHANNEL BOUND WITH ATPGAMMAS (CLASS1 5.0A) 
679, 5yw9A, 0.6061, 3.29, 0.074, 325, 95, STRUCTURE OF PANCREATIC ATP-SENSITIVE POTASSIUM CHANNEL BOUND WITH ATPGAMMAS (CLASS1 5.0A) 
680, 5yw8G, 0.6061, 3.29, 0.074, 325, 95, STRUCTURE OF PANCREATIC ATP-SENSITIVE POTASSIUM CHANNEL BOUND WITH ATPGAMMAS (ALL PARTICLES AT 4.4A) 
681, 5yw8E, 0.6061, 3.29, 0.074, 325, 95, STRUCTURE OF PANCREATIC ATP-SENSITIVE POTASSIUM CHANNEL BOUND WITH ATPGAMMAS (ALL PARTICLES AT 4.4A) 
682, 5yw8C, 0.6061, 3.29, 0.074, 325, 95, STRUCTURE OF PANCREATIC ATP-SENSITIVE POTASSIUM CHANNEL BOUND WITH ATPGAMMAS (ALL PARTICLES AT 4.4A) 
683, 5yw8A, 0.6061, 3.29, 0.074, 325, 95, STRUCTURE OF PANCREATIC ATP-SENSITIVE POTASSIUM CHANNEL BOUND WITH ATPGAMMAS (ALL PARTICLES AT 4.4A) 
684, 5ykfG, 0.6061, 3.29, 0.074, 325, 95, STRUCTURE OF PANCREATIC ATP-SENSITIVE POTASSIUM CHANNEL BOUND WITH GLIBENCLAMIDE AND ATPGAMMAS (3D CLASS1 AT 4.33A) 
685, 5ykfE, 0.6061, 3.29, 0.074, 325, 95, STRUCTURE OF PANCREATIC ATP-SENSITIVE POTASSIUM CHANNEL BOUND WITH GLIBENCLAMIDE AND ATPGAMMAS (3D CLASS1 AT 4.33A) 
686, 5ykfC, 0.6061, 3.29, 0.074, 325, 95, STRUCTURE OF PANCREATIC ATP-SENSITIVE POTASSIUM CHANNEL BOUND WITH GLIBENCLAMIDE AND ATPGAMMAS (3D CLASS1 AT 4.33A) 
687, 5ykfA, 0.6061, 3.29, 0.074, 325, 95, STRUCTURE OF PANCREATIC ATP-SENSITIVE POTASSIUM CHANNEL BOUND WITH GLIBENCLAMIDE AND ATPGAMMAS (3D CLASS1 AT 4.33A) 
688, 6h4aA, 0.6060, 3.63, 0.042, 358, 96, HUMAN MALT1(329-728) IN COMPLEX WITH MLT-748 
689, 6c3oD, 0.6060, 3.34, 0.063, 328, 95, CRYO-EM STRUCTURE OF HUMAN KATP BOUND TO ATP AND ADP IN QUATREFOIL FORM
690, 6c3oC, 0.6060, 3.34, 0.063, 328, 95, CRYO-EM STRUCTURE OF HUMAN KATP BOUND TO ATP AND ADP IN QUATREFOIL FORM
691, 6c3oB, 0.6060, 3.34, 0.063, 328, 95, CRYO-EM STRUCTURE OF HUMAN KATP BOUND TO ATP AND ADP IN QUATREFOIL FORM
692, 6c3oA, 0.6060, 3.34, 0.063, 328, 95, CRYO-EM STRUCTURE OF HUMAN KATP BOUND TO ATP AND ADP IN QUATREFOIL FORM
693, 2wllB, 0.6060, 3.20, 0.033, 266, 91, POTASSIUM CHANNEL FROM BURKHOLDERIA PSEUDOMALLEI
694, 5ywcG, 0.6059, 3.30, 0.074, 325, 95, STRUCTURE OF PANCREATIC ATP-SENSITIVE POTASSIUM CHANNEL BOUND WITH MG- ADP (CTD CLASS1 AT 4.3A) 
695, 5ywcE, 0.6059, 3.30, 0.074, 325, 95, STRUCTURE OF PANCREATIC ATP-SENSITIVE POTASSIUM CHANNEL BOUND WITH MG- ADP (CTD CLASS1 AT 4.3A) 
696, 5ywcC, 0.6059, 3.30, 0.074, 325, 95, STRUCTURE OF PANCREATIC ATP-SENSITIVE POTASSIUM CHANNEL BOUND WITH MG- ADP (CTD CLASS1 AT 4.3A) 
697, 5ywcA, 0.6059, 3.30, 0.074, 325, 95, STRUCTURE OF PANCREATIC ATP-SENSITIVE POTASSIUM CHANNEL BOUND WITH MG- ADP (CTD CLASS1 AT 4.3A) 
698, 4yn2A, 0.6058, 3.44, 0.074, 281, 94, THE ATOMIC STRUCTURE OF WISEANA SPP ENTOMOPOXVIRUS (WSEPV) FUSOLIN SPINDLES
699, 2bvtB, 0.6058, 3.19, 0.126, 451, 87, THE STRUCTURE OF A MODULAR ENDO-BETA-14-MANNANASE FROM CELLULOMONAS FIMI EXPLAINS THE PRODUCT SPECIFICITY OF GLYCOSIDE HYDROLASE FAMILY 26 MANNANASES.
700, 2bvtA, 0.6058, 3.19, 0.126, 451, 87, THE STRUCTURE OF A MODULAR ENDO-BETA-14-MANNANASE FROM CELLULOMONAS FIMI EXPLAINS THE PRODUCT SPECIFICITY OF GLYCOSIDE HYDROLASE FAMILY 26 MANNANASES.
701, 1y6kR, 0.6058, 2.77, 0.045, 205, 88, CRYSTAL STRUCTURE OF HUMAN IL-10 COMPLEXED WITH THE SOLUBLE IL-10R1 CHAIN
702, 6gq8C, 0.6055, 2.56, 0.093, 109, 86, SUPEROXIDE REDUCTASE FROM NANOARCHAEUM EQUITANS 
703, 4bv1B, 0.6054, 2.57, 0.093, 109, 86, SUPEROXIDE REDUCTASE (NEELAREDOXIN) FROM NANOARCHAEUM EQUITANS
704, 2xkyL, 0.6054, 3.77, 0.040, 309, 99, SINGLE PARTICLE ANALYSIS OF KIR2.1NC_4 IN NEGATIVE STAIN
705, 2xkyK, 0.6054, 3.77, 0.040, 309, 99, SINGLE PARTICLE ANALYSIS OF KIR2.1NC_4 IN NEGATIVE STAIN
706, 2xkyJ, 0.6054, 3.77, 0.040, 309, 99, SINGLE PARTICLE ANALYSIS OF KIR2.1NC_4 IN NEGATIVE STAIN
707, 2xkyI, 0.6054, 3.77, 0.040, 309, 99, SINGLE PARTICLE ANALYSIS OF KIR2.1NC_4 IN NEGATIVE STAIN
708, 2wljB, 0.6053, 3.46, 0.108, 269, 93, POTASSIUM CHANNEL FROM MAGNETOSPIRILLUM MAGNETOTACTICUM
709, 6h03A, 0.6052, 3.00, 0.112, 1223, 89, struct.pdbx_descriptor              
710, 5t98A, 0.6052, 3.48, 0.064, 756, 94, CRYSTAL STRUCTURE OF BUGH2AWT
711, 3dohB, 0.6052, 3.07, 0.099, 373, 91, CRYSTAL STRUCTURE OF A THERMOSTABLE ESTERASE
712, 1yycA, 0.6051, 3.42, 0.097, 174, 93, SOLUTION STRUCTURE OF A PUTATIVE LATE EMBRYOGENESIS ABUNDANT (LEA) PROTEIN AT2G46140.1
713, 1o75A, 0.6051, 3.11, 0.065, 399, 93, TP47 THE 47-KILODALTON LIPOPROTEIN OF TREPONEMA PALLIDUM
714, 4es8B, 0.6050, 3.14, 0.078, 297, 90, CRYSTAL STRUCTURE OF THE ADHESIN DOMAIN OF EPF FROM STREPTOCOCCUS PYOGENES IN P212121
715, 3syoA, 0.6049, 3.28, 0.095, 309, 95, CRYSTAL STRUCTURE OF THE G PROTEIN-GATED INWARD RECTIFIER K+ CHANNEL GIRK2 (KIR3.2) IN COMPLEX WITH SODIUM
716, 4bv1C, 0.6048, 2.57, 0.093, 109, 86, SUPEROXIDE REDUCTASE (NEELAREDOXIN) FROM NANOARCHAEUM EQUITANS
717, 1om9B, 0.6048, 3.36, 0.125, 142, 96, STRUCTURE OF THE GGA1-APPENDAGE IN COMPLEX WITH THE P56 BINDING PEPTIDE
718, 3fjvA, 0.6046, 3.43, 0.061, 190, 98, CRYSTAL STRUCTURE OF NOVEL PROTEIN OF UNKNOWN FUNCTION (YP_111841.1) FROM BURKHOLDERIA PSEUDOMALLEI K96243 AT 1.90 A RESOLUTION
719, 3bpnB, 0.6046, 3.09, 0.101, 199, 89, CRYSTAL STRUCTURE OF THE IL4-IL4R-IL13RA TERNARY COMPLEX
720, 3km9A, 0.6045, 3.28, 0.116, 1459, 95, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH THE C-TERMINAL BETA-GRASP DOMAIN OF SSL7
721, 1om9A, 0.6045, 3.37, 0.125, 142, 96, STRUCTURE OF THE GGA1-APPENDAGE IN COMPLEX WITH THE P56 BINDING PEPTIDE
722, 6nfrA, 0.6044, 2.72, 0.082, 97, 85, COPC FROM PSEUDOMONAS FLUORESCENS 
723, 4tw1O, 0.6043, 3.42, 0.098, 283, 92, CRYSTAL STRUCTURE OF THE OCTAMERIC PORE COMPLEX OF THE STAPHYLOCOCCUS AUREUS BI-COMPONENT TOXIN LUKGH
724, 2vtcB, 0.6040, 3.54, 0.020, 228, 98, THE STRUCTURE OF A GLYCOSIDE HYDROLASE FAMILY 61 MEMBER CEL61B FROM THE HYPOCREA JECORINA.
725, 2wlmA, 0.6039, 3.37, 0.087, 271, 92, POTASSIUM CHANNEL FROM MAGNETOSPIRILLUM MAGNETOTACTICUM
726, 1xwvB, 0.6039, 3.21, 0.095, 129, 95, STRUCTURE OF THE HOUSE DUST MITE ALLERGEN DER F 2: IMPLICATIONS FOR FUNCTION AND MOLECULAR BASIS OF IGE CROSS- REACTIVITY
727, 6d89D, 0.6038, 2.83, 0.069, 571, 87, BACTEROIDES UNIFORMIS BETA-GLUCURONIDASE 1 WITH N-TERMINAL LOOP DELETION 
728, 5o2wA, 0.6038, 3.55, 0.082, 247, 97, EXTENDED CATALYTIC DOMAIN OF HYPOCREA JECORINA LPMO 9A.
729, 3g6jC, 0.6038, 3.45, 0.095, 642, 95, C3B IN COMPLEX WITH A C3B SPECIFIC FAB
730, 6d89B, 0.6037, 2.83, 0.079, 568, 89, BACTEROIDES UNIFORMIS BETA-GLUCURONIDASE 1 WITH N-TERMINAL LOOP DELETION 
731, 3km9B, 0.6037, 3.29, 0.116, 1459, 95, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH THE C-TERMINAL BETA-GRASP DOMAIN OF SSL7
732, 1bquB, 0.6036, 2.70, 0.035, 215, 86, CYTOKYNE-BINDING REGION OF GP130
733, 3dgcS, 0.6035, 2.68, 0.069, 207, 87, STRUCTURE OF IL-22/IL-22R1
734, 1j0kB, 0.6035, 2.84, 0.047, 588, 86, CRYSTAL STRUCTURE OF NEOPULLULANASE E357Q COMPLEX WITH ISOPANOSE
735, 1eaoA, 0.6034, 3.48, 0.138, 124, 94, THE RUNX1 RUNT DOMAIN AT 1.4A RESOLUTION: A STRUCTURAL SWITCH AND SPECIFICALLY BOUND CHLORIDE IONS MODULATE DNA BINDING
736, 5o2xA, 0.6033, 3.57, 0.082, 247, 97, EXTENDED CATALYTIC DOMAIN OF H. JECORINA LPMO9A A.K.A EG4
737, 1lyqA, 0.6032, 2.63, 0.060, 101, 84, CRYSTAL STRUCTURE OF PCOC A METHIONINE RICH COPPER RESISTANCE PROTEIN FROM ESCHERICHIA COLI
738, 2q3xA, 0.6029, 3.55, 0.160, 137, 94, THE RIM1ALPHA C2B DOMAIN
739, 1xl4B, 0.6029, 3.47, 0.097, 277, 93, INTERMEDIATE GATING STRUCTURE 1 OF THE INWARDLY RECTIFYING K+ CHANNEL KIRBAC3.1
740, 4wrnA, 0.6027, 3.91, 0.040, 693, 101, CRYSTAL STRUCTURE OF THE POLYMERIZATION REGION OF HUMAN UROMODULIN/TAMM-HORSFALL PROTEIN
741, 6d89A, 0.6025, 2.93, 0.068, 571, 88, BACTEROIDES UNIFORMIS BETA-GLUCURONIDASE 1 WITH N-TERMINAL LOOP DELETION 
742, 5j11B, 0.6025, 2.82, 0.059, 196, 85, STRUCTURE OF HUMAN TSLP IN COMPLEX WITH TSLPR AND IL-7RALPHA
743, 4tw1K, 0.6025, 3.35, 0.099, 281, 91, CRYSTAL STRUCTURE OF THE OCTAMERIC PORE COMPLEX OF THE STAPHYLOCOCCUS AUREUS BI-COMPONENT TOXIN LUKGH
744, 3dlqR, 0.6025, 2.61, 0.080, 201, 87, CRYSTAL STRUCTURE OF THE IL-22/IL-22R1 COMPLEX
745, 1yvlB, 0.6025, 3.53, 0.105, 653, 95, STRUCTURE OF UNPHOSPHORYLATED STAT1
746, 1j0iA, 0.6024, 2.61, 0.047, 588, 85, CRYSTAL STRUCTURE OF NEOPULLULANASE COMPLEX WITH PANOSE
747, 2dwxC, 0.6023, 3.41, 0.135, 128, 96, CO-CRYSTAL STRUCTURE ANALYSIS OF GGA1-GAE WITH THE WNSF MOTIF
748, 1lyqB, 0.6023, 2.64, 0.060, 104, 84, CRYSTAL STRUCTURE OF PCOC A METHIONINE RICH COPPER RESISTANCE PROTEIN FROM ESCHERICHIA COLI
749, 2dwxA, 0.6022, 3.46, 0.134, 129, 97, CO-CRYSTAL STRUCTURE ANALYSIS OF GGA1-GAE WITH THE WNSF MOTIF
750, 5z1bD, 0.6021, 3.16, 0.034, 622, 89, STRUCTURE OF BIFIDOBACTERIUM DENTIUM BETA-GLUCURONIDASE COMPLEXED WITH COUMARIN-3-O-GLUCURONIDE 
751, 3lb6D, 0.6019, 2.98, 0.057, 284, 88, THE STRUCTURE OF IL-13 IN COMPLEX WITH IL-13RALPHA2
752, 3d85D, 0.6019, 3.02, 0.090, 290, 89, CRYSTAL STRUCTURE OF IL-23 IN COMPLEX WITH NEUTRALIZING FAB
753, 2dwyC, 0.6019, 3.37, 0.135, 132, 96, CRYSTAL STRUCTURE ANALYSIS OF GGA1-GAE
754, 3up1B, 0.6017, 3.08, 0.057, 196, 87, CRYSTAL STRUCTURE OF THE UNLIGANDED HUMAN INTERLEUKIN-7 RECEPTOR EXTRACELLULAR DOMAIN
755, 1j0jB, 0.6016, 2.71, 0.047, 588, 85, CRYSTAL STRUCTURE OF NEOPULLULANASE E357Q COMPLEX WITH MALTOTETRAOSE
756, 1i1rA, 0.6016, 2.71, 0.035, 301, 86, CRYSTAL STRUCTURE OF A CYTOKINE/RECEPTOR COMPLEX
757, 6dpsC, 0.6015, 2.87, 0.116, 123, 86, CRYSTAL STRUCTURE OF NEISSERIA MENINGITIDIS DSBD N-TERMINAL DOMAIN IN THE OXIDISED FORM 
758, 1p9mA, 0.6015, 2.65, 0.035, 298, 86, CRYSTAL STRUCTURE OF THE HEXAMERIC HUMAN IL-6/IL-6 ALPHA RECEPTOR/GP130 COMPLEX
759, 1iu1B, 0.6014, 3.43, 0.094, 123, 96, CRYSTAL STRUCTURE OF HUMAN GAMMA1-ADAPTIN EAR DOMAIN
760, 1gywB, 0.6013, 3.44, 0.094, 128, 96, GAMMA-ADAPTIN APPENDAGE DOMAIN FROM CLATHRIN ADAPTOR AP1 A753D MUTANT
761, 6d7fA, 0.6012, 2.85, 0.079, 579, 89, BACTEROIDES UNIFORMIS BETA-GLUCURONIDASE 1 BOUND TO THIOPHENYL-BETA-D- GLUCURONIDE 
762, 1j0iB, 0.6012, 2.69, 0.047, 588, 85, CRYSTAL STRUCTURE OF NEOPULLULANASE COMPLEX WITH PANOSE
763, 1fg9D, 0.6012, 3.17, 0.088, 205, 91, 3:1 COMPLEX OF INTERFERON-GAMMA RECEPTOR WITH INTERFERON- GAMMA DIMER
764, 4i1rA, 0.6010, 3.66, 0.042, 353, 96, HUMAN MALT1 (CASPASE-IG3) IN COMPLEX WITH THIORIDAZINE
765, 6d7fD, 0.6009, 2.85, 0.079, 579, 89, BACTEROIDES UNIFORMIS BETA-GLUCURONIDASE 1 BOUND TO THIOPHENYL-BETA-D- GLUCURONIDE 
766, 5k59B, 0.6009, 3.37, 0.098, 293, 92, CRYSTAL STRUCTURE OF LUKGH FROM STAPHYLOCOCCUS AUREUS IN COMPLEX WITH A NEUTRALISING ANTIBODY
767, 5t9gD, 0.6008, 3.67, 0.063, 811, 95, CRYSTAL STRUCTURE OF BUGH2CWT IN COMPLEX WITH GALACTOISOFAGOMINE
768, 3klsA, 0.6008, 3.30, 0.116, 1622, 95, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH SSL7
769, 2c9pC, 0.6008, 2.56, 0.036, 102, 84, CU(I)CU(II)-COPC AT PH 4.5
770, 3mtxA, 0.6007, 3.77, 0.081, 138, 99, CRYSTAL STRUCTURE OF CHICKEN MD-1
771, 3klsB, 0.6007, 3.30, 0.116, 1478, 95, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH SSL7
772, 6d7fF, 0.6006, 2.85, 0.079, 579, 89, BACTEROIDES UNIFORMIS BETA-GLUCURONIDASE 1 BOUND TO THIOPHENYL-BETA-D- GLUCURONIDE 
773, 2bvyA, 0.6006, 3.05, 0.128, 451, 86, THE STRUCTURE AND CHARACTERIZATION OF A MODULAR ENDO-BETA-14-MANNANASE FROM CELLULOMONAS FIMI
774, 6d41A, 0.6004, 3.00, 0.067, 579, 89, BACTERIODES UNIFORMIS BETA-GLUCURONIDASE 1 BOUND TO D-GLUCARO-1;5- LACTONE 
775, 4es9C, 0.6004, 3.02, 0.067, 301, 89, CRYSTAL STRUCTURE OF THE ADHESIN DOMAIN OF EPF FROM STREPTOCOCCUS PYOGENES IN P21
776, 3g6jA, 0.6004, 3.37, 0.096, 642, 94, C3B IN COMPLEX WITH A C3B SPECIFIC FAB
777, 3fjvB, 0.6004, 3.48, 0.052, 175, 97, CRYSTAL STRUCTURE OF NOVEL PROTEIN OF UNKNOWN FUNCTION (YP_111841.1) FROM BURKHOLDERIA PSEUDOMALLEI K96243 AT 1.90 A RESOLUTION
778, 5t9gA, 0.6002, 3.68, 0.063, 810, 95, CRYSTAL STRUCTURE OF BUGH2CWT IN COMPLEX WITH GALACTOISOFAGOMINE
779, 6d1nA, 0.6001, 2.84, 0.068, 579, 88, APO STRUCTURE OF BACTEROIDES UNIFORMIS BETA-GLUCURONIDASE 1 
780, 2c9qA, 0.6001, 2.65, 0.059, 102, 85, CU(I)CU(II)-COPC AT PH 7.5
781, 1j0kA, 0.6001, 2.78, 0.035, 588, 85, CRYSTAL STRUCTURE OF NEOPULLULANASE E357Q COMPLEX WITH ISOPANOSE
782, 1j0jA, 0.6001, 2.65, 0.047, 588, 85, CRYSTAL STRUCTURE OF NEOPULLULANASE E357Q COMPLEX WITH MALTOTETRAOSE
783, 1j0hA, 0.6001, 2.62, 0.047, 588, 85, CRYSTAL STRUCTURE OF BACILLUS STEAROTHERMOPHILUS NEOPULLULANASE
784, 6nfqA, 0.6000, 2.61, 0.084, 96, 83, COPC FROM PSEUDOMONAS FLUORESCENS 
785, 5k3xA, 0.5999, 3.97, 0.103, 343, 97, CRYSTAL STRUCTURE OF THE SULFITE DEHYDROGENASE SORT R78K MUTANT FROM SINORHIZOBIUM MELILOTI
786, 5fucD, 0.5998, 2.76, 0.059, 198, 85, BIOPHYSICAL AND CELLULAR CHARACTERISATION OF A JUNCTIONAL EPITOPE ANTIBODY THAT LOCKS IL-6 AND GP80 TOGETHER IN A STABLE COMPLEX: IMPLICATIONS FOR NEW THERAPEUTIC STRATEGIES
787, 3cfuA, 0.5998, 3.43, 0.074, 141, 95, CRYSTAL STRUCTURE OF THE YJHA PROTEIN FROM BACILLUS SUBTILIS. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET SR562
788, 2d0fA, 0.5998, 2.76, 0.071, 637, 85, CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA- AMYLASE 1 (TVAI) MUTANT D356N COMPLEXED WITH P2 A PULLULAN MODEL OLIGOSACCHARIDE
789, 1uh4A, 0.5998, 2.76, 0.071, 637, 85, THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE 1/MALTO- TRIDECAOSE COMPLEX
790, 1ji1A, 0.5998, 2.77, 0.071, 637, 85, CRYSTAL STRUCTURE ANALYSIS OF THERMOACTINOMYCES VULGARIS R-47 ALPHA- AMYLASE 1
791, 2v8mC, 0.5997, 2.90, 0.091, 106, 88, CARBOHYDRATE-BINDING OF THE STARCH BINDING DOMAIN OF RHIZOPUS ORYZAE GLUCOAMYLASE IN COMPLEX WITH BETA- CYCLODEXTRIN AND MALTOHEPTAOSE
792, 5m6wA, 0.5996, 3.61, 0.094, 645, 96, PROPERDIN IN COMPLEX WITH ALTERNATIVE PATHWAY C3 CONVERTASE
793, 3qwrA, 0.5996, 3.40, 0.098, 295, 92, CRYSTAL STRUCTURE OF IL-23 IN COMPLEX WITH AN ADNECTIN
794, 2d0gA, 0.5996, 2.77, 0.071, 637, 85, CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA- AMYLASE 1 (TVAI) MUTANT D356N/E396Q COMPLEXED WITH P5 A PULLULAN MODEL OLIGOSACCHARIDE
795, 1uh2A, 0.5996, 2.76, 0.071, 637, 85, THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE/MALTO-HEXAOSE COMPLEX
796, 1p7bB, 0.5996, 3.14, 0.056, 258, 90, CRYSTAL STRUCTURE OF AN INWARD RECTIFIER POTASSIUM CHANNEL
797, 6dpsF, 0.5995, 3.06, 0.115, 120, 87, CRYSTAL STRUCTURE OF NEISSERIA MENINGITIDIS DSBD N-TERMINAL DOMAIN IN THE OXIDISED FORM 
798, 6d7fE, 0.5995, 2.84, 0.068, 579, 88, BACTEROIDES UNIFORMIS BETA-GLUCURONIDASE 1 BOUND TO THIOPHENYL-BETA-D- GLUCURONIDE 
799, 4lmhA, 0.5995, 3.03, 0.075, 693, 93, CRYSTAL STRUCTURE OF THE OUTER MEMBRANE DECAHEME CYTOCHROME OMCA
800, 2yeqB, 0.5995, 2.82, 0.069, 522, 87, STRUCTURE OF PHOD
801, 1ljmB, 0.5995, 3.44, 0.105, 114, 95, DNA RECOGNITION IS MEDIATED BY CONFORMATIONAL TRANSITION AND BY DNA BENDING
802, 6d6wB, 0.5994, 2.84, 0.068, 579, 88, BACTEROIDES UNIFORMIS BETA-GLUCURONIDASE 1 BOUND TO GLUCURONATE 
803, 6d6wA, 0.5994, 2.82, 0.068, 579, 88, BACTEROIDES UNIFORMIS BETA-GLUCURONIDASE 1 BOUND TO GLUCURONATE 
804, 4oy7G, 0.5994, 3.38, 0.064, 196, 94, STRUCTURE OF CELLULOSE ACTIVE LPMO CELS2 (SCLPMO10C) IN COMPLEX WITH COPPER.
805, 4es9D, 0.5994, 3.16, 0.056, 299, 90, CRYSTAL STRUCTURE OF THE ADHESIN DOMAIN OF EPF FROM STREPTOCOCCUS PYOGENES IN P21
806, 1ji1B, 0.5994, 2.77, 0.071, 637, 85, CRYSTAL STRUCTURE ANALYSIS OF THERMOACTINOMYCES VULGARIS R-47 ALPHA- AMYLASE 1
807, 1uh3A, 0.5993, 2.77, 0.071, 637, 85, THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE/ACARBOSE COMPLEX
808, 1fyhE, 0.5993, 3.27, 0.121, 201, 91, 1:1 COMPLEX BETWEEN AN INTERFERON GAMMA SINGLE-CHAIN VARIANT AND ITS RECEPTOR
809, 6d6wD, 0.5992, 2.82, 0.068, 579, 88, BACTEROIDES UNIFORMIS BETA-GLUCURONIDASE 1 BOUND TO GLUCURONATE 
810, 2c9pB, 0.5992, 2.69, 0.035, 102, 85, CU(I)CU(II)-COPC AT PH 4.5
811, 1p7bA, 0.5992, 3.15, 0.056, 258, 90, CRYSTAL STRUCTURE OF AN INWARD RECTIFIER POTASSIUM CHANNEL
812, 1na8B, 0.5992, 3.37, 0.135, 145, 96, CRYSTAL STRUCTURE OF ADP-RIBOSYLATION FACTOR BINDING PROTEIN GGA1
813, 6d6wC, 0.5991, 2.82, 0.068, 579, 88, BACTEROIDES UNIFORMIS BETA-GLUCURONIDASE 1 BOUND TO GLUCURONATE 
814, 5njdG, 0.5991, 3.42, 0.077, 293, 91, STRUCTURE OF INTERLEUKIN 23 IN COMPLEX WITH BRIAKINUMAB FAB
815, 4es9A, 0.5991, 3.20, 0.088, 296, 91, CRYSTAL STRUCTURE OF THE ADHESIN DOMAIN OF EPF FROM STREPTOCOCCUS PYOGENES IN P21
816, 5z0tA, 0.5989, 2.77, 0.071, 637, 85, THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE I (TVA I) MUTANT A357V/Q359N/Y360E (AQY/VNE)
817, 5t9gC, 0.5989, 3.70, 0.063, 811, 95, CRYSTAL STRUCTURE OF BUGH2CWT IN COMPLEX WITH GALACTOISOFAGOMINE
818, 6e3kC, 0.5988, 3.33, 0.088, 207, 91, INTERFERON GAMMA SIGNALLING COMPLEX WITH IFNGR1 AND IFNGR2 
819, 6d7fC, 0.5988, 3.05, 0.078, 579, 90, BACTEROIDES UNIFORMIS BETA-GLUCURONIDASE 1 BOUND TO THIOPHENYL-BETA-D- GLUCURONIDE 
820, 6d8kA, 0.5987, 2.88, 0.079, 570, 89, BACTEROIDES MULTIPLE SPECIES BETA-GLUCURONIDASE 
821, 6d89C, 0.5987, 3.04, 0.078, 571, 90, BACTEROIDES UNIFORMIS BETA-GLUCURONIDASE 1 WITH N-TERMINAL LOOP DELETION 
822, 5z0tB, 0.5987, 2.77, 0.071, 637, 85, THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE I (TVA I) MUTANT A357V/Q359N/Y360E (AQY/VNE)
823, 3mtxB, 0.5987, 3.75, 0.081, 140, 99, CRYSTAL STRUCTURE OF CHICKEN MD-1
824, 1izjA, 0.5987, 2.78, 0.071, 637, 85, THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE 1 MUTANT ENZYME F313A
825, 6h1zB, 0.5986, 3.50, 0.062, 227, 96, AFGH61B WILD-TYPE 
826, 3wcyA, 0.5986, 2.60, 0.093, 318, 86, MURINE IFNAR1 IN COMPLEX WITH INTERFERON-BETA
827, 2c9rA, 0.5985, 2.81, 0.059, 97, 85, APO-H91F COPC
828, 5njdI, 0.5984, 3.06, 0.090, 292, 89, STRUCTURE OF INTERLEUKIN 23 IN COMPLEX WITH BRIAKINUMAB FAB
829, 4eq3A, 0.5984, 3.14, 0.100, 203, 90, CRYSTAL STRUCTURE ANALYSIS OF SELENOMETHIONINE (SE-MET) SUBSTITUTED CHICKEN INTERFERON GAMMA RECEPTOR ALPHA CHAIN
830, 2ygtA, 0.5983, 3.60, 0.074, 282, 94, CLOSTRIDIUM PERFRINGENS DELTA-TOXIN
831, 5t9aB, 0.5982, 3.70, 0.063, 812, 95, CRYSTAL STRUCTURE OF BUGH2CWT
832, 5m5eB, 0.5982, 2.81, 0.093, 203, 86, CRYSTAL STRUCTURE OF A INTERLEUKIN-2 VARIANT IN COMPLEX WITH INTERLEUKIN-2 RECEPTOR
833, 2xwxA, 0.5982, 3.44, 0.032, 385, 94, VIBRIO CHOLERAE COLONIZATION FACTOR GBPA CRYSTAL STRUCTURE
834, 1eanA, 0.5982, 3.40, 0.129, 114, 93, THE RUNX1 RUNT DOMAIN AT 1.70A RESOLUTION: A STRUCTURAL SWITCH AND SPECIFICALLY BOUND CHLORIDE IONS MODULATE DNA BINDING
835, 6h3jC, 0.5981, 3.11, 0.099, 397, 91, STRUCTURAL SNAPSHOTS OF THE TYPE 9 PROTEIN TRANSLOCON PLUG-COMPLEX 
836, 5t9aC, 0.5981, 3.68, 0.063, 811, 95, CRYSTAL STRUCTURE OF BUGH2CWT
837, 2c9pA, 0.5981, 2.73, 0.035, 102, 85, CU(I)CU(II)-COPC AT PH 4.5
838, 1izkA, 0.5981, 2.78, 0.071, 637, 85, THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE 1 MUTANT ENZYME W398V
839, 1y6mR, 0.5980, 2.83, 0.045, 204, 88, CRYSTAL STRUCTURE OF EPSTEIN-BARR VIRUS IL-10 COMPLEXED WITH THE SOLUBLE IL-10R1 CHAIN
840, 6d8kB, 0.5979, 2.91, 0.079, 571, 89, BACTEROIDES MULTIPLE SPECIES BETA-GLUCURONIDASE 
841, 4es8A, 0.5979, 3.27, 0.088, 302, 91, CRYSTAL STRUCTURE OF THE ADHESIN DOMAIN OF EPF FROM STREPTOCOCCUS PYOGENES IN P212121
842, 6e3lC, 0.5978, 3.34, 0.088, 204, 91, INTERFERON GAMMA SIGNALLING COMPLEX WITH IFNGR1 AND IFNGR2 
843, 4ow5A, 0.5978, 3.74, 0.073, 307, 96, STRUCTURAL BASIS FOR THE ENHANCEMENT OF VIRULENCE BY ENTOMOPOXVIRUS FUSOLIN AND ITS IN VIVO CRYSTALLIZATION INTO VIRAL SPINDLES
844, 3aqxA, 0.5978, 2.62, 0.108, 101, 83, CRYSTAL STRUCTURE OF BOMBYX MORI BETA-GRP/GNBP3 N-TERMINAL DOMAIN WITH LAMINARIHEXAOSES
845, 6haqB, 0.5977, 3.39, 0.053, 227, 95, AFGH61B WILD-TYPE COPPER LOADED 
846, 6dpsA, 0.5977, 2.93, 0.116, 122, 86, CRYSTAL STRUCTURE OF NEISSERIA MENINGITIDIS DSBD N-TERMINAL DOMAIN IN THE OXIDISED FORM 
847, 6cpdB, 0.5977, 3.15, 0.118, 127, 93, CRYSTAL STRUCTURE OF PMOD SOLUBLE DOMAIN FROM METHYLOCYSTIS SP. ATCC 49242 (ROCKWELL) 
848, 4es9B, 0.5977, 3.19, 0.067, 300, 90, CRYSTAL STRUCTURE OF THE ADHESIN DOMAIN OF EPF FROM STREPTOCOCCUS PYOGENES IN P21
849, 1fyhB, 0.5977, 3.08, 0.111, 201, 90, 1:1 COMPLEX BETWEEN AN INTERFERON GAMMA SINGLE-CHAIN VARIANT AND ITS RECEPTOR
850, 5t9aD, 0.5976, 3.69, 0.063, 811, 95, CRYSTAL STRUCTURE OF BUGH2CWT
851, 5k59A, 0.5976, 3.40, 0.098, 292, 92, CRYSTAL STRUCTURE OF LUKGH FROM STAPHYLOCOCCUS AUREUS IN COMPLEX WITH A NEUTRALISING ANTIBODY
852, 2wllA, 0.5976, 3.25, 0.033, 264, 91, POTASSIUM CHANNEL FROM BURKHOLDERIA PSEUDOMALLEI
853, 2v8lA, 0.5976, 2.95, 0.091, 106, 88, CARBOHYDRATE-BINDING OF THE STARCH BINDING DOMAIN OF RHIZOPUS ORYZAE GLUCOAMYLASE IN COMPLEX WITH BETA- CYCLODEXTRIN AND MALTOHEPTAOSE
854, 5t9gB, 0.5975, 3.66, 0.063, 810, 95, CRYSTAL STRUCTURE OF BUGH2CWT IN COMPLEX WITH GALACTOISOFAGOMINE
855, 3ie4A, 0.5975, 2.57, 0.060, 101, 83, B-GLUCAN BINDING DOMAIN OF DROSOPHILA GNBP3 DEFINES A NOVEL FAMILY OF PATTERN RECOGNITION RECEPTOR
856, 6h1zA, 0.5974, 3.52, 0.062, 227, 96, AFGH61B WILD-TYPE 
857, 6dpsB, 0.5974, 2.92, 0.116, 122, 86, CRYSTAL STRUCTURE OF NEISSERIA MENINGITIDIS DSBD N-TERMINAL DOMAIN IN THE OXIDISED FORM 
858, 4oy6A, 0.5974, 3.20, 0.067, 186, 89, STRUCTURE OF SCLPMO10B IN COMPLEX WITH COPPER.
859, 5njdA, 0.5973, 3.05, 0.090, 298, 89, STRUCTURE OF INTERLEUKIN 23 IN COMPLEX WITH BRIAKINUMAB FAB
860, 5mzvA, 0.5973, 3.49, 0.076, 303, 92, IL-23:IL-23R:NB22E11 COMPLEX
861, 6d41B, 0.5972, 3.06, 0.078, 579, 90, BACTERIODES UNIFORMIS BETA-GLUCURONIDASE 1 BOUND TO D-GLUCARO-1;5- LACTONE 
862, 5z0uA, 0.5972, 2.79, 0.071, 626, 85, THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE I (TVA I) 11 RESIDUES (FROM A363 TO N373) DELETION MUTANT (DEL11)
863, 3aqzA, 0.5972, 2.58, 0.084, 100, 83, CRYSTAL STRUCTURE OF PLODIA INTERPUNCTELLA BETA-GRP/GNBP3 N-TERMINAL DOMAIN WITH LAMINARIHEXAOSES
864, 2ymtA, 0.5972, 3.55, 0.094, 122, 96, GAMMA 2 ADAPTIN EAR DOMAIN CRYSTAL STRUCTURE WITH PHAGE PEPTIDE GEEWGPWV
865, 1ea9C, 0.5972, 2.63, 0.058, 583, 86, CYCLOMALTODEXTRINASE
866, 4ziqA, 0.5971, 3.14, 0.056, 1450, 90, CRYSTAL STRUCTURE OF TRYPSIN ACTIVATED ALPHA-2-MACROGLOBULIN FROM ESCHERICHIA COLI.
867, 3duhB, 0.5970, 3.60, 0.096, 294, 94, STRUCTURE OF INTERLEUKIN-23
868, 2yoyB, 0.5969, 3.29, 0.055, 178, 91, BACILLUS AMYLOLIQUEFACIENS CBM33 IN COMPLEX WITH CU(I) REDUCED USING ASCORBATE
869, 1pvhA, 0.5969, 2.80, 0.046, 201, 87, CRYSTAL STRUCTURE OF LEUKEMIA INHIBITORY FACTOR IN COMPLEX WITH GP130
870, 2yoyA, 0.5968, 3.30, 0.055, 178, 91, BACILLUS AMYLOLIQUEFACIENS CBM33 IN COMPLEX WITH CU(I) REDUCED USING ASCORBATE
871, 2wbkB, 0.5968, 3.90, 0.069, 840, 101, STRUCTURE OF THE MICHAELIS COMPLEX OF BETA-MANNOSIDASE MAN2A PROVIDES INSIGHT INTO THE CONFORMATIONAL ITINERARY OF MANNOSIDE HYDROLYSIS
872, 2v8mD, 0.5968, 2.99, 0.115, 106, 87, CARBOHYDRATE-BINDING OF THE STARCH BINDING DOMAIN OF RHIZOPUS ORYZAE GLUCOAMYLASE IN COMPLEX WITH BETA- CYCLODEXTRIN AND MALTOHEPTAOSE
873, 5njdK, 0.5967, 3.06, 0.090, 297, 89, STRUCTURE OF INTERLEUKIN 23 IN COMPLEX WITH BRIAKINUMAB FAB
874, 5njdC, 0.5967, 3.05, 0.090, 294, 89, STRUCTURE OF INTERLEUKIN 23 IN COMPLEX WITH BRIAKINUMAB FAB
875, 6cpdA, 0.5964, 3.05, 0.140, 126, 93, CRYSTAL STRUCTURE OF PMOD SOLUBLE DOMAIN FROM METHYLOCYSTIS SP. ATCC 49242 (ROCKWELL) 
876, 6d1nB, 0.5963, 3.07, 0.078, 579, 90, APO STRUCTURE OF BACTEROIDES UNIFORMIS BETA-GLUCURONIDASE 1 
877, 3aqzB, 0.5963, 2.60, 0.084, 102, 83, CRYSTAL STRUCTURE OF PLODIA INTERPUNCTELLA BETA-GRP/GNBP3 N-TERMINAL DOMAIN WITH LAMINARIHEXAOSES
878, 5ijuB, 0.5962, 3.27, 0.044, 178, 91, STRUCTURE OF AN AA10 LYTIC POLYSACCHARIDE MONOOXYGENASE FROM BACILLUS AMYLOLIQUEFACIENS WITH CU(II) BOUND
879, 1bquA, 0.5962, 2.85, 0.034, 208, 87, CYTOKYNE-BINDING REGION OF GP130
880, 4oy7A, 0.5961, 3.29, 0.054, 196, 93, STRUCTURE OF CELLULOSE ACTIVE LPMO CELS2 (SCLPMO10C) IN COMPLEX WITH COPPER.
881, 2j6wA, 0.5961, 3.60, 0.094, 124, 96, R164N MUTANT OF THE RUNX1 RUNT DOMAIN
882, 1pvhC, 0.5961, 2.81, 0.046, 201, 87, CRYSTAL STRUCTURE OF LEUKEMIA INHIBITORY FACTOR IN COMPLEX WITH GP130
883, 2erjB, 0.5960, 2.92, 0.081, 204, 86, CRYSTAL STRUCTURE OF THE HETEROTRIMERIC INTERLEUKIN-2 RECEPTOR IN COMPLEX WITH INTERLEUKIN-2
884, 4oy7B, 0.5959, 3.52, 0.063, 196, 95, STRUCTURE OF CELLULOSE ACTIVE LPMO CELS2 (SCLPMO10C) IN COMPLEX WITH COPPER.
885, 3aqxB, 0.5958, 2.60, 0.108, 100, 83, CRYSTAL STRUCTURE OF BOMBYX MORI BETA-GRP/GNBP3 N-TERMINAL DOMAIN WITH LAMINARIHEXAOSES
886, 5t9aA, 0.5957, 3.71, 0.063, 811, 95, CRYSTAL STRUCTURE OF BUGH2CWT
887, 4x27A, 0.5957, 3.59, 0.105, 307, 95, STRUCTURAL BASIS FOR THE ENHANCEMENT OF VIRULENCE BY ENTOMOPOXVIRUS FUSOLIN AND ITS IN VIVO CRYSTALLIZATION INTO VIRAL SPINDLES (COMPLEX WITH COPPER)
888, 3duhA, 0.5957, 3.40, 0.098, 300, 92, STRUCTURE OF INTERLEUKIN-23
889, 3qazH, 0.5956, 2.46, 0.098, 196, 82, IL-2 MUTANT D10 TERNARY COMPLEX
890, 3ie4B, 0.5956, 2.62, 0.060, 101, 83, B-GLUCAN BINDING DOMAIN OF DROSOPHILA GNBP3 DEFINES A NOVEL FAMILY OF PATTERN RECOGNITION RECEPTOR
891, 4yn1A, 0.5954, 3.48, 0.096, 261, 94, THE ATOMIC STRUCTURE OF ANOMALA CUPREA ENTOMOPOXVIRUS (ACEPV) FUSOLIN SPINDLES
892, 2yoxB, 0.5953, 3.40, 0.043, 178, 93, BACILLUS AMYLOLIQUEFACIENS CBM33 IN COMPLEX WITH CU(I) AFTER PHOTOREDUCTION
893, 2q3xB, 0.5953, 3.52, 0.170, 140, 94, THE RIM1ALPHA C2B DOMAIN
894, 1gywA, 0.5953, 3.48, 0.094, 126, 96, GAMMA-ADAPTIN APPENDAGE DOMAIN FROM CLATHRIN ADAPTOR AP1 A753D MUTANT
895, 1gviA, 0.5953, 2.59, 0.070, 588, 86, THERMUS MALTOGENIC AMYLASE IN COMPLEX WITH BETA-CD
896, 6d7fB, 0.5952, 3.03, 0.067, 579, 89, BACTEROIDES UNIFORMIS BETA-GLUCURONIDASE 1 BOUND TO THIOPHENYL-BETA-D- GLUCURONIDE 
897, 4p05B, 0.5952, 2.88, 0.193, 564, 88, BACTERIAL ARYLSULFATE SULFOTRANSFERASE (ASST) H436N MUTANT WITH 4- NITROPHENYL SULFATE (PNS) IN THE ACTIVE SITE
898, 2yoxA, 0.5952, 3.30, 0.055, 178, 91, BACILLUS AMYLOLIQUEFACIENS CBM33 IN COMPLEX WITH CU(I) AFTER PHOTOREDUCTION
899, 5cgmB, 0.5951, 3.47, 0.076, 667, 92, STRUCTURE OF MYCOBACTERIUM THERMORESISTIBILE GLGE IN COMPLEX WITH MALTOSE AT 1.95A RESOLUTION
900, 1j0hB, 0.5951, 2.57, 0.070, 588, 86, CRYSTAL STRUCTURE OF BACILLUS STEAROTHERMOPHILUS NEOPULLULANASE
901, 4grwD, 0.5950, 3.22, 0.088, 292, 91, STRUCTURE OF A COMPLEX OF HUMAN IL-23 WITH 3 NANOBODIES (LLAMA VHHS)
902, 2yowB, 0.5950, 3.25, 0.044, 178, 91, BACILLUS AMYLOLIQUEFACIENS CBM33
903, 2vr4A, 0.5950, 4.05, 0.069, 835, 102, TRANSITION-STATE MIMICRY IN MANNOSIDE HYDROLYSIS: CHARACTERISATION OF TWENTY SIX INHIBITORS AND INSIGHT INTO BINDING FROM LINEAR FREE ENERGY RELATIONSHIPS AND 3-D STRUCTURE
904, 6haqA, 0.5949, 3.45, 0.053, 226, 95, AFGH61B WILD-TYPE COPPER LOADED 
905, 6ha5B, 0.5949, 3.54, 0.062, 227, 96, AFGH61B L90V/D131S/M134L/A141W VARIANT 
906, 4a02A, 0.5949, 3.24, 0.055, 166, 91, X-RAY CRYSTALLOGRAPHIC STRUCTURE OF EFCBM33A
907, 3bplC, 0.5949, 2.85, 0.081, 194, 86, CRYSTAL STRUCTURE OF THE IL4-IL4R-COMMON GAMMA TERNARY COMPLEX
908, 2xwxB, 0.5949, 3.47, 0.032, 385, 94, VIBRIO CHOLERAE COLONIZATION FACTOR GBPA CRYSTAL STRUCTURE
909, 5uwcG, 0.5948, 3.20, 0.022, 253, 93, CYTOKINE-RECEPTOR COMPLEX
910, 5l2vA, 0.5948, 3.39, 0.076, 166, 92, CATALYTIC DOMAIN OF LPMO LMO2467 FROM LISTERIA MONOCYTOGENES
911, 4p05A, 0.5948, 2.89, 0.193, 564, 88, BACTERIAL ARYLSULFATE SULFOTRANSFERASE (ASST) H436N MUTANT WITH 4- NITROPHENYL SULFATE (PNS) IN THE ACTIVE SITE
912, 3ettA, 0.5948, 2.89, 0.193, 564, 88, CRYSTAL STRUCTURE OF A BACTERIAL ARYLSULFATE SULFOTRANSFERASE CATALYTIC INTERMEDIATE WITH 4-NITROPHENOL BOUND IN THE ACTIVE SITE
913, 3etsA, 0.5948, 2.99, 0.193, 562, 88, CRYSTAL STRUCTURE OF A BACTERIAL ARYLSULFATE SULFOTRANSFERASE CATALYTIC INTERMEDIATE WITH 4- METHYLUMBELLIFERONE BOUND IN THE ACTIVE SITE
914, 2vquB, 0.5947, 3.90, 0.069, 840, 101, STRUCTURAL AND BIOCHEMICAL EVIDENCE FOR A BOAT-LIKE TRANSITION STATE IN BETA-MANNOSIDASES
915, 4x29A, 0.5946, 3.61, 0.084, 306, 95, STRUCTURAL BASIS FOR THE ENHANCEMENT OF VIRULENCE BY ENTOMOPOXVIRUS FUSOLIN AND ITS IN VIVO CRYSTALLIZATION INTO VIRAL SPINDLES (COMPLEX WITH ZINC)
916, 3spjA, 0.5946, 3.21, 0.065, 321, 92, APO INWARD RECTIFIER POTASSIUM CHANNEL KIR2.2 I223L MUTANT
917, 5twvG, 0.5945, 3.36, 0.074, 325, 95, CRYO-EM STRUCTURE OF THE PANCREATIC ATP-SENSITIVE K+ CHANNEL SUR1/KIR6.2 IN THE PRESENCE OF ATP AND GLIBENCLAMIDE
918, 5twvE, 0.5945, 3.36, 0.074, 325, 95, CRYO-EM STRUCTURE OF THE PANCREATIC ATP-SENSITIVE K+ CHANNEL SUR1/KIR6.2 IN THE PRESENCE OF ATP AND GLIBENCLAMIDE
919, 5twvC, 0.5945, 3.36, 0.074, 325, 95, CRYO-EM STRUCTURE OF THE PANCREATIC ATP-SENSITIVE K+ CHANNEL SUR1/KIR6.2 IN THE PRESENCE OF ATP AND GLIBENCLAMIDE
920, 5twvA, 0.5945, 3.36, 0.074, 325, 95, CRYO-EM STRUCTURE OF THE PANCREATIC ATP-SENSITIVE K+ CHANNEL SUR1/KIR6.2 IN THE PRESENCE OF ATP AND GLIBENCLAMIDE
921, 2yowA, 0.5945, 3.26, 0.044, 178, 91, BACILLUS AMYLOLIQUEFACIENS CBM33
922, 4bcxA, 0.5944, 3.57, 0.083, 120, 96, GAMMA 2 ADAPTIN EAR DOMAIN CRYSTAL STRUCTURE
923, 5ijuA, 0.5943, 3.30, 0.055, 178, 91, STRUCTURE OF AN AA10 LYTIC POLYSACCHARIDE MONOOXYGENASE FROM BACILLUS AMYLOLIQUEFACIENS WITH CU(II) BOUND
924, 4p04B, 0.5943, 2.91, 0.193, 563, 88, APO FORM OF BACTERIAL ARYLSULFATE SULFOTRANSFERASE (ASST) H436N MUTANT WITH MPO IN THE ACTIVE SITE
925, 2votB, 0.5943, 3.91, 0.069, 839, 101, STRUCTURAL AND BIOCHEMICAL EVIDENCE FOR A BOAT-LIKE TRANSITION STATE IN BETA-MANNOSIDASES
926, 2vl4B, 0.5942, 3.96, 0.069, 841, 101, STRUCTURAL AND BIOCHEMICAL EVIDENCE FOR A BOAT-LIKE TRANSITION STATE IN BETA-MANNOSIDASES
927, 4oy7D, 0.5941, 3.42, 0.064, 196, 94, STRUCTURE OF CELLULOSE ACTIVE LPMO CELS2 (SCLPMO10C) IN COMPLEX WITH COPPER.
928, 4p04A, 0.5940, 2.91, 0.193, 567, 88, APO FORM OF BACTERIAL ARYLSULFATE SULFOTRANSFERASE (ASST) H436N MUTANT WITH MPO IN THE ACTIVE SITE
929, 3ettB, 0.5940, 2.90, 0.193, 564, 88, CRYSTAL STRUCTURE OF A BACTERIAL ARYLSULFATE SULFOTRANSFERASE CATALYTIC INTERMEDIATE WITH 4-NITROPHENOL BOUND IN THE ACTIVE SITE
930, 2erjF, 0.5940, 2.80, 0.071, 201, 85, CRYSTAL STRUCTURE OF THE HETEROTRIMERIC INTERLEUKIN-2 RECEPTOR IN COMPLEX WITH INTERLEUKIN-2
931, 1iu1A, 0.5940, 3.47, 0.094, 120, 96, CRYSTAL STRUCTURE OF HUMAN GAMMA1-ADAPTIN EAR DOMAIN
932, 5l2vB, 0.5939, 3.30, 0.077, 166, 91, CATALYTIC DOMAIN OF LPMO LMO2467 FROM LISTERIA MONOCYTOGENES
933, 2vr4B, 0.5939, 3.92, 0.069, 841, 101, TRANSITION-STATE MIMICRY IN MANNOSIDE HYDROLYSIS: CHARACTERISATION OF TWENTY SIX INHIBITORS AND INSIGHT INTO BINDING FROM LINEAR FREE ENERGY RELATIONSHIPS AND 3-D STRUCTURE
934, 1smaB, 0.5939, 2.63, 0.070, 588, 86, CRYSTAL STRUCTURE OF A MALTOGENIC AMYLASE
935, 1smaA, 0.5939, 2.63, 0.070, 588, 86, CRYSTAL STRUCTURE OF A MALTOGENIC AMYLASE
936, 5wa0D, 0.5938, 3.80, 0.116, 365, 95, CRYSTAL STRUCTURE OF THE SULFITE DEHYDROGENASE SORT R78Q MUTANT FROM SINORHIZOBIUM MELILOTI
937, 4p07A, 0.5938, 2.90, 0.193, 570, 88, BACTERIAL ARYL SULFOTRANSFERASE (ASST) SOAKED WITH HUMAN URINE
938, 4oy8A, 0.5938, 3.20, 0.067, 186, 90, STRUCTURE OF SCLPMO10B IN COMPLEX WITH ZINC.
939, 4lmhB, 0.5938, 3.06, 0.086, 694, 93, CRYSTAL STRUCTURE OF THE OUTER MEMBRANE DECAHEME CYTOCHROME OMCA
940, 3aqyB, 0.5938, 2.55, 0.085, 99, 82, CRYSTAL STRUCTURE OF PLODIA INTERPUNCTELLA BETA-GRP/GNBP3 N-TERMINAL DOMAIN
941, 2qkiA, 0.5938, 3.47, 0.021, 631, 96, HUMAN C3C IN COMPLEX WITH THE INHIBITOR COMPSTATIN
942, 3di3B, 0.5937, 3.04, 0.047, 193, 86, CRYSTAL STRUCTURE OF THE COMPLEX OF HUMAN INTERLEUKIN-7 WITH GLYCOSYLATED HUMAN INTERLEUKIN-7 RECEPTOR ALPHA ECTODOMAIN
943, 6dpsD, 0.5936, 3.01, 0.116, 124, 86, CRYSTAL STRUCTURE OF NEISSERIA MENINGITIDIS DSBD N-TERMINAL DOMAIN IN THE OXIDISED FORM 
944, 2vqtB, 0.5936, 3.78, 0.091, 839, 99, STRUCTURAL AND BIOCHEMICAL EVIDENCE FOR A BOAT-LIKE TRANSITION STATE IN BETA-MANNOSIDASES
945, 1ljmA, 0.5936, 3.52, 0.106, 114, 94, DNA RECOGNITION IS MEDIATED BY CONFORMATIONAL TRANSITION AND BY DNA BENDING
946, 1d01F, 0.5936, 2.97, 0.034, 168, 88, STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A HUMAN CD30 PEPTIDE
947, 6ha5A, 0.5935, 3.55, 0.062, 227, 96, AFGH61B L90V/D131S/M134L/A141W VARIANT 
948, 4p07B, 0.5935, 2.91, 0.193, 570, 88, BACTERIAL ARYL SULFOTRANSFERASE (ASST) SOAKED WITH HUMAN URINE
949, 1d01D, 0.5935, 2.97, 0.034, 168, 88, STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A HUMAN CD30 PEPTIDE
950, 4grwB, 0.5934, 3.13, 0.090, 293, 89, STRUCTURE OF A COMPLEX OF HUMAN IL-23 WITH 3 NANOBODIES (LLAMA VHHS)
951, 3zhfA, 0.5934, 3.58, 0.083, 123, 96, GAMMA 2 ADAPTIN EAR DOMAIN CRYSTAL STRUCTURE WITH PRES1 SITE1 PEPTIDE NPDWDFN
952, 3qazK, 0.5934, 2.49, 0.085, 196, 82, IL-2 MUTANT D10 TERNARY COMPLEX
953, 3etsB, 0.5934, 2.90, 0.193, 563, 88, CRYSTAL STRUCTURE OF A BACTERIAL ARYLSULFATE SULFOTRANSFERASE CATALYTIC INTERMEDIATE WITH 4- METHYLUMBELLIFERONE BOUND IN THE ACTIVE SITE
954, 2yn3A, 0.5934, 2.84, 0.080, 270, 87, STRUCTURAL INSIGHT INTO THE GIANT CALCIUM-BINDING ADHESIN SIIE: IMPLICATIONS FOR THE ADHESION OF SALMONELLA ENTERICA TO POLARIZED EPITHELIAL CELLS
955, 2je8B, 0.5934, 4.06, 0.069, 841, 102, STRUCTURE OF A BETA-MANNOSIDASE FROM BACTEROIDES THETAIOTAOMICRON
956, 3qazi, 0.5933, 2.51, 0.073, 196, 82, IL-2 MUTANT D10 TERNARY COMPLEX
957, 3hs8A, 0.5933, 3.56, 0.117, 238, 94, INTERSECTIN 1-PEPTIDE-AP2 ALPHA EAR COMPLEX
958, 5wa0A, 0.5932, 3.83, 0.116, 365, 95, CRYSTAL STRUCTURE OF THE SULFITE DEHYDROGENASE SORT R78Q MUTANT FROM SINORHIZOBIUM MELILOTI
959, 5ak7A, 0.5932, 3.81, 0.093, 419, 97, STRUCTURE OF WT PORPHYROMONAS GINGIVALIS PEPTIDYLARGININE DEIMINASE
960, 4pw9A, 0.5932, 3.83, 0.105, 363, 95, CRYSTAL STRUCTURE OF THE ELECTRON-TRANSFER COMPLEX FORMED BETWEEN A SULFITE DEHYDROGENASE AND A C-TYPE CYTOCHROME FROM SINORHIZOBIUM MELILOTI
961, 2vqtA, 0.5932, 3.93, 0.069, 836, 101, STRUCTURAL AND BIOCHEMICAL EVIDENCE FOR A BOAT-LIKE TRANSITION STATE IN BETA-MANNOSIDASES
962, 1d01E, 0.5932, 2.98, 0.034, 168, 88, STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A HUMAN CD30 PEPTIDE
963, 5wa0C, 0.5930, 3.79, 0.126, 365, 95, CRYSTAL STRUCTURE OF THE SULFITE DEHYDROGENASE SORT R78Q MUTANT FROM SINORHIZOBIUM MELILOTI
964, 3qc6X, 0.5930, 3.28, 0.108, 351, 93, GSPB
965, 5wa0B, 0.5929, 3.80, 0.126, 365, 95, CRYSTAL STRUCTURE OF THE SULFITE DEHYDROGENASE SORT R78Q MUTANT FROM SINORHIZOBIUM MELILOTI
966, 5j12B, 0.5929, 2.83, 0.036, 194, 84, CYTOKINE RECEPTOR COMPLEX
967, 3elqA, 0.5929, 2.91, 0.193, 564, 88, CRYSTAL STRUCTURE OF A BACTERIAL ARYLSULFATE SULFOTRANSFERASE
968, 2vjxA, 0.5927, 3.93, 0.079, 836, 101, STRUCTURAL AND BIOCHEMICAL EVIDENCE FOR A BOAT-LIKE TRANSITION STATE IN BETA-MANNOSIDASES
969, 5opfA, 0.5926, 3.35, 0.011, 194, 93, STRUCTURE OF LPMO10B FROM FROM MICROMONOSPORA AURANTIACA
970, 4p06B, 0.5926, 2.90, 0.193, 564, 88, BACTERIAL ARYLSULFATE SULFOTRANSFERASE (ASST) H436N MUTANT WITH 4- METHYLUMBELLIFERYL SULFATE (MUS) IN THE ACTIVE SITE
971, 4nn5B, 0.5926, 2.87, 0.035, 197, 85, CYTOKINE RECEPTOR COMPLEX - CRYSTAL FORM 1A
972, 5u9mD, 0.5925, 3.30, 0.065, 234, 93, COPPER-ZINC SUPEROXIDE DISMUTASE IS ACTIVATED THROUGH A SULFENIC ACID INTERMEDIATE AT A COPPER-ION ENTRY SITE
973, 4oy7H, 0.5925, 3.29, 0.065, 195, 92, STRUCTURE OF CELLULOSE ACTIVE LPMO CELS2 (SCLPMO10C) IN COMPLEX WITH COPPER.
974, 2votA, 0.5925, 3.97, 0.100, 837, 100, STRUCTURAL AND BIOCHEMICAL EVIDENCE FOR A BOAT-LIKE TRANSITION STATE IN BETA-MANNOSIDASES
975, 2vmfA, 0.5925, 3.92, 0.069, 835, 101, STRUCTURAL AND BIOCHEMICAL EVIDENCE FOR A BOAT-LIKE TRANSITION STATE IN BETA-MANNOSIDASES
976, 3qazE, 0.5924, 2.48, 0.085, 196, 82, IL-2 MUTANT D10 TERNARY COMPLEX
977, 4pw3D, 0.5922, 3.83, 0.116, 365, 95, CRYSTAL STRUCTURE OF THE SULFITE DEHYDROGENASE SORT FROM SINORHIZOBIUM MELILOTI
978, 4pw3B, 0.5922, 3.83, 0.116, 363, 95, CRYSTAL STRUCTURE OF THE SULFITE DEHYDROGENASE SORT FROM SINORHIZOBIUM MELILOTI
979, 3qazf, 0.5922, 2.52, 0.085, 196, 82, IL-2 MUTANT D10 TERNARY COMPLEX
980, 1gviB, 0.5922, 2.69, 0.057, 588, 87, THERMUS MALTOGENIC AMYLASE IN COMPLEX WITH BETA-CD
981, 5k3xB, 0.5921, 3.85, 0.116, 345, 95, CRYSTAL STRUCTURE OF THE SULFITE DEHYDROGENASE SORT R78K MUTANT FROM SINORHIZOBIUM MELILOTI
982, 4pw3C, 0.5921, 3.83, 0.116, 365, 95, CRYSTAL STRUCTURE OF THE SULFITE DEHYDROGENASE SORT FROM SINORHIZOBIUM MELILOTI
983, 4pw3A, 0.5921, 3.83, 0.116, 365, 95, CRYSTAL STRUCTURE OF THE SULFITE DEHYDROGENASE SORT FROM SINORHIZOBIUM MELILOTI
984, 2vo5B, 0.5921, 3.94, 0.069, 841, 101, STRUCTURAL AND BIOCHEMICAL EVIDENCE FOR A BOAT-LIKE TRANSITION STATE IN BETA-MANNOSIDASES
985, 2d0hA, 0.5921, 2.81, 0.071, 637, 85, CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA- AMYLASE 1 (TVAI) MUTANT D356N/E396Q COMPLEXED WITH P2 A PULLULAN MODEL OLIGOSACCHARIDE
986, 3elqB, 0.5920, 2.91, 0.193, 566, 88, CRYSTAL STRUCTURE OF A BACTERIAL ARYLSULFATE SULFOTRANSFERASE
987, 3qazT, 0.5919, 2.47, 0.085, 196, 82, IL-2 MUTANT D10 TERNARY COMPLEX
988, 3gm8A, 0.5919, 3.36, 0.118, 770, 93, CRYSTAL STRUCTURE OF A BETA-GLYCOSIDASE FROM BACTEROIDES VULGATUS
989, 1u4fB, 0.5919, 3.30, 0.043, 195, 92, CRYSTAL STRUCTURE OF CYTOPLASMIC DOMAINS OF IRK1 (KIR2.1) CHANNEL
990, 6d8kC, 0.5918, 2.86, 0.080, 569, 88, BACTEROIDES MULTIPLE SPECIES BETA-GLUCURONIDASE 
991, 2hkaA, 0.5918, 3.31, 0.096, 130, 94, CRYSTAL STRUCTURE OF BOVINE NPC2 AND CHOLESTEROL SULFATE COMPLEX
992, 1lqsS, 0.5918, 2.86, 0.045, 206, 88, CRYSTAL STRUCTURE OF HUMAN CYTOMEGALOVIRUS IL-10 BOUND TO SOLUBLE HUMAN IL-10R1
993, 4qi8A, 0.5917, 3.78, 0.061, 214, 98, LYTIC POLYSACCHARIDE MONOOXYGENASE 9F FROM NEUROSPORA CRASSA NCLPMO9F
994, 4p06A, 0.5917, 2.93, 0.193, 564, 88, BACTERIAL ARYLSULFATE SULFOTRANSFERASE (ASST) H436N MUTANT WITH 4- METHYLUMBELLIFERYL SULFATE (MUS) IN THE ACTIVE SITE
995, 4alrA, 0.5917, 3.32, 0.044, 166, 91, X-RAY PHOTOREDUCTION OF POLYSACCHARIDE MONOOXYGENASE CBM33
996, 4alcA, 0.5917, 3.32, 0.044, 166, 91, X-RAY PHOTOREDUCTION OF POLYSACCHARIDE MONOOXIGENASE CBM33
997, 3jycA, 0.5917, 3.30, 0.076, 321, 92, CRYSTAL STRUCTURE OF THE EUKARYOTIC STRONG INWARD-RECTIFIER K+ CHANNEL KIR2.2 AT 3.1 ANGSTROM RESOLUTION
998, 4altA, 0.5916, 3.33, 0.044, 166, 91, X-RAY PHOTOREDUCTION OF POLYSACCHARIDE MONOOXYGENASE CBM33
999, 4alqA, 0.5916, 3.33, 0.044, 166, 91, X-RAY PHOTOREDUCTION OF POLYSACCHARIDE MONOOXYGENASE CBM33
1000, 4alsA, 0.5915, 3.33, 0.044, 166, 91, X-RAY PHOTOREDUCTION OF POLYSACCHARIDE MONOOXYGENASE CBM33
1001, 4aleA, 0.5915, 3.33, 0.044, 166, 91, STRUCTURE CHANGES OF POLYSACCHARIDE MONOOXYGENASE CBM33A FROM ENTEROCOCCUS FAECALIS BY X-RAY INDUCED PHOTOREDUCTION.
1002, 3szkF, 0.5915, 2.74, 0.091, 141, 88, CRYSTAL STRUCTURE OF HUMAN METHAEMOGLOBIN COMPLEXED WITH THE FIRST NEAT DOMAIN OF ISDH FROM STAPHYLOCOCCUS AUREUS
1003, 2vjxB, 0.5915, 3.89, 0.050, 839, 101, STRUCTURAL AND BIOCHEMICAL EVIDENCE FOR A BOAT-LIKE TRANSITION STATE IN BETA-MANNOSIDASES
1004, 6e3kD, 0.5914, 3.34, 0.111, 203, 90, INTERFERON GAMMA SIGNALLING COMPLEX WITH IFNGR1 AND IFNGR2 
1005, 5f7uA, 0.5914, 2.93, 0.080, 1059, 87, CYCLOALTERNAN-FORMING ENZYME FROM LISTERIA MONOCYTOGENES IN COMPLEX WITH PENTASACCHARIDE SUBSTRATE
1006, 4lmhD, 0.5914, 3.07, 0.075, 695, 93, CRYSTAL STRUCTURE OF THE OUTER MEMBRANE DECAHEME CYTOCHROME OMCA
1007, 3qazc, 0.5914, 2.48, 0.098, 196, 82, IL-2 MUTANT D10 TERNARY COMPLEX
1008, 3qazW, 0.5914, 2.48, 0.098, 196, 82, IL-2 MUTANT D10 TERNARY COMPLEX
1009, 5o4uF, 0.5913, 3.07, 0.114, 207, 88, THE FLAGELLIN OF PYROCOCCUS FURIOSUS
1010, 5ya6A, 0.5912, 3.01, 0.136, 163, 88, CRYSTAL STRUCTURE OF ARCHAEAL FLAGELLIN FLAB1 FROM METHANOCALDOCOCCUS JANNASCHII 
1011, 5o4uH, 0.5912, 3.07, 0.102, 207, 88, THE FLAGELLIN OF PYROCOCCUS FURIOSUS
1012, 6i0xB, 0.5911, 3.81, 0.093, 422, 97, PORPHYROMONAS GINGIVALIS PEPTIDYLARGININE DEMINASE (PPAD) MUTANT G231N/E232T/N235D IN COMPLEX WITH CL-AMIDINE. 
1013, 2vquA, 0.5911, 3.93, 0.069, 836, 101, STRUCTURAL AND BIOCHEMICAL EVIDENCE FOR A BOAT-LIKE TRANSITION STATE IN BETA-MANNOSIDASES
1014, 5x6aB, 0.5910, 3.46, 0.063, 229, 95, CRYSTAL STRUCTURE OF AN ENDOGLUCANASE PMO-5
1015, 5ya6B, 0.5909, 3.07, 0.135, 165, 89, CRYSTAL STRUCTURE OF ARCHAEAL FLAGELLIN FLAB1 FROM METHANOCALDOCOCCUS JANNASCHII 
1016, 3v55A, 0.5909, 3.90, 0.042, 368, 96, HUMAN MALT1 (334-719) IN ITS LIGAND FREE FORM
1017, 6h04A, 0.5908, 3.12, 0.101, 1219, 89, CLOSED CONFORMATION OF THE MEMBRANE ATTACK COMPLEX 
1018, 3hn8B, 0.5908, 3.81, 0.071, 279, 98, CRYSTAL STRUCTURE OF SYNAPTOTAGMIN
1019, 3cfuB, 0.5908, 3.32, 0.097, 131, 93, CRYSTAL STRUCTURE OF THE YJHA PROTEIN FROM BACILLUS SUBTILIS. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET SR562
1020, 4ytbA, 0.5906, 3.30, 0.086, 422, 93, CRYSTAL STRUCTURE OF PORPHYROMONAS GINGIVALIS PEPTIDYLARGININE DEIMINASE (PPAD) IN COMPLEX WITH DIPEPTIDE ASP-GLN.
1021, 1qupB, 0.5906, 3.34, 0.065, 217, 93, CRYSTAL STRUCTURE OF THE COPPER CHAPERONE FOR SUPEROXIDE DISMUTASE
1022, 1xwvA, 0.5905, 3.56, 0.094, 129, 96, STRUCTURE OF THE HOUSE DUST MITE ALLERGEN DER F 2: IMPLICATIONS FOR FUNCTION AND MOLECULAR BASIS OF IGE CROSS- REACTIVITY
1023, 5w06T, 0.5902, 2.99, 0.092, 198, 87, HUMAN TISSUE FACTOR IN COMPLEX WITH ANTIBODY M1587
1024, 3qazZ, 0.5901, 2.52, 0.073, 196, 82, IL-2 MUTANT D10 TERNARY COMPLEX
1025, 1u4fA, 0.5900, 3.38, 0.043, 197, 92, CRYSTAL STRUCTURE OF CYTOPLASMIC DOMAINS OF IRK1 (KIR2.1) CHANNEL
1026, 3qzmA, 0.5899, 2.86, 0.111, 124, 90, STAPHYLOCOCCUS AUREUS ISDA NEAT DOMAIN H83A VARIANT IN COMPLEX WITH HEME
1027, 3mzgB, 0.5899, 3.08, 0.082, 206, 85, CRYSTAL STRUCTURE OF A HUMAN PROLACTIN RECEPTOR ANTAGONIST IN COMPLEX WITH THE EXTRACELLULAR DOMAIN OF THE HUMAN PROLACTIN RECEPTOR
1028, 2vo5A, 0.5899, 3.82, 0.091, 833, 99, STRUCTURAL AND BIOCHEMICAL EVIDENCE FOR A BOAT-LIKE TRANSITION STATE IN BETA-MANNOSIDASES
1029, 2vl4A, 0.5899, 3.90, 0.050, 836, 101, STRUCTURAL AND BIOCHEMICAL EVIDENCE FOR A BOAT-LIKE TRANSITION STATE IN BETA-MANNOSIDASES
1030, 6ecaB, 0.5898, 2.80, 0.035, 592, 86, LACTOBACILLUS RHAMNOSUS BETA-GLUCURONIDASE 
1031, 4zbhA, 0.5897, 2.82, 0.131, 119, 84, THE CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF SULFOLOBUS ACIDOCALDARIUS FLAF
1032, 1czyB, 0.5897, 2.99, 0.034, 168, 88, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE TRAF DOMAIN OF HUMAN TRAF2 AND AN LMP1 BINDING PEPTIDE
1033, 6f7iB, 0.5896, 3.86, 0.042, 365, 96, HUMAN MALT1(329-728) IN COMPLEX WITH MLT-747 
1034, 6f7iA, 0.5896, 3.87, 0.042, 355, 96, HUMAN MALT1(329-728) IN COMPLEX WITH MLT-747 
1035, 4nn7B, 0.5896, 2.88, 0.036, 195, 84, CYTOKINE RECEPTOR COMPLEX - CRYSTAL FORM 2
1036, 1u4eA, 0.5896, 3.35, 0.022, 200, 92, CRYSTAL STRUCTURE OF CYTOPLASMIC DOMAINS OF GIRK1 CHANNEL
1037, 3spgA, 0.5895, 3.25, 0.086, 332, 93, INWARD RECTIFIER POTASSIUM CHANNEL KIR2.2 R186A MUTANT IN COMPLEX WITH PIP2
1038, 3nccB, 0.5895, 3.09, 0.082, 206, 85, A HUMAN PROLACTIN RECEPTOR ANTAGONIST IN COMPLEX WITH THE MUTANT EXTRACELLULAR DOMAIN H188A OF THE HUMAN PROLACTIN RECEPTOR
1039, 5fjqC, 0.5894, 3.57, 0.075, 180, 93, STRUCTURAL AND FUNCTIONAL ANALYSIS OF A LYTIC POLYSACCHARIDE MONOOXYGENASE IMPORTANT FOR EFFICIENT UTILIZATION OF CHITIN IN CELLVIBRIO JAPONICUS
1040, 4gboB, 0.5894, 3.28, 0.067, 186, 89, STRUCTURE OF T.FUSCA E7
1041, 4bfnA, 0.5894, 3.23, 0.112, 106, 89, CRYSTAL STRUCTURE OF THE STARCH-BINDING DOMAIN FROM RHIZOPUS ORYZAE GLUCOAMYLASE IN COMPLEX WITH ISOMALTOTETRAOSE
1042, 3t4aD, 0.5894, 3.24, 0.091, 633, 88, STRUCTURE OF A TRUNCATED FORM OF STAPHYLOCOCCAL COMPLEMENT INHIBITOR B BOUND TO HUMAN C3C AT 3.4 ANGSTROM RESOLUTION
1043, 6if7A, 0.5893, 3.51, 0.043, 183, 93, CRYSTAL STRUCTURE OF AA10 LYTIC POLYSACCHARIDE MONOOXYGENASE FROM TECTARIA MACRODONTA 
1044, 5fjqB, 0.5893, 3.55, 0.075, 180, 93, STRUCTURAL AND FUNCTIONAL ANALYSIS OF A LYTIC POLYSACCHARIDE MONOOXYGENASE IMPORTANT FOR EFFICIENT UTILIZATION OF CHITIN IN CELLVIBRIO JAPONICUS
1045, 2x12B, 0.5893, 3.39, 0.086, 199, 93, PH-INDUCED MODULATION OF STREPTOCOCCUS PARASANGUINIS ADHESION BY FAP1 FIMBRIAE
1046, 4bk8A, 0.5892, 3.10, 0.080, 123, 88, SUPEROXIDE REDUCTASE (NEELAREDOXIN) FROM IGNICOCCUS HOSPITALIS
1047, 3t4aA, 0.5892, 3.24, 0.091, 633, 88, STRUCTURE OF A TRUNCATED FORM OF STAPHYLOCOCCAL COMPLEMENT INHIBITOR B BOUND TO HUMAN C3C AT 3.4 ANGSTROM RESOLUTION
1048, 3n0pB, 0.5891, 3.09, 0.082, 206, 85, A MUTANT HUMAN PROLACTIN RECEPTOR ANTAGONIST H30A IN COMPLEX WITH THE EXTRACELLULAR DOMAIN OF THE HUMAN PROLACTIN RECEPTOR
1049, 6i0xA, 0.5890, 3.75, 0.094, 420, 96, PORPHYROMONAS GINGIVALIS PEPTIDYLARGININE DEMINASE (PPAD) MUTANT G231N/E232T/N235D IN COMPLEX WITH CL-AMIDINE. 
1050, 5uizB, 0.5890, 3.29, 0.067, 186, 89, STRUCTURE OF T.FUSCA AA10A
1051, 2x12A, 0.5890, 3.39, 0.086, 199, 93, PH-INDUCED MODULATION OF STREPTOCOCCUS PARASANGUINIS ADHESION BY FAP1 FIMBRIAE
1052, 2vmfB, 0.5890, 3.95, 0.100, 840, 100, STRUCTURAL AND BIOCHEMICAL EVIDENCE FOR A BOAT-LIKE TRANSITION STATE IN BETA-MANNOSIDASES
1053, 5o4uP, 0.5889, 3.01, 0.103, 207, 87, THE FLAGELLIN OF PYROCOCCUS FURIOSUS
1054, 2xtsC, 0.5889, 3.71, 0.096, 389, 94, CRYSTAL STRUCTURE OF THE SULFANE DEHYDROGENASE SOXCD FROM PARACOCCUS PANTOTROPHUS
1055, 1u4fC, 0.5889, 3.27, 0.044, 195, 91, CRYSTAL STRUCTURE OF CYTOPLASMIC DOMAINS OF IRK1 (KIR2.1) CHANNEL
1056, 5jpnA, 0.5888, 3.39, 0.065, 651, 93, STRUCTURE OF HUMAN COMPLEMENT C4 REBUILT USING IMDFF
1057, 3ncfB, 0.5888, 3.10, 0.082, 206, 85, A MUTANT HUMAN PROLACTIN RECEPTOR ANTAGONIST H30A IN COMPLEX WITH THE MUTANT EXTRACELLULAR DOMAIN H188A OF THE HUMAN PROLACTIN RECEPTOR
1058, 3ncbB, 0.5888, 3.08, 0.082, 206, 85, A MUTANT HUMAN PROLACTIN RECEPTOR ANTAGONIST H180A IN COMPLEX WITH THE EXTRACELLULAR DOMAIN OF THE HUMAN PROLACTIN RECEPTOR
1059, 2xtsA, 0.5888, 3.71, 0.096, 389, 94, CRYSTAL STRUCTURE OF THE SULFANE DEHYDROGENASE SOXCD FROM PARACOCCUS PANTOTROPHUS
1060, 2blfA, 0.5888, 3.64, 0.106, 373, 94, SULFITE DEHYDROGENASE FROM STARKEYA NOVELLA
1061, 1fg9E, 0.5888, 3.01, 0.103, 193, 87, 3:1 COMPLEX OF INTERFERON-GAMMA RECEPTOR WITH INTERFERON- GAMMA DIMER
1062, 5hpoA, 0.5886, 3.28, 0.089, 1030, 90, CYCLOALTERNAN-FORMING ENZYME FROM LISTERIA MONOCYTOGENES IN COMPLEX WITH MALTOPENTAOSE
1063, 2wbkA, 0.5886, 4.04, 0.059, 837, 102, STRUCTURE OF THE MICHAELIS COMPLEX OF BETA-MANNOSIDASE MAN2A PROVIDES INSIGHT INTO THE CONFORMATIONAL ITINERARY OF MANNOSIDE HYDROLYSIS
1064, 1nepA, 0.5886, 3.28, 0.086, 130, 93, CRYSTAL STRUCTURE ANALYSIS OF THE BOVINE NPC2 (NIEMANN-PICK C2) PROTEIN
1065, 2c9xA, 0.5885, 3.67, 0.117, 373, 94, SULFITE DEHYDROGENASE FROM STARKEYA NOVELLA Y236F MUTANT
1066, 4oy7C, 0.5884, 3.34, 0.064, 196, 94, STRUCTURE OF CELLULOSE ACTIVE LPMO CELS2 (SCLPMO10C) IN COMPLEX WITH COPPER.
1067, 2gixB, 0.5884, 3.55, 0.043, 201, 93, CYTOPLASMIC DOMAIN STRUCTURE OF KIR2.1 CONTAINING ANDERSEN S MUTATION R218Q AND RESCUE MUTATION T309K
1068, 2ca3A, 0.5884, 3.64, 0.106, 373, 94, SULFITE DEHYDROGENASE FROM STARKEYA NOVELLA R55M MUTANT
1069, 2bpbA, 0.5884, 3.68, 0.117, 373, 94, SULFITE DEHYDROGENASE FROM STARKEYA NOVELLA
1070, 1u4fD, 0.5884, 3.25, 0.044, 197, 91, CRYSTAL STRUCTURE OF CYTOPLASMIC DOMAINS OF IRK1 (KIR2.1) CHANNEL
1071, 1f45A, 0.5884, 3.46, 0.098, 282, 92, HUMAN INTERLEUKIN-12
1072, 1eaqB, 0.5884, 3.50, 0.095, 122, 95, THE RUNX1 RUNT DOMAIN AT 1.25A RESOLUTION: A STRUCTURAL SWITCH AND SPECIFICALLY BOUND CHLORIDE IONS MODULATE DNA BINDING
1073, 1d0jD, 0.5884, 3.01, 0.034, 168, 88, STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A M4-1BB PEPTIDE
1074, 5o4uK, 0.5883, 2.98, 0.115, 207, 87, THE FLAGELLIN OF PYROCOCCUS FURIOSUS
1075, 5hdwA, 0.5883, 3.68, 0.051, 131, 98, APAG DOMAIN OF FBXO3
1076, 5cgmA, 0.5883, 3.47, 0.077, 669, 91, STRUCTURE OF MYCOBACTERIUM THERMORESISTIBILE GLGE IN COMPLEX WITH MALTOSE AT 1.95A RESOLUTION
1077, 4yueH, 0.5883, 2.86, 0.047, 223, 86, MOUSE IL-2 BOUND TO S4B6 FAB FRAGMENT
1078, 4qi8B, 0.5883, 3.70, 0.052, 214, 97, LYTIC POLYSACCHARIDE MONOOXYGENASE 9F FROM NEUROSPORA CRASSA NCLPMO9F
1079, 3uo8C, 0.5883, 3.72, 0.043, 363, 94, CRYSTAL STRUCTURE OF THE MALT1 PARACASPASE (P1 FORM)
1080, 2ca4A, 0.5883, 3.74, 0.116, 373, 95, SULFITE DEHYDROGENASE FROM STARKEYA NOVELLA MUTANT
1081, 5gniA, 0.5882, 2.92, 0.128, 196, 86, THE CRYSTAL STRUCTURE OF PECAM-1 IGL1-2 TRANS-HOMOPHILIC DIMER
1082, 3qzoD, 0.5881, 2.85, 0.090, 124, 89, STAPHYLOCOCCUS AUREUS ISDA NEAT DOMAIN IN COMPLEX WITH HEME REDUCED CRYSTAL
1083, 5z1bC, 0.5880, 3.22, 0.044, 624, 91, STRUCTURE OF BIFIDOBACTERIUM DENTIUM BETA-GLUCURONIDASE COMPLEXED WITH COUMARIN-3-O-GLUCURONIDE 
1084, 5oj6B, 0.5880, 3.55, 0.085, 689, 94, CRYSTAL STRUCTURE OF THE CHICKEN MDGA1 ECTODOMAIN IN COMPLEX WITH THE HUMAN NEUROLIGIN 1 (NL1(-A-B)) CHOLINESTERASE DOMAIN.
1085, 5mhnA, 0.5880, 3.31, 0.136, 688, 88, FXIIIA IN COMPLEX WITH THE INHIBITOR ZED2360
1086, 1ca9B, 0.5880, 3.04, 0.034, 191, 88, STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A PEPTIDE FROM TNF-R2
1087, 2e9gA, 0.5878, 3.57, 0.084, 131, 95, SOLUTION STRUCTURE OF THE ALPHA ADAPTINC2 DOMAIN FROM HUMAN ADAPTER-RELATED PROTEIN COMPLEX 1 GAMMA 2 SUBUNIT
1088, 2e4fA, 0.5877, 3.20, 0.089, 191, 90, CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF G-PROTEIN-GATED INWARD RECTIFIER POTASSIUM CHANNEL KIR3.2
1089, 5x6aA, 0.5876, 3.51, 0.063, 229, 95, CRYSTAL STRUCTURE OF AN ENDOGLUCANASE PMO-5
1090, 5o4uI, 0.5876, 3.08, 0.102, 207, 88, THE FLAGELLIN OF PYROCOCCUS FURIOSUS
1091, 4pygB, 0.5876, 3.53, 0.101, 685, 89, TRANSGLUTAMINASE2 COMPLEXED WITH GTP
1092, 5ot1A, 0.5875, 2.26, 0.087, 572, 80, THE TYPE III PULLULAN HYDROLASE FROM THERMOCOCCUS KODAKARENSIS 
1093, 5cn2A, 0.5875, 3.33, 0.096, 115, 94, CRYSTAL STRUCTURE OF YEAST GGA1_GAE DOMAIN-C2221
1094, 4oy7F, 0.5875, 3.26, 0.065, 195, 92, STRUCTURE OF CELLULOSE ACTIVE LPMO CELS2 (SCLPMO10C) IN COMPLEX WITH COPPER.
1095, 43c9B, 0.5875, 2.75, 0.070, 118, 86, CRYSTALLOGRAPHIC STRUCTURE OF THE ESTEROLYTIC AND AMIDOLYTIC 43C9 ANTIBODY
1096, 2yetB, 0.5875, 3.51, 0.074, 226, 95, THERMOASCUS GH61 ISOZYME A
1097, 1lqsR, 0.5875, 2.95, 0.045, 207, 89, CRYSTAL STRUCTURE OF HUMAN CYTOMEGALOVIRUS IL-10 BOUND TO SOLUBLE HUMAN IL-10R1
1098, 3hmxA, 0.5874, 3.53, 0.099, 295, 91, CRYSTAL STRUCTURE OF USTEKINUMAB FAB/IL-12 COMPLEX
1099, 3atbA, 0.5874, 3.32, 0.088, 196, 91, CRYSTAL STRUCTURE OF THE KIR3.2 CYTOPLASMIC DOMAIN (NA+-FREE CRYSTAL SOAKED IN 10 MM GADOLINIUM CHLORIDE)
1100, 3agwA, 0.5874, 3.32, 0.088, 196, 91, CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF G-PROTEIN-GATED INWARD RECTIFIER POTASSIUM CHANNEL KIR3.2 IN THE ABSENCE OF NA+
1101, 2gixD, 0.5874, 3.36, 0.044, 205, 91, CYTOPLASMIC DOMAIN STRUCTURE OF KIR2.1 CONTAINING ANDERSEN S MUTATION R218Q AND RESCUE MUTATION T309K
1102, 2b5iB, 0.5874, 2.51, 0.098, 196, 82, CYTOKINE RECEPTOR COMPLEX
1103, 3k4dA, 0.5873, 2.77, 0.094, 596, 85, CRYSTAL STRUCTURE OF E. COLI BETA-GLUCURONIDASE WITH THE GLUCARO-D- LACTAM INHIBITOR BOUND
1104, 2je8A, 0.5873, 4.05, 0.049, 837, 102, STRUCTURE OF A BETA-MANNOSIDASE FROM BACTEROIDES THETAIOTAOMICRON
1105, 5z1bB, 0.5872, 3.33, 0.033, 620, 92, STRUCTURE OF BIFIDOBACTERIUM DENTIUM BETA-GLUCURONIDASE COMPLEXED WITH COUMARIN-3-O-GLUCURONIDE 
1106, 5z19B, 0.5872, 2.83, 0.023, 601, 86, THE CRYSTAL STRUCTURE OF RUMINOCOCCUS GNAVUS BETA-GLUCURONIDASE IN COMPLEX WITH URONIC ISOFAGOMINE 
1107, 3hs9A, 0.5872, 3.30, 0.087, 233, 92, INTERSECTIN 1-PEPTIDE-AP2 BETA EAR COMPLEX
1108, 3at9A, 0.5872, 3.31, 0.088, 196, 91, CRYSTAL STRUCTURE OF THE KIR3.2 CYTOPLASMIC DOMAIN (NA+-FREE CRYSTAL SOAKED IN 10 MM BARIUM CHLORIDE AND 10 MM MAGNESIUM CHLORIDE)
1109, 2a74D, 0.5872, 3.23, 0.091, 633, 88, HUMAN COMPLEMENT COMPONENT C3C
1110, 1czyC, 0.5872, 3.08, 0.034, 168, 89, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE TRAF DOMAIN OF HUMAN TRAF2 AND AN LMP1 BINDING PEPTIDE
1111, 6a8pB, 0.5871, 3.54, 0.101, 666, 89, TRANSGLUTAMINASE 2 MUTANT G224V IN COMPLEX WITH GTP 
1112, 5z1bA, 0.5871, 3.25, 0.043, 627, 92, STRUCTURE OF BIFIDOBACTERIUM DENTIUM BETA-GLUCURONIDASE COMPLEXED WITH COUMARIN-3-O-GLUCURONIDE 
1113, 5o4uG, 0.5871, 2.98, 0.115, 207, 87, THE FLAGELLIN OF PYROCOCCUS FURIOSUS
1114, 6a8pA, 0.5870, 3.59, 0.101, 681, 89, TRANSGLUTAMINASE 2 MUTANT G224V IN COMPLEX WITH GTP 
1115, 5o4uM, 0.5870, 3.03, 0.115, 207, 87, THE FLAGELLIN OF PYROCOCCUS FURIOSUS
1116, 3ly6C, 0.5870, 3.55, 0.101, 683, 89, CRYSTAL STRUCTURE OF HUMAN TRANSGLUTAMINASE 2 COMPLEX WITH ADENOSINE 5  TRIPHOSPHATE
1117, 4bfoA, 0.5869, 3.12, 0.114, 106, 88, CRYSTAL STRUCTURE OF THE STARCH-BINDING DOMAIN FROM RHIZOPUS ORYZAE GLUCOAMYLASE IN COMPLEX WITH ISOMALTOTRIOSE
1118, 2x2yB, 0.5869, 3.03, 0.141, 451, 85, CELLULOMONAS FIMI ENDO-BETA-14-MANNANASE DOUBLE MUTANT
1119, 1kv3A, 0.5869, 3.57, 0.101, 651, 89, HUMAN TISSUE TRANSGLUTAMINASE IN GDP BOUND FORM
1120, 5z18E, 0.5868, 2.82, 0.023, 586, 86, THE CRYSTAL STRUCTURE OF RUMINOCOCCUS GNAVUS BETA-GLUCURONIDASE 
1121, 5vt4C, 0.5868, 3.40, 0.078, 635, 90, SCO GLGEI-V279S IN COMPLEX WITH A PYROLIDENE-BASED METHYL-PHOSPHONATE COMPOUND
1122, 5vsjB, 0.5868, 3.41, 0.078, 649, 90, SCO GLGEI-V279S IN COMPLEX WITH A PYROLIDENE-BASED ETHYL-PHOSPHONATE COMPOUND
1123, 5o4uB, 0.5868, 2.99, 0.103, 207, 87, THE FLAGELLIN OF PYROCOCCUS FURIOSUS
1124, 3uajH, 0.5868, 2.94, 0.081, 219, 86, CRYSTAL STRUCTURE OF THE ENVELOPE GLYCOPROTEIN ECTODOMAIN FROM DENGUE VIRUS SEROTYPE 4 IN COMPLEX WITH THE FAB FRAGMENT OF THE CHIMPANZEE MONOCLONAL ANTIBODY 5H2
1125, 3ly6B, 0.5868, 3.55, 0.101, 683, 89, CRYSTAL STRUCTURE OF HUMAN TRANSGLUTAMINASE 2 COMPLEX WITH ADENOSINE 5  TRIPHOSPHATE
1126, 3ly6A, 0.5868, 3.55, 0.101, 683, 89, CRYSTAL STRUCTURE OF HUMAN TRANSGLUTAMINASE 2 COMPLEX WITH ADENOSINE 5  TRIPHOSPHATE
1127, 1kv3E, 0.5868, 3.57, 0.101, 651, 89, HUMAN TISSUE TRANSGLUTAMINASE IN GDP BOUND FORM
1128, 1d0jE, 0.5868, 3.03, 0.034, 168, 88, STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A M4-1BB PEPTIDE
1129, 6a8pC, 0.5867, 3.56, 0.101, 680, 89, TRANSGLUTAMINASE 2 MUTANT G224V IN COMPLEX WITH GTP 
1130, 5z19D, 0.5867, 2.82, 0.023, 596, 86, THE CRYSTAL STRUCTURE OF RUMINOCOCCUS GNAVUS BETA-GLUCURONIDASE IN COMPLEX WITH URONIC ISOFAGOMINE 
1131, 4brjA, 0.5867, 3.13, 0.080, 124, 88, SUPEROXIDE REDUCTASE (NEELAREDOXIN) FROM IGNICOCCUS HOSPITALIS T24K
1132, 1ca4E, 0.5867, 3.01, 0.034, 168, 88, STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 (TRAF2)
1133, 1bhgA, 0.5867, 3.18, 0.078, 611, 90, HUMAN BETA-GLUCURONIDASE AT 2.6 A RESOLUTION
1134, 5o4uJ, 0.5866, 2.95, 0.103, 207, 87, THE FLAGELLIN OF PYROCOCCUS FURIOSUS
1135, 5m5eC, 0.5866, 2.90, 0.105, 193, 86, CRYSTAL STRUCTURE OF A INTERLEUKIN-2 VARIANT IN COMPLEX WITH INTERLEUKIN-2 RECEPTOR
1136, 4h56N, 0.5866, 3.57, 0.086, 267, 93, CRYSTAL STRUCTURE OF THE CLOSTRIDIUM PERFRINGENS NETB TOXIN IN THE MEMBRANE INSERTED FORM
1137, 4h56M, 0.5866, 3.57, 0.086, 267, 93, CRYSTAL STRUCTURE OF THE CLOSTRIDIUM PERFRINGENS NETB TOXIN IN THE MEMBRANE INSERTED FORM
1138, 4h56L, 0.5866, 3.57, 0.086, 267, 93, CRYSTAL STRUCTURE OF THE CLOSTRIDIUM PERFRINGENS NETB TOXIN IN THE MEMBRANE INSERTED FORM
1139, 4h56K, 0.5866, 3.57, 0.086, 267, 93, CRYSTAL STRUCTURE OF THE CLOSTRIDIUM PERFRINGENS NETB TOXIN IN THE MEMBRANE INSERTED FORM
1140, 4h56J, 0.5866, 3.57, 0.086, 267, 93, CRYSTAL STRUCTURE OF THE CLOSTRIDIUM PERFRINGENS NETB TOXIN IN THE MEMBRANE INSERTED FORM
1141, 4h56H, 0.5866, 3.57, 0.086, 267, 93, CRYSTAL STRUCTURE OF THE CLOSTRIDIUM PERFRINGENS NETB TOXIN IN THE MEMBRANE INSERTED FORM
1142, 4h56G, 0.5866, 3.57, 0.086, 267, 93, CRYSTAL STRUCTURE OF THE CLOSTRIDIUM PERFRINGENS NETB TOXIN IN THE MEMBRANE INSERTED FORM
1143, 4h56D, 0.5866, 3.57, 0.086, 267, 93, CRYSTAL STRUCTURE OF THE CLOSTRIDIUM PERFRINGENS NETB TOXIN IN THE MEMBRANE INSERTED FORM
1144, 1czyA, 0.5866, 3.02, 0.034, 168, 88, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE TRAF DOMAIN OF HUMAN TRAF2 AND AN LMP1 BINDING PEPTIDE
1145, 5a42A, 0.5865, 3.27, 0.033, 1597, 91, CRYO-EM SINGLE PARTICLE 3D RECONSTRUCTION OF THE  NATIVE CONFORMATION OF E. COLI ALPHA-2-MACROGLOBULIN (ECAM)
1146, 4h56I, 0.5865, 3.57, 0.086, 267, 93, CRYSTAL STRUCTURE OF THE CLOSTRIDIUM PERFRINGENS NETB TOXIN IN THE MEMBRANE INSERTED FORM
1147, 4h56F, 0.5865, 3.57, 0.086, 267, 93, CRYSTAL STRUCTURE OF THE CLOSTRIDIUM PERFRINGENS NETB TOXIN IN THE MEMBRANE INSERTED FORM
1148, 4h56E, 0.5865, 3.57, 0.086, 267, 93, CRYSTAL STRUCTURE OF THE CLOSTRIDIUM PERFRINGENS NETB TOXIN IN THE MEMBRANE INSERTED FORM
1149, 4h56C, 0.5865, 3.57, 0.086, 267, 93, CRYSTAL STRUCTURE OF THE CLOSTRIDIUM PERFRINGENS NETB TOXIN IN THE MEMBRANE INSERTED FORM
1150, 4h56B, 0.5865, 3.57, 0.086, 267, 93, CRYSTAL STRUCTURE OF THE CLOSTRIDIUM PERFRINGENS NETB TOXIN IN THE MEMBRANE INSERTED FORM
1151, 4h56A, 0.5865, 3.57, 0.086, 267, 93, CRYSTAL STRUCTURE OF THE CLOSTRIDIUM PERFRINGENS NETB TOXIN IN THE MEMBRANE INSERTED FORM
1152, 4b5qA, 0.5865, 3.51, 0.074, 217, 95, THE LYTIC POLYSACCHARIDE MONOOXYGENASE GH61D STRUCTURE FROM THE BASIDIOMYCOTA FUNGUS PHANEROCHAETE CHRYSOSPORIUM
1153, 3l5hA, 0.5865, 2.94, 0.034, 585, 89, CRYSTAL STRUCTURE OF THE FULL ECTODOMAIN OF HUMAN GP130: NEW INSIGHTS INTO THE MOLECULAR ASSEMBLY OF RECEPTOR COMPLEXES
1154, 1kv3F, 0.5865, 3.57, 0.101, 651, 89, HUMAN TISSUE TRANSGLUTAMINASE IN GDP BOUND FORM
1155, 3at8A, 0.5864, 3.31, 0.088, 196, 91, CRYSTAL STRUCTURE OF THE KIR3.2 CYTOPLASMIC DOMAIN (NA+-FREE CRYSTAL SOAKED IN 10 MM BARIUM CHLORIDE)
1156, 1soxB, 0.5864, 4.13, 0.093, 458, 97, SULFITE OXIDASE FROM CHICKEN LIVER
1157, 1kv3D, 0.5864, 3.56, 0.101, 651, 89, HUMAN TISSUE TRANSGLUTAMINASE IN GDP BOUND FORM
1158, 1kv3C, 0.5864, 3.57, 0.101, 651, 89, HUMAN TISSUE TRANSGLUTAMINASE IN GDP BOUND FORM
1159, 1ix2B, 0.5864, 2.85, 0.059, 98, 85, CRYSTAL STRUCTURE OF SELENOMETHIONINE PCOC A COPPER RESISTANCE PROTEIN FROM ESCHERICHIA COLI
1160, 4u2yB, 0.5863, 3.41, 0.078, 649, 90, SCO GLGEI-V279S IN COMPLEX WITH REACTION INTERMEDIATE AZASUGAR
1161, 4eaeB, 0.5863, 3.54, 0.073, 186, 96, THE CRYSTAL STRUCTURE OF A FUNCTIONALLY UNKNOWN PROTEIN FROM LISTERIA MONOCYTOGENES EGD-E
1162, 43c9D, 0.5863, 2.75, 0.070, 118, 86, CRYSTALLOGRAPHIC STRUCTURE OF THE ESTEROLYTIC AND AMIDOLYTIC 43C9 ANTIBODY
1163, 3qzpB, 0.5863, 2.82, 0.090, 125, 89, STAPHYLOCOCCUS AUREUS ISDA NEAT DOMAIN IN COMPLEX WITH COBALT- PROTOPORPHYRIN IX
1164, 3qb7C, 0.5863, 3.00, 0.081, 191, 86, INTERLEUKIN-4 MUTANT RGA BOUND TO CYTOKINE RECEPTOR COMMON GAMMA
1165, 3ataA, 0.5863, 3.29, 0.088, 196, 91, CRYSTAL STRUCTURE OF THE KIR3.2 CYTOPLASMIC DOMAIN (NA+-FREE CRYSTAL SOAKED IN 10 MM BARIUM CHLORIDE AND 10 MM SPERMINE)
1166, 2v8mA, 0.5863, 3.28, 0.101, 106, 89, CARBOHYDRATE-BINDING OF THE STARCH BINDING DOMAIN OF RHIZOPUS ORYZAE GLUCOAMYLASE IN COMPLEX WITH BETA- CYCLODEXTRIN AND MALTOHEPTAOSE
1167, 1d00H, 0.5863, 3.04, 0.034, 168, 88, STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A 5-RESIDUE CD40 PEPTIDE
1168, 5o4uN, 0.5862, 3.00, 0.115, 207, 87, THE FLAGELLIN OF PYROCOCCUS FURIOSUS
1169, 4b5qB, 0.5862, 3.50, 0.074, 217, 95, THE LYTIC POLYSACCHARIDE MONOOXYGENASE GH61D STRUCTURE FROM THE BASIDIOMYCOTA FUNGUS PHANEROCHAETE CHRYSOSPORIUM
1170, 3hn3B, 0.5862, 3.30, 0.099, 609, 91, HUMAN BETA-GLUCURONIDASE AT 1.7 A RESOLUTION
1171, 2iv8A, 0.5862, 3.31, 0.087, 233, 92, BETA APPENDAGE IN COMPLEX WITH B-ARRESTIN PEPTIDE
1172, 1kv3B, 0.5862, 3.57, 0.101, 651, 89, HUMAN TISSUE TRANSGLUTAMINASE IN GDP BOUND FORM
1173, 1d0jA, 0.5862, 3.04, 0.034, 168, 88, STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A M4-1BB PEPTIDE
1174, 1czzB, 0.5862, 3.02, 0.034, 187, 88, STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A 17-RESIDUE CD40 PEPTIDE
1175, 3uajC, 0.5861, 2.95, 0.081, 220, 86, CRYSTAL STRUCTURE OF THE ENVELOPE GLYCOPROTEIN ECTODOMAIN FROM DENGUE VIRUS SEROTYPE 4 IN COMPLEX WITH THE FAB FRAGMENT OF THE CHIMPANZEE MONOCLONAL ANTIBODY 5H2
1176, 3ateA, 0.5861, 3.35, 0.088, 196, 91, CRYSTAL STRUCTURE OF THE KIR3.2 CYTOPLASMIC DOMAIN (NA+-FREE CRYSTAL SOAKED IN 10 MM PRASEODYMIUM (III) ACETATE)
1177, 2vq4A, 0.5861, 2.92, 0.106, 106, 85, CARBOHYDRATE-BINDING OF THE STARCH BINDING DOMAIN OF RHIZOPUS ORYZAE GLUCOAMYLASE IN COMPLEX WITH BETA- CYCLODEXTRIN AND MALTOHEPTAOSE
1178, 3zt6D, 0.5860, 3.43, 0.078, 649, 90, GLGE ISOFORM 1 FROM STREPTOMYCES COELICOLOR WITH ALPHA- CYCLODEXTRIN AND MALTOSE BOUND
1179, 3hn3A, 0.5860, 3.29, 0.099, 608, 91, HUMAN BETA-GLUCURONIDASE AT 1.7 A RESOLUTION
1180, 3bpoC, 0.5860, 2.91, 0.071, 286, 85, CRYSTAL STRUCTURE OF THE IL13-IL4R-IL13RA TERNARY COMPLEX
1181, 5z18C, 0.5859, 2.83, 0.023, 588, 86, THE CRYSTAL STRUCTURE OF RUMINOCOCCUS GNAVUS BETA-GLUCURONIDASE 
1182, 5o4uD, 0.5859, 2.99, 0.115, 207, 87, THE FLAGELLIN OF PYROCOCCUS FURIOSUS
1183, 5n1tM, 0.5859, 2.60, 0.036, 124, 83, CRYSTAL STRUCTURE OF COMPLEX BETWEEN FLAVOCYTOCHROME C AND COPPER CHAPERONE COPC FROM T. PARADOXUS
1184, 2iv9A, 0.5859, 3.33, 0.098, 236, 92, B2-APPENDAGE FROM AP2 IN COMPLEX WITH EPS15 PEPTIDE
1185, 6go1B, 0.5858, 2.82, 0.107, 318, 84, CRYSTAL STRUCTURE OF A BACILLUS ANTHRACIS PEPTIDOGLYCAN DEACETYLASE 
1186, 6ec6A, 0.5858, 2.89, 0.023, 594, 87, RUMINOCOCCUS GNAVUS BETA-GLUCURONIDASE 
1187, 5z19A, 0.5858, 2.82, 0.023, 593, 86, THE CRYSTAL STRUCTURE OF RUMINOCOCCUS GNAVUS BETA-GLUCURONIDASE IN COMPLEX WITH URONIC ISOFAGOMINE 
1188, 5o4uL, 0.5858, 2.99, 0.092, 207, 87, THE FLAGELLIN OF PYROCOCCUS FURIOSUS
1189, 3zudA, 0.5858, 3.61, 0.083, 227, 96, THERMOASCUS GH61 ISOZYME A
1190, 3npzC, 0.5858, 3.30, 0.056, 199, 90, PROLACTIN RECEPTOR (PRLR) COMPLEXED WITH THE NATURAL HORMONE (PRL)
1191, 6e3lD, 0.5857, 3.24, 0.122, 202, 90, INTERFERON GAMMA SIGNALLING COMPLEX WITH IFNGR1 AND IFNGR2 
1192, 5z19F, 0.5857, 2.84, 0.023, 600, 86, THE CRYSTAL STRUCTURE OF RUMINOCOCCUS GNAVUS BETA-GLUCURONIDASE IN COMPLEX WITH URONIC ISOFAGOMINE 
1193, 1d00E, 0.5857, 3.04, 0.034, 168, 88, STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A 5-RESIDUE CD40 PEPTIDE
1194, 5z19C, 0.5856, 2.85, 0.023, 600, 86, THE CRYSTAL STRUCTURE OF RUMINOCOCCUS GNAVUS BETA-GLUCURONIDASE IN COMPLEX WITH URONIC ISOFAGOMINE 
1195, 1d0jF, 0.5856, 3.03, 0.034, 168, 88, STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A M4-1BB PEPTIDE
1196, 1ca9C, 0.5856, 3.06, 0.034, 191, 88, STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A PEPTIDE FROM TNF-R2
1197, 4cn4B, 0.5855, 3.41, 0.078, 649, 90, GLGE ISOFORM 1 FROM STREPTOMYCES COELICOLOR E423A MUTANT WITH 2-DEOXY-2-FLUORO-BETA-MALTOSYL MODIFICATION
1198, 3zstB, 0.5855, 3.43, 0.078, 649, 90, GLGE ISOFORM 1 FROM STREPTOMYCES COELICOLOR WITH ALPHA-CYCLODEXTRIN BOUND
1199, 2itfD, 0.5855, 2.90, 0.090, 121, 89, CRYSTAL STRUCTURE ISDA NEAT DOMAIN FROM STAPHYLOCOCCUS AUREUS WITH HEME BOUND
1200, 1xo8A, 0.5855, 3.06, 0.092, 151, 87, SOLUTION STRUCTURE OF AT1G01470 FROM ARABIDOPSIS THALIANA
1201, 1e42B, 0.5855, 3.33, 0.098, 233, 92, BETA2-ADAPTIN APPENDAGE DOMAIN FROM CLATHRIN ADAPTOR AP2
1202, 1d0aE, 0.5855, 3.02, 0.034, 168, 88, STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 (TRAF2) IN COMPLEX WITH A HUMAN OX40 PEPTIDE
1203, 2yeqA, 0.5854, 3.06, 0.045, 522, 89, STRUCTURE OF PHOD
1204, 1ix2A, 0.5854, 2.73, 0.060, 97, 84, CRYSTAL STRUCTURE OF SELENOMETHIONINE PCOC A COPPER RESISTANCE PROTEIN FROM ESCHERICHIA COLI
1205, 5vsjA, 0.5853, 3.42, 0.078, 649, 90, SCO GLGEI-V279S IN COMPLEX WITH A PYROLIDENE-BASED ETHYL-PHOSPHONATE COMPOUND
1206, 5o4uE, 0.5853, 3.01, 0.103, 207, 87, THE FLAGELLIN OF PYROCOCCUS FURIOSUS
1207, 5o4uA, 0.5853, 2.99, 0.103, 207, 87, THE FLAGELLIN OF PYROCOCCUS FURIOSUS
1208, 4u2yA, 0.5853, 3.42, 0.078, 649, 90, SCO GLGEI-V279S IN COMPLEX WITH REACTION INTERMEDIATE AZASUGAR
1209, 4p94A, 0.5853, 2.84, 0.131, 116, 84, THE CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF SULFOLOBUS ACIDOCALDARIUS FLAF (RESIDUES 35-164)
1210, 3ob8A, 0.5853, 3.32, 0.043, 1024, 94, STRUCTURE OF THE BETA-GALACTOSIDASE FROM KLUYVEROMYCES LACTIS IN COMPLEX WITH GALACTOSE
1211, 1e42A, 0.5853, 3.34, 0.098, 233, 92, BETA2-ADAPTIN APPENDAGE DOMAIN FROM CLATHRIN ADAPTOR AP2
1212, 1ca9D, 0.5853, 3.06, 0.034, 186, 88, STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A PEPTIDE FROM TNF-R2
1213, 6qhdB, 0.5852, 3.85, 0.061, 530, 99, LYSINE ACETYLATED AND TYROSINE PHOSPHORYLATED STAT3 IN A COMPLEX WITH DNA 
1214, 4nn6B, 0.5852, 2.88, 0.036, 193, 83, CYTOKINE RECEPTOR COMPLEX - CRYSTAL FORM 1B
1215, 3ob8B, 0.5852, 3.32, 0.043, 1024, 94, STRUCTURE OF THE BETA-GALACTOSIDASE FROM KLUYVEROMYCES LACTIS IN COMPLEX WITH GALACTOSE
1216, 2yetA, 0.5852, 3.54, 0.084, 226, 95, THERMOASCUS GH61 ISOZYME A
1217, 5z18D, 0.5851, 2.84, 0.023, 591, 86, THE CRYSTAL STRUCTURE OF RUMINOCOCCUS GNAVUS BETA-GLUCURONIDASE 
1218, 5z18B, 0.5851, 2.84, 0.023, 586, 86, THE CRYSTAL STRUCTURE OF RUMINOCOCCUS GNAVUS BETA-GLUCURONIDASE 
1219, 5o4uO, 0.5851, 3.10, 0.102, 207, 88, THE FLAGELLIN OF PYROCOCCUS FURIOSUS
1220, 1d01A, 0.5851, 3.04, 0.034, 168, 88, STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A HUMAN CD30 PEPTIDE
1221, 4u2zB, 0.5850, 3.43, 0.078, 649, 90, X-RAY CRYSTAL STRUCTURE OF AN SCO GLGEI-V279S/122-TRIFLUROMALTOSE COMPLEX
1222, 3aazH, 0.5850, 3.16, 0.057, 229, 88, CRYSTAL STRUCTURE OF THE HUMANIZED RECOMBINANT FAB FRAGMENT OF A MURINE; ANTIBODY
1223, 2v8mB, 0.5850, 3.15, 0.102, 106, 88, CARBOHYDRATE-BINDING OF THE STARCH BINDING DOMAIN OF RHIZOPUS ORYZAE GLUCOAMYLASE IN COMPLEX WITH BETA- CYCLODEXTRIN AND MALTOHEPTAOSE
1224, 2g30A, 0.5850, 3.33, 0.098, 233, 92, BETA APPENDAGE OF AP2 COMPLEXED WITH ARH PEPTIDE
1225, 1d01C, 0.5850, 3.04, 0.034, 168, 88, STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A HUMAN CD30 PEPTIDE
1226, 1d00A, 0.5850, 3.04, 0.034, 168, 88, STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A 5-RESIDUE CD40 PEPTIDE
1227, 5i0dB, 0.5849, 3.28, 0.089, 1030, 90, CYCLOALTERNAN-FORMING ENZYME FROM LISTERIA MONOCYTOGENES IN COMPLEX WITH CYCLOALTERNAN
1228, 4gs7B, 0.5849, 2.53, 0.073, 192, 82, STRUCTURE OF THE INTERLEUKIN-15 QUATERNARY COMPLEX
1229, 3qzmB, 0.5849, 2.83, 0.101, 123, 89, STAPHYLOCOCCUS AUREUS ISDA NEAT DOMAIN H83A VARIANT IN COMPLEX WITH HEME
1230, 5vt4B, 0.5848, 3.43, 0.078, 648, 90, SCO GLGEI-V279S IN COMPLEX WITH A PYROLIDENE-BASED METHYL-PHOSPHONATE COMPOUND
1231, 5vt4A, 0.5848, 3.44, 0.078, 648, 90, SCO GLGEI-V279S IN COMPLEX WITH A PYROLIDENE-BASED METHYL-PHOSPHONATE COMPOUND
1232, 3zt7D, 0.5848, 3.43, 0.078, 649, 90, GLGE ISOFORM 1 FROM STREPTOMYCES COELICOLOR WITH BETA-CYCLODEXTRIN AND MALTOSE BOUND
1233, 3zstA, 0.5848, 3.43, 0.078, 649, 90, GLGE ISOFORM 1 FROM STREPTOMYCES COELICOLOR WITH ALPHA-CYCLODEXTRIN BOUND
1234, 3aqyA, 0.5848, 2.57, 0.086, 99, 81, CRYSTAL STRUCTURE OF PLODIA INTERPUNCTELLA BETA-GRP/GNBP3 N-TERMINAL DOMAIN
1235, 2mmxA, 0.5848, 2.89, 0.094, 111, 85, NMR STUDY OF 6AJL2
1236, 5lgwB, 0.5847, 3.43, 0.078, 648, 90, GLGE ISOFORM 1 FROM STREPTOMYCES COELICOLOR D394A MUTANT CO- CRYSTALLISED WITH MALTODEXTRIN
1237, 4u31A, 0.5847, 3.43, 0.078, 649, 90, SCO GLGEI-V279S IN COMPLEX WITH MALTOSE-C-PHOSPHONATE
1238, 3zt7A, 0.5847, 3.42, 0.078, 649, 90, GLGE ISOFORM 1 FROM STREPTOMYCES COELICOLOR WITH BETA-CYCLODEXTRIN AND MALTOSE BOUND
1239, 4wjgX, 0.5846, 2.87, 0.112, 144, 89, STRUCTURE OF T. BRUCEI HAPTOGLOBIN-HEMOGLOBIN RECEPTOR BINDING TO HUMAN HAPTOGLOBIN-HEMOGLOBIN
1240, 4wjgD, 0.5846, 2.86, 0.112, 144, 89, STRUCTURE OF T. BRUCEI HAPTOGLOBIN-HEMOGLOBIN RECEPTOR BINDING TO HUMAN HAPTOGLOBIN-HEMOGLOBIN
1241, 4pygE, 0.5846, 3.58, 0.101, 685, 89, TRANSGLUTAMINASE2 COMPLEXED WITH GTP
1242, 1ktjB, 0.5846, 3.52, 0.073, 129, 96, X-RAY STRUCTURE OF DER P 2 THE MAJOR HOUSE DUST MITE ALLERGEN
1243, 1d01B, 0.5846, 3.05, 0.034, 168, 88, STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A HUMAN CD30 PEPTIDE
1244, 1ca9A, 0.5846, 3.14, 0.034, 191, 89, STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A PEPTIDE FROM TNF-R2
1245, 4wjgI, 0.5845, 2.87, 0.112, 144, 89, STRUCTURE OF T. BRUCEI HAPTOGLOBIN-HEMOGLOBIN RECEPTOR BINDING TO HUMAN HAPTOGLOBIN-HEMOGLOBIN
1246, 4wjg3, 0.5845, 2.87, 0.112, 144, 89, STRUCTURE OF T. BRUCEI HAPTOGLOBIN-HEMOGLOBIN RECEPTOR BINDING TO HUMAN HAPTOGLOBIN-HEMOGLOBIN
1247, 4pygA, 0.5845, 3.59, 0.101, 685, 89, TRANSGLUTAMINASE2 COMPLEXED WITH GTP
1248, 4brvA, 0.5845, 3.12, 0.092, 124, 87, SUPEROXIDE REDUCTASE (NEELAREDOXIN) FROM IGNICOCCUS HOSPITALIS E23A
1249, 2gixA, 0.5845, 3.44, 0.043, 206, 92, CYTOPLASMIC DOMAIN STRUCTURE OF KIR2.1 CONTAINING ANDERSEN S MUTATION R218Q AND RESCUE MUTATION T309K
1250, 1czzA, 0.5845, 3.04, 0.034, 187, 88, STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A 17-RESIDUE CD40 PEPTIDE
1251, 5z18F, 0.5844, 2.85, 0.023, 582, 86, THE CRYSTAL STRUCTURE OF RUMINOCOCCUS GNAVUS BETA-GLUCURONIDASE 
1252, 5vt4D, 0.5844, 3.42, 0.078, 649, 90, SCO GLGEI-V279S IN COMPLEX WITH A PYROLIDENE-BASED METHYL-PHOSPHONATE COMPOUND
1253, 5hxmA, 0.5844, 3.30, 0.089, 1030, 90, CYCLOALTERNAN-FORMING ENZYME FROM LISTERIA MONOCYTOGENES IN COMPLEX WITH PANOSE
1254, 4kwuA, 0.5844, 3.35, 0.088, 1030, 91, 1.9 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF UNCHARACTERIZED PROTEIN LMO2446 FROM LISTERIA MONOCYTOGENES EGD-E IN COMPLEX WITH ALPHA-D- GLUCOSE BETA-D-GLUCOSE MAGNESIUM AND CALCIUM
1255, 3zt6A, 0.5844, 3.44, 0.089, 649, 90, GLGE ISOFORM 1 FROM STREPTOMYCES COELICOLOR WITH ALPHA- CYCLODEXTRIN AND MALTOSE BOUND
1256, 5mhmB, 0.5843, 3.40, 0.148, 683, 88, FXIIIA IN COMPLEX WITH THE INHIBITOR ZED1630
1257, 4wjgN, 0.5843, 2.87, 0.112, 144, 89, STRUCTURE OF T. BRUCEI HAPTOGLOBIN-HEMOGLOBIN RECEPTOR BINDING TO HUMAN HAPTOGLOBIN-HEMOGLOBIN
1258, 4cn4A, 0.5843, 3.43, 0.078, 649, 90, GLGE ISOFORM 1 FROM STREPTOMYCES COELICOLOR E423A MUTANT WITH 2-DEOXY-2-FLUORO-BETA-MALTOSYL MODIFICATION
1259, 3uoaC, 0.5843, 3.75, 0.043, 363, 94, CRYSTAL STRUCTURE OF THE MALT1 PARACASPASE (P21 FORM)
1260, 3n06B, 0.5843, 3.04, 0.059, 206, 85, A MUTANT HUMAN PROLACTIN RECEPTOR ANTAGONIST H27A IN COMPLEX WITH THE EXTRACELLULAR DOMAIN OF THE HUMAN PROLACTIN RECEPTOR
1261, 5lgvB, 0.5842, 3.43, 0.078, 649, 90, GLGE ISOFORM 1 FROM STREPTOMYCES COELICOLOR E423A MUTANT SOAKED IN MALTOOCTAOSE
1262, 4u31B, 0.5842, 3.44, 0.078, 649, 90, SCO GLGEI-V279S IN COMPLEX WITH MALTOSE-C-PHOSPHONATE
1263, 3zt6B, 0.5842, 3.44, 0.078, 649, 90, GLGE ISOFORM 1 FROM STREPTOMYCES COELICOLOR WITH ALPHA- CYCLODEXTRIN AND MALTOSE BOUND
1264, 1soxA, 0.5842, 4.14, 0.093, 463, 97, SULFITE OXIDASE FROM CHICKEN LIVER
1265, 4cn6B, 0.5841, 3.44, 0.078, 649, 90, GLGE ISOFORM 1 FROM STREPTOMYCES COELICOLOR E423A MUTANT WITH MALTOSE BOUND
1266, 4aq1A, 0.5841, 2.81, 0.106, 721, 85, STRUCTURE OF THE SBSB S-LAYER PROTEIN OF GEOBACILLUS STEAROTHERMOPHILUS PV72P2 IN COMPLEX WITH NANOBODY KB6
1267, 3zssA, 0.5841, 3.44, 0.078, 649, 90, APO FORM OF GLGE ISOFORM 1 FROM STREPTOMYCES COELICOLOR
1268, 3f8uB, 0.5841, 3.38, 0.064, 361, 94, TAPASIN/ERP57 HETERODIMER
1269, 5z19E, 0.5840, 2.84, 0.023, 597, 86, THE CRYSTAL STRUCTURE OF RUMINOCOCCUS GNAVUS BETA-GLUCURONIDASE IN COMPLEX WITH URONIC ISOFAGOMINE 
1270, 5lgwA, 0.5840, 3.43, 0.078, 648, 90, GLGE ISOFORM 1 FROM STREPTOMYCES COELICOLOR D394A MUTANT CO- CRYSTALLISED WITH MALTODEXTRIN
1271, 4oy7E, 0.5840, 3.33, 0.054, 195, 93, STRUCTURE OF CELLULOSE ACTIVE LPMO CELS2 (SCLPMO10C) IN COMPLEX WITH COPPER.
1272, 3s48A, 0.5840, 2.76, 0.136, 143, 88, HUMAN ALPHA-HAEMOGLOBIN COMPLEXED WITH THE FIRST NEAT DOMAIN OF ISDH FROM STAPHYLOCOCCUS AUREUS
1273, 1d00C, 0.5840, 3.04, 0.034, 168, 88, STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A 5-RESIDUE CD40 PEPTIDE
1274, 5mj4A, 0.5839, 3.50, 0.075, 289, 93, INTERLEUKIN-23 COMPLEX WITH AN ANTAGONISTIC ALPHABODY CRYSTAL FORM 2
1275, 5i0dA, 0.5839, 3.34, 0.077, 1030, 91, CYCLOALTERNAN-FORMING ENZYME FROM LISTERIA MONOCYTOGENES IN COMPLEX WITH CYCLOALTERNAN
1276, 3zt7B, 0.5839, 3.43, 0.078, 649, 90, GLGE ISOFORM 1 FROM STREPTOMYCES COELICOLOR WITH BETA-CYCLODEXTRIN AND MALTOSE BOUND
1277, 1d0jC, 0.5839, 3.05, 0.034, 168, 88, STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A M4-1BB PEPTIDE
1278, 1d00F, 0.5839, 3.05, 0.034, 168, 88, STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A 5-RESIDUE CD40 PEPTIDE
1279, 1d00B, 0.5839, 3.08, 0.034, 168, 88, STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A 5-RESIDUE CD40 PEPTIDE
1280, 5lgvA, 0.5838, 3.44, 0.078, 649, 90, GLGE ISOFORM 1 FROM STREPTOMYCES COELICOLOR E423A MUTANT SOAKED IN MALTOOCTAOSE
1281, 4u2zA, 0.5838, 3.43, 0.078, 649, 90, X-RAY CRYSTAL STRUCTURE OF AN SCO GLGEI-V279S/122-TRIFLUROMALTOSE COMPLEX
1282, 4og9A, 0.5838, 3.50, 0.075, 289, 93, INTERLEUKIN-23 COMPLEX WITH AN ANTAGONISTIC ALPHABODY CRYSTAL FORM 2
1283, 4gfxA, 0.5838, 3.02, 0.094, 151, 85, CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF TXNIP
1284, 1d0aA, 0.5838, 3.05, 0.034, 168, 88, STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 (TRAF2) IN COMPLEX WITH A HUMAN OX40 PEPTIDE
1285, 1ahwC, 0.5838, 2.84, 0.082, 200, 85, A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9)
1286, 3qznC, 0.5837, 2.92, 0.101, 121, 89, STAPHYLOCOCCUS AUREUS ISDA NEAT DOMAIN Y166A VARIANT IN COMPLEX WITH HEME
1287, 3ovuB, 0.5837, 2.85, 0.112, 144, 89, CRYSTAL STRUCTURE OF HUMAN ALPHA-HAEMOGLOBIN COMPLEXED WITH AHSP AND THE FIRST NEAT DOMAIN OF ISDH FROM STAPHYLOCOCCUS AUREUS
1288, 3obaB, 0.5837, 3.34, 0.043, 1024, 94, STRUCTURE OF THE BETA-GALACTOSIDASE FROM KLUYVEROMYCES LACTIS
1289, 3zt5D, 0.5836, 3.45, 0.078, 649, 90, GLGE ISOFORM 1 FROM STREPTOMYCES COELICOLOR WITH MALTOSE BOUND
1290, 3aazA, 0.5836, 3.16, 0.057, 228, 88, CRYSTAL STRUCTURE OF THE HUMANIZED RECOMBINANT FAB FRAGMENT OF A MURINE; ANTIBODY
1291, 1d0jB, 0.5836, 3.05, 0.034, 168, 88, STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A M4-1BB PEPTIDE
1292, 5cvsB, 0.5835, 3.44, 0.078, 649, 90, GLGE ISOFORM 1 FROM STREPTOMYCES COELICOLOR E423A MUTANT SOAKED IN MALTOHEPTAOSE
1293, 3uc0H, 0.5835, 2.93, 0.081, 215, 86, CRYSTAL STRUCTURE OF DOMAIN I OF THE ENVELOPE GLYCOPROTEIN ECTODOMAIN FROM DENGUE VIRUS SEROTYPE 4 IN COMPLEX WITH THE FAB FRAGMENT OF THE CHIMPANZEE MONOCLONAL ANTIBODY 5H2
1294, 3mu3A, 0.5835, 3.86, 0.080, 140, 100, CRYSTAL STRUCTURE OF CHICKEN MD-1 COMPLEXED WITH LIPID IVA
1295, 1hxmA, 0.5835, 3.01, 0.058, 206, 86, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1296, 5cvsA, 0.5834, 3.45, 0.078, 649, 90, GLGE ISOFORM 1 FROM STREPTOMYCES COELICOLOR E423A MUTANT SOAKED IN MALTOHEPTAOSE
1297, 3qzpA, 0.5834, 2.90, 0.100, 124, 90, STAPHYLOCOCCUS AUREUS ISDA NEAT DOMAIN IN COMPLEX WITH COBALT- PROTOPORPHYRIN IX
1298, 3atfA, 0.5834, 3.23, 0.089, 193, 90, CRYSTAL STRUCTURE OF THE KIR3.2 CYTOPLASMIC DOMAIN (NA+-FREE CRYSTAL SOAKED IN 200 MM CESIUM CHLORIDE)
1299, 4cn1A, 0.5833, 3.43, 0.078, 649, 90, GLGE ISOFORM 1 FROM STREPTOMYCES COELICOLOR D394A MUTANT WITH MALTOSE-1-PHOSPHATE BOUND
1300, 3zssC, 0.5833, 3.45, 0.078, 649, 90, APO FORM OF GLGE ISOFORM 1 FROM STREPTOMYCES COELICOLOR
1301, 3e0gA, 0.5833, 3.02, 0.067, 479, 90, STRUCTURE OF THE LEUKEMIA INHIBITORY FACTOR RECEPTOR (LIF-R) DOMAINS D1-D5
1302, 5c70A, 0.5832, 2.98, 0.080, 588, 87, THE STRUCTURE OF ASPERGILLUS ORYZAE BETA-GLUCURONIDASE
1303, 4jklA, 0.5832, 2.74, 0.071, 587, 85, CRYSTAL STRUCTURE OF STREPTOCOCCUS AGALACTIAE BETA-GLUCURONIDASE IN SPACE GROUP P21212
1304, 4cn1B, 0.5832, 3.43, 0.078, 649, 90, GLGE ISOFORM 1 FROM STREPTOMYCES COELICOLOR D394A MUTANT WITH MALTOSE-1-PHOSPHATE BOUND
1305, 3zt7C, 0.5832, 3.44, 0.078, 649, 90, GLGE ISOFORM 1 FROM STREPTOMYCES COELICOLOR WITH BETA-CYCLODEXTRIN AND MALTOSE BOUND
1306, 3zt6C, 0.5832, 3.45, 0.078, 649, 90, GLGE ISOFORM 1 FROM STREPTOMYCES COELICOLOR WITH ALPHA- CYCLODEXTRIN AND MALTOSE BOUND
1307, 1ktjA, 0.5832, 3.55, 0.073, 129, 96, X-RAY STRUCTURE OF DER P 2 THE MAJOR HOUSE DUST MITE ALLERGEN
1308, 5z18A, 0.5831, 2.85, 0.023, 586, 86, THE CRYSTAL STRUCTURE OF RUMINOCOCCUS GNAVUS BETA-GLUCURONIDASE 
1309, 4brvD, 0.5831, 3.15, 0.091, 124, 88, SUPEROXIDE REDUCTASE (NEELAREDOXIN) FROM IGNICOCCUS HOSPITALIS E23A
1310, 4brvC, 0.5831, 3.15, 0.091, 124, 88, SUPEROXIDE REDUCTASE (NEELAREDOXIN) FROM IGNICOCCUS HOSPITALIS E23A
1311, 3cmgA, 0.5831, 3.85, 0.085, 661, 94, CRYSTAL STRUCTURE OF PUTATIVE BETA-GALACTOSIDASE FROM BACTEROIDES FRAGILIS
1312, 5n40A, 0.5830, 3.26, 0.165, 352, 85, STRUCTURE OF YERSINIA PSEUDOTUBERCULOSIS ADHESIN INVE
1313, 5mhnB, 0.5830, 3.38, 0.148, 685, 88, FXIIIA IN COMPLEX WITH THE INHIBITOR ZED2360
1314, 5fjqA, 0.5830, 3.61, 0.075, 180, 93, STRUCTURAL AND FUNCTIONAL ANALYSIS OF A LYTIC POLYSACCHARIDE MONOOXYGENASE IMPORTANT FOR EFFICIENT UTILIZATION OF CHITIN IN CELLVIBRIO JAPONICUS
1315, 4wjgS, 0.5830, 2.80, 0.101, 144, 89, STRUCTURE OF T. BRUCEI HAPTOGLOBIN-HEMOGLOBIN RECEPTOR BINDING TO HUMAN HAPTOGLOBIN-HEMOGLOBIN
1316, 4jkmA, 0.5830, 3.03, 0.057, 602, 87, CRYSTAL STRUCTURE OF CLOSTRIDIUM PERFRINGENS BETA-GLUCURONIDASE
1317, 3qzoB, 0.5830, 3.03, 0.066, 121, 91, STAPHYLOCOCCUS AUREUS ISDA NEAT DOMAIN IN COMPLEX WITH HEME REDUCED CRYSTAL
1318, 3hn3E, 0.5830, 3.19, 0.089, 606, 90, HUMAN BETA-GLUCURONIDASE AT 1.7 A RESOLUTION
1319, 5mwnN, 0.5829, 3.04, 0.093, 117, 86, STRUCTURE OF THE EAEC T6SS COMPONENT TSSK N-TERMINAL DOMAIN IN COMPLEX WITH LLAMA NANOBODIES NBK18 AND NBK27
1320, 4kmqA, 0.5829, 3.36, 0.088, 1029, 91, 1.9 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF UNCHARACTERIZED PROTEIN LMO2446 FROM LISTERIA MONOCYTOGENES EGD-E
1321, 3qzoA, 0.5829, 2.92, 0.089, 121, 90, STAPHYLOCOCCUS AUREUS ISDA NEAT DOMAIN IN COMPLEX WITH HEME REDUCED CRYSTAL
1322, 3atdA, 0.5829, 3.35, 0.088, 196, 91, CRYSTAL STRUCTURE OF THE KIR3.2 CYTOPLASMIC DOMAIN (NA+-FREE CRYSTAL SOAKED IN 10 MM GADOLINIUM CHLORIDE AND 10 MM MAGNESIUM CHLORIDE)
1323, 5m94B, 0.5828, 2.96, 0.092, 120, 87, CRYSTAL STRUCTURE OF STAPHYLOCOCCUS CAPITIS DIVALENT METAL ION TRANSPORTER (DMT) IN COMPLEX WITH NANOBODY
1324, 4cn6A, 0.5828, 3.46, 0.078, 649, 90, GLGE ISOFORM 1 FROM STREPTOMYCES COELICOLOR E423A MUTANT WITH MALTOSE BOUND
1325, 1ca4D, 0.5828, 3.06, 0.034, 168, 88, STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 (TRAF2)
1326, 5m95B, 0.5827, 2.96, 0.092, 120, 87, STAPHYLOCOCCUS CAPITIS DIVALENT METAL ION TRANSPORTER (DMT) IN COMPLEX WITH MANGANESE
1327, 4wgwB, 0.5827, 2.96, 0.092, 120, 87, STAPHYLOCOCCUS CAPITIS DIVALENT METAL ION TRANSPORTER (DMT) IN COMPLEX WITH MANGANESE
1328, 4wgvB, 0.5827, 2.96, 0.092, 120, 87, CRYSTAL STRUCTURE OF STAPHYLOCOCCUS CAPITIS DIVALENT METAL ION TRANSPORTER (DMT) IN COMPLEX WITH NANOBODY
1329, 4brvB, 0.5827, 3.16, 0.091, 124, 88, SUPEROXIDE REDUCTASE (NEELAREDOXIN) FROM IGNICOCCUS HOSPITALIS E23A
1330, 3zt5C, 0.5827, 3.47, 0.078, 649, 90, GLGE ISOFORM 1 FROM STREPTOMYCES COELICOLOR WITH MALTOSE BOUND
1331, 3zssB, 0.5827, 3.45, 0.078, 649, 90, APO FORM OF GLGE ISOFORM 1 FROM STREPTOMYCES COELICOLOR
1332, 3hbqA, 0.5827, 4.15, 0.093, 373, 97, STRUCTURE OF RECOMBINANT CHICKEN LIVER SULFITE OXIDASE MUTANT CYS 185 ALA
1333, 3fn9B, 0.5827, 3.82, 0.106, 672, 94, CRYSTAL STRUCTURE OF PUTATIVE BETA-GALACTOSIDASE FROM BACTEROIDES FRAGILIS
1334, 1ea9D, 0.5827, 2.83, 0.057, 583, 87, CYCLOMALTODEXTRINASE
1335, 5c71C, 0.5826, 2.87, 0.106, 583, 85, THE STRUCTURE OF ASPERGILLUS ORYZAE A-GLUCURONIDASE COMPLEXED WITH GLYCYRRHETINIC ACID MONOGLUCURONIDE
1336, 3zt5A, 0.5826, 3.46, 0.078, 649, 90, GLGE ISOFORM 1 FROM STREPTOMYCES COELICOLOR WITH MALTOSE BOUND
1337, 2hkaB, 0.5826, 3.46, 0.085, 130, 94, CRYSTAL STRUCTURE OF BOVINE NPC2 AND CHOLESTEROL SULFATE COMPLEX
1338, 1d0aB, 0.5826, 3.05, 0.034, 168, 88, STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 (TRAF2) IN COMPLEX WITH A HUMAN OX40 PEPTIDE
1339, 1ca9E, 0.5826, 3.08, 0.034, 186, 88, STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A PEPTIDE FROM TNF-R2
1340, 1ahwF, 0.5826, 2.85, 0.082, 200, 85, A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9)
1341, 6ed2A, 0.5825, 3.11, 0.105, 591, 86, FAECALIBACTERIUM PRAUSNITZII BETA-GLUCURONIDASE 
1342, 5vmmE, 0.5825, 2.82, 0.068, 329, 88, STAPHYLOCOCCUS AUREUS ISDB BOUND TO HUMAN HEMOGLOBIN
1343, 4d7pA, 0.5825, 2.77, 0.107, 96, 84, SUPEROXIDE REDUCTASE (1FE-SOR) FROM GIARDIA INTESTINALIS
1344, 3r18A, 0.5825, 4.11, 0.093, 373, 97, CHICKEN SULFITE OXIDASE DOUBLE MUTANT WITH ALTERED ACTIVITY AND SUBSTRATE AFFINITY
1345, 1nugA, 0.5825, 3.59, 0.129, 675, 93, ROLE OF CALCIUM IONS IN THE ACTIVATION AND ACTIVITY OF THE TRANSGLUTAMINASE 3 ENZYME (2 CALCIUMS 1 MG INACTIVE FORM)
1346, 4lnvB, 0.5824, 2.92, 0.072, 1063, 83, CRYSTAL STRUCTURE OF TEP1S
1347, 4fc3E, 0.5824, 2.80, 0.090, 144, 89, CRYSTAL STRUCTURE OF HUMAN METHAEMOGLOBIN COMPLEXED WITH THE SECOND NEAT DOMAIN OF ISDH FROM STAPHYLOCOCCUS AUREUS
1348, 3zt5B, 0.5824, 3.46, 0.078, 649, 90, GLGE ISOFORM 1 FROM STREPTOMYCES COELICOLOR WITH MALTOSE BOUND
1349, 2b5iC, 0.5824, 2.94, 0.081, 191, 86, CYTOKINE RECEPTOR COMPLEX
1350, 6mvhB, 0.5823, 3.30, 0.112, 638, 89, CRYSTAL STRUCTURE OF FMN-BINDING BETA-GLUCURONIDASE FROM ROSEBURIA HOMINIS 
1351, 3hc2A, 0.5823, 4.12, 0.093, 372, 97, CRYSTAL STRUCTURE OF CHICKEN SULFITE OXIDASE MUTANT TYR 322 PHE
1352, 2a9aA, 0.5823, 4.17, 0.093, 371, 97, CRYSTAL STRUCTURE OF RECOMBINANT CHICKEN SULFITE OXIDASE WITH THE BOUND PRODUCT SULFATE AT THE ACTIVE SITE
1353, 3zssD, 0.5822, 3.45, 0.078, 649, 90, APO FORM OF GLGE ISOFORM 1 FROM STREPTOMYCES COELICOLOR
1354, 3vsqA, 0.5822, 3.32, 0.077, 197, 91, CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF G-PROTEIN-GATED INWARD RECTIFIER POTASSIUM CHANNEL KIR3.2 E236R MUTANT IN THE PRESENCE OF ETHANOL
1355, 3qzoC, 0.5822, 2.91, 0.089, 123, 90, STAPHYLOCOCCUS AUREUS ISDA NEAT DOMAIN IN COMPLEX WITH HEME REDUCED CRYSTAL
1356, 3qazC, 0.5822, 2.97, 0.081, 188, 86, IL-2 MUTANT D10 TERNARY COMPLEX
1357, 3bc9A, 0.5822, 3.00, 0.070, 585, 86, ALPHA-AMYLASE B IN COMPLEX WITH ACARBOSE
1358, 1m42A, 0.5822, 2.79, 0.071, 102, 84, SOLUTION STRUCTURE OF APOCOPC FROM PSEUDOMONAS SYRINGAE
1359, 6gvlA, 0.5821, 3.66, 0.071, 199, 98, SECOND PAIR OF FIBRONECTIN TYPE III DOMAINS OF INTEGRIN BETA4 BOUND TO THE BULLOUS PEMPHIGOID ANTIGEN BP230 (BPAG1E) 
1360, 4m7lT, 0.5821, 2.83, 0.094, 194, 85, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN HUMAN TISSUE FACTOR EXTRACELLULAR DOMAIN AND ANTIBODY 10H10 FAB FRAGMENT
1361, 4a5wA, 0.5821, 3.61, 0.106, 1528, 94, CRYSTAL STRUCTURE OF C5B6
1362, 43c9F, 0.5821, 2.81, 0.070, 118, 86, CRYSTALLOGRAPHIC STRUCTURE OF THE ESTEROLYTIC AND AMIDOLYTIC 43C9 ANTIBODY
1363, 3qazI, 0.5821, 2.97, 0.081, 188, 86, IL-2 MUTANT D10 TERNARY COMPLEX
1364, 1czzC, 0.5821, 3.15, 0.034, 187, 89, STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A 17-RESIDUE CD40 PEPTIDE
1365, 3uo8B, 0.5820, 3.85, 0.042, 364, 95, CRYSTAL STRUCTURE OF THE MALT1 PARACASPASE (P1 FORM)
1366, 2covD, 0.5820, 2.52, 0.050, 92, 80, CRYSTAL STRUCTURE OF CBM31 FROM BETA-13-XYLANASE
1367, 1d00D, 0.5820, 3.13, 0.034, 168, 89, STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A 5-RESIDUE CD40 PEPTIDE
1368, 5o4uC, 0.5819, 3.03, 0.115, 207, 87, THE FLAGELLIN OF PYROCOCCUS FURIOSUS
1369, 5d1zI, 0.5819, 2.81, 0.068, 149, 88, ISDB NEAT1 BOUND BY CLONE D4-10
1370, 3f8uD, 0.5819, 3.46, 0.063, 361, 95, TAPASIN/ERP57 HETERODIMER
1371, 6cxwA, 0.5818, 3.04, 0.092, 127, 87, SYNAPTOTAGMIN 1 C2A BETA4 CHIMERA WITH ENHANCED PIP2 BINDING FUNCTION 
1372, 2a9dB, 0.5818, 4.17, 0.093, 359, 97, CRYSTAL STRUCTURE OF RECOMBINANT CHICKEN SULFITE OXIDASE WITH ARG AT RESIDUE 161
1373, 2yn3D, 0.5817, 2.52, 0.111, 205, 81, STRUCTURAL INSIGHT INTO THE GIANT CALCIUM-BINDING ADHESIN SIIE: IMPLICATIONS FOR THE ADHESION OF SALMONELLA ENTERICA TO POLARIZED EPITHELIAL CELLS
1374, 1zanH, 0.5817, 2.89, 0.023, 216, 86, CRYSTAL STRUCTURE OF ANTI-NGF AD11 FAB
1375, 1jsyA, 0.5817, 3.28, 0.053, 358, 94, CRYSTAL STRUCTURE OF BOVINE ARRESTIN-2
1376, 6ec6B, 0.5816, 2.93, 0.023, 600, 87, RUMINOCOCCUS GNAVUS BETA-GLUCURONIDASE 
1377, 5n1tW, 0.5816, 3.12, 0.080, 124, 87, CRYSTAL STRUCTURE OF COMPLEX BETWEEN FLAVOCYTOCHROME C AND COPPER CHAPERONE COPC FROM T. PARADOXUS
1378, 1hxmE, 0.5816, 3.04, 0.058, 206, 86, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1379, 6mvhA, 0.5815, 3.43, 0.109, 639, 92, CRYSTAL STRUCTURE OF FMN-BINDING BETA-GLUCURONIDASE FROM ROSEBURIA HOMINIS 
1380, 5ak8A, 0.5815, 3.53, 0.086, 419, 93, STRUCTURE OF C351A MUTANT OF PORPHYROMONAS GINGIVALIS PEPTIDYLARGININE DEIMINASE
1381, 2a9cA, 0.5815, 4.13, 0.093, 359, 97, CRYSTAL STRUCTURE OF R138Q MUTANT OF RECOMBINANT CHICKEN SULFITE OXIDASE WITH THE BOUND PRODUCT SULFATE AT THE ACTIVE SITE
1382, 4ytgA, 0.5814, 3.81, 0.074, 417, 95, CRYSTAL STRUCTURE OF PORPHYROMONAS GINGIVALIS PEPTIDYLARGININE DEIMINASE (PPAD) MUTANT C351A IN COMPLEX WITH DIPEPTIDE MET-ARG.
1383, 3uoaB, 0.5814, 3.85, 0.042, 364, 95, CRYSTAL STRUCTURE OF THE MALT1 PARACASPASE (P21 FORM)
1384, 3dgcR, 0.5814, 3.07, 0.068, 202, 88, STRUCTURE OF IL-22/IL-22R1
1385, 5um4A, 0.5813, 3.29, 0.033, 195, 90, CRYSTAL STRUCTURE OF THE F255A MUTANT KIR3.1 CYTOPLASMIC PORE DOMAIN
1386, 3qazO, 0.5813, 2.97, 0.081, 191, 86, IL-2 MUTANT D10 TERNARY COMPLEX
1387, 3lpfA, 0.5813, 2.74, 0.095, 590, 84, STRUCTURE OF E. COLI BETA-GLUCURONIDASE BOUND WITH A NOVEL POTENT INHIBITOR 1-((67-DIMETHYL-2-OXO-12-DIHYDROQUINOLIN-3-YL)METHYL)-1- (2-HYDROXYETHYL)-3-(3-METHOXYPHENYL)THIOUREA
1388, 3fn9C, 0.5813, 3.73, 0.108, 673, 93, CRYSTAL STRUCTURE OF PUTATIVE BETA-GALACTOSIDASE FROM BACTEROIDES FRAGILIS
1389, 2a99A, 0.5813, 4.19, 0.093, 372, 97, CRYSTAL STRUCTURE OF RECOMBINANT CHICKEN SULFITE OXIDASE AT RESTING STATE
1390, 1n6vA, 0.5813, 3.15, 0.068, 212, 88, AVERAGE STRUCTURE OF THE INTERFERON-BINDING ECTODOMAIN OF THE HUMAN TYPE I INTERFERON RECEPTOR
1391, 6cxsB, 0.5812, 3.06, 0.057, 599, 87, CRYSTAL STRUCTURE OF CLOSTRIDIUM PERFRINGENS BETA-GLUCURONIDASE BOUND WITH A NOVEL; POTENT INHIBITOR 4-(8-(PIPERAZIN-1-YL)-1;2;3;4- TETRAHYDRO-[1;2;3]TRIAZINO[4 ;5 :4;5]THIENO[2;3-C]ISOQUINOLIN-5-YL) MORPHOLINE 
1392, 6cxsA, 0.5812, 3.04, 0.057, 598, 87, CRYSTAL STRUCTURE OF CLOSTRIDIUM PERFRINGENS BETA-GLUCURONIDASE BOUND WITH A NOVEL; POTENT INHIBITOR 4-(8-(PIPERAZIN-1-YL)-1;2;3;4- TETRAHYDRO-[1;2;3]TRIAZINO[4 ;5 :4;5]THIENO[2;3-C]ISOQUINOLIN-5-YL) MORPHOLINE 
1393, 4dsyD, 0.5812, 3.22, 0.103, 426, 87, CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT CC24201
1394, 3uc0I, 0.5812, 2.91, 0.058, 217, 86, CRYSTAL STRUCTURE OF DOMAIN I OF THE ENVELOPE GLYCOPROTEIN ECTODOMAIN FROM DENGUE VIRUS SEROTYPE 4 IN COMPLEX WITH THE FAB FRAGMENT OF THE CHIMPANZEE MONOCLONAL ANTIBODY 5H2
1395, 3r19A, 0.5812, 4.12, 0.093, 372, 97, CHICKEN SULFITE OXIDASE TRIPLE MUTANT WITH ALTERED ACTIVITY AND SUBSTRATE AFFINITY
1396, 3fn9D, 0.5812, 3.73, 0.108, 666, 93, CRYSTAL STRUCTURE OF PUTATIVE BETA-GALACTOSIDASE FROM BACTEROIDES FRAGILIS
1397, 1hxmG, 0.5812, 3.23, 0.045, 206, 89, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1398, 4yhdB, 0.5811, 3.64, 0.054, 283, 93, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
1399, 3fn9A, 0.5811, 3.70, 0.129, 672, 93, CRYSTAL STRUCTURE OF PUTATIVE BETA-GALACTOSIDASE FROM BACTEROIDES FRAGILIS
1400, 1l9mB, 0.5811, 3.65, 0.129, 681, 93, THREE-DIMENSIONAL STRUCTURE OF THE HUMAN TRANSGLUTAMINASE 3 ENZYME: BINDING OF CALCIUM IONS CHANGE STRUCTURE FOR ACTIVATION
1401, 1wlhB, 0.5809, 3.06, 0.102, 306, 88, MOLECULAR STRUCTURE OF THE ROD DOMAIN OF DICTYOSTELIUM FILAMIN
1402, 5da4B, 0.5808, 3.29, 0.068, 123, 88, STRUCTURE OF A NANOBODY RECOGNIZING THE FUMARATE TRANSPORTER SLC26DG
1403, 1d00G, 0.5808, 3.15, 0.034, 168, 89, STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A 5-RESIDUE CD40 PEPTIDE
1404, 1c8pA, 0.5808, 2.91, 0.092, 102, 87, NMR STRUCTURE OF THE LIGAND BINDING DOMAIN OF THE COMMON BETA-CHAIN IN THE GM-CSF IL-3 AND IL-5 RECEPTORS
1405, 4kkzD, 0.5807, 3.21, 0.103, 426, 87, THE CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH DIETHYLENE GLYCOL MONOVANADATE
1406, 1d0aD, 0.5807, 3.14, 0.034, 168, 89, STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 (TRAF2) IN COMPLEX WITH A HUMAN OX40 PEPTIDE
1407, 3lqmA, 0.5806, 3.09, 0.056, 201, 89, STRUCTURE OF THE IL-10R2 COMMON CHAIN
1408, 3lpfB, 0.5806, 2.71, 0.095, 590, 84, STRUCTURE OF E. COLI BETA-GLUCURONIDASE BOUND WITH A NOVEL POTENT INHIBITOR 1-((67-DIMETHYL-2-OXO-12-DIHYDROQUINOLIN-3-YL)METHYL)-1- (2-HYDROXYETHYL)-3-(3-METHOXYPHENYL)THIOUREA
1409, 2gixC, 0.5806, 3.34, 0.043, 206, 92, CYTOPLASMIC DOMAIN STRUCTURE OF KIR2.1 CONTAINING ANDERSEN S MUTATION R218Q AND RESCUE MUTATION T309K
1410, 5z1aA, 0.5805, 3.77, 0.086, 655, 93, THE CRYSTAL STRUCTURE OF BACTEROIDES FRAGILIS BETA-GLUCURONIDASE IN COMPLEX WITH URONIC ISOFAGOMINE 
1411, 4p94B, 0.5805, 2.88, 0.094, 130, 85, THE CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF SULFOLOBUS ACIDOCALDARIUS FLAF (RESIDUES 35-164)
1412, 2bemA, 0.5805, 3.60, 0.043, 170, 93, CRYSTAL STRUCTURE OF THE SERRATIA MARCESCENS CHITIN-BINDING PROTEIN CBP21
1413, 1jpsT, 0.5805, 3.01, 0.093, 200, 86, CRYSTAL STRUCTURE OF TISSUE FACTOR IN COMPLEX WITH HUMANIZED FAB D3H44
1414, 1ca4F, 0.5805, 3.14, 0.034, 168, 89, STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 (TRAF2)
1415, 5m95D, 0.5804, 2.98, 0.092, 120, 87, STAPHYLOCOCCUS CAPITIS DIVALENT METAL ION TRANSPORTER (DMT) IN COMPLEX WITH MANGANESE
1416, 5dgyC, 0.5804, 3.45, 0.074, 789, 95, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN
1417, 4zwjC, 0.5804, 3.45, 0.074, 789, 95, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO ARRESTIN BY FEMTOSECOND X-RAY LASER
1418, 4wgwD, 0.5804, 2.98, 0.092, 120, 87, STAPHYLOCOCCUS CAPITIS DIVALENT METAL ION TRANSPORTER (DMT) IN COMPLEX WITH MANGANESE
1419, 4wgvD, 0.5804, 2.98, 0.092, 120, 87, CRYSTAL STRUCTURE OF STAPHYLOCOCCUS CAPITIS DIVALENT METAL ION TRANSPORTER (DMT) IN COMPLEX WITH NANOBODY
1420, 6hwrC, 0.5803, 3.21, 0.092, 423, 87, RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH ADENOSINE DIVANADATE 
1421, 2bemB, 0.5803, 3.56, 0.053, 170, 94, CRYSTAL STRUCTURE OF THE SERRATIA MARCESCENS CHITIN-BINDING PROTEIN CBP21
1422, 6bk9A, 0.5802, 3.15, 0.088, 280, 91, CRYSTAL STRUCTURE OF SQUID ARRESTIN 
1423, 5da4C, 0.5802, 3.31, 0.068, 123, 88, STRUCTURE OF A NANOBODY RECOGNIZING THE FUMARATE TRANSPORTER SLC26DG
1424, 4gs7C, 0.5802, 2.90, 0.071, 193, 85, STRUCTURE OF THE INTERLEUKIN-15 QUATERNARY COMPLEX
1425, 4e9lA, 0.5802, 3.18, 0.128, 314, 86, FDEC A NOVEL BROADLY CONSERVED ESCHERICHIA COLI ADHESIN ELICITING PROTECTION AGAINST URINARY TRACT INFECTIONS
1426, 2dleA, 0.5802, 2.73, 0.107, 104, 84, SOLUTION STRUCTURE OF THE FOURTH FN3 DOMAIN OF HUMAN RECEPTOR-TYPE TYROSINE-PROTEIN PHOSPHATASE ETA
1427, 1d0aF, 0.5802, 3.15, 0.034, 168, 89, STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 (TRAF2) IN COMPLEX WITH A HUMAN OX40 PEPTIDE
1428, 4jklB, 0.5801, 2.91, 0.069, 587, 87, CRYSTAL STRUCTURE OF STREPTOCOCCUS AGALACTIAE BETA-GLUCURONIDASE IN SPACE GROUP P21212
1429, 3bpnC, 0.5801, 3.10, 0.080, 295, 88, CRYSTAL STRUCTURE OF THE IL4-IL4R-IL13RA TERNARY COMPLEX
1430, 2itfC, 0.5801, 2.94, 0.090, 119, 89, CRYSTAL STRUCTURE ISDA NEAT DOMAIN FROM STAPHYLOCOCCUS AUREUS WITH HEME BOUND
1431, 1d0aC, 0.5801, 3.15, 0.034, 168, 89, STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 (TRAF2) IN COMPLEX WITH A HUMAN OX40 PEPTIDE
1432, 5fk0E, 0.5800, 3.39, 0.097, 263, 93, YEAST DELTA-COP-I MU-HOMOLOGY DOMAIN
1433, 5da4A, 0.5800, 3.31, 0.068, 123, 88, STRUCTURE OF A NANOBODY RECOGNIZING THE FUMARATE TRANSPORTER SLC26DG
1434, 3qaza, 0.5799, 2.96, 0.081, 191, 86, IL-2 MUTANT D10 TERNARY COMPLEX
1435, 2iteA, 0.5799, 2.96, 0.089, 119, 90, CRYSTAL STRUCTURE OF THE ISDA NEAT DOMAIN FROM STAPHYLOCOCCUS AUREUS
1436, 1n9pA, 0.5799, 3.28, 0.034, 189, 88, CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF G-PROTEIN ACTIVATED INWARD RECTIFIER POTASSIUM CHANNEL 1
1437, 6g46C, 0.5798, 3.21, 0.103, 424, 87, RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH 2-(NAPHTHALEN- 1-YL)THIAZOLE-4-CARBOXYLIC ACID 
1438, 5ldyB, 0.5798, 2.96, 0.133, 339, 83, STRUCTURE OF YERSINIA PSEUDOTUBERCULOSIS INVD
1439, 4kbpB, 0.5798, 3.23, 0.103, 424, 87, KIDNEY BEAN PURPLE ACID PHOSPHATASE
1440, 3hbgA, 0.5798, 4.09, 0.094, 353, 96, STRUCTURE OF RECOMBINANT CHICKEN LIVER SULFITE OXIDASE MUTANT C185S
1441, 2covE, 0.5798, 2.53, 0.050, 92, 80, CRYSTAL STRUCTURE OF CBM31 FROM BETA-13-XYLANASE
1442, 2a9cB, 0.5798, 4.07, 0.094, 359, 96, CRYSTAL STRUCTURE OF R138Q MUTANT OF RECOMBINANT CHICKEN SULFITE OXIDASE WITH THE BOUND PRODUCT SULFATE AT THE ACTIVE SITE
1443, 4kkzC, 0.5797, 3.21, 0.103, 423, 87, THE CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH DIETHYLENE GLYCOL MONOVANADATE
1444, 4jkkA, 0.5797, 2.89, 0.069, 588, 87, CRYSTAL STRUCTURE OF STREPTOCOCCUS AGALACTIAE BETA-GLUCURONIDASE IN SPACE GROUP I222
1445, 43caB, 0.5797, 2.79, 0.059, 117, 85, CRYSTALLOGRAPHIC STRUCTURE OF THE ESTEROLYTIC AND AMIDOLYTIC 43C9 ANTIBODY WITH BOUND P-NITROPHENOL
1446, 3t6qD, 0.5797, 4.00, 0.118, 139, 102, CRYSTAL STRUCTURE OF MOUSE RP105/MD-1 COMPLEX
1447, 3t6qC, 0.5797, 4.00, 0.118, 139, 102, CRYSTAL STRUCTURE OF MOUSE RP105/MD-1 COMPLEX
1448, 4dhlB, 0.5796, 3.26, 0.115, 425, 87, CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT MO07123
1449, 3qzlA, 0.5796, 3.05, 0.088, 121, 91, STAPHYLOCOCCUS AUREUS ISDA NEAT DOMAIN K75A VARIANT IN COMPLEX WITH HEME
1450, 2iv9B, 0.5796, 3.36, 0.098, 233, 92, B2-APPENDAGE FROM AP2 IN COMPLEX WITH EPS15 PEPTIDE
1451, 2a9bA, 0.5796, 4.14, 0.093, 372, 97, CRYSTAL STRUCTURE OF R138Q MUTANT OF RECOMBINANT SULFITE OXIDASE AT RESTING STATE
1452, 6g46D, 0.5795, 3.30, 0.091, 423, 88, RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH 2-(NAPHTHALEN- 1-YL)THIAZOLE-4-CARBOXYLIC ACID 
1453, 5tugD, 0.5795, 2.89, 0.094, 130, 85, ARCHAELLUM PERIPLASMIC STATOR PROTEIN COMPLEX FLAF AND FLAG FROM SULFOLOBUS ACIDOCALDARIUS
1454, 3wdiA, 0.5795, 2.64, 0.112, 697, 80, CRYSTAL STRUCTURE OF PULLULANASE COMPLEXED WITH MALTOTRIOSE FROM ANOXYBACILLUS SP. LM18-11
1455, 3qazg, 0.5795, 2.92, 0.082, 191, 85, IL-2 MUTANT D10 TERNARY COMPLEX
1456, 2a9aB, 0.5795, 4.19, 0.093, 359, 97, CRYSTAL STRUCTURE OF RECOMBINANT CHICKEN SULFITE OXIDASE WITH THE BOUND PRODUCT SULFATE AT THE ACTIVE SITE
1457, 1hxmC, 0.5795, 3.19, 0.057, 206, 88, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1458, 4acqA, 0.5794, 3.23, 0.136, 1269, 88, ALPHA-2 MACROGLOBULIN
1459, 3hbpA, 0.5794, 4.13, 0.093, 373, 97, THE CRYSTAL STRUCTURE OF C185S MUTANT OF RECOMBINANT SULFITE OXIDASE WITH BOUND SUBSTRATE SULFITE AT THE ACTIVE SITE
1460, 3h1zA, 0.5794, 3.40, 0.098, 233, 92, MOLECULAR BASIS FOR THE ASSOCIATION OF PIPKIGAMMA -P90 WITH THE CLATHRIN ADAPTOR AP-2
1461, 6mnrH, 0.5793, 3.39, 0.102, 219, 88, RHESUS MACAQUE ANTI-HIV V3 ANTIBODY DH753 WITH GP120 V3 ZAM18 PEPTIDE 
1462, 4yt9A, 0.5793, 3.88, 0.093, 418, 97, CRYSTAL STRUCTURE OF PORPHYROMONAS GINGIVALIS PEPTIDYLARGININE DEIMINASE (PPAD) SUBSTRATE-UNBOUND.
1463, 5m94D, 0.5792, 2.99, 0.092, 120, 87, CRYSTAL STRUCTURE OF STAPHYLOCOCCUS CAPITIS DIVALENT METAL ION TRANSPORTER (DMT) IN COMPLEX WITH NANOBODY
1464, 5hdoA, 0.5792, 2.95, 0.071, 126, 84, CRYSTAL STRUCTURE OF A NANOBODY RAISED AGAINST UROKINASE-TYPE PLASMINOGEN ACTIVATOR
1465, 4gjhC, 0.5792, 3.32, 0.088, 177, 91, CRYSTAL STRUCTURE OF THE TRAF DOMAIN OF TRAF5
1466, 2iteB, 0.5792, 2.96, 0.089, 119, 90, CRYSTAL STRUCTURE OF THE ISDA NEAT DOMAIN FROM STAPHYLOCOCCUS AUREUS
1467, 2a9dA, 0.5792, 4.16, 0.093, 369, 97, CRYSTAL STRUCTURE OF RECOMBINANT CHICKEN SULFITE OXIDASE WITH ARG AT RESIDUE 161
1468, 1l0aA, 0.5792, 3.38, 0.066, 192, 91, DOWNSTREAM REGULATOR TANK BINDS TO THE CD40 RECOGNITION SITE ON TRAF3
1469, 1ca4B, 0.5792, 3.13, 0.034, 168, 89, STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 (TRAF2)
1470, 5dgyA, 0.5791, 3.45, 0.074, 833, 95, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN
1471, 4zwjA, 0.5791, 3.45, 0.074, 833, 95, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO ARRESTIN BY FEMTOSECOND X-RAY LASER
1472, 5wszD, 0.5790, 3.66, 0.021, 168, 94, CRYSTAL STRUCTURE OF A LYTIC POLYSACCHARIDE MONOOXYGENASEBTLPMO10A FROM BACILLUS THURINGIENSIS
1473, 3lqmB, 0.5790, 2.99, 0.057, 196, 88, STRUCTURE OF THE IL-10R2 COMMON CHAIN
1474, 2qfrA, 0.5790, 3.26, 0.115, 424, 87, CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE WITH BOUND SULFATE
1475, 2hkaC, 0.5790, 3.36, 0.086, 130, 93, CRYSTAL STRUCTURE OF BOVINE NPC2 AND CHOLESTEROL SULFATE COMPLEX
1476, 5vmmH, 0.5789, 2.99, 0.078, 141, 90, STAPHYLOCOCCUS AUREUS ISDB BOUND TO HUMAN HEMOGLOBIN
1477, 4i1pA, 0.5789, 3.89, 0.032, 379, 95, HUMAN MALT1 (CASPASE-IG3) IN COMPLEX WITH ACTIVITY BASED-PROBE
1478, 4dhlA, 0.5789, 3.22, 0.092, 424, 87, CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT MO07123
1479, 1ca9F, 0.5789, 3.13, 0.034, 186, 88, STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A PEPTIDE FROM TNF-R2
1480, 5tugB, 0.5788, 2.90, 0.094, 130, 85, ARCHAELLUM PERIPLASMIC STATOR PROTEIN COMPLEX FLAF AND FLAG FROM SULFOLOBUS ACIDOCALDARIUS
1481, 2qfpA, 0.5788, 3.25, 0.115, 424, 87, CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH FLUORIDE
1482, 1ca4A, 0.5788, 3.17, 0.034, 168, 89, STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 (TRAF2)
1483, 6n16A, 0.5787, 2.90, 0.070, 217, 86, VACCINE-ELICITED NHP FP-TARGETING NEUTRALIZING ANTIBODY 0PV-B.01 IN COMPLEX WITH HIV FUSION PEPTIDE (RESIDUE 512-519) 
1484, 6mvhC, 0.5787, 3.33, 0.111, 638, 90, CRYSTAL STRUCTURE OF FMN-BINDING BETA-GLUCURONIDASE FROM ROSEBURIA HOMINIS 
1485, 2bemC, 0.5787, 3.58, 0.053, 170, 94, CRYSTAL STRUCTURE OF THE SERRATIA MARCESCENS CHITIN-BINDING PROTEIN CBP21
1486, 6n16H, 0.5786, 3.14, 0.091, 219, 88, VACCINE-ELICITED NHP FP-TARGETING NEUTRALIZING ANTIBODY 0PV-B.01 IN COMPLEX WITH HIV FUSION PEPTIDE (RESIDUE 512-519) 
1487, 5fk0G, 0.5786, 3.41, 0.097, 263, 93, YEAST DELTA-COP-I MU-HOMOLOGY DOMAIN
1488, 5fk0C, 0.5786, 3.40, 0.097, 263, 93, YEAST DELTA-COP-I MU-HOMOLOGY DOMAIN
1489, 4yhdD, 0.5786, 3.63, 0.108, 282, 93, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
1490, 3mu3B, 0.5786, 3.84, 0.081, 138, 99, CRYSTAL STRUCTURE OF CHICKEN MD-1 COMPLEXED WITH LIPID IVA
1491, 6n16K, 0.5785, 2.88, 0.081, 219, 86, VACCINE-ELICITED NHP FP-TARGETING NEUTRALIZING ANTIBODY 0PV-B.01 IN COMPLEX WITH HIV FUSION PEPTIDE (RESIDUE 512-519) 
1492, 4i1pC, 0.5785, 3.91, 0.032, 380, 95, HUMAN MALT1 (CASPASE-IG3) IN COMPLEX WITH ACTIVITY BASED-PROBE
1493, 3qazU, 0.5785, 2.95, 0.082, 191, 85, IL-2 MUTANT D10 TERNARY COMPLEX
1494, 3wdjA, 0.5784, 2.66, 0.112, 683, 80, CRYSTAL STRUCTURE OF PULLULANASE COMPLEXED WITH MALTOTETRAOSE FROM ANOXYBACILLUS SP. LM18-11
1495, 6okqA, 0.5783, 3.11, 0.058, 230, 86, CRYSTAL STRUCTURE OF THE SF12 FAB 
1496, 5euvB, 0.5783, 2.84, 0.048, 731, 84, CRYSTAL STRUCTURE OF A COLD-ADAPTED DIMERIC BETA-D-GALACTOSIDASE FROM PARACOCCUS SP. 32D STRAIN
1497, 4geiA, 0.5783, 3.27, 0.092, 144, 87, N-TERMINAL DOMAIN OF VDUP-1
1498, 43c9H, 0.5783, 2.88, 0.070, 118, 86, CRYSTALLOGRAPHIC STRUCTURE OF THE ESTEROLYTIC AND AMIDOLYTIC 43C9 ANTIBODY
1499, 3ob8D, 0.5783, 3.44, 0.042, 1024, 96, STRUCTURE OF THE BETA-GALACTOSIDASE FROM KLUYVEROMYCES LACTIS IN COMPLEX WITH GALACTOSE
1500, 3iflH, 0.5783, 3.11, 0.069, 214, 87, X-RAY STRUCTURE OF AMYLOID BETA PEPTIDE:ANTIBODY (ABETA1-7:12A11) COMPLEX
1501, 5fk0F, 0.5782, 3.41, 0.097, 263, 93, YEAST DELTA-COP-I MU-HOMOLOGY DOMAIN
1502, 5fk0B, 0.5782, 3.41, 0.097, 263, 93, YEAST DELTA-COP-I MU-HOMOLOGY DOMAIN
1503, 6gs4H, 0.5781, 3.14, 0.081, 125, 86, CRYSTAL STRUCTURE OF PEPTIDE TRANSPORTER DTPA-NANOBODY IN COMPLEX WITH VALGANCICLOVIR 
1504, 5fk0A, 0.5781, 3.41, 0.097, 263, 93, YEAST DELTA-COP-I MU-HOMOLOGY DOMAIN
1505, 2yn3C, 0.5781, 3.02, 0.080, 281, 88, STRUCTURAL INSIGHT INTO THE GIANT CALCIUM-BINDING ADHESIN SIIE: IMPLICATIONS FOR THE ADHESION OF SALMONELLA ENTERICA TO POLARIZED EPITHELIAL CELLS
1506, 4p48A, 0.5780, 3.54, 0.078, 235, 90, THE STRUCTURE OF A CHICKEN ANTI-CARDIAC TROPONIN I SCFV
1507, 5dgyB, 0.5779, 3.46, 0.074, 673, 95, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN
1508, 5d1zJ, 0.5779, 2.90, 0.067, 149, 89, ISDB NEAT1 BOUND BY CLONE D4-10
1509, 4zwjB, 0.5779, 3.46, 0.074, 673, 95, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO ARRESTIN BY FEMTOSECOND X-RAY LASER
1510, 4acqD, 0.5779, 3.25, 0.136, 1269, 88, ALPHA-2 MACROGLOBULIN
1511, 3d87B, 0.5779, 3.14, 0.056, 298, 90, CRYSTAL STRUCTURE OF INTERLEUKIN-23
1512, 2wb7A, 0.5779, 3.71, 0.043, 514, 94, PT26-6P
1513, 6n16C, 0.5778, 3.14, 0.091, 219, 88, VACCINE-ELICITED NHP FP-TARGETING NEUTRALIZING ANTIBODY 0PV-B.01 IN COMPLEX WITH HIV FUSION PEPTIDE (RESIDUE 512-519) 
1514, 5dgyD, 0.5778, 3.46, 0.074, 833, 95, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN
1515, 4zwjD, 0.5778, 3.46, 0.074, 833, 95, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO ARRESTIN BY FEMTOSECOND X-RAY LASER
1516, 4acqC, 0.5778, 3.25, 0.136, 1402, 88, ALPHA-2 MACROGLOBULIN
1517, 43caD, 0.5778, 2.98, 0.057, 117, 87, CRYSTALLOGRAPHIC STRUCTURE OF THE ESTEROLYTIC AND AMIDOLYTIC 43C9 ANTIBODY WITH BOUND P-NITROPHENOL
1518, 3obaC, 0.5778, 3.43, 0.042, 1024, 96, STRUCTURE OF THE BETA-GALACTOSIDASE FROM KLUYVEROMYCES LACTIS
1519, 3obaA, 0.5778, 3.43, 0.042, 1024, 96, STRUCTURE OF THE BETA-GALACTOSIDASE FROM KLUYVEROMYCES LACTIS
1520, 1axsB, 0.5778, 2.90, 0.059, 221, 85, MATURE OXY-COPE CATALYTIC ANTIBODY WITH HAPTEN
1521, 6gs7H, 0.5777, 3.17, 0.081, 125, 86, CRYSTAL STRUCTURE OF PEPTIDE TRANSPORTER DTPA-NANOBODY IN GLYCINE BUFFER 
1522, 4eaeA, 0.5777, 3.67, 0.053, 182, 95, THE CRYSTAL STRUCTURE OF A FUNCTIONALLY UNKNOWN PROTEIN FROM LISTERIA MONOCYTOGENES EGD-E
1523, 3se4A, 0.5777, 2.74, 0.071, 285, 85, HUMAN IFNW-IFNAR TERNARY COMPLEX
1524, 3obaD, 0.5777, 3.43, 0.042, 1024, 96, STRUCTURE OF THE BETA-GALACTOSIDASE FROM KLUYVEROMYCES LACTIS
1525, 1qfhA, 0.5777, 3.08, 0.102, 212, 88, DIMERIZATION OF GELATION FACTOR FROM DICTYOSTELIUM DISCOIDEUM: CRYSTAL STRUCTURE OF ROD DOMAINS 5 AND 6
1526, 5euvA, 0.5776, 2.84, 0.048, 731, 84, CRYSTAL STRUCTURE OF A COLD-ADAPTED DIMERIC BETA-D-GALACTOSIDASE FROM PARACOCCUS SP. 32D STRAIN
1527, 3spiA, 0.5776, 3.30, 0.064, 332, 94, INWARD RECTIFIER POTASSIUM CHANNEL KIR2.2 IN COMPLEX WITH PIP2
1528, 1wlhA, 0.5776, 3.11, 0.102, 308, 88, MOLECULAR STRUCTURE OF THE ROD DOMAIN OF DICTYOSTELIUM FILAMIN
1529, 1wc7B, 0.5776, 3.09, 0.105, 223, 86, FAB FRAGMENT OF PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH PHOSPHOPYRIDOXYL-L-ALANINE
1530, 6mnsH, 0.5775, 3.33, 0.102, 222, 88, RHESUS MACAQUE ANTI-HIV V3 ANTIBODY DH753 WITH GP120 V3 ZAM18 PEPTIDE 
1531, 2hftA, 0.5775, 2.92, 0.082, 205, 85, THE CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN TISSUE FACTOR AT 1.7 ANGSTROMS RESOLUTION
1532, 1fllA, 0.5775, 3.29, 0.078, 205, 90, MOLECULAR BASIS FOR CD40 SIGNALING MEDIATED BY TRAF3
1533, 1ca4C, 0.5774, 3.18, 0.034, 168, 89, STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 (TRAF2)
1534, 5tfyZ, 0.5773, 3.12, 0.091, 164, 88, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
1535, 5tfyX, 0.5773, 3.12, 0.091, 164, 88, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
1536, 5tfyW, 0.5773, 3.12, 0.091, 164, 88, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
1537, 5tfyV, 0.5773, 3.12, 0.091, 164, 88, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
1538, 5tfyU, 0.5773, 3.12, 0.091, 164, 88, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
1539, 5tfyT, 0.5773, 3.12, 0.091, 164, 88, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
1540, 5tfyS, 0.5773, 3.12, 0.091, 164, 88, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
1541, 5tfyR, 0.5773, 3.12, 0.091, 164, 88, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
1542, 5tfyQ, 0.5773, 3.12, 0.091, 164, 88, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
1543, 5tfyP, 0.5773, 3.12, 0.091, 164, 88, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
1544, 5tfyO, 0.5773, 3.12, 0.091, 164, 88, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
1545, 5tfyN, 0.5773, 3.12, 0.091, 164, 88, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
1546, 5tfyM, 0.5773, 3.12, 0.091, 164, 88, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
1547, 5tfyJ, 0.5773, 3.12, 0.091, 164, 88, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
1548, 5tfyI, 0.5773, 3.12, 0.091, 164, 88, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
1549, 5tfyF, 0.5773, 3.12, 0.091, 164, 88, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
1550, 5tfyE, 0.5773, 3.12, 0.091, 164, 88, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
1551, 5tfyB, 0.5773, 3.12, 0.091, 164, 88, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
1552, 5tfyA, 0.5773, 3.12, 0.091, 164, 88, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
1553, 4p24B, 0.5773, 3.66, 0.120, 291, 92, PORE FORMING TOXIN
1554, 3bisB, 0.5773, 2.52, 0.062, 212, 81, CRYSTAL STRUCTURE OF THE PD-L1
1555, 2c9aA, 0.5773, 3.05, 0.035, 256, 85, CRYSTAL STRUCTURE OF THE MAM-IG MODULE OF RECEPTOR PROTEIN TYROSINE PHOSPHATASE MU
1556, 6okqD, 0.5772, 3.32, 0.080, 230, 88, CRYSTAL STRUCTURE OF THE SF12 FAB 
1557, 5tfyY, 0.5772, 3.13, 0.091, 164, 88, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
1558, 5tfyL, 0.5772, 3.12, 0.091, 164, 88, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
1559, 5tfyK, 0.5772, 3.12, 0.091, 164, 88, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
1560, 5tfyH, 0.5772, 3.12, 0.091, 164, 88, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
1561, 5tfyG, 0.5772, 3.12, 0.091, 164, 88, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
1562, 5tfyD, 0.5772, 3.12, 0.091, 164, 88, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
1563, 5tfyC, 0.5772, 3.13, 0.091, 164, 88, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
1564, 2itfB, 0.5772, 3.09, 0.066, 119, 91, CRYSTAL STRUCTURE ISDA NEAT DOMAIN FROM STAPHYLOCOCCUS AUREUS WITH HEME BOUND
1565, 1qfhB, 0.5772, 3.08, 0.102, 212, 88, DIMERIZATION OF GELATION FACTOR FROM DICTYOSTELIUM DISCOIDEUM: CRYSTAL STRUCTURE OF ROD DOMAINS 5 AND 6
1566, 1j9cT, 0.5772, 2.84, 0.106, 210, 85, CRYSTAL STRUCTURE OF TISSUE FACTOR-FACTOR VIIA COMPLEX
1567, 5wszC, 0.5771, 3.55, 0.021, 168, 94, CRYSTAL STRUCTURE OF A LYTIC POLYSACCHARIDE MONOOXYGENASEBTLPMO10A FROM BACILLUS THURINGIENSIS
1568, 5hdoB, 0.5771, 3.29, 0.069, 127, 87, CRYSTAL STRUCTURE OF A NANOBODY RAISED AGAINST UROKINASE-TYPE PLASMINOGEN ACTIVATOR
1569, 5c71B, 0.5771, 3.08, 0.079, 582, 89, THE STRUCTURE OF ASPERGILLUS ORYZAE A-GLUCURONIDASE COMPLEXED WITH GLYCYRRHETINIC ACID MONOGLUCURONIDE
1570, 4x7eC, 0.5771, 3.29, 0.069, 121, 87, CRYSTAL STRUCTURE OF NOROVIRUS GII.10 P DOMAIN IN COMPLEX WITH NANO-85
1571, 4v33B, 0.5770, 2.95, 0.060, 315, 84, CRYSTAL STRUCTURE OF THE PUTATIVE POLYSACCHARIDE DEACETYLASE BA0330 FROM BACILLUS ANTHRACIS
1572, 1rfdH, 0.5770, 3.21, 0.103, 220, 87, ANTI-COCAINE ANTIBODY M82G2
1573, 6mvgA, 0.5769, 3.27, 0.045, 637, 89, CRYSTAL STRUCTURE OF FMN-BINDING BETA-GLUCURONIDASE FROM RUMINOCOCCUS GNAVUS 
1574, 5fjzB, 0.5769, 3.40, 0.098, 260, 92, YEAST DELTA-COP-I MU-HOMOLOGY DOMAIN COMPLEXED WITH DSL1 WXWXV PEPTIDE
1575, 3k46A, 0.5769, 2.99, 0.093, 597, 86, CRYSTAL STRUCTURE OF FULL-LENGTH E. COLI BETA-GLUCURONIDASE
1576, 2iq9H, 0.5769, 3.22, 0.091, 221, 88, PFA2 FAB FRAGMENT TRICLINIC APO FORM
1577, 1wcqB, 0.5769, 3.87, 0.074, 601, 94, MUTAGENESIS OF THE NUCLEOPHILIC TYROSINE IN A BACTERIAL SIALIDASE TO PHENYLALANINE.
1578, 3ob8C, 0.5768, 3.32, 0.042, 1024, 95, STRUCTURE OF THE BETA-GALACTOSIDASE FROM KLUYVEROMYCES LACTIS IN COMPLEX WITH GALACTOSE
1579, 3bkjH, 0.5768, 3.20, 0.080, 224, 87, CRYSTAL STRUCTURE OF FAB WO2 BOUND TO THE N TERMINAL DOMAIN OF AMYLOID BETA PEPTIDE (1-16)
1580, 4r7fA, 0.5767, 3.04, 0.080, 390, 87, CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN (PARMER_01801) FROM PARABACTEROIDES MERDAE ATCC 43184 AT 2.30 A RESOLUTION
1581, 4dsyA, 0.5767, 3.22, 0.092, 425, 87, CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT CC24201
1582, 4acqB, 0.5767, 3.25, 0.136, 1269, 88, ALPHA-2 MACROGLOBULIN
1583, 2v5yA, 0.5767, 3.12, 0.034, 564, 87, CRYSTAL STRUCTURE OF THE RECEPTOR PROTEIN TYROSINE PHOSPHATASE MU ECTODOMAIN
1584, 3hi1B, 0.5766, 3.30, 0.080, 225, 88, STRUCTURE OF HIV-1 GP120 (CORE WITH V3) IN COMPLEX WITH CD4-BINDING- SITE ANTIBODY F105
1585, 2bmkB, 0.5766, 3.17, 0.103, 223, 87, FAB FRAGMENT OF PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH PHOSPHOPYRIDOXYL-D-ALANINE
1586, 5wszA, 0.5765, 3.65, 0.032, 169, 95, CRYSTAL STRUCTURE OF A LYTIC POLYSACCHARIDE MONOOXYGENASEBTLPMO10A FROM BACILLUS THURINGIENSIS
1587, 3qazd, 0.5765, 3.00, 0.081, 191, 86, IL-2 MUTANT D10 TERNARY COMPLEX
1588, 5mhsN, 0.5764, 3.36, 0.057, 205, 88, T1L REOVIRUS SIGMA1 COMPLEXED WITH 5C6 FAB FRAGMENTS
1589, 5gjtH, 0.5763, 3.19, 0.105, 211, 86, CRYSTAL STRUCTURE OF H1 HEMAGGLUTININ FROM A/WASHINGTON/05/2011 IN COMPLEX WITH A NEUTRALIZING ANTIBODY 3E1
1590, 4dsyB, 0.5763, 3.21, 0.092, 426, 87, CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT CC24201
1591, 5uizA, 0.5762, 3.65, 0.032, 186, 94, STRUCTURE OF T.FUSCA AA10A
1592, 5grjA, 0.5762, 2.69, 0.073, 213, 82, CRYSTAL STRUCTURE OF HUMAN PD-L1 WITH MONOCLONAL ANTIBODY AVELUMAB
1593, 4gboA, 0.5762, 3.65, 0.032, 186, 94, STRUCTURE OF T.FUSCA E7
1594, 3qznA, 0.5762, 3.08, 0.066, 121, 91, STAPHYLOCOCCUS AUREUS ISDA NEAT DOMAIN Y166A VARIANT IN COMPLEX WITH HEME
1595, 3npzB, 0.5762, 3.06, 0.060, 202, 84, PROLACTIN RECEPTOR (PRLR) COMPLEXED WITH THE NATURAL HORMONE (PRL)
1596, 2hymA, 0.5762, 3.20, 0.045, 212, 88, NMR BASED DOCKING MODEL OF THE COMPLEX BETWEEN THE HUMAN TYPE I INTERFERON RECEPTOR AND HUMAN INTERFERON ALPHA-2
1597, 4tqeH, 0.5761, 2.99, 0.047, 220, 86, STRUCTURE OF TAU PEPTIDE IN COMPLEX WITH TAU5 ANTIBODY FAB FRAGMENT
1598, 3spcA, 0.5761, 3.31, 0.064, 327, 94, INWARD RECTIFIER POTASSIUM CHANNEL KIR2.2 IN COMPLEX WITH DIOCTANOYLGLYCEROL PYROPHOSPHATE (DGPP)
1599, 5gniB, 0.5760, 3.03, 0.080, 198, 87, THE CRYSTAL STRUCTURE OF PECAM-1 IGL1-2 TRANS-HOMOPHILIC DIMER
1600, 4yhdE, 0.5760, 3.81, 0.053, 268, 94, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
1601, 3anzG, 0.5760, 3.49, 0.110, 294, 91, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1602, 1aifB, 0.5760, 3.23, 0.092, 218, 87, ANTI-IDIOTYPIC FAB 409.5.3 (IGG2A) FAB FROM MOUSE
1603, 4x7eD, 0.5759, 3.30, 0.069, 120, 87, CRYSTAL STRUCTURE OF NOROVIRUS GII.10 P DOMAIN IN COMPLEX WITH NANO-85
1604, 2yn5A, 0.5759, 3.00, 0.080, 283, 88, STRUCTURAL INSIGHT INTO THE GIANT CALCIUM-BINDING ADHESIN SIIE: IMPLICATIONS FOR THE ADHESION OF SALMONELLA ENTERICA TO POLARIZED EPITHELIAL CELLS
1605, 2ipuH, 0.5759, 3.22, 0.080, 223, 88, PFA1 FAB FRAGMENT COMPLEXED WITH ABETA 1-8 PEPTIDE
1606, 2jlpC, 0.5758, 3.41, 0.075, 167, 93, CRYSTAL STRUCTURE OF HUMAN EXTRACELLULAR COPPER-ZINC SUPEROXIDE DISMUTASE.
1607, 1w2kT, 0.5758, 2.90, 0.094, 188, 85, TF7A_4380 COMPLEX
1608, 4kbpD, 0.5757, 3.04, 0.118, 424, 85, KIDNEY BEAN PURPLE ACID PHOSPHATASE
1609, 3k46B, 0.5757, 2.90, 0.071, 596, 84, CRYSTAL STRUCTURE OF FULL-LENGTH E. COLI BETA-GLUCURONIDASE
1610, 2jlpB, 0.5757, 3.30, 0.087, 166, 92, CRYSTAL STRUCTURE OF HUMAN EXTRACELLULAR COPPER-ZINC SUPEROXIDE DISMUTASE.
1611, 2bmkH, 0.5757, 3.34, 0.102, 221, 88, FAB FRAGMENT OF PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH PHOSPHOPYRIDOXYL-D-ALANINE
1612, 1aifH, 0.5757, 3.22, 0.092, 218, 87, ANTI-IDIOTYPIC FAB 409.5.3 (IGG2A) FAB FROM MOUSE
1613, 5gjsH, 0.5756, 3.15, 0.093, 211, 86, CRYSTAL STRUCTURE OF H1 HEMAGGLUTININ FROM A/CALIFORNIA/04/2009 IN COMPLEX WITH A NEUTRALIZING ANTIBODY 3E1
1614, 5c71D, 0.5756, 3.10, 0.079, 582, 89, THE STRUCTURE OF ASPERGILLUS ORYZAE A-GLUCURONIDASE COMPLEXED WITH GLYCYRRHETINIC ACID MONOGLUCURONIDE
1615, 4jkmB, 0.5756, 3.12, 0.069, 602, 87, CRYSTAL STRUCTURE OF CLOSTRIDIUM PERFRINGENS BETA-GLUCURONIDASE
1616, 2o1aA, 0.5756, 3.07, 0.088, 120, 91, CRYSTAL STRUCTURE OF IRON-REGULATED SURFACE DETERMINANT PROTEIN A FROM STAPHYLOCOCCUS AUREUS- TARGETED DOMAIN 47...188
1617, 5z1lR, 0.5755, 3.09, 0.138, 199, 87, CRYO-EM STRUCTURE OF METHANOCCUS MARIPALUDIS ARCHAELLUM 
1618, 5z1lP, 0.5755, 3.09, 0.138, 199, 87, CRYO-EM STRUCTURE OF METHANOCCUS MARIPALUDIS ARCHAELLUM 
1619, 5z1lK, 0.5755, 3.09, 0.138, 199, 87, CRYO-EM STRUCTURE OF METHANOCCUS MARIPALUDIS ARCHAELLUM 
1620, 5z1lI, 0.5755, 3.09, 0.138, 199, 87, CRYO-EM STRUCTURE OF METHANOCCUS MARIPALUDIS ARCHAELLUM 
1621, 5z1lG, 0.5755, 3.09, 0.138, 199, 87, CRYO-EM STRUCTURE OF METHANOCCUS MARIPALUDIS ARCHAELLUM 
1622, 5z1lF, 0.5755, 3.09, 0.138, 199, 87, CRYO-EM STRUCTURE OF METHANOCCUS MARIPALUDIS ARCHAELLUM 
1623, 5z1lC, 0.5755, 3.09, 0.138, 199, 87, CRYO-EM STRUCTURE OF METHANOCCUS MARIPALUDIS ARCHAELLUM 
1624, 5z1lA, 0.5755, 3.09, 0.138, 199, 87, CRYO-EM STRUCTURE OF METHANOCCUS MARIPALUDIS ARCHAELLUM 
1625, 5c70B, 0.5755, 3.09, 0.090, 584, 89, THE STRUCTURE OF ASPERGILLUS ORYZAE BETA-GLUCURONIDASE
1626, 2gkwA, 0.5755, 3.28, 0.067, 192, 90, KEY CONTACTS PROMOTE RECONGNITO OF BAFF-R BY TRAF3
1627, 1ky6A, 0.5755, 3.88, 0.020, 247, 100, AP-2 CLATHRIN ADAPTOR ALPHA-APPENDAGE IN COMPLEX WITH EPSIN DPW PEPTIDE
1628, 5z1lQ, 0.5754, 3.09, 0.138, 199, 87, CRYO-EM STRUCTURE OF METHANOCCUS MARIPALUDIS ARCHAELLUM 
1629, 5z1lO, 0.5754, 3.09, 0.138, 199, 87, CRYO-EM STRUCTURE OF METHANOCCUS MARIPALUDIS ARCHAELLUM 
1630, 5z1lN, 0.5754, 3.09, 0.138, 199, 87, CRYO-EM STRUCTURE OF METHANOCCUS MARIPALUDIS ARCHAELLUM 
1631, 5z1lM, 0.5754, 3.09, 0.138, 199, 87, CRYO-EM STRUCTURE OF METHANOCCUS MARIPALUDIS ARCHAELLUM 
1632, 5z1lL, 0.5754, 3.09, 0.138, 199, 87, CRYO-EM STRUCTURE OF METHANOCCUS MARIPALUDIS ARCHAELLUM 
1633, 5z1lJ, 0.5754, 3.09, 0.138, 199, 87, CRYO-EM STRUCTURE OF METHANOCCUS MARIPALUDIS ARCHAELLUM 
1634, 5z1lH, 0.5754, 3.09, 0.138, 199, 87, CRYO-EM STRUCTURE OF METHANOCCUS MARIPALUDIS ARCHAELLUM 
1635, 5z1lE, 0.5754, 3.09, 0.138, 199, 87, CRYO-EM STRUCTURE OF METHANOCCUS MARIPALUDIS ARCHAELLUM 
1636, 5z1lD, 0.5754, 3.09, 0.138, 199, 87, CRYO-EM STRUCTURE OF METHANOCCUS MARIPALUDIS ARCHAELLUM 
1637, 5z1lB, 0.5754, 3.09, 0.138, 199, 87, CRYO-EM STRUCTURE OF METHANOCCUS MARIPALUDIS ARCHAELLUM 
1638, 5cj5B, 0.5754, 3.59, 0.077, 678, 91, STRUCTURE OF MYCOBACTERIUM THERMORESISTIBILE GLGE APO FORM AT 3.13A RESOLUTION
1639, 4hd5A, 0.5754, 3.01, 0.083, 315, 84, CRYSTAL STRUCTURE OF BC0361 A POLYSACCHARIDE DEACETYLASE FROM BACILLUS CEREUS
1640, 1nudB, 0.5754, 3.46, 0.132, 673, 91, ROLE OF CALCIUM IONS IN THE ACTIVATION AND ACTIVITY OF THE TRANSGLUTAMINASE 3 ENZYME (3 CALCIUMS ACTIVE FORM)
1641, 4ylqT, 0.5753, 2.90, 0.094, 210, 85, CRYSTAL STRUCTURE OF A FVIIA-TRYPSIN CHIMERA (FT) IN COMPLEX WITH SOLUBLE TISSUE FACTOR
1642, 3auwD, 0.5753, 3.30, 0.067, 175, 89, CYTOPLASMIC DOMAIN OF INWARD RECTIFIER POTASSIUM CHANNEL KIR3.2 IN COMPLEX WITH CADMIUM
1643, 2r83B, 0.5753, 3.63, 0.064, 279, 94, CRYSTAL STRUCTURE ANALYSIS OF HUMAN SYNAPTOTAGMIN 1 C2A-C2B
1644, 6oc3C, 0.5752, 3.43, 0.115, 221, 87, CRYSTAL STRUCTURE OF FLUA-20 FAB IN COMPLEX WITH THE HEAD DOMAIN OF H1 (A/SOLOMON ISLANDS/3/2006) 
1645, 6hwrB, 0.5752, 3.23, 0.103, 425, 87, RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH ADENOSINE DIVANADATE 
1646, 4p24E, 0.5752, 3.69, 0.054, 291, 93, PORE FORMING TOXIN
1647, 4aeeA, 0.5752, 3.16, 0.058, 684, 86, CRYSTAL STRUCTURE OF MALTOGENIC AMYLASE FROM S.MARINUS
1648, 3baeH, 0.5752, 3.02, 0.071, 219, 85, CRYSTAL STRUCTURE OF FAB WO2 BOUND TO THE N TERMINAL DOMAIN OF AMYLOID BETA PEPTIDE (1-28)
1649, 1zshA, 0.5752, 3.40, 0.053, 354, 95, CRYSTAL STRUCTURE OF BOVINE ARRESTIN-2 IN COMPLEX WITH INOSITOL HEXAKISPHOSPHATE (IP6)
1650, 1kzzA, 0.5752, 3.55, 0.065, 192, 92, DOWNSTREAM REGULATOR TANK BINDS TO THE CD40 RECOGNITION SITE ON TRAF3
1651, 6mvfB, 0.5751, 3.39, 0.044, 643, 90, CRYSTAL STRUCTURE OF FMN-BINDING BETA-GLUCURONIDASE FROM FACAELIBACTERIUM PRAUSNITZII L2-6 
1652, 5w5nB, 0.5751, 3.16, 0.023, 211, 87, CRYSTAL STRUCTURE OF HUMAN IGG4-SIGMA2 FC FRAGMENT
1653, 4kkzB, 0.5751, 3.21, 0.092, 425, 87, THE CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH DIETHYLENE GLYCOL MONOVANADATE
1654, 6oc3A, 0.5750, 3.18, 0.118, 224, 85, CRYSTAL STRUCTURE OF FLUA-20 FAB IN COMPLEX WITH THE HEAD DOMAIN OF H1 (A/SOLOMON ISLANDS/3/2006) 
1655, 6mvgC, 0.5750, 3.28, 0.045, 637, 89, CRYSTAL STRUCTURE OF FMN-BINDING BETA-GLUCURONIDASE FROM RUMINOCOCCUS GNAVUS 
1656, 1zlgA, 0.5750, 2.92, 0.138, 680, 87, SOLUTION STRUCTURE OF THE EXTRACELLULAR MATRIX PROTEIN ANOSMIN-1
1657, 1q72H, 0.5750, 3.19, 0.103, 220, 87, ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH COCAINE
1658, 6mvfC, 0.5749, 3.39, 0.044, 643, 90, CRYSTAL STRUCTURE OF FMN-BINDING BETA-GLUCURONIDASE FROM FACAELIBACTERIUM PRAUSNITZII L2-6 
1659, 5aoqB, 0.5749, 3.20, 0.071, 233, 84, STRUCTURAL BASIS OF NEUROHORMONE PERCEPTION BY THE RECEPTOR TYROSINE KINASE TORSO
1660, 4aeeB, 0.5749, 2.96, 0.071, 684, 84, CRYSTAL STRUCTURE OF MALTOGENIC AMYLASE FROM S.MARINUS
1661, 2r15B, 0.5749, 2.69, 0.134, 207, 82, CRYSTAL STRUCTURE OF THE MYOMESIN DOMAINS 12 AND 13
1662, 6mvfD, 0.5748, 3.39, 0.044, 643, 90, CRYSTAL STRUCTURE OF FMN-BINDING BETA-GLUCURONIDASE FROM FACAELIBACTERIUM PRAUSNITZII L2-6 
1663, 5wszB, 0.5748, 3.45, 0.022, 168, 92, CRYSTAL STRUCTURE OF A LYTIC POLYSACCHARIDE MONOOXYGENASEBTLPMO10A FROM BACILLUS THURINGIENSIS
1664, 5u9mB, 0.5748, 3.81, 0.052, 226, 96, COPPER-ZINC SUPEROXIDE DISMUTASE IS ACTIVATED THROUGH A SULFENIC ACID INTERMEDIATE AT A COPPER-ION ENTRY SITE
1665, 1pgrF, 0.5748, 2.98, 0.114, 209, 88, 2:2 COMPLEX OF G-CSF WITH ITS RECEPTOR
1666, 5ldrA, 0.5747, 2.90, 0.048, 731, 84, CRYSTAL STRUCTURE OF A COLD-ADAPTED DIMERIC BETA-D-GALACTOSIDASE FROM PARACOCCUS SP. 32D STRAIN IN COMPLEX WITH GALACTOSE
1667, 4dohR, 0.5747, 3.23, 0.067, 204, 89, IL20/IL201/IL20R2 TERNARY COMPLEX
1668, 1w0yT, 0.5747, 2.92, 0.094, 188, 85, TF7A_3771 COMPLEX
1669, 1uusA, 0.5747, 4.20, 0.110, 464, 100, STRUCTURE OF AN ACTIVATED DICTYOSTELIUM STAT IN ITS DNA-UNBOUND FORM
1670, 6db5H, 0.5746, 3.14, 0.093, 228, 86, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB TA6 IN COMPLEX WITH A HIV-1 GP120 V3 PEPTIDE FROM NY5 STRAIN 
1671, 4w2oE, 0.5746, 3.23, 0.057, 118, 87, ANTI-MARBURGVIRUS NUCLEOPROTEIN SINGLE DOMAIN ANTIBODY B COMPLEXED WITH NUCLEOPROTEIN C-TERMINAL DOMAIN
1672, 2r0zH, 0.5746, 3.23, 0.068, 216, 88, PFA1 FAB COMPLEXED WITH GRIPI PEPTIDE FRAGMENT
1673, 2benA, 0.5746, 3.42, 0.065, 170, 92, CRYSTAL STRUCTURE OF THE SERRATIA MARCESCENS CHITIN-BINDING PROTEIN CBP21 Y54A MUTANT.
1674, 1zmsA, 0.5746, 3.42, 0.066, 192, 91, LMP1 PROTEIN BINDS TO TRAF3 AS A STRUCTURAL CD40
1675, 1pgrB, 0.5746, 2.98, 0.114, 208, 88, 2:2 COMPLEX OF G-CSF WITH ITS RECEPTOR
1676, 5kynB, 0.5745, 3.89, 0.021, 719, 96, STRUCTURE OF SEC23 AND TANGO1 COMPLEX
1677, 5hm1B, 0.5745, 3.14, 0.092, 119, 87, LLAMA VHH 2E7 IN COMPLEX WITH GP41
1678, 2lhsA, 0.5745, 3.71, 0.053, 170, 94, STRUCTURE OF THE CHITIN BINDING PROTEIN 21 (CBP21)
1679, 6mvfA, 0.5744, 3.51, 0.076, 643, 92, CRYSTAL STRUCTURE OF FMN-BINDING BETA-GLUCURONIDASE FROM FACAELIBACTERIUM PRAUSNITZII L2-6 
1680, 4u3cE, 0.5744, 3.54, 0.056, 660, 89, DOCKING SITE OF MALTOHEXAOSE IN THE MTB GLGE
1681, 4nkqA, 0.5744, 2.91, 0.083, 412, 84, STRUCTURE OF A CYTOKINE RECEPTOR COMPLEX
1682, 5gn0A, 0.5743, 3.30, 0.080, 222, 87, STRUCTURE OF TAZ-TEAD COMPLEX
1683, 2wb7B, 0.5743, 3.70, 0.032, 514, 94, PT26-6P
1684, 2covF, 0.5743, 2.45, 0.051, 87, 79, CRYSTAL STRUCTURE OF CBM31 FROM BETA-13-XYLANASE
1685, 6mnsA, 0.5742, 3.36, 0.102, 223, 88, RHESUS MACAQUE ANTI-HIV V3 ANTIBODY DH753 WITH GP120 V3 ZAM18 PEPTIDE 
1686, 6mvfE, 0.5741, 3.51, 0.076, 643, 92, CRYSTAL STRUCTURE OF FMN-BINDING BETA-GLUCURONIDASE FROM FACAELIBACTERIUM PRAUSNITZII L2-6 
1687, 6gs1H, 0.5741, 3.19, 0.081, 125, 86, CRYSTAL STRUCTURE OF PEPTIDE TRANSPORTER DTPA-NANOBODY IN MES BUFFER 
1688, 5hnpB, 0.5741, 3.54, 0.097, 166, 93, THE STRUCTURE OF THE KDO-CAPPED SACCHARIDE BINDING SUBUNIT OF THE O-12 SPECIFIC ABC TRANSPORTER WZT
1689, 3hn8C, 0.5741, 3.84, 0.062, 279, 97, CRYSTAL STRUCTURE OF SYNAPTOTAGMIN
1690, 2z0uA, 0.5741, 3.62, 0.136, 127, 88, CRYSTAL STRUCTURE OF C2 DOMAIN OF KIBRA PROTEIN
1691, 2benB, 0.5741, 3.58, 0.043, 169, 93, CRYSTAL STRUCTURE OF THE SERRATIA MARCESCENS CHITIN-BINDING PROTEIN CBP21 Y54A MUTANT.
1692, 1f42A, 0.5741, 3.31, 0.103, 297, 87, THE P40 DOMAIN OF HUMAN INTERLEUKIN-12
1693, 6mqrH, 0.5740, 2.93, 0.081, 227, 86, VACCINE-ELICITED NHP FP-TARGETING NEUTRALIZING ANTIBODY 0PV-A.01 IN COMPLEX WITH FP (RESIDUE 512-519) 
1694, 6fd0B, 0.5740, 3.51, 0.115, 128, 87, HUMAN KIBRA C2 DOMAIN MUTANT M734I S735A 
1695, 3szkC, 0.5740, 2.94, 0.112, 144, 89, CRYSTAL STRUCTURE OF HUMAN METHAEMOGLOBIN COMPLEXED WITH THE FIRST NEAT DOMAIN OF ISDH FROM STAPHYLOCOCCUS AUREUS
1696, 3hn8A, 0.5740, 3.84, 0.062, 279, 97, CRYSTAL STRUCTURE OF SYNAPTOTAGMIN
1697, 2itfA, 0.5740, 3.14, 0.066, 119, 91, CRYSTAL STRUCTURE ISDA NEAT DOMAIN FROM STAPHYLOCOCCUS AUREUS WITH HEME BOUND
1698, 2covG, 0.5740, 2.54, 0.050, 88, 80, CRYSTAL STRUCTURE OF CBM31 FROM BETA-13-XYLANASE
1699, 1egjA, 0.5740, 3.04, 0.071, 101, 85, DOMAIN 4 OF THE BETA COMMON CHAIN IN COMPLEX WITH AN ANTIBODY
1700, 6mvfF, 0.5739, 3.50, 0.076, 643, 92, CRYSTAL STRUCTURE OF FMN-BINDING BETA-GLUCURONIDASE FROM FACAELIBACTERIUM PRAUSNITZII L2-6 
1701, 43caF, 0.5739, 3.03, 0.057, 117, 87, CRYSTALLOGRAPHIC STRUCTURE OF THE ESTEROLYTIC AND AMIDOLYTIC 43C9 ANTIBODY WITH BOUND P-NITROPHENOL
1702, 4ghuA, 0.5738, 3.30, 0.067, 190, 90, CRYSTAL STRUCTURE OF TRAF3/CARDIF
1703, 3iy5B, 0.5738, 3.21, 0.069, 122, 87, VARIABLE DOMAINS OF THE MOUSE FAB (1AIF) FITTED INTO THE CRYOEM RECONSTRUCTION OF THE VIRUS-FAB 16 COMPLEX
1704, 2hzyA, 0.5738, 3.96, 0.102, 416, 98, MOUSE FUMARYLACETOACETATE HYDROLASE COMPLEXES WITH A TRANSITION-STATE MIMIC OF THE COMPLETE SUBSTRATE
1705, 5vnkA, 0.5737, 3.60, 0.054, 708, 93, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL LL SORTING MOTIF
1706, 5ldrB, 0.5737, 2.87, 0.048, 731, 84, CRYSTAL STRUCTURE OF A COLD-ADAPTED DIMERIC BETA-D-GALACTOSIDASE FROM PARACOCCUS SP. 32D STRAIN IN COMPLEX WITH GALACTOSE
1707, 5gztB, 0.5737, 2.75, 0.093, 1134, 86, CRYSTAL STRUCTURE OF CHITINASE CHIW FROM PAENIBACILLUS SP. STR. FPU-7 REVEALS A NOVEL TYPE OF BACTERIAL CELL-SURFACE-EXPRESSED MULTI- MODULAR ENZYME MACHINERY
1708, 4z6aT, 0.5737, 2.88, 0.094, 201, 85, CRYSTAL STRUCTURE OF A FVIIA-TRYPSIN CHIMERA (YT) IN COMPLEX WITH SOLUBLE TISSUE FACTOR
1709, 3k4aA, 0.5737, 2.83, 0.095, 584, 84, CRYSTAL STRUCTURE OF SELENOMETHIONINE SUBSTITUTED E. COLI BETA- GLUCURONIDASE
1710, 3egsB, 0.5737, 3.23, 0.057, 216, 88, CRYSTAL STRUCTURE OF THE HIV-1 BROADLY NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH THE GP41 SCRAMBLEDFP-MPER SCRHYB3K CONSTRUCT GIGAFGLLGFLAAGSKK-AHX-K656NEQELLELDKWASLWN671 SOAKED IN AMMONIUM SULFATE
1711, 2iqaH, 0.5737, 2.99, 0.070, 221, 86, PFA2 FAB FRAGMENT MONOCLINIC APO FORM
1712, 2hzyB, 0.5737, 3.96, 0.102, 418, 98, MOUSE FUMARYLACETOACETATE HYDROLASE COMPLEXES WITH A TRANSITION-STATE MIMIC OF THE COMPLETE SUBSTRATE
1713, 6osyH, 0.5736, 2.94, 0.094, 122, 85, CRYO-EM STRUCTURE OF VACCINE-ELICITED ANTIBODY 0PV-A.01 IN COMPLEX WITH HIV-1 ENV BG505 DS-SOSIP AND ANTIBODIES VRC03 AND PGT122 
1714, 6gciB, 0.5736, 3.15, 0.082, 124, 85, STRUCTURE OF THE BONGKREKIC ACID-INHIBITED MITOCHONDRIAL ADP/ATP CARRIER 
1715, 6ce0D, 0.5736, 3.49, 0.045, 240, 88, CRYSTAL STRUCTURE OF A HIV-1 CLADE B TIER-3 ISOLATE H078.14 UFO-BG ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING FABS PGT124 AND 35O22 AT 4.6 ANGSTROM 
1716, 5hggS, 0.5736, 3.14, 0.071, 128, 85, CRYSTAL STRUCTURE OF UPA IN COMPLEX WITH A CAMELID-DERIVED ANTIBODY FRAGMENT
1717, 2moqA, 0.5736, 2.92, 0.068, 148, 88, SOLUTION STRUCTURE AND MOLECULAR DETERMINANTS OF HEMOGLOBIN BINDING OF THE FIRST NEAT DOMAIN OF ISDB IN STAPHYLOCOCCUS AUREUS
1718, 6fytI, 0.5735, 3.23, 0.093, 124, 86, STRUCTURE OF H1 (A/SOLOMON ISLANDS/3/06) INFLUENZA HEMAGGLUTININ IN COMPLEX WITH SD38 
1719, 4u33A, 0.5735, 3.49, 0.056, 661, 89, STRUCTURE OF MTB GLGE BOUND TO MALTOSE
1720, 4dhlD, 0.5735, 3.09, 0.081, 423, 86, CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT MO07123
1721, 1cd9B, 0.5735, 3.39, 0.056, 206, 89, 2:2 COMPLEX OF G-CSF WITH ITS RECEPTOR
1722, 2e8zA, 0.5734, 2.75, 0.136, 712, 81, CRYSTAL STRUCTURE OF PULLULANASE TYPE I FROM BACILLUS SUBTILIS STR. 168 COMPLEXED WITH ALPHA-CYCLODEXTRIN
1723, 6ck8A, 0.5733, 3.18, 0.093, 124, 86, CRYSTAL STRUCTURE OF ANTI-INFLUENZA SINGLE-DOMAIN LLAMA ANTIBODY SD38 
1724, 3drqB, 0.5733, 3.23, 0.057, 216, 88, CRYSTAL STRUCTURE OF THE HIV-1 BROADLY NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH THE GP41 FP-MPER HYB3K CONSTRUCT 514GIGALFLGFLGAAGS528KK-AHX-655KNEQELLELDKWASLWN671 SOAKED IN PEG/2- PROPANOL SOLUTION
1725, 2djmA, 0.5733, 3.02, 0.082, 106, 85, SOLUTION STRUCTURE OF N-TERMINAL STARCH-BINDING DOMAIN OF GLUCOAMYLASE FROM RHIZOPUS ORYZAE
1726, 6okqF, 0.5732, 3.34, 0.080, 230, 88, CRYSTAL STRUCTURE OF THE SF12 FAB 
1727, 5vxjD, 0.5732, 3.19, 0.103, 118, 87, 2.50 A RESOLUTION STRUCTURE OF IPAD FROM SHIGELLA FLEXNERI IN COMPLEX WITH SINGLE-DOMAIN ANTIBODY JMK-E3
1728, 5uqyD, 0.5732, 3.38, 0.080, 218, 88, CRYSTAL STRUCTURE OF MARBURG VIRUS GP IN COMPLEX WITH THE HUMAN SURVIVOR ANTIBODY MR78
1729, 4p1xF, 0.5732, 3.98, 0.074, 255, 95, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL LUK PREPORE
1730, 43caH, 0.5732, 2.98, 0.058, 117, 86, CRYSTALLOGRAPHIC STRUCTURE OF THE ESTEROLYTIC AND AMIDOLYTIC 43C9 ANTIBODY WITH BOUND P-NITROPHENOL
1731, 3qazR, 0.5732, 3.14, 0.081, 188, 86, IL-2 MUTANT D10 TERNARY COMPLEX
1732, 3mnmB, 0.5732, 3.32, 0.077, 109, 91, CRYSTAL STRUCTURE OF GAE DOMAIN OF GGA2P FROM SACCHAROMYCES CEREVISIAE
1733, 3bquB, 0.5732, 3.30, 0.068, 214, 88, CRYSTAL STRUCTURE OF THE 2F5 FAB -3H6 FAB COMPLEX
1734, 1flkB, 0.5732, 3.35, 0.078, 205, 90, MOLECULAR BASIS FOR CD40 SIGNALING MEDIATED BY TRAF3
1735, 6mvgB, 0.5731, 3.20, 0.045, 636, 88, CRYSTAL STRUCTURE OF FMN-BINDING BETA-GLUCURONIDASE FROM RUMINOCOCCUS GNAVUS 
1736, 6fd0A, 0.5731, 3.33, 0.118, 129, 85, HUMAN KIBRA C2 DOMAIN MUTANT M734I S735A 
1737, 5tz8B, 0.5731, 3.66, 0.132, 558, 91, CRYSTAL STRUCTURE OF S. AUREUS TARS
1738, 5mzvC, 0.5731, 3.10, 0.059, 293, 85, IL-23:IL-23R:NB22E11 COMPLEX
1739, 2r0wH, 0.5731, 3.23, 0.091, 217, 88, PFA2 FAB COMPLEXED WITH ABETA1-8
1740, 2gysB, 0.5731, 2.81, 0.084, 406, 83, 2.7 A STRUCTURE OF THE EXTRACELLULAR DOMAINS OF THE HUMAN BETA COMMON RECEPTOR INVOLVED IN IL-3 IL-5 AND GM-CSF SIGNALLING
1741, 6mdtD, 0.5730, 3.50, 0.045, 240, 88, CRYSTAL STRUCTURE OF THE B41 SOSIP.664 ENV TRIMER WITH PGT124 AND 35O22 FABS; IN P63 SPACE GROUP 
1742, 5u02A, 0.5730, 3.44, 0.101, 355, 89, CRYSTAL STRUCTURE OF S. AUREUS TARS 217-571
1743, 4p1xD, 0.5730, 3.98, 0.074, 257, 95, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL LUK PREPORE
1744, 4ij2H, 0.5730, 2.80, 0.136, 197, 88, HUMAN METHEMOGLOBIN IN COMPLEX WITH THE SECOND AND THIRD NEAT DOMAINS OF ISDH FROM STAPHYLOCOCCUS AUREUS
1745, 4f37H, 0.5730, 3.34, 0.057, 225, 88, STRUCTURE OF THE TETHERED N-TERMINUS OF ALZHEIMER S DISEASE A PEPTIDE
1746, 2e8yA, 0.5730, 2.75, 0.136, 712, 81, CRYSTAL STRUCTURE OF PULLULANASE TYPE I FROM BACILLUS SUBTILIS STR. 168
1747, 1m2vA, 0.5730, 3.54, 0.054, 705, 93, CRYSTAL STRUCTURE OF THE YEAST SEC23/24 HETERODIMER
1748, 6obzH, 0.5729, 3.14, 0.118, 221, 85, CRYSTAL STRUCTURE OF FLUA-20 FAB 
1749, 2yn5B, 0.5729, 3.09, 0.080, 284, 88, STRUCTURAL INSIGHT INTO THE GIANT CALCIUM-BINDING ADHESIN SIIE: IMPLICATIONS FOR THE ADHESION OF SALMONELLA ENTERICA TO POLARIZED EPITHELIAL CELLS
1750, 2ipuG, 0.5729, 3.09, 0.069, 219, 87, PFA1 FAB FRAGMENT COMPLEXED WITH ABETA 1-8 PEPTIDE
1751, 1rf3A, 0.5729, 3.46, 0.065, 192, 92, STRUCTURALLY DISTINCT RECOGNITION MOTIFS IN LYMPHOTOXIN-B RECEPTOR AND CD40 FOR TRAF-MEDIATED SIGNALING
1752, 6ocbH, 0.5728, 3.14, 0.118, 222, 85, CRYSTAL STRUCTURE OF FLUA-20 FAB IN COMPLEX WITH THE HEAD DOMAIN OF H3 (A/HONG KONG/1/1968) 
1753, 6g46B, 0.5728, 3.21, 0.092, 425, 87, RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH 2-(NAPHTHALEN- 1-YL)THIAZOLE-4-CARBOXYLIC ACID 
1754, 4u3cA, 0.5728, 3.54, 0.056, 660, 89, DOCKING SITE OF MALTOHEXAOSE IN THE MTB GLGE
1755, 4re1A, 0.5728, 3.19, 0.082, 206, 85, CRYSTAL STRUCTURE OF HUMAN TEAD1 AND DISULFIDE-ENGINEERED YAP
1756, 2q7nC, 0.5728, 2.94, 0.048, 480, 84, CRYSTAL STRUCTURE OF LEUKEMIA INHIBITORY FACTOR IN COMPLEX WITH LIF RECEPTOR (DOMAINS 1-5)
1757, 1l9nA, 0.5728, 3.43, 0.089, 673, 90, THREE-DIMENSIONAL STRUCTURE OF THE HUMAN TRANSGLUTAMINASE 3 ENZYME: BINDING OF CALCIUM IONS CHANGE STRUCTURE FOR ACTIVATION
1758, 6hwrD, 0.5727, 3.08, 0.081, 426, 86, RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH ADENOSINE DIVANADATE 
1759, 5njdE, 0.5727, 3.39, 0.044, 294, 91, STRUCTURE OF INTERLEUKIN 23 IN COMPLEX WITH BRIAKINUMAB FAB
1760, 4u33F, 0.5727, 3.50, 0.056, 661, 89, STRUCTURE OF MTB GLGE BOUND TO MALTOSE
1761, 4dhlC, 0.5727, 3.23, 0.080, 424, 87, CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT MO07123
1762, 3og6B, 0.5727, 3.10, 0.034, 200, 88, THE CRYSTAL STRUCTURE OF HUMAN INTERFERON LAMBDA 1 COMPLEXED WITH ITS HIGH AFFINITY RECEPTOR IN SPACE GROUP P212121
1763, 3drtB, 0.5727, 3.24, 0.057, 216, 88, CRYSTAL STRUCTURE OF THE HIV-1 BROADLY NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH THE GP41 SCRAMBLEDFP-MPER SCRHYB3K CONSTRUCT GIGAFGLLGFLAAGSKK-AHX-K656NEQELLELDKWASLWN671
1764, 2lfgA, 0.5727, 2.82, 0.106, 113, 85, SOLUTION STRUCTURE OF THE HUMAN PROLACTIN RECEPTOR ECD DOMAIN D2
1765, 1tjhH, 0.5727, 3.29, 0.057, 236, 88, CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY 2F5 IN COMPLEX WITH A GP41 11MER EPITOPE
1766, 1ocwH, 0.5727, 2.96, 0.047, 120, 86, FREE CONFORMATION AB2 OF THE IGE SPE-7
1767, 5w5mB, 0.5726, 3.07, 0.023, 209, 86, CRYSTAL STRUCTURE OF HUMAN IGG4-SIGMA1 FC FRAGMENT
1768, 5uddO, 0.5726, 3.25, 0.105, 216, 86, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
1769, 5uddM, 0.5726, 3.22, 0.093, 221, 86, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
1770, 4f8tA, 0.5726, 3.13, 0.057, 210, 87, CRYSTAL STRUCTURE OF THE HUMAN BTN3A3 ECTODOMAIN
1771, 4aq1C, 0.5726, 3.32, 0.116, 627, 86, STRUCTURE OF THE SBSB S-LAYER PROTEIN OF GEOBACILLUS STEAROTHERMOPHILUS PV72P2 IN COMPLEX WITH NANOBODY KB6
1772, 3moaH, 0.5726, 3.28, 0.057, 236, 88, CRYSTAL STRUCTURE OF THE NEUTRALIZING HIV ANTIBODY 2F5 FAB FRAGMENT (RECOMBINANTLY PRODUCED FAB) WITH 17 AA GP41 MPER-DERIVED PEPTIDE
1773, 2l0dA, 0.5726, 3.45, 0.080, 114, 87, SOLUTION NMR STRUCTURE OF PUTATIVE CELL SURFACE PROTEIN MA_4588 (272- 376 DOMAIN) FROM METHANOSARCINA ACETIVORANS NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET MVR254A
1774, 2covI, 0.5726, 2.48, 0.051, 88, 79, CRYSTAL STRUCTURE OF CBM31 FROM BETA-13-XYLANASE
1775, 1tjiH, 0.5726, 3.29, 0.057, 236, 88, CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY 2F5 IN COMPLEX WITH A GP41 17MER EPITOPE
1776, 4u3cF, 0.5725, 3.53, 0.056, 660, 89, DOCKING SITE OF MALTOHEXAOSE IN THE MTB GLGE
1777, 4u3cC, 0.5725, 3.55, 0.056, 660, 89, DOCKING SITE OF MALTOHEXAOSE IN THE MTB GLGE
1778, 5sx4J, 0.5724, 3.13, 0.071, 205, 85, CRYSTAL STRUCTURE OF PANITUMUMAB IN COMPLEX WITH EPIDERMAL GROWTH FACTOR RECEPTOR DOMAIN 3.
1779, 5cn1C, 0.5724, 3.37, 0.098, 112, 92, CRYSTAL STRUCTURE OF YEAST GGA1_GAE DOMAIN-P21
1780, 3modH, 0.5724, 3.29, 0.057, 237, 88, CRYSTAL STRUCTURE OF THE NEUTRALIZING HIV ANTIBODY 2F5 FAB FRAGMENT (RECOMBINANTLY PRODUCED IGG) WITH 11 AA GP41 MPER-DERIVED PEPTIDE
1781, 3k6nA, 0.5724, 2.93, 0.035, 175, 85, CRYSTAL STRUCTURE OF THE S225E MUTANT KIR3.1 CYTOPLASMIC PORE DOMAIN
1782, 3go1H, 0.5724, 3.01, 0.047, 222, 86, CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 268-D IN COMPLEX WITH V3 PEPTIDE MN
1783, 1axsH, 0.5724, 3.06, 0.059, 221, 85, MATURE OXY-COPE CATALYTIC ANTIBODY WITH HAPTEN
1784, 6obzA, 0.5723, 3.14, 0.118, 221, 85, CRYSTAL STRUCTURE OF FLUA-20 FAB 
1785, 6ck8B, 0.5723, 3.24, 0.093, 124, 86, CRYSTAL STRUCTURE OF ANTI-INFLUENZA SINGLE-DOMAIN LLAMA ANTIBODY SD38 
1786, 4u3cB, 0.5723, 3.54, 0.056, 660, 89, DOCKING SITE OF MALTOHEXAOSE IN THE MTB GLGE
1787, 3rg1L, 0.5723, 4.03, 0.079, 138, 101, CRYSTAL STRUCTURE OF THE RP105/MD-1 COMPLEX
1788, 3levH, 0.5723, 3.29, 0.057, 237, 88, HIV-1 ANTIBODY 2F5 IN COMPLEX WITH EPITOPE SCAFFOLD ES2
1789, 2yn3B, 0.5723, 2.51, 0.114, 243, 79, STRUCTURAL INSIGHT INTO THE GIANT CALCIUM-BINDING ADHESIN SIIE: IMPLICATIONS FOR THE ADHESION OF SALMONELLA ENTERICA TO POLARIZED EPITHELIAL CELLS
1790, 2bzdA, 0.5723, 3.76, 0.075, 601, 93, GALACTOSE RECOGNITION BY THE CARBOHYDRATE-BINDING MODULE OF A BACTERIAL SIALIDASE.
1791, 1qqjB, 0.5723, 3.98, 0.102, 416, 98, CRYSTAL STRUCTURE OF MOUSE FUMARYLACETOACETATE HYDROLASE REFINED AT 1.55 ANGSTROM RESOLUTION
1792, 5vvfH, 0.5722, 3.34, 0.045, 223, 88, CRYSTAL STRUCTURE OF 354BG1 FAB
1793, 5uqyP, 0.5722, 3.40, 0.080, 211, 88, CRYSTAL STRUCTURE OF MARBURG VIRUS GP IN COMPLEX WITH THE HUMAN SURVIVOR ANTIBODY MR78
1794, 5uqyH, 0.5722, 3.39, 0.080, 220, 88, CRYSTAL STRUCTURE OF MARBURG VIRUS GP IN COMPLEX WITH THE HUMAN SURVIVOR ANTIBODY MR78
1795, 5ovwL, 0.5722, 3.20, 0.093, 126, 86, NANOBODY-BOUND BTUF THE VITAMIN B12 BINDING PROTEIN IN ESCHERICHIA COLI
1796, 3mobH, 0.5722, 3.30, 0.057, 233, 88, CRYSTAL STRUCTURE OF THE NEUTRALIZING HIV ANTIBODY 2F5 FAB FRAGMENT (RECOMBINANTLY PRODUCED FAB) WITH 11 AA GP41 MPER-DERIVED PEPTIDE
1797, 5hdoC, 0.5721, 3.37, 0.069, 125, 87, CRYSTAL STRUCTURE OF A NANOBODY RAISED AGAINST UROKINASE-TYPE PLASMINOGEN ACTIVATOR
1798, 4u3cD, 0.5721, 3.56, 0.056, 660, 89, DOCKING SITE OF MALTOHEXAOSE IN THE MTB GLGE
1799, 4qkuD, 0.5721, 4.05, 0.101, 427, 99, CRYSTAL STRUCTURE OF A PUTATIVE HYDROLASE FROM BURKHOLDERIA CENOCEPACIA
1800, 3qc5X, 0.5721, 3.09, 0.091, 352, 88, GSPB
1801, 3bkcH, 0.5721, 3.24, 0.080, 224, 87, CRYSTAL STRUCTURE OF ANTI-AMYLOID BETA FAB WO2 (P21 FORMB)
1802, 2bjmH, 0.5721, 3.15, 0.034, 120, 88, SPE7:ANTHRONE COMPLEX
1803, 1n6uA, 0.5721, 2.87, 0.059, 212, 85, NMR STRUCTURE OF THE INTERFERON-BINDING ECTODOMAIN OF THE HUMAN INTERFERON RECEPTOR
1804, 6db7H, 0.5720, 3.19, 0.081, 234, 86, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 1334 IN COMPLEX WITH A HIV-1 GP120 V3 PEPTIDE FROM MN STRAIN 
1805, 6cbvH, 0.5720, 3.27, 0.092, 227, 87, CRYSTAL STRUCTURE OF BRIL BOUND TO AN AFFINITY MATURED SYNTHETIC ANTIBODY. 
1806, 5cn1B, 0.5720, 3.34, 0.098, 113, 92, CRYSTAL STRUCTURE OF YEAST GGA1_GAE DOMAIN-P21
1807, 4kbpC, 0.5720, 3.20, 0.080, 424, 87, KIDNEY BEAN PURPLE ACID PHOSPHATASE
1808, 4ij2F, 0.5720, 2.87, 0.159, 309, 88, HUMAN METHEMOGLOBIN IN COMPLEX WITH THE SECOND AND THIRD NEAT DOMAINS OF ISDH FROM STAPHYLOCOCCUS AUREUS
1809, 4ij2E, 0.5720, 2.87, 0.159, 300, 88, HUMAN METHEMOGLOBIN IN COMPLEX WITH THE SECOND AND THIRD NEAT DOMAINS OF ISDH FROM STAPHYLOCOCCUS AUREUS
1810, 4dt2A, 0.5720, 3.08, 0.081, 426, 86, CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT CC27209
1811, 3qznB, 0.5720, 3.05, 0.088, 121, 91, STAPHYLOCOCCUS AUREUS ISDA NEAT DOMAIN Y166A VARIANT IN COMPLEX WITH HEME
1812, 1a22B, 0.5720, 3.17, 0.046, 192, 87, HUMAN GROWTH HORMONE BOUND TO SINGLE RECEPTOR
1813, 5tp3B, 0.5719, 3.44, 0.091, 125, 88, CRYSTAL STRUCTURE OF THE RSV-NEUTRALIZING SINGLE-DOMAIN ANTIBODY F- VHH-4
1814, 4u33C, 0.5719, 3.51, 0.056, 661, 89, STRUCTURE OF MTB GLGE BOUND TO MALTOSE
1815, 4ij2G, 0.5719, 2.88, 0.159, 300, 88, HUMAN METHEMOGLOBIN IN COMPLEX WITH THE SECOND AND THIRD NEAT DOMAINS OF ISDH FROM STAPHYLOCOCCUS AUREUS
1816, 3rg1H, 0.5719, 4.04, 0.079, 138, 101, CRYSTAL STRUCTURE OF THE RP105/MD-1 COMPLEX
1817, 2p8mB, 0.5719, 3.23, 0.057, 217, 88, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELLELDKWASLWN IN NEW CRYSTAL FORM
1818, 2covH, 0.5719, 2.39, 0.051, 87, 78, CRYSTAL STRUCTURE OF CBM31 FROM BETA-13-XYLANASE
1819, 1zxqA, 0.5719, 2.84, 0.048, 192, 84, THE CRYSTAL STRUCTURE OF ICAM-2
1820, 1u6aH, 0.5719, 3.42, 0.092, 222, 87, CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV FAB F105
1821, 1p53B, 0.5719, 3.07, 0.085, 250, 82, THE CRYSTAL STRUCTURE OF ICAM-1 D3-D5 FRAGMENT
1822, 1kbpD, 0.5719, 3.21, 0.080, 424, 87, KIDNEY BEAN PURPLE ACID PHOSPHATASE
1823, 1kbpA, 0.5719, 3.11, 0.116, 424, 86, KIDNEY BEAN PURPLE ACID PHOSPHATASE
1824, 1iaiI, 0.5719, 3.26, 0.092, 218, 87, IDIOTYPE-ANTI-IDIOTYPE FAB COMPLEX
1825, 4pb0H, 0.5718, 3.37, 0.093, 214, 86, STRUCTURE OF THE FAB FRAGMENT OF THE ANTI-FRANCISELLA TULARENSIS GROEL ANTIBODY AB53
1826, 3eysH, 0.5718, 3.16, 0.092, 215, 87, PFA1 FAB FRAGMENT COMPLEXED WITH PYRO-GLU3-A-BETA (3-8)
1827, 1ntlA, 0.5718, 3.30, 0.045, 551, 88, MODEL OF MOUSE CRRY-IG DETERMINED BY SOLUTION SCATTERING CURVE FITTING AND HOMOLOGY MODELLING
1828, 1kbpB, 0.5718, 3.21, 0.080, 424, 87, KIDNEY BEAN PURPLE ACID PHOSPHATASE
1829, 6g46A, 0.5717, 3.19, 0.080, 424, 87, RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH 2-(NAPHTHALEN- 1-YL)THIAZOLE-4-CARBOXYLIC ACID 
1830, 5mszA, 0.5717, 3.87, 0.052, 195, 96, LYTIC POLYSACCHARIDE MONOOXYGENASE AA15 FROM THERMOBIA DOMESTICA IN THE CU(I) STATE
1831, 5hggT, 0.5717, 3.17, 0.071, 127, 85, CRYSTAL STRUCTURE OF UPA IN COMPLEX WITH A CAMELID-DERIVED ANTIBODY FRAGMENT
1832, 2e9bA, 0.5717, 2.77, 0.136, 712, 81, CRYSTAL STRUCTURE OF PULLULANASE TYPE I FROM BACILLUS SUBTILIS STR. 168 COMPLEXED WITH MALTOSE
1833, 1kbpC, 0.5717, 3.21, 0.080, 424, 87, KIDNEY BEAN PURPLE ACID PHOSPHATASE
1834, 4u33E, 0.5716, 3.50, 0.056, 661, 89, STRUCTURE OF MTB GLGE BOUND TO MALTOSE
1835, 2p8pB, 0.5716, 3.30, 0.057, 221, 88, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE LELDKWASLW[N-AC]
1836, 2j88H, 0.5716, 3.10, 0.058, 162, 86, HYALURONIDASE IN COMPLEX WITH A MONOCLONAL IGG FAB FRAGMENT
1837, 1qcoB, 0.5716, 4.00, 0.092, 418, 98, CRYSTAL STRUCTURE OF FUMARYLACETOACETATE HYDROLASE COMPLEXED WITH FUMARATE AND ACETOACETATE
1838, 4w2oA, 0.5715, 3.30, 0.057, 118, 87, ANTI-MARBURGVIRUS NUCLEOPROTEIN SINGLE DOMAIN ANTIBODY B COMPLEXED WITH NUCLEOPROTEIN C-TERMINAL DOMAIN
1839, 4qkuC, 0.5715, 4.05, 0.101, 420, 99, CRYSTAL STRUCTURE OF A PUTATIVE HYDROLASE FROM BURKHOLDERIA CENOCEPACIA
1840, 4b9iA, 0.5715, 3.15, 0.128, 125, 86, STRUCTURE OF CSSA SUBUNIT COMPLEMENTED WITH DONOR STRAND FROM CSSB SUBUNIT OF ENTEROTOXIGENIC ESCHERICHIA COLI COLONIZATION FACTOR CS6
1841, 2qfpD, 0.5715, 3.09, 0.116, 424, 86, CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH FLUORIDE
1842, 2f5aH, 0.5715, 3.23, 0.057, 228, 88, CRYSTAL STRUCTURE OF FAB  FROM THE HIV-1 NEUTRALIZING ANTIBODY 2F5
1843, 1n10B, 0.5715, 3.47, 0.105, 228, 86, CRYSTAL STRUCTURE OF PHL P 1 A MAJOR TIMOTHY GRASS POLLEN ALLERGEN
1844, 1hyoB, 0.5715, 4.01, 0.092, 419, 98, CRYSTAL STRUCTURE OF FUMARYLACETOACETATE HYDROLASE COMPLEXED WITH 4-(HYDROXYMETHYLPHOSPHINOYL)-3-OXO-BUTANOIC ACID
1845, 6hwrA, 0.5714, 3.08, 0.081, 424, 86, RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH ADENOSINE DIVANADATE 
1846, 5uqyL, 0.5714, 3.41, 0.080, 222, 88, CRYSTAL STRUCTURE OF MARBURG VIRUS GP IN COMPLEX WITH THE HUMAN SURVIVOR ANTIBODY MR78
1847, 5hm1C, 0.5714, 3.17, 0.092, 119, 87, LLAMA VHH 2E7 IN COMPLEX WITH GP41
1848, 3uh8A, 0.5714, 3.73, 0.031, 118, 96, N-TERMINAL DOMAIN OF PHAGE TP901-1 ORF48
1849, 1x5aA, 0.5714, 2.98, 0.070, 107, 86, THE SOLUTION STRUCTURE OF THE SECOND FIBRONECTIN TYPE III DOMAIN OF MOUSE EPHRIN TYPE-A RECEPTOR 1
1850, 1wcbH, 0.5714, 3.26, 0.103, 222, 87, PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH ITS HAPTEN
1851, 1u95B, 0.5714, 3.26, 0.057, 227, 88, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDHWAS
1852, 1u93B, 0.5714, 3.26, 0.057, 227, 88, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ANALOG EQDKW- [DAP]-S (CYCLIC)
1853, 1u92B, 0.5714, 3.26, 0.057, 224, 88, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ANALOG E-[DAP]- DKWQS (CYCLIC)
1854, 1u91B, 0.5714, 3.26, 0.057, 227, 88, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ANALOG ENDKW- [DAP]-S (CYCLIC)
1855, 1u8qB, 0.5714, 3.26, 0.057, 227, 88, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELEKWAS
1856, 1u8pB, 0.5714, 3.26, 0.057, 227, 88, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ECDKWCS
1857, 1u8oB, 0.5714, 3.26, 0.057, 227, 88, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKHAS
1858, 1u8nB, 0.5714, 3.26, 0.057, 227, 88, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKFAS
1859, 1u8mB, 0.5714, 3.26, 0.057, 227, 88, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKYAS
1860, 1u8lB, 0.5714, 3.26, 0.057, 227, 88, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE DLDRWAS
1861, 1u8kB, 0.5714, 3.24, 0.057, 228, 88, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE LELDKWASL
1862, 1u8jB, 0.5714, 3.26, 0.057, 227, 88, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKWAG
1863, 1u8iB, 0.5714, 3.26, 0.057, 227, 88, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKWAN
1864, 1u8hB, 0.5714, 3.26, 0.057, 227, 88, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ALDKWAS
1865, 1n10A, 0.5714, 3.47, 0.105, 228, 86, CRYSTAL STRUCTURE OF PHL P 1 A MAJOR TIMOTHY GRASS POLLEN ALLERGEN
1866, 1mvuB, 0.5714, 3.04, 0.059, 121, 85, SINGLE CHAIN FV OF C219 HEAVY CHAIN V101L MUTANT IN COMPLEX WITH SYNTHETIC EPITOPE PEPTIDE
1867, 4yk4C, 0.5713, 3.35, 0.092, 220, 87, HUMAN ANTIBODY 641 I-9 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 SOLOMON ISLANDS/03/2006
1868, 4dt2D, 0.5713, 3.23, 0.092, 426, 87, CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT CC27209
1869, 3droB, 0.5713, 3.24, 0.068, 216, 88, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELLELDKWASLWN GROWN IN AMMONIUM SULFATE
1870, 3b07B, 0.5713, 3.96, 0.106, 270, 94, CRYSTAL STRUCTURE OF OCTAMERIC PORE FORM OF GAMMA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1871, 1za3H, 0.5713, 3.24, 0.080, 224, 87, THE CRYSTAL STRUCTURE OF THE YSD1 FAB BOUND TO DR5
1872, 6ieqD, 0.5712, 3.50, 0.045, 229, 88, CRYSTAL STRUCTURE OF HIV-1 ENV CONM SOSIP.V7 IN COMPLEX WITH BNAB PGT124 AND 35O22 
1873, 6dduA, 0.5712, 3.63, 0.074, 862, 95, MOUSE BETA-MANNOSIDASE BOUND TO BETA-D-MANNOSE (MANBA) 
1874, 5wduU, 0.5712, 3.47, 0.045, 242, 88, HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB 35O22 FAB AND NIH45-46 SCFV
1875, 5um8D, 0.5712, 3.57, 0.045, 240, 88, CRYSTAL STRUCTURE OF HIV-1 ENVELOPE TRIMER 16055 NFL TD CC (T569G) IN COMPLEX WITH FABS 35022 AND PGT124
1876, 4kdwA, 0.5712, 2.99, 0.143, 102, 84, CRYSTAL STRUCTURE OF A BACTERIAL IMMUNOGLOBULIN-LIKE DOMAIN FROM THE M. PRIMORYENSIS ICE-BINDING ADHESIN
1877, 3idgB, 0.5712, 3.27, 0.057, 227, 88, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ALDKWD
1878, 3b07F, 0.5712, 3.96, 0.106, 270, 94, CRYSTAL STRUCTURE OF OCTAMERIC PORE FORM OF GAMMA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1879, 1wc7H, 0.5712, 3.23, 0.103, 223, 87, FAB FRAGMENT OF PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH PHOSPHOPYRIDOXYL-L-ALANINE
1880, 1qqjA, 0.5712, 4.00, 0.092, 416, 98, CRYSTAL STRUCTURE OF MOUSE FUMARYLACETOACETATE HYDROLASE REFINED AT 1.55 ANGSTROM RESOLUTION
1881, 6qn9H, 0.5711, 3.29, 0.080, 193, 88, STRUCTURE OF BOVINE ANTI-RSV FAB B4 
1882, 5w6dD, 0.5711, 3.50, 0.045, 223, 88, CRYSTAL STRUCTURE OF BG505-SOSIP.V4.1-GT1-N137A IN COMPLEX WITH FABS 35022 AND 9H/109L
1883, 5tp3A, 0.5711, 3.34, 0.092, 125, 87, CRYSTAL STRUCTURE OF THE RSV-NEUTRALIZING SINGLE-DOMAIN ANTIBODY F- VHH-4
1884, 5sx4H, 0.5711, 3.43, 0.045, 210, 88, CRYSTAL STRUCTURE OF PANITUMUMAB IN COMPLEX WITH EPIDERMAL GROWTH FACTOR RECEPTOR DOMAIN 3.
1885, 5ovwH, 0.5711, 3.23, 0.093, 126, 86, NANOBODY-BOUND BTUF THE VITAMIN B12 BINDING PROTEIN IN ESCHERICHIA COLI
1886, 5hcgH, 0.5711, 3.43, 0.080, 332, 88, CRYSTAL STRUCTURE OF FREE-CODV.
1887, 4p99A, 0.5711, 3.11, 0.141, 415, 85, CA2+-STABILIZED ADHESIN HELPS AN ANTARCTIC BACTERIUM REACH OUT AND BIND ICE
1888, 4kkzA, 0.5711, 3.09, 0.081, 424, 86, THE CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH DIETHYLENE GLYCOL MONOVANADATE
1889, 4kbpA, 0.5711, 3.11, 0.116, 424, 86, KIDNEY BEAN PURPLE ACID PHOSPHATASE
1890, 3kbpA, 0.5711, 3.22, 0.092, 424, 87, KIDNEY BEAN PURPLE ACID PHOSPHATASE
1891, 3d0lB, 0.5711, 3.24, 0.057, 218, 88, CRYSTAL STRUCTURE OF THE HIV-1 BROADLY NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH THE GP41 FP-MPER HYB3K CONSTRUCT 514GIGALFLGFLGAAGS528KK-AHX-655KNEQELLELDKWASLWN671
1892, 6ck8C, 0.5710, 3.23, 0.093, 124, 86, CRYSTAL STRUCTURE OF ANTI-INFLUENZA SINGLE-DOMAIN LLAMA ANTIBODY SD38 
1893, 2qfrB, 0.5710, 3.11, 0.116, 424, 86, CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE WITH BOUND SULFATE
1894, 1g4mA, 0.5710, 3.46, 0.053, 356, 95, CRYSTAL STRUCTURE OF BOVINE BETA-ARRESTIN 1
1895, 5sx5J, 0.5709, 3.49, 0.068, 207, 88, CRYSTAL STRUCTURE OF PANITUMUMAB IN COMPLEX WITH EPIDERMAL GROWTH FACTOR RECEPTOR DOMAIN 3 MUTANT S468R.
1896, 5irbB, 0.5709, 2.77, 0.107, 314, 84, STRUCTURAL INSIGHT INTO HOST CELL SURFACE RETENTION OF A 1.5-MDA BACTERIAL ICE-BINDING ADHESIN
1897, 4x4mA, 0.5709, 3.14, 0.068, 218, 88, STRUCTURE OF FCGAMMARI IN COMPLEX WITH FC REVEALS THE IMPORTANCE OF GLYCAN RECOGNITION FOR HIGH AFFINITY IGG BINDING
1898, 3idiB, 0.5709, 3.23, 0.057, 217, 88, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 FAB  FRAGMENT IN COMPLEX WITH GP41 PEPTIDE ALDKWNQ
1899, 1za3B, 0.5709, 2.98, 0.094, 224, 85, THE CRYSTAL STRUCTURE OF THE YSD1 FAB BOUND TO DR5
1900, 1p53A, 0.5709, 3.06, 0.085, 250, 82, THE CRYSTAL STRUCTURE OF ICAM-1 D3-D5 FRAGMENT
1901, 6g4aA, 0.5708, 3.38, 0.078, 114, 90, FLN5 (FULL LENGTH) 
1902, 5nstB, 0.5708, 3.15, 0.034, 336, 87, HUMAN MONOCLONAL ANTIBODY WITH A LAIR1 INSERTION
1903, 5fykD, 0.5708, 3.52, 0.045, 242, 88, CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE B JR-FL SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 35O22 AND VRC01
1904, 3kbpD, 0.5708, 3.22, 0.092, 424, 87, KIDNEY BEAN PURPLE ACID PHOSPHATASE
1905, 3kbpB, 0.5708, 3.22, 0.092, 424, 87, KIDNEY BEAN PURPLE ACID PHOSPHATASE
1906, 3idjB, 0.5708, 3.27, 0.057, 229, 88, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 FAB  FRAGMENT IN COMPLEX WITH GP41 PEPTIDE ANALOG ELD(ORN)WAS
1907, 3b2dC, 0.5708, 3.99, 0.100, 139, 100, CRYSTAL STRUCTURE OF HUMAN RP105/MD-1 COMPLEX
1908, 3b07D, 0.5708, 3.99, 0.105, 270, 95, CRYSTAL STRUCTURE OF OCTAMERIC PORE FORM OF GAMMA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1909, 2qfpB, 0.5708, 3.11, 0.081, 424, 86, CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH FLUORIDE
1910, 1a9vA, 0.5708, 3.44, 0.076, 129, 92, TERTIARY STRUCTURE OF THE MAJOR HOUSE DUST MITE ALLERGEN DER P 2 NMR 10 STRUCTURES
1911, 6oz6E, 0.5707, 3.25, 0.070, 126, 86, CRYSTAL STRUCTURE OF MRAY BOUND TO 3 -HYDROXYMUREIDOMYCIN A 
1912, 5z2qB, 0.5707, 3.30, 0.080, 215, 87, VGLL1-TEAD4 CORE COMPLEX
1913, 5irbA, 0.5707, 2.87, 0.118, 313, 85, STRUCTURAL INSIGHT INTO HOST CELL SURFACE RETENTION OF A 1.5-MDA BACTERIAL ICE-BINDING ADHESIN
1914, 5cexD, 0.5707, 3.40, 0.080, 232, 87, CRYSTAL STRUCTURE OF FAB 32H+109L A PUTATIVE PRECURSOR OF THE PGT121 FAMILY OF POTENT HIV-1 ANTIBODIES
1915, 4w2qC, 0.5707, 3.32, 0.080, 117, 87, ANTI-MARBURGVIRUS NUCLEOPROTEIN SINGLE DOMAIN ANTIBODY C COMPLEXED WITH NUCLEOPROTEIN C-TERMINAL DOMAIN
1916, 4iknA, 0.5707, 3.52, 0.087, 249, 92, CRYSTAL STRUCTURE OF ADAPTOR PROTEIN COMPLEX 3 (AP-3) MU3A SUBUNIT C- TERMINAL DOMAIN IN COMPLEX WITH A SORTING PEPTIDE FROM TGN38
1917, 2pr4H, 0.5707, 3.25, 0.068, 218, 88, CRYSTAL STRUCTURE OF FAB  FROM THE HIV-1 NEUTRALIZING ANTIBODY 2F5
1918, 1f3rB, 0.5707, 3.36, 0.080, 257, 88, COMPLEX BETWEEN FV ANTIBODY FRAGMENT AND AN ANALOGUE OF THE MAIN IMMUNOGENIC REGION OF THE ACETYLCHOLINE RECEPTOR
1919, 5wduH, 0.5706, 3.55, 0.045, 242, 88, HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB 35O22 FAB AND NIH45-46 SCFV
1920, 5w5mA, 0.5706, 2.95, 0.035, 207, 85, CRYSTAL STRUCTURE OF HUMAN IGG4-SIGMA1 FC FRAGMENT
1921, 5tz8A, 0.5706, 3.43, 0.102, 558, 88, CRYSTAL STRUCTURE OF S. AUREUS TARS
1922, 4gejF, 0.5706, 3.29, 0.094, 136, 85, N-TERMINAL DOMAIN OF VDUP-1
1923, 3lsoB, 0.5706, 3.04, 0.094, 439, 85, CRYSTAL STRUCTURE OF PUTATIVE MEMBRANE ANCHORED PROTEIN FROM CORYNEBACTERIUM DIPHTHERIAE
1924, 3b07H, 0.5706, 4.00, 0.105, 270, 95, CRYSTAL STRUCTURE OF OCTAMERIC PORE FORM OF GAMMA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1925, 1d6vH, 0.5706, 3.14, 0.035, 221, 86, CONFORMATION EFFECTS IN BIOLOGICAL CATALYSIS INTRODUCED BY OXY-COPE ANTIBODY MATURATION
1926, 3kbpC, 0.5705, 3.23, 0.092, 424, 87, KIDNEY BEAN PURPLE ACID PHOSPHATASE
1927, 3idnB, 0.5705, 3.27, 0.057, 215, 88, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 FAB  FRAGMENT IN COMPLEX WITH GP41 PEPTIDE ANALOG ELD(PAF)WAS
1928, 1d5bH, 0.5705, 3.10, 0.059, 221, 85, UNLIGANDED MATURE OXY-COPE CATALYTIC ANTIBODY
1929, 5utfD, 0.5704, 3.51, 0.045, 242, 88, CRYSTAL STRUCTURE OF A STABILIZED DS-SOSIP.6MUT BG505 GP140 HIV-1 ENV TRIMER CONTAINING MUTATIONS I201C-P433C (DS) L154M Y177W N300M N302M T320L I420M IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 4.3 A
1930, 4kdvA, 0.5704, 3.00, 0.143, 102, 84, CRYSTAL STRUCTURE OF A BACTERIAL IMMUNOGLOBULIN-LIKE DOMAIN FROM THE M. PRIMORYENSIS ICE-BINDING ADHESIN
1931, 4jmhA, 0.5704, 2.84, 0.095, 200, 84, CRYSTAL STRUCTURE OF SYNTHETIC PROTEIN IN COMPLEX WITH DOUBLE PY PEPTIDE
1932, 3fl7A, 0.5704, 3.00, 0.131, 482, 84, CRYSTAL STRUCTURE OF THE HUMAN EPHRIN A2 ECTODOMAIN
1933, 1hwgC, 0.5704, 3.25, 0.057, 191, 88, 1:2 COMPLEX OF HUMAN GROWTH HORMONE WITH ITS SOLUBLE BINDING PROTEIN
1934, 1ayrC, 0.5704, 3.48, 0.084, 368, 95, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1935, 6i6jC, 0.5703, 3.30, 0.092, 121, 87, CRYSTAL STRUCTURE OF THE KDEL RECEPTOR BOUND TO SYNTHETIC NANOBODY. 
1936, 5udcE, 0.5703, 3.34, 0.105, 220, 86, CRYSTAL STRUCTURE OF RSV F A2 BOUND TO MEDI8897
1937, 5t3sD, 0.5703, 3.52, 0.045, 240, 88, HIV GP140 TRIMER MD39-10MUTA IN COMPLEX WITH FABS PGT124 AND 35022
1938, 5h10A, 0.5703, 3.29, 0.045, 192, 88, TRAF1-TANK COMPLEX
1939, 4dt2B, 0.5703, 3.10, 0.116, 426, 86, CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT CC27209
1940, 6mcoD, 0.5702, 3.54, 0.045, 240, 88, CRYSTAL STRUCTURE OF THE B41 SOSIP.664 ENV TRIMER WITH PGT124 AND 35O22 FABS; IN P23 SPACE GROUP 
1941, 5kwyD, 0.5702, 3.50, 0.106, 132, 94, STRUCTURE OF HUMAN NPC1 MIDDLE LUMENAL DOMAIN BOUND TO NPC2
1942, 3lpgB, 0.5702, 2.87, 0.094, 590, 85, STRUCTURE OF E. COLI BETA-GLUCURONIDASE BOUND WITH A NOVEL POTENT INHIBITOR 3-(2-FLUOROPHENYL)-1-(2-HYDROXYETHYL)-1-((6-METHYL-2-OXO-1 2-DIHYDROQUINOLIN-3-YL)METHYL)UREA
1943, 3eyuH, 0.5702, 3.15, 0.080, 218, 87, PFA1 FAB FRAGMENT COMPLEXED WITH ROR2(518-525)
1944, 2xzcH, 0.5702, 3.29, 0.103, 211, 87, CRYSTAL STRUCTURE OF PHOSPHONATE-MODIFIED RECOMBINANT A.17 ANTIBODY FAB FRAGMENT
1945, 2vxqA, 0.5702, 2.92, 0.085, 92, 82, CRYSTAL STRUCTURE OF THE MAJOR GRASS POLLEN ALLERGEN PHL P 2 IN COMPLEX WITH ITS SPECIFIC IGE-FAB
1946, 2o5nA, 0.5702, 3.02, 0.069, 264, 87, CRYSTAL STRUCTURE OF A VIRAL GLYCOPROTEIN
1947, 2iqaB, 0.5702, 3.31, 0.091, 220, 88, PFA2 FAB FRAGMENT MONOCLINIC APO FORM
1948, 2f5bH, 0.5702, 3.26, 0.057, 231, 88, CRYSTAL STRUCTURE OF FAB  FROM THE HIV-1 NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH ITS GP41 EPITOPE
1949, 2di7A, 0.5702, 3.14, 0.080, 124, 87, SOLUTION STRUCTURE OF THE FILAMIN DOMAIN FROM HUMAN BK158_1 PROTEIN
1950, 1o0vA, 0.5702, 3.26, 0.034, 319, 88, THE CRYSTAL STRUCTURE OF IGE FC REVEALS AN ASYMMETRICALLY BENT CONFORMATION
1951, 6h7lC, 0.5701, 3.29, 0.069, 120, 87, ACTIVATED TURKEY BETA1 ADRENOCEPTOR WITH BOUND PARTIAL AGONIST DOBUTAMINE AND NANOBODY NB6B9 
1952, 6h7kD, 0.5701, 3.29, 0.069, 120, 87, ACTIVATED TURKEY BETA1 ADRENOCEPTOR WITH BOUND AGONIST FORMOTEROL AND NANOBODY NB80 
1953, 6h3uH, 0.5701, 3.16, 0.069, 121, 87, SCHMALLENBERG VIRUS GLYCOPROTEIN GC HEAD DOMAIN IN COMPLEX WITH SCFV 4B6 
1954, 6fjcB, 0.5701, 3.66, 0.136, 129, 88, HUMAN KIBRA C2 DOMAIN MUTANT C771A IN COMPLEX WITH PHOSPHATIDYLINOSITOL 3;4;5-TRISPHOSPHATE 
1955, 4rgmH, 0.5701, 3.13, 0.035, 216, 86, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO THE NEUTRALIZING ANTIBODY 20B1
1956, 4o9hH, 0.5701, 3.30, 0.080, 200, 87, STRUCTURE OF INTERLEUKIN-6 IN COMPLEX WITH A CAMELID FAB FRAGMENT
1957, 4k0vA, 0.5701, 3.41, 0.047, 514, 86, STRUCTURAL BASIS FOR ANGIOPOIETIN-1 MEDIATED SIGNALING INITIATION
1958, 4jqiA, 0.5701, 3.38, 0.043, 353, 94, STRUCTURE OF ACTIVE BETA-ARRESTIN1 BOUND TO A G PROTEIN-COUPLED RECEPTOR PHOSPHOPEPTIDE
1959, 2r83A, 0.5701, 3.44, 0.087, 279, 92, CRYSTAL STRUCTURE ANALYSIS OF HUMAN SYNAPTOTAGMIN 1 C2A-C2B
1960, 2qfpC, 0.5701, 3.26, 0.092, 424, 87, CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH FLUORIDE
1961, 2jlpA, 0.5701, 3.52, 0.108, 168, 93, CRYSTAL STRUCTURE OF HUMAN EXTRACELLULAR COPPER-ZINC SUPEROXIDE DISMUTASE.
1962, 1w8oA, 0.5701, 3.76, 0.065, 601, 92, CONTRIBUTION OF THE ACTIVE SITE ASPARTIC ACID TO CATALYSIS IN THE BACTERIAL NEURAMINIDASE FROM MICROMONOSPORA VIRIDIFACIENS
1963, 6ddtA, 0.5700, 3.64, 0.074, 862, 95, MOUSE BETA-MANNOSIDASE (MANBA) 
1964, 6d58B, 0.5700, 3.11, 0.035, 207, 85, CRYSTAL STRUCTURE OF A FC FRAGMENT OF HUMAN IGG3 
1965, 5ti1A, 0.5700, 3.98, 0.112, 426, 98, CRYSTAL STRUCTURE OF FUMARYLACETOACETATE HYDROLASE FROM BURKHOLDERIA XENOVORANS LB400
1966, 4p1xH, 0.5700, 4.03, 0.074, 258, 94, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL LUK PREPORE
1967, 4f37F, 0.5700, 3.30, 0.045, 225, 88, STRUCTURE OF THE TETHERED N-TERMINUS OF ALZHEIMER S DISEASE A PEPTIDE
1968, 2e8zB, 0.5700, 2.78, 0.136, 712, 81, CRYSTAL STRUCTURE OF PULLULANASE TYPE I FROM BACILLUS SUBTILIS STR. 168 COMPLEXED WITH ALPHA-CYCLODEXTRIN
1969, 1wcbB, 0.5700, 2.99, 0.082, 224, 85, PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH ITS HAPTEN
1970, 2iptH, 0.5699, 3.04, 0.058, 223, 86, PFA1 FAB FRAGMENT
1971, 2atyB, 0.5699, 2.93, 0.060, 376, 84, COMPLEMENT RECEPTOR CHIMAERIC CONJUGATE CR2-IG
1972, 1qcoA, 0.5699, 4.01, 0.102, 416, 98, CRYSTAL STRUCTURE OF FUMARYLACETOACETATE HYDROLASE COMPLEXED WITH FUMARATE AND ACETOACETATE
1973, 6iblD, 0.5698, 3.30, 0.069, 120, 87, ACTIVATED TURKEY BETA1 ADRENOCEPTOR WITH BOUND AGONIST FORMOTEROL AND NANOBODY NB80 
1974, 5t5wB, 0.5698, 3.13, 0.045, 188, 88, STRUCTURE OF AN AFFINITY MATURED LAMBDA-IFN/IFN-LAMBDAR1/IL-10RBETA RECEPTOR COMPLEX
1975, 5fucC, 0.5698, 3.00, 0.057, 199, 88, BIOPHYSICAL AND CELLULAR CHARACTERISATION OF A JUNCTIONAL EPITOPE ANTIBODY THAT LOCKS IL-6 AND GP80 TOGETHER IN A STABLE COMPLEX: IMPLICATIONS FOR NEW THERAPEUTIC STRATEGIES
1976, 4fzeH, 0.5698, 3.19, 0.105, 221, 86, CRYSTAL STRUCTURE OF N26_I1 FAB AN ADCC MEDIATING ANTI-HIV-1 ANTIBODY.
1977, 6h7oD, 0.5697, 3.44, 0.068, 121, 88, ACTIVATED TURKEY BETA1 ADRENOCEPTOR WITH BOUND WEAK PARTIAL AGONIST CYANOPINDOLOL AND NANOBODY NB6B9 
1978, 4yhdA, 0.5697, 3.85, 0.053, 281, 94, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
1979, 4hs8H, 0.5697, 3.37, 0.080, 225, 88, HEPATITUS C ENVELOPE GLYCOPROTEIN E2 FRAGMENT 412-423 WITH HUMANIZED AND AFFINITY-MATURED ANTIBODY HU5B3.V3
1980, 1hyoA, 0.5697, 3.97, 0.102, 416, 98, CRYSTAL STRUCTURE OF FUMARYLACETOACETATE HYDROLASE COMPLEXED WITH 4-(HYDROXYMETHYLPHOSPHINOYL)-3-OXO-BUTANOIC ACID
1981, 5ti1B, 0.5696, 4.00, 0.112, 429, 98, CRYSTAL STRUCTURE OF FUMARYLACETOACETATE HYDROLASE FROM BURKHOLDERIA XENOVORANS LB400
1982, 5ovwI, 0.5696, 3.25, 0.093, 126, 86, NANOBODY-BOUND BTUF THE VITAMIN B12 BINDING PROTEIN IN ESCHERICHIA COLI
1983, 5ovwG, 0.5696, 3.24, 0.093, 126, 86, NANOBODY-BOUND BTUF THE VITAMIN B12 BINDING PROTEIN IN ESCHERICHIA COLI
1984, 4yhdC, 0.5696, 3.80, 0.054, 279, 93, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
1985, 4janH, 0.5696, 3.15, 0.081, 218, 86, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH103 IN COMPLEX WITH HIV-1 GP120
1986, 3egxA, 0.5696, 3.73, 0.021, 708, 94, CRYSTAL STRUCTURE OF THE MAMMALIAN COPII-COAT PROTEIN SEC23A/24A COMPLEXED WITH THE SNARE PROTEIN SEC22B AND BOUND TO THE TRANSPORT SIGNAL SEQUENCE OF THE SNARE PROTEIN BET1
1987, 1gh7B, 0.5696, 2.70, 0.099, 408, 81, CRYSTAL STRUCTURE OF THE COMPLETE EXTRACELLULAR DOMAIN OF THE BETA- COMMON RECEPTOR OF IL-3 IL-5 AND GM-CSF
1988, 5cn2B, 0.5695, 3.53, 0.144, 114, 90, CRYSTAL STRUCTURE OF YEAST GGA1_GAE DOMAIN-C2221
1989, 4x7dD, 0.5695, 3.38, 0.068, 121, 88, CRYSTAL STRUCTURE OF 2012 NSW GII.4 P DOMAIN IN COMPLEX WITH NANO-85
1990, 4rtdA, 0.5695, 3.01, 0.060, 1103, 83, ESCHERICHIA COLI ALPHA-2-MACROGLOBULIN ACTIVATED BY PORCINE ELASTASE
1991, 4qkuA, 0.5695, 4.02, 0.071, 421, 98, CRYSTAL STRUCTURE OF A PUTATIVE HYDROLASE FROM BURKHOLDERIA CENOCEPACIA
1992, 4jm2A, 0.5695, 3.44, 0.056, 227, 89, CRYSTAL STRUCTURE OF PGT 135 FAB IN COMPLEX WITH GP120 CORE PROTEIN FROM HIV-1 STRAIN JR-FL BOUND TO CD4 AND 17B FAB
1993, 4f80A, 0.5695, 3.14, 0.057, 209, 87, CRYSTAL STRUCTURE OF THE HUMAN BTN3A1 ECTODOMAIN
1994, 2vuoB, 0.5695, 3.08, 0.059, 214, 85, CRYSTAL STRUCTURE OF THE RABBIT IGG FC FRAGMENT
1995, 1f18A, 0.5695, 3.38, 0.045, 153, 89, CRYSTAL STRUCTURE OF YEAST COPPER-ZINC SUPEROXIDE DISMUTASE MUTANT GLY85ARG
1996, 1bp3B, 0.5695, 3.00, 0.035, 197, 86, THE XRAY STRUCTURE OF A GROWTH HORMONE-PROLACTIN RECEPTOR COMPLEX
1997, 3kgrB, 0.5694, 2.70, 0.085, 97, 82, CRYSTAL STRUCTURE OF THE HUMAN LEUKOCYTE-ASSOCIATED IG-LIKE RECEPTOR-1 (LAIR-1)
1998, 1kf9F, 0.5694, 3.08, 0.047, 184, 86, PHAGE DISPLAY DERIVED VARIANT OF HUMAN GROWTH HORMONE COMPLEXED WITH TWO COPIES OF THE EXTRACELLULAR DOMAIN OF ITS RECEPTOR
1999, 1gh7A, 0.5694, 2.70, 0.086, 408, 81, CRYSTAL STRUCTURE OF THE COMPLETE EXTRACELLULAR DOMAIN OF THE BETA- COMMON RECEPTOR OF IL-3 IL-5 AND GM-CSF
2000, 6gszA, 0.5693, 3.29, 0.090, 863, 89, CRYSTAL STRUCTURE OF NATIVE ALFA-L-RHAMNOSIDASE FROM ASPERGILLUS TERREUS 
2001, 6fb4B, 0.5693, 3.41, 0.140, 129, 86, HUMAN KIBRA C2 DOMAIN MUTANT C771A 
2002, 6cezH, 0.5693, 3.46, 0.069, 222, 87, CRYSTAL STRUCTURE OF RABBIT ANTI-HIV-1 GP120 V2 FAB 16C2 IN COMPLEX WITH V2 PEPTIDE CONB 
2003, 5vnvA, 0.5693, 3.34, 0.057, 120, 87, CRYSTAL STRUCTURE OF NB.B201
2004, 5vkdH, 0.5693, 3.46, 0.091, 229, 88, CRYSTAL STRUCTURE OF C-TERMINAL DOMAIN OF EBOLA (BUNDIBUGYO) NUCLEOPROTEIN IN COMPLEX WITH FAB FRAGMENT 
2005, 5sx5H, 0.5693, 3.42, 0.057, 207, 88, CRYSTAL STRUCTURE OF PANITUMUMAB IN COMPLEX WITH EPIDERMAL GROWTH FACTOR RECEPTOR DOMAIN 3 MUTANT S468R.
2006, 5n9bA, 0.5693, 3.32, 0.047, 244, 86, CRYSTAL STRUCTURE OF UNLIGANDED HUMAN IL-17RA 
2007, 4lcvC, 0.5693, 3.31, 0.092, 129, 87, CRYSTAL STRUCTURE OF DOC2B C2A DOMAIN
2008, 1whpA, 0.5693, 3.19, 0.071, 94, 84, ALLERGEN PHL P 2
2009, 1d5bB, 0.5693, 3.12, 0.059, 221, 85, UNLIGANDED MATURE OXY-COPE CATALYTIC ANTIBODY
2010, 6h7lD, 0.5692, 3.28, 0.069, 120, 87, ACTIVATED TURKEY BETA1 ADRENOCEPTOR WITH BOUND PARTIAL AGONIST DOBUTAMINE AND NANOBODY NB6B9 
2011, 4qkuB, 0.5692, 4.18, 0.071, 427, 99, CRYSTAL STRUCTURE OF A PUTATIVE HYDROLASE FROM BURKHOLDERIA CENOCEPACIA
2012, 3og4B, 0.5692, 3.34, 0.045, 197, 88, THE CRYSTAL STRUCTURE OF HUMAN INTERFERON LAMBDA 1 COMPLEXED WITH ITS HIGH AFFINITY RECEPTOR IN SPACE GROUP P21212
2013, 3k4dB, 0.5692, 2.99, 0.035, 596, 85, CRYSTAL STRUCTURE OF E. COLI BETA-GLUCURONIDASE WITH THE GLUCARO-D- LACTAM INHIBITOR BOUND
2014, 2z0uB, 0.5692, 3.67, 0.136, 127, 88, CRYSTAL STRUCTURE OF C2 DOMAIN OF KIBRA PROTEIN
2015, 5tugC, 0.5691, 2.93, 0.157, 115, 83, ARCHAELLUM PERIPLASMIC STATOR PROTEIN COMPLEX FLAF AND FLAG FROM SULFOLOBUS ACIDOCALDARIUS
2016, 4w2qE, 0.5691, 3.26, 0.081, 116, 86, ANTI-MARBURGVIRUS NUCLEOPROTEIN SINGLE DOMAIN ANTIBODY C COMPLEXED WITH NUCLEOPROTEIN C-TERMINAL DOMAIN
2017, 4uv4H, 0.5691, 3.36, 0.092, 229, 87, CRYSTAL STRUCTURE OF ANTI-FPR FPRO0165 FAB FRAGMENT
2018, 4mqtB, 0.5691, 3.54, 0.068, 121, 88, STRUCTURE OF ACTIVE HUMAN M2 MUSCARINIC ACETYLCHOLINE RECEPTOR BOUND TO THE AGONIST IPEROXO AND ALLOSTERIC MODULATOR LY2119620
2019, 4gejG, 0.5691, 3.25, 0.094, 136, 85, N-TERMINAL DOMAIN OF VDUP-1
2020, 3m8oH, 0.5691, 3.23, 0.091, 221, 88, HUMAN IGA1 FAB FRAGMENT
2021, 2xzaH, 0.5691, 3.30, 0.103, 211, 87, CRYSTAL STRUCTURE OF RECOMBINANT A.17 ANTIBODY FAB FRAGMENT
2022, 2pw2B, 0.5691, 3.28, 0.057, 221, 88, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKWKSL
2023, 2pw1B, 0.5691, 3.28, 0.057, 221, 88, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKWNSL
2024, 1wcqA, 0.5691, 3.90, 0.118, 601, 93, MUTAGENESIS OF THE NUCLEOPHILIC TYROSINE IN A BACTERIAL SIALIDASE TO PHENYLALANINE.
2025, 1kf9C, 0.5691, 3.07, 0.047, 175, 86, PHAGE DISPLAY DERIVED VARIANT OF HUMAN GROWTH HORMONE COMPLEXED WITH TWO COPIES OF THE EXTRACELLULAR DOMAIN OF ITS RECEPTOR
2026, 6h7jD, 0.5690, 3.31, 0.069, 120, 87, ACTIVATED TURKEY BETA1 ADRENOCEPTOR WITH BOUND AGONIST ISOPRENALINE AND NANOBODY NB80 
2027, 5u8qA, 0.5690, 3.24, 0.068, 801, 88, STRUCTURE OF THE ECTODOMAIN OF THE HUMAN TYPE 1 INSULIN-LIKE GROWTH FACTOR RECEPTOR IN COMPLEX WITH IGF-I
2028, 5ovwK, 0.5690, 3.25, 0.093, 126, 86, NANOBODY-BOUND BTUF THE VITAMIN B12 BINDING PROTEIN IN ESCHERICHIA COLI
2029, 5j75B, 0.5690, 3.13, 0.071, 233, 85, FLUOROGEN ACTIVATING PROGEIN AM2.2 IN COMPLEX WITH ML342
2030, 4dohE, 0.5690, 3.31, 0.067, 204, 89, IL20/IL201/IL20R2 TERNARY COMPLEX
2031, 3kgrC, 0.5690, 2.55, 0.074, 99, 81, CRYSTAL STRUCTURE OF THE HUMAN LEUKOCYTE-ASSOCIATED IG-LIKE RECEPTOR-1 (LAIR-1)
2032, 2hh0H, 0.5690, 3.05, 0.047, 217, 86, STRUCTURE OF AN ANTI-PRP FAB P-CLONE IN COMPLEX WITH ITS COGNATE BOVINE PEPTIDE EPITOPE.
2033, 1t66H, 0.5690, 3.30, 0.081, 220, 86, THE STRUCTURE OF FAB WITH INTERMEDIATE AFFINITY FOR FLUORESCEIN.
2034, 6okpQ, 0.5689, 3.38, 0.080, 131, 88, B41 SOSIP.664 IN COMPLEX WITH THE SILENT-FACE ANTIBODY SF12 AND V3- TARGETING ANTIBODY 10-1074 
2035, 6okpO, 0.5689, 3.38, 0.080, 131, 88, B41 SOSIP.664 IN COMPLEX WITH THE SILENT-FACE ANTIBODY SF12 AND V3- TARGETING ANTIBODY 10-1074 
2036, 6okpM, 0.5689, 3.38, 0.080, 131, 88, B41 SOSIP.664 IN COMPLEX WITH THE SILENT-FACE ANTIBODY SF12 AND V3- TARGETING ANTIBODY 10-1074 
2037, 6h7oC, 0.5689, 3.30, 0.069, 120, 87, ACTIVATED TURKEY BETA1 ADRENOCEPTOR WITH BOUND WEAK PARTIAL AGONIST CYANOPINDOLOL AND NANOBODY NB6B9 
2038, 3se3A, 0.5689, 2.88, 0.047, 285, 86, HUMAN IFNA2-IFNAR TERNARY COMPLEX
2039, 2p8lB, 0.5689, 3.28, 0.057, 222, 88, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELLELDKWASLWN
2040, 2e9bB, 0.5689, 2.81, 0.148, 712, 81, CRYSTAL STRUCTURE OF PULLULANASE TYPE I FROM BACILLUS SUBTILIS STR. 168 COMPLEXED WITH MALTOSE
2041, 1gigH, 0.5689, 3.42, 0.068, 221, 88, REFINED THREE-DIMENSIONAL STRUCTURE OF THE FAB FRAGMENT OF A MURINE IGG1 LAMBDA ANTIBODY
2042, 5vmmJ, 0.5688, 2.95, 0.067, 135, 90, STAPHYLOCOCCUS AUREUS ISDB BOUND TO HUMAN HEMOGLOBIN
2043, 3m7oA, 0.5688, 3.91, 0.121, 137, 99, CRYSTAL STRUCTURE OF MOUSE MD-1 IN COMPLEX WITH PHOSPHATIDYLCHOLINE
2044, 3l7eB, 0.5688, 3.48, 0.092, 215, 87, CRYSTAL STRUCTURE OF ANTI-IL-13 ANTIBODY C836
2045, 3d0vB, 0.5688, 3.28, 0.057, 221, 88, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE LLELDKWASLW
2046, 2zwlT, 0.5688, 2.88, 0.095, 191, 84, HUMAN FACTOR VIIA-TISSUE FACTOR COMPLEXED WITH HIGHLY SELECTIVE PEPTIDE INHIBITOR
2047, 1tjgH, 0.5688, 3.19, 0.057, 236, 87, CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY 2F5 IN COMPLEX WITH A GP41 7MER EPITOPE
2048, 5ti1H, 0.5687, 4.05, 0.082, 430, 98, CRYSTAL STRUCTURE OF FUMARYLACETOACETATE HYDROLASE FROM BURKHOLDERIA XENOVORANS LB400
2049, 5ovwJ, 0.5687, 3.25, 0.093, 126, 86, NANOBODY-BOUND BTUF THE VITAMIN B12 BINDING PROTEIN IN ESCHERICHIA COLI
2050, 5eivB, 0.5687, 3.06, 0.060, 181, 83, CRYSTAL STRUCTURE OF COMPLEX OF OSTEOCLAST-ASSOCIATED IMMUNOGLOBULIN- LIKE RECEPTOR (OSCAR) AND A SYNTHETIC COLLAGEN CONSENSUS PEPTIDE
2051, 4dsyC, 0.5687, 3.11, 0.116, 423, 86, CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT CC24201
2052, 3d87D, 0.5687, 3.24, 0.044, 296, 91, CRYSTAL STRUCTURE OF INTERLEUKIN-23
2053, 1qygH, 0.5687, 3.19, 0.081, 220, 86, ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH BENZOYLECGONINE
2054, 5hdoD, 0.5686, 3.42, 0.069, 124, 87, CRYSTAL STRUCTURE OF A NANOBODY RAISED AGAINST UROKINASE-TYPE PLASMINOGEN ACTIVATOR
2055, 4w2oG, 0.5686, 3.26, 0.069, 118, 87, ANTI-MARBURGVIRUS NUCLEOPROTEIN SINGLE DOMAIN ANTIBODY B COMPLEXED WITH NUCLEOPROTEIN C-TERMINAL DOMAIN
2056, 4c54A, 0.5686, 3.07, 0.047, 210, 85, CRYSTAL STRUCTURE OF RECOMBINANT HUMAN IGG4 FC
2057, 3idmB, 0.5686, 3.28, 0.057, 227, 88, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 FAB  FRAGMENT IN COMPLEX WITH GP41 PEPTIDE ANALOG ELD(NRG)WAS
2058, 3auwB, 0.5685, 3.48, 0.077, 175, 91, CYTOPLASMIC DOMAIN OF INWARD RECTIFIER POTASSIUM CHANNEL KIR3.2 IN COMPLEX WITH CADMIUM
2059, 1sbsH, 0.5685, 3.51, 0.080, 222, 88, CRYSTAL STRUCTURE OF AN ANTI-HCG FAB
2060, 1flkA, 0.5685, 3.57, 0.065, 205, 92, MOLECULAR BASIS FOR CD40 SIGNALING MEDIATED BY TRAF3
2061, 6apqA, 0.5684, 3.40, 0.067, 119, 89, ANTI-MARBURGVIRUS NUCLEOPROTEIN SINGLE DOMAIN ANTIBODY B
2062, 5fjxC, 0.5684, 3.45, 0.097, 257, 93, YEAST DELTA-COP-I MU-HOMOLOGY DOMAIN COMPLEXED WITH GCS1 WXXF PEPTIDE
2063, 3x2dH, 0.5684, 3.46, 0.067, 226, 89, CRYSTAL STRUCTURE OF MARBURG VIRUS GP IN COMPLEX WITH THE HUMAN SURVIVOR ANTIBODY MR78
2064, 2lagB, 0.5684, 3.16, 0.046, 212, 87, STRUCTURE OF THE 44 KDA COMPLEX OF INTERFERON-ALPHA2 WITH THE EXTRACELLULAR PART OF IFNAR2 OBTAINED BY 2D-DOUBLE DIFFERENCE NOESY
2065, 1t66D, 0.5684, 3.21, 0.105, 220, 86, THE STRUCTURE OF FAB WITH INTERMEDIATE AFFINITY FOR FLUORESCEIN.
2066, 1kydA, 0.5684, 3.79, 0.020, 247, 99, AP-2 CLATHRIN ADAPTOR ALPHA-APPENDAGE IN COMPLEX WITH EPSIN DPW PEPTIDE
2067, 1hdmA, 0.5684, 2.89, 0.084, 184, 83, HISTOCOMPATIBILITY ANTIGEN HLA-DM
2068, 4tvpD, 0.5683, 3.54, 0.045, 242, 88, CRYSTAL STRUCTURE OF THE HIV-1 BG505 SOSIP.664 ENV TRIMER ECTODOMAIN COMPRISING ATOMIC-LEVEL DEFINITION OF PRE-FUSION GP120 AND GP41 IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22
2069, 5u4yB, 0.5682, 3.06, 0.047, 212, 85, IGG FC BOUND TO 3 HELIX OF THE B-DOMAIN FROM PROTEIN A
2070, 4n9gM, 0.5682, 3.24, 0.058, 223, 86, CRYSTAL STRUCTURE OF A COMPUTATIONALLY DESIGNED RSV-PRESENTING EPITOPE SCAFFOLD AND ITS ELICITED ANTIBODY 17HD9
2071, 1ayrA, 0.5682, 3.40, 0.074, 368, 95, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
2072, 5k8gA, 0.5681, 3.13, 0.118, 511, 85, CRYSTAL STRUCTURE OF A PUTATIVE PEPTIDE-BINDING DOMAIN OF MPAFP
2073, 5fx8U, 0.5681, 3.63, 0.033, 309, 92, COMPLETE STRUCTURE OF MANGANESE LIPOXYGENASE OF GAEUMANNOMYCES GRAMINIS AND PARTIAL STRUCTURE OF ZONADHESIN OF KOMAGATAELLA PASTORIS
2074, 4wi5B, 0.5681, 2.89, 0.024, 208, 83, STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION H310A
2075, 4wi5A, 0.5681, 2.90, 0.024, 208, 83, STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION H310A
2076, 4p99C, 0.5681, 3.10, 0.141, 415, 85, CA2+-STABILIZED ADHESIN HELPS AN ANTARCTIC BACTERIUM REACH OUT AND BIND ICE
2077, 4c54B, 0.5681, 3.09, 0.047, 209, 85, CRYSTAL STRUCTURE OF RECOMBINANT HUMAN IGG4 FC
2078, 3zghA, 0.5681, 3.99, 0.052, 177, 97, CRYSTAL STRUCTURE OF THE KRT10-BINDING REGION DOMAIN OF THE PNEUMOCOCCAL SERINE RICH REPEAT PROTEIN PSRP
2079, 1wtgT, 0.5681, 2.89, 0.095, 191, 84, HUMAN FACTOR VIIA-TISSUE FACTOR COMPLEXED WITH ETHYLSULFONAMIDE-D-BIPHENYLALANINE-GLN-P-AMINOBENZAMIDINE
2080, 1m6uA, 0.5681, 4.16, 0.079, 265, 101, CRYSTAL STRUCTURE OF A NOVEL DNA-BINDING DOMAIN FROM NDT80 A TRANSCRIPTIONAL ACTIVATOR REQUIRED FOR MEIOSIS IN YEAST
2081, 1hwhB, 0.5681, 3.22, 0.046, 196, 87, 1:1 COMPLEX OF HUMAN GROWTH HORMONE MUTANT G120R WITH ITS SOLUBLE BINDING PROTEIN
2082, 1fllB, 0.5681, 3.54, 0.077, 205, 91, MOLECULAR BASIS FOR CD40 SIGNALING MEDIATED BY TRAF3
2083, 6gniA, 0.5680, 3.55, 0.054, 733, 93, CRYO-TOMOGRAPHY AND SUBTOMOGRAM AVERAGING OF SAR1-SEC23-SEC24 - FITTED MODEL. 
2084, 5j75A, 0.5680, 3.15, 0.071, 233, 85, FLUOROGEN ACTIVATING PROGEIN AM2.2 IN COMPLEX WITH ML342
2085, 5cn1A, 0.5680, 3.42, 0.075, 113, 93, CRYSTAL STRUCTURE OF YEAST GGA1_GAE DOMAIN-P21
2086, 4uojB, 0.5680, 3.89, 0.081, 917, 99, STRUCTURE OF FUNGAL BETA-MANNOSIDASE (GH2) FROM TRICHODERMA HARZIANUM
2087, 4ldlB, 0.5680, 3.32, 0.057, 120, 87, STRUCTURE OF BETA2 ADRENOCEPTOR BOUND TO HYDROXYBENZYLISOPROTERENOL AND AN ENGINEERED NANOBODY
2088, 4lcvA, 0.5680, 3.22, 0.093, 123, 86, CRYSTAL STRUCTURE OF DOC2B C2A DOMAIN
2089, 4bziG, 0.5680, 3.55, 0.054, 733, 93, THE STRUCTURE OF THE COPII COAT ASSEMBLED ON MEMBRANES
2090, 4bziD, 0.5680, 3.55, 0.054, 733, 93, THE STRUCTURE OF THE COPII COAT ASSEMBLED ON MEMBRANES
2091, 4bziA, 0.5680, 3.55, 0.054, 733, 93, THE STRUCTURE OF THE COPII COAT ASSEMBLED ON MEMBRANES
2092, 4bz2H, 0.5680, 3.11, 0.059, 213, 85, STRUCTURE OF DENGUE VIRUS EDIII IN COMPLEX WITH FAB 2D73
2093, 3kgrA, 0.5680, 2.76, 0.085, 99, 82, CRYSTAL STRUCTURE OF THE HUMAN LEUKOCYTE-ASSOCIATED IG-LIKE RECEPTOR-1 (LAIR-1)
2094, 2rqeA, 0.5680, 2.78, 0.110, 102, 82, SOLUTION STRUCTURE OF THE SILKWORM BGRP/GNBP3 N-TERMINAL DOMAIN REVEALS THE MECHANISM FOR B-13-GLUCAN SPECIFIC RECOGNITION
2095, 2qtvA, 0.5680, 3.55, 0.054, 733, 93, STRUCTURE OF SEC23-SAR1 COMPLEXED WITH THE ACTIVE FRAGMENT OF SEC31
2096, 1f1gF, 0.5680, 3.38, 0.045, 153, 89, CRYSTAL STRUCTURE OF YEAST CUZNSOD EXPOSED TO NITRIC OXIDE
2097, 6gjuC, 0.5679, 3.09, 0.059, 120, 85, HUMAN NBD1 OF CFTR IN COMPLEX WITH NANOBODIES T2A AND T4 
2098, 5tugA, 0.5679, 2.94, 0.145, 115, 83, ARCHAELLUM PERIPLASMIC STATOR PROTEIN COMPLEX FLAF AND FLAG FROM SULFOLOBUS ACIDOCALDARIUS
2099, 5e1tB, 0.5679, 3.06, 0.047, 191, 86, CRYSTAL STRUCTURE OF TRAF1 TRAF DOMAIN
2100, 4qthH, 0.5679, 3.21, 0.035, 224, 86, CRYSTAL STRUCTURE OF ANTI-UPAR FAB 8B12
2101, 2zp0T, 0.5679, 2.79, 0.084, 191, 83, HUMAN FACTOR VIIA-TISSUE FACTOR COMPLEXED WITH BENZYLSULFONAMIDE-D- ILE-GLN-P-AMINOBENZAMIDINE
2102, 1kf9B, 0.5679, 3.22, 0.046, 193, 87, PHAGE DISPLAY DERIVED VARIANT OF HUMAN GROWTH HORMONE COMPLEXED WITH TWO COPIES OF THE EXTRACELLULAR DOMAIN OF ITS RECEPTOR
2103, 1f6aB, 0.5679, 3.10, 0.034, 217, 88, STRUCTURE OF THE HUMAN IGE-FC BOUND TO ITS HIGH AFFINITY RECEPTOR FC(EPSILON)RI(ALPHA)
2104, 5jo4A, 0.5678, 3.72, 0.056, 221, 90, ANTIBODY FAB FRAGMENT COMPLEX
2105, 4c55A, 0.5678, 2.94, 0.036, 208, 84, CRYSTAL STRUCTURE OF SERUM-DERIVED HUMAN IGG4 FC
2106, 3qazL, 0.5678, 3.17, 0.080, 191, 88, IL-2 MUTANT D10 TERNARY COMPLEX
2107, 3l5wB, 0.5678, 3.47, 0.080, 221, 87, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND C836 FAB
2108, 2nutA, 0.5678, 3.67, 0.021, 708, 94, CRYSTAL STRUCTURE OF THE HUMAN SEC23A/24A HETERODIMER COMPLEXED WITH THE SNARE PROTEIN SEC22B
2109, 2dwxB, 0.5678, 3.22, 0.136, 119, 88, CO-CRYSTAL STRUCTURE ANALYSIS OF GGA1-GAE WITH THE WNSF MOTIF
2110, 2atyA, 0.5678, 2.78, 0.060, 376, 83, COMPLEMENT RECEPTOR CHIMAERIC CONJUGATE CR2-IG
2111, 1f1gC, 0.5678, 3.39, 0.045, 153, 89, CRYSTAL STRUCTURE OF YEAST CUZNSOD EXPOSED TO NITRIC OXIDE
2112, 6de7D, 0.5677, 3.50, 0.045, 205, 88, CRYSTAL STRUCTURE AT 4.3 A RESOLUTION OF GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER WITH INTERDOMAIN STABILIZATION 113C-429GCG IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 AND 35O22 
2113, 5vmmF, 0.5677, 2.85, 0.092, 325, 87, STAPHYLOCOCCUS AUREUS ISDB BOUND TO HUMAN HEMOGLOBIN
2114, 5h10C, 0.5677, 3.17, 0.046, 195, 87, TRAF1-TANK COMPLEX
2115, 5drxA, 0.5677, 2.98, 0.047, 216, 86, CRYSTAL STRUCTURE OF THE BCR FAB FRAGMENT FROM SUBSET  4 CASE CLL240
2116, 4w2oC, 0.5677, 3.31, 0.057, 118, 87, ANTI-MARBURGVIRUS NUCLEOPROTEIN SINGLE DOMAIN ANTIBODY B COMPLEXED WITH NUCLEOPROTEIN C-TERMINAL DOMAIN
2117, 4r4bB, 0.5677, 3.43, 0.080, 220, 87, CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C
2118, 3wn5B, 0.5677, 2.99, 0.036, 210, 84, CRYSTAL STRUCTURE OF ASYMMETRICALLY ENGINEERED FC VARIANT IN COMPLEX WITH FCGRIIIA
2119, 3ijsB, 0.5677, 3.35, 0.103, 221, 87, STRUCTURE OF S67-27 IN COMPLEX WITH TSBP
2120, 3hzvB, 0.5677, 3.08, 0.094, 220, 85, CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.8) KDO(2.4)KDO
2121, 3b2dD, 0.5677, 4.10, 0.099, 139, 101, CRYSTAL STRUCTURE OF HUMAN RP105/MD-1 COMPLEX
2122, 1kyfA, 0.5677, 3.82, 0.020, 247, 99, AP-2 CLATHRIN ADAPTOR ALPHA-APPENDAGE IN COMPLEX WITH EPS15 DPF PEPTIDE
2123, 6h7nC, 0.5676, 3.30, 0.069, 120, 87, ACTIVATED TURKEY BETA1 ADRENOCEPTOR WITH BOUND PARTIAL AGONIST XAMOTEROL AND NANOBODY NB6B9 
2124, 5g64B, 0.5676, 2.87, 0.035, 306, 85, THE COMPLEX BETWEEN HUMAN IGE-FC AND TWO ANTI-IGE FAB FRAGMENTS
2125, 4uojA, 0.5676, 3.94, 0.100, 917, 100, STRUCTURE OF FUNGAL BETA-MANNOSIDASE (GH2) FROM TRICHODERMA HARZIANUM
2126, 3ixtA, 0.5676, 3.45, 0.068, 212, 88, CRYSTAL STRUCTURE OF MOTAVIZUMAB FAB BOUND TO PEPTIDE EPITOPE
2127, 1f1gE, 0.5676, 3.38, 0.045, 153, 89, CRYSTAL STRUCTURE OF YEAST CUZNSOD EXPOSED TO NITRIC OXIDE
2128, 1f1gB, 0.5676, 3.38, 0.045, 153, 89, CRYSTAL STRUCTURE OF YEAST CUZNSOD EXPOSED TO NITRIC OXIDE
2129, 1f1gA, 0.5676, 3.39, 0.045, 153, 89, CRYSTAL STRUCTURE OF YEAST CUZNSOD EXPOSED TO NITRIC OXIDE
2130, 6grsA, 0.5675, 2.60, 0.062, 578, 81, PAIRED IMMUNOGLOBULIN-LIKE RECEPTOR B (PIRB) OR LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR SUBFAMILY B MEMBER 3 (LILRB3) FULL EXTRACELLULAR DOMAIN 
2131, 5u7mD, 0.5675, 3.53, 0.045, 242, 88, CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-378806 IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 3.8 ANGSTROM
2132, 5e80A, 0.5675, 3.94, 0.043, 149, 94, THE CRYSTAL STRUCTURE OF PDED IN COMPLEX WITH INHIBITOR-2A
2133, 3ixtH, 0.5675, 3.45, 0.068, 213, 88, CRYSTAL STRUCTURE OF MOTAVIZUMAB FAB BOUND TO PEPTIDE EPITOPE
2134, 3hzkB, 0.5675, 3.08, 0.094, 222, 85, CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO
2135, 2jlpD, 0.5675, 3.54, 0.108, 169, 93, CRYSTAL STRUCTURE OF HUMAN EXTRACELLULAR COPPER-ZINC SUPEROXIDE DISMUTASE.
2136, 6nb8H, 0.5674, 3.53, 0.045, 230, 88, CRYSTAL STRUCTURE OF ANTI- SARS-COV HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT 
2137, 6iw0H, 0.5674, 3.06, 0.047, 120, 85, CRYSTAL STRUCTURE OF 5A SCFV IN COMPLEX WITH YFV-17D SE IN POSTFUSION STATE 
2138, 5xkuC, 0.5674, 3.41, 0.080, 219, 88, CRYSTAL STRUCTURE OF HEMAGGLUTININ GLOBULAR HEAD FROM AN H7N9 INFLUENZA VIRUS IN COMPLEX WITH A NEUTRALIZING ANTIBODY HNIGGA6
2139, 3qazF, 0.5674, 3.09, 0.080, 186, 87, IL-2 MUTANT D10 TERNARY COMPLEX
2140, 1m7uA, 0.5674, 4.25, 0.079, 249, 101, CRYSTAL STRUCTURE OF A NOVEL DNA-BINDING DOMAIN FROM NDT80 A TRANSCRIPTIONAL ACTIVATOR REQUIRED FOR MEIOSIS IN YEAST
2141, 1f1gD, 0.5674, 3.38, 0.045, 153, 89, CRYSTAL STRUCTURE OF YEAST CUZNSOD EXPOSED TO NITRIC OXIDE
2142, 6oq8D, 0.5673, 3.48, 0.067, 119, 89, STRUCTURE OF THE GTD DOMAIN OF CLOSTRIDIUM DIFFICILE TOXIN B IN COMPLEX WITH VHH 7F 
2143, 6oq8C, 0.5673, 3.51, 0.067, 120, 89, STRUCTURE OF THE GTD DOMAIN OF CLOSTRIDIUM DIFFICILE TOXIN B IN COMPLEX WITH VHH 7F 
2144, 6iutH, 0.5673, 3.18, 0.071, 219, 85, CRYSTAL STRUCTURE OF INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH THE FAB OF ANTIBODY AVFLUIGG01 
2145, 5vxjB, 0.5673, 3.27, 0.103, 119, 87, 2.50 A RESOLUTION STRUCTURE OF IPAD FROM SHIGELLA FLEXNERI IN COMPLEX WITH SINGLE-DOMAIN ANTIBODY JMK-E3
2146, 5uddN, 0.5673, 3.47, 0.091, 221, 88, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
2147, 5durB, 0.5673, 3.31, 0.070, 213, 86, INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH ANTIBODY 100F4
2148, 5cn1D, 0.5673, 3.48, 0.074, 114, 94, CRYSTAL STRUCTURE OF YEAST GGA1_GAE DOMAIN-P21
2149, 4k55A, 0.5673, 3.20, 0.046, 118, 87, STRUCTURE OF THE EXTRACELLULAR DOMAIN OF BUTYROPHILIN BTN3A1 IN COMPLEX WITH (E)-4-HYDROXY-3-METHYL-BUT-2-ENYL PYROPHOSPHATE (HMBPP)
2150, 4gejJ, 0.5673, 3.16, 0.095, 129, 84, N-TERMINAL DOMAIN OF VDUP-1
2151, 4gejB, 0.5673, 3.17, 0.095, 136, 84, N-TERMINAL DOMAIN OF VDUP-1
2152, 3s3jA, 0.5673, 3.55, 0.105, 650, 86, TRANSGLUTAMINASE 2 IN COMPLEX WITH A NOVEL INHIBITOR
2153, 2r15A, 0.5673, 2.86, 0.134, 207, 82, CRYSTAL STRUCTURE OF THE MYOMESIN DOMAINS 12 AND 13
2154, 1q9kB, 0.5673, 3.10, 0.094, 222, 85, S25-2 FAB UNLIGANDED 1
2155, 6ejdA, 0.5672, 3.93, 0.087, 693, 92, HUMAN XYLOSYLTRANSFERASE 1 IN COMPLEX WITH PEPTIDE QEEEGSGGPQGG 
2156, 6ejcA, 0.5672, 3.92, 0.087, 701, 92, HUMAN XYLOSYLTRANSFERASE 1 IN COMPLEX WITH PEPTIDE QEEEGSGVGQGG 
2157, 6ejaA, 0.5672, 3.89, 0.087, 696, 92, HUMAN XYLOSYLTRANSFERASE 1 IN COMPLEX WITH PEPTIDE QEEEYSGGGQGG 
2158, 6bcsA, 0.5672, 3.23, 0.057, 196, 87, LILRB2 D1D2 DOMAINS COMPLEXED WITH BENZAMIDINE 
2159, 4ldoB, 0.5672, 3.33, 0.057, 120, 87, STRUCTURE OF BETA2 ADRENOCEPTOR BOUND TO ADRENALINE AND AN ENGINEERED NANOBODY
2160, 3hhrC, 0.5672, 3.27, 0.057, 194, 88, HUMAN GROWTH HORMONE AND EXTRACELLULAR DOMAIN OF ITS RECEPTOR: CRYSTAL STRUCTURE OF THE COMPLEX
2161, 6h7nD, 0.5671, 3.30, 0.069, 121, 87, ACTIVATED TURKEY BETA1 ADRENOCEPTOR WITH BOUND PARTIAL AGONIST XAMOTEROL AND NANOBODY NB6B9 
2162, 6h7mD, 0.5671, 3.30, 0.069, 120, 87, ACTIVATED TURKEY BETA1 ADRENOCEPTOR WITH BOUND PARTIAL AGONIST SALBUTAMOL AND NANOBODY NB6B9 
2163, 6h7mC, 0.5671, 3.31, 0.069, 120, 87, ACTIVATED TURKEY BETA1 ADRENOCEPTOR WITH BOUND PARTIAL AGONIST SALBUTAMOL AND NANOBODY NB6B9 
2164, 4rgmC, 0.5671, 3.17, 0.035, 217, 86, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO THE NEUTRALIZING ANTIBODY 20B1
2165, 2wqrA, 0.5671, 3.17, 0.023, 319, 88, THE HIGH RESOLUTION CRYSTAL STRUCTURE OF IGE FC
2166, 2khaA, 0.5671, 2.95, 0.081, 113, 86, SOLUTION STRUCTURE OF A PATHOGEN RECOGNITION DOMAIN FROM A LEPIDOPTERAN INSECT PLODIA INTERPUNCTELLA
2167, 6n32K, 0.5670, 3.47, 0.045, 219, 88, ANTI-HIV-1 FAB 2G12 RE-REFINEMENT 
2168, 6fjcA, 0.5670, 3.59, 0.138, 130, 87, HUMAN KIBRA C2 DOMAIN MUTANT C771A IN COMPLEX WITH PHOSPHATIDYLINOSITOL 3;4;5-TRISPHOSPHATE 
2169, 5uddK, 0.5670, 3.29, 0.093, 220, 86, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
2170, 4mqsB, 0.5670, 3.67, 0.067, 121, 89, STRUCTURE OF ACTIVE HUMAN M2 MUSCARINIC ACETYLCHOLINE RECEPTOR BOUND TO THE AGONIST IPEROXO
2171, 1whoA, 0.5670, 3.03, 0.084, 94, 83, ALLERGEN PHL P 2
2172, 6ej8A, 0.5669, 3.89, 0.098, 703, 92, HUMAN XYLOSYLTRANSFERASE 1 IN COMPLEX WITH PEPTIDE QEEEGSGGGQGG 
2173, 4jy4B, 0.5669, 3.41, 0.080, 232, 87, CRYSTAL STRUCTURE OF HUMAN FAB PGT121 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
2174, 2e8yB, 0.5669, 2.78, 0.111, 712, 81, CRYSTAL STRUCTURE OF PULLULANASE TYPE I FROM BACILLUS SUBTILIS STR. 168
2175, 1qtsA, 0.5669, 3.82, 0.020, 247, 99, CRYSTAL STRUCTURE OF THE AP-2 CLATHRIN ADAPTOR ALPHA- APPENDAGE
2176, 6fjdB, 0.5668, 3.53, 0.138, 126, 87, HUMAN KIBRA C2 DOMAIN MUTANT C771A IN COMPLEX WITH PHOSPHATIDYLINOSITOL 4;5-BISPHOSPHATE 
2177, 6df3L, 0.5668, 3.25, 0.056, 199, 90, CRYSTAL STRUCTURE OF TERNARY COMPLEX OF IL-24 WITH SOLUBLE RECEPTORS IL-22RA AND IL-20RB 
2178, 5vcoB, 0.5668, 3.04, 0.081, 215, 86, THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 10B9
2179, 5tb5B, 0.5668, 3.87, 0.087, 150, 92, CRYSTAL STRUCTURE OF FULL-LENGTH FARNESYLATED AND METHYLATED KRAS4B IN COMPLEX WITH PDE-DELTA (CRYSTAL FORM I - WITH PARTIALLY DISORDERED HYPERVARIABLE REGION)
2180, 4pp2B, 0.5668, 3.04, 0.081, 215, 86, THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 10B9
2181, 4gejD, 0.5668, 3.34, 0.094, 131, 85, N-TERMINAL DOMAIN OF VDUP-1
2182, 4fq1H, 0.5668, 3.50, 0.092, 229, 87, CRYSTAL STRUCTURE OF PGT121 FAB
2183, 1jcvA, 0.5668, 3.39, 0.045, 153, 89, REDUCED BRIDGE-BROKEN YEAST CU/ZN SUPEROXIDE DISMUTASE LOW TEMPERATURE (-180C) STRUCTURE
2184, 5w6dH, 0.5667, 3.18, 0.071, 231, 85, CRYSTAL STRUCTURE OF BG505-SOSIP.V4.1-GT1-N137A IN COMPLEX WITH FABS 35022 AND 9H/109L
2185, 5v7uH, 0.5667, 3.42, 0.080, 216, 88, CYRSTAL STRUCTURE OF ANTI-TAU ANTIBODY CBTAU-22.1 FAB
2186, 5uddL, 0.5667, 3.47, 0.091, 221, 88, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
2187, 5e1tA, 0.5667, 3.16, 0.046, 192, 87, CRYSTAL STRUCTURE OF TRAF1 TRAF DOMAIN
2188, 5c71A, 0.5667, 3.12, 0.056, 583, 89, THE STRUCTURE OF ASPERGILLUS ORYZAE A-GLUCURONIDASE COMPLEXED WITH GLYCYRRHETINIC ACID MONOGLUCURONIDE
2189, 3ikcB, 0.5667, 3.36, 0.092, 221, 87, STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)-7-O-METHYL-KDO
2190, 3ifnH, 0.5667, 3.17, 0.080, 215, 87, X-RAY STRUCTURE OF AMYLOID BETA PEPTIDE:ANTIBODY (ABETA1-40:12A11) COMPLEX
2191, 1wssT, 0.5667, 2.81, 0.084, 191, 83, HUMAN FACTOR VIIA-TISSUE FACTOR IN COMPLEX WITH PEPTIDE-MIMETIC INHIBITOR THAT HAS TWO CHARGED GROUPS IN P2 AND P4
2192, 1riuH, 0.5667, 3.31, 0.103, 220, 87, ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH NORBENZOYLECGONINE
2193, 3sbwC, 0.5666, 2.62, 0.050, 208, 80, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE EXTRACELLULAR DOMAINS OF MOUSE PD-1 MUTANT AND HUMAN PD-L1
2194, 2j6eI, 0.5666, 3.50, 0.080, 220, 88, CRYSTAL STRUCTURE OF AN AUTOIMMUNE COMPLEX BETWEEN A HUMAN IGM RHEUMATOID FACTOR AND IGG1 FC REVEALS A NOVEL FC EPITOPE AND EVIDENCE FOR AFFINITY MATURATION
2195, 6oyzG, 0.5665, 3.32, 0.081, 125, 86, CRYSTAL STRUCTURE OF MRAY BOUND TO CAPURAMYCIN 
2196, 6ncyA, 0.5665, 2.96, 0.071, 585, 85, CRYSTAL STRUCTURE OF HYBRID BETA-GLUCURONIDASE/BETA-GALACTURONIDASE FROM FUSICATENIBACTER SACCHARIVORANS 
2197, 6jbtH, 0.5665, 3.19, 0.070, 217, 86, COMPLEX STRUCTURE OF TORIPALIMAB-FAB AND PD-1 
2198, 5tb5D, 0.5665, 3.87, 0.087, 146, 92, CRYSTAL STRUCTURE OF FULL-LENGTH FARNESYLATED AND METHYLATED KRAS4B IN COMPLEX WITH PDE-DELTA (CRYSTAL FORM I - WITH PARTIALLY DISORDERED HYPERVARIABLE REGION)
2199, 5jrpH, 0.5665, 3.47, 0.080, 220, 88, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY MR78 FAB
2200, 5erpA, 0.5665, 3.46, 0.057, 443, 88, CRYSTAL STRUCTURE OF HUMAN DESMOCOLLIN-2 ECTODOMAIN FRAGMENT EC2-5
2201, 5cezH, 0.5665, 3.18, 0.082, 231, 85, CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH AN EARLY PUTATIVE PRECURSOR OF THE PGT121 FAMILY AT 3.0 ANGSTROM
2202, 4qhlA, 0.5665, 3.53, 0.102, 223, 88, I3.2 (UNBOUND) FROM CH103 LINEAGE
2203, 3x2dD, 0.5665, 3.46, 0.067, 226, 89, CRYSTAL STRUCTURE OF MARBURG VIRUS GP IN COMPLEX WITH THE HUMAN SURVIVOR ANTIBODY MR78
2204, 3hhrB, 0.5665, 3.08, 0.058, 195, 86, HUMAN GROWTH HORMONE AND EXTRACELLULAR DOMAIN OF ITS RECEPTOR: CRYSTAL STRUCTURE OF THE COMPLEX
2205, 2g2rH, 0.5665, 3.38, 0.080, 219, 88, GREEN-FLUORESCENT ANTIBODY 11G10 IN COMPLEX WITH ITS HAPTEN (NITRO-STILBENE DERIVATIVE)
2206, 1wcqC, 0.5665, 3.79, 0.120, 599, 92, MUTAGENESIS OF THE NUCLEOPHILIC TYROSINE IN A BACTERIAL SIALIDASE TO PHENYLALANINE.
2207, 1rivH, 0.5665, 3.42, 0.080, 220, 88, ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH META- OXYBENZOYLECGONINE
2208, 1qscB, 0.5665, 3.34, 0.034, 172, 88, CRYSTAL STRUCTURE OF THE TRAF DOMAIN OF TRAF2 IN A COMPLEX WITH A PEPTIDE FROM THE CD40 RECEPTOR
2209, 1p7qD, 0.5665, 3.00, 0.047, 183, 86, CRYSTAL STRUCTURE OF HLA-A2 BOUND TO LIR-1 A HOST AND VIRAL MHC RECEPTOR
2210, 1g0dA, 0.5665, 3.58, 0.091, 666, 88, CRYSTAL STRUCTURE OF RED SEA BREAM TRANSGLUTAMINASE
2211, 5fjwC, 0.5664, 3.48, 0.097, 258, 93, YEAST DELTA-COP-I MU-HOMOLOGY DOMAIN COMPLEXED WITH DSL1 WXWX(MSE) PEPTIDE
2212, 4wwiD, 0.5664, 2.89, 0.024, 201, 83, CRYSTAL STRUCTURE OF THE C DOMAIN OF STAPHYLOCOCCAL PROTEIN A IN COMPLEX WITH THE FC FRAGMENT OF HUMAN IGG AT 2.3 ANGSTROM RESOLUTION
2213, 4idjA, 0.5664, 3.79, 0.054, 276, 93, S.AUREUS A-HEMOLYSIN MONOMER IN COMPLEX WITH FAB
2214, 3k4aB, 0.5664, 3.25, 0.057, 584, 88, CRYSTAL STRUCTURE OF SELENOMETHIONINE SUBSTITUTED E. COLI BETA- GLUCURONIDASE
2215, 2ap2B, 0.5664, 3.31, 0.057, 122, 87, SINGLE CHAIN FV OF C219 IN COMPLEX WITH SYNTHETIC EPITOPE PEPTIDE
2216, 6ge5A, 0.5663, 3.23, 0.082, 204, 85, TEAD4 (216-434);Y429F COMPLEXED WITH YAP PEPTIDE (60-100) AND MYRISTOATE (COVALENTLY BOUND) AT 2.05A (P41212 CRYSTAL FORM); MYRISTOYLATION WAS DONE BY ADDING MYR-COA 
2217, 5xjdA, 0.5663, 3.14, 0.082, 209, 85, TEAD IN COMPLEX WITH FRAGMENT
2218, 5lhnB, 0.5663, 3.39, 0.092, 135, 87, THE CATALYTIC DOMAIN OF MURINE UROKINASE-TYPE PLASMINOGEN ACTIVATOR IN COMPLEX WITH THE ALLOSTERIC INHIBITORY NANOBODY NB7
2219, 3ijyB, 0.5663, 3.36, 0.103, 221, 87, STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)KDO
2220, 1uunA, 0.5663, 3.85, 0.063, 184, 95, MAIN PORIN FROM MYCOBACTERIA SMEGMATIS (MSPA)
2221, 1pz5B, 0.5663, 3.24, 0.070, 220, 86, STRUCTURAL BASIS OF PEPTIDE-CARBOHYDRATE MIMICRY IN AN ANTIBODY COMBINING SITE
2222, 5vxjF, 0.5662, 2.91, 0.071, 118, 84, 2.50 A RESOLUTION STRUCTURE OF IPAD FROM SHIGELLA FLEXNERI IN COMPLEX WITH SINGLE-DOMAIN ANTIBODY JMK-E3
2223, 5ukrH, 0.5662, 3.48, 0.114, 221, 88, STRUCTURE OF UNLIGANDED ANTI-GP120 CD4BS ANTIBODY DH522.2 FAB IN COMPLEX WITH A GP120 CORE
2224, 5t5fH, 0.5662, 3.16, 0.058, 212, 86, NEISSERIA MENINGITIDIS FACTOR H BINDING PROTEIN IN COMPLEX WITH MONOCLONAL ANTIBODY JAR5
2225, 5fjwE, 0.5662, 3.43, 0.098, 258, 92, YEAST DELTA-COP-I MU-HOMOLOGY DOMAIN COMPLEXED WITH DSL1 WXWX(MSE) PEPTIDE
2226, 4lcvD, 0.5662, 3.26, 0.093, 126, 86, CRYSTAL STRUCTURE OF DOC2B C2A DOMAIN
2227, 4jhzA, 0.5662, 2.95, 0.094, 583, 85, STRUCTURE OF E. COLI BETA-GLUCURONIDASE BOUND WITH A NOVEL POTENT INHIBITOR 2-[4-(13-BENZODIOXOL-5-YLMETHYL)PIPERAZIN-1-YL]-N-[(1S2S 5S)-25-DIMETHOXYCYCLOHEXYL]ACETAMIDE
2228, 4ak1A, 0.5662, 4.10, 0.087, 600, 104, STRUCTURE OF BT4661 A SUSE-LIKE SURFACE LOCATED POLYSACCHARIDE BINDING PROTEIN FROM THE BACTEROIDES THETAIOTAOMICRON HEPARIN UTILISATION LOCUS
2229, 3ijhB, 0.5662, 3.37, 0.092, 221, 87, STRUCTURE OF S67-27 IN COMPLEX WITH KO
2230, 2mkwA, 0.5662, 3.03, 0.093, 111, 86, SOLUTION STRUCTURE OF 6AJL2 AND 6AJL2-R24G AMYLOIDOGENICS LIGHT CHAIN PROTEINS
2231, 1pgrH, 0.5662, 3.38, 0.056, 200, 90, 2:2 COMPLEX OF G-CSF WITH ITS RECEPTOR
2232, 6ejbA, 0.5661, 3.93, 0.087, 702, 92, HUMAN XYLOSYLTRANSFERASE 1 IN COMPLEX WITH PEPTIDE QEEEGSAGGQGG 
2233, 6baeB, 0.5661, 3.25, 0.092, 223, 87, TRASTUZUMAB FAB V3 IN COMPLEX WITH CQFDLSTRRLKC 
2234, 5kelM, 0.5661, 3.28, 0.057, 121, 87, EBOV GP IN COMPLEX WITH VARIABLE FAB DOMAINS OF IGGS C2G4 AND C13C6
2235, 5kelJ, 0.5661, 3.28, 0.057, 121, 87, EBOV GP IN COMPLEX WITH VARIABLE FAB DOMAINS OF IGGS C2G4 AND C13C6
2236, 5kelC, 0.5661, 3.28, 0.057, 121, 87, EBOV GP IN COMPLEX WITH VARIABLE FAB DOMAINS OF IGGS C2G4 AND C13C6
2237, 4r4bH, 0.5661, 3.39, 0.057, 220, 87, CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C
2238, 4qkxB, 0.5661, 3.34, 0.057, 120, 87, STRUCTURE OF BETA2 ADRENOCEPTOR BOUND TO A COVALENT AGONIST AND AN ENGINEERED NANOBODY
2239, 3phoB, 0.5661, 3.39, 0.092, 216, 87, CRYSTAL STRUCTURE OF S64-4 IN COMPLEX WITH PSBP
2240, 3ifoH, 0.5661, 3.33, 0.091, 216, 88, X-RAY STRUCTURE OF AMYLOID BETA PEPTIDE:ANTIBODY (ABETA1-7:10D5) COMPLEX
2241, 3hzyB, 0.5661, 3.41, 0.080, 219, 87, CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO(2.4)KDO
2242, 2erjG, 0.5661, 3.05, 0.011, 195, 89, CRYSTAL STRUCTURE OF THE HETEROTRIMERIC INTERLEUKIN-2 RECEPTOR IN COMPLEX WITH INTERLEUKIN-2
2243, 1hwgB, 0.5661, 3.08, 0.070, 194, 86, 1:2 COMPLEX OF HUMAN GROWTH HORMONE WITH ITS SOLUBLE BINDING PROTEIN
2244, 6fb4A, 0.5660, 3.59, 0.138, 129, 87, HUMAN KIBRA C2 DOMAIN MUTANT C771A 
2245, 6ej9A, 0.5660, 3.92, 0.087, 701, 92, HUMAN XYLOSYLTRANSFERASE 1 IN COMPLEX WITH PEPTIDE QEPEGSGGGQGG 
2246, 6dtkA, 0.5660, 3.67, 0.053, 312, 94, HETERODIMERS OF FALS MUTANT SOD ENZYME 
2247, 5nanB, 0.5660, 3.16, 0.048, 271, 84, CRYSTAL STRUCTURE OF HUMAN IL-17AF IN COMPLEX WITH HUMAN IL-17RA
2248, 5kyxA, 0.5660, 3.69, 0.032, 716, 94, CRYSTAL STRUCTURE OF SEC23 AND TANGO1 PEPTIDE1 COMPLEX
2249, 4qhlC, 0.5660, 3.32, 0.080, 219, 87, I3.2 (UNBOUND) FROM CH103 LINEAGE
2250, 3qycA, 0.5660, 3.17, 0.058, 125, 86, STRUCTURE OF A DIMERIC ANTI-HER2 SINGLE DOMAIN ANTIBODY
2251, 3do3B, 0.5660, 2.92, 0.024, 210, 83, HUMAN 1GG1 FC FRAGMENT 2.5 ANGSTROM STRUCTURE
2252, 3b9vC, 0.5660, 3.04, 0.095, 119, 84, CRYSTAL STRUCTURE OF AN AUTONOMOUS VH DOMAIN
2253, 2y23A, 0.5660, 2.88, 0.072, 303, 83, CRYSTAL STRUCTURE OF THE MYOMESIN DOMAINS MY9-MY11
2254, 5vphD, 0.5659, 3.13, 0.105, 214, 86, CRYSTAL STRUCTURE OF DER P 1 COMPLEXED WITH FAB 4C1
2255, 5hnoA, 0.5659, 3.54, 0.097, 164, 93, THE STRUCTURE OF THE KDO-CAPPED SACCHARIDE BINDING SUBUNIT OF THE O-12 SPECIFIC ABC TRANSPORTER WZT
2256, 4ypjB, 0.5659, 3.51, 0.045, 810, 89, X-RAY STRUCTURE OF THE MUTANT OF GLYCOSIDE HYDROLASE
2257, 4ypjA, 0.5659, 3.52, 0.045, 810, 89, X-RAY STRUCTURE OF THE MUTANT OF GLYCOSIDE HYDROLASE
2258, 3rvxD, 0.5659, 3.13, 0.105, 214, 86, CRYSTAL STRUCTURE OF DER P 1 COMPLEXED WITH FAB 4C1
2259, 3pnwW, 0.5659, 3.37, 0.080, 220, 87, CRYSTAL STRUCTURE OF THE TUDOR DOMAIN OF HUMAN TDRD3 IN COMPLEX WITH AN ANTI-TDRD3 FAB
2260, 3pnwE, 0.5659, 3.33, 0.080, 226, 87, CRYSTAL STRUCTURE OF THE TUDOR DOMAIN OF HUMAN TDRD3 IN COMPLEX WITH AN ANTI-TDRD3 FAB
2261, 1pgrD, 0.5659, 3.39, 0.056, 200, 90, 2:2 COMPLEX OF G-CSF WITH ITS RECEPTOR
2262, 4zypN, 0.5658, 3.42, 0.068, 213, 88, CRYSTAL STRUCTURE OF MOTAVIZUMAB AND QUATERNARY-SPECIFIC RSV- NEUTRALIZING HUMAN ANTIBODY AM14 IN COMPLEX WITH PREFUSION RSV F GLYCOPROTEIN
2263, 4zfgH, 0.5658, 3.39, 0.115, 215, 87, DUAL-SPECIFICITY FAB 5A12 IN COMPLEX WITH ANGIOPOIETIN 2
2264, 4jhzB, 0.5658, 2.96, 0.094, 583, 85, STRUCTURE OF E. COLI BETA-GLUCURONIDASE BOUND WITH A NOVEL POTENT INHIBITOR 2-[4-(13-BENZODIOXOL-5-YLMETHYL)PIPERAZIN-1-YL]-N-[(1S2S 5S)-25-DIMETHOXYCYCLOHEXYL]ACETAMIDE
2265, 1qscC, 0.5658, 3.15, 0.058, 172, 86, CRYSTAL STRUCTURE OF THE TRAF DOMAIN OF TRAF2 IN A COMPLEX WITH A PEPTIDE FROM THE CD40 RECEPTOR
2266, 1qscA, 0.5658, 3.15, 0.058, 172, 86, CRYSTAL STRUCTURE OF THE TRAF DOMAIN OF TRAF2 IN A COMPLEX WITH A PEPTIDE FROM THE CD40 RECEPTOR
2267, 6gekA, 0.5657, 3.27, 0.056, 202, 90, TEAD4 (216-434);Y429F COMPLEXED WITH YAP PEPTIDE (60-100) AND MYRISTOATE (COVALENTLY BOUND) AT 2.28A (P212121 CRYSTAL FORM); MYRISTOYLATION WAS DONE BY ADDING MYR-COA 
2268, 5lhpB, 0.5657, 3.37, 0.092, 135, 87, THE P-AMINOBENZAMIDINE ACTIVE SITE INHIBITED CATALYTIC DOMAIN OF MURINE UROKINASE-TYPE PLASMINOGEN ACTIVATOR IN COMPLEX WITH THE ALLOSTERIC INHIBITORY NANOBODY NB7
2269, 5lg1A, 0.5657, 3.11, 0.047, 209, 85, ROOM TEMPERATURE STRUCTURE OF HUMAN IGG4-FC FROM CRYSTALS ANALYSED IN SITU
2270, 4n90F, 0.5657, 3.37, 0.091, 214, 88, CRYSTAL STRUCTURE OF TERNARY COMPLEX OF TRAIL DR5 AND FAB FRAGMENT FROM A DR5 AGONIST ANTIBODY
2271, 4m7jH, 0.5657, 3.35, 0.080, 219, 88, CRYSTAL STRUCTURE OF S25-26 IN COMPLEX WITH KDO(2.8)KDO(2.4)KDO TRISACCHARIDE
2272, 4ioiB, 0.5657, 3.25, 0.092, 220, 87, MEDITOPE-ENABLED TRASTUZUMAB IN COMPLEX WITH CQFDLSTRRLKC
2273, 3ijhD, 0.5657, 3.38, 0.092, 221, 87, STRUCTURE OF S67-27 IN COMPLEX WITH KO
2274, 3hzmB, 0.5657, 3.40, 0.092, 225, 87, CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO
2275, 3eakA, 0.5657, 3.59, 0.080, 127, 88, NBBCII10 HUMANIZED (FGLA MUTANT)
2276, 1zlvH, 0.5657, 3.61, 0.045, 213, 88, FAB 2G12 + MAN7
2277, 1nfdH, 0.5657, 3.30, 0.092, 222, 87, AN ALPHA-BETA T CELL RECEPTOR (TCR) HETERODIMER IN COMPLEX WITH AN ANTI-TCR FAB FRAGMENT DERIVED FROM A MITOGENIC ANTIBODY
2278, 1ky7A, 0.5657, 3.84, 0.020, 247, 99, THE AP-2 CLATHRIN ADAPTOR ALPHA-APPENDAGE IN COMPLEX WITH AMPHIPHYSIN FXDXF
2279, 6gffL, 0.5656, 3.09, 0.058, 214, 86, STRUCTURE OF GARP (LRRC32) IN COMPLEX WITH LATENT TGF-BETA1 AND MHG-8 FAB 
2280, 6foaA, 0.5656, 3.93, 0.087, 699, 92, HUMAN XYLOSYLTRANSFERASE 1 APO STRUCTURE 
2281, 5w1kD, 0.5656, 3.01, 0.071, 225, 84, JUNV GP1 CR1-10 FAB CR1-28 FAB COMPLEX 
2282, 5gn0C, 0.5656, 3.36, 0.067, 222, 90, STRUCTURE OF TAZ-TEAD COMPLEX
2283, 5fjwA, 0.5656, 3.50, 0.097, 258, 93, YEAST DELTA-COP-I MU-HOMOLOGY DOMAIN COMPLEXED WITH DSL1 WXWX(MSE) PEPTIDE
2284, 4qthA, 0.5656, 3.11, 0.035, 215, 85, CRYSTAL STRUCTURE OF ANTI-UPAR FAB 8B12
2285, 4g6kH, 0.5656, 3.44, 0.092, 220, 87, CRYSTAL STRUCTURE OF THE THERAPEUTIC ANTIBODY BINDING FRAGMENT OF GEVOKIZUMAB IN ITS UNBOUND STATE
2286, 2g2rB, 0.5656, 3.38, 0.080, 219, 88, GREEN-FLUORESCENT ANTIBODY 11G10 IN COMPLEX WITH ITS HAPTEN (NITRO-STILBENE DERIVATIVE)
2287, 1yzzB, 0.5656, 3.36, 0.057, 115, 87, HUMANIZED CABAN33 AT ROOM TEMPERATURE
2288, 1x9qA, 0.5656, 3.51, 0.056, 231, 89, 4M5.3 ANTI-FLUORESCEIN SINGLE CHAIN ANTIBODY FRAGMENT (SCFV)
2289, 1om3K, 0.5656, 3.50, 0.045, 225, 88, FAB 2G12 UNLIGANDED
2290, 5w0pC, 0.5655, 3.89, 0.040, 849, 99, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN DETERMINED BY X-RAY FREE ELECTRON LASER
2291, 5uddJ, 0.5655, 3.45, 0.080, 224, 88, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
2292, 5thrT, 0.5655, 3.08, 0.081, 131, 86, CRYO-EM STRUCTURE OF A BG505 ENV-SCD4-17B-8ANC195 COMPLEX
2293, 5thrR, 0.5655, 3.08, 0.081, 131, 86, CRYO-EM STRUCTURE OF A BG505 ENV-SCD4-17B-8ANC195 COMPLEX
2294, 5thrP, 0.5655, 3.08, 0.081, 131, 86, CRYO-EM STRUCTURE OF A BG505 ENV-SCD4-17B-8ANC195 COMPLEX
2295, 5eivA, 0.5655, 3.01, 0.073, 181, 82, CRYSTAL STRUCTURE OF COMPLEX OF OSTEOCLAST-ASSOCIATED IMMUNOGLOBULIN- LIKE RECEPTOR (OSCAR) AND A SYNTHETIC COLLAGEN CONSENSUS PEPTIDE
2296, 4r4hH, 0.5655, 3.36, 0.057, 220, 87, CRYSTAL STRUCTURE OF NON-NEUTRALIZING A32-LIKE ANTIBODY 2.2C IN COMPLEX WITH HIV-1 ENV GP120
2297, 4n90H, 0.5655, 3.19, 0.105, 215, 86, CRYSTAL STRUCTURE OF TERNARY COMPLEX OF TRAIL DR5 AND FAB FRAGMENT FROM A DR5 AGONIST ANTIBODY
2298, 3m7oD, 0.5655, 4.05, 0.121, 131, 99, CRYSTAL STRUCTURE OF MOUSE MD-1 IN COMPLEX WITH PHOSPHATIDYLCHOLINE
2299, 1wqvT, 0.5655, 2.81, 0.084, 191, 83, HUMAN FACTOR VIIA-TISSUE FACTOR COMPLEXED WITH PROPYLSULFONAMIDE-D- THR-MET-P-AMINOBENZAMIDINE
2300, 5hnpA, 0.5654, 3.58, 0.097, 161, 93, THE STRUCTURE OF THE KDO-CAPPED SACCHARIDE BINDING SUBUNIT OF THE O-12 SPECIFIC ABC TRANSPORTER WZT
2301, 4lcvB, 0.5654, 3.22, 0.093, 131, 86, CRYSTAL STRUCTURE OF DOC2B C2A DOMAIN
2302, 4j4pH, 0.5654, 3.25, 0.081, 224, 86, THE COMPLEX OF HUMAN IGE-FC WITH TWO BOUND FAB FRAGMENTS
2303, 3s3sA, 0.5654, 3.41, 0.107, 620, 84, TRANSGLUTAMINASE 2 IN COMPLEX WITH A NOVEL INHIBITOR
2304, 1xzwA, 0.5654, 3.36, 0.093, 424, 86, SWEET POTATO PURPLE ACID PHOSPHATASE/PHOSPHATE COMPLEX
2305, 1danU, 0.5654, 2.87, 0.096, 116, 83, COMPLEX OF ACTIVE SITE INHIBITED HUMAN BLOOD COAGULATION FACTOR VIIA WITH HUMAN RECOMBINANT SOLUBLE TISSUE FACTOR
2306, 5vcoD, 0.5653, 3.06, 0.081, 219, 86, THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 10B9
2307, 4pp2D, 0.5653, 3.06, 0.081, 219, 86, THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 10B9
2308, 2zzuT, 0.5653, 2.89, 0.095, 191, 84, HUMAN FACTOR VIIA-TISSUE FACTOR COMPLEXED WITH ETHYLSULFONAMIDE-D-5- (3-CARBOXYBENZYLOXY)-TRP-GLN-P-AMINOBENZAMIDINE
2309, 1yazA, 0.5653, 3.39, 0.045, 153, 89, AZIDE-BOUND YEAST CU(II)/ZN SUPEROXIDE DISMUTASE ROOM TEMPERATURE (298K) STRUCTURE
2310, 1b6uA, 0.5653, 2.80, 0.024, 199, 84, CRYSTAL STRUCTURE OF THE HUMAN KILLER CELL INHIBITORY RECEPTOR (KIR2DL3) SPECIFIC FOR HLA-CW3 RELATED ALLELES
2311, 6grsB, 0.5652, 3.00, 0.024, 587, 84, PAIRED IMMUNOGLOBULIN-LIKE RECEPTOR B (PIRB) OR LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR SUBFAMILY B MEMBER 3 (LILRB3) FULL EXTRACELLULAR DOMAIN 
2312, 5vneA, 0.5652, 3.97, 0.042, 708, 95, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH EMP24 SORTING MOTIF
2313, 5fhbH, 0.5652, 3.44, 0.057, 228, 88, CRYSTAL STRUCTURE OF PROTECTIVE EBOLA VIRUS ANTIBODY 100
2314, 5erwA, 0.5652, 3.37, 0.093, 212, 86, STRUCTURE OF HCV E2 GLYCOPROTEIN ANTIGENIC EPITOPE II BOUND TO THE BROADLY NEUTRALIZING ANTIBODY HC84-26
2315, 4zxbE, 0.5652, 3.28, 0.080, 800, 87, STRUCTURE OF THE HUMAN INSULIN RECEPTOR ECTODOMAIN IRDELTABETA CONSTRUCT IN COMPLEX WITH FOUR FAB MOLECULES
2316, 4gejH, 0.5652, 3.30, 0.094, 139, 85, N-TERMINAL DOMAIN OF VDUP-1
2317, 3ldbC, 0.5652, 3.13, 0.023, 210, 86, STRUCTURE OF JMJD6 COMPLEXD WITH ALPHA-KETOGLUTARATE AND FAB FRAGMENT.
2318, 1ysoA, 0.5652, 3.45, 0.045, 153, 89, YEAST CU ZN SUPEROXIDE DISMUTASE WITH THE REDUCED BRIDGE BROKEN
2319, 1c5dH, 0.5652, 3.35, 0.057, 214, 88, THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A RAT MONOCLONAL ANTIBODY AGAINST THE MAIN IMMUNOGENIC REGION OF THE HUMAN MUSCLE ACETYLCHOLINE RECEPTOR
2320, 5fwoA, 0.5651, 3.19, 0.082, 129, 85, LLAMA NANOBODY PORM_130
2321, 5e80B, 0.5651, 3.99, 0.064, 149, 94, THE CRYSTAL STRUCTURE OF PDED IN COMPLEX WITH INHIBITOR-2A
2322, 5e1tC, 0.5651, 3.24, 0.046, 186, 87, CRYSTAL STRUCTURE OF TRAF1 TRAF DOMAIN
2323, 4j4pC, 0.5651, 2.99, 0.071, 222, 84, THE COMPLEX OF HUMAN IGE-FC WITH TWO BOUND FAB FRAGMENTS
2324, 4iblT, 0.5651, 2.88, 0.083, 198, 84, RUBIDIUM SITES IN BLOOD COAGULATION FACTOR VIIA
2325, 3t5gB, 0.5651, 3.88, 0.087, 147, 92, STRUCTURE OF FULLY MODIFIED FARNESYLATED RHEB IN COMPLEX WITH PDE6D
2326, 3i02D, 0.5651, 3.44, 0.103, 212, 87, CRYSTAL STRUCTURE OF S54-10 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO(2.4)KDO
2327, 3ew3B, 0.5651, 2.92, 0.035, 203, 85, THE 1:2 COMPLEX BETWEEN A NTERMINAL ELONGATED PROLACTIN AND THE EXTRA CELLULAR DOMAIN OF THE RAT PROLACTIN RECEPTOR
2328, 1n8zB, 0.5651, 3.45, 0.126, 220, 87, CRYSTAL STRUCTURE OF EXTRACELLULAR DOMAIN OF HUMAN HER2 COMPLEXED WITH HERCEPTIN FAB
2329, 1ap2D, 0.5651, 3.11, 0.059, 123, 85, SINGLE CHAIN FV OF C219
2330, 6hikA, 0.5650, 3.27, 0.054, 215, 92, X-RAY STRUCTURE OF TEAD4(Y429H) MUTANT) COMPLEXED WITH YAP (WILDTYPE): MOLECULAR AND STRUCTURAL CHARACTERIZATION OF A TEAD MUTATION AT THE ORIGIN OF SVEINSSON S CHORIORETINAL ATROPHY 
2331, 6h3uI, 0.5650, 2.89, 0.059, 122, 85, SCHMALLENBERG VIRUS GLYCOPROTEIN GC HEAD DOMAIN IN COMPLEX WITH SCFV 4B6 
2332, 5vxjJ, 0.5650, 3.17, 0.105, 117, 86, 2.50 A RESOLUTION STRUCTURE OF IPAD FROM SHIGELLA FLEXNERI IN COMPLEX WITH SINGLE-DOMAIN ANTIBODY JMK-E3
2333, 5o04D, 0.5650, 3.01, 0.047, 119, 85, GII.10 VIETNAM 026 NOROVIRUS PROTRUDING DOMAIN IN COMPLEX WITH NANOBODY NANO-26 AND NANO-85
2334, 5drwA, 0.5650, 2.91, 0.047, 218, 85, CRYSTAL STRUCTURE OF THE BCR FAB FRAGMENT FROM SUBSET  4 CASE CLL183
2335, 3x2dP, 0.5650, 3.45, 0.080, 226, 88, CRYSTAL STRUCTURE OF MARBURG VIRUS GP IN COMPLEX WITH THE HUMAN SURVIVOR ANTIBODY MR78
2336, 3l7eH, 0.5650, 3.37, 0.069, 216, 87, CRYSTAL STRUCTURE OF ANTI-IL-13 ANTIBODY C836
2337, 2jcwA, 0.5650, 3.45, 0.045, 153, 89, REDUCED BRIDGE-BROKEN YEAST CU/ZN SUPEROXIDE DISMUTASE ROOM TEMPERATURE (298K) STRUCTURE
2338, 6ey6K, 0.5649, 3.20, 0.071, 130, 85, C-TERMINAL PART (RESIDUES 315-516) OF PORM WITH THE LLAMA NANOBODY NB130
2339, 5kwyC, 0.5649, 3.70, 0.105, 133, 95, STRUCTURE OF HUMAN NPC1 MIDDLE LUMENAL DOMAIN BOUND TO NPC2
2340, 3pnwK, 0.5649, 3.38, 0.080, 218, 87, CRYSTAL STRUCTURE OF THE TUDOR DOMAIN OF HUMAN TDRD3 IN COMPLEX WITH AN ANTI-TDRD3 FAB
2341, 3b2vH, 0.5649, 3.11, 0.116, 217, 86, CRYSTAL STRUCTURE OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8
2342, 2j6eH, 0.5649, 3.29, 0.081, 216, 86, CRYSTAL STRUCTURE OF AN AUTOIMMUNE COMPLEX BETWEEN A HUMAN IGM RHEUMATOID FACTOR AND IGG1 FC REVEALS A NOVEL FC EPITOPE AND EVIDENCE FOR AFFINITY MATURATION
2343, 2dwyB, 0.5649, 3.45, 0.066, 126, 91, CRYSTAL STRUCTURE ANALYSIS OF GGA1-GAE
2344, 6ecaA, 0.5648, 3.15, 0.057, 590, 88, LACTOBACILLUS RHAMNOSUS BETA-GLUCURONIDASE 
2345, 6bu0B, 0.5648, 3.23, 0.058, 126, 86, CRYSTAL STRUCTURE OF THE PI3KC2ALPHA C2 DOMAIN IN COMPLEX WITH IP6 
2346, 5molA, 0.5648, 3.22, 0.034, 318, 88, HUMAN IGE-FC CRYSTAL STRUCTURE
2347, 4ztoI, 0.5648, 3.46, 0.080, 221, 87, FAB/EPITOPE COMPLEX STRUCTURE OF RABBIT MONOCLONAL ANTIBODY R53 TARGETING AN EPITOPE IN HIV-1 GP120 C4 REGION
2348, 4qgyA, 0.5648, 3.45, 0.103, 135, 87, CAMELID (LLAMA) NANOBODY N25 (VHH) AGAINST TYPE 6 SECRETION SYSTEM TSSM PROTEIN
2349, 4k8uA, 0.5648, 3.23, 0.069, 178, 87, CRYSTAL STRUCTURE OF TRAF4 TRAF DOMAIN
2350, 3rg1D, 0.5648, 3.97, 0.071, 136, 99, CRYSTAL STRUCTURE OF THE RP105/MD-1 COMPLEX
2351, 3rg1C, 0.5648, 3.88, 0.082, 138, 98, CRYSTAL STRUCTURE OF THE RP105/MD-1 COMPLEX
2352, 3qhfH, 0.5648, 3.27, 0.080, 225, 87, CRYSTAL STRUCTURE OF FAB DEL2D1 A DELETION VARIANT OF ANTI-INFLUENZA ANTIBODY 2D1
2353, 1nfdF, 0.5648, 3.29, 0.080, 222, 87, AN ALPHA-BETA T CELL RECEPTOR (TCR) HETERODIMER IN COMPLEX WITH AN ANTI-TCR FAB FRAGMENT DERIVED FROM A MITOGENIC ANTIBODY
2354, 6ge6A, 0.5647, 3.28, 0.054, 214, 92, X-RAY STRUCTURE OF TEAD4(E263A+Y429F MUTANT) COMPLEXED WITH YAP(WILDTYPE): THE ROLE OF RESIDUAL FLEXIBILITY AND WATER MOLECULES IN THE ADAPTATION OF A BOUND INTRINSICALLY DISORDERED PROTEIN TO MUTATIONS AT A BINDING INTERFACE 
2355, 6dtkG, 0.5647, 3.69, 0.053, 313, 94, HETERODIMERS OF FALS MUTANT SOD ENZYME 
2356, 6csyN, 0.5647, 3.41, 0.057, 122, 87, CRYSTAL STRUCTURE OF HUMAN BETA2 ADRENERGIC RECEPTOR BOUND TO SALMETEROL AND NB71 
2357, 5fjwB, 0.5647, 3.49, 0.097, 258, 93, YEAST DELTA-COP-I MU-HOMOLOGY DOMAIN COMPLEXED WITH DSL1 WXWX(MSE) PEPTIDE
2358, 3riaG, 0.5647, 3.30, 0.035, 200, 86, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND IODIDE.
2359, 3riaF, 0.5647, 3.29, 0.035, 191, 86, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND IODIDE.
2360, 3rhwG, 0.5647, 3.30, 0.035, 200, 86, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND IVERMECTIN
2361, 3rhwF, 0.5647, 3.29, 0.035, 191, 86, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND IVERMECTIN
2362, 3lrsC, 0.5647, 3.51, 0.057, 228, 88, STRUCTURE OF PG16 AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1
2363, 3g9vC, 0.5647, 2.76, 0.083, 176, 84, CRYSTAL STRUCTURE OF A SOLUBLE DECOY RECEPTOR IL-22BP BOUND TO INTERLEUKIN-22
2364, 1ntlB, 0.5647, 3.06, 0.047, 551, 85, MODEL OF MOUSE CRRY-IG DETERMINED BY SOLUTION SCATTERING CURVE FITTING AND HOMOLOGY MODELLING
2365, 1l9mA, 0.5647, 3.37, 0.105, 675, 86, THREE-DIMENSIONAL STRUCTURE OF THE HUMAN TRANSGLUTAMINASE 3 ENZYME: BINDING OF CALCIUM IONS CHANGE STRUCTURE FOR ACTIVATION
2366, 6f8fD, 0.5646, 3.00, 0.108, 137, 83, CO-CRYSTAL STRUCTURE OF SPOP MATH DOMAIN AND HUMAN PDX1 FRAGMENT 
2367, 5mxaA, 0.5646, 2.80, 0.086, 301, 81, STRUCTURE OF UNBOUND INTERLEUKIN-23
2368, 5h1dA, 0.5646, 4.35, 0.073, 135, 96, CRYSTAL STRUCTURE OF C-TERMINAL OF RHOGDI2
2369, 5gzoC, 0.5646, 3.28, 0.116, 214, 86, STRUCTURE OF NEUTRALIZING ANTIBODY BOUND TO ZIKA ENVELOPE PROTEIN
2370, 4zfoA, 0.5646, 3.21, 0.046, 215, 87, J22.9-XI: CHIMERIC MOUSE/HUMAN ANTIBODY AGAINST HUMAN BCMA (CD269)
2371, 4tnwX, 0.5646, 3.19, 0.035, 224, 85, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2372, 1ej8A, 0.5646, 3.35, 0.056, 140, 90, CRYSTAL STRUCTURE OF DOMAIN 2 OF THE YEAST COPPER CHAPERONE FOR SUPEROXIDE DISMUTASE (LYS7) AT 1.55 A RESOLUTION
2373, 1axiB, 0.5646, 3.23, 0.046, 191, 87, STRUCTURAL PLASTICITY AT THE HGH:HGHBP INTERFACE
2374, 6q36A, 0.5645, 3.46, 0.054, 215, 92, TEAD4(216-434) COMPLEXED WITH OPTIMIZED PEPTIDE 9 AND MYRISTOATE (COVALENTLY BOUND) AT 2.01A RESOLUTION: STRUCTURE-BASED DESIGN OF POTENT LINEAR PEPTIDE INHIBITORS OF THE YAP-TEAD PROTEIN-PROTEIN INTERACTION DERIVED FROM THE YAP OMEGA-LOOP SEQUENCE 
2375, 6osyR, 0.5645, 3.06, 0.092, 122, 87, CRYO-EM STRUCTURE OF VACCINE-ELICITED ANTIBODY 0PV-A.01 IN COMPLEX WITH HIV-1 ENV BG505 DS-SOSIP AND ANTIBODIES VRC03 AND PGT122 
2376, 6oe5B, 0.5645, 3.55, 0.091, 213, 88, SPLAYED OPEN PREFUSION RSV F CAPTURED BY CR9501 AND MOTAVIZUMAB FABS 
2377, 6mxtN, 0.5645, 3.41, 0.057, 122, 87, CRYSTAL STRUCTURE OF HUMAN BETA2 ADRENERGIC RECEPTOR BOUND TO SALMETEROL AND NB71 
2378, 6mnfM, 0.5645, 3.51, 0.045, 224, 88, ANTI-HIV-1 FAB 2G12 + MAN8 RE-REFINEMENT 
2379, 6bu0C, 0.5645, 3.58, 0.067, 128, 89, CRYSTAL STRUCTURE OF THE PI3KC2ALPHA C2 DOMAIN IN COMPLEX WITH IP6 
2380, 6b9yB, 0.5645, 3.24, 0.092, 223, 87, TRASTUZUMAB FAB V3 IN COMPLEX WITH 5-PHENYL MEDITOPE VARIANT 
2381, 5u8rA, 0.5645, 3.32, 0.068, 801, 88, STRUCTURE OF THE ECTODOMAIN OF THE HUMAN TYPE 1 INSULIN-LIKE GROWTH FACTOR RECEPTOR
2382, 4pozD, 0.5645, 3.05, 0.058, 215, 86, FAB FRAGMENT OF DER P 1 SPECIFIC ANTIBODY 10B9
2383, 2bzdC, 0.5645, 3.78, 0.109, 600, 92, GALACTOSE RECOGNITION BY THE CARBOHYDRATE-BINDING MODULE OF A BACTERIAL SIALIDASE.
2384, 1qlrB, 0.5645, 3.30, 0.070, 209, 86, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A HUMAN MONOCLONAL IGM COLD AGGLUTININ
2385, 1cd9D, 0.5645, 3.33, 0.066, 204, 91, 2:2 COMPLEX OF G-CSF WITH ITS RECEPTOR
2386, 6db5I, 0.5644, 3.04, 0.047, 228, 85, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB TA6 IN COMPLEX WITH A HIV-1 GP120 V3 PEPTIDE FROM NY5 STRAIN 
2387, 5fjxB, 0.5644, 3.50, 0.097, 257, 93, YEAST DELTA-COP-I MU-HOMOLOGY DOMAIN COMPLEXED WITH GCS1 WXXF PEPTIDE
2388, 5fjwG, 0.5644, 3.49, 0.097, 258, 93, YEAST DELTA-COP-I MU-HOMOLOGY DOMAIN COMPLEXED WITH DSL1 WXWX(MSE) PEPTIDE
2389, 4x80H, 0.5644, 3.44, 0.092, 223, 87, CRYSTAL STRUCTURE OF MURINE 7B4 FAB MONOCLONAL ANTIBODY AGAINST ADAMTS5
2390, 4ldeB, 0.5644, 3.36, 0.057, 120, 87, STRUCTURE OF BETA2 ADRENOCEPTOR BOUND TO BI167107 AND AN ENGINEERED NANOBODY
2391, 3wifA, 0.5644, 3.16, 0.047, 211, 86, CRYSTAL STRUCTURE OF ANTI-PROSTAGLANDIN E2 FAB FRAGMENT 9CL-PGF2BETA COMPLEX
2392, 3rajH, 0.5644, 3.20, 0.058, 215, 86, CRYSTAL STRUCTURE OF HUMAN CD38 IN COMPLEX WITH THE FAB FRAGMENT OF ANTIBODY HB7
2393, 3i02B, 0.5644, 3.46, 0.103, 220, 87, CRYSTAL STRUCTURE OF S54-10 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO(2.4)KDO
2394, 3gd1E, 0.5644, 3.39, 0.064, 300, 94, STRUCTURE OF AN ARRESTIN/CLATHRIN COMPLEX REVEALS A NOVEL CLATHRIN BINDING DOMAIN THAT MODULATES RECEPTOR TRAFFICKING
2395, 1m7dB, 0.5644, 3.62, 0.080, 220, 88, CRYSTAL STRUCTURE OF A MONOCLONAL FAB SPECIFIC FOR SHIGELLA FLEXNERI Y LIPOPOLYSACCHARIDE COMPLEXED WITH A TRISACCHARIDE
2396, 1m71B, 0.5644, 3.33, 0.081, 220, 86, CRYSTAL STRUCTURE OF A MONOCLONAL FAB SPECIFIC FOR SHIGELLA FLEXNERI Y LIPOPOLYSACCHARIDE
2397, 1jk9D, 0.5644, 3.83, 0.053, 243, 95, HETERODIMER BETWEEN H48F-YSOD1 AND YCCS
2398, 5jpmD, 0.5643, 3.65, 0.074, 651, 95, STRUCTURE OF THE COMPLEX OF HUMAN COMPLEMENT C4 WITH MASP-2 REBUILT USING IMDFF
2399, 2q7nA, 0.5643, 3.06, 0.035, 480, 85, CRYSTAL STRUCTURE OF LEUKEMIA INHIBITORY FACTOR IN COMPLEX WITH LIF RECEPTOR (DOMAINS 1-5)
2400, 2b3rB, 0.5643, 3.19, 0.093, 124, 86, CRYSTAL STRUCTURE OF THE C2 DOMAIN OF CLASS II PHOSPHATIDYLINOSITIDE 3-KINASE C2
2401, 1f1dA, 0.5643, 3.40, 0.045, 153, 89, CRYSTAL STRUCTURE OF YEAST H46C CUZNSOD MUTANT
2402, 1ayrB, 0.5643, 3.46, 0.096, 363, 94, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
2403, 5y1aA, 0.5642, 3.47, 0.064, 314, 94, HBP35 OF PORPHYROMONAS GINGIVALIS 
2404, 5u5mB, 0.5642, 3.26, 0.092, 223, 87, CRYSTAL STRUCTURE OF I83E MEDITOPE-ENABLED TRASTUZUMAB WITH AZIDO- MEDITOPE
2405, 4ln0A, 0.5642, 3.23, 0.056, 213, 89, CRYSTAL STRUCTURE OF THE VGLL4-TEAD4 COMPLEX
2406, 3qhzH, 0.5642, 3.58, 0.114, 221, 88, CRYSTAL STRUCTURE OF HUMAN ANTI-INFLUENZA FAB 2D1
2407, 2fjgH, 0.5642, 3.25, 0.105, 218, 86, STRUCTURE OF THE G6 FAB A PHAGE DERIVED FAB FRAGMENT IN COMPLEX WITH VEGF
2408, 1wunT, 0.5642, 2.92, 0.095, 191, 84, HUMAN FACTOR VIIA-TISSUE FACTOR COMPLEXED WITH ETHYLSULFONAMIDE-D-TRP-GLN-P-AMINOBENZAMIDINE
2409, 1eutA, 0.5642, 3.77, 0.121, 601, 91, SIALIDASE LARGE 68KD FORM COMPLEXED WITH GALACTOSE
2410, 6oq5D, 0.5641, 3.42, 0.080, 126, 87, STRUCTURE OF THE FULL-LENGTH CLOSTRIDIUM DIFFICILE TOXIN B IN COMPLEX WITH 3 VHHS 
2411, 6mu3M, 0.5641, 3.48, 0.045, 216, 88, ANTI-HIV-1 FAB 2G12 + MAN7 RE-REFINEMENT 
2412, 6ey6N, 0.5641, 3.40, 0.080, 129, 87, C-TERMINAL PART (RESIDUES 315-516) OF PORM WITH THE LLAMA NANOBODY NB130
2413, 6ey6I, 0.5641, 3.40, 0.080, 129, 87, C-TERMINAL PART (RESIDUES 315-516) OF PORM WITH THE LLAMA NANOBODY NB130
2414, 5nanC, 0.5641, 3.12, 0.048, 271, 83, CRYSTAL STRUCTURE OF HUMAN IL-17AF IN COMPLEX WITH HUMAN IL-17RA
2415, 5j56B, 0.5641, 3.78, 0.078, 129, 90, RTA-V1C7
2416, 5dwuB, 0.5641, 2.84, 0.084, 181, 83, BETA COMMON RECEPTOR IN COMPLEX WITH A FAB
2417, 5czkA, 0.5641, 3.12, 0.057, 587, 87, STRUCTURE OF E. COLI BETA-GLUCURONIDASE BOUND WITH A NOVEL POTENT INHIBITOR 1-((68-DIMETHYL-2-OXO-12-DIHYDROQUINOLIN-3-YL)METHYL)-1- (2-HYDROXYETHYL)-3-(4-HYDROXYPHENYL)THIOUREA
2418, 4p24F, 0.5641, 3.54, 0.032, 290, 93, PORE FORMING TOXIN
2419, 4iofE, 0.5641, 3.17, 0.082, 211, 85, CRYSTAL STRUCTURE ANALYSIS OF FAB-BOUND HUMAN INSULIN DEGRADING ENZYME (IDE)
2420, 3ri5F, 0.5641, 3.30, 0.035, 188, 86, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND PICROTOXIN
2421, 3rbsA, 0.5641, 2.74, 0.074, 201, 81, CRYSTAL STRUCTURE OF THE MYOMESIN DOMAINS 10 AND 11
2422, 2dibA, 0.5641, 3.13, 0.034, 128, 87, SOLUTION STRUCTURE OF THE 11TH FILAMIN DOMAIN FROM HUMAN FILAMIN-B
2423, 1ayrD, 0.5641, 3.46, 0.096, 363, 94, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
2424, 5viyJ, 0.5640, 3.39, 0.045, 223, 88, BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195
2425, 5viyH, 0.5640, 3.39, 0.045, 223, 88, BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195
2426, 5u6aB, 0.5640, 3.26, 0.092, 223, 87, CRYSTAL STRUCTURE OF I83E MEDITOPE-ENABLED TRASTUZUMAB WITH AZIDO- PEG3-MEDITOPE
2427, 5mhlA, 0.5640, 3.72, 0.103, 692, 87, FXIIIA IN COMPLEX WITH THE INHIBITOR MI0621
2428, 4tnwW, 0.5640, 3.19, 0.035, 224, 85, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2429, 4tnwF, 0.5640, 3.20, 0.035, 221, 85, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2430, 4ln0B, 0.5640, 3.28, 0.056, 194, 90, CRYSTAL STRUCTURE OF THE VGLL4-TEAD4 COMPLEX
2431, 4jhaH, 0.5640, 3.31, 0.081, 226, 86, CRYSTAL STRUCTURE OF RSV-NEUTRALIZING HUMAN ANTIBODY D25
2432, 3ri5G, 0.5640, 3.30, 0.035, 200, 86, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND PICROTOXIN
2433, 3qo0B, 0.5640, 3.32, 0.092, 220, 87, MONOCLINIC FORM OF IGG1 FAB FRAGMENT (IN COMPLEX WITH ANTIGENIC PEPTIDE) SHARING SAME FV AS IGA
2434, 3pnwQ, 0.5640, 3.35, 0.080, 218, 87, CRYSTAL STRUCTURE OF THE TUDOR DOMAIN OF HUMAN TDRD3 IN COMPLEX WITH AN ANTI-TDRD3 FAB
2435, 1b4tA, 0.5640, 3.41, 0.045, 153, 89, H48C YEAST CU(II)/ZN SUPEROXIDE DISMUTASE ROOM TEMPERATURE (298K) STRUCTURE
2436, 6h7kC, 0.5639, 3.30, 0.058, 119, 86, ACTIVATED TURKEY BETA1 ADRENOCEPTOR WITH BOUND AGONIST FORMOTEROL AND NANOBODY NB80 
2437, 6ey6J, 0.5639, 3.39, 0.080, 130, 87, C-TERMINAL PART (RESIDUES 315-516) OF PORM WITH THE LLAMA NANOBODY NB130
2438, 6btyB, 0.5639, 3.18, 0.070, 128, 86, CRYSTAL STRUCTURE OF THE PI3KC2ALPHA C2 DOMAIN IN SPACE GROUP P41212 
2439, 5vpgD, 0.5639, 3.25, 0.103, 218, 87, CRYSTAL STRUCTURE OF DER P 1 COMPLEXED WITH FAB 4C1
2440, 5u5fB, 0.5639, 3.26, 0.092, 223, 87, MEDITOPE ENABLED TRASTUZUMAB I83E VARIANT IN COMPLEX WITH (AC) CQFDA(PH)2STRRLRCGGSK
2441, 4n90D, 0.5639, 3.32, 0.091, 218, 88, CRYSTAL STRUCTURE OF TERNARY COMPLEX OF TRAIL DR5 AND FAB FRAGMENT FROM A DR5 AGONIST ANTIBODY
2442, 3rvwD, 0.5639, 3.25, 0.103, 218, 87, CRYSTAL STRUCTURE OF DER P 1 COMPLEXED WITH FAB 4C1
2443, 3rifF, 0.5639, 3.30, 0.047, 171, 86, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND GLUTAMATE.
2444, 1w8nA, 0.5639, 3.85, 0.120, 601, 92, CONTRIBUTION OF THE ACTIVE SITE ASPARTIC ACID TO CATALYSIS IN THE BACTERIAL NEURAMINIDASE FROM MICROMONOSPORA VIRIDIFACIENS.
2445, 6nczE, 0.5638, 2.97, 0.071, 589, 85, CRYSTAL STRUCTURE OF HYBRID BETA-GLUCURONIDASE/BETA-GALACTURONIDASE FROM FUSICATENIBACTER SACCHARIVORANS BOUND TO PHENYL-THIO-BETA-D- GLUCURONIDE 
2446, 6fp6R, 0.5638, 3.64, 0.063, 232, 95, COMPLEX OF HUMAN CU;ZN SOD1 WITH THE HUMAN COPPER CHAPERONE FOR SOD1 IN A COMPACT CONFORMATION 
2447, 6b3sC, 0.5638, 3.34, 0.102, 213, 88, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF NECITUMUMAB (FAB11F8) IN COMPLEX WITH DOMAIN III FROM A CETUXIMAB RESISTANT VARIANT OF EGFR (SEGFRD3-S468R)
2448, 5esaA, 0.5638, 3.42, 0.068, 213, 88, CRYSTAL STRUCTURE OF ANTI-HCV E2 ANTIBODY HC84-26
2449, 4tnvV, 0.5638, 3.17, 0.035, 224, 85, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2450, 4jkwA, 0.5638, 3.23, 0.046, 119, 87, STRUCTURE OF THE EXTRACELLULAR DOMAIN OF BUTYROPHILIN BTN3A1 IN COMPLEX WITH ISOPENTENYL PYROPHOSPHATE (IPP)
2451, 3rg1G, 0.5638, 3.89, 0.082, 138, 98, CRYSTAL STRUCTURE OF THE RP105/MD-1 COMPLEX
2452, 3oauH, 0.5638, 3.35, 0.047, 218, 86, ANTIBODY 2G12 RECOGNIZES DI-MANNOSE EQUIVALENTLY IN DOMAIN- AND NON- DOMAIN-EXCHANGED FORMS BUT ONLY BINDS THE HIV-1 GLYCAN SHIELD IF DOMAIN-EXCHANGED
2453, 3cwgB, 0.5638, 3.90, 0.083, 507, 96, UNPHOSPHORYLATED MOUSE STAT3 CORE FRAGMENT
2454, 6iblC, 0.5637, 3.30, 0.058, 119, 86, ACTIVATED TURKEY BETA1 ADRENOCEPTOR WITH BOUND AGONIST FORMOTEROL AND NANOBODY NB80 
2455, 6ey6M, 0.5637, 3.45, 0.092, 130, 87, C-TERMINAL PART (RESIDUES 315-516) OF PORM WITH THE LLAMA NANOBODY NB130
2456, 6e5gA, 0.5637, 3.40, 0.055, 207, 91, CRYSTAL STRUCTURE OF HUMAN TEAD2-YAP BINDING DOMAIN COVALENTLY BOUND TO AN ALLOSTERIC REGULATOR 
2457, 4tnwG, 0.5637, 3.36, 0.034, 222, 87, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2458, 4tnvF, 0.5637, 3.18, 0.035, 222, 85, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2459, 4p24A, 0.5637, 3.54, 0.032, 292, 93, PORE FORMING TOXIN
2460, 4m4eA, 0.5637, 3.21, 0.070, 159, 86, TRAF DOMAIN OF HUMAN TRAF4
2461, 3p0gB, 0.5637, 3.33, 0.070, 121, 86, STRUCTURE OF A NANOBODY-STABILIZED ACTIVE STATE OF THE BETA2 ADRENOCEPTOR
2462, 3cwgA, 0.5637, 3.93, 0.083, 501, 96, UNPHOSPHORYLATED MOUSE STAT3 CORE FRAGMENT
2463, 1b4lA, 0.5637, 3.41, 0.045, 153, 89, ATMOSPHERE OXYGEN YEAST CU/ZN SUPEROXIDE DISMUTASE ROOM TEMPERATURE (298K) STRUCTURE
2464, 1ap2B, 0.5637, 3.04, 0.059, 120, 85, SINGLE CHAIN FV OF C219
2465, 6gecA, 0.5636, 3.31, 0.044, 207, 90, TEAD4 (216-434) COMPLEXED WITH YAP PEPTIDE (60-100);S94A AND MYRISTOATE (COVALENTLY BOUND) AT 1.70A (P41212 CRYSTAL FORM); MYRISTOYLATION WAS DONE BY ADDING MYR-COA 
2466, 5tokD, 0.5636, 3.32, 0.081, 123, 86, CRYSTAL STRUCTURE OF THE RSV F GLYCOPROTEIN IN COMPLEX WITH THE NEUTRALIZING SINGLE-DOMAIN ANTIBODY F-VHH-L66
2467, 4tnvU, 0.5636, 3.18, 0.035, 221, 85, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2468, 4ldcA, 0.5636, 3.17, 0.106, 149, 85, CRYSTAL STRUCTURE OF DOC2B C2B DOMAIN
2469, 4jznI, 0.5636, 3.35, 0.081, 215, 86, THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC84-1
2470, 4c55B, 0.5636, 2.99, 0.036, 206, 84, CRYSTAL STRUCTURE OF SERUM-DERIVED HUMAN IGG4 FC
2471, 3riaI, 0.5636, 3.18, 0.035, 199, 85, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND IODIDE.
2472, 3rhwI, 0.5636, 3.18, 0.035, 199, 85, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND IVERMECTIN
2473, 3qxwE, 0.5636, 3.27, 0.071, 124, 85, FREE STRUCTURE OF AN ANTI-METHOTREXATE CDR1-4 GRAFT VHH ANTIBODY
2474, 3qwoH, 0.5636, 3.40, 0.068, 220, 88, CRYSTAL STRUCTURE OF A MOTAVIZUMAB EPITOPE-SCAFFOLD BOUND TO MOTAVIZUMAB FAB
2475, 3pnwN, 0.5636, 3.12, 0.071, 226, 85, CRYSTAL STRUCTURE OF THE TUDOR DOMAIN OF HUMAN TDRD3 IN COMPLEX WITH AN ANTI-TDRD3 FAB
2476, 3ijsD, 0.5636, 3.39, 0.092, 221, 87, STRUCTURE OF S67-27 IN COMPLEX WITH TSBP
2477, 2iglB, 0.5636, 3.15, 0.107, 116, 84, CRYSTAL STRUCTURE OF E. COLI YEDX A TRANSTHYRETIN RELATED PROTEIN
2478, 2ap2D, 0.5636, 3.37, 0.057, 122, 87, SINGLE CHAIN FV OF C219 IN COMPLEX WITH SYNTHETIC EPITOPE PEPTIDE
2479, 1q9lB, 0.5636, 3.43, 0.091, 222, 88, S25-2 FAB UNLIGANDED 2
2480, 6i5pA, 0.5635, 2.87, 0.122, 136, 82, CO-CRYSTAL STRUCTURE OF HUMAN SPOP MATH DOMAIN (E47K) AND HUMAN BRD3 FRAGMENT 
2481, 6ey6P, 0.5635, 3.21, 0.071, 130, 85, C-TERMINAL PART (RESIDUES 315-516) OF PORM WITH THE LLAMA NANOBODY NB130
2482, 6dtkC, 0.5635, 3.83, 0.063, 311, 95, HETERODIMERS OF FALS MUTANT SOD ENZYME 
2483, 6cxlH, 0.5635, 3.50, 0.045, 218, 88, ANTI-HIV-1 FAB 2G12 IN COMPLEX WITH GLYCOPEPTIDE 10F5 
2484, 5tarB, 0.5635, 3.89, 0.087, 148, 92, CRYSTAL STRUCTURE OF FARNESYLATED AND METHYLATED KRAS4B IN COMPLEX WITH PDE-DELTA (CRYSTAL FORM II - WITH ORDERED HYPERVARIABLE REGION)
2485, 5myoB, 0.5635, 3.35, 0.057, 221, 88, STRUCTURE OF PYROGLUTAMATE-ABETA-SPECIFIC FAB C 6 IN COMPLEX WITH HUMAN ABETA-PE3-12-PEGB
2486, 5kjrH, 0.5635, 3.23, 0.105, 218, 86, CRYSTAL STRUCTURE OF THE ADCC-POTENT ANTIBODY N60-I3 FAB IN COMPLEX WITH HIV-1 CLADE A/E GP120 W69A/S115W MUTANT AND M48U1.
2487, 5fjxA, 0.5635, 3.49, 0.097, 257, 93, YEAST DELTA-COP-I MU-HOMOLOGY DOMAIN COMPLEXED WITH GCS1 WXXF PEPTIDE
2488, 4tnwI, 0.5635, 3.38, 0.034, 222, 87, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2489, 4gejC, 0.5635, 3.19, 0.095, 136, 84, N-TERMINAL DOMAIN OF VDUP-1
2490, 4b9jA, 0.5635, 3.10, 0.118, 123, 85, STRUCTURE OF SELF-COMPLEMENTED CSSA SUBUNIT OF ENTEROTOXIGENIC ESCHERICHIA COLI COLONIZATION FACTOR CS6
2491, 3s48B, 0.5635, 3.01, 0.090, 141, 89, HUMAN ALPHA-HAEMOGLOBIN COMPLEXED WITH THE FIRST NEAT DOMAIN OF ISDH FROM STAPHYLOCOCCUS AUREUS
2492, 3riaH, 0.5635, 3.18, 0.035, 221, 85, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND IODIDE.
2493, 3rhwH, 0.5635, 3.18, 0.035, 221, 85, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND IVERMECTIN
2494, 3p9wB, 0.5635, 3.37, 0.080, 123, 87, CRYSTAL STRUCTURE OF AN ENGINEERED HUMAN AUTONOMOUS VH DOMAIN IN COMPLEX WITH VEGF
2495, 3b2uF, 0.5635, 3.35, 0.114, 215, 88, CRYSTAL STRUCTURE OF ISOLATED DOMAIN III OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8
2496, 2n80B, 0.5635, 4.25, 0.073, 174, 96, P75NTR DD:RHOGDI
2497, 6osyI, 0.5634, 3.08, 0.092, 122, 87, CRYO-EM STRUCTURE OF VACCINE-ELICITED ANTIBODY 0PV-A.01 IN COMPLEX WITH HIV-1 ENV BG505 DS-SOSIP AND ANTIBODIES VRC03 AND PGT122 
2498, 5w5nA, 0.5634, 2.98, 0.036, 206, 84, CRYSTAL STRUCTURE OF HUMAN IGG4-SIGMA2 FC FRAGMENT
2499, 5fjwD, 0.5634, 3.51, 0.097, 258, 93, YEAST DELTA-COP-I MU-HOMOLOGY DOMAIN COMPLEXED WITH DSL1 WXWX(MSE) PEPTIDE
2500, 4tnvJ, 0.5634, 3.18, 0.035, 223, 85, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2501, 4tnvG, 0.5634, 3.18, 0.035, 224, 85, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2502, 4plnD, 0.5634, 3.41, 0.087, 204, 92, CRYSTAL STRUCTURE OF CHICKEN NETRIN-1 (LN-LE3) COMPLEXED WITH MOUSE NEOGENIN (FN4-5)
2503, 6b3sJ, 0.5633, 3.35, 0.114, 213, 88, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF NECITUMUMAB (FAB11F8) IN COMPLEX WITH DOMAIN III FROM A CETUXIMAB RESISTANT VARIANT OF EGFR (SEGFRD3-S468R)
2504, 5lcvH, 0.5633, 3.60, 0.057, 226, 88, STRUCTURAL BASIS OF ZIKA AND DENGUE VIRUS POTENT ANTIBODY CROSS- NEUTRALIZATION
2505, 5h10B, 0.5633, 3.11, 0.047, 190, 86, TRAF1-TANK COMPLEX
2506, 5bk3C, 0.5633, 3.28, 0.082, 218, 85, CRYSTAL STRUCTURE OF THE NEUTRALIZING ANTI-CIRCUMSPOROZOITE PROTEIN 580 ANTIBODY
2507, 4nqsA, 0.5633, 3.06, 0.024, 210, 84, KNOB-INTO-HOLE IGG FC
2508, 3qwoA, 0.5633, 3.43, 0.080, 220, 88, CRYSTAL STRUCTURE OF A MOTAVIZUMAB EPITOPE-SCAFFOLD BOUND TO MOTAVIZUMAB FAB
2509, 2v9uH, 0.5633, 3.80, 0.063, 132, 95, RIM DOMAIN OF MAIN PORIN FROM MYCOBACTERIA SMEGMATIS
2510, 2gy5A, 0.5633, 3.41, 0.035, 423, 86, TIE2 LIGAND-BINDING DOMAIN CRYSTAL STRUCTURE
2511, 1l9nB, 0.5633, 3.38, 0.105, 673, 86, THREE-DIMENSIONAL STRUCTURE OF THE HUMAN TRANSGLUTAMINASE 3 ENZYME: BINDING OF CALCIUM IONS CHANGE STRUCTURE FOR ACTIVATION
2512, 1f1aA, 0.5633, 3.40, 0.045, 153, 89, CRYSTAL STRUCTURE OF YEAST H48Q CUZNSOD FALS MUTANT ANALOG
2513, 6h7jC, 0.5632, 3.33, 0.070, 119, 86, ACTIVATED TURKEY BETA1 ADRENOCEPTOR WITH BOUND AGONIST ISOPRENALINE AND NANOBODY NB80 
2514, 6ey6L, 0.5632, 3.43, 0.080, 130, 87, C-TERMINAL PART (RESIDUES 315-516) OF PORM WITH THE LLAMA NANOBODY NB130
2515, 5lhqB, 0.5632, 3.39, 0.080, 135, 87, THE EGR-CMK ACTIVE SITE INHIBITED CATALYTIC DOMAIN OF MURINE UROKINASE-TYPE PLASMINOGEN ACTIVATOR IN COMPLEX WITH THE ALLOSTERIC INHIBITORY NANOBODY NB7
2516, 5d1zF, 0.5632, 3.48, 0.045, 223, 89, ISDB NEAT1 BOUND BY CLONE D4-10
2517, 5albH, 0.5632, 3.46, 0.092, 228, 87, TICAGRELOR ANTIDOTE CANDIDATE MEDI2452 IN COMPLEX WITH TICAGRELOR
2518, 4xwoI, 0.5632, 3.56, 0.080, 220, 88, STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF SEC22
2519, 4tnwU, 0.5632, 3.37, 0.034, 221, 87, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2520, 1zlvM, 0.5632, 3.50, 0.045, 217, 88, FAB 2G12 + MAN7
2521, 1nugB, 0.5632, 3.44, 0.103, 679, 87, ROLE OF CALCIUM IONS IN THE ACTIVATION AND ACTIVITY OF THE TRANSGLUTAMINASE 3 ENZYME (2 CALCIUMS 1 MG INACTIVE FORM)
2522, 5fjwF, 0.5631, 3.40, 0.098, 258, 92, YEAST DELTA-COP-I MU-HOMOLOGY DOMAIN COMPLEXED WITH DSL1 WXWX(MSE) PEPTIDE
2523, 3qa3B, 0.5631, 3.44, 0.057, 224, 88, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
2524, 3ld8C, 0.5631, 3.15, 0.023, 210, 86, STRUCTURE OF JMJD6 AND FAB FRAGMENTS
2525, 3l15A, 0.5631, 3.25, 0.067, 189, 89, HUMAN TEAD2 TRANSCRIPTIONAL FACTOR
2526, 2v9uD, 0.5631, 3.80, 0.063, 132, 95, RIM DOMAIN OF MAIN PORIN FROM MYCOBACTERIA SMEGMATIS
2527, 2hwzH, 0.5631, 3.42, 0.080, 227, 88, FAB FRAGMENT OF HUMANIZED ANTI-VIRAL ANTIBODY MEDI-493 (SYNAGIS TM)
2528, 1n6qH, 0.5631, 3.43, 0.057, 225, 88, HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO PRE- TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX N)
2529, 6oyhH, 0.5630, 3.35, 0.081, 126, 86, CRYSTAL STRUCTURE OF MRAY BOUND TO CARBACAPRAZAMYCIN 
2530, 6njnO, 0.5630, 3.46, 0.069, 215, 87, STRUCTURE OF A COMPLEX 
2531, 6nczA, 0.5630, 2.98, 0.071, 588, 85, CRYSTAL STRUCTURE OF HYBRID BETA-GLUCURONIDASE/BETA-GALACTURONIDASE FROM FUSICATENIBACTER SACCHARIVORANS BOUND TO PHENYL-THIO-BETA-D- GLUCURONIDE 
2532, 6gkdJ, 0.5630, 3.09, 0.047, 123, 85, HUMAN NBD1 OF CFTR IN COMPLEX WITH NANOBODIES D12 AND G3A 
2533, 5y9cH, 0.5630, 3.14, 0.047, 210, 86, CRYSTAL STRUCTURE OF HPV58 PENTAMER IN COMPLEX WITH THE FAB FRAGMENT OF ANTIBODY A12A3
2534, 5tz8C, 0.5630, 3.54, 0.125, 558, 88, CRYSTAL STRUCTURE OF S. AUREUS TARS
2535, 5h9yA, 0.5630, 2.69, 0.086, 412, 81, CRYSTAL STRUCTURE OF GH FAMILY 64 LAMINARIPENTAOSE-PRODUCING BETA-13- GLUCANASE FROM PAENIBACILLUS BARENGOLTZII COMPLEXED WITH LAMINARIHEXAOSE.
2536, 5erpB, 0.5630, 3.33, 0.057, 438, 87, CRYSTAL STRUCTURE OF HUMAN DESMOCOLLIN-2 ECTODOMAIN FRAGMENT EC2-5
2537, 5d1zG, 0.5630, 3.28, 0.081, 222, 86, ISDB NEAT1 BOUND BY CLONE D4-10
2538, 4tnvX, 0.5630, 3.18, 0.035, 224, 85, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2539, 4rbpM, 0.5630, 3.51, 0.045, 224, 88, CRYSTAL STRUCTURE OF HIV NEUTRALIZING ANTIBODY 2G12 IN COMPLEX WITH A BACTERIAL OLIGOSACCHARIDE ANALOG OF MAMMALIAN OLIGOMANOSE
2540, 4lriP, 0.5630, 3.46, 0.115, 222, 87, ANTI CMV FAB FRAGMENT
2541, 4k8uB, 0.5630, 3.28, 0.057, 176, 87, CRYSTAL STRUCTURE OF TRAF4 TRAF DOMAIN
2542, 3x2dL, 0.5630, 3.52, 0.067, 226, 89, CRYSTAL STRUCTURE OF MARBURG VIRUS GP IN COMPLEX WITH THE HUMAN SURVIVOR ANTIBODY MR78
2543, 3ijyD, 0.5630, 3.40, 0.092, 220, 87, STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)KDO
2544, 3fo9B, 0.5630, 3.35, 0.081, 218, 86, CRYSTAL STRUCTURE OF ALDOLASE ANTIBODY 33F12 FAB  IN COMPLEX WITH HAPTEN 13-DIKETONE
2545, 2kzbA, 0.5630, 3.32, 0.057, 114, 88, SOLUTION STRUCTURE OF ALPHA-MANNOSIDASE BINDING DOMAIN OF ATG19
2546, 1m7iB, 0.5630, 3.29, 0.070, 220, 86, CRYSTAL STRUCTURE OF A MONOCLONAL FAB SPECIFIC FOR SHIGELLA FLEXNERI Y LIPOPOLYSACCHARIDE COMPLEXED WITH A PENTASACCHARIDE
2547, 6nczD, 0.5629, 2.98, 0.071, 589, 85, CRYSTAL STRUCTURE OF HYBRID BETA-GLUCURONIDASE/BETA-GALACTURONIDASE FROM FUSICATENIBACTER SACCHARIVORANS BOUND TO PHENYL-THIO-BETA-D- GLUCURONIDE 
2548, 6my4A, 0.5629, 3.43, 0.115, 223, 87, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98M;HC- G99M;LC-S30BR] 
2549, 6b3sH, 0.5629, 3.35, 0.114, 213, 88, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF NECITUMUMAB (FAB11F8) IN COMPLEX WITH DOMAIN III FROM A CETUXIMAB RESISTANT VARIANT OF EGFR (SEGFRD3-S468R)
2550, 4qwwD, 0.5629, 3.39, 0.069, 225, 87, CRYSTAL STRUCTURE OF THE FAB410-BFACHE COMPLEX
2551, 3ri5J, 0.5629, 3.17, 0.035, 215, 85, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND PICROTOXIN
2552, 3ri5H, 0.5629, 3.18, 0.035, 221, 85, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND PICROTOXIN
2553, 3oayH, 0.5629, 3.47, 0.045, 217, 88, A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY
2554, 3ivkH, 0.5629, 3.34, 0.091, 224, 88, CRYSTAL STRUCTURE OF THE CATALYTIC CORE OF AN RNA POLYMERASE RIBOZYME COMPLEXED WITH AN ANTIGEN BINDING ANTIBODY FRAGMENT
2555, 3bikA, 0.5629, 2.67, 0.062, 212, 81, CRYSTAL STRUCTURE OF THE PD-1/PD-L1 COMPLEX
2556, 1uc6A, 0.5629, 3.09, 0.103, 109, 87, SOLUTION STRUCTURE OF THE CARBOXYL TERMINAL DOMAIN OF THE CILIARY NEUROTROPHIC FACTOR RECEPTOR
2557, 1ot4A, 0.5629, 2.99, 0.059, 102, 85, SOLUTION STRUCTURE OF CU(II)-COPC FROM PSEUDOMONAS SYRINGAE
2558, 1mamH, 0.5629, 3.59, 0.092, 217, 87, CRYSTAL STRUCTURE TO 2.45 A RESOLUTION OF A MONOCLONAL FAB SPECIFIC FOR THE BRUCELLA A CELL WALL POLYSACCHARIDE ANTIGEN
2559, 1acyH, 0.5629, 3.14, 0.047, 221, 86, CRYSTAL STRUCTURE OF THE PRINCIPAL NEUTRALIZING SITE OF HIV- 2 1
2560, 6mxrA, 0.5628, 3.50, 0.102, 220, 88, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98M;HC- G99M] 
2561, 6gekB, 0.5628, 3.33, 0.044, 209, 90, TEAD4 (216-434);Y429F COMPLEXED WITH YAP PEPTIDE (60-100) AND MYRISTOATE (COVALENTLY BOUND) AT 2.28A (P212121 CRYSTAL FORM); MYRISTOYLATION WAS DONE BY ADDING MYR-COA 
2562, 6btzC, 0.5628, 3.04, 0.071, 126, 85, CRYSTAL STRUCTURE OF THE PI3KC2ALPHA C2 DOMAIN IN SPACE GROUP C121 
2563, 5w0pD, 0.5628, 4.02, 0.120, 773, 100, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN DETERMINED BY X-RAY FREE ELECTRON LASER
2564, 4tnvW, 0.5628, 3.18, 0.035, 224, 85, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2565, 4nbyC, 0.5628, 3.33, 0.094, 123, 85, CRYSTAL STRUCTURE OF TCDA-A2 BOUND TO TWO MOLECULES OF A20.1 VHH
2566, 3rifI, 0.5628, 3.18, 0.035, 192, 85, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND GLUTAMATE.
2567, 3rg1O, 0.5628, 3.99, 0.071, 138, 99, CRYSTAL STRUCTURE OF THE RP105/MD-1 COMPLEX
2568, 3ivkA, 0.5628, 3.34, 0.091, 224, 88, CRYSTAL STRUCTURE OF THE CATALYTIC CORE OF AN RNA POLYMERASE RIBOZYME COMPLEXED WITH AN ANTIGEN BINDING ANTIBODY FRAGMENT
2569, 3ikcD, 0.5628, 3.40, 0.092, 221, 87, STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)-7-O-METHYL-KDO
2570, 2wanA, 0.5628, 2.88, 0.148, 809, 81, PULLULANASE FROM BACILLUS ACIDOPULLULYTICUS
2571, 2mejB, 0.5628, 3.40, 0.087, 195, 92, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN BCL-XL AND THE P53 CORE DOMAIN DETERMINED WITH PRE RESTRAINTS
2572, 1d5iH, 0.5628, 3.29, 0.034, 221, 87, UNLIGANDED GERMLINE PRECURSOR OF AN OXY-COPE CATALYTIC ANTIBODY
2573, 1boyA, 0.5628, 3.21, 0.146, 211, 89, EXTRACELLULAR REGION OF HUMAN TISSUE FACTOR
2574, 6nczF, 0.5627, 2.98, 0.071, 589, 85, CRYSTAL STRUCTURE OF HYBRID BETA-GLUCURONIDASE/BETA-GALACTURONIDASE FROM FUSICATENIBACTER SACCHARIVORANS BOUND TO PHENYL-THIO-BETA-D- GLUCURONIDE 
2575, 6i7aG, 0.5627, 3.06, 0.119, 137, 84, CO-CRYSTAL STRUCTURE OF HUMAN SPOP MATH DOMAIN (D140N) AND HUMAN BRD3 FRAGMENT 
2576, 6fp6J, 0.5627, 3.65, 0.063, 232, 95, COMPLEX OF HUMAN CU;ZN SOD1 WITH THE HUMAN COPPER CHAPERONE FOR SOD1 IN A COMPACT CONFORMATION 
2577, 6fjdA, 0.5627, 3.49, 0.140, 129, 86, HUMAN KIBRA C2 DOMAIN MUTANT C771A IN COMPLEX WITH PHOSPHATIDYLINOSITOL 4;5-BISPHOSPHATE 
2578, 6entA, 0.5627, 3.82, 0.071, 176, 98, STRUCTURE OF THE RAT RKIP VARIANT DELTA143-146
2579, 6btzA, 0.5627, 3.17, 0.070, 125, 86, CRYSTAL STRUCTURE OF THE PI3KC2ALPHA C2 DOMAIN IN SPACE GROUP C121 
2580, 5tokF, 0.5627, 3.35, 0.081, 123, 86, CRYSTAL STRUCTURE OF THE RSV F GLYCOPROTEIN IN COMPLEX WITH THE NEUTRALIZING SINGLE-DOMAIN ANTIBODY F-VHH-L66
2581, 5mhmA, 0.5627, 3.53, 0.106, 684, 85, FXIIIA IN COMPLEX WITH THE INHIBITOR ZED1630
2582, 5b6fH, 0.5627, 3.21, 0.106, 210, 85, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF AN ANTI-LEUKOTRIENE C4 MONOCLONAL ANTIBODY COMPLEXED WITH LTC4
2583, 4zxbA, 0.5627, 3.44, 0.068, 214, 88, STRUCTURE OF THE HUMAN INSULIN RECEPTOR ECTODOMAIN IRDELTABETA CONSTRUCT IN COMPLEX WITH FOUR FAB MOLECULES
2584, 4ydjA, 0.5627, 3.51, 0.045, 238, 89, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY 44- VRC13.01 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057 GP120
2585, 4tnwV, 0.5627, 3.20, 0.035, 224, 85, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2586, 4plnC, 0.5627, 3.44, 0.087, 205, 92, CRYSTAL STRUCTURE OF CHICKEN NETRIN-1 (LN-LE3) COMPLEXED WITH MOUSE NEOGENIN (FN4-5)
2587, 4jlrA, 0.5627, 3.44, 0.080, 215, 88, CRYSTAL STRUCTURE OF A DESIGNED RESPIRATORY SYNCYTIAL VIRUS IMMUNOGEN IN COMPLEX WITH MOTAVIZUMAB
2588, 3qazN, 0.5627, 2.95, 0.047, 195, 85, IL-2 MUTANT D10 TERNARY COMPLEX
2589, 2dwyA, 0.5627, 3.80, 0.113, 129, 97, CRYSTAL STRUCTURE ANALYSIS OF GGA1-GAE
2590, 2berA, 0.5627, 3.81, 0.109, 601, 92, Y370G ACTIVE SITE MUTANT OF THE SIALIDASE FROM MICROMONOSPORA VIRIDIFACIENS IN COMPLEX WITH BETA-NEU5AC (SIALIC ACID).
2591, 6mxsA, 0.5626, 3.44, 0.115, 218, 87, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98F;HC- G99M] 
2592, 6mubM, 0.5626, 3.51, 0.045, 219, 88, ANTI-HIV-1 FAB 2G12 + MAN5 RE-REFINEMENT 
2593, 6btzB, 0.5626, 3.03, 0.071, 125, 85, CRYSTAL STRUCTURE OF THE PI3KC2ALPHA C2 DOMAIN IN SPACE GROUP C121 
2594, 5vxjH, 0.5626, 3.32, 0.103, 119, 87, 2.50 A RESOLUTION STRUCTURE OF IPAD FROM SHIGELLA FLEXNERI IN COMPLEX WITH SINGLE-DOMAIN ANTIBODY JMK-E3
2595, 5uknH, 0.5626, 3.33, 0.105, 227, 86, STRUCTURE OF UNLIGANDED ANTI-GP120 CD4BS ANTIBODY DH522UCA FAB
2596, 5d1zD, 0.5626, 3.56, 0.045, 230, 89, ISDB NEAT1 BOUND BY CLONE D4-10
2597, 3fo9H, 0.5626, 3.38, 0.081, 218, 86, CRYSTAL STRUCTURE OF ALDOLASE ANTIBODY 33F12 FAB  IN COMPLEX WITH HAPTEN 13-DIKETONE
2598, 3dwtG, 0.5626, 3.54, 0.081, 125, 86, STRUCTURE OF CABBCII-10 NANOBODY
2599, 3auvA, 0.5626, 3.41, 0.102, 225, 88, PREDICTING AMINO ACID PREFERENCES IN THE COMPLEMENTARITY DETERMINING REGIONS OF AN ANTIBODY-ANTIGEN RECOGNITION INTERFACE
2600, 3amkA, 0.5626, 3.34, 0.024, 675, 83, STRUCTURE OF THE STARCH BRANCHING ENZYME I (BEI) FROM ORYZA SATIVA L
2601, 2v9uE, 0.5626, 3.82, 0.063, 132, 95, RIM DOMAIN OF MAIN PORIN FROM MYCOBACTERIA SMEGMATIS
2602, 2v9uB, 0.5626, 3.83, 0.063, 132, 95, RIM DOMAIN OF MAIN PORIN FROM MYCOBACTERIA SMEGMATIS
2603, 2bzdB, 0.5626, 3.89, 0.108, 601, 93, GALACTOSE RECOGNITION BY THE CARBOHYDRATE-BINDING MODULE OF A BACTERIAL SIALIDASE.
2604, 1f8tH, 0.5626, 3.13, 0.058, 220, 86, FAB (LNKB-2) OF MONOCLONAL ANTIBODY CRYSTAL STRUCTURE
2605, 5ud9H, 0.5625, 3.43, 0.057, 227, 88, CRYSTAL STRUCTURE OF 354BG18 FAB
2606, 5bv7H, 0.5625, 3.47, 0.115, 222, 87, CRYSTAL STRUCTURE OF HUMAN LCAT (L4F N5D) IN COMPLEX WITH FAB OF AN AGONISTIC ANTIBODY
2607, 5bk3E, 0.5625, 3.41, 0.070, 218, 86, CRYSTAL STRUCTURE OF THE NEUTRALIZING ANTI-CIRCUMSPOROZOITE PROTEIN 580 ANTIBODY
2608, 4xamB, 0.5625, 3.64, 0.074, 651, 95, COMPLEMENT COMPONENT C4B
2609, 4tnwY, 0.5625, 3.39, 0.034, 221, 87, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2610, 4p24C, 0.5625, 3.55, 0.032, 291, 93, PORE FORMING TOXIN
2611, 4fqxC, 0.5625, 2.90, 0.107, 186, 84, CRYSTAL STRUCTURE OF HLA-DM BOUND TO HLA-DR1
2612, 3vu2A, 0.5625, 3.22, 0.024, 692, 82, STRUCTURE OF THE STARCH BRANCHING ENZYME I (BEI) COMPLEXED WITH MALTOPENTAOSE FROM ORYZA SATIVA L
2613, 2y7qB, 0.5625, 3.05, 0.034, 287, 88, THE HIGH-AFFINITY COMPLEX BETWEEN IGE AND ITS RECEPTOR FC EPSILON RI
2614, 2visB, 0.5625, 3.40, 0.057, 221, 88, INFLUENZA VIRUS HEMAGGLUTININ (ESCAPE) MUTANT WITH THR 131 REPLACED BY ILE COMPLEXED WITH A NEUTRALIZING ANTIBODY
2615, 2virB, 0.5625, 3.19, 0.047, 221, 86, INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY
2616, 1h3uB, 0.5625, 2.97, 0.024, 206, 83, CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENTGLYCOFORM (M3N2F)2
2617, 6btzD, 0.5624, 3.17, 0.070, 126, 86, CRYSTAL STRUCTURE OF THE PI3KC2ALPHA C2 DOMAIN IN SPACE GROUP C121 
2618, 5vplD, 0.5624, 3.18, 0.105, 216, 86, CRYSTAL STRUCTURE OF DER F 1 COMPLEXED WITH FAB 4C1
2619, 5lgkC, 0.5624, 3.06, 0.058, 306, 86, CRYSTAL STRUCTURE OF THE HUMAN IGE-FC BOUND TO ITS B CELL RECEPTOR DERCD23
2620, 5ifjD, 0.5624, 3.40, 0.080, 217, 87, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E01 FAB FRAGMENT IN COMPLEX OF PEPTIDE PLQPEQPFP
2621, 4ydjH, 0.5624, 3.63, 0.044, 238, 90, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY 44- VRC13.01 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057 GP120
2622, 4rrpP, 0.5624, 3.41, 0.070, 156, 86, CRYSTAL STRUCTURE OF THE FAB COMPLEXED WITH ANTIGEN ASF1P NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET PDR16
2623, 4qwwF, 0.5624, 3.39, 0.069, 219, 87, CRYSTAL STRUCTURE OF THE FAB410-BFACHE COMPLEX
2624, 3vg0H, 0.5624, 3.22, 0.081, 219, 86, ANTIBODY FAB FRAGMENT
2625, 3qycB, 0.5624, 3.19, 0.058, 123, 86, STRUCTURE OF A DIMERIC ANTI-HER2 SINGLE DOMAIN ANTIBODY
2626, 2vitB, 0.5624, 3.19, 0.047, 221, 86, INFLUENZA VIRUS HEMAGGLUTININ MUTANT WITH THR 155 REPLACED BY ILE COMPLEXED WITH A NEUTRALIZING ANTIBODY
2627, 6oz6G, 0.5623, 3.35, 0.081, 126, 86, CRYSTAL STRUCTURE OF MRAY BOUND TO 3 -HYDROXYMUREIDOMYCIN A 
2628, 6nczC, 0.5623, 2.99, 0.071, 589, 85, CRYSTAL STRUCTURE OF HYBRID BETA-GLUCURONIDASE/BETA-GALACTURONIDASE FROM FUSICATENIBACTER SACCHARIVORANS BOUND TO PHENYL-THIO-BETA-D- GLUCURONIDE 
2629, 6gkdG, 0.5623, 3.15, 0.035, 122, 85, HUMAN NBD1 OF CFTR IN COMPLEX WITH NANOBODIES D12 AND G3A 
2630, 6dezB, 0.5623, 3.24, 0.094, 210, 85, ANTI-PHOSPHOTYROSINE ANTIBODY PY20-4D5 FAB COMPLEXED WITH SULFATE 
2631, 6b3sF, 0.5623, 3.37, 0.114, 214, 88, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF NECITUMUMAB (FAB11F8) IN COMPLEX WITH DOMAIN III FROM A CETUXIMAB RESISTANT VARIANT OF EGFR (SEGFRD3-S468R)
2632, 6a9yA, 0.5623, 3.52, 0.108, 284, 93, THE CRYSTAL STRUCTURE OF MU HOMOLOGY DOMAIN OF SGIP1 
2633, 5kenQ, 0.5623, 3.38, 0.046, 121, 87, EBOV GP IN COMPLEX WITH VARIABLE FAB DOMAINS OF IGGS C4G7 AND C13C6
2634, 5c6wJ, 0.5623, 3.44, 0.057, 238, 88, ANTI-CXCL13 SCFV - E10
2635, 5bk3A, 0.5623, 3.24, 0.082, 219, 85, CRYSTAL STRUCTURE OF THE NEUTRALIZING ANTI-CIRCUMSPOROZOITE PROTEIN 580 ANTIBODY
2636, 4janA, 0.5623, 3.30, 0.046, 218, 87, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH103 IN COMPLEX WITH HIV-1 GP120
2637, 3rg1K, 0.5623, 3.94, 0.071, 136, 98, CRYSTAL STRUCTURE OF THE RP105/MD-1 COMPLEX
2638, 1sdyD, 0.5623, 3.49, 0.045, 153, 89, STRUCTURE SOLUTION AND MOLECULAR DYNAMICS REFINEMENT OF THE YEAST CUZN ENZYME SUPEROXIDE DISMUTASE
2639, 1n5yH, 0.5623, 3.43, 0.057, 225, 88, HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO POST- TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX P)
2640, 1lilA, 0.5623, 3.12, 0.094, 212, 85, BENCE JONES PROTEIN CLE A LAMBDA III IMMUNOGLOBULIN LIGHT- CHAIN DIMER
2641, 1jk9B, 0.5623, 4.14, 0.052, 243, 96, HETERODIMER BETWEEN H48F-YSOD1 AND YCCS
2642, 1f58H, 0.5623, 3.41, 0.057, 228, 88, IGG1 FAB FRAGMENT (58.2) COMPLEX WITH 24-RESIDUE PEPTIDE (RESIDUES 308-333 OF HIV-1 GP120 (MN ISOLATE) WITH ALA TO AIB SUBSTITUTION AT POSITION 323
2643, 6h0eA, 0.5622, 3.46, 0.080, 215, 87, FAB DMCBTAU-22.1 IN COMPLEX WITH TAU PEPTIDE V1088-23 
2644, 5drxH, 0.5622, 3.06, 0.058, 220, 86, CRYSTAL STRUCTURE OF THE BCR FAB FRAGMENT FROM SUBSET  4 CASE CLL240
2645, 5dqeA, 0.5622, 3.24, 0.056, 193, 89, CRYSTAL STRUCTURE OF HUMAN TRANSCRIPTION FACTOR TEAD2 IN COMPLEX WITH BROMO-FENAMIC ACID
2646, 4eigB, 0.5622, 3.32, 0.080, 117, 87, CA1698 CAMEL ANTIBODY FRAGMENT IN COMPLEX WITH DHFR
2647, 2q3zA, 0.5622, 3.30, 0.108, 655, 83, TRANSGLUTAMINASE 2 UNDERGOES LARGE CONFORMATIONAL CHANGE UPON ACTIVATION
2648, 1moeA, 0.5622, 3.49, 0.056, 240, 89, THE THREE-DIMENSIONAL STRUCTURE OF AN ENGINEERED SCFV T84.66 DIMER OR DIABODY IN VL TO VH LINKAGE.
2649, 6nczB, 0.5621, 2.99, 0.071, 588, 85, CRYSTAL STRUCTURE OF HYBRID BETA-GLUCURONIDASE/BETA-GALACTURONIDASE FROM FUSICATENIBACTER SACCHARIVORANS BOUND TO PHENYL-THIO-BETA-D- GLUCURONIDE 
2650, 5w6cH, 0.5621, 3.54, 0.102, 225, 88, UCA FAB (UNBOUND) FROM 6649 LINEAGE
2651, 5t4zA, 0.5621, 3.53, 0.080, 218, 88, STRUCTURE OF THE ANTI-HIV ANTIBODY DH501 THAT BINDS GP120 V3 GLYCAN AND THE BASE OF V3 WITH FREE MAN9 GLYCAN
2652, 5fhxH, 0.5621, 3.72, 0.078, 340, 90, CRYSTAL STRUCTURE OF CODV IN COMPLEX WITH IL4 AT 2.55 ANG. RESOLUTION.
2653, 4zncD, 0.5621, 3.05, 0.024, 207, 84, FC FRAGMENT OF HUMAN IGG IN COMPLEX WITH THE C DOMAIN OF STAPHYLOCOCCAL PROTEIN A MUTANT - Q9W
2654, 4zjgA, 0.5621, 3.12, 0.034, 301, 87, CRYSTAL STRUCTURE OF NATIVE ALPHA-2-MACROGLOBULIN FROM ESCHERICHIA COLI SPANNING DOMAINS MG0-NIE-MG1.
2655, 4g6mH, 0.5621, 3.48, 0.103, 220, 87, CRYSTAL STRUCTURE OF HUMAN IL-1BETA IN COMPLEX WITH THERAPEUTIC ANTIBODY BINDING FRAGMENT OF GEVOKIZUMAB
2656, 3hqhA, 0.5621, 2.83, 0.134, 134, 82, STRUCTURES OF SPOP-SUBSTRATE COMPLEXES: INSIGHTS INTO MOLECULAR ARCHITECTURES OF BTB-CUL3 UBIQUITIN LIGASES: SPOPMATHX- MACROH2ASBCPEP1
2657, 3b2uJ, 0.5621, 3.17, 0.116, 217, 86, CRYSTAL STRUCTURE OF ISOLATED DOMAIN III OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8
2658, 2gy7B, 0.5621, 3.48, 0.047, 423, 86, ANGIOPOIETIN-2/TIE2 COMPLEX CRYSTAL STRUCTURE
2659, 1zlsH, 0.5621, 3.53, 0.045, 213, 88, FAB 2G12 + MAN4
2660, 1sdyC, 0.5621, 3.44, 0.045, 153, 89, STRUCTURE SOLUTION AND MOLECULAR DYNAMICS REFINEMENT OF THE YEAST CUZN ENZYME SUPEROXIDE DISMUTASE
2661, 1sdyA, 0.5621, 3.49, 0.045, 153, 89, STRUCTURE SOLUTION AND MOLECULAR DYNAMICS REFINEMENT OF THE YEAST CUZN ENZYME SUPEROXIDE DISMUTASE
2662, 6njlK, 0.5620, 3.41, 0.069, 215, 87, STRUCTURE OF A COMPLEX 
2663, 6h06A, 0.5620, 3.46, 0.080, 218, 87, FAB CBTAU-22.1 IN COMPLEX WITH TAU PEPTIDE V1088-5 
2664, 6b14H, 0.5620, 3.46, 0.091, 225, 88, CRYSTAL STRUCTURE OF SPINACH RNA APTAMER IN COMPLEX WITH FAB BL3-6S97N
2665, 4z18B, 0.5620, 2.55, 0.063, 210, 79, CRYSTAL STRUCTURE OF HUMAN PD-L1
2666, 4p99B, 0.5620, 3.04, 0.133, 415, 83, CA2+-STABILIZED ADHESIN HELPS AN ANTARCTIC BACTERIUM REACH OUT AND BIND ICE
2667, 4f8qA, 0.5620, 3.23, 0.057, 208, 87, CRYSTAL STRUCTURE OF THE HUMAN BTN3A2 ECTODOMAIN
2668, 3mnmA, 0.5620, 3.38, 0.087, 109, 92, CRYSTAL STRUCTURE OF GAE DOMAIN OF GGA2P FROM SACCHAROMYCES CEREVISIAE
2669, 1q9lD, 0.5620, 3.43, 0.080, 222, 88, S25-2 FAB UNLIGANDED 2
2670, 1om3H, 0.5620, 3.70, 0.045, 224, 88, FAB 2G12 UNLIGANDED
2671, 5jw5A, 0.5619, 3.05, 0.048, 223, 84, STRUCTURE OF MEDI8852 FAB FRAGMENT
2672, 5eszH, 0.5619, 3.51, 0.069, 229, 87, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH04 ISOLATED FROM DONOR CH0219 IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE AE STRAIN A244
2673, 4zncE, 0.5619, 3.07, 0.036, 207, 84, FC FRAGMENT OF HUMAN IGG IN COMPLEX WITH THE C DOMAIN OF STAPHYLOCOCCAL PROTEIN A MUTANT - Q9W
2674, 4i18C, 0.5619, 2.64, 0.049, 188, 81, CRYSTAL STRUCTURE OF HUMAN PROLACTIN RECEPTOR COMPLEXED WITH FAB FRAGMENT
2675, 3auvB, 0.5619, 3.28, 0.092, 225, 87, PREDICTING AMINO ACID PREFERENCES IN THE COMPLEMENTARITY DETERMINING REGIONS OF AN ANTIBODY-ANTIGEN RECOGNITION INTERFACE
2676, 1yedH, 0.5619, 3.24, 0.081, 226, 86, STRUCTURE OF A CATALYTIC ANTIBODY IGG2A FAB FRAGMENT (D2.4)
2677, 1op3H, 0.5619, 3.65, 0.045, 224, 88, CRYSTAL STRUCTURE OF FAB 2G12 BOUND TO MAN1->2MAN
2678, 1j5oH, 0.5619, 3.23, 0.035, 220, 86, CRYSTAL STRUCTURE OF MET184ILE MUTANT OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DOUBLE STRANDED DNA TEMPLATE- PRIMER
2679, 6qgxB, 0.5618, 3.67, 0.080, 126, 88, CRYSTAL STRUCTURE OF E.COLI BAMA BETA-BARREL IN COMPLEX WITH NANOBODY F7 
2680, 6cxgH, 0.5618, 3.50, 0.045, 219, 88, ANTI-HIV-1 FAB 2G12 IN COMPLEX WITH GLYCOPEPTIDE 10V1S 
2681, 5myoD, 0.5618, 3.39, 0.045, 219, 88, STRUCTURE OF PYROGLUTAMATE-ABETA-SPECIFIC FAB C 6 IN COMPLEX WITH HUMAN ABETA-PE3-12-PEGB
2682, 5j72A, 0.5618, 3.13, 0.093, 638, 86, CWP6 FROM CLOSTRIDIUM DIFFICILE
2683, 4tnvH, 0.5618, 3.38, 0.034, 223, 87, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2684, 4i77H, 0.5618, 3.45, 0.102, 219, 88, LEBRIKIZUMAB FAB BOUND TO IL-13
2685, 3rifJ, 0.5618, 3.47, 0.045, 200, 88, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND GLUTAMATE.
2686, 3rifG, 0.5618, 3.47, 0.045, 214, 88, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND GLUTAMATE.
2687, 3qb7D, 0.5618, 3.42, 0.067, 183, 89, INTERLEUKIN-4 MUTANT RGA BOUND TO CYTOKINE RECEPTOR COMMON GAMMA
2688, 3pnwT, 0.5618, 3.31, 0.081, 225, 86, CRYSTAL STRUCTURE OF THE TUDOR DOMAIN OF HUMAN TDRD3 IN COMPLEX WITH AN ANTI-TDRD3 FAB
2689, 3pnwB, 0.5618, 3.32, 0.081, 225, 86, CRYSTAL STRUCTURE OF THE TUDOR DOMAIN OF HUMAN TDRD3 IN COMPLEX WITH AN ANTI-TDRD3 FAB
2690, 3o45A, 0.5618, 3.42, 0.103, 220, 87, CRYSTAL STRUCTURE OF 101F FAB BOUND TO 17-MER PEPTIDE EPITOPE
2691, 3l5wH, 0.5618, 3.17, 0.071, 223, 85, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND C836 FAB
2692, 1ttgA, 0.5618, 2.53, 0.127, 94, 79, THE THREE-DIMENSIONAL STRUCTURE OF THE TENTH TYPE III MODULE OF FIBRONECTIN: AN INSIGHT INTO RGD-MEDIATED INTERACTIONS
2693, 1etzH, 0.5618, 3.12, 0.047, 228, 85, THE THREE-DIMENSIONAL STRUCTURE OF AN ANTI-SWEETENER FAB NC10.14 SHOWS THE EXTENT OF STRUCTURAL DIVERSITY IN ANTIGEN RECOGNITION BY IMMUNOGLOBULINS
2694, 6onbC, 0.5617, 3.28, 0.102, 114, 88, CRYSTAL STRUCTURE OF THE ZIG-8-RIG-5 IG1-IG1 HETERODIMER; MONOCLINIC FORM 
2695, 6mtrH, 0.5617, 3.17, 0.071, 221, 85, CRYSTAL STRUCTURE OF VRC43.01 FAB 
2696, 6msyH, 0.5617, 3.54, 0.045, 213, 88, ANTI-HIV-1 FAB FAB 2G12 + MAN4 RE-REFINEMENT 
2697, 6geeA, 0.5617, 3.31, 0.067, 207, 90, TEAD4 (216-434);E263A COMPLEXED WITH YAP PEPTIDE (60-100); S94A AND MYRISTOATE (COVALENTLY BOUND) AT 1.96A (P41212 CRYSTAL FORM); MYRISTOYLATION WAS DONE BY ADDING MYR-COA 
2698, 6bz4B, 0.5617, 3.10, 0.036, 206, 84, HUMAN IGG1 LACKING COMPLEMENT-DEPENDENT CYTOTOXICITY: HU3S193 FC MUTANT K322A 
2699, 4gh7B, 0.5617, 3.22, 0.093, 275, 86, CRYSTAL STRUCTURE OF ANTICALIN N7A IN COMPLEX WITH ONCOFETAL FIBRONECTIN FRAGMENT FN7B8
2700, 1op5M, 0.5617, 3.53, 0.045, 225, 88, CRYSTAL STRUCTURE OF FAB 2G12 BOUND TO MAN9GLCNAC2
2701, 6e5pR, 0.5616, 3.53, 0.045, 225, 88, BACKBONE MODEL BASED ON CRYO-EM MAP AT 8.5 A OF DOMAIN-SWAPPED; GLYCAN-REACTIVE; NEUTRALIZING ANTIBODY 2G12 BOUND TO HIV-1 ENV BG505 DS-SOSIP; WHICH WAS ALSO BOUND TO CD4-BINDING SITE ANTIBODY VRC03 
2702, 6e5pM, 0.5616, 3.53, 0.045, 225, 88, BACKBONE MODEL BASED ON CRYO-EM MAP AT 8.5 A OF DOMAIN-SWAPPED; GLYCAN-REACTIVE; NEUTRALIZING ANTIBODY 2G12 BOUND TO HIV-1 ENV BG505 DS-SOSIP; WHICH WAS ALSO BOUND TO CD4-BINDING SITE ANTIBODY VRC03 
2703, 6e5p2, 0.5616, 3.53, 0.045, 225, 88, BACKBONE MODEL BASED ON CRYO-EM MAP AT 8.5 A OF DOMAIN-SWAPPED; GLYCAN-REACTIVE; NEUTRALIZING ANTIBODY 2G12 BOUND TO HIV-1 ENV BG505 DS-SOSIP; WHICH WAS ALSO BOUND TO CD4-BINDING SITE ANTIBODY VRC03 
2704, 5jw4W, 0.5616, 3.07, 0.060, 223, 84, STRUCTURE OF MEDI8852 FAB FRAGMENT IN COMPLEX WITH H5 HA
2705, 5b71D, 0.5616, 3.39, 0.069, 219, 87, CRYSTAL STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH SKY59
2706, 5a7xN, 0.5616, 3.30, 0.105, 224, 86, NEGATIVE STAIN EM OF BG505 SOSIP.664 IN COMPLEX WITH SCD4 17B AND 8ANC195
2707, 4zypJ, 0.5616, 3.44, 0.068, 213, 88, CRYSTAL STRUCTURE OF MOTAVIZUMAB AND QUATERNARY-SPECIFIC RSV- NEUTRALIZING HUMAN ANTIBODY AM14 IN COMPLEX WITH PREFUSION RSV F GLYCOPROTEIN
2708, 4ocyH, 0.5616, 3.22, 0.057, 210, 87, FAB FOR METHOTREXATE (UNBOUND APO)
2709, 3rp1C, 0.5616, 2.67, 0.062, 98, 81, CRYSTAL STRUCTURE OF HUMAN LAIR-1 IN C2 SPACE GROUP
2710, 3riaJ, 0.5616, 3.47, 0.045, 215, 88, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND IODIDE.
2711, 3rhwJ, 0.5616, 3.47, 0.045, 215, 88, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND IVERMECTIN
2712, 3ft1A, 0.5616, 2.94, 0.074, 100, 81, CRYSTAL STRUCTURE OF POLLEN ALLERGEN PHL P 3
2713, 3eakB, 0.5616, 3.35, 0.082, 127, 85, NBBCII10 HUMANIZED (FGLA MUTANT)
2714, 3b9kH, 0.5616, 2.88, 0.071, 214, 84, CRYSTAL STRUCTURE OF CD8ALPHA-BETA IN COMPLEX WITH YTS 156.7 FAB
2715, 2y7lA, 0.5616, 3.85, 0.074, 312, 94, STRUCTURE OF N-TERMINAL DOMAIN OF CANDIDA ALBICANS ALS9-2 IN COMPLEX WITH HUMAN FIBRINOGEN GAMMA PEPTIDE
2716, 2v9uA, 0.5616, 3.82, 0.063, 132, 95, RIM DOMAIN OF MAIN PORIN FROM MYCOBACTERIA SMEGMATIS
2717, 1yedB, 0.5616, 3.24, 0.081, 226, 86, STRUCTURE OF A CATALYTIC ANTIBODY IGG2A FAB FRAGMENT (D2.4)
2718, 1sdyB, 0.5616, 3.45, 0.045, 153, 89, STRUCTURE SOLUTION AND MOLECULAR DYNAMICS REFINEMENT OF THE YEAST CUZN ENZYME SUPEROXIDE DISMUTASE
2719, 1kelH, 0.5616, 3.19, 0.082, 218, 85, CATALYTIC ANTIBODY 28B4 FAB FRAGMENT COMPLEXED WITH HAPTEN (1-[N-4 -NITROBENZYL-N-4 -CARBOXYBUTYLAMINO] METHYLPHOSPHONIC ACID)
2720, 6j71B, 0.5615, 3.58, 0.044, 233, 90, HUA21-SCFV IN COMPLEX WITH THE EXTRACELLULAR DOMAIN(ECD) OF HER2 
2721, 2e59A, 0.5615, 4.01, 0.060, 144, 100, CRYSTAL STRUCTURE OF HUMAN MD-2 IN COMPLEX WITH LIPID IVA
2722, 6r2sB, 0.5614, 3.36, 0.081, 218, 86, THE STRUCTURE OF PLASMODIUM VIVAX DUFFY BINDING PROTEIN (PVDBP) BOUND TO HUMAN ANTIBODY DB9 
2723, 6ncyB, 0.5614, 3.01, 0.071, 585, 85, CRYSTAL STRUCTURE OF HYBRID BETA-GLUCURONIDASE/BETA-GALACTURONIDASE FROM FUSICATENIBACTER SACCHARIVORANS 
2724, 6ncxD, 0.5614, 3.77, 0.067, 555, 89, CRYSTAL STRUCTURE OF GH2 BETA-GALACTURONIDASE FROM EISENBERGIELLA TAYI BOUND TO GALACTURONATE 
2725, 6mqmG, 0.5614, 3.52, 0.069, 222, 87, VACCINE-ELICITED NHP FP-TARGETING NEUTRALIZING ANTIBODY DF1W-A.01 IN COMPLEX WITH HIV FUSION PEPTIDE (RESIDUE 512-519) 
2726, 6bi2H, 0.5614, 3.47, 0.103, 222, 87, TRASTUZUMAB FAB D185A (LIGHT CHAIN) MUTANT BIOTIN CONJUGATION.
2727, 5uslH, 0.5614, 3.16, 0.105, 213, 86, STRUCTURE OF VACCINIA VIRUS D8 PROTEIN BOUND TO HUMAN FAB VV304
2728, 5lwfC, 0.5614, 3.40, 0.106, 122, 85, STRUCTURE OF A SINGLE DOMAIN CAMELID ANTIBODY FRAGMENT CAB-G10S IN COMPLEX WITH THE BLAP BETA-LACTAMASE FROM BACILLUS LICHENIFORMIS
2729, 5a8hR, 0.5614, 3.30, 0.105, 224, 86, CRYO-ET SUBTOMOGRAM AVERAGING OF BG505 SOSIP.664 IN COMPLEX WITH SCD4 17B AND 8ANC195
2730, 5a8hL, 0.5614, 3.30, 0.105, 224, 86, CRYO-ET SUBTOMOGRAM AVERAGING OF BG505 SOSIP.664 IN COMPLEX WITH SCD4 17B AND 8ANC195
2731, 5a8hF, 0.5614, 3.30, 0.105, 224, 86, CRYO-ET SUBTOMOGRAM AVERAGING OF BG505 SOSIP.664 IN COMPLEX WITH SCD4 17B AND 8ANC195
2732, 5a7xR, 0.5614, 3.30, 0.105, 224, 86, NEGATIVE STAIN EM OF BG505 SOSIP.664 IN COMPLEX WITH SCD4 17B AND 8ANC195
2733, 5a7xP, 0.5614, 3.30, 0.105, 224, 86, NEGATIVE STAIN EM OF BG505 SOSIP.664 IN COMPLEX WITH SCD4 17B AND 8ANC195
2734, 4zffA, 0.5614, 3.51, 0.091, 206, 88, DUAL-ACTING FAB 5A12 IN COMPLEX WITH VEGF
2735, 4tnvY, 0.5614, 3.38, 0.034, 221, 87, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2736, 4p9mH, 0.5614, 3.30, 0.105, 224, 86, CRYSTAL STRUCTURE OF 8ANC195 FAB
2737, 3q3gH, 0.5614, 3.46, 0.057, 224, 88, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
2738, 3ivbA, 0.5614, 2.97, 0.120, 137, 83, STRUCTURES OF SPOP-SUBSTRATE COMPLEXES: INSIGHTS INTO ARCHITECTURES OF BTB-CUL3 UBIQUITIN LIGASES: SPOPMATH- MACROH2ASBCPEP1
2739, 3dwtA, 0.5614, 3.53, 0.081, 125, 86, STRUCTURE OF CABBCII-10 NANOBODY
2740, 2oz4A, 0.5614, 3.03, 0.086, 265, 81, STRUCTURAL PLASTICITY IN IGSF DOMAIN 4 OF ICAM-1 MEDIATES CELL SURFACE DIMERIZATION
2741, 1nudA, 0.5614, 3.67, 0.102, 673, 88, ROLE OF CALCIUM IONS IN THE ACTIVATION AND ACTIVITY OF THE TRANSGLUTAMINASE 3 ENZYME (3 CALCIUMS ACTIVE FORM)
2742, 1ai1H, 0.5614, 3.34, 0.057, 221, 88, HIV-1 V3 LOOP MIMIC
2743, 6ewaH, 0.5613, 2.98, 0.047, 188, 85, CRYSTAL STRUCTURE OF HLA-A2 IN COMPLEX WITH LILRB1 
2744, 5oclF, 0.5613, 3.28, 0.058, 118, 86, NANOBODY-ANTI-VGLUT NANOBODY COMPLEX
2745, 4ztpH, 0.5613, 3.43, 0.092, 223, 87, FAB STRUCTURE OF RABBIT MONOCLONAL ANTIBODY R53 TARGETING AN EPITOPE IN HIV-1 GP120 C4 REGION
2746, 4xamA, 0.5613, 3.66, 0.074, 651, 95, COMPLEMENT COMPONENT C4B
2747, 4x4mC, 0.5613, 3.15, 0.058, 212, 86, STRUCTURE OF FCGAMMARI IN COMPLEX WITH FC REVEALS THE IMPORTANCE OF GLYCAN RECOGNITION FOR HIGH AFFINITY IGG BINDING
2748, 4wi8B, 0.5613, 2.95, 0.024, 208, 83, STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION Y436A
2749, 4lt7A, 0.5613, 3.03, 0.118, 128, 85, CRYSTAL STRUCTURE OF THE C2A DOMAIN OF RABPHILIN-3A IN COMPLEX WITH A CALCIUM
2750, 3wknA, 0.5613, 3.09, 0.036, 209, 84, CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG
2751, 3mj9H, 0.5613, 3.24, 0.070, 210, 86, CRYSTAL STRUCTURE OF JAML IN COMPLEX WITH THE STIMULATORY ANTIBODY HL4E10
2752, 3b2uN, 0.5613, 3.35, 0.102, 218, 88, CRYSTAL STRUCTURE OF ISOLATED DOMAIN III OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8
2753, 2r23B, 0.5613, 3.50, 0.103, 222, 87, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
2754, 2a9nI, 0.5613, 3.41, 0.069, 126, 87, A MUTATION DESIGNED TO ALTER CRYSTAL PACKING PERMITS STRUCTURAL ANALYSIS OF A TIGHT-BINDING FLUORESCEIN-SCFV COMPLEX
2755, 1q9wB, 0.5613, 3.44, 0.092, 226, 87, S45-18 FAB PENTASACCHARIDE BISPHOSPHATE COMPLEX
2756, 1mh5H, 0.5613, 3.39, 0.069, 190, 87, THE STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF THE ESTEROLYTIC ANTIBODY MS6-164 AND A TRANSITION-STATE ANALOG
2757, 6oz6F, 0.5612, 3.37, 0.093, 126, 86, CRYSTAL STRUCTURE OF MRAY BOUND TO 3 -HYDROXYMUREIDOMYCIN A 
2758, 6ejeA, 0.5612, 4.02, 0.108, 695, 93, HUMAN XYLOSYLTRANSFERASE 1 IN COMPLEX WITH PEPTIDE PAAEGSGEQDFT 
2759, 5w0pB, 0.5612, 3.81, 0.081, 802, 99, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN DETERMINED BY X-RAY FREE ELECTRON LASER
2760, 5tokE, 0.5612, 3.44, 0.081, 126, 86, CRYSTAL STRUCTURE OF THE RSV F GLYCOPROTEIN IN COMPLEX WITH THE NEUTRALIZING SINGLE-DOMAIN ANTIBODY F-VHH-L66
2761, 5en2A, 0.5612, 3.28, 0.047, 219, 86, MOLECULAR BASIS FOR ANTIBODY-MEDIATED NEUTRALIZATION OF NEW WORLD HEMORRHAGIC FEVER MAMMARENAVIRUSES
2762, 4tprH, 0.5612, 3.03, 0.035, 221, 86, STRUCTURE OF TAU5 ANTIBODY FAB FRAGMENT
2763, 3t5iB, 0.5612, 3.94, 0.087, 142, 92, STRUCTURE OF FULLY MODIFIED FARNESYLATED RHEB PEPTIDE IN COMPLEX WITH PDE6D
2764, 1ohqB, 0.5612, 2.94, 0.083, 119, 84, CRYSTAL STRUCTURE OF HEL4 A SOLUBLE HUMAN VH ANTIBODY DOMAIN RESISTANT TO AGGREGATION
2765, 1mh5B, 0.5612, 3.45, 0.069, 172, 87, THE STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF THE ESTEROLYTIC ANTIBODY MS6-164 AND A TRANSITION-STATE ANALOG
2766, 1euuA, 0.5612, 3.77, 0.121, 601, 91, SIALIDASE OR NEURAMINIDASE LARGE 68KD FORM
2767, 5o2uD, 0.5611, 3.18, 0.094, 116, 85, LLAMA VHH IN COMPLEX WITH P24
2768, 4zypK, 0.5611, 3.45, 0.068, 213, 88, CRYSTAL STRUCTURE OF MOTAVIZUMAB AND QUATERNARY-SPECIFIC RSV- NEUTRALIZING HUMAN ANTIBODY AM14 IN COMPLEX WITH PREFUSION RSV F GLYCOPROTEIN
2769, 4yo0C, 0.5611, 3.59, 0.057, 198, 87, CRYSTAL STRUCTURE OF MONOCLONAL ANTI-HUMAN PODOPLANIN ANTIBODY NZ-1 WITH BOUND PA PEPTIDE
2770, 4tnvI, 0.5611, 3.38, 0.034, 222, 87, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2771, 4nn5C, 0.5611, 2.69, 0.111, 183, 81, CYTOKINE RECEPTOR COMPLEX - CRYSTAL FORM 1A
2772, 4gjhB, 0.5611, 3.38, 0.079, 176, 89, CRYSTAL STRUCTURE OF THE TRAF DOMAIN OF TRAF5
2773, 2g5bF, 0.5611, 3.57, 0.080, 216, 88, CRYSTAL STRUCTURE OF THE ANTI-BAX MONOCLONAL ANTIBODY 6A7 AND A BAX PEPTIDE.
2774, 2b3rA, 0.5611, 3.21, 0.093, 124, 86, CRYSTAL STRUCTURE OF THE C2 DOMAIN OF CLASS II PHOSPHATIDYLINOSITIDE 3-KINASE C2
2775, 2aepH, 0.5611, 3.43, 0.092, 143, 87, AN EPIDEMIOLOGICALLY SIGNIFICANT EPITOPE OF A 1998 INFLUENZA VIRUS NEURAMINIDASE FORMS A HIGHLY HYDRATED INTERFACE IN THE NA-ANTIBODY COMPLEX.
2776, 1xzwB, 0.5611, 3.27, 0.106, 426, 85, SWEET POTATO PURPLE ACID PHOSPHATASE/PHOSPHATE COMPLEX
2777, 1wv7T, 0.5611, 2.83, 0.084, 191, 83, HUMAN FACTOR VIIA-TISSUE FACTOR COMPLEXED WITH ETHYLSULFONAMIDE-D-5-PROPOXY-TRP-GLN-P-AMINOBENZAMIDINE
2778, 1ogpE, 0.5611, 3.99, 0.128, 388, 94, THE CRYSTAL STRUCTURE OF PLANT SULFITE OXIDASE PROVIDES INSIGHT INTO SULFITE OXIDATION IN PLANTS AND ANIMALS
2779, 6gkdP, 0.5610, 3.35, 0.057, 123, 87, HUMAN NBD1 OF CFTR IN COMPLEX WITH NANOBODIES D12 AND G3A 
2780, 6e5pH, 0.5610, 3.59, 0.045, 225, 88, BACKBONE MODEL BASED ON CRYO-EM MAP AT 8.5 A OF DOMAIN-SWAPPED; GLYCAN-REACTIVE; NEUTRALIZING ANTIBODY 2G12 BOUND TO HIV-1 ENV BG505 DS-SOSIP; WHICH WAS ALSO BOUND TO CD4-BINDING SITE ANTIBODY VRC03 
2781, 5fjwH, 0.5610, 3.39, 0.098, 258, 92, YEAST DELTA-COP-I MU-HOMOLOGY DOMAIN COMPLEXED WITH DSL1 WXWX(MSE) PEPTIDE
2782, 4ktyA, 0.5610, 3.55, 0.106, 695, 85, FIBRIN-STABILIZING FACTOR WITH A BOUND LIGAND
2783, 4jo3I, 0.5610, 3.48, 0.070, 227, 86, CRYSTAL STRUCTURE OF RABBIT MAB R20 FAB IN COMPLEX WITH V3 C-TERMINUS OF HIV-1 CONSENSUS B GP120
2784, 3okmB, 0.5610, 3.52, 0.080, 215, 88, CRYSTAL STRUCTURE OF UNLIGANDED S25-39
2785, 1t03H, 0.5610, 3.45, 0.057, 225, 88, HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO TENOFOVIR TERMINATED TEMPLATE-PRIMER (COMPLEX P)
2786, 1op5H, 0.5610, 3.59, 0.045, 225, 88, CRYSTAL STRUCTURE OF FAB 2G12 BOUND TO MAN9GLCNAC2
2787, 1ogpD, 0.5610, 3.99, 0.128, 388, 94, THE CRYSTAL STRUCTURE OF PLANT SULFITE OXIDASE PROVIDES INSIGHT INTO SULFITE OXIDATION IN PLANTS AND ANIMALS
2788, 1nufA, 0.5610, 3.48, 0.103, 675, 87, ROLE OF CALCIUM IONS IN THE ACTIVATION AND ACTIVITY OF THE TRANSGLUTAMINASE 3 ENZYME
2789, 6fp6X, 0.5609, 3.66, 0.063, 232, 95, COMPLEX OF HUMAN CU;ZN SOD1 WITH THE HUMAN COPPER CHAPERONE FOR SOD1 IN A COMPACT CONFORMATION 
2790, 6f8gD, 0.5609, 3.16, 0.095, 140, 84, CO-CRYSTAL STRUCTURE OF SPOP MATH DOMAIN AND HAMSTER PDX1 FRAGMENT 
2791, 6e5pS, 0.5609, 3.59, 0.045, 225, 88, BACKBONE MODEL BASED ON CRYO-EM MAP AT 8.5 A OF DOMAIN-SWAPPED; GLYCAN-REACTIVE; NEUTRALIZING ANTIBODY 2G12 BOUND TO HIV-1 ENV BG505 DS-SOSIP; WHICH WAS ALSO BOUND TO CD4-BINDING SITE ANTIBODY VRC03 
2792, 6e5p3, 0.5609, 3.59, 0.045, 225, 88, BACKBONE MODEL BASED ON CRYO-EM MAP AT 8.5 A OF DOMAIN-SWAPPED; GLYCAN-REACTIVE; NEUTRALIZING ANTIBODY 2G12 BOUND TO HIV-1 ENV BG505 DS-SOSIP; WHICH WAS ALSO BOUND TO CD4-BINDING SITE ANTIBODY VRC03 
2793, 5hguB, 0.5609, 3.23, 0.056, 206, 89, CRYSTAL STRUCTURE OF HUMAN TRANSCRIPTION FACTOR TEAD2 IN COMPLEX WITH PALMITATE
2794, 5cjoH, 0.5609, 3.26, 0.071, 215, 85, CRYSTAL STRUCTURE ANALYSIS OF ELBOW-ENGINEERED-FAB-BOUND HUMAN INSULIN DEGRADING ENZYME (IDE) IN COMPLEX WITH INSULIN
2795, 4ztoH, 0.5609, 3.39, 0.081, 221, 86, FAB/EPITOPE COMPLEX STRUCTURE OF RABBIT MONOCLONAL ANTIBODY R53 TARGETING AN EPITOPE IN HIV-1 GP120 C4 REGION
2796, 4rrpN, 0.5609, 3.46, 0.070, 152, 86, CRYSTAL STRUCTURE OF THE FAB COMPLEXED WITH ANTIGEN ASF1P NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET PDR16
2797, 4eazA, 0.5609, 3.41, 0.056, 218, 90, VGLL1-TEAD4 STRUCTURE
2798, 4cadH, 0.5609, 3.25, 0.023, 221, 86, MECHANISM OF FARNESYLATED CAAX PROTEIN PROCESSING BY THE INTEGRAL MEMBRANE PROTEASE RCE1
2799, 3rifH, 0.5609, 3.37, 0.034, 221, 87, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND GLUTAMATE.
2800, 3ri5I, 0.5609, 3.37, 0.034, 199, 87, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND PICROTOXIN
2801, 3qazQ, 0.5609, 3.15, 0.035, 195, 86, IL-2 MUTANT D10 TERNARY COMPLEX
2802, 3dwtF, 0.5609, 3.56, 0.081, 125, 86, STRUCTURE OF CABBCII-10 NANOBODY
2803, 3aveB, 0.5609, 3.16, 0.047, 208, 85, CRYSTAL STRUCTURE OF THE FUCOSYLATED FC FRAGMENT FROM HUMAN IMMUNOGLOBULIN G1
2804, 3auvE, 0.5609, 3.29, 0.092, 225, 87, PREDICTING AMINO ACID PREFERENCES IN THE COMPLEMENTARITY DETERMINING REGIONS OF AN ANTIBODY-ANTIGEN RECOGNITION INTERFACE
2805, 3auvC, 0.5609, 3.30, 0.092, 225, 87, PREDICTING AMINO ACID PREFERENCES IN THE COMPLEMENTARITY DETERMINING REGIONS OF AN ANTIBODY-ANTIGEN RECOGNITION INTERFACE
2806, 6iw2K, 0.5608, 2.79, 0.024, 120, 83, CRYSTAL STRUCTURE OF 5A SCFV IN COMPLEX WITH YFV-17D SE IN PREFUSION STATE 
2807, 6e5gB, 0.5608, 3.46, 0.055, 208, 91, CRYSTAL STRUCTURE OF HUMAN TEAD2-YAP BINDING DOMAIN COVALENTLY BOUND TO AN ALLOSTERIC REGULATOR 
2808, 6ch8D, 0.5608, 3.55, 0.034, 235, 88, CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22 
2809, 5vaaB, 0.5608, 3.18, 0.071, 206, 85, CRYSTAL STRUCTURE OF MOUSE IGG2A FC T370K MUTANT
2810, 5lw4A, 0.5608, 3.67, 0.089, 172, 90, NMR SOLUTION STRUCTURE OF THE CHITIN-ACTIVE LYTIC POLYSACCHARIDE MONOOXYGENASE BLLPMO10A
2811, 5k9jH, 0.5608, 3.59, 0.080, 228, 88, CRYSTAL STRUCTURE OF MULTIDONOR HV6-1-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 56.A.09 ISOLATED FOLLOWING H5 IMMUNIZATION.
2812, 3rvvD, 0.5608, 3.44, 0.102, 216, 88, CRYSTAL STRUCTURE OF DER F 1 COMPLEXED WITH FAB 4C1
2813, 3b2uQ, 0.5608, 3.38, 0.114, 217, 88, CRYSTAL STRUCTURE OF ISOLATED DOMAIN III OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8
2814, 2f58H, 0.5608, 3.42, 0.068, 228, 88, IGG1 FAB FRAGMENT (58.2) COMPLEX WITH 12-RESIDUE CYCLIC PEPTIDE (INCLUDING RESIDUES 315-324 OF HIV-1 GP120) (MN ISOLATE)
2815, 1ogpA, 0.5608, 3.99, 0.128, 388, 94, THE CRYSTAL STRUCTURE OF PLANT SULFITE OXIDASE PROVIDES INSIGHT INTO SULFITE OXIDATION IN PLANTS AND ANIMALS
2816, 1etzB, 0.5608, 3.37, 0.069, 228, 87, THE THREE-DIMENSIONAL STRUCTURE OF AN ANTI-SWEETENER FAB NC10.14 SHOWS THE EXTENT OF STRUCTURAL DIVERSITY IN ANTIGEN RECOGNITION BY IMMUNOGLOBULINS
2817, 6fywC, 0.5607, 3.49, 0.057, 129, 87, STRUCTURE OF B/BRISBANE/60/2008 INFLUENZA HEMAGGLUTININ IN COMPLEX WITH SD83 
2818, 6fp6H, 0.5607, 3.67, 0.063, 230, 95, COMPLEX OF HUMAN CU;ZN SOD1 WITH THE HUMAN COPPER CHAPERONE FOR SOD1 IN A COMPACT CONFORMATION 
2819, 5o04C, 0.5607, 3.47, 0.069, 121, 87, GII.10 VIETNAM 026 NOROVIRUS PROTRUDING DOMAIN IN COMPLEX WITH NANOBODY NANO-26 AND NANO-85
2820, 5ijkB, 0.5607, 3.49, 0.080, 211, 88, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E03 FAB FRAGMENT IN COMPLEX OF PEPTIDE PLQPEQPFP
2821, 5hl3A, 0.5607, 3.38, 0.091, 344, 88, CRYSTAL STRUCTURE OF LISTERIA MONOCYTOGENES INLP
2822, 5bzwB, 0.5607, 3.48, 0.057, 230, 88, CRYSTAL STRUCTURE OF PCDN-27B AN ANTIBODY FROM THE PCDN FAMILY OF HIV-1 ANTIBODIES
2823, 4m4rC, 0.5607, 3.18, 0.106, 516, 85, EPHA4 ECTODOMAIN COMPLEX WITH EPHRIN A5
2824, 4i0nA, 0.5607, 3.61, 0.034, 264, 89, PORE FORMING PROTEIN
2825, 4dt2C, 0.5607, 2.93, 0.155, 426, 84, CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT CC27209
2826, 3sy0B, 0.5607, 3.48, 0.103, 222, 87, S25-2- A(2-8)-A(2-4)KDO TRISACCHARIDE COMPLEX
2827, 3dwtH, 0.5607, 3.54, 0.081, 125, 86, STRUCTURE OF CABBCII-10 NANOBODY
2828, 2r2hB, 0.5607, 3.50, 0.103, 215, 87, STRUCTURE OF S25-2 IN COMPLEX WITH KO
2829, 2i60R, 0.5607, 3.42, 0.093, 222, 86, CRYSTAL STRUCTURE OF [PHE23]M47 A SCORPION-TOXIN MIMIC OF CD4 IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
2830, 6mqsA, 0.5606, 3.04, 0.047, 224, 85, VACCINE-ELICITED NHP FP-TARGETING HIV NEUTRALIZING ANTIBODY A12V163- A.01 IN COMPLEX WITH HIV FUSION PEPTIDE (RESIDUE 512-519) 
2831, 6bhqA, 0.5606, 3.03, 0.060, 208, 83, MOUSE IMMUNOGLOBULIN G 2C FC FRAGMENT WITH COMPLEX-TYPE GLYCAN
2832, 5vcnF, 0.5606, 3.35, 0.070, 214, 86, THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 5H8
2833, 5u4lB, 0.5606, 3.48, 0.080, 131, 87, RTA-V1C7_G29R-HIGH-SALT
2834, 5jw4U, 0.5606, 3.07, 0.060, 223, 84, STRUCTURE OF MEDI8852 FAB FRAGMENT IN COMPLEX WITH H5 HA
2835, 5ifjA, 0.5606, 3.42, 0.092, 216, 87, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E01 FAB FRAGMENT IN COMPLEX OF PEPTIDE PLQPEQPFP
2836, 4w2qG, 0.5606, 3.46, 0.069, 117, 87, ANTI-MARBURGVIRUS NUCLEOPROTEIN SINGLE DOMAIN ANTIBODY C COMPLEXED WITH NUCLEOPROTEIN C-TERMINAL DOMAIN
2837, 4pp1F, 0.5606, 3.35, 0.070, 214, 86, THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 5H8
2838, 4jzoD, 0.5606, 3.70, 0.080, 214, 88, THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC84-27
2839, 3okoB, 0.5606, 3.46, 0.092, 219, 87, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.8)KDO(2.4)KDO
2840, 3juaC, 0.5606, 3.41, 0.067, 213, 90, STRUCTURAL BASIS OF YAP RECOGNITION BY TEAD4 IN THE HIPPO PATHWAY
2841, 3ixyI, 0.5606, 3.26, 0.058, 221, 86, THE PSEUDO-ATOMIC STRUCTURE OF DENGUE IMMATURE VIRUS IN COMPLEX WITH FAB FRAGMENTS OF THE ANTI-FUSION LOOP ANTIBODY E53
2842, 3dwtE, 0.5606, 3.55, 0.081, 125, 86, STRUCTURE OF CABBCII-10 NANOBODY
2843, 2v9uF, 0.5606, 3.85, 0.063, 132, 95, RIM DOMAIN OF MAIN PORIN FROM MYCOBACTERIA SMEGMATIS
2844, 1w16A, 0.5606, 3.05, 0.094, 125, 85, RAT SYNAPTOTAGMIN 4 C2B DOMAIN IN THE ABSENCE OF CALCIUM
2845, 1r0aH, 0.5606, 3.45, 0.057, 225, 88, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COVALENTLY TETHERED TO DNA TEMPLATE-PRIMER SOLVED TO 2.8 ANGSTROMS
2846, 1q9oB, 0.5606, 3.17, 0.094, 226, 85, S45-18 FAB UNLIGANDED
2847, 1g9nH, 0.5606, 3.55, 0.091, 229, 88, HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
2848, 5tuhA, 0.5605, 2.82, 0.098, 107, 82, ARCHAELLUM PERIPLASMIC STATOR PROTEIN FLAG FROM SULFOLOBUS ACIDOCALDARIUS
2849, 5jw4O, 0.5605, 3.07, 0.048, 223, 84, STRUCTURE OF MEDI8852 FAB FRAGMENT IN COMPLEX WITH H5 HA
2850, 5fhcH, 0.5605, 3.54, 0.057, 215, 87, CRYSTAL STRUCTURE OF PROTECTIVE HUMAN ANTIBODIES 100 AND 114 IN COMPLEX WITH EBOLA VIRUS FUSION GLYCOPROTEIN (GP)
2851, 5cbaC, 0.5605, 3.36, 0.034, 127, 87, 3B4 IN COMPLEX WITH CXCL13 - 3B4-CXCL13
2852, 3wjlA, 0.5605, 3.16, 0.024, 212, 85, CRYSTAL STRUCTURE OF IIB SELECTIVE FC VARIANT FC(V12) IN COMPLEX WITH FCGRIIB
2853, 3wdhA, 0.5605, 2.92, 0.049, 698, 82, CRYSTAL STRUCTURE OF PULLULANASE FROM ANOXYBACILLUS SP. LM18-11
2854, 2r2bB, 0.5605, 3.50, 0.103, 214, 87, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
2855, 2r1yB, 0.5605, 3.50, 0.103, 216, 87, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
2856, 2erjC, 0.5605, 3.25, 0.011, 195, 90, CRYSTAL STRUCTURE OF THE HETEROTRIMERIC INTERLEUKIN-2 RECEPTOR IN COMPLEX WITH INTERLEUKIN-2
2857, 1nd0H, 0.5605, 3.12, 0.081, 222, 86, CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG
2858, 1f3vB, 0.5605, 3.26, 0.034, 164, 87, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE N-TERMINAL DOMAIN OF TRADD AND THE TRAF DOMAIN OF TRAF2
2859, 6oyhG, 0.5604, 3.08, 0.083, 125, 84, CRYSTAL STRUCTURE OF MRAY BOUND TO CARBACAPRAZAMYCIN 
2860, 6fpvB, 0.5604, 3.28, 0.057, 121, 87, A LLAMA-DERIVED JBP1-TARGETING NANOBODY 
2861, 6cdmA, 0.5604, 3.27, 0.058, 218, 86, STRUCTURE OF VACCINE-ELICITED HIV-1 NEUTRALIZING ANTIBODY VFP7.04 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519 
2862, 6a4kI, 0.5604, 3.58, 0.080, 230, 88, HUMAN ANTIBODY 32D6 FAB IN COMPLEX WITH H1N1 INFLUENZA A VIRUS HA1 
2863, 5udcB, 0.5604, 3.52, 0.092, 218, 87, CRYSTAL STRUCTURE OF RSV F A2 BOUND TO MEDI8897
2864, 5lo8A, 0.5604, 3.15, 0.106, 140, 85, THE C2B DOMAIN OF RABPHILIN 3A IN COMPLEX WITH PI(45)P2
2865, 5jw3H, 0.5604, 3.03, 0.060, 222, 84, STRUCTURE OF MEDI8852 FAB FRAGMENT IN COMPLEX WITH H7 HA
2866, 4gagH, 0.5604, 3.11, 0.058, 212, 86, STRUCTURE OF THE BROADLY NEUTRALIZING ANTIBODY AP33 IN COMPLEX WITH ITS HCV EPITOPE (E2 RESIDUES 412-423)
2867, 3b2uH, 0.5604, 3.18, 0.105, 217, 86, CRYSTAL STRUCTURE OF ISOLATED DOMAIN III OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8
2868, 2r1xB, 0.5604, 3.50, 0.103, 215, 87, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
2869, 2gjjA, 0.5604, 3.58, 0.078, 236, 90, CRYSTAL STRUCTURE OF A SINGLE CHAIN ANTIBODY SCA21 AGAINST HER2/ERBB2
2870, 6ncwB, 0.5603, 3.59, 0.066, 560, 91, CRYSTAL STRUCTURE OF A GH2 BETA-GALACTURONIDASE FROM EISENBERGIELLA TAYI BOUND TO GLYCEROL 
2871, 6h06E, 0.5603, 3.29, 0.081, 215, 86, FAB CBTAU-22.1 IN COMPLEX WITH TAU PEPTIDE V1088-5 
2872, 6fp6L, 0.5603, 3.75, 0.042, 234, 96, COMPLEX OF HUMAN CU;ZN SOD1 WITH THE HUMAN COPPER CHAPERONE FOR SOD1 IN A COMPACT CONFORMATION 
2873, 5x72A, 0.5603, 4.03, 0.032, 149, 94, THE CRYSTAL STRUCTURE PDE DELTA IN COMPLEX WITH (RAC)-P9
2874, 5ldyA, 0.5603, 3.33, 0.155, 335, 84, STRUCTURE OF YERSINIA PSEUDOTUBERCULOSIS INVD
2875, 5hnoC, 0.5603, 3.66, 0.086, 166, 93, THE STRUCTURE OF THE KDO-CAPPED SACCHARIDE BINDING SUBUNIT OF THE O-12 SPECIFIC ABC TRANSPORTER WZT
2876, 5a8hJ, 0.5603, 3.57, 0.091, 229, 88, CRYO-ET SUBTOMOGRAM AVERAGING OF BG505 SOSIP.664 IN COMPLEX WITH SCD4 17B AND 8ANC195
2877, 5a7xL, 0.5603, 3.57, 0.091, 229, 88, NEGATIVE STAIN EM OF BG505 SOSIP.664 IN COMPLEX WITH SCD4 17B AND 8ANC195
2878, 4yc2H, 0.5603, 3.19, 0.034, 220, 87, CRYSTAL STRUCTURE OF THE STABILIZED INNER DOMAIN OF CLADE A/E HIV-1 GP120 FROM E. COLI IN COMPLEX WITH THE ANTIBODY A32.
2879, 4xwoO, 0.5603, 3.63, 0.080, 218, 88, STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF SEC22
2880, 3t77B, 0.5603, 3.51, 0.103, 224, 87, S25-2- A(2-4)KDO DISACCHARIDE COMPLEX
2881, 3t65B, 0.5603, 3.50, 0.103, 222, 87, S25-2- A(2-8)KDO DISACCHARIDE COMPLEX
2882, 3qazB, 0.5603, 2.96, 0.047, 195, 85, IL-2 MUTANT D10 TERNARY COMPLEX
2883, 3p0vH, 0.5603, 3.19, 0.107, 218, 84, ANTI-EGFR/HER3 FAB DL11 ALONE
2884, 3okdB, 0.5603, 3.50, 0.103, 218, 87, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO
2885, 3o41H, 0.5603, 3.34, 0.093, 220, 86, CRYSTAL STRUCTURE OF 101F FAB BOUND TO 15-MER PEPTIDE EPITOPE
2886, 3klhD, 0.5603, 3.45, 0.057, 225, 88, CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO POST-TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX P)
2887, 3ifoA, 0.5603, 3.19, 0.092, 216, 87, X-RAY STRUCTURE OF AMYLOID BETA PEPTIDE:ANTIBODY (ABETA1-7:10D5) COMPLEX
2888, 2hmiD, 0.5603, 3.25, 0.047, 220, 86, HIV-1 REVERSE TRANSCRIPTASE/FRAGMENT OF FAB 28/DNA COMPLEX
2889, 1t83A, 0.5603, 2.98, 0.024, 210, 84, CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (ORTHORHOMBIC)
2890, 1cf1B, 0.5603, 3.72, 0.052, 360, 96, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
2891, 6ncwC, 0.5602, 3.60, 0.066, 559, 91, CRYSTAL STRUCTURE OF A GH2 BETA-GALACTURONIDASE FROM EISENBERGIELLA TAYI BOUND TO GLYCEROL 
2892, 6bgtB, 0.5602, 3.46, 0.103, 210, 87, STRUCTURE OF TRASTUZUMAB FAB MUTANT IN COMPLEX WITH HER2 EXTRACELLULAR DOMAIN 
2893, 5kenJ, 0.5602, 3.37, 0.046, 121, 87, EBOV GP IN COMPLEX WITH VARIABLE FAB DOMAINS OF IGGS C4G7 AND C13C6
2894, 4nbyB, 0.5602, 3.39, 0.094, 123, 85, CRYSTAL STRUCTURE OF TCDA-A2 BOUND TO TWO MOLECULES OF A20.1 VHH
2895, 4hsaC, 0.5602, 3.13, 0.096, 272, 83, STRUCTURE OF INTERLEUKIN 17A IN COMPLEX WITH IL17RA RECEPTOR
2896, 3qo1B, 0.5602, 3.32, 0.093, 219, 86, MONOCLINIC FORM OF IGG1 FAB FRAGMENT (APO FORM) SHARING SAME FV AS IGA
2897, 3fn3B, 0.5602, 2.61, 0.062, 211, 80, DIMERIC STRUCTURE OF PD-L1
2898, 3dwtB, 0.5602, 3.51, 0.081, 125, 86, STRUCTURE OF CABBCII-10 NANOBODY
2899, 3b2uC, 0.5602, 3.40, 0.102, 213, 88, CRYSTAL STRUCTURE OF ISOLATED DOMAIN III OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8
2900, 2ygvC, 0.5602, 3.60, 0.080, 155, 87, CONSERVED N-TERMINAL DOMAIN OF THE YEAST HISTONE CHAPERONE ASF1 IN COMPLEX WITH THE C-TERMINAL FRAGMENT OF RAD53
2901, 2jhwB, 0.5602, 4.43, 0.073, 138, 96, CRYSTAL STRUCTURE OF RHOGDI E155A E157A MUTANT
2902, 1fstB, 0.5602, 4.00, 0.043, 148, 92, CRYSTAL STRUCTURE OF TRUNCATED HUMAN RHOGDI TRIPLE MUTANT
2903, 6h0eE, 0.5601, 3.30, 0.081, 215, 86, FAB DMCBTAU-22.1 IN COMPLEX WITH TAU PEPTIDE V1088-23 
2904, 6fp6D, 0.5601, 3.67, 0.063, 234, 95, COMPLEX OF HUMAN CU;ZN SOD1 WITH THE HUMAN COPPER CHAPERONE FOR SOD1 IN A COMPACT CONFORMATION 
2905, 6ezwB, 0.5601, 3.19, 0.059, 128, 85, CRYSTAL STRUCTURE OF A LLAMA VHH ANTIBODY BCD090-M2 AGAINST HUMAN ERBB3 IN SPACE GROUP C2
2906, 5xcuD, 0.5601, 3.41, 0.046, 165, 87, CRYSTAL STRUCTURE OF 12CA5 FV-CLASP FRAGMENT WITH ITS ANTIGEN PEPTIDE
2907, 5ti1D, 0.5601, 3.73, 0.074, 429, 94, CRYSTAL STRUCTURE OF FUMARYLACETOACETATE HYDROLASE FROM BURKHOLDERIA XENOVORANS LB400
2908, 5lbsH, 0.5601, 3.46, 0.080, 121, 87, STRUCTURAL BASIS OF ZIKA AND DENGUE VIRUS POTENT ANTIBODY CROSS- NEUTRALIZATION
2909, 4r4bD, 0.5601, 3.47, 0.080, 220, 87, CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C
2910, 4p2cJ, 0.5601, 3.32, 0.081, 127, 86, COMPLEX OF SHIGA TOXIN 2E WITH A NEUTRALIZING SINGLE-DOMAIN ANTIBODY
2911, 4jhwH, 0.5601, 3.56, 0.080, 226, 88, CRYSTAL STRUCTURE OF RESPIRATORY SYNCYTIAL VIRUS FUSION GLYCOPROTEIN STABILIZED IN THE PREFUSION CONFORMATION BY HUMAN ANTIBODY D25
2912, 4i18H, 0.5601, 3.49, 0.092, 227, 87, CRYSTAL STRUCTURE OF HUMAN PROLACTIN RECEPTOR COMPLEXED WITH FAB FRAGMENT
2913, 2r1wB, 0.5601, 3.50, 0.103, 219, 87, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
2914, 2e56A, 0.5601, 4.04, 0.060, 144, 100, CRYSTAL STRUCTURE OF HUMAN MD-2
2915, 2arjB, 0.5601, 3.47, 0.080, 212, 88, CD8ALPHA-ALPHA IN COMPLEX WITH YTS 105.18 FAB
2916, 1yymH, 0.5601, 3.43, 0.093, 229, 86, CRYSTAL STRUCTURE OF F23 A SCORPION-TOXIN MIMIC OF CD4 IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
2917, 1q9oD, 0.5601, 3.47, 0.092, 226, 87, S45-18 FAB UNLIGANDED
2918, 6gkdB, 0.5600, 3.15, 0.058, 126, 86, HUMAN NBD1 OF CFTR IN COMPLEX WITH NANOBODIES D12 AND G3A 
2919, 6fp6B, 0.5600, 3.67, 0.074, 231, 95, COMPLEX OF HUMAN CU;ZN SOD1 WITH THE HUMAN COPPER CHAPERONE FOR SOD1 IN A COMPACT CONFORMATION 
2920, 6f5gB, 0.5600, 3.34, 0.082, 127, 85, COMPLETE PCSK9 C-TER DOMAIN IN COMPLEX WITH VHH P.140 
2921, 6cdmD, 0.5600, 3.19, 0.071, 218, 85, STRUCTURE OF VACCINE-ELICITED HIV-1 NEUTRALIZING ANTIBODY VFP7.04 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519 
2922, 5nstD, 0.5600, 3.22, 0.057, 322, 87, HUMAN MONOCLONAL ANTIBODY WITH A LAIR1 INSERTION
2923, 5ijkA, 0.5600, 3.47, 0.080, 213, 88, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E03 FAB FRAGMENT IN COMPLEX OF PEPTIDE PLQPEQPFP
2924, 4gejA, 0.5600, 3.33, 0.095, 134, 84, N-TERMINAL DOMAIN OF VDUP-1
2925, 3t4yB, 0.5600, 3.50, 0.103, 222, 87, S25-2- KDO MONOSACCHARIDE COMPLEX
2926, 1rh8A, 0.5600, 3.68, 0.056, 142, 90, THREE-DIMENSIONAL STRUCTURE OF THE CALCIUM-FREE PICCOLO C2A- DOMAIN
2927, 1nc4D, 0.5600, 3.18, 0.081, 215, 86, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 2D12.5 FAB COMPLEXED WITH GD- DOTA
2928, 1bhgB, 0.5600, 3.39, 0.078, 611, 90, HUMAN BETA-GLUCURONIDASE AT 2.6 A RESOLUTION
2929, 6fp6P, 0.5599, 3.67, 0.074, 231, 95, COMPLEX OF HUMAN CU;ZN SOD1 WITH THE HUMAN COPPER CHAPERONE FOR SOD1 IN A COMPACT CONFORMATION 
2930, 5wkzH, 0.5599, 3.61, 0.045, 221, 88, VH1-69 GERMLINE ANTIBODY PREDICTED FROM CR6261 
2931, 5tdnD, 0.5599, 3.18, 0.094, 213, 85, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-HER2 ANTIBODY 4D5 WITH REDESIGNED HEAVY AND LIGHT CHAIN INTERFACES
2932, 5t5wA, 0.5599, 3.30, 0.066, 198, 91, STRUCTURE OF AN AFFINITY MATURED LAMBDA-IFN/IFN-LAMBDAR1/IL-10RBETA RECEPTOR COMPLEX
2933, 5mp6H, 0.5599, 3.32, 0.069, 229, 87, STRUCTURE OF THE UNLIGANDED FAB FROM HIV-1 NEUTRALIZING ANTIBODY CAP248-2B THAT BINDS TO THE GP120 C-TERMINUS - GP41 INTERFACE AT TWO ANGSTROM RESOLUTION.
2934, 5lbsI, 0.5599, 3.46, 0.080, 122, 87, STRUCTURAL BASIS OF ZIKA AND DENGUE VIRUS POTENT ANTIBODY CROSS- NEUTRALIZATION
2935, 5ghuA, 0.5599, 2.68, 0.085, 201, 82, CRYSTAL STRUCTURE OF ECPD CHAPERONE AT 1.63 ANGSTROM
2936, 5dmyB, 0.5599, 3.61, 0.067, 858, 90, BETA-GALACTOSIDASE - CONSTRUCT 33-930
2937, 4ybqD, 0.5599, 3.42, 0.046, 120, 87, RAT GLUT5 WITH FV IN THE OUTWARD-OPEN FORM
2938, 4jfyH, 0.5599, 3.73, 0.080, 225, 88, APO STRUCTURE OF PHOSPHOTYROSINE (PYAB) SCAFFOLD
2939, 4iofC, 0.5599, 3.19, 0.071, 216, 84, CRYSTAL STRUCTURE ANALYSIS OF FAB-BOUND HUMAN INSULIN DEGRADING ENZYME (IDE)
2940, 4hsaF, 0.5599, 3.09, 0.049, 271, 82, STRUCTURE OF INTERLEUKIN 17A IN COMPLEX WITH IL17RA RECEPTOR
2941, 3qa3H, 0.5599, 3.51, 0.057, 224, 88, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
2942, 3bpcB, 0.5599, 3.50, 0.103, 214, 87, CO-CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH 5-DEOXY-4- EPI-23-DEHYDRO KDO (4.8) KDO
2943, 2i5yH, 0.5599, 3.40, 0.093, 224, 86, CRYSTAL STRUCTURE OF CD4M47 A SCORPION-TOXIN MIMIC OF CD4 IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
2944, 5ml4B, 0.5598, 3.98, 0.043, 149, 94, THE CRYSTAL STRUCTURE OF PDE6D IN COMPLEX TO INHIBITOR-7
2945, 5kanG, 0.5598, 3.42, 0.080, 231, 87, CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.G.07 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ
2946, 5bjzD, 0.5598, 3.40, 0.080, 231, 87, CRYSTAL STRUCTURE OF MALTOSE BINDING PROTEIN IN COMPLEX WITH AN ALLOSTERIC SYNTHETIC ANTIBODY
2947, 4mkmA, 0.5598, 3.57, 0.122, 290, 90, REPEAT DOMAINS 1  and 2 OF CLOSTRIDIUM PERFRINGENS CPE0147
2948, 4lvnC, 0.5598, 3.06, 0.058, 216, 86, CRYSTAL STRUCTURE OF PFSUB1-PRODOMAIN-NIMP.M7 FAB COMPLEX
2949, 4k8uC, 0.5598, 3.40, 0.057, 176, 87, CRYSTAL STRUCTURE OF TRAF4 TRAF DOMAIN
2950, 4jv8B, 0.5598, 4.07, 0.064, 147, 94, THE CRYSTAL STRUCTURE OF PDE6D IN COMPLEX WITH RAC-S1
2951, 3faxA, 0.5598, 2.89, 0.062, 771, 80, THE CRYSTAL STRUCTURE OF GBS PULLULANASE SAP IN COMPLEX WITH MALTOTETRAOSE
2952, 2gjjB, 0.5598, 3.47, 0.079, 234, 89, CRYSTAL STRUCTURE OF A SINGLE CHAIN ANTIBODY SCA21 AGAINST HER2/ERBB2
2953, 1wg3A, 0.5598, 3.50, 0.070, 166, 86, STRUCTURAL ANALYSIS OF YEAST NUCLEOSOME-ASSEMBLY FACTOR CIA1P
2954, 1txkA, 0.5598, 3.90, 0.041, 480, 97, CRYSTAL STRUCTURE OF ESCHERICHIA COLI OPGG
2955, 1q9wD, 0.5598, 3.29, 0.093, 226, 86, S45-18 FAB PENTASACCHARIDE BISPHOSPHATE COMPLEX
2956, 1ajwA, 0.5598, 4.04, 0.086, 145, 93, STRUCTURE OF RHOGDI: A C-TERMINAL BINDING DOMAIN TARGETS AN N-TERMINAL INHIBITORY PEPTIDE TO GTPASES NMR 20 STRUCTURES
2957, 6i7aE, 0.5597, 3.08, 0.119, 138, 84, CO-CRYSTAL STRUCTURE OF HUMAN SPOP MATH DOMAIN (D140N) AND HUMAN BRD3 FRAGMENT 
2958, 6ej7A, 0.5597, 4.03, 0.108, 706, 93, HUMAN XYLOSYLTRANSFERASE 1 IN COMPLEX WITH UDP-XYLOSE AND PEPTIDE QEEEGAGGGQGG 
2959, 6bi2I, 0.5597, 3.48, 0.103, 212, 87, TRASTUZUMAB FAB D185A (LIGHT CHAIN) MUTANT BIOTIN CONJUGATION.
2960, 5t7jA, 0.5597, 3.94, 0.032, 232, 94, X-RAY CRYSTAL STRUCTURE OF AA13 LPMO
2961, 5ml3B, 0.5597, 4.01, 0.064, 149, 94, THE CRYSTAL STRUCTURE OF PDE6D IN COMPLEX TO DELTASONAMIDE1
2962, 5h9xA, 0.5597, 2.74, 0.099, 412, 81, CRYSTAL STRUCTURE OF GH FAMILY 64 LAMINARIPENTAOSE-PRODUCING BETA-13- GLUCANASE FROM PAENIBACILLUS BARENGOLTZII
2963, 4ns0A, 0.5597, 2.98, 0.119, 128, 84, THE C2A DOMAIN OF RABPHILIN 3A IN COMPLEX WITH PI(45)P2
2964, 4hdiL, 0.5597, 3.01, 0.133, 219, 83, CRYSTAL STRUCTURE OF 3E5 IGG3 FAB FROM MUS MUSCULUS
2965, 3tnmH, 0.5597, 3.18, 0.034, 221, 87, CRYSTAL STRUCTURE OF A32 FAB AN ADCC MEDIATING ANTI-HIV-1 ANTIBODY
2966, 3auvD, 0.5597, 3.59, 0.089, 227, 90, PREDICTING AMINO ACID PREFERENCES IN THE COMPLEMENTARITY DETERMINING REGIONS OF AN ANTIBODY-ANTIGEN RECOGNITION INTERFACE
2967, 1wfuA, 0.5597, 3.08, 0.058, 120, 86, SOLUTION STRUCTURE OF FIBRONECTIN TYPE III DOMAIN OF MOUSE HYPOTHETICAL PROTEIN
2968, 6my5A, 0.5596, 3.47, 0.126, 221, 87, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98F;HC- G99M;LC-S30BR] 
2969, 6fp6F, 0.5596, 3.68, 0.074, 234, 95, COMPLEX OF HUMAN CU;ZN SOD1 WITH THE HUMAN COPPER CHAPERONE FOR SOD1 IN A COMPACT CONFORMATION 
2970, 5vngA, 0.5596, 3.91, 0.021, 696, 94, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL II SORTING MOTIF
2971, 5jtwA, 0.5596, 3.67, 0.074, 651, 95, CRYSTAL STRUCTURE OF COMPLEMENT C4B RE-REFINED USING IMDFF
2972, 4y7mA, 0.5596, 3.40, 0.093, 129, 86, T6SS PROTEIN TSSM C-TERMINAL DOMAIN (835-1129) FROM EAEC
2973, 4xcfH, 0.5596, 3.34, 0.070, 218, 86, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH ITS PEPTIDE EPITOPE ON HIV-1 GP41; CRYSTALS CRYOPROTECTED WITH PHOSPHATIDYLCHOLINE (03:0 PC)
2974, 4lriC, 0.5596, 3.48, 0.103, 223, 87, ANTI CMV FAB FRAGMENT
2975, 4fabH, 0.5596, 3.30, 0.093, 216, 86, THREE-DIMENSIONAL STRUCTURE OF A FLUORESCEIN-FAB COMPLEX CRYSTALLIZED IN 2-METHYL-24-PENTANEDIOL
2976, 3b2uW, 0.5596, 3.08, 0.070, 216, 86, CRYSTAL STRUCTURE OF ISOLATED DOMAIN III OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8
2977, 1fveB, 0.5596, 3.37, 0.103, 223, 87, X-RAY STRUCTURES OF THE ANTIGEN-BINDING DOMAINS FROM THREE VARIANTS OF HUMANIZED ANTI-P185-HER2 ANTIBODY 4D5 AND COMPARISON WITH MOLECULAR MODELING
2978, 1cf1C, 0.5596, 3.67, 0.063, 380, 95, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
2979, 6qv1F, 0.5595, 3.32, 0.081, 115, 86, STRUCTURE OF ATPGS-BOUND OUTWARD-FACING TM287/288 IN COMPLEX WITH NANOBODY NB_TM1 
2980, 6n35M, 0.5595, 3.61, 0.045, 218, 88, ANTI-HIV-1 FAB 2G12 + MAN1-2 RE-REFINEMENT 
2981, 6al1H, 0.5595, 3.74, 0.057, 209, 88, THE NZ-1 FAB COMPLEXED WITH THE PDZ TANDEM FRAGMENT OF A. AEOLICUS S2P HOMOLOG WITH THE PA12 TAG INSERTED BETWEEN THE RESIDUES 181 AND 184 
2982, 5k9kA, 0.5595, 3.38, 0.070, 226, 86, CRYSTAL STRUCTURE OF MULTIDONOR HV6-1-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 56.A.09 IN COMPLEX WITH HEMAGGLUTININ HONG KONG 1968.
2983, 4xcrB, 0.5595, 3.26, 0.057, 110, 87, MONOMERIC HUMAN CUZN SUPEROXIDE DISMUTASE LOOPS IV AND VII DELETED APO FORM MUTANT I35A
2984, 4ocxH, 0.5595, 2.97, 0.047, 210, 85, FAB COMPLEX WITH METHOTREXATE
2985, 3oknB, 0.5595, 3.51, 0.103, 216, 87, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.4)KDO(2.4)KDO
2986, 3b2uT, 0.5595, 3.26, 0.103, 216, 87, CRYSTAL STRUCTURE OF ISOLATED DOMAIN III OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8
2987, 2g5bB, 0.5595, 3.46, 0.080, 216, 87, CRYSTAL STRUCTURE OF THE ANTI-BAX MONOCLONAL ANTIBODY 6A7 AND A BAX PEPTIDE.
2988, 1ugkA, 0.5595, 3.29, 0.093, 138, 86, SOLUTION STRUCTURE OF THE FIRST C2 DOMAIN OF SYNAPTOTAGMIN IV FROM HUMAN FETAL BRAIN (KIAA1342)
2989, 6nnjD, 0.5594, 3.33, 0.035, 128, 85, CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO CH31 SCFV IN COMPLEX WITH CRYSTALLIZATION CHAPERONES 3H109L FAB AND 35O22 SCFV AT 3.1 ANGSTROM 
2990, 6i41A, 0.5594, 3.23, 0.106, 139, 85, CO-CRYSTAL STRUCTURE OF HUMAN SPOP MATH DOMAIN (WILD-TYPE) AND HUMAN BRD3 FRAGMENT 
2991, 4ynyC, 0.5594, 3.73, 0.068, 209, 88, CRYSTAL STRUCTURE OF MONOCLONAL ANTI-HUMAN PODOPLANIN ANTIBODY NZ-1
2992, 4nc1D, 0.5594, 3.42, 0.106, 122, 85, CRYSTAL STRUCTURE OF TCDA-A2 BOUND TO A20.1 VHH AND A26.8 VHH
2993, 4g8aD, 0.5594, 4.37, 0.069, 140, 102, CRYSTAL STRUCTURE OF HUMAN TLR4 POLYMORPHIC VARIANT D299G AND T399I IN COMPLEX WITH MD-2 AND LPS
2994, 3p9wD, 0.5594, 3.34, 0.081, 121, 86, CRYSTAL STRUCTURE OF AN ENGINEERED HUMAN AUTONOMOUS VH DOMAIN IN COMPLEX WITH VEGF
2995, 3oklB, 0.5594, 3.51, 0.103, 222, 87, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.8)KDO
2996, 3k80A, 0.5594, 3.37, 0.035, 124, 86, STRUCTURE OF ESSENTIAL PROTEIN FROM TRYPANOSOMA BRUCEI
2997, 2vuoA, 0.5594, 3.25, 0.071, 215, 85, CRYSTAL STRUCTURE OF THE RABBIT IGG FC FRAGMENT
2998, 1n67A, 0.5594, 3.94, 0.061, 332, 98, CLUMPING FACTOR A FROM STAPHYLOCOCCUS AUREUS
2999, 6qv1E, 0.5593, 3.32, 0.081, 115, 86, STRUCTURE OF ATPGS-BOUND OUTWARD-FACING TM287/288 IN COMPLEX WITH NANOBODY NB_TM1 
3000, 6n4yG, 0.5593, 3.58, 0.080, 123, 87, METABOTROPIC GLUTAMATE RECEPTOR 5 EXTRACELLULAR DOMAIN WITH NB43 
3001, 6my5H, 0.5593, 3.27, 0.093, 222, 86, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98F;HC- G99M;LC-S30BR] 
3002, 6j7wB, 0.5593, 3.05, 0.083, 118, 84, CRYSTAL STRUCTURE OF HUMAN BCMA IN COMPLEX WITH UNIAB(TM) VH 
3003, 6ge4A, 0.5593, 3.38, 0.056, 208, 90, TEAD4 (216-434);E263A COMPLEXED WITH YAP PEPTIDE (60-100) AND MYRISTOATE (COVALENTLY BOUND) AT 1.97A (P41212 CRYSTAL FORM); MYRISTOYLATION WAS DONE BY ADDING MYR-COA 
3004, 6ewoH, 0.5593, 2.99, 0.047, 176, 85, CRYSTAL STRUCTURE OF NON-PHOSPHORYLATED FORM OF RTF PHOSPHOPEPTIDE BOUND TO HLA-A2 IN COMPLEX WITH LILRB1 
3005, 5tppH, 0.5593, 3.44, 0.069, 228, 87, CRYSTAL STRUCTURE OF DH270.5 (UNLIGANDED) FROM THE DH270 BROADLY NEUTRALIZING N332-GLYCAN DEPENDENT LINEAGE
3006, 5ftzA, 0.5593, 3.55, 0.066, 172, 91, AA10 LYTIC POLYSACCHARIDE MONOOXYGENASE (LPMO) FROM STREPTOMYCES LIVIDANS
3007, 5bk2C, 0.5593, 3.64, 0.102, 228, 88, CRYSTAL STRUCTURE OF MALTOSE BINDING PROTEIN IN COMPLEX WITH A PERISTERIC SYNTHETIC ANTIBODY
3008, 4y7mB, 0.5593, 3.60, 0.103, 129, 87, T6SS PROTEIN TSSM C-TERMINAL DOMAIN (835-1129) FROM EAEC
3009, 4jlrH, 0.5593, 3.48, 0.080, 215, 88, CRYSTAL STRUCTURE OF A DESIGNED RESPIRATORY SYNCYTIAL VIRUS IMMUNOGEN IN COMPLEX WITH MOTAVIZUMAB
3010, 3b9kD, 0.5593, 2.91, 0.071, 214, 84, CRYSTAL STRUCTURE OF CD8ALPHA-BETA IN COMPLEX WITH YTS 156.7 FAB
3011, 2uudJ, 0.5593, 3.25, 0.082, 121, 85, CRYSTAL STRUCTURE OF THE TEPC15-VK45.1 ANTI-2-PHENYL-5- OXAZOLONE NQ10-1.12 SCFV IN COMPLEX WITH THE HAPTEN
3012, 1m6uB, 0.5593, 4.20, 0.091, 250, 99, CRYSTAL STRUCTURE OF A NOVEL DNA-BINDING DOMAIN FROM NDT80 A TRANSCRIPTIONAL ACTIVATOR REQUIRED FOR MEIOSIS IN YEAST
3013, 6mqmJ, 0.5592, 3.58, 0.057, 222, 88, VACCINE-ELICITED NHP FP-TARGETING NEUTRALIZING ANTIBODY DF1W-A.01 IN COMPLEX WITH HIV FUSION PEPTIDE (RESIDUE 512-519) 
3014, 5w5lB, 0.5592, 3.33, 0.034, 210, 87, CRYSTAL STRUCTURE OF HUMAN IGG1-SIGMA FC FRAGMENT
3015, 4np9A, 0.5592, 2.99, 0.119, 128, 84, STRUCTURE OF RABPHILIN C2A DOMAIN BOUND TO IP3
3016, 4nkqB, 0.5592, 3.28, 0.092, 191, 87, STRUCTURE OF A CYTOKINE RECEPTOR COMPLEX
3017, 3ux9D, 0.5592, 3.70, 0.067, 230, 89, STRUCTURAL INSIGHTS INTO A HUMAN ANTI-IFN ANTIBODY EXERTING THERAPEUTIC POTENTIAL FOR SYSTEMIC LUPUS ERYTHEMATOSUS
3018, 3o45H, 0.5592, 3.58, 0.102, 220, 88, CRYSTAL STRUCTURE OF 101F FAB BOUND TO 17-MER PEPTIDE EPITOPE
3019, 2p9rA, 0.5592, 3.20, 0.128, 102, 86, HUMAN ALPHA2-MACROGLOGULIN IS COMPOSED OF MULTIPLE DOMAINS AS PREDICTED BY HOMOLOGY WITH COMPLEMENT COMPONENT C3
3020, 1yylR, 0.5592, 3.50, 0.092, 229, 87, CRYSTAL STRUCTURE OF CD4M33 A SCORPION-TOXIN MIMIC OF CD4 IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
3021, 1uunB, 0.5592, 3.98, 0.042, 184, 96, MAIN PORIN FROM MYCOBACTERIA SMEGMATIS (MSPA)
3022, 1tdqA, 0.5592, 3.29, 0.046, 271, 87, STRUCTURAL BASIS FOR THE INTERACTIONS BETWEEN TENASCINS AND THE C-TYPE LECTIN DOMAINS FROM LECTICANS: EVIDENCE FOR A CROSS-LINKING ROLE FOR TENASCINS
3023, 6fp6T, 0.5591, 3.68, 0.063, 223, 95, COMPLEX OF HUMAN CU;ZN SOD1 WITH THE HUMAN COPPER CHAPERONE FOR SOD1 IN A COMPACT CONFORMATION 
3024, 6dzrH, 0.5591, 3.45, 0.069, 220, 87, CRYSTAL STRUCTURE OF H38C2 K99R MUTATION 
3025, 5w1kO, 0.5591, 3.01, 0.071, 225, 84, JUNV GP1 CR1-10 FAB CR1-28 FAB COMPLEX 
3026, 5cexB, 0.5591, 3.27, 0.082, 233, 85, CRYSTAL STRUCTURE OF FAB 32H+109L A PUTATIVE PRECURSOR OF THE PGT121 FAMILY OF POTENT HIV-1 ANTIBODIES
3027, 4ywgI, 0.5591, 3.18, 0.012, 226, 86, CRYSTAL STRUCTURE OF 830A IN COMPLEX WITH V1V2
3028, 4w2pA, 0.5591, 3.27, 0.081, 126, 86, ANTI-MARBURGVIRUS NUCLEOPROTEIN SINGLE DOMAIN ANTIBODY C
3029, 4no0D, 0.5591, 3.07, 0.047, 192, 86, CRYSTAL STRUCTURE OF NON-PHOSPHORYLATED FORM OF RQA_V PHOSPHOPEPTIDE BOUND TO HLA-A2 IN COMPLEX WITH LILRB1
3030, 4i0pE, 0.5591, 2.90, 0.107, 188, 84, HLA-DO IN COMPLEX WITH HLA-DM
3031, 4bq9A, 0.5591, 3.33, 0.077, 205, 91, CRYSTAL STRUCTURE OF THE FN5 AND FN6 DOMAINS OF NEO1 FORM 1
3032, 2ygvA, 0.5591, 3.60, 0.080, 154, 87, CONSERVED N-TERMINAL DOMAIN OF THE YEAST HISTONE CHAPERONE ASF1 IN COMPLEX WITH THE C-TERMINAL FRAGMENT OF RAD53
3033, 1moeB, 0.5591, 3.52, 0.068, 240, 88, THE THREE-DIMENSIONAL STRUCTURE OF AN ENGINEERED SCFV T84.66 DIMER OR DIABODY IN VL TO VH LINKAGE.
3034, 1efxE, 0.5591, 2.94, 0.036, 197, 84, STRUCTURE OF A COMPLEX BETWEEN THE HUMAN NATURAL KILLER CELL RECEPTOR KIR2DL2 AND A CLASS I MHC LIGAND HLA-CW3
3035, 5yavB, 0.5590, 4.05, 0.064, 146, 94, FRAGMENT-BASED DRUG DISCOVERY OF INHIBITORS TO BLOCK PDEDELTA-RAS PROTEIN-PROTEIN INTERACTION 
3036, 5vgpB, 0.5590, 3.22, 0.047, 209, 85, FC FRAGMENT OF HUMAN IGG1 ANTIBODY; FROM NIST MAB 
3037, 5kzsA, 0.5590, 3.52, 0.112, 324, 89, LISTERIA MONOCYTOGENES INTERNALIN-LIKE PROTEIN LMO2027
3038, 5k65A, 0.5590, 3.18, 0.047, 215, 85, CRYSTAL STRUCTURE OF VEGF BINDING IGG1-FC (FCAB CT6)
3039, 5jueH, 0.5590, 3.47, 0.080, 225, 87, CRYSTAL STRUCTURE OF UIC2 FAB
3040, 5b6fF, 0.5590, 2.96, 0.096, 212, 83, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF AN ANTI-LEUKOTRIENE C4 MONOCLONAL ANTIBODY COMPLEXED WITH LTC4
3041, 4z8fH, 0.5590, 3.54, 0.092, 226, 87, FAB STRUCTURE OF ANTIBODY S1-15 IN COMPLEX WITH SSDNA DNA 5 -P5(DT)P- 3 
3042, 4p1yB, 0.5590, 3.70, 0.066, 264, 91, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL GAMMA-HEMOLYSIN PREPORE
3043, 4hqqL, 0.5590, 3.06, 0.071, 212, 85, CRYSTAL STRUCTURE OF RV144-ELICITED ANTIBODY CH58
3044, 3amlA, 0.5590, 3.09, 0.025, 693, 81, STRUCTURE OF THE STARCH BRANCHING ENZYME I (BEI) FROM ORYZA SATIVA L
3045, 2y07H, 0.5590, 3.23, 0.047, 215, 86, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-(4-HYDROXY-3- NITROPHENYL) -ACETYL MURINE GERMLINE MONOCLONAL ANTIBODY BBE6.12H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE PPYPAWHAPGNI
3046, 2vq1F, 0.5590, 3.43, 0.105, 211, 86, ANTI TRIMERIC LEWIS X FAB54-5C10-A
3047, 1w15A, 0.5590, 3.07, 0.094, 132, 85, RAT SYNAPTOTAGMIN 4 C2B DOMAIN IN THE PRESENCE OF CALCIUM
3048, 1t4kD, 0.5590, 3.17, 0.070, 217, 86, CRYSTAL STRUCTURE OF UNLIGANDED ALDOLASE ANTIBODY 93F3 FAB
3049, 1cicD, 0.5590, 3.53, 0.080, 218, 88, IDIOTOPE-ANTI-IDIOTOPE FAB-FAB COMPLEX; D1.3-E225
3050, 1cf1A, 0.5590, 3.56, 0.064, 373, 94, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
3051, 1a3rH, 0.5590, 3.27, 0.057, 212, 88, FAB FRAGMENT (ANTIBODY 8F5) COMPLEXED WITH PEPTIDE FROM HUMAN RHINOVIRUS (SEROTYPE 2) VIRAL CAPSID PROTEIN VP2 (RESIDUES 156-170)
3052, 6mtjD, 0.5589, 3.32, 0.035, 128, 85, CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-378806 IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 2.9 ANGSTROM 
3053, 6jhhA, 0.5589, 2.94, 0.099, 642, 81, CRYSTAL STRUCTURE OF MUTANT D350A OF PULLULANASE FROM PAENIBACILLUS BARENGOLTZII COMPLEXED WITH MALTOTRIOSE 
3054, 6iebH, 0.5589, 3.05, 0.048, 211, 84, STRUCTURE OF RVFV GN AND HUMAN MONOCLONAL ANTIBODY R15 
3055, 6gffN, 0.5589, 3.22, 0.059, 118, 85, STRUCTURE OF GARP (LRRC32) IN COMPLEX WITH LATENT TGF-BETA1 AND MHG-8 FAB 
3056, 5w0pA, 0.5589, 3.85, 0.081, 847, 99, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN DETERMINED BY X-RAY FREE ELECTRON LASER
3057, 5tkjG, 0.5589, 3.29, 0.047, 208, 86, STRUCTURE OF VACCINE-ELICITED DIVERSE HIV-1 NEUTRALIZING ANTIBODY VFP1.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519
3058, 4rqsD, 0.5589, 3.62, 0.091, 223, 88, CRYSTAL STRUCTURE OF FULLY GLYCOSYLATED HIV-1 GP120 CORE BOUND TO CD4 AND 17B FAB
3059, 4oduH, 0.5589, 3.57, 0.092, 224, 87, UNLIGANDED FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY S1-15
3060, 3w14F, 0.5589, 3.07, 0.058, 580, 86, INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1CRL2 FNIII-1 AND ALPHACT PEPTIDE IN COMPLEX WITH BOVINE INSULIN AND FAB 83-14
3061, 3w14E, 0.5589, 3.08, 0.058, 580, 86, INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1CRL2 FNIII-1 AND ALPHACT PEPTIDE IN COMPLEX WITH BOVINE INSULIN AND FAB 83-14
3062, 3q1sH, 0.5589, 3.45, 0.034, 211, 87, HIV-1 NEUTRALIZING ANTIBODY Z13E1 IN COMPLEX WITH EPITOPE DISPLAY PROTEIN
3063, 3okkB, 0.5589, 3.48, 0.103, 217, 87, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.4)KDO
3064, 3okeB, 0.5589, 3.46, 0.092, 217, 87, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KO
3065, 3g9hA, 0.5589, 3.74, 0.115, 262, 96, CRYSTAL STRUCTURE OF THE C-TERMINAL MU HOMOLOGY DOMAIN OF SYP1
3066, 2chdA, 0.5589, 3.10, 0.118, 128, 85, CRYSTAL STRUCTURE OF THE C2A DOMAIN OF RABPHILIN-3A
3067, 1i1cA, 0.5589, 2.98, 0.060, 205, 83, NON-FCRN BINDING FC FRAGMENT OF RAT IGG2A
3068, 1afvK, 0.5589, 3.47, 0.080, 220, 88, HIV-1 CAPSID PROTEIN (P24) COMPLEX WITH FAB25.3
3069, 6nf2W, 0.5588, 3.16, 0.047, 125, 85, CRYO-EM STRUCTURE OF VACCINE-ELICITED ANTIBODY 0PV-C.01 IN COMPLEX WITH HIV-1 ENV BG505 DS-SOSIP AND ANTIBODIES VRC03 AND PGT122 
3070, 6nf2O, 0.5588, 3.16, 0.047, 125, 85, CRYO-EM STRUCTURE OF VACCINE-ELICITED ANTIBODY 0PV-C.01 IN COMPLEX WITH HIV-1 ENV BG505 DS-SOSIP AND ANTIBODIES VRC03 AND PGT122 
3071, 6nf2H, 0.5588, 3.16, 0.047, 125, 85, CRYO-EM STRUCTURE OF VACCINE-ELICITED ANTIBODY 0PV-C.01 IN COMPLEX WITH HIV-1 ENV BG505 DS-SOSIP AND ANTIBODIES VRC03 AND PGT122 
3072, 6ncxC, 0.5588, 3.59, 0.055, 559, 91, CRYSTAL STRUCTURE OF GH2 BETA-GALACTURONIDASE FROM EISENBERGIELLA TAYI BOUND TO GALACTURONATE 
3073, 6hilD, 0.5588, 3.27, 0.034, 203, 89, X-RAY STRUCTURE OF TEAD1(Y421H MUTANT) COMPLEXED WITH YAP(WILDTYPE): MOLECULAR AND STRUCTURAL CHARACTERIZATION OF A TEAD MUTATION AT THE ORIGIN OF SVEINSSON S CHORIORETINAL ATROPHY 
3074, 5w2bH, 0.5588, 3.46, 0.103, 226, 87, CRYSTAL STRUCTURE OF C-TERMINAL DOMAIN OF EBOLA (RESTON) NUCLEOPROTEIN IN COMPLEX WITH FAB FRAGMENT 
3075, 5tuhB, 0.5588, 3.07, 0.145, 103, 83, ARCHAELLUM PERIPLASMIC STATOR PROTEIN FLAG FROM SULFOLOBUS ACIDOCALDARIUS
3076, 5tkjJ, 0.5588, 3.28, 0.047, 211, 86, STRUCTURE OF VACCINE-ELICITED DIVERSE HIV-1 NEUTRALIZING ANTIBODY VFP1.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519
3077, 4lhjB, 0.5588, 3.08, 0.047, 120, 85, RICIN A CHAIN BOUND TO CAMELID NANOBODY (VHH5)
3078, 4gjhA, 0.5588, 3.29, 0.080, 175, 88, CRYSTAL STRUCTURE OF THE TRAF DOMAIN OF TRAF5
3079, 3umnC, 0.5588, 3.54, 0.067, 118, 90, CRYSTAL STRUCTURE OF LAMIN-B1
3080, 3pgfH, 0.5588, 3.43, 0.081, 222, 86, CRYSTAL STRUCTURE OF MALTOSE BOUND MBP WITH A CONFORMATIONALLY SPECIFIC SYNTHETIC ANTIGEN BINDER (SAB)
3081, 3hqmA, 0.5588, 2.95, 0.120, 135, 83, STRUCTURES OF SPOP-SUBSTRATE COMPLEXES: INSIGHTS INTO MOLECULAR ARCHITECTURES OF BTB-CUL3 UBIQUITIN LIGASES: SPOPMATHX-CISBC2
3082, 2y7mA, 0.5588, 4.12, 0.086, 300, 93, STRUCTURE OF N-TERMINAL DOMAIN OF CANDIDA ALBICANS ALS9-2 (PT DERIVATIVE)
3083, 1fc2D, 0.5588, 2.95, 0.024, 206, 83, CRYSTALLOGRAPHIC REFINEMENT AND ATOMIC MODELS OF A HUMAN FC FRAGMENT AND ITS COMPLEX WITH FRAGMENT B OF PROTEIN A FROM STAPHYLOCOCCUS AUREUS AT 2.9-AND 2.8-ANGSTROMS RESOLUTION
3084, 6qw6S, 0.5587, 3.33, 0.068, 2001, 88, struct.pdbx_descriptor              
3085, 6mu6D, 0.5587, 3.36, 0.035, 128, 85, CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-814508 IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.2 ANGSTROM 
3086, 5o4eB, 0.5587, 3.17, 0.047, 216, 85, CRYSTAL STRUCTURE OF VEGF IN COMPLEX WITH HETERODIMERIC FCAB JANUSCT6
3087, 5eh1A, 0.5587, 2.81, 0.095, 209, 84, CRYSTAL STRUCTURE OF THE EXTRACELLULAR PART OF RECEPTOR 2 OF HUMAN INTERFERON GAMMA
3088, 5c92A, 0.5587, 3.22, 0.083, 481, 84, NOVEL FUNGAL ALCOHOL OXIDASE WITH CATALYTIC DIVERSITY AMONG THE AA5 FAMILY IN COMPLEX WITH COPPER
3089, 4utaH, 0.5587, 3.37, 0.081, 221, 86, CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C8
3090, 4p1yF, 0.5587, 3.84, 0.065, 264, 93, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL GAMMA-HEMOLYSIN PREPORE
3091, 4jo4H, 0.5587, 3.55, 0.093, 227, 86, CRYSTAL STRUCTURE OF RABBIT MAB R20 FAB
3092, 4i0pA, 0.5587, 2.92, 0.107, 188, 84, HLA-DO IN COMPLEX WITH HLA-DM
3093, 3u9pK, 0.5587, 3.13, 0.070, 200, 86, CRYSTAL STRUCTURE OF MURINE SIDEROCALIN IN COMPLEX WITH AN FAB FRAGMENT
3094, 2jhtA, 0.5587, 4.25, 0.052, 138, 96, CRYSTAL STRUCTURE OF RHOGDI K135TK138TK141T MUTANT
3095, 1l3nB, 0.5587, 3.63, 0.065, 153, 92, THE SOLUTION STRUCTURE OF REDUCED DIMERIC COPPER ZINC SOD: THE STRUCTURAL EFFECTS OF DIMERIZATION
3096, 1kf9E, 0.5587, 3.03, 0.058, 193, 86, PHAGE DISPLAY DERIVED VARIANT OF HUMAN GROWTH HORMONE COMPLEXED WITH TWO COPIES OF THE EXTRACELLULAR DOMAIN OF ITS RECEPTOR
3097, 6oyzE, 0.5586, 3.30, 0.082, 124, 85, CRYSTAL STRUCTURE OF MRAY BOUND TO CAPURAMYCIN 
3098, 6dg5C, 0.5586, 3.14, 0.034, 193, 89, STRUCTURE OF A DE NOVO DESIGNED INTERLEUKIN-2/INTERLEUKIN-15 MIMETIC COMPLEX WITH IL-2RB AND IL-2RG 
3099, 5i30H, 0.5586, 3.70, 0.091, 212, 88, CRYSTAL STRUCTURE OF THE HUMAN ASTROVIRUS 2 NEUTRALIZING MONOCLONAL ANTIBODY PL-2 FAB FRAGMENT AT 1.9 A RESOLUTION
3100, 5fb8B, 0.5586, 3.57, 0.045, 223, 88, STRUCTURE OF INTERLEUKIN-16 BOUND TO THE 14.1 ANTIBODY
3101, 4yo0A, 0.5586, 3.74, 0.068, 209, 88, CRYSTAL STRUCTURE OF MONOCLONAL ANTI-HUMAN PODOPLANIN ANTIBODY NZ-1 WITH BOUND PA PEPTIDE
3102, 4jv6B, 0.5586, 4.06, 0.064, 146, 94, THE CRYSTAL STRUCTURE OF PDE6D IN COMPLEX TO INHIBITOR-1
3103, 4hkzB, 0.5586, 3.44, 0.115, 221, 87, TRASTUZUMAB FAB COMPLEXED WITH PROTEIN L AND PROTEIN A FRAGMENTS
3104, 4dz8B, 0.5586, 2.89, 0.024, 205, 82, HUMAN IGG1 FC FRAGMENT HETERODIMER
3105, 3th1A, 0.5586, 3.42, 0.057, 246, 87, CRYSTAL STRUCTURE OF CHLOROCATECHOL 12-DIOXYGENASE FROM PSEUDOMONAS PUTIDA
3106, 3t5iC, 0.5586, 3.93, 0.097, 149, 93, STRUCTURE OF FULLY MODIFIED FARNESYLATED RHEB PEPTIDE IN COMPLEX WITH PDE6D
3107, 3qa3D, 0.5586, 3.42, 0.057, 224, 87, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
3108, 3p9wH, 0.5586, 3.33, 0.081, 122, 86, CRYSTAL STRUCTURE OF AN ENGINEERED HUMAN AUTONOMOUS VH DOMAIN IN COMPLEX WITH VEGF
3109, 1tzhB, 0.5586, 3.44, 0.103, 222, 87, CRYSTAL STRUCTURE OF THE FAB YADS1 COMPLEXED WITH H-VEGF
3110, 6oq5F, 0.5585, 3.44, 0.069, 116, 87, STRUCTURE OF THE FULL-LENGTH CLOSTRIDIUM DIFFICILE TOXIN B IN COMPLEX WITH 3 VHHS 
3111, 5jdrA, 0.5585, 2.84, 0.061, 209, 82, STRUCTURE OF PD-L1
3112, 5f6jB, 0.5585, 3.62, 0.103, 210, 87, CRYSTAL STRUCTURE OF TIER 2 NEUTRALIZING ANTIBODY DH427 FROM A RHESUS MACAQUE IN COMPLEX WITH HIV-1 GP120 CORE
3113, 4p1yH, 0.5585, 3.84, 0.065, 264, 93, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL GAMMA-HEMOLYSIN PREPORE
3114, 4bq6A, 0.5585, 3.29, 0.078, 205, 90, CRYSTAL STRUCTURE OF THE RGMB-NEO1 COMPLEX FORM 1
3115, 3qpxH, 0.5585, 3.17, 0.071, 228, 85, CRYSTAL STRUCTURE OF FAB C2507
3116, 2ybgB, 0.5585, 3.46, 0.087, 192, 92, STRUCTURE OF LYS120-ACETYLATED P53 CORE DOMAIN
3117, 2iqyA, 0.5585, 3.80, 0.082, 190, 97, RAT PHOSPHATIDYLETHANOLAMINE-BINDING PROTEIN
3118, 1a14H, 0.5585, 3.24, 0.035, 120, 85, COMPLEX BETWEEN NC10 ANTI-INFLUENZA VIRUS NEURAMINIDASE SINGLE CHAIN ANTIBODY WITH A 5 RESIDUE LINKER AND INFLUENZA VIRUS NEURAMINIDASE
3119, 6fp6N, 0.5584, 3.68, 0.063, 234, 95, COMPLEX OF HUMAN CU;ZN SOD1 WITH THE HUMAN COPPER CHAPERONE FOR SOD1 IN A COMPACT CONFORMATION 
3120, 5yc1A, 0.5584, 3.22, 0.058, 158, 86, TRAF4_GPIB COMPLEX
3121, 5w3lE, 0.5584, 3.49, 0.057, 116, 87, CRYOEM STRUCTURE OF RHINOVIRUS B14 IN COMPLEX WITH C5 FAB (4 DEGREES CELSIUS MOLAR RATIO 1:3 FULL PARTICLE)
3122, 5lobC, 0.5584, 3.16, 0.106, 138, 85, STRUCTURE OF THE CA2+-BOUND RABPHILIN3A C2B- SNAP25 COMPLEX (C2 SPACE GROUP)
3123, 5f6jH, 0.5584, 3.61, 0.103, 210, 87, CRYSTAL STRUCTURE OF TIER 2 NEUTRALIZING ANTIBODY DH427 FROM A RHESUS MACAQUE IN COMPLEX WITH HIV-1 GP120 CORE
3124, 3ux9B, 0.5584, 3.75, 0.067, 229, 89, STRUCTURAL INSIGHTS INTO A HUMAN ANTI-IFN ANTIBODY EXERTING THERAPEUTIC POTENTIAL FOR SYSTEMIC LUPUS ERYTHEMATOSUS
3125, 2znwB, 0.5584, 3.36, 0.081, 221, 86, CRYSTAL STRUCTURE OF SCFV10 IN COMPLEX WITH HEN EGG LYSOZYME
3126, 2g5bD, 0.5584, 3.59, 0.080, 216, 88, CRYSTAL STRUCTURE OF THE ANTI-BAX MONOCLONAL ANTIBODY 6A7 AND A BAX PEPTIDE.
3127, 1eaqA, 0.5584, 3.69, 0.094, 121, 96, THE RUNX1 RUNT DOMAIN AT 1.25A RESOLUTION: A STRUCTURAL SWITCH AND SPECIFICALLY BOUND CHLORIDE IONS MODULATE DNA BINDING
3128, 1dl7H, 0.5584, 2.78, 0.061, 112, 82, THE STRUCTURAL BASIS OF REPERTOIRE SHIFT IN AN IMMUNE RESPONSE TO PHOSPHOCHOLINE
3129, 6nm6D, 0.5583, 3.33, 0.035, 128, 85, CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO N6 FR3-03 SCFV IN COMPLEX WITH CRYSTALLIZATION CHAPERONES 3H109L FAB AND 35O22 SCFV AT 3.2 ANGSTROM 
3130, 6hn5E, 0.5583, 3.22, 0.079, 584, 89, LEUCINE-ZIPPERED HUMAN INSULIN RECEPTOR ECTODOMAIN WITH SINGLE BOUND INSULIN -  UPPER  MEMBRANE-DISTAL PART 
3131, 6fysD, 0.5583, 3.50, 0.058, 127, 86, STRUCTURE OF SINGLE DOMAIN ANTIBODY SD83 
3132, 6a4kJ, 0.5583, 3.59, 0.080, 230, 88, HUMAN ANTIBODY 32D6 FAB IN COMPLEX WITH H1N1 INFLUENZA A VIRUS HA1 
3133, 5wvsA, 0.5583, 2.94, 0.099, 642, 81, CATALYTIC MECHANISM CYCLODEXTRIN INHIBITION AND ALLOSTERIC REGULATION OF PAENIBACILLUS BARENGOLTZII PULLLULANASE
3134, 5jw4S, 0.5583, 3.04, 0.036, 223, 84, STRUCTURE OF MEDI8852 FAB FRAGMENT IN COMPLEX WITH H5 HA
3135, 5emwC, 0.5583, 3.31, 0.067, 207, 90, CRYSTAL STRUCTURE OF THE PALMITOYLATED HUMAN TEAD3 TRANSCRIPTION FACTOR
3136, 5dq8A, 0.5583, 3.26, 0.067, 193, 89, CRYSTAL STRUCTURE OF HUMAN TRANSCRIPTION FACTOR TEAD2 IN COMPLEX WITH FLUFENAMIC ACID
3137, 5c6wH, 0.5583, 3.61, 0.056, 236, 89, ANTI-CXCL13 SCFV - E10
3138, 4lo9D, 0.5583, 3.47, 0.087, 194, 92, HUMAN P53 CORE DOMAIN MUTANT N235K
3139, 4bq7B, 0.5583, 3.29, 0.078, 202, 90, CRYSTAL STRUCTURE OF THE RGMB-NEO1 COMPLEX FORM 2
3140, 4bq7A, 0.5583, 3.29, 0.078, 202, 90, CRYSTAL STRUCTURE OF THE RGMB-NEO1 COMPLEX FORM 2
3141, 3fjtB, 0.5583, 3.22, 0.047, 209, 85, CRYSTAL STRUCTURE OF A HUMAN FC FRAGMENT ENGINEERED FOR EXTENDED SERUM HALF-LIFE
3142, 2x11A, 0.5583, 2.96, 0.134, 488, 82, CRYSTAL STRUCTURE OF THE COMPLETE EPHA2 ECTODOMAIN IN COMPLEX WITH EPHRIN A5 RECEPTOR BINDING DOMAIN
3143, 2flbT, 0.5583, 2.82, 0.049, 151, 81, DISCOVERY OF A NOVEL HYDROXY PYRAZOLE BASED FACTOR IXA INHIBITOR
3144, 1oazH, 0.5583, 3.34, 0.047, 122, 86, IGE FV SPE7 COMPLEXED WITH A RECOMBINANT THIOREDOXIN
3145, 1dlfH, 0.5583, 3.09, 0.071, 120, 84, HIGH RESOLUTION CRYSTAL STRUCTURE OF THE FV FRAGMENT FROM AN ANTI-DANSYL SWITCH VARIANT ANTIBODY IGG2A(S) CRYSTALLIZED AT PH 5.25
3146, 1afvH, 0.5583, 3.47, 0.080, 220, 88, HIV-1 CAPSID PROTEIN (P24) COMPLEX WITH FAB25.3
3147, 6my4H, 0.5582, 3.50, 0.091, 223, 88, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98M;HC- G99M;LC-S30BR] 
3148, 6mu7D, 0.5582, 3.35, 0.035, 128, 85, CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-818251 IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.1 ANGSTROM 
3149, 5yc1B, 0.5582, 3.29, 0.058, 149, 86, TRAF4_GPIB COMPLEX
3150, 5nalB, 0.5582, 4.03, 0.064, 150, 94, THE CRYSTAL STRUCTURE OF INHIBITOR-15 COVALENTLY BOUND TO PDE6D
3151, 5h37I, 0.5582, 3.42, 0.045, 127, 88, CRYO-EM STRUCTURE OF ZIKA VIRUS COMPLEXED WITH FAB C10 AT PH 8.0
3152, 4tvsa, 0.5582, 3.48, 0.103, 128, 87, LAP1(AA356-583) H.SAPIENS BOUND TO VHH-BS1
3153, 4jg1H, 0.5582, 3.70, 0.080, 225, 88, STRUCTURE OF PHOSPHOSERINE/THREONINE (PSTAB) SCAFFOLD BOUND TO PTHR PEPTIDE
3154, 4fmrB, 0.5582, 3.83, 0.095, 231, 95, CRYSTAL STRUCTURE OF A PUTATIVE BACTERIAL DNA BINDING PROTEIN (BVU_2165) FROM BACTEROIDES VULGATUS ATCC 8482 AT 2.25 A RESOLUTION
3155, 3w11C, 0.5582, 3.39, 0.068, 118, 88, INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1-CR IN COMPLEX WITH HUMAN INSULIN ALPHA-CT PEPTIDE(704-719) AND FAB 83-7
3156, 2r2eB, 0.5582, 3.40, 0.115, 221, 87, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
3157, 1oazJ, 0.5582, 3.34, 0.047, 122, 86, IGE FV SPE7 COMPLEXED WITH A RECOMBINANT THIOREDOXIN
3158, 1kemH, 0.5582, 3.29, 0.081, 218, 86, CATALYTIC ANTIBODY 28B4 FAB FRAGMENT
3159, 6a4kK, 0.5581, 3.58, 0.080, 230, 88, HUMAN ANTIBODY 32D6 FAB IN COMPLEX WITH H1N1 INFLUENZA A VIRUS HA1 
3160, 5xcuA, 0.5581, 3.46, 0.046, 171, 87, CRYSTAL STRUCTURE OF 12CA5 FV-CLASP FRAGMENT WITH ITS ANTIGEN PEPTIDE
3161, 5h30K, 0.5581, 3.44, 0.046, 127, 87, CRYO-EM STRUCTURE OF ZIKA VIRUS COMPLEXED WITH FAB C10 AT PH 6.5
3162, 5dk2E, 0.5581, 3.07, 0.036, 159, 84, FC HETERODIMER E356K/D399K + K392D/K409D
3163, 5dk2A, 0.5581, 3.25, 0.047, 207, 85, FC HETERODIMER E356K/D399K + K392D/K409D
3164, 4p1yD, 0.5581, 3.83, 0.065, 264, 93, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL GAMMA-HEMOLYSIN PREPORE
3165, 4opbA, 0.5581, 3.85, 0.032, 232, 94, AA13 LYTIC POLYSACCHARIDE MONOOXYGENASE FROM ASPERGILLUS ORYZAE
3166, 4i18A, 0.5581, 3.53, 0.080, 219, 87, CRYSTAL STRUCTURE OF HUMAN PROLACTIN RECEPTOR COMPLEXED WITH FAB FRAGMENT
3167, 3ivqB, 0.5581, 3.33, 0.094, 138, 85, STRUCTURES OF SPOP-SUBSTRATE COMPLEXES: INSIGHTS INTO MOLECULAR ARCHITECTURES OF BTB-CUL3 UBIQUITIN LIGASES: SPOPMATH-CISBC2
3168, 6ahdKB, 0.5580, 3.37, 0.068, 1699, 88, The Cryo-EM Structure of Human Pre-catalytic Spliceosome (B complex) at 3.8 angstrom resolution  
3169, 5n6uB, 0.5580, 3.92, 0.092, 811, 98, CRYSTAL STRUCTURE OF BETA-D-MANNOSIDASE FROM DICTYOGLOMUS THERMOPHILUM.
3170, 5jpmA, 0.5580, 3.79, 0.074, 651, 95, STRUCTURE OF THE COMPLEX OF HUMAN COMPLEMENT C4 WITH MASP-2 REBUILT USING IMDFF
3171, 5e0qA, 0.5580, 3.44, 0.103, 126, 87, CRYSTAL STRUCTURE OF THE NUP98 C-TERMINAL DOMAIN BOUND TO NANOBODY TP377
3172, 5d4qB, 0.5580, 3.23, 0.035, 208, 85, CRYSTAL STRUCTURE OF GASDALIE IGG1 FC
3173, 5b71B, 0.5580, 3.35, 0.057, 222, 87, CRYSTAL STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH SKY59
3174, 4xvtH, 0.5580, 3.23, 0.058, 228, 86, CRYSTAL STRUCTURE OF HIV-1 93TH057 COREE GP120 WITH ANTIBODY 45- VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995)
3175, 4u6hA, 0.5580, 3.37, 0.058, 217, 86, VACCINIA L1/M12B9-FAB COMPLEX
3176, 4qlrA, 0.5580, 3.48, 0.093, 130, 86, LLAMA NANOBODY N02 RAISED AGAINST EAEC T6SS TSSM
3177, 3se3C, 0.5580, 3.32, 0.081, 183, 86, HUMAN IFNA2-IFNAR TERNARY COMPLEX
3178, 3ft1C, 0.5580, 2.95, 0.074, 99, 81, CRYSTAL STRUCTURE OF POLLEN ALLERGEN PHL P 3
3179, 2g5bH, 0.5580, 3.61, 0.080, 216, 88, CRYSTAL STRUCTURE OF THE ANTI-BAX MONOCLONAL ANTIBODY 6A7 AND A BAX PEPTIDE.
3180, 2cm6B, 0.5580, 3.14, 0.094, 148, 85, CRYSTAL STRUCTURE OF THE C2B DOMAIN OF RABPHILIN3A
3181, 6gjqH, 0.5579, 3.34, 0.103, 121, 87, HUMAN NBD1 OF CFTR IN COMPLEX WITH NANOBODY T27 
3182, 5vu0A, 0.5579, 3.18, 0.024, 215, 85, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN AFUCOSYLATED/GALACTOSYLATED HUMAN IGG1 FC AND FC GAMMA RECEPTOR IIIA (CD16A) WITH MAN5 N-GLYCANS 
3183, 5vicH, 0.5579, 3.62, 0.103, 219, 87, CRYSTAL STRUCTURE OF ANTI-ZIKA ANTIBODY Z004 BOUND TO DENV-1 ENVELOPE PROTEIN DIII
3184, 5n6uC, 0.5579, 3.97, 0.081, 811, 99, CRYSTAL STRUCTURE OF BETA-D-MANNOSIDASE FROM DICTYOGLOMUS THERMOPHILUM.
3185, 5mhsH, 0.5579, 3.52, 0.057, 201, 87, T1L REOVIRUS SIGMA1 COMPLEXED WITH 5C6 FAB FRAGMENTS
3186, 4w2qA, 0.5579, 3.36, 0.081, 116, 86, ANTI-MARBURGVIRUS NUCLEOPROTEIN SINGLE DOMAIN ANTIBODY C COMPLEXED WITH NUCLEOPROTEIN C-TERMINAL DOMAIN
3187, 4p99D, 0.5579, 2.97, 0.145, 415, 83, CA2+-STABILIZED ADHESIN HELPS AN ANTARCTIC BACTERIUM REACH OUT AND BIND ICE
3188, 3hkfA, 0.5579, 3.03, 0.036, 205, 84, MURINE UNGLYCOSYLATED IGG FC FRAGMENT
3189, 3dnkA, 0.5579, 2.94, 0.024, 209, 83, ENZYME DEGLYCOSYLATED HUMAN IGG1 FC FRAGMENT
3190, 3bisA, 0.5579, 2.84, 0.061, 212, 82, CRYSTAL STRUCTURE OF THE PD-L1
3191, 1uj3C, 0.5579, 3.06, 0.149, 205, 87, CRYSTAL STRUCTURE OF A HUMANIZED FAB FRAGMENT OF ANTI- TISSUE-FACTOR ANTIBODY IN COMPLEX WITH TISSUE FACTOR
3192, 1j05H, 0.5579, 3.22, 0.047, 121, 86, THE CRYSTAL STRUCTURE OF ANTI-CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY T84.66 FV FRAGMENT
3193, 6mxsH, 0.5578, 3.42, 0.115, 217, 87, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98F;HC- G99M] 
3194, 6gkdS, 0.5578, 3.34, 0.057, 123, 87, HUMAN NBD1 OF CFTR IN COMPLEX WITH NANOBODIES D12 AND G3A 
3195, 5vcnD, 0.5578, 3.31, 0.058, 213, 86, THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 5H8
3196, 5tkjD, 0.5578, 3.30, 0.047, 211, 86, STRUCTURE OF VACCINE-ELICITED DIVERSE HIV-1 NEUTRALIZING ANTIBODY VFP1.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519
3197, 5tkjA, 0.5578, 3.30, 0.047, 211, 86, STRUCTURE OF VACCINE-ELICITED DIVERSE HIV-1 NEUTRALIZING ANTIBODY VFP1.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519
3198, 4wtxA, 0.5578, 3.07, 0.080, 97, 87, CRYSTAL STRUCTURE OF THE FOURTH FNIII DOMAIN OF INTEGRIN BETA4
3199, 4utaI, 0.5578, 3.38, 0.081, 211, 86, CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C8
3200, 4pp1D, 0.5578, 3.31, 0.058, 213, 86, THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 5H8
3201, 4oduA, 0.5578, 3.52, 0.080, 219, 87, UNLIGANDED FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY S1-15
3202, 4m4eC, 0.5578, 3.61, 0.056, 170, 89, TRAF DOMAIN OF HUMAN TRAF4
3203, 4bqbD, 0.5578, 3.35, 0.077, 203, 91, CRYSTAL STRUCTURE OF THE FN5 AND FN6 DOMAINS OF NEO1 FORM 2
3204, 3w9dC, 0.5578, 3.26, 0.071, 211, 85, STRUCTURE OF HUMAN MONOCLONAL ANTIBODY E317 FAB
3205, 2v17H, 0.5578, 3.61, 0.114, 222, 88, STRUCTURE OF THE COMPLEX OF ANTIBODY MN423 WITH A FRAGMENT OF TAU PROTEIN
3206, 2a9nH, 0.5578, 3.41, 0.069, 126, 87, A MUTATION DESIGNED TO ALTER CRYSTAL PACKING PERMITS STRUCTURAL ANALYSIS OF A TIGHT-BINDING FLUORESCEIN-SCFV COMPLEX
3207, 1s5iH, 0.5578, 3.17, 0.058, 220, 86, FAB (LNKB-2) OF MONOCLONAL ANTIBODY TO HUMAN INTERLEUKIN-2 CRYSTAL STRUCTURE
3208, 1cwvA, 0.5578, 3.42, 0.083, 484, 84, CRYSTAL STRUCTURE OF INVASIN: A BACTERIAL INTEGRIN-BINDING PROTEIN
3209, 6mu8D, 0.5577, 3.36, 0.035, 128, 85, CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-386150 IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.5 ANGSTROM 
3210, 6hilB, 0.5577, 3.26, 0.034, 203, 89, X-RAY STRUCTURE OF TEAD1(Y421H MUTANT) COMPLEXED WITH YAP(WILDTYPE): MOLECULAR AND STRUCTURAL CHARACTERIZATION OF A TEAD MUTATION AT THE ORIGIN OF SVEINSSON S CHORIORETINAL ATROPHY 
3211, 5yc1D, 0.5577, 3.24, 0.058, 161, 86, TRAF4_GPIB COMPLEX
3212, 5x74A, 0.5577, 4.07, 0.064, 150, 94, THE CRYSTAL STRUCTURE PDE DELTA IN COMPLEX WITH COMPOUND (R R)-1G
3213, 5h30G, 0.5577, 3.45, 0.046, 127, 87, CRYO-EM STRUCTURE OF ZIKA VIRUS COMPLEXED WITH FAB C10 AT PH 6.5
3214, 5dvoA, 0.5577, 2.88, 0.024, 205, 83, FC K392D/K409D HOMODIMER
3215, 4z95H, 0.5577, 3.54, 0.092, 226, 87, FAB STRUCTURE OF ANTIBODY S1-15 IN COMPLEX WITH SSDNA DNA 5 -5(DT)-P- 3 
3216, 4z18A, 0.5577, 2.85, 0.061, 212, 82, CRYSTAL STRUCTURE OF HUMAN PD-L1
3217, 4xwoU, 0.5577, 3.54, 0.103, 214, 87, STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF SEC22
3218, 4jvbB, 0.5577, 3.98, 0.065, 146, 93, CRYSTAL STRUCTURE OF PDE6D IN COMPLEX WITH THE INHIBITOR RAC-2
3219, 3zjbB, 0.5577, 3.47, 0.057, 184, 88, THE STRUCTURE OF THE TRAF DOMAIN OF HUMAN TRAF4
3220, 3wyrA, 0.5577, 2.94, 0.060, 189, 84, CRYSTAL STRUCTURE OF KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR 2DL4
3221, 3bdxC, 0.5577, 3.01, 0.083, 111, 84, CRYSTAL STRUCTURE OF THE UNSTABLE AND HIGHLY FIBRILLOGENIC PRO7SER MUTANT OF THE RECOMBINANT VARIABLE DOMAIN 6AJL2
3222, 2ocjD, 0.5577, 3.47, 0.087, 194, 92, HUMAN P53 CORE DOMAIN IN THE ABSENCE OF DNA
3223, 2cr2A, 0.5577, 3.33, 0.105, 159, 86, SOLUTION STRUCTURE OF N-TERMINAL DOMAIN OF SPECKLE-TYPE POZ PROTEIN
3224, 1ibgH, 0.5577, 3.43, 0.080, 217, 87, STRUCTURE AND SPECIFICITY OF THE ANTI-DIGOXIN ANTIBODY 40-50
3225, 1fl6B, 0.5577, 3.40, 0.093, 219, 86, THE HAPTEN COMPLEXED GERMLINE PRECURSOR TO SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4
3226, 6ayzA, 0.5576, 3.38, 0.071, 149, 85, CRYSTAL STRUCTURE OF ASF1-FAB 12E COMPLEX
3227, 5xhvP, 0.5576, 3.10, 0.108, 223, 83, CRYSTAL STRUCTURE OF FAB S40 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ HA1 SUBUNIT.
3228, 5wwbA, 0.5576, 2.94, 0.099, 645, 81, CATALYTIC MECHANISM CYCLODEXTRIN INHIBITION AND ALLOSTERIC REGULATION OF PAENIBACILLUS BARENGOLTZII PULLLULANASE
3229, 5ukoH, 0.5576, 3.22, 0.059, 226, 85, STRUCTURE OF UNLIGANDED ANTI-GP120 CD4BS ANTIBODY DH522IA FAB
3230, 5gqxA, 0.5576, 3.13, 0.061, 755, 82, CRYSTAL STRUCTURE OF BRANCHING ENZYME W610N MUTANT FROM CYANOTHECE SP. ATCC 51142 IN COMPLEX WITH MALTOHEPTAOSE
3231, 4xmkI, 0.5576, 3.25, 0.081, 217, 86, CRYSTAL STRUCTURE OF FAB OF HIV-1 GP120 V3-SPECIFIC HUMAN MONOCLONAL ANTIBODY 2424 IN COMPLEX WITH JR-FL V3 PEPTIDE
3232, 4tw1A, 0.5576, 3.79, 0.032, 281, 93, CRYSTAL STRUCTURE OF THE OCTAMERIC PORE COMPLEX OF THE STAPHYLOCOCCUS AUREUS BI-COMPONENT TOXIN LUKGH
3233, 4k3hB, 0.5576, 2.99, 0.060, 109, 84, IMMUNOGLOBULIN LAMBDA VARIABLE DOMAIN L5(L89S) FLUOROGEN ACTIVATIONG PROTEIN IN COMPLEX WITH MALACHITE GREEN
3234, 3npsB, 0.5576, 3.53, 0.068, 226, 88, CRYSTAL STRUCTURE OF MEMBRANE-TYPE SERINE PROTEASE 1 (MT-SP1) IN COMPLEX WITH THE FAB INHIBITOR S4
3235, 3lzfH, 0.5576, 3.63, 0.091, 216, 88, CRYSTAL STRUCTURE OF FAB 2D1 IN COMPLEX WITH THE 1918 INFLUENZA VIRUS HEMAGGLUTININ
3236, 2y7nA, 0.5576, 3.82, 0.065, 311, 92, STRUCTURE OF N-TERMINAL DOMAIN OF CANDIDA ALBICANS ALS9-2 - APO FORM
3237, 1r24B, 0.5576, 3.34, 0.047, 217, 85, FAB FROM MURINE IGG3 KAPPA
3238, 1op3M, 0.5576, 3.62, 0.045, 224, 88, CRYSTAL STRUCTURE OF FAB 2G12 BOUND TO MAN1->2MAN
3239, 1majA, 0.5576, 3.03, 0.059, 113, 85, SOLUTION STRUCTURE OF AN ISOLATED ANTIBODY VL DOMAIN
3240, 1lf6A, 0.5576, 3.47, 0.102, 674, 88, CRYSTAL STRUCTURE OF BACTERIAL GLUCOAMYLASE
3241, 1jnhD, 0.5576, 3.36, 0.058, 214, 86, CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES
3242, 6fysB, 0.5575, 3.32, 0.059, 127, 85, STRUCTURE OF SINGLE DOMAIN ANTIBODY SD83 
3243, 6fgoC, 0.5575, 3.23, 0.047, 208, 85, FC IN COMPLEX WITH ENGINEERED CALCIUM BINDING DOMAIN Z 
3244, 6do1D, 0.5575, 3.37, 0.069, 126, 87, STRUCTURE OF NANOBODY-STABILIZED ANGIOTENSIN II TYPE 1 RECEPTOR BOUND TO S1I8 
3245, 5z2qA, 0.5575, 3.34, 0.056, 219, 90, VGLL1-TEAD4 CORE COMPLEX
3246, 5utzB, 0.5575, 3.38, 0.081, 219, 86, HUMAN IL-2/FAB COMPLEX 
3247, 5ob5H, 0.5575, 3.31, 0.071, 220, 85, FAB COMPLEX WITH GROBETA. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION-MAKING IN ANTIBODY DRUG DISCOVERY.
3248, 5iusB, 0.5575, 3.04, 0.058, 115, 86, CRYSTAL STRUCTURE OF HUMAN PD-L1 IN COMPLEX WITH HIGH AFFINITY PD-1 MUTANT
3249, 4xcyJ, 0.5575, 3.38, 0.070, 221, 86, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDYLGLYCEROL (06:0 PG)
3250, 4ibsA, 0.5575, 3.46, 0.087, 193, 92, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R273H (FORM I)
3251, 3turB, 0.5575, 3.40, 0.099, 269, 91, CRYSTAL STRUCTURE OF M. TUBERCULOSIS LD-TRANSPEPTIDASE TYPE 2 COMPLEXED WITH A PEPTIDOGLYCAN FRAGMENT
3252, 3mj8H, 0.5575, 3.21, 0.083, 211, 84, CRYSTAL STRUCTURE OF HL4E10 FAB A HAMSTER AB STIMULATORY FOR GAMMADELTA T CELLS
3253, 3auvF, 0.5575, 3.25, 0.093, 224, 86, PREDICTING AMINO ACID PREFERENCES IN THE COMPLEMENTARITY DETERMINING REGIONS OF AN ANTIBODY-ANTIGEN RECOGNITION INTERFACE
3254, 2gjzH, 0.5575, 3.30, 0.058, 221, 86, STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 13G5 FROM A CRYSTAL IN SPACE GROUP P2(1)
3255, 1qtpA, 0.5575, 3.85, 0.020, 243, 98, CRYSTAL STRUCTURE OF THE AP-2 CLATHRIN ADAPTOR ALPHA- APPENDAGE
3256, 6oq6D, 0.5574, 3.59, 0.080, 128, 88, STRUCTURE OF THE PORE FORMING FRAGMENT OF CLOSTRIDIUM DIFFICILE TOXIN B IN COMPLEX WITH VHH 5D 
3257, 6mtnD, 0.5574, 3.38, 0.035, 128, 85, CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR COMPOUND 484 IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.0 ANGSTROM 
3258, 6mqmA, 0.5574, 3.21, 0.047, 222, 86, VACCINE-ELICITED NHP FP-TARGETING NEUTRALIZING ANTIBODY DF1W-A.01 IN COMPLEX WITH HIV FUSION PEPTIDE (RESIDUE 512-519) 
3259, 6jhgA, 0.5574, 2.97, 0.099, 644, 81, CRYSTAL STRUCTURE OF APO PULLULANASE FROM PAENIBACILLUS BARENGOLTZII IN SPACE GROUP P212121 
3260, 6hygA, 0.5574, 3.27, 0.057, 416, 87, HETEROMERIC TANDEM IGG4/IGG1 FC 
3261, 6ddvB, 0.5574, 3.41, 0.057, 222, 87, CRYSTAL STRUCTURE ANALYSIS OF THE EPITOPE OF AN ANTI-MICA ANTIBODY 
3262, 5yc1C, 0.5574, 3.43, 0.057, 161, 87, TRAF4_GPIB COMPLEX
3263, 5u65B, 0.5574, 3.51, 0.092, 127, 87, CAMEL NANOBODY VHH-5
3264, 5tojE, 0.5574, 3.41, 0.093, 123, 86, CRYSTAL STRUCTURE OF THE RSV F GLYCOPROTEIN IN COMPLEX WITH THE NEUTRALIZING SINGLE-DOMAIN ANTIBODY F-VHH-4
3265, 5j11C, 0.5574, 3.30, 0.083, 190, 84, STRUCTURE OF HUMAN TSLP IN COMPLEX WITH TSLPR AND IL-7RALPHA
3266, 5iusA, 0.5574, 3.27, 0.035, 117, 86, CRYSTAL STRUCTURE OF HUMAN PD-L1 IN COMPLEX WITH HIGH AFFINITY PD-1 MUTANT
3267, 5f2uB, 0.5574, 3.96, 0.087, 148, 92, STRUCTURE OF FULLY MODIFIED FARNESYLATED INPP5E PEPTIDE IN COMPLEX WITH PDE6D
3268, 4xmkJ, 0.5574, 3.24, 0.081, 216, 86, CRYSTAL STRUCTURE OF FAB OF HIV-1 GP120 V3-SPECIFIC HUMAN MONOCLONAL ANTIBODY 2424 IN COMPLEX WITH JR-FL V3 PEPTIDE
3269, 4jo3H, 0.5574, 3.65, 0.069, 227, 87, CRYSTAL STRUCTURE OF RABBIT MAB R20 FAB IN COMPLEX WITH V3 C-TERMINUS OF HIV-1 CONSENSUS B GP120
3270, 4gbxC, 0.5574, 2.93, 0.107, 189, 84, CRYSTAL STRUCTURE OF AN IMMUNE COMPLEX AT PH 6.5
3271, 3lpgA, 0.5574, 3.14, 0.057, 590, 87, STRUCTURE OF E. COLI BETA-GLUCURONIDASE BOUND WITH A NOVEL POTENT INHIBITOR 3-(2-FLUOROPHENYL)-1-(2-HYDROXYETHYL)-1-((6-METHYL-2-OXO-1 2-DIHYDROQUINOLIN-3-YL)METHYL)UREA
3272, 3h3bD, 0.5574, 3.45, 0.079, 236, 89, CRYSTAL STRUCTURE OF THE SINGLE-CHAIN FV (SCFV) FRAGMENT OF AN ANTI- ERBB2 ANTIBODY CHA21 IN COMPLEX WITH RESIDUES 1-192 OF ERBB2 EXTRACELLULAR DOMAIN
3273, 2qk7A, 0.5574, 3.63, 0.098, 259, 92, A COVALENT S-F HETERODIMER OF STAPHYLOCOCCAL GAMMA-HEMOLYSIN
3274, 1uz6F, 0.5574, 3.29, 0.060, 208, 84, ANTI-LEWIS X FAB FRAGMENT UNCOMPLEXED
3275, 1ujtA, 0.5574, 3.30, 0.069, 120, 87, SOLUTION STRUCTURE OF THE SECOND FIBRONECTIN TYPE III DOMAIN OF HUMAN KIAA1568 PROTEIN
3276, 1s4iB, 0.5574, 3.64, 0.067, 152, 90, CRYSTAL STRUCTURE OF A SOD-LIKE PROTEIN FROM BACILLUS SUBTILIS
3277, 1ggiH, 0.5574, 3.35, 0.059, 215, 85, CRYSTAL STRUCTURE OF AN HIV-1 NEUTRALIZING ANTIBODY 50.1 IN COMPLEX WITH ITS V3 LOOP PEPTIDE ANTIGEN
3278, 1a7qH, 0.5574, 3.61, 0.068, 116, 88, FV FRAGMENT OF MOUSE MONOCLONAL ANTIBODY D1.3 (BALB/C IGG1 K) HIGH AFFINITY EXPRESSED VARIANT CONTAINING SER26L->GLY ILE29L->THR GLU81L->ASP THR97L->SER PRO240H->LEU ASP258H->ALA LYS281H->GLU ASN283H->ASP AND LEU312H->VAL
3279, 6mhrD, 0.5573, 3.47, 0.046, 217, 87, STRUCTURE OF THE HUMAN 4-1BB / URELUMAB FAB COMPLEX 
3280, 5xcsA, 0.5573, 3.43, 0.046, 168, 87, CRYSTAL STRUCTURE OF 12CA5 FV-CLASP FRAGMENT WITH ITS ANTIGEN PEPTIDE
3281, 5tojD, 0.5573, 3.51, 0.092, 126, 87, CRYSTAL STRUCTURE OF THE RSV F GLYCOPROTEIN IN COMPLEX WITH THE NEUTRALIZING SINGLE-DOMAIN ANTIBODY F-VHH-4
3282, 3vu2B, 0.5573, 3.27, 0.024, 691, 83, STRUCTURE OF THE STARCH BRANCHING ENZYME I (BEI) COMPLEXED WITH MALTOPENTAOSE FROM ORYZA SATIVA L
3283, 3kysC, 0.5573, 3.29, 0.033, 213, 90, CRYSTAL STRUCTURE OF HUMAN YAP AND TEAD COMPLEX
3284, 3ejaB, 0.5573, 3.78, 0.095, 208, 95, MAGNESIUM-BOUND GLYCOSIDE HYDROLASE 61 ISOFORM E FROM THIELAVIA TERRESTRIS
3285, 1xtmA, 0.5573, 3.98, 0.076, 152, 92, CRYSTAL STRUCTURE OF THE DOUBLE MUTANT Y88H-P104H OF A SOD-LIKE PROTEIN FROM BACILLUS SUBTILIS.
3286, 6gjqF, 0.5572, 3.36, 0.103, 121, 87, HUMAN NBD1 OF CFTR IN COMPLEX WITH NANOBODY T27 
3287, 6crkH, 0.5572, 3.41, 0.034, 236, 87, HETEROTRIMERIC G-PROTEIN IN COMPLEX WITH AN ANTIBODY FRAGMENT 
3288, 6ca9B, 0.5572, 3.29, 0.057, 229, 87, CRYSTAL STRUCTURE OF FAB PCT64_LMCA (SAR); THE LEAST MUTATED COMMON ANCESTOR OF THE HIV-1 BROADLY NEUTRALIZING ANTIBODY LINEAGE PCT64 
3289, 5wkoK, 0.5572, 3.33, 0.058, 225, 86, CRYSTAL STRUCTURE OF ANTIBODY 27F3 RECOGNIZING THE HA FROM A/CALIFORNIA/04/2009 (H1N1) INFLUENZA VIRUS
3290, 5o4eA, 0.5572, 3.19, 0.047, 209, 85, CRYSTAL STRUCTURE OF VEGF IN COMPLEX WITH HETERODIMERIC FCAB JANUSCT6
3291, 5n88H, 0.5572, 3.24, 0.071, 126, 85, CRYSTAL STRUCTURE OF ANTIBODY BOUND TO VIRAL PROTEIN
3292, 5hyiD, 0.5572, 3.03, 0.024, 209, 84, GLYCOSYLATED DISULFIDE-LINKED HOLE-HOLE FC FRAGMENT
3293, 5b6fD, 0.5572, 3.20, 0.107, 211, 84, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF AN ANTI-LEUKOTRIENE C4 MONOCLONAL ANTIBODY COMPLEXED WITH LTC4
3294, 4ynyA, 0.5572, 3.63, 0.057, 209, 87, CRYSTAL STRUCTURE OF MONOCLONAL ANTI-HUMAN PODOPLANIN ANTIBODY NZ-1
3295, 4umgA, 0.5572, 3.36, 0.115, 102, 87, CRYSTAL STRUCTURE OF THE LIN-41 FILAMIN DOMAIN
3296, 4oiaA, 0.5572, 3.07, 0.086, 374, 81, CRYSTAL STRUCTURE OF ICAM-5 D1-D4 ECTODOMAIN FRAGMENT SPACE GROUP P4322
3297, 4hs6B, 0.5572, 3.14, 0.035, 214, 86, HEPATITUS C ENVELOPE GLYCOPROTEIN E2 FRAGMENT 412-423 WITH HUMANIZED AND AFFINITY-MATURED ANTIBODY MRCT10.V362
3298, 4bq6B, 0.5572, 3.33, 0.077, 205, 91, CRYSTAL STRUCTURE OF THE RGMB-NEO1 COMPLEX FORM 1
3299, 3t0bB, 0.5572, 3.78, 0.063, 1015, 95, E. COLI (LACZ) BETA-GALACTOSIDASE (S796T) IPTG COMPLEX
3300, 3mbxH, 0.5572, 3.42, 0.094, 229, 85, CRYSTAL STRUCTURE OF CHIMERIC ANTIBODY X836
3301, 3ft1D, 0.5572, 2.97, 0.074, 99, 81, CRYSTAL STRUCTURE OF POLLEN ALLERGEN PHL P 3
3302, 2i5yR, 0.5572, 3.50, 0.092, 223, 87, CRYSTAL STRUCTURE OF CD4M47 A SCORPION-TOXIN MIMIC OF CD4 IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
3303, 2b4iB, 0.5572, 3.57, 0.161, 234, 87, CRYSTAL STRUCTURE OF THE RHESUS ROTAVIRUS VP5 ANTIGEN DOMAIN TRIMER
3304, 1yc8A, 0.5572, 3.46, 0.069, 116, 87, CABAN33- Y37V/E44G/R45L TRIPLE MUTANT
3305, 1t89B, 0.5572, 3.06, 0.036, 213, 84, CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (HEXAGONAL)
3306, 1qcnB, 0.5572, 3.99, 0.094, 403, 96, CRYSTAL STRUCTURE OF FUMARYLACETOACETATE HYDROLASE
3307, 1kyuA, 0.5572, 3.95, 0.020, 247, 99, AP-2 CLATHRIN ADAPTOR ALPHA-APPENDAGE IN COMPLEX WITH EPS15 DPF PEPTIDE
3308, 1beyH, 0.5572, 3.39, 0.080, 210, 87, ANTIBODY TO CAMPATH-1H HUMANIZED FAB
3309, 6q36B, 0.5571, 3.36, 0.044, 214, 90, TEAD4(216-434) COMPLEXED WITH OPTIMIZED PEPTIDE 9 AND MYRISTOATE (COVALENTLY BOUND) AT 2.01A RESOLUTION: STRUCTURE-BASED DESIGN OF POTENT LINEAR PEPTIDE INHIBITORS OF THE YAP-TEAD PROTEIN-PROTEIN INTERACTION DERIVED FROM THE YAP OMEGA-LOOP SEQUENCE 
3310, 6mhrA, 0.5571, 3.49, 0.057, 219, 87, STRUCTURE OF THE HUMAN 4-1BB / URELUMAB FAB COMPLEX 
3311, 6eynD, 0.5571, 3.35, 0.058, 194, 86, STRUCTURE OF THE 8D6 (ANTI-IGE) FAB 
3312, 6do1C, 0.5571, 3.44, 0.080, 125, 87, STRUCTURE OF NANOBODY-STABILIZED ANGIOTENSIN II TYPE 1 RECEPTOR BOUND TO S1I8 
3313, 5yncA, 0.5571, 3.04, 0.085, 1052, 82, CRYSTAL STRUCTURE OF PULLULANASE FROM KLEBSIELLA PNEUMONIAE COMPLEX AT 1 MM BETA-CYCLODEXTRIN 
3314, 5xmhA, 0.5571, 3.16, 0.047, 208, 85, CRYSTAL STRUCTURE OF AN IGM RHEUMATOID FACTOR YES8C IN COMPLEX WITH IGG1 FC
3315, 5k65B, 0.5571, 2.99, 0.036, 212, 83, CRYSTAL STRUCTURE OF VEGF BINDING IGG1-FC (FCAB CT6)
3316, 4yhkH, 0.5571, 3.52, 0.080, 222, 88, REVERSAL AGENT FOR DABIGATRAN
3317, 4x7tA, 0.5571, 3.69, 0.102, 222, 88, STRUCTURE OF OMALIZUMAB FAB FRAGMENT CRYSTAL FORM 2
3318, 4jfxB, 0.5571, 3.86, 0.079, 225, 89, STRUCTURE OF PHOSPHOTYROSINE (PTYR) SCAFFOLD BOUND TO PTYR PEPTIDE
3319, 3qxwB, 0.5571, 3.26, 0.071, 124, 84, FREE STRUCTURE OF AN ANTI-METHOTREXATE CDR1-4 GRAFT VHH ANTIBODY
3320, 3pnwH, 0.5571, 3.28, 0.058, 218, 86, CRYSTAL STRUCTURE OF THE TUDOR DOMAIN OF HUMAN TDRD3 IN COMPLEX WITH AN ANTI-TDRD3 FAB
3321, 3d48R, 0.5571, 3.29, 0.022, 195, 89, CRYSTAL STRUCTURE OF A PROLACTIN RECEPTOR ANTAGONIST BOUND TO THE EXTRACELLULAR DOMAIN OF THE PROLACTIN RECEPTOR
3322, 2ralB, 0.5571, 4.36, 0.087, 315, 104, CRYSTAL STRUCTURE ANALYSIS OF DOUBLE CYSTEINE MUTANT OF S.EPIDERMIDIS ADHESIN SDRG: EVIDENCE FOR THE DOCKLOCK AND LATCH LIGAND BINDING MECHANISM
3323, 2k3hA, 0.5571, 3.02, 0.107, 127, 84, STRUCTURAL DETERMINANTS FOR CA2+ AND PIP2 BINDING BY THE C2A DOMAIN OF RABPHILIN-3A
3324, 1yymR, 0.5571, 3.53, 0.092, 229, 87, CRYSTAL STRUCTURE OF F23 A SCORPION-TOXIN MIMIC OF CD4 IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
3325, 1nd0F, 0.5571, 3.11, 0.093, 222, 86, CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG
3326, 6gkdM, 0.5570, 3.35, 0.057, 124, 87, HUMAN NBD1 OF CFTR IN COMPLEX WITH NANOBODIES D12 AND G3A 
3327, 6cm3O, 0.5570, 3.25, 0.094, 127, 85, BG505 SOSIP IN COMPLEX WITH SCD4; 17B; 8ANC195 
3328, 5ww2A, 0.5570, 2.96, 0.087, 646, 80, CATALYTIC MECHANISM CYCLODEXTRIN INHIBITION AND ALLOSTERIC REGULATION OF PAENIBACILLUS BARENGOLTZII PULLLULANASE
3329, 5w1kI, 0.5570, 3.43, 0.034, 225, 88, JUNV GP1 CR1-10 FAB CR1-28 FAB COMPLEX 
3330, 4xcnA, 0.5570, 3.39, 0.081, 227, 86, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA); 2.9 A RESOLUTION
3331, 4x4yA, 0.5570, 3.16, 0.071, 119, 85, RETROFITTING ANTIBODIES WITH STABILIZING MUTATIONS. HERCEPTIN SCFV MUTANT K30D/S52D.
3332, 4rs1B, 0.5570, 3.25, 0.105, 267, 86, CRYSTAL STRUCTURE OF RECEPTOR-CYTOKINE COMPLEX
3333, 4p9hH, 0.5570, 3.41, 0.103, 215, 87, CRYSTAL STRUCTURE OF 8ANC195 FAB IN COMPLEX WITH GP120 OF 93TH057 HIV- 1 AND SOLUBLE CD4 D1D2
3334, 4m4eB, 0.5570, 3.27, 0.058, 166, 86, TRAF DOMAIN OF HUMAN TRAF4
3335, 4lgrB, 0.5570, 3.29, 0.094, 122, 85, RICIN A CHAIN BOUND TO CAMELID NANOBODY (VHH3)
3336, 3ck0H, 0.5570, 3.63, 0.080, 211, 87, ANTI-ANTI-IDIOTYPIC ANTIBODY AGAINST HUMAN ANGIOTENSIN II COMPLEX WITH HUMAN ANGIOTENSIN II
3337, 3c09C, 0.5570, 3.55, 0.092, 191, 87, CRYSTAL STRUCTURE THE FAB FRAGMENT OF MATUZUMAB (FAB72000) IN COMPLEX WITH DOMAIN III OF THE EXTRACELLULAR REGION OF EGFR
3338, 1t4kB, 0.5570, 3.17, 0.047, 217, 86, CRYSTAL STRUCTURE OF UNLIGANDED ALDOLASE ANTIBODY 93F3 FAB
3339, 1nd0D, 0.5570, 3.12, 0.093, 222, 86, CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG
3340, 1fe8J, 0.5570, 3.30, 0.059, 210, 85, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A FAB FRAGMENT OF IGG RU5 THAT INHIBITS COLLAGEN BINDING
3341, 1dqdH, 0.5570, 3.14, 0.047, 221, 86, CRYSTAL STRUCTURE OF FAB HGR-2 F6 A COMPETITIVE ANTAGONIST OF THE GLUCAGON RECEPTOR
3342, 6nqdK, 0.5569, 3.11, 0.094, 130, 85, CRYO-EM STRUCTURE OF T/F100 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH 8ANC195 FAB 
3343, 6nqdG, 0.5569, 3.11, 0.094, 130, 85, CRYO-EM STRUCTURE OF T/F100 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH 8ANC195 FAB 
3344, 6nqdC, 0.5569, 3.11, 0.094, 130, 85, CRYO-EM STRUCTURE OF T/F100 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH 8ANC195 FAB 
3345, 6n4bS, 0.5569, 3.13, 0.036, 232, 84, CANNABINOID RECEPTOR 1-G PROTEIN COMPLEX 
3346, 6jfjA, 0.5569, 2.96, 0.087, 646, 80, CRYSTAL STRUCTURE OF PULLULANASE FROM PAENIBACILLUS BARENGOLTZII COMPLEX WITH MALTOHEXAOSE AND ALPHA-CYCLODEXTRIN 
3347, 6j11H, 0.5569, 3.48, 0.011, 128, 88, MERS-COV SPIKE N-TERMINAL DOMAIN AND 7D10 SCFV COMPLEX 
3348, 6gjqB, 0.5569, 3.37, 0.103, 121, 87, HUMAN NBD1 OF CFTR IN COMPLEX WITH NANOBODY T27 
3349, 6eduT, 0.5569, 3.28, 0.093, 131, 86, B41 SOSIP.664 IN COMPLEX WITH SOLUBLE CD4 (D1-D2); THE CO-RECEPTOR MIMICKING ANTIBODY 21C AND THE BROADLY NEUTRALIZING ANTIBODY 8ANC195 
3350, 6eduR, 0.5569, 3.28, 0.093, 131, 86, B41 SOSIP.664 IN COMPLEX WITH SOLUBLE CD4 (D1-D2); THE CO-RECEPTOR MIMICKING ANTIBODY 21C AND THE BROADLY NEUTRALIZING ANTIBODY 8ANC195 
3351, 6eduP, 0.5569, 3.28, 0.093, 131, 86, B41 SOSIP.664 IN COMPLEX WITH SOLUBLE CD4 (D1-D2); THE CO-RECEPTOR MIMICKING ANTIBODY 21C AND THE BROADLY NEUTRALIZING ANTIBODY 8ANC195 
3352, 6db8H, 0.5569, 3.51, 0.102, 224, 88, STRUCTURAL BASIS FOR PROMISCUOUS BINDING AND ACTIVATION OF FLUOROGENIC DYES BY DIR2S RNA APTAMER 
3353, 6cm3M, 0.5569, 3.25, 0.094, 127, 85, BG505 SOSIP IN COMPLEX WITH SCD4; 17B; 8ANC195 
3354, 6cm3K, 0.5569, 3.25, 0.094, 127, 85, BG505 SOSIP IN COMPLEX WITH SCD4; 17B; 8ANC195 
3355, 6ca9D, 0.5569, 3.31, 0.057, 229, 87, CRYSTAL STRUCTURE OF FAB PCT64_LMCA (SAR); THE LEAST MUTATED COMMON ANCESTOR OF THE HIV-1 BROADLY NEUTRALIZING ANTIBODY LINEAGE PCT64 
3356, 6a67C, 0.5569, 3.51, 0.103, 222, 87, CRYSTAL STRUCTURE OF INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH THE FAB OF ANTIBODY FLD21.140 
3357, 6a4kH, 0.5569, 3.48, 0.080, 230, 87, HUMAN ANTIBODY 32D6 FAB IN COMPLEX WITH H1N1 INFLUENZA A VIRUS HA1 
3358, 5uelH, 0.5569, 3.42, 0.046, 232, 87, CRYSTAL STRUCTURE OF 354NC102 FAB
3359, 5kjrL, 0.5569, 3.18, 0.071, 212, 85, CRYSTAL STRUCTURE OF THE ADCC-POTENT ANTIBODY N60-I3 FAB IN COMPLEX WITH HIV-1 CLADE A/E GP120 W69A/S115W MUTANT AND M48U1.
3360, 5h30I, 0.5569, 3.45, 0.057, 127, 87, CRYO-EM STRUCTURE OF ZIKA VIRUS COMPLEXED WITH FAB C10 AT PH 6.5
3361, 5eiiH, 0.5569, 3.57, 0.103, 225, 87, STRUCTURAL DETERMINATION OF AN PROTEIN COMPLEX OF A FAB WITH INCREASED SOLUBILITY
3362, 4ybqF, 0.5569, 3.43, 0.046, 119, 87, RAT GLUT5 WITH FV IN THE OUTWARD-OPEN FORM
3363, 4hzlH, 0.5569, 3.41, 0.069, 217, 87, NEUTRALIZING ANTIBODY MAB 8 IN COMPLEX WITH THE EPITOPE II OF HCV E2 ENVELOPE PROTEIN
3364, 4g80C, 0.5569, 3.17, 0.095, 219, 84, CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (WT 3.8 A)
3365, 3zhkB, 0.5569, 3.48, 0.069, 119, 87, THE CRYSTAL STRUCTURE OF SINGLE DOMAIN ANTIBODY 2X1 SCAFFOLD
3366, 3wjjA, 0.5569, 3.21, 0.047, 212, 86, CRYSTAL STRUCTURE OF IIB SELECTIVE FC VARIANT FC(P238D) IN COMPLEX WITH FCGRIIB
3367, 3vmpA, 0.5569, 3.40, 0.092, 632, 87, CRYSTAL STRUCTURE OF DEXTRANASE FROM STREPTOCOCCUS MUTANS IN COMPLEX WITH 45-EPOXYPENTYL ALPHA-D-GLUCOPYRANOSIDE
3368, 3v6oD, 0.5569, 3.30, 0.058, 215, 86, LEPTIN RECEPTOR-ANTIBODY COMPLEX
3369, 3juyF, 0.5569, 3.26, 0.059, 234, 85, CRYSTAL STRUCTURE OF A 3B3 VARIANT A BROADLY NEUTRALIZING HIV-1 SCFV ANTIBODY
3370, 3h3bC, 0.5569, 3.54, 0.079, 234, 89, CRYSTAL STRUCTURE OF THE SINGLE-CHAIN FV (SCFV) FRAGMENT OF AN ANTI- ERBB2 ANTIBODY CHA21 IN COMPLEX WITH RESIDUES 1-192 OF ERBB2 EXTRACELLULAR DOMAIN
3371, 2q7aB, 0.5569, 3.59, 0.065, 152, 93, CRYSTAL STRUCTURE OF THE CELL SURFACE HEME TRANSFER PROTEIN SHP
3372, 2c4fU, 0.5569, 2.95, 0.096, 116, 83, CRYSTAL STRUCTURE OF FACTOR VII.STF COMPLEXED WITH PD0297121
3373, 1rz8D, 0.5569, 3.59, 0.091, 228, 88, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 17B
3374, 1lf6B, 0.5569, 3.48, 0.091, 674, 88, CRYSTAL STRUCTURE OF BACTERIAL GLUCOAMYLASE
3375, 1a7pH, 0.5569, 3.48, 0.080, 116, 87, FV FRAGMENT OF MOUSE MONOCLONAL ANTIBODY D1.3 (BALB/C IGG1 K) ENGINEERED MUTANT PRO95L->SER ON VARIANT CHAIN L GLU81- >ASP AND CHAIN H LEU312->VAL
3376, 6ff9D, 0.5568, 3.48, 0.087, 193, 92, MUTANT R280K OF HUMAN P53 
3377, 6ey6O, 0.5568, 3.24, 0.071, 129, 84, C-TERMINAL PART (RESIDUES 315-516) OF PORM WITH THE LLAMA NANOBODY NB130
3378, 5zo2A, 0.5568, 2.87, 0.073, 196, 82, CRYSTAL STRUCTURE OF MOUSE NECTIN-LIKE MOLECULE 4 (MNECL-4) FULL ECTODOMAIN IN COMPLEX WITH MOUSE NECTIN-LIKE MOLECULE 1 (MNECL-1) IG1 DOMAIN; 3.3A 
3379, 5ww1A, 0.5568, 2.95, 0.099, 646, 81, CATALYTIC MECHANISM CYCLODEXTRIN INHIBITION AND ALLOSTERIC REGULATION OF PAENIBACILLUS BARENGOLTZII PULLLULANASE
3380, 5lobA, 0.5568, 3.20, 0.059, 138, 85, STRUCTURE OF THE CA2+-BOUND RABPHILIN3A C2B- SNAP25 COMPLEX (C2 SPACE GROUP)
3381, 4ut9I, 0.5568, 3.31, 0.058, 127, 86, CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN DIMER IN COMPLEX WITH THE SCFV FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C10
3382, 4odtH, 0.5568, 3.56, 0.092, 226, 87, FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY S1-15 IN COMPLEX WITH LIPID A CARBOHYDRATE BACKBONE
3383, 4duwC, 0.5568, 3.79, 0.063, 1015, 95, E. COLI (LACZ) BETA-GALACTOSIDASE (G974A) IN COMPLEX WITH ALLOLACTOSE
3384, 3wjjB, 0.5568, 3.01, 0.036, 206, 84, CRYSTAL STRUCTURE OF IIB SELECTIVE FC VARIANT FC(P238D) IN COMPLEX WITH FCGRIIB
3385, 3o41A, 0.5568, 3.50, 0.057, 217, 88, CRYSTAL STRUCTURE OF 101F FAB BOUND TO 15-MER PEPTIDE EPITOPE
3386, 2znwA, 0.5568, 3.65, 0.091, 221, 88, CRYSTAL STRUCTURE OF SCFV10 IN COMPLEX WITH HEN EGG LYSOZYME
3387, 2bc4A, 0.5568, 2.95, 0.084, 188, 83, CRYSTAL STRUCTURE OF HLA-DM
3388, 1a6vJ, 0.5568, 3.03, 0.012, 120, 85, B1-8 FV FRAGMENT COMPLEXED WITH A (4-HYDROXY-3-NITROPHENYL) ACETATE COMPOUND
3389, 6n9tB, 0.5567, 3.03, 0.024, 207, 83, STRUCTURE OF A PEPTIDE-BASED PHOTO-AFFINITY CROSS-LINKER WITH HERCEPTIN FC 
3390, 6jhfA, 0.5567, 2.96, 0.099, 652, 81, CRYSTAL STRUCTURE OF APO PULLULANASE FROM PAENIBACILLUS BARENGOLTZII 
3391, 5ynhA, 0.5567, 3.05, 0.085, 1055, 82, CRYSTAL STRUCTURE OF PULLULANASE FROM KLEBSIELLA PNEUMONIAE COMPLEX AT 10 MM GAMMA-CYCLODEXTRIN 
3392, 5yndA, 0.5567, 3.05, 0.085, 1055, 82, CRYSTAL STRUCTURE OF PULLULANASE FROM KLEBSIELLA PNEUMONIAE COMPLEX AT 1 MM GAMMA-CYCLODEXTRIN 
3393, 5wkoI, 0.5567, 3.31, 0.058, 225, 86, CRYSTAL STRUCTURE OF ANTIBODY 27F3 RECOGNIZING THE HA FROM A/CALIFORNIA/04/2009 (H1N1) INFLUENZA VIRUS
3394, 5kovE, 0.5567, 3.47, 0.093, 224, 86, CRYSTAL STRUCTURE OF THE HUMAN ASTROVIRUS 2 CAPSID PROTEIN SPIKE IN COMPLEX WITH A SINGLE CHAIN VARIABLE FRAGMENT OF AN ASTROVIRUS NEUTRALIZING ANTIBODY AT 3.24-A RESOLUTION
3395, 5iieH, 0.5567, 3.49, 0.057, 219, 88, STRUCTURE OF THE UNLIGANDED ANTI-HIV ANTIBODY DH501 THAT BINDS GP120 V3 GLYCAN AND THE BASE OF V3
3396, 5gs0F, 0.5567, 3.34, 0.035, 122, 86, CRYSTAL STRUCTURE OF THE COMPLEX OF TLR3 AND BI-SPECIFIC DIABODY
3397, 5gr6A, 0.5567, 3.13, 0.061, 755, 82, CRYSTAL STRUCTURE OF BRANCHING ENZYME Y500A/D501A DOUBLE MUTANT FROM CYANOTHECE SP. ATCC 51142
3398, 5fehF, 0.5567, 3.29, 0.092, 229, 87, CRYSTAL STRUCTURE OF PCT64_35B A BROADLY NEUTRALIZING ANTI-HIV ANTIBODY
3399, 5bupA, 0.5567, 3.26, 0.068, 159, 88, CRYSTAL STRUCTURE OF THE ZP-C DOMAIN OF MOUSE ZP2
3400, 4w2pB, 0.5567, 3.41, 0.090, 122, 89, ANTI-MARBURGVIRUS NUCLEOPROTEIN SINGLE DOMAIN ANTIBODY C
3401, 4q6yA, 0.5567, 3.19, 0.035, 208, 85, CRYSTAL STRUCTURE OF A CHEMOENZYMATIC GLYCOENGINEERED DISIALYLATED FC (DI-SFC)
3402, 4ibtA, 0.5567, 3.47, 0.087, 196, 92, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R273H AND SECOND-SITE SUPPRESSOR MUTATION T284R
3403, 4ibqA, 0.5567, 3.47, 0.087, 192, 92, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R273C
3404, 3qazj, 0.5567, 3.13, 0.011, 191, 88, IL-2 MUTANT D10 TERNARY COMPLEX
3405, 3q3gB, 0.5567, 3.31, 0.035, 224, 86, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
3406, 3dnkB, 0.5567, 2.98, 0.024, 210, 83, ENZYME DEGLYCOSYLATED HUMAN IGG1 FC FRAGMENT
3407, 1tfhA, 0.5567, 3.03, 0.149, 202, 87, EXTRACELLULAR DOMAIN OF HUMAN TISSUE FACTOR
3408, 1nd0B, 0.5567, 3.11, 0.093, 222, 86, CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG
3409, 1fl6H, 0.5567, 3.40, 0.093, 219, 86, THE HAPTEN COMPLEXED GERMLINE PRECURSOR TO SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4
3410, 6jfxA, 0.5566, 2.95, 0.099, 650, 81, CRYSTAL STRUCTURE OF PULLULANASE FROM PAENIBACILLUS BARENGOLTZII COMPLEX WITH MALTOPENTAOSE 
3411, 6b9zB, 0.5566, 3.44, 0.103, 220, 87, TRASTUZUMAB FAB V3 
3412, 5yneA, 0.5566, 3.05, 0.085, 1054, 82, CRYSTAL STRUCTURE OF PULLULANASE FROM KLEBSIELLA PNEUMONIAE COMPLEX AT 10 MM ALPHA-CYCLODEXTRIN 
3413, 5v4eA, 0.5566, 3.14, 0.036, 218, 84, ENGINEERED HUMAN IGG FC DOMAIN GLYCO801 (FC801)
3414, 5uk0I, 0.5566, 3.67, 0.056, 236, 90, CRYOEM STRUCTURE OF AN INFLUENZA VIRUS RECEPTOR-BINDING SITE ANTIBODY- ANTIGEN INTERFACE - CLASS 2
3415, 5uk0H, 0.5566, 3.67, 0.056, 236, 90, CRYOEM STRUCTURE OF AN INFLUENZA VIRUS RECEPTOR-BINDING SITE ANTIBODY- ANTIGEN INTERFACE - CLASS 2
3416, 5uk0G, 0.5566, 3.67, 0.056, 236, 90, CRYOEM STRUCTURE OF AN INFLUENZA VIRUS RECEPTOR-BINDING SITE ANTIBODY- ANTIGEN INTERFACE - CLASS 2
3417, 5u4mB, 0.5566, 3.43, 0.069, 129, 87, RTA-V1C7-G29R-NO_SALT
3418, 5t29H, 0.5566, 3.68, 0.092, 232, 87, CRYSTAL STRUCTURE OF 10E8 FAB LIGHT CHAIN MUTANT3 AGAINST THE MPER REGION OF THE HIV-1 ENV IN COMPLEX WITH THE MPER EPITOPE SCAFFOLD T117V2
3419, 5gr4A, 0.5566, 3.13, 0.061, 755, 82, CRYSTAL STRUCTURE OF BRANCHING ENZYME L541A MUTANT FROM CYANOTHECE SP. ATCC 51142 IN COMPLEX WITH MALTOHEPTAOSE
3420, 5cbaA, 0.5566, 3.39, 0.034, 127, 87, 3B4 IN COMPLEX WITH CXCL13 - 3B4-CXCL13
3421, 5c8jC, 0.5566, 3.62, 0.080, 230, 88, A YIDC-LIKE PROTEIN IN THE ARCHAEAL PLASMA MEMBRANE
3422, 4mjjA, 0.5566, 3.04, 0.107, 116, 84, CRYSTAL STRUCTURE OF THE C2A DOMAIN OF DOC2A
3423, 3qa3K, 0.5566, 3.33, 0.035, 224, 86, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
3424, 3nn8C, 0.5566, 3.27, 0.034, 122, 87, CRYSTAL STRUCTURE OF ENGINEERED ANTIBODY FRAGMENT BASED ON 3D5
3425, 2yoaA, 0.5566, 3.57, 0.067, 149, 90, SYNAPTOTAGMIN-1 C2B DOMAIN WITH PHOSPHOSERINE
3426, 1fccB, 0.5566, 3.05, 0.024, 206, 83, CRYSTAL STRUCTURE OF THE C2 FRAGMENT OF STREPTOCOCCAL PROTEIN G IN COMPLEX WITH THE FC DOMAIN OF HUMAN IGG
3427, 1fccA, 0.5566, 3.05, 0.024, 206, 83, CRYSTAL STRUCTURE OF THE C2 FRAGMENT OF STREPTOCOCCAL PROTEIN G IN COMPLEX WITH THE FC DOMAIN OF HUMAN IGG
3428, 6qv0F, 0.5565, 3.39, 0.080, 124, 87, STRUCTURE OF ATP-BOUND OUTWARD-FACING TM287/288 IN COMPLEX WITH SYBODY SB_TM35 
3429, 6ncxA, 0.5565, 3.57, 0.057, 554, 87, CRYSTAL STRUCTURE OF GH2 BETA-GALACTURONIDASE FROM EISENBERGIELLA TAYI BOUND TO GALACTURONATE 
3430, 6jeqA, 0.5565, 2.96, 0.099, 651, 81, CRYSTAL STRUCTURE OF PULLULANASE FROM PAENIBACILLUS BARENGOLTZII COMPLEX WITH BETA-CYCLODEXTRIN 
3431, 6gjsB, 0.5565, 3.18, 0.047, 122, 85, HUMAN NBD1 OF CFTR IN COMPLEX WITH NANOBODIES D12 AND T4 
3432, 6eyoA, 0.5565, 2.95, 0.035, 307, 86, STRUCTURE OF EXTENDED IGE-FC IN COMPLEX WITH TWO ANTI-IGE FABS 
3433, 6dfjH, 0.5565, 3.20, 0.047, 219, 86, CRYSTAL STRUCTURE OF ANTI-ZIKA ANTIBODY Z021 BOUND TO DENV-1 ENVELOPE PROTEIN DIII 
3434, 5x73A, 0.5565, 4.08, 0.064, 148, 94, THE CRYSTAL STRUCTURE PDE DELTA IN COMPLEX WITH R-P9
3435, 5x3jA, 0.5565, 3.15, 0.084, 718, 83, KFLA1895 D451A MUTANT IN COMPLEX WITH CYCLOBIS-(1->6)-ALPHA-NIGEROSYL
3436, 5h32K, 0.5565, 3.30, 0.047, 127, 86, CRYO-EM STRUCTURE OF ZIKA VIRUS COMPLEXED WITH FAB C10 AT PH 5.0
3437, 5gqvA, 0.5565, 3.11, 0.061, 755, 82, CRYSTAL STRUCTURE OF BRANCHING ENZYME FROM CYANOTHECE SP. ATCC 51142 IN COMPLEX WITH MALTOHEXAOSE
3438, 4xceA, 0.5565, 3.61, 0.091, 225, 88, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLCHOLINE (06:0 PC); C2 SPACE GROUP
3439, 4qhmA, 0.5565, 3.36, 0.069, 217, 87, I3.1 (UNBOUND) FROM CH103 LINEAGE
3440, 4jhpB, 0.5565, 4.07, 0.087, 142, 92, THE CRYSTAL STRUCTURE OF THE RPGR RCC1-LIKE DOMAIN IN COMPLEX WITH PDE6D
3441, 4hgwB, 0.5565, 3.51, 0.103, 213, 87, CRYSTAL STRUCTURE OF S25-2 IN COMPLEX WITH A 56-DEHYDRO-KDO DISACCHARIDE
3442, 3u9uC, 0.5565, 3.28, 0.047, 215, 86, CRYSTAL STRUCTURE OF EXTRACELLULAR DOMAIN OF HUMAN ERBB4/HER4 IN COMPLEX WITH THE FAB FRAGMENT OF MAB1479
3443, 1ggtA, 0.5565, 3.61, 0.103, 710, 87, THREE-DIMENSIONAL STRUCTURE OF A TRANSGLUTAMINASE: HUMAN BLOOD COAGULATION FACTOR XIII
3444, 6j7wA, 0.5564, 3.07, 0.083, 118, 84, CRYSTAL STRUCTURE OF HUMAN BCMA IN COMPLEX WITH UNIAB(TM) VH 
3445, 6i6xB, 0.5564, 3.50, 0.101, 597, 89, NEW IRREVERSIBLE A-L-IDURONIDASE INHIBITORS AND ACTIVITY-BASED PROBES 
3446, 6fabH, 0.5564, 3.38, 0.047, 222, 86, THREE-DIMENSIONAL STRUCTURE OF MURINE ANTI-P- AZOPHENYLARSONATE FAB 36-71. 1. X-RAY CRYSTALLOGRAPHY SITE-DIRECTED MUTAGENESIS AND MODELING OF THE COMPLEX WITH HAPTEN
3447, 6cdpA, 0.5564, 3.23, 0.071, 221, 85, VACCINE-ELICITED HIV-1 NEUTRALIZING ANTIBODY VFP20.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519 
3448, 6a67H, 0.5564, 3.50, 0.103, 222, 87, CRYSTAL STRUCTURE OF INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH THE FAB OF ANTIBODY FLD21.140 
3449, 5fcsH, 0.5564, 3.76, 0.067, 233, 90, DIABODY
3450, 5djcE, 0.5564, 3.26, 0.047, 207, 85, FC HETERODIMER DESIGN 8.1 L368V/Y407A + T366V/K409F
3451, 4p49A, 0.5564, 3.44, 0.080, 226, 87, THE STRUCTURE OF A CHICKEN ANTI-PROSTATE SPECIFIC ANTIGEN SCFV
3452, 4ibzA, 0.5564, 3.46, 0.087, 193, 92, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R273C AND SECOND-SITE SUPPRESSOR MUTATION T284R
3453, 3zhkA, 0.5564, 3.47, 0.069, 119, 87, THE CRYSTAL STRUCTURE OF SINGLE DOMAIN ANTIBODY 2X1 SCAFFOLD
3454, 3w12C, 0.5564, 3.20, 0.070, 116, 86, INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1-CR IN COMPLEX WITH HIGH-AFFINITY INSULIN ANALOGUE [D-PRO-B26]-DTI-NH2 ALPHA-CT PEPTIDE(704-719) AND FAB 83-7
3455, 3l15B, 0.5564, 3.46, 0.056, 200, 90, HUMAN TEAD2 TRANSCRIPTIONAL FACTOR
3456, 3bdyH, 0.5564, 3.51, 0.115, 216, 87, DUAL SPECIFIC BH1 FAB IN COMPLEX WITH VEGF
3457, 2qejA, 0.5564, 2.98, 0.074, 211, 81, CRYSTAL STRUCTURE OF A STAPHYLOCOCCUS AUREUS PROTEIN (SSL7) IN COMPLEX WITH FC OF HUMAN IGA1
3458, 1ggiJ, 0.5564, 3.31, 0.059, 215, 85, CRYSTAL STRUCTURE OF AN HIV-1 NEUTRALIZING ANTIBODY 50.1 IN COMPLEX WITH ITS V3 LOOP PEPTIDE ANTIGEN
3459, 1fveD, 0.5564, 3.55, 0.091, 223, 88, X-RAY STRUCTURES OF THE ANTIGEN-BINDING DOMAINS FROM THREE VARIANTS OF HUMANIZED ANTI-P185-HER2 ANTIBODY 4D5 AND COMPARISON WITH MOLECULAR MODELING
3460, 1c12B, 0.5564, 3.04, 0.047, 220, 86, INSIGHT IN ODORANT PERCEPTION: THE CRYSTAL STRUCTURE AND BINDING CHARACTERISTICS OF ANTIBODY FRAGMENTS DIRECTED AGAINST THE MUSK ODORANT TRASEOLIDE
3461, 6mph1, 0.5563, 3.40, 0.057, 118, 87, CRYO-EM STRUCTURE AT 3.8 A RESOLUTION OF HIV-1 FUSION PEPTIDE-DIRECTED ANTIBODY; DF1W-A.01; ELICITED BY VACCINATION OF RHESUS MACAQUES; IN COMPLEX WITH STABILIZED HIV-1 ENV BG505 DS-SOSIP; WHICH WAS ALSO BOUND TO ANTIBODIES VRC03 AND PGT122 
3462, 5k9kH, 0.5563, 3.54, 0.057, 224, 88, CRYSTAL STRUCTURE OF MULTIDONOR HV6-1-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 56.A.09 IN COMPLEX WITH HEMAGGLUTININ HONG KONG 1968.
3463, 5h37K, 0.5563, 3.28, 0.059, 127, 85, CRYO-EM STRUCTURE OF ZIKA VIRUS COMPLEXED WITH FAB C10 AT PH 8.0
3464, 5h32I, 0.5563, 3.43, 0.045, 127, 88, CRYO-EM STRUCTURE OF ZIKA VIRUS COMPLEXED WITH FAB C10 AT PH 5.0
3465, 5gqyA, 0.5563, 3.00, 0.062, 755, 81, CRYSTAL STRUCTURE OF BRANCHING ENZYME FROM CYANOTHECE SP. ATCC 51142 IN COMPLEX WITH MALTOHEPTAOSE
3466, 4k3hG, 0.5563, 3.15, 0.058, 109, 86, IMMUNOGLOBULIN LAMBDA VARIABLE DOMAIN L5(L89S) FLUOROGEN ACTIVATIONG PROTEIN IN COMPLEX WITH MALACHITE GREEN
3467, 4hjgB, 0.5563, 3.46, 0.115, 221, 87, MEDITOPE-ENABLED TRASTUZUMAB
3468, 4b5eB, 0.5563, 3.48, 0.058, 127, 86, CRYSTAL STRUCTURE OF AN AMYLOID-BETA BINDING SINGLE CHAIN ANTIBODY PS2-8
3469, 3mckB, 0.5563, 3.41, 0.080, 226, 87, CRYSTAL STRUCTURE OF ANTI-BETA-AMYLOID ANTIBODY C705
3470, 3cspA, 0.5563, 3.26, 0.046, 121, 87, CRYSTAL STRUCTURE OF THE DM2 MUTANT OF MYELIN OLIGODENDROCYTE GLYCOPROTEIN
3471, 2ny6D, 0.5563, 3.41, 0.093, 222, 86, HIV-1 GP120 ENVELOPE GLYCOPROTEIN (M95W W96C I109C T123C T257S V275CS334A S375W Q428C G431C) COMPLEXED WITH CD4 AND ANTIBODY 17B
3472, 2gjzB, 0.5563, 3.30, 0.058, 221, 86, STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 13G5 FROM A CRYSTAL IN SPACE GROUP P2(1)
3473, 1ttfA, 0.5563, 2.65, 0.112, 94, 80, THE THREE-DIMENSIONAL STRUCTURE OF THE TENTH TYPE III MODULE OF FIBRONECTIN: AN INSIGHT INTO RGD-MEDIATED INTERACTIONS
3474, 1axtH, 0.5563, 3.31, 0.093, 218, 86, IMMUNE VERSUS NATURAL SELECTION: ANTIBODY ALDOLASES WITH THE RATES OF NATURAL ENZYMES
3475, 6im5A, 0.5562, 3.19, 0.034, 216, 88, YAP-BINDING DOMAIN OF HUMAN TEAD1 
3476, 6dtkI, 0.5562, 3.70, 0.064, 313, 94, HETERODIMERS OF FALS MUTANT SOD ENZYME 
3477, 6adqK, 0.5562, 3.49, 0.022, 147, 90, RESPIRATORY COMPLEX CIII2CIV2SOD2 FROM MYCOBACTERIUM SMEGMATIS 
3478, 5wvqA, 0.5562, 2.96, 0.099, 655, 81, CATALYTIC MECHANISM CYCLODEXTRIN INHIBITION AND ALLOSTERIC REGULATION OF PAENIBACILLUS BARENGOLTZII PULLLULANASE
3479, 5uk4r, 0.5562, 3.46, 0.103, 125, 87, VESICULAR STOMATITS VIRUS N PROTEIN IN COMPLEX WITH INHIBITORY NANOBODY 1307
3480, 5m63H, 0.5562, 3.46, 0.116, 222, 86, CRYSTAL STRUCTURE OF GROUP B STREPTOCOCCUS TYPE III DP2 OLIGOSACCHARIDE BOUND TO FAB NVS-1-19-5
3481, 5hyeC, 0.5562, 3.14, 0.071, 207, 84, GLYCOSYLATED KNOB-KNOB FC FRAGMENT (P212121)
3482, 5e8fA, 0.5562, 3.98, 0.087, 147, 92, STRUCTURE OF FULLY MODIFIED GERANYLGERANYLATED PDE6C PEPTIDE IN COMPLEX WITH PDE6D
3483, 4qhmE, 0.5562, 3.41, 0.092, 217, 87, I3.1 (UNBOUND) FROM CH103 LINEAGE
3484, 4pb9H, 0.5562, 3.32, 0.105, 216, 86, STRUCTURE OF THE FAB FRAGMENT OF THE ANTI-FRANCISELLA TULARENSIS GROEL ANTIBODY AB64
3485, 3p4lA, 0.5562, 3.35, 0.077, 198, 91, CRYSTAL STRUCTURE OF A HEMOJUVELIN-BINDING FRAGMENT OF NEOGENIN
3486, 1qcnA, 0.5562, 3.99, 0.094, 400, 96, CRYSTAL STRUCTURE OF FUMARYLACETOACETATE HYDROLASE
3487, 1hzhK, 0.5562, 3.19, 0.034, 444, 87, CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN
3488, 1cbvH, 0.5562, 3.39, 0.069, 219, 87, AN AUTOANTIBODY TO SINGLE-STRANDED DNA: COMPARISON OF THE THREE- DIMENSIONAL STRUCTURES OF THE UNLIGANDED FAB AND A DEOXYNUCLEOTIDE- FAB COMPLEX
3489, 5wobI, 0.5561, 3.23, 0.083, 215, 84, CRYSTAL STRUCTURE ANALYSIS OF FAB1-BOUND HUMAN INSULIN DEGRADING ENZYME (IDE) IN COMPLEX WITH INSULIN 
3490, 5uk4k, 0.5561, 3.46, 0.103, 125, 87, VESICULAR STOMATITS VIRUS N PROTEIN IN COMPLEX WITH INHIBITORY NANOBODY 1307
3491, 5e8fC, 0.5561, 3.98, 0.087, 149, 92, STRUCTURE OF FULLY MODIFIED GERANYLGERANYLATED PDE6C PEPTIDE IN COMPLEX WITH PDE6D
3492, 5e08H, 0.5561, 3.27, 0.058, 229, 86, SPECIFIC RECOGNITION OF A SINGLE-STRANDED RNA SEQUENCE BY AN ENGINEERED SYNTHETIC ANTIBODY FRAGMENT
3493, 5a2jH, 0.5561, 3.55, 0.055, 225, 91, CRYSTAL STRUCTURE OF SCFV-SM3 IN COMPLEX WITH THE NAKED PEPTIDE APDTRP
3494, 4qhmC, 0.5561, 3.15, 0.047, 217, 85, I3.1 (UNBOUND) FROM CH103 LINEAGE
3495, 4qgtB, 0.5561, 3.18, 0.047, 207, 85, THE CRYSTAL STRUCTURE OF HUMAN IGG FC DOMAIN WITH ENHANCED AROMATIC SEQUON
3496, 4f9lA, 0.5561, 3.25, 0.057, 214, 87, CRYSTAL STRUCTURE OF THE HUMAN BTN3A1 ECTODOMAIN IN COMPLEX WITH THE 20.1 SINGLE CHAIN ANTIBODY
3497, 3rp1A, 0.5561, 2.83, 0.061, 96, 82, CRYSTAL STRUCTURE OF HUMAN LAIR-1 IN C2 SPACE GROUP
3498, 3qxvD, 0.5561, 3.38, 0.071, 124, 85, STRUCTURE OF AN ANTI-METHOTREXATE CDR1-4 GRAFT VHH ANTIBODY IN COMPLEX WITH METHOTREXATE
3499, 3k91B, 0.5561, 3.39, 0.068, 128, 88, POLYSULFANE BRIDGE IN CU-ZN SUPEROXIDE DISMUTASE
3500, 3i75B, 0.5561, 3.44, 0.092, 223, 87, ANTIBODY STRUCTURE
3501, 2n62L, 0.5561, 3.36, 0.114, 221, 88, DDFLN5+110
3502, 2dtsB, 0.5561, 3.19, 0.047, 208, 85, CRYSTAL STRUCTURE OF THE DEFUCOSYLATED FC FRAGMENT FROM HUMAN IMMUNOGLOBULIN G1
3503, 1nc2D, 0.5561, 3.34, 0.068, 215, 88, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 2D12.5 FAB COMPLEXED WITH Y- DOTA
3504, 1lf9A, 0.5561, 3.47, 0.102, 674, 88, CRYSTAL STRUCTURE OF BACTERIAL GLUCOAMYLASE COMPLEXED WITH ACARBOSE
3505, 1jnhH, 0.5561, 3.61, 0.057, 214, 88, CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES
3506, 6jhiA, 0.5560, 2.95, 0.099, 646, 81, CRYSTAL STRUCTURE OF MUTANT D470A OF PULLULANASE FROM PAENIBACILLUS BARENGOLTZII COMPLEXED WITH MALTOTETRAOSE 
3507, 6dnvA, 0.5560, 3.68, 0.125, 123, 88, CRYSTAL STRUCTURE OF NEISSERIA MENINGITIDIS DSBD N-TERMINAL DOMAIN IN THE REDUCED FORM 
3508, 6adqW, 0.5560, 3.49, 0.022, 147, 90, RESPIRATORY COMPLEX CIII2CIV2SOD2 FROM MYCOBACTERIUM SMEGMATIS 
3509, 5vnwD, 0.5560, 3.54, 0.093, 120, 86, CRYSTAL STRUCTURE OF NB.B201 BOUND TO HUMAN SERUM ALBUMIN
3510, 5t4zH, 0.5560, 3.49, 0.057, 227, 88, STRUCTURE OF THE ANTI-HIV ANTIBODY DH501 THAT BINDS GP120 V3 GLYCAN AND THE BASE OF V3 WITH FREE MAN9 GLYCAN
3511, 5hvwA, 0.5560, 3.18, 0.047, 210, 85, MONOMERIC IGG4 FC
3512, 5gr5A, 0.5560, 3.00, 0.062, 755, 81, CRYSTAL STRUCTURE OF BRANCHING ENZYME W610A MUTANT FROM CYANOTHECE SP. ATCC 51142
3513, 4tvsb, 0.5560, 3.52, 0.103, 128, 87, LAP1(AA356-583) H.SAPIENS BOUND TO VHH-BS1
3514, 4bqbC, 0.5560, 3.35, 0.077, 199, 91, CRYSTAL STRUCTURE OF THE FN5 AND FN6 DOMAINS OF NEO1 FORM 2
3515, 3t2qB, 0.5560, 3.77, 0.063, 1015, 95, E. COLI (LACZ) BETA-GALACTOSIDASE (S796D) IN COMPLEX WITH GALACTONOLACTONE
3516, 3t0dB, 0.5560, 3.79, 0.063, 1015, 95, E.COLI (LACZ) BETA-GALACTOSIDASE (S796T) IN COMPLEX WITH GALACTONOLACTONE
3517, 3s7gA, 0.5560, 3.25, 0.047, 208, 85, AGLYCOSYLATED HUMAN IGG1 FC FRAGMENT
3518, 3qt2B, 0.5560, 3.32, 0.116, 307, 86, STRUCTURE OF A CYTOKINE LIGAND-RECEPTOR COMPLEX
3519, 3fn3A, 0.5560, 2.92, 0.073, 215, 82, DIMERIC STRUCTURE OF PD-L1
3520, 2q7aA, 0.5560, 3.45, 0.043, 152, 93, CRYSTAL STRUCTURE OF THE CELL SURFACE HEME TRANSFER PROTEIN SHP
3521, 2gk0B, 0.5560, 3.47, 0.070, 216, 86, STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 13G5 FROM A TWINNED CRYSTAL IN SPACE GROUP C2
3522, 2fjfD, 0.5560, 3.18, 0.118, 218, 85, STRUCTURE OF THE G6 FAB A PHAGE DERIVED VEGF BINDING FAB
3523, 2dlfH, 0.5560, 3.05, 0.071, 120, 84, HIGH RESOLUTION CRYSTAL STRUCTURE OF THE FV FRAGMENT FROM AN ANTI-DANSYL SWITCH VARIANT ANTIBODY IGG2A(S) CRYSTALLIZED AT PH 6.75
3524, 1i1cB, 0.5560, 3.12, 0.060, 205, 83, NON-FCRN BINDING FC FRAGMENT OF RAT IGG2A
3525, 1fvdB, 0.5560, 3.36, 0.092, 223, 87, X-RAY STRUCTURES OF THE ANTIGEN-BINDING DOMAINS FROM THREE VARIANTS OF HUMANIZED ANTI-P185-HER2 ANTIBODY 4D5 AND COMPARISON WITH MOLECULAR MODELING
3526, 1e4kB, 0.5560, 3.38, 0.047, 216, 86, CRYSTAL STRUCTURE OF SOLUBLE HUMAN IGG1 FC FRAGMENT-FC-GAMMA RECEPTOR III COMPLEX
3527, 6n8dD, 0.5559, 3.60, 0.057, 216, 88, CRYSTAL STRUCTURE OF GII.4 2002 NOROVIRUS P DOMAIN IN COMPLEX WITH NEUTRALIZING HUMAN ANTIBODY A1431 
3528, 6mphH, 0.5559, 3.40, 0.057, 118, 87, CRYO-EM STRUCTURE AT 3.8 A RESOLUTION OF HIV-1 FUSION PEPTIDE-DIRECTED ANTIBODY; DF1W-A.01; ELICITED BY VACCINATION OF RHESUS MACAQUES; IN COMPLEX WITH STABILIZED HIV-1 ENV BG505 DS-SOSIP; WHICH WAS ALSO BOUND TO ANTIBODIES VRC03 AND PGT122 
3529, 6f0dA, 0.5559, 3.49, 0.069, 128, 87, CRYSTAL STRUCTURE OF A LLAMA VHH ANTIBODY BCD090-M2 AGAINST HUMAN ERBB3 IN SPACE GROUP P1 WITH CADMIUM IONS
3530, 5yn7A, 0.5559, 3.05, 0.085, 1054, 82, CRYSTAL STRUCTURE OF PULLULANASE FROM KLEBSIELLA PNEUMONIAE COMPLEX AT 0.1 MM BETA-CYCLODEXTRIN 
3531, 5y0aH, 0.5559, 3.08, 0.083, 129, 84, CRYO-EM STRUCTURE OF ZIKA VIRUS COMPLEXED WITH FAB OF ZKA190 AT PH 8.0 AND 37 CELSIUS DEGREE
3532, 5y0aF, 0.5559, 3.08, 0.083, 129, 84, CRYO-EM STRUCTURE OF ZIKA VIRUS COMPLEXED WITH FAB OF ZKA190 AT PH 8.0 AND 37 CELSIUS DEGREE
3533, 5y0aD, 0.5559, 3.08, 0.083, 129, 84, CRYO-EM STRUCTURE OF ZIKA VIRUS COMPLEXED WITH FAB OF ZKA190 AT PH 8.0 AND 37 CELSIUS DEGREE
3534, 5xj3C, 0.5559, 3.37, 0.078, 115, 90, COMPLEX STRUCTURE OF IPILIMUMAB-SCFV AND CTLA-4 
3535, 5wvtA, 0.5559, 2.95, 0.099, 646, 81, CATALYTIC MECHANISM CYCLODEXTRIN INHIBITION AND ALLOSTERIC REGULATION OF PAENIBACILLUS BARENGOLTZII PULLLULANASE
3536, 5tojF, 0.5559, 3.52, 0.092, 125, 87, CRYSTAL STRUCTURE OF THE RSV F GLYCOPROTEIN IN COMPLEX WITH THE NEUTRALIZING SINGLE-DOMAIN ANTIBODY F-VHH-4
3537, 5k9qH, 0.5559, 3.59, 0.068, 228, 88, CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.A.26 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ
3538, 5gqzA, 0.5559, 3.14, 0.061, 755, 82, CRYSTAL STRUCTURE OF BRANCHING ENZYME Y500A MUTANT FROM CYANOTHECE SP. ATCC 51142
3539, 5d6dA, 0.5559, 3.20, 0.035, 209, 85, CRYSTAL STRUCTURE OF GASDALIE IGG1 FC IN COMPLEX WITH FCGRIIIA
3540, 5axgB, 0.5559, 3.72, 0.112, 584, 89, CRYSTAL STRUCTURE OF THERMOPHILIC DEXTRANASE FROM THERMOANAEROBACTER PSEUDETHANOLICUS
3541, 4xvuI, 0.5559, 3.56, 0.092, 207, 87, STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF NYV1
3542, 4xt1C, 0.5559, 3.30, 0.069, 116, 87, STRUCTURE OF A NANOBODY-BOUND VIRAL GPCR BOUND TO HUMAN CHEMOKINE CX3CL1
3543, 4re1B, 0.5559, 3.29, 0.033, 202, 90, CRYSTAL STRUCTURE OF HUMAN TEAD1 AND DISULFIDE-ENGINEERED YAP
3544, 4r0lD, 0.5559, 3.31, 0.070, 118, 86, ANTI-CANINE CD28 ANTIBODY 1C6 BOUND CANINE CD28
3545, 4llaB, 0.5559, 2.88, 0.024, 198, 82, CRYSTAL STRUCTURE OF D3D4 DOMAIN OF THE LILRB2 MOLECULE
3546, 4jamH, 0.5559, 3.39, 0.081, 223, 86, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY CH103
3547, 4g7yH, 0.5559, 3.62, 0.103, 212, 87, CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (R217E 2.8 A)
3548, 3wknI, 0.5559, 3.22, 0.047, 209, 85, CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG
3549, 3t0bC, 0.5559, 3.79, 0.063, 1015, 95, E. COLI (LACZ) BETA-GALACTOSIDASE (S796T) IPTG COMPLEX
3550, 3mckH, 0.5559, 3.41, 0.080, 226, 87, CRYSTAL STRUCTURE OF ANTI-BETA-AMYLOID ANTIBODY C705
3551, 3ft1B, 0.5559, 2.98, 0.074, 100, 81, CRYSTAL STRUCTURE OF POLLEN ALLERGEN PHL P 3
3552, 2yoaB, 0.5559, 3.39, 0.057, 149, 88, SYNAPTOTAGMIN-1 C2B DOMAIN WITH PHOSPHOSERINE
3553, 2ny7H, 0.5559, 3.59, 0.045, 230, 88, HIV-1 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH THE BROADLY NEUTRALIZING CD4-BINDING-SITE ANTIBODY B12
3554, 1efxD, 0.5559, 2.92, 0.024, 197, 84, STRUCTURE OF A COMPLEX BETWEEN THE HUMAN NATURAL KILLER CELL RECEPTOR KIR2DL2 AND A CLASS I MHC LIGAND HLA-CW3
3555, 1bfoD, 0.5559, 3.44, 0.081, 216, 86, CAMPATH-1G IGG2B RAT MONOCLONAL FAB
3556, 6i7aA, 0.5558, 3.23, 0.095, 137, 84, CO-CRYSTAL STRUCTURE OF HUMAN SPOP MATH DOMAIN (D140N) AND HUMAN BRD3 FRAGMENT 
3557, 6erxD, 0.5558, 3.49, 0.069, 215, 87, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
3558, 5ynaA, 0.5558, 3.04, 0.085, 1055, 82, CRYSTAL STRUCTURE OF PULLULANASE FROM KLEBSIELLA PNEUMONIAE COMPLEX AT 1 MM ALPHA-CYCLODEXTRIN 
3559, 5xhgD, 0.5558, 3.50, 0.103, 220, 87, CRYSTAL STRUCTURE OF TRASTUZUMAB FAB FRAGMENT BEARING NE-(O- AZIDOBENZYLOXYCARBONYL)-L-LYSINE
3560, 5n6uA, 0.5558, 3.97, 0.081, 811, 99, CRYSTAL STRUCTURE OF BETA-D-MANNOSIDASE FROM DICTYOGLOMUS THERMOPHILUM.
3561, 5a2lH, 0.5558, 3.54, 0.055, 225, 91, CRYSTAL STRUCTURE OF SCFV-SM3 IN COMPLEX WITH APD-CGALNAC-RP
3562, 4fmrA, 0.5558, 4.08, 0.071, 228, 98, CRYSTAL STRUCTURE OF A PUTATIVE BACTERIAL DNA BINDING PROTEIN (BVU_2165) FROM BACTEROIDES VULGATUS ATCC 8482 AT 2.25 A RESOLUTION
3563, 4dbfA, 0.5558, 3.91, 0.043, 258, 92, CRYSTAL STRUCTURES OF CG1458
3564, 3w82B, 0.5558, 3.51, 0.101, 616, 89, HUMAN ALPHA-L-IDURONIDASE IN COMPLEX WITH IDURONIC ACID
3565, 2ee3A, 0.5558, 3.15, 0.057, 108, 88, SOLUTION STRUCTURES OF THE FN3 DOMAIN OF HUMAN COLLAGEN ALPHA-1(XX) CHAIN
3566, 1nc2B, 0.5558, 3.19, 0.059, 218, 85, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 2D12.5 FAB COMPLEXED WITH Y- DOTA
3567, 6mqsC, 0.5557, 3.33, 0.034, 221, 87, VACCINE-ELICITED NHP FP-TARGETING HIV NEUTRALIZING ANTIBODY A12V163- A.01 IN COMPLEX WITH HIV FUSION PEPTIDE (RESIDUE 512-519) 
3568, 6i68C, 0.5557, 3.22, 0.143, 139, 84, CO-CRYSTAL STRUCTURE OF HUMAN SPOP MATH DOMAIN (M117V) AND HUMAN BRD3 FRAGMENT 
3569, 6gzpA, 0.5557, 3.34, 0.082, 121, 85, LLAMA NANOBODY PORM_02 STRUCTURE DETERMINED AT ROOM TEMPERATURE BY IN- SITU DIFFRACTION 
3570, 6fzqH, 0.5557, 3.51, 0.055, 226, 91, CRYSTAL STRUCTURE OF SCFV-SM3 IN COMPLEX WITH COMPOUND 3 
3571, 6bu0A, 0.5557, 3.01, 0.072, 123, 83, CRYSTAL STRUCTURE OF THE PI3KC2ALPHA C2 DOMAIN IN COMPLEX WITH IP6 
3572, 5yd5A, 0.5557, 3.41, 0.047, 251, 86, CRYSTAL STRUCTURE OF THE SCFV ANTIBODY 4B08 WITH EPITOPE PEPTIDE (MUTATION N3A) 
3573, 5uk4t, 0.5557, 3.47, 0.103, 125, 87, VESICULAR STOMATITS VIRUS N PROTEIN IN COMPLEX WITH INHIBITORY NANOBODY 1307
3574, 5uk4h, 0.5557, 3.49, 0.103, 125, 87, VESICULAR STOMATITS VIRUS N PROTEIN IN COMPLEX WITH INHIBITORY NANOBODY 1307
3575, 5ik3C, 0.5557, 3.63, 0.080, 225, 88, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E03 FAB FRAGMENT
3576, 5gzoH, 0.5557, 3.21, 0.058, 214, 86, STRUCTURE OF NEUTRALIZING ANTIBODY BOUND TO ZIKA ENVELOPE PROTEIN
3577, 5gr2A, 0.5557, 3.01, 0.062, 755, 81, CRYSTAL STRUCTURE OF BRANCHING ENZYME L541A MUTANT FROM CYANOTHECE SP. ATCC 51142
3578, 5b8cB, 0.5557, 3.46, 0.046, 120, 87, HIGH RESOLUTION STRUCTURE OF THE HUMAN PD-1 IN COMPLEX WITH PEMBROLIZUMAB FV
3579, 4y5xD, 0.5557, 3.40, 0.059, 124, 85, DIABODY 305 COMPLEX WITH EPOR
3580, 4xwoK, 0.5557, 3.23, 0.083, 216, 84, STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF SEC22
3581, 4ui2A, 0.5557, 3.49, 0.065, 201, 92, CRYSTAL STRUCTURE OF THE TERNARY RGMB-BMP2-NEO1 COMPLEX
3582, 4ub0H, 0.5557, 3.49, 0.103, 215, 87, NEW DESIGN FOR MONOVALENT BISPECIFIC IGG THROUGH CYSTEINE ENGINEERING OF THE CH1-CL INTERFACE
3583, 4k2uI, 0.5557, 3.36, 0.081, 214, 86, CRYSTAL STRUCTURE OF PFEBA-175 F1 IN COMPLEX WITH R218 ANTIBODY FAB FRAGMENT
3584, 4jzoC, 0.5557, 3.75, 0.092, 214, 87, THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC84-27
3585, 3v95B, 0.5557, 3.14, 0.035, 209, 85, CRYSTAL STRUCTURE OF MONOCLONAL HUMAN ANTI-RHESUS D FC AND IGG1 T125(YB2/0) IN THE PRESENCE OF EDTA
3586, 3mugD, 0.5557, 3.44, 0.058, 237, 86, CRYSTAL STRUCTURE OF HUMAN FAB PG16 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
3587, 3hn3D, 0.5557, 3.56, 0.043, 607, 93, HUMAN BETA-GLUCURONIDASE AT 1.7 A RESOLUTION
3588, 2v9uG, 0.5557, 3.83, 0.054, 132, 93, RIM DOMAIN OF MAIN PORIN FROM MYCOBACTERIA SMEGMATIS
3589, 1rz8B, 0.5557, 3.33, 0.106, 228, 85, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 17B
3590, 6os9D, 0.5556, 3.40, 0.035, 231, 86, HUMAN NEUROTENSIN RECEPTOR 1 (HNTSR1) - GI1 PROTEIN COMPLEX IN CANONICAL CONFORMATION (C STATE) 
3591, 6fpvA, 0.5556, 3.21, 0.024, 122, 85, A LLAMA-DERIVED JBP1-TARGETING NANOBODY 
3592, 5xwdH, 0.5556, 3.28, 0.035, 119, 86, CRYSTAL STRUCTURE OF THE COMPLEX OF 059-152-FV AND EGFR-ECD
3593, 5ukqL, 0.5556, 3.12, 0.082, 213, 85, STRUCTURE OF UNLIGANDED ANTI-GP120 CD4BS ANTIBODY DH522.2 FAB
3594, 4ut9H, 0.5556, 3.40, 0.046, 127, 87, CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN DIMER IN COMPLEX WITH THE SCFV FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C10
3595, 4p2cK, 0.5556, 3.40, 0.093, 120, 86, COMPLEX OF SHIGA TOXIN 2E WITH A NEUTRALIZING SINGLE-DOMAIN ANTIBODY
3596, 3ugxA, 0.5556, 3.77, 0.062, 369, 96, CRYSTAL STRUCTURE OF VISUAL ARRESTIN
3597, 3t0bD, 0.5556, 3.78, 0.063, 1015, 95, E. COLI (LACZ) BETA-GALACTOSIDASE (S796T) IPTG COMPLEX
3598, 3t0bA, 0.5556, 3.86, 0.073, 1014, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (S796T) IPTG COMPLEX
3599, 3t09C, 0.5556, 3.79, 0.063, 1015, 95, E. COLI (LACZ) BETA-GALACTOSIDASE (S796A) GALACTONOLACTONE COMPLEX
3600, 6hn4F, 0.5555, 3.34, 0.091, 498, 88, LEUCINE-ZIPPERED HUMAN INSULIN RECEPTOR ECTODOMAIN WITH SINGLE BOUND INSULIN -  LOWER  MEMBRANE-PROXIMAL PART 
3601, 6dbeA, 0.5555, 3.27, 0.071, 115, 85, CRYSTAL STRUCTURE OF VHH R330 
3602, 6cm3T, 0.5555, 3.23, 0.106, 131, 85, BG505 SOSIP IN COMPLEX WITH SCD4; 17B; 8ANC195 
3603, 6cm3R, 0.5555, 3.23, 0.106, 131, 85, BG505 SOSIP IN COMPLEX WITH SCD4; 17B; 8ANC195 
3604, 6cm3P, 0.5555, 3.23, 0.106, 131, 85, BG505 SOSIP IN COMPLEX WITH SCD4; 17B; 8ANC195 
3605, 5yc1E, 0.5555, 3.30, 0.058, 156, 86, TRAF4_GPIB COMPLEX
3606, 5k8aB, 0.5555, 3.47, 0.080, 222, 87, NIST FAB
3607, 5jtwD, 0.5555, 3.67, 0.074, 651, 95, CRYSTAL STRUCTURE OF COMPLEMENT C4B RE-REFINED USING IMDFF
3608, 5j3hC, 0.5555, 3.29, 0.069, 116, 87, HUMAN INSULIN RECEPTOR DOMAINS L1-CR IN COMPLEX WITH PEPTIDE S519C16 AND 83-7 FV
3609, 5dq8B, 0.5555, 3.26, 0.067, 208, 89, CRYSTAL STRUCTURE OF HUMAN TRANSCRIPTION FACTOR TEAD2 IN COMPLEX WITH FLUFENAMIC ACID
3610, 4ttgB, 0.5555, 3.68, 0.064, 1014, 94, BETA-GALACTOSIDASE (E. COLI) IN THE PRESENCE OF POTASSIUM CHLORIDE.
3611, 4s10B, 0.5555, 3.57, 0.057, 126, 87, GELSOLIN NANOBODY SHIELDING MUTANT PLASMA GELSOLIN FROM FURIN PROTEOLYSIS
3612, 4q5zW, 0.5555, 3.36, 0.082, 204, 85, CRYSTAL STRUCTURE ANALYSIS OF FAB-BOUND HUMAN INSULIN DEGRADING ENZYME (IDE) IN COMPLEX WITH INSULIN
3613, 4ouoA, 0.5555, 3.54, 0.081, 227, 86, ANTI-BLA G 1 SCFV
3614, 4j12A, 0.5555, 3.03, 0.024, 209, 83, MONOMERIC FC
3615, 3vdbD, 0.5555, 3.80, 0.063, 1015, 95, E. COLI (LACZ) BETA-GALACTOSIDASE (N460T) IN COMPLEX WITH GALACTONOLACTONE
3616, 3u30F, 0.5555, 3.63, 0.116, 218, 86, CRYSTAL STRUCTURE OF A LINEAR-SPECIFIC UBIQUITIN FAB BOUND TO LINEAR UBIQUITIN
3617, 3s7gC, 0.5555, 3.23, 0.047, 208, 85, AGLYCOSYLATED HUMAN IGG1 FC FRAGMENT
3618, 3mugH, 0.5555, 3.43, 0.058, 237, 86, CRYSTAL STRUCTURE OF HUMAN FAB PG16 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
3619, 3mlyI, 0.5555, 3.42, 0.070, 230, 86, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 3074 IN COMPLEX WITH A UR29 V3 PEPTIDE
3620, 2b4iA, 0.5555, 3.59, 0.161, 232, 87, CRYSTAL STRUCTURE OF THE RHESUS ROTAVIRUS VP5 ANTIGEN DOMAIN TRIMER
3621, 1nkrA, 0.5555, 2.98, 0.012, 195, 84, INHIBITORY RECEPTOR (P58-CL42) FOR HUMAN NATURAL KILLER CELLS
3622, 1il1A, 0.5555, 3.32, 0.092, 219, 87, CRYSTAL STRUCTURE OF G3-519 AN ANTI-HIV MONOCLONAL ANTIBODY
3623, 1hl5C, 0.5555, 3.41, 0.067, 153, 89, THE STRUCTURE OF HOLO TYPE HUMAN CU ZN SUPEROXIDE DISMUTASE
3624, 1f90H, 0.5555, 3.22, 0.058, 220, 86, FAB FRAGMENT OF MONOCLONAL ANTIBODY (LNKB-2) AGAINST HUMAN INTERLEUKIN-2 IN COMPLEX WITH ANTIGENIC PEPTIDE
3625, 1bfoF, 0.5555, 3.43, 0.081, 216, 86, CAMPATH-1G IGG2B RAT MONOCLONAL FAB
3626, 1bf2A, 0.5555, 3.18, 0.084, 750, 83, STRUCTURE OF PSEUDOMONAS ISOAMYLASE
3627, 6n48B, 0.5554, 3.48, 0.057, 120, 87, STRUCTURE OF BETA2 ADRENERGIC RECEPTOR BOUND TO BI167107; NANOBODY 6B9; AND A POSITIVE ALLOSTERIC MODULATOR 
3628, 6im5B, 0.5554, 3.34, 0.034, 216, 89, YAP-BINDING DOMAIN OF HUMAN TEAD1 
3629, 6frjH, 0.5554, 3.51, 0.055, 226, 91, CRYSTAL STRUCTURE OF SCFV-SM3 IN COMPLEX WITH APD-SETHRGALNAC-RP 
3630, 5yn2A, 0.5554, 3.06, 0.085, 1054, 82, CRYSTAL STRUCTURE OF APO PULLULANASE FROM KLEBSIELLA PNEUMONIAE IN SPACE GROUP P43212 
3631, 5vr9A, 0.5554, 3.48, 0.080, 222, 88, CH1/CKAPPA FAB BASED ON MATUZUMAB
3632, 5n88A, 0.5554, 3.52, 0.081, 126, 86, CRYSTAL STRUCTURE OF ANTIBODY BOUND TO VIRAL PROTEIN
3633, 5eziH, 0.5554, 3.48, 0.057, 222, 87, CRYSTAL STRUCTURE OF FAB OF PARASITE INVASION INHIBITORY ANTIBODY C1 - HEXAGONAL FORM
3634, 5d1zB, 0.5554, 3.56, 0.069, 218, 87, ISDB NEAT1 BOUND BY CLONE D4-10
3635, 4y5xA, 0.5554, 3.60, 0.057, 124, 87, DIABODY 305 COMPLEX WITH EPOR
3636, 4ut9K, 0.5554, 3.39, 0.046, 127, 87, CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN DIMER IN COMPLEX WITH THE SCFV FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C10
3637, 4ttgD, 0.5554, 3.73, 0.074, 1014, 95, BETA-GALACTOSIDASE (E. COLI) IN THE PRESENCE OF POTASSIUM CHLORIDE.
3638, 4pirJ, 0.5554, 3.22, 0.059, 124, 85, X-RAY STRUCTURE OF THE MOUSE SEROTONIN 5-HT3 RECEPTOR
3639, 4n8vI, 0.5554, 2.61, 0.013, 190, 78, CRYSTAL STRUCTURE OF KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR KIR2DS2 IN COMPLEX WITH HLA-A
3640, 4lvoC, 0.5554, 3.09, 0.047, 214, 86, CRYSTAL STRUCTURE OF PFSUB1-PRODOMAIN-NIMP.M7 FAB COMPLEX WITH ADDED CACL2
3641, 4irzH, 0.5554, 3.53, 0.091, 217, 88, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB NATALIZUMAB
3642, 3zjbC, 0.5554, 3.22, 0.059, 172, 85, THE STRUCTURE OF THE TRAF DOMAIN OF HUMAN TRAF4
3643, 3w81A, 0.5554, 3.38, 0.102, 616, 88, HUMAN ALPHA-L-IDURONIDASE
3644, 3w13C, 0.5554, 2.91, 0.060, 116, 84, INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1-CR IN COMPLEX WITH HIGH-AFFINITY INSULIN ANALOGUE [D-PRO-B26]-DTI-NH2 ALPHACT PEPTIDE(693-719) AND FAB 83-7
3645, 3p9wF, 0.5554, 3.34, 0.081, 122, 86, CRYSTAL STRUCTURE OF AN ENGINEERED HUMAN AUTONOMOUS VH DOMAIN IN COMPLEX WITH VEGF
3646, 3h0tB, 0.5554, 3.20, 0.036, 223, 84, HEPCIDIN-FAB COMPLEX
3647, 3ft9A, 0.5554, 2.89, 0.087, 94, 80, X-RAY CRYSTAL STRUCTURE OF POLLEN ALLERGEN - PHL P 3
3648, 3cqqB, 0.5554, 3.41, 0.068, 126, 88, HUMAN SOD1 G85R VARIANT STRUCTURE II
3649, 2nxyD, 0.5554, 3.64, 0.091, 227, 88, HIV-1 GP120 ENVELOPE GLYCOPROTEIN(S334A) COMPLEXED WITH CD4 AND ANTIBODY 17B
3650, 2fjhH, 0.5554, 3.32, 0.105, 219, 86, STRUCTURE OF THE B20-4 FAB A PHAGE DERIVED FAB FRAGMENT IN COMPLEX WITH VEGF
3651, 6hn4E, 0.5553, 3.27, 0.080, 202, 87, LEUCINE-ZIPPERED HUMAN INSULIN RECEPTOR ECTODOMAIN WITH SINGLE BOUND INSULIN -  LOWER  MEMBRANE-PROXIMAL PART 
3652, 6bhzH, 0.5553, 3.53, 0.115, 212, 87, TRASTUZUMAB FAB D185A (LIGHT CHAIN) MUTANT.
3653, 6ah0D, 0.5553, 3.39, 0.068, 1874, 88, THE CRYO-EM STRUCTURE OF THE PRECUSOR OF HUMAN PRE-CATALYTIC SPLICEOSOME (PRE-B COMPLEX) 
3654, 5xj3I, 0.5553, 3.38, 0.078, 115, 90, COMPLEX STRUCTURE OF IPILIMUMAB-SCFV AND CTLA-4 
3655, 5wobW, 0.5553, 3.25, 0.083, 204, 84, CRYSTAL STRUCTURE ANALYSIS OF FAB1-BOUND HUMAN INSULIN DEGRADING ENZYME (IDE) IN COMPLEX WITH INSULIN 
3656, 5vsiH, 0.5553, 3.19, 0.107, 220, 84, CH1/CKAPPA FAB MUTANT 15.1
3657, 5l2hD, 0.5553, 3.09, 0.083, 96, 84, CRYSTAL STRUCTURE OF W26A MUTANT OF ANTI-EGFR CENTYRIN P54AR4-83V2
3658, 5awsB, 0.5553, 3.58, 0.106, 265, 94, CRYSTAL STRUCTURE OF THE SGIP1 MU HOMOLOGY DOMAIN IN THE P1 SPACE GROUP
3659, 4xcyH, 0.5553, 3.29, 0.094, 224, 85, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDYLGLYCEROL (06:0 PG)
3660, 4xbgA, 0.5553, 3.44, 0.092, 227, 87, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION
3661, 4ktyB, 0.5553, 3.80, 0.102, 698, 88, FIBRIN-STABILIZING FACTOR WITH A BOUND LIGAND
3662, 4duwA, 0.5553, 3.80, 0.063, 1015, 95, E. COLI (LACZ) BETA-GALACTOSIDASE (G974A) IN COMPLEX WITH ALLOLACTOSE
3663, 3sepA, 0.5553, 3.74, 0.074, 1015, 95, E. COLI (LACZ) BETA-GALACTOSIDASE (S796A)
3664, 3jcrC, 0.5553, 3.39, 0.068, 1885, 88, 3D STRUCTURE DETERMINATION OF THE HUMAN*U4/U6.U5* TRI-SNRNP COMPLEX
3665, 3j1sH, 0.5553, 3.63, 0.057, 218, 88, STRUCTURE OF ADENO-ASSOCIATED VIRUS-2 IN COMPLEX WITH NEUTRALIZING MONOCLONAL ANTIBODY A20
3666, 3hqiB, 0.5553, 3.14, 0.119, 284, 84, STRUCTURES OF SPOP-SUBSTRATE COMPLEXES: INSIGHTS INTO MOLECULAR ARCHITECTURES OF BTB-CUL3 UBIQUITIN LIGASES: SPOPMATHX/BTB/3-BOX-PUCSBC1
3667, 2ny5H, 0.5553, 3.64, 0.091, 221, 88, HIV-1 GP120 ENVELOPE GLYCOPROTEIN (M95W W96C I109C T257S V275C S334A S375W Q428C A433M) COMPLEXED WITH CD4 AND ANTIBODY 17B
3668, 1zq7D, 0.5553, 3.69, 0.093, 200, 86, X-RAY CRYSTAL STRUCTURE OF PROTEIN Q8PZK8 FROM METHANOSARCINA MAZEI. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET MAR9.
3669, 1z6jT, 0.5553, 3.09, 0.148, 207, 88, CRYSTAL STRUCTURE OF A TERNARY COMPLEX OF FACTOR VIIA/TISSUE FACTOR/PYRAZINONE INHIBITOR
3670, 1rzjH, 0.5553, 3.44, 0.093, 229, 86, HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
3671, 1oaqH, 0.5553, 3.20, 0.047, 120, 85, FREE CONFORMATION AB1 OF THE IGE SPE-7
3672, 1fvcD, 0.5553, 3.34, 0.093, 120, 86, X-RAY STRUCTURES OF THE ANTIGEN-BINDING DOMAINS FROM THREE VARIANTS OF HUMANIZED ANTI-P185-HER2 ANTIBODY 4D5 AND COMPARISON WITH MOLECULAR MODELING
3673, 6i68A, 0.5552, 3.39, 0.094, 141, 85, CO-CRYSTAL STRUCTURE OF HUMAN SPOP MATH DOMAIN (M117V) AND HUMAN BRD3 FRAGMENT 
3674, 5uk4j, 0.5552, 3.50, 0.103, 125, 87, VESICULAR STOMATITS VIRUS N PROTEIN IN COMPLEX WITH INHIBITORY NANOBODY 1307
3675, 5owpH, 0.5552, 3.50, 0.055, 226, 91, CRYSTAL STRUCTURE OF GLYCOPEPTIDE GVTSAFPDT*RPAP IN COMPLEX WITH SCFV-SM3
3676, 5gr1A, 0.5552, 3.14, 0.061, 755, 82, CRYSTAL STRUCTURE OF BRANCHING ENZYME Y500A/D501A MUTANT FROM CYANOTHECE SP. ATCC 51142 IN COMPLEX WITH MALTOHEPTAOSE
3677, 5a16G, 0.5552, 3.60, 0.068, 226, 88, CRYSTAL STRUCTURE OF FAB4201 RAISED AGAINST HUMAN ERYTHROCYTE ANION EXCHANGER 1
3678, 4j3sA, 0.5552, 3.02, 0.062, 854, 80, CRYSTAL STRUCTURE OF BARLEY LIMIT DEXTRINASE SOAKED WITH 300MM MALTOTETRAOSE
3679, 3zgiC, 0.5552, 3.94, 0.032, 170, 93, CRYSTAL STRUCTURE OF THE KRT10-BINDING REGION DOMAIN OF THE PNEUMOCOCCAL SERINE RICH REPEAT PROTEIN PSRP
3680, 3uluD, 0.5552, 3.38, 0.081, 224, 86, STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM1)
3681, 3qcuH, 0.5552, 3.15, 0.023, 219, 86, CRYSTAL STRUCTURE OF THE LT3015 ANTIBODY FAB FRAGMENT IN COMPLEX WITH LYSOPHOSPHATIDIC ACID (14:0)
3682, 2l7wA, 0.5552, 3.86, 0.109, 187, 92, SOLUTION STRUCTURE OF THE HUMAN RAF-1 KINASE INHIBITOR PROTEIN
3683, 1oztG, 0.5552, 3.39, 0.068, 130, 88, CRYSTAL STRUCTURE OF APO-H46R FAMILIAL ALS MUTANT HUMAN CU ZN SUPEROXIDE DISMUTASE (CUZNSOD) TO 2.5A RESOLUTION
3684, 1lf9B, 0.5552, 3.48, 0.102, 674, 88, CRYSTAL STRUCTURE OF BACTERIAL GLUCOAMYLASE COMPLEXED WITH ACARBOSE
3685, 1jrhH, 0.5552, 3.20, 0.047, 180, 86, COMPLEX (ANTIBODY/ANTIGEN)
3686, 1j05B, 0.5552, 3.33, 0.057, 121, 87, THE CRYSTAL STRUCTURE OF ANTI-CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY T84.66 FV FRAGMENT
3687, 1frtC, 0.5552, 2.96, 0.024, 205, 82, CRYSTAL STRUCTURE OF THE COMPLEX OF RAT NEONATAL FC RECEPTOR WITH FC
3688, 1cd0A, 0.5552, 3.10, 0.082, 111, 85, STRUCTURE OF HUMAN LAMDA-6 LIGHT CHAIN DIMER JTO
3689, 1a7nH, 0.5552, 3.50, 0.080, 116, 87, FV FRAGMENT OF MOUSE MONOCLONAL ANTIBODY D1.3 (BALB/C IGG1 K) VARIANT FOR CHAIN L GLU81->ASP AND CHAIN H LEU312->VAL
3690, 6oyhF, 0.5551, 3.41, 0.070, 125, 86, CRYSTAL STRUCTURE OF MRAY BOUND TO CARBACAPRAZAMYCIN 
3691, 6nnfD, 0.5551, 3.37, 0.035, 128, 85, CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO VRC01 FR3-03 SCFV IN COMPLEX WITH CRYSTALLIZATION CHAPERONES 3H109L FAB AND 35O22 SCFV AT 3.5 ANGSTROM 
3692, 6gk4E, 0.5551, 3.22, 0.047, 122, 85, HUMAN NBD1 OF CFTR IN COMPLEX WITH NANOBODIES D12 AND T8 
3693, 6ehxB, 0.5551, 3.40, 0.047, 228, 86, SCFV ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN DRUG DISCOVERY
3694, 6dezH, 0.5551, 3.50, 0.092, 217, 87, ANTI-PHOSPHOTYROSINE ANTIBODY PY20-4D5 FAB COMPLEXED WITH SULFATE 
3695, 6cdoA, 0.5551, 3.45, 0.023, 230, 88, STRUCTURE OF VACCINE-ELICITED HIV-1 NEUTRALIZING ANTIBODY VFP16.02 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519 
3696, 5wwaA, 0.5551, 2.94, 0.099, 645, 81, CATALYTIC MECHANISM CYCLODEXTRIN INHIBITION AND ALLOSTERIC REGULATION OF PAENIBACILLUS BARENGOLTZII PULLLULANASE
3697, 5w5lA, 0.5551, 3.11, 0.024, 209, 85, CRYSTAL STRUCTURE OF HUMAN IGG1-SIGMA FC FRAGMENT
3698, 5ou7B, 0.5551, 2.71, 0.087, 173, 80, CRYSTAL STRUCTURE OF THE GLYCOPROTEIN VI LOOP TRUNCATION MUTANT PAVS- PAPYKN 
3699, 5o04E, 0.5551, 3.41, 0.081, 112, 86, GII.10 VIETNAM 026 NOROVIRUS PROTRUDING DOMAIN IN COMPLEX WITH NANOBODY NANO-26 AND NANO-85
3700, 4xbgH, 0.5551, 3.60, 0.091, 230, 88, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION
3701, 4rfoL, 0.5551, 3.20, 0.071, 212, 85, CRYSTAL STRUCTURE OF THE ADCC-POTENT ANTIBODY N60-I3 FAB IN COMPLEX WITH HIV-1 CLADE A/E GP120 AND M48U1
3702, 4lexH, 0.5551, 3.46, 0.116, 217, 86, UNLIGANDED CRYSTAL STRUCTURE OF MAB7
3703, 4leeB, 0.5551, 3.95, 0.021, 313, 95, STRUCTURE OF THE ALS3 ADHESIN FROM CANDIDA ALBICANS RESIDUES 1-313 (MATURE SEQUENCE) TRIPLE MUTANT IN THE BINDING CAVITY: K59M A116V Y301F
3704, 4j3uA, 0.5551, 3.03, 0.087, 870, 80, CRYSTAL STRUCTURE OF BARLEY LIMIT DEXTRINASE IN COMPLEX WITH MALTOSYL- S-BETACYCLODEXTRIN
3705, 4acpB, 0.5551, 3.26, 0.047, 208, 85, DEACTIVATION OF HUMAN IGG1 FC BY ENDOGLYCOSIDASE TREATMENT
3706, 3zgiB, 0.5551, 3.93, 0.032, 170, 93, CRYSTAL STRUCTURE OF THE KRT10-BINDING REGION DOMAIN OF THE PNEUMOCOCCAL SERINE RICH REPEAT PROTEIN PSRP
3707, 3wfhA, 0.5551, 3.14, 0.023, 211, 86, CRYSTAL STRUCTURE OF ANTI-PROSTAGLANDIN E2 FAB FRAGMENT PGE2 COMPLEX
3708, 3qq9D, 0.5551, 3.30, 0.059, 212, 85, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-HUMAN RSV (RESPIRATORY SYNCYTIAL VIRUS) F PROTEIN MAB 101F
3709, 3qazX, 0.5551, 3.16, 0.011, 191, 88, IL-2 MUTANT D10 TERNARY COMPLEX
3710, 3mugB, 0.5551, 3.43, 0.058, 237, 86, CRYSTAL STRUCTURE OF HUMAN FAB PG16 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
3711, 2gysA, 0.5551, 3.14, 0.060, 397, 83, 2.7 A STRUCTURE OF THE EXTRACELLULAR DOMAINS OF THE HUMAN BETA COMMON RECEPTOR INVOLVED IN IL-3 IL-5 AND GM-CSF SIGNALLING
3712, 1jpsH, 0.5551, 3.44, 0.081, 213, 86, CRYSTAL STRUCTURE OF TISSUE FACTOR IN COMPLEX WITH HUMANIZED FAB D3H44
3713, 1bfoB, 0.5551, 3.49, 0.080, 216, 87, CAMPATH-1G IGG2B RAT MONOCLONAL FAB
3714, 6gjsC, 0.5550, 3.43, 0.069, 117, 87, HUMAN NBD1 OF CFTR IN COMPLEX WITH NANOBODIES D12 AND T4 
3715, 5wtbC, 0.5550, 4.20, 0.089, 323, 101, COMPLEX STRUCTURE OF STAPHYLOCOCCUS AUREUS SDRE WITH HUMAN COMPLEMENT FACTOR H
3716, 5uk4q, 0.5550, 3.47, 0.103, 125, 87, VESICULAR STOMATITS VIRUS N PROTEIN IN COMPLEX WITH INHIBITORY NANOBODY 1307
3717, 5oclC, 0.5550, 3.35, 0.058, 117, 86, NANOBODY-ANTI-VGLUT NANOBODY COMPLEX
3718, 5gr0A, 0.5550, 3.01, 0.062, 755, 81, CRYSTAL STRUCTURE OF BRANCHING ENZYME D501A MUTANT FROM CYANOTHECE SP. ATCC 51142
3719, 4xcnH, 0.5550, 3.60, 0.091, 230, 88, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA); 2.9 A RESOLUTION
3720, 4p2cG, 0.5550, 3.16, 0.058, 121, 86, COMPLEX OF SHIGA TOXIN 2E WITH A NEUTRALIZING SINGLE-DOMAIN ANTIBODY
3721, 4m4rE, 0.5550, 3.20, 0.106, 516, 85, EPHA4 ECTODOMAIN COMPLEX WITH EPHRIN A5
3722, 3vmnA, 0.5550, 3.51, 0.091, 633, 88, CRYSTAL STRUCTURE OF DEXTRANASE FROM STREPTOCOCCUS MUTANS
3723, 3t08A, 0.5550, 3.77, 0.074, 1015, 95, E. COLI (LACZ) BETA-GALACTOSIDASE (S796A) IPTG COMPLEX
3724, 3rg1P, 0.5550, 3.95, 0.082, 135, 97, CRYSTAL STRUCTURE OF THE RP105/MD-1 COMPLEX
3725, 3qumH, 0.5550, 3.30, 0.071, 217, 85, CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN (PSA) IN FAB SANDWICH WITH A HIGH AFFINITY AND A PCA SELECTIVE ANTIBODY
3726, 3nceB, 0.5550, 3.32, 0.022, 206, 89, A MUTANT HUMAN PROLACTIN RECEPTOR ANTAGONIST H27A IN COMPLEX WITH THE MUTANT EXTRACELLULAR DOMAIN H188A OF THE HUMAN PROLACTIN RECEPTOR
3727, 3m7oB, 0.5550, 4.13, 0.111, 131, 99, CRYSTAL STRUCTURE OF MOUSE MD-1 IN COMPLEX WITH PHOSPHATIDYLCHOLINE
3728, 2iglC, 0.5550, 3.36, 0.118, 116, 85, CRYSTAL STRUCTURE OF E. COLI YEDX A TRANSTHYRETIN RELATED PROTEIN
3729, 1to4D, 0.5550, 3.73, 0.065, 156, 92, STRUCTURE OF THE CYTOSOLIC CUZN SOD FROM S. MANSONI
3730, 6mqmD, 0.5549, 3.31, 0.047, 222, 86, VACCINE-ELICITED NHP FP-TARGETING NEUTRALIZING ANTIBODY DF1W-A.01 IN COMPLEX WITH HIV FUSION PEPTIDE (RESIDUE 512-519) 
3731, 6f0yA, 0.5549, 3.61, 0.069, 172, 87, RTT109 PEPTIDE BOUND TO ASF1
3732, 5xj3L, 0.5549, 3.38, 0.078, 115, 90, COMPLEX STRUCTURE OF IPILIMUMAB-SCFV AND CTLA-4 
3733, 5w6gH, 0.5549, 3.51, 0.103, 225, 87, HUMAN ANTIBODY 6649 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 SOLOMON ISLANDS
3734, 5e94B, 0.5549, 3.41, 0.046, 224, 87, ANTIBODY-BOUND GLUCAGON-LIKE PEPTIDE-1 RECEPTOR EXTRACELLULAR DOMAIN
3735, 4ut9J, 0.5549, 3.40, 0.046, 127, 87, CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN DIMER IN COMPLEX WITH THE SCFV FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C10
3736, 4n8vG, 0.5549, 2.92, 0.024, 190, 83, CRYSTAL STRUCTURE OF KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR KIR2DS2 IN COMPLEX WITH HLA-A
3737, 4k3hF, 0.5549, 2.99, 0.060, 109, 84, IMMUNOGLOBULIN LAMBDA VARIABLE DOMAIN L5(L89S) FLUOROGEN ACTIVATIONG PROTEIN IN COMPLEX WITH MALACHITE GREEN
3738, 4k3hC, 0.5549, 3.16, 0.058, 109, 86, IMMUNOGLOBULIN LAMBDA VARIABLE DOMAIN L5(L89S) FLUOROGEN ACTIVATIONG PROTEIN IN COMPLEX WITH MALACHITE GREEN
3739, 4ibqD, 0.5549, 3.49, 0.087, 193, 92, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R273C
3740, 4fmrD, 0.5549, 3.93, 0.104, 230, 96, CRYSTAL STRUCTURE OF A PUTATIVE BACTERIAL DNA BINDING PROTEIN (BVU_2165) FROM BACTEROIDES VULGATUS ATCC 8482 AT 2.25 A RESOLUTION
3741, 4f9lB, 0.5549, 3.32, 0.057, 213, 87, CRYSTAL STRUCTURE OF THE HUMAN BTN3A1 ECTODOMAIN IN COMPLEX WITH THE 20.1 SINGLE CHAIN ANTIBODY
3742, 3umnA, 0.5549, 3.46, 0.067, 118, 89, CRYSTAL STRUCTURE OF LAMIN-B1
3743, 3mlxI, 0.5549, 3.43, 0.070, 228, 86, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 3074 IN COMPLEX WITH AN MN V3 PEPTIDE
3744, 1to4C, 0.5549, 3.74, 0.065, 156, 92, STRUCTURE OF THE CYTOSOLIC CUZN SOD FROM S. MANSONI
3745, 5uk4a, 0.5548, 3.47, 0.103, 125, 87, VESICULAR STOMATITS VIRUS N PROTEIN IN COMPLEX WITH INHIBITORY NANOBODY 1307
3746, 5oaqA, 0.5548, 3.39, 0.055, 204, 91, TEAD4 COMPLEXED WITH YAP PEPTIDE AND MYRISTATE (COVALENTLY BOUND)
3747, 5n7bH, 0.5548, 3.51, 0.055, 226, 91, UNDERSTANDING THE SINGULAR CONFORMATIONAL LANDSCAPE OF THE TN ANTIGENS: SULFUR-FOR- OXYGEN SUBSTITUTION IN THE GLYCOSIDIC LINKAGE PROVIDES NEW INSIGHTS INTO MOLECULAR RECOGNITION BY AN ANTIBODY 
3748, 5mhsE, 0.5548, 3.52, 0.057, 210, 87, T1L REOVIRUS SIGMA1 COMPLEXED WITH 5C6 FAB FRAGMENTS
3749, 5hysH, 0.5548, 3.33, 0.106, 222, 85, STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB
3750, 5gqwA, 0.5548, 3.00, 0.062, 755, 81, CRYSTAL STRUCTURE OF BRANCHING ENZYME W610N MUTANT FROM CYANOTHECE SP. ATCC 51142
3751, 5gquA, 0.5548, 3.02, 0.062, 755, 81, CRYSTAL STRUCTURE OF BRANCHING ENZYME FROM CYANOTHECE SP. ATCC 51142
3752, 5f88D, 0.5548, 3.64, 0.068, 214, 88, CETUXIMAB FAB IN COMPLEX WITH L5Y MEDITOPE VARIANT
3753, 4xcyA, 0.5548, 3.48, 0.080, 228, 87, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDYLGLYCEROL (06:0 PG)
3754, 3tnnE, 0.5548, 3.39, 0.094, 210, 85, CRYSTAL STRUCTURE OF N5-I5 FAB AN ADCC MEDIATING AND NON-NEUTRALIZING CD4I ANTI-HIV- 1 ANTIBODY.
3755, 3fzuC, 0.5548, 3.31, 0.094, 214, 85, IGG1 FAB CHARACTERIZED BY H/D EXCHANGE
3756, 2jixD, 0.5548, 3.34, 0.119, 216, 84, CRYSTAL STRUCTURE OF ABT-007 FAB FRAGMENT WITH THE SOLUBLE DOMAIN OF EPO RECEPTOR
3757, 1bfoH, 0.5548, 3.50, 0.080, 216, 87, CAMPATH-1G IGG2B RAT MONOCLONAL FAB
3758, 6mufD, 0.5547, 3.36, 0.035, 128, 85, CRYSTAL STRUCTURE OF HIV-1 B41 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.4 ANGSTROM 
3759, 6k7oD, 0.5547, 3.66, 0.056, 225, 89, COMPLEX STRUCTURE OF LILRB4 AND H128-3 ANTIBODY 
3760, 6i7aC, 0.5547, 3.20, 0.095, 139, 84, CO-CRYSTAL STRUCTURE OF HUMAN SPOP MATH DOMAIN (D140N) AND HUMAN BRD3 FRAGMENT 
3761, 5xj3F, 0.5547, 3.37, 0.078, 115, 90, COMPLEX STRUCTURE OF IPILIMUMAB-SCFV AND CTLA-4 
3762, 5oclA, 0.5547, 3.24, 0.047, 115, 85, NANOBODY-ANTI-VGLUT NANOBODY COMPLEX
3763, 5gr3A, 0.5547, 3.02, 0.062, 755, 81, CRYSTAL STRUCTURE OF BRANCHING ENZYME L541A/W655A MUTANT FROM CYANOTHECE SP. ATCC 51142
3764, 5f0mB, 0.5547, 3.52, 0.087, 286, 92, STRUCTURE OF RETROMER VPS26-VPS35 SUBUNITS BOUND TO SNX3 AND DMT1 (SEMET LABELED)
3765, 5ek5B, 0.5547, 3.32, 0.068, 120, 88, STRUCTURAL CHARACTERIZATION OF IRMA FROM ESCHERICHIA COLI
3766, 5cwsH, 0.5547, 3.38, 0.058, 223, 86, CRYSTAL STRUCTURE OF THE INTACT CHAETOMIUM THERMOPHILUM NSP1-NUP49- NUP57 CHANNEL NUCLEOPORIN HETEROTRIMER BOUND TO ITS NIC96 NUCLEAR PORE COMPLEX ATTACHMENT SITE
3767, 5bmfH, 0.5547, 3.25, 0.071, 216, 85, CRYSTAL STRUCTURE OF A THEOPHYLLINE BINDING ANTIBODY FAB FRAGMENT
3768, 4gt7C, 0.5547, 3.01, 0.024, 214, 84, AN ENGINEERED DISULFIDE BOND REVERSIBLY TRAPS THE IGE-FC3-4 IN A CLOSED NON-RECEPTOR BINDING CONFORMATION
3769, 4grgC, 0.5547, 3.01, 0.024, 214, 84, CRYSTAL STRUCTURE OF IGE COMPLEXED WITH E2_79 AN ANTI-IGE INHIBITOR
3770, 4fmrC, 0.5547, 3.96, 0.094, 228, 96, CRYSTAL STRUCTURE OF A PUTATIVE BACTERIAL DNA BINDING PROTEIN (BVU_2165) FROM BACTEROIDES VULGATUS ATCC 8482 AT 2.25 A RESOLUTION
3771, 4dvbA, 0.5547, 3.35, 0.048, 212, 84, THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF PRO-UPA ANTIBODY MAB-112
3772, 4duxB, 0.5547, 3.80, 0.063, 1015, 95, E. COLI (LACZ) BETA-GALACTOSIDASE (N460S) IN COMPLEX WITH L-RIBOSE
3773, 3vd9A, 0.5547, 3.74, 0.074, 1015, 95, E. COLI (LACZ) BETA-GALACTOSIDASE (N460S) IN COMPLEX WITH IPTG
3774, 3qq9H, 0.5547, 3.31, 0.059, 214, 85, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-HUMAN RSV (RESPIRATORY SYNCYTIAL VIRUS) F PROTEIN MAB 101F
3775, 3nn8A, 0.5547, 3.17, 0.035, 121, 86, CRYSTAL STRUCTURE OF ENGINEERED ANTIBODY FRAGMENT BASED ON 3D5
3776, 2z34B, 0.5547, 3.69, 0.092, 149, 87, CRYSTAL STRUCTURE OF SPCIA1/ASF1 COMPLEX WITH HIP1
3777, 2vq1B, 0.5547, 3.38, 0.070, 213, 86, ANTI TRIMERIC LEWIS X FAB54-5C10-A
3778, 2jnzA, 0.5547, 2.83, 0.075, 108, 80, SOLUTION STRUCTURE OF PHL P 3 A MAJOR ALLERGEN FROM TIMOTHY GRASS POLLEN
3779, 1oaxJ, 0.5547, 3.34, 0.047, 122, 86, FV STRUCTURE OF THE IGE SPE-7 IN COMPLEX WITH ACENAPHTHENEQUINONE
3780, 6mugD, 0.5546, 3.36, 0.035, 128, 85, CRYSTAL STRUCTURE OF HIV-1 B41 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-386150 IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.8 ANGSTROM 
3781, 6k7oB, 0.5546, 3.68, 0.067, 225, 89, COMPLEX STRUCTURE OF LILRB4 AND H128-3 ANTIBODY 
3782, 6c5hH, 0.5546, 3.33, 0.069, 212, 87, S25-5 FAB IN COMPLEX WITH CHLAMYDIACEAE-SPECIFIC LPS ANTIGEN 
3783, 5wobS, 0.5546, 3.36, 0.082, 215, 85, CRYSTAL STRUCTURE ANALYSIS OF FAB1-BOUND HUMAN INSULIN DEGRADING ENZYME (IDE) IN COMPLEX WITH INSULIN 
3784, 5v4eD, 0.5546, 3.07, 0.024, 200, 83, ENGINEERED HUMAN IGG FC DOMAIN GLYCO801 (FC801)
3785, 5uk4f, 0.5546, 3.48, 0.103, 125, 87, VESICULAR STOMATITS VIRUS N PROTEIN IN COMPLEX WITH INHIBITORY NANOBODY 1307
3786, 4x7cC, 0.5546, 3.12, 0.024, 116, 84, CRYSTAL STRUCTURE OF SAGA-2006 GII.4 P DOMAIN IN COMPLEX WITH NANO-85
3787, 4q5zS, 0.5546, 3.35, 0.082, 215, 85, CRYSTAL STRUCTURE ANALYSIS OF FAB-BOUND HUMAN INSULIN DEGRADING ENZYME (IDE) IN COMPLEX WITH INSULIN
3788, 4g7vH, 0.5546, 3.37, 0.118, 215, 85, CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (R217E 2.5 A)
3789, 3h2qA, 0.5546, 3.41, 0.068, 136, 88, HUMAN SOD1 H80R VARIANT P21 CRYSTAL FORM
3790, 3bcdA, 0.5546, 3.14, 0.069, 585, 87, ALPHA-AMYLASE B IN COMPLEX WITH MALTOTETRAOSE AND ALPHA-CYCLODEXTRIN
3791, 2ny3D, 0.5546, 3.65, 0.091, 223, 88, HIV-1 GP120 ENVELOPE GLYCOPROTEIN (K231C T257S E267C S334A S375W) COMPLEXED WITH CD4 AND ANTIBODY 17B
3792, 1xtlA, 0.5546, 3.97, 0.076, 152, 92, CRYSTAL STRUCTURE OF P104H MUTANT OF SOD-LIKE PROTEIN FROM BACILLUS SUBTILIS.
3793, 1to5D, 0.5546, 3.72, 0.065, 156, 92, STRUCTURE OF THE CYTOSOLIC CUZN SOD FROM S. MANSONI
3794, 1f2xK, 0.5546, 3.37, 0.081, 126, 86, STRUCTURE OF THE SINGLE-DOMAIN CAMELID ANTIBODY CAB-CA05
3795, 6quzF, 0.5545, 3.40, 0.080, 124, 87, STRUCTURE OF ATPGS-BOUND OUTWARD-FACING TM287/288 IN COMPLEX WITH SYBODY SB_TM35 
3796, 6g6yA, 0.5545, 4.12, 0.054, 319, 92, EG5-INHIBITOR COMPLEX 
3797, 6anjA, 0.5545, 3.44, 0.115, 138, 87, SYNAPTOTAGMIN-7 C2A DOMAIN
3798, 6amjH, 0.5545, 3.39, 0.093, 205, 86, CAT192 FAB WILD TYPE
3799, 5yd5C, 0.5545, 3.42, 0.047, 240, 86, CRYSTAL STRUCTURE OF THE SCFV ANTIBODY 4B08 WITH EPITOPE PEPTIDE (MUTATION N3A) 
3800, 5x3kB, 0.5545, 3.21, 0.084, 709, 83, KFLA1895 D451A MUTANT IN COMPLEX WITH ISOMALTOSE
3801, 5x3iA, 0.5545, 3.16, 0.084, 708, 83, KFLA1895 D451A MUTANT
3802, 5uk4n, 0.5545, 3.48, 0.103, 125, 87, VESICULAR STOMATITS VIRUS N PROTEIN IN COMPLEX WITH INHIBITORY NANOBODY 1307
3803, 5mubO, 0.5545, 3.42, 0.083, 212, 84, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (CG05)
3804, 5djcA, 0.5545, 3.23, 0.047, 207, 85, FC HETERODIMER DESIGN 8.1 L368V/Y407A + T366V/K409F
3805, 5czkB, 0.5545, 3.10, 0.080, 588, 87, STRUCTURE OF E. COLI BETA-GLUCURONIDASE BOUND WITH A NOVEL POTENT INHIBITOR 1-((68-DIMETHYL-2-OXO-12-DIHYDROQUINOLIN-3-YL)METHYL)-1- (2-HYDROXYETHYL)-3-(4-HYDROXYPHENYL)THIOUREA
3806, 4uinH, 0.5545, 3.35, 0.035, 221, 86, CRYSTAL STRUCTURE OF QUININE-DEPENDENT FAB 314.3 WITH QUININE
3807, 4rzcA, 0.5545, 3.71, 0.045, 119, 88, FV M6P-1 IN COMPLEX WITH MANNOSE-6-PHOSPHATE
3808, 4nzdA, 0.5545, 3.23, 0.112, 210, 89, INTERLEUKIN 21 RECEPTOR
3809, 4larH, 0.5545, 3.26, 0.011, 117, 87, CRYSTAL STRUCTURES OF A THERAPEUTIC SINGLE CHAIN ANTIBODY IN THE FREE FORM AND IN COMPLEX WITH AMPHETAMINE AND 4-HYDROXYMETHAMPHETAMINE
3810, 4kteL, 0.5545, 3.32, 0.057, 216, 88, FAB FRAGMENT OF HIV VACCINE-ELICITED CD4BS-DIRECTED ANTIBODY GE148 FROM NON-HUMAN PRIMATE
3811, 4jo4I, 0.5545, 3.55, 0.070, 227, 86, CRYSTAL STRUCTURE OF RABBIT MAB R20 FAB
3812, 4cadK, 0.5545, 3.22, 0.000, 221, 86, MECHANISM OF FARNESYLATED CAAX PROTEIN PROCESSING BY THE INTEGRAL MEMBRANE PROTEASE RCE1
3813, 3ugxC, 0.5545, 3.58, 0.094, 358, 96, CRYSTAL STRUCTURE OF VISUAL ARRESTIN
3814, 3ugxB, 0.5545, 3.68, 0.074, 352, 95, CRYSTAL STRUCTURE OF VISUAL ARRESTIN
3815, 3s7gD, 0.5545, 3.03, 0.024, 207, 83, AGLYCOSYLATED HUMAN IGG1 FC FRAGMENT
3816, 3fkuZ, 0.5545, 3.44, 0.058, 236, 86, CRYSTAL STRUCTURE OF INFLUENZA HEMAGGLUTININ (H5) IN COMPLEX WITH A BROADLY NEUTRALIZING ANTIBODY F10
3817, 3fkuU, 0.5545, 3.46, 0.070, 234, 86, CRYSTAL STRUCTURE OF INFLUENZA HEMAGGLUTININ (H5) IN COMPLEX WITH A BROADLY NEUTRALIZING ANTIBODY F10
3818, 2mcpH, 0.5545, 3.43, 0.070, 222, 86, REFINED CRYSTAL STRUCTURE OF THE MC/PC603 FAB-PHOSPHOCHOLINE COMPLEX AT 3.1 ANGSTROMS RESOLUTION
3819, 1to4A, 0.5545, 3.74, 0.065, 156, 92, STRUCTURE OF THE CYTOSOLIC CUZN SOD FROM S. MANSONI
3820, 1g9mH, 0.5545, 3.64, 0.091, 229, 88, HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
3821, 1cf1D, 0.5545, 3.59, 0.094, 368, 96, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
3822, 6nb5H, 0.5544, 3.56, 0.093, 220, 86, CRYSTAL STRUCTURE OF ANTI- MERS-COV HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT 
3823, 6fy0I, 0.5544, 3.20, 0.059, 216, 85, CRYSTAL STRUCTURE OF A V2-DIRECTED; RV144 VACCINE-LIKE ANTIBODY FROM HIV-1 INFECTION; CAP228-16H; BOUND TO A HETEROLOGOUS V2 PEPTIDE 
3824, 5uk4i, 0.5544, 3.49, 0.103, 125, 87, VESICULAR STOMATITS VIRUS N PROTEIN IN COMPLEX WITH INHIBITORY NANOBODY 1307
3825, 5ujzI, 0.5544, 3.68, 0.056, 236, 90, CRYOEM STRUCTURE OF AN INFLUENZA VIRUS RECEPTOR-BINDING SITE ANTIBODY- ANTIGEN INTERFACE - CLASS 1
3826, 5ujzH, 0.5544, 3.68, 0.056, 236, 90, CRYOEM STRUCTURE OF AN INFLUENZA VIRUS RECEPTOR-BINDING SITE ANTIBODY- ANTIGEN INTERFACE - CLASS 1
3827, 5ujzG, 0.5544, 3.68, 0.056, 236, 90, CRYOEM STRUCTURE OF AN INFLUENZA VIRUS RECEPTOR-BINDING SITE ANTIBODY- ANTIGEN INTERFACE - CLASS 1
3828, 5bzdD, 0.5544, 3.59, 0.091, 226, 88, CRYSTAL STRUCTURE OF PCDN-27A AN ANTIBODY FROM THE PCDN FAMILY OF HIV-1 ANTIBODIES
3829, 4zncF, 0.5544, 2.86, 0.025, 195, 80, FC FRAGMENT OF HUMAN IGG IN COMPLEX WITH THE C DOMAIN OF STAPHYLOCOCCAL PROTEIN A MUTANT - Q9W
3830, 4j3xA, 0.5544, 3.08, 0.062, 875, 80, CRYSTAL STRUCTURE OF BARLEY LIMIT DEXTRINASE (E510A MUTANT) IN COMPLEX WITH A BRANCHED MALTOHEPTASACCHARIDE
3831, 4cniA, 0.5544, 3.58, 0.080, 220, 87, CRYSTAL STRUCTURE OF THE FAB PORTION OF OLOKIZUMAB IN COMPLEX WITH IL-6
3832, 3w81B, 0.5544, 3.50, 0.101, 616, 89, HUMAN ALPHA-L-IDURONIDASE
3833, 3vfgL, 0.5544, 3.08, 0.110, 211, 82, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 3F8 FAB FRAGMENT THAT BINDS TO GD2 GANGLIOSIDE
3834, 3uguA, 0.5544, 3.73, 0.082, 345, 97, CRYSTAL STRUCTURE OF P44 (SPLICE VARIANT OF VISUAL ARRESTIN)
3835, 3bdxA, 0.5544, 3.33, 0.103, 111, 87, CRYSTAL STRUCTURE OF THE UNSTABLE AND HIGHLY FIBRILLOGENIC PRO7SER MUTANT OF THE RECOMBINANT VARIABLE DOMAIN 6AJL2
3836, 2idcA, 0.5544, 3.48, 0.070, 167, 86, STRUCTURE OF THE HISTONE H3-ASF1 CHAPERONE INTERACTION
3837, 2gj7B, 0.5544, 3.23, 0.047, 207, 85, CRYSTAL STRUCTURE OF A GE-GI/FC COMPLEX
3838, 2bxwA, 0.5544, 4.18, 0.084, 138, 95, CRYSTAL STRUCTURE OF RHOGDI LYS(135138141)TYR MUTANT
3839, 2bc4C, 0.5544, 2.99, 0.095, 195, 84, CRYSTAL STRUCTURE OF HLA-DM
3840, 1xtlC, 0.5544, 3.85, 0.066, 152, 91, CRYSTAL STRUCTURE OF P104H MUTANT OF SOD-LIKE PROTEIN FROM BACILLUS SUBTILIS.
3841, 1tjxA, 0.5544, 3.62, 0.055, 156, 91, CRYSTALLOGRAPHIC IDENTIFICATION OF CA2+ COORDINATION SITES IN SYNAPTOTAGMIN I C2B DOMAIN
3842, 1qblH, 0.5544, 3.52, 0.068, 219, 88, FAB E8 (FABE8A) X-RAY STRUCTURE AT 2.26 ANGSTROM RESOLUTION
3843, 1pkqJ, 0.5544, 3.22, 0.047, 118, 86, MYELIN OLIGODENDROCYTE GLYCOPROTEIN-(8-18C5) FAB-COMPLEX
3844, 1dn2B, 0.5544, 3.23, 0.047, 207, 85, FC FRAGMENT OF HUMAN IGG1 IN COMPLEX WITH AN ENGINEERED 13 RESIDUE PEPTIDE DCAWHLGELVWCT-NH2
3845, 6h0eH, 0.5543, 3.18, 0.059, 216, 85, FAB DMCBTAU-22.1 IN COMPLEX WITH TAU PEPTIDE V1088-23 
3846, 6eleH, 0.5543, 3.57, 0.069, 218, 87, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
3847, 5u52B, 0.5543, 3.21, 0.036, 209, 84, HELIX MINIMIZED VERSION OF THE B-DOMAIN FROM PROTEIN A (Z34C0 BOUND TO IGG1 FC (MONOCLINIC FORM)
3848, 5lvyA, 0.5543, 3.39, 0.056, 154, 89, STRUCTURAL STUDIES OF THE AGGREGATIVE ADHERENCE FIMBRIAE OF ENTEROAGGREGATIVE ESCHERICHIA COLI
3849, 5dj8A, 0.5543, 3.25, 0.047, 208, 85, FC HETERODIMER DESIGN 7.7 D399M/Y407A + T366V/K409I
3850, 4jm2D, 0.5543, 3.47, 0.093, 220, 86, CRYSTAL STRUCTURE OF PGT 135 FAB IN COMPLEX WITH GP120 CORE PROTEIN FROM HIV-1 STRAIN JR-FL BOUND TO CD4 AND 17B FAB
3851, 3tnnC, 0.5543, 3.40, 0.094, 212, 85, CRYSTAL STRUCTURE OF N5-I5 FAB AN ADCC MEDIATING AND NON-NEUTRALIZING CD4I ANTI-HIV- 1 ANTIBODY.
3852, 3juyB, 0.5543, 3.46, 0.046, 240, 87, CRYSTAL STRUCTURE OF A 3B3 VARIANT A BROADLY NEUTRALIZING HIV-1 SCFV ANTIBODY
3853, 3juyA, 0.5543, 3.48, 0.057, 233, 87, CRYSTAL STRUCTURE OF A 3B3 VARIANT A BROADLY NEUTRALIZING HIV-1 SCFV ANTIBODY
3854, 3hqlA, 0.5543, 3.12, 0.096, 134, 83, STRUCTURES OF SPOP-SUBSTRATE COMPLEXES: INSIGHTS INTO MOLECULAR ARCHITECTURES OF BTB-CUL3 UBIQUITIN LIGASES:SPOPMATHX-PUCSBC1_PEP2
3855, 3fzuH, 0.5543, 3.63, 0.080, 217, 87, IGG1 FAB CHARACTERIZED BY H/D EXCHANGE
3856, 3ejaA, 0.5543, 3.79, 0.095, 208, 95, MAGNESIUM-BOUND GLYCOSIDE HYDROLASE 61 ISOFORM E FROM THIELAVIA TERRESTRIS
3857, 2hffB, 0.5543, 3.54, 0.103, 214, 87, CRYSTAL STRUCTURE OF CB2 FAB
3858, 2h3kA, 0.5543, 3.11, 0.122, 144, 90, SOLUTION STRUCTURE OF THE FIRST NEAT DOMAIN OF ISDH
3859, 1zq7B, 0.5543, 3.69, 0.093, 200, 86, X-RAY CRYSTAL STRUCTURE OF PROTEIN Q8PZK8 FROM METHANOSARCINA MAZEI. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET MAR9.
3860, 1uz6W, 0.5543, 3.24, 0.048, 212, 84, ANTI-LEWIS X FAB FRAGMENT UNCOMPLEXED
3861, 1uowA, 0.5543, 3.62, 0.055, 156, 91, CALCIUM BINDING DOMAIN C2B
3862, 1p84J, 0.5543, 3.34, 0.058, 127, 86, HDBT INHIBITED YEAST CYTOCHROME BC1 COMPLEX
3863, 1oaxH, 0.5543, 3.35, 0.047, 122, 86, FV STRUCTURE OF THE IGE SPE-7 IN COMPLEX WITH ACENAPHTHENEQUINONE
3864, 1i1aC, 0.5543, 2.96, 0.049, 205, 82, CRYSTAL STRUCTURE OF THE NEONATAL FC RECEPTOR COMPLEXED WITH A HETERODIMERIC FC
3865, 1fc1B, 0.5543, 3.03, 0.024, 206, 83, CRYSTALLOGRAPHIC REFINEMENT AND ATOMIC MODELS OF A HUMAN FC FRAGMENT AND ITS COMPLEX WITH FRAGMENT B OF PROTEIN A FROM STAPHYLOCOCCUS AUREUS AT 2.9-AND 2.8-ANGSTROMS RESOLUTION
3866, 6fzrH, 0.5542, 3.52, 0.055, 226, 91, CRYSTAL STRUCTURE OF SCFV-SM3 IN COMPLEX WITH COMPOUND 2 
3867, 6fy2X, 0.5542, 3.40, 0.069, 219, 87, CRYSTAL STRUCTURE OF A V2P-REACTIVE RV144 VACCINE-LIKE ANTIBODY; CAP228-16H; IN COMPLEX WITH A HETEROLOGOUS CAP225 V1V2 
3868, 6f0dB, 0.5542, 3.52, 0.057, 128, 87, CRYSTAL STRUCTURE OF A LLAMA VHH ANTIBODY BCD090-M2 AGAINST HUMAN ERBB3 IN SPACE GROUP P1 WITH CADMIUM IONS
3869, 6cw3A, 0.5542, 3.42, 0.069, 222, 87, CRYSTAL STRUCTURE OF A YEAST SAGA TRANSCRIPTIONAL COACTIVATOR ADA2/GCN5 HAT SUBCOMPLEX; CRYSTAL FORM 2 
3870, 5v43A, 0.5542, 3.26, 0.035, 209, 85, ENGINEERED HUMAN IGG FC DOMAIN AGLYCO801
3871, 5mubI, 0.5542, 3.42, 0.095, 217, 84, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (CG05)
3872, 5mubF, 0.5542, 3.43, 0.095, 217, 84, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (CG05)
3873, 5bqdA, 0.5542, 3.81, 0.087, 197, 92, CRYSTAL STRUCTURE OF TBX5 (1-239) DIMER
3874, 4n9gE, 0.5542, 3.21, 0.060, 223, 83, CRYSTAL STRUCTURE OF A COMPUTATIONALLY DESIGNED RSV-PRESENTING EPITOPE SCAFFOLD AND ITS ELICITED ANTIBODY 17HD9
3875, 4llaC, 0.5542, 3.04, 0.024, 198, 83, CRYSTAL STRUCTURE OF D3D4 DOMAIN OF THE LILRB2 MOLECULE
3876, 4j2qB, 0.5542, 3.68, 0.074, 346, 95, CRYSTAL STRUCTURE OF C-TERMINALLY TRUNCATED ARRESTIN REVEALS MECHANISM OF ARRESTIN ACTIVATION
3877, 4hs6H, 0.5542, 3.20, 0.035, 215, 86, HEPATITUS C ENVELOPE GLYCOPROTEIN E2 FRAGMENT 412-423 WITH HUMANIZED AND AFFINITY-MATURED ANTIBODY MRCT10.V362
3878, 4ebqH, 0.5542, 3.37, 0.058, 218, 86, FAB STRUCTURE OF ANTI-VACCINIA VIRUS D8L ANTIGEN MOUSE IGG2A LA5
3879, 4duxA, 0.5542, 3.87, 0.083, 1015, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (N460S) IN COMPLEX WITH L-RIBOSE
3880, 2vsdA, 0.5542, 2.84, 0.062, 93, 80, CRYSTAL STRUCTURE OF CHIR-AB1
3881, 2dwxD, 0.5542, 3.88, 0.133, 129, 98, CO-CRYSTAL STRUCTURE ANALYSIS OF GGA1-GAE WITH THE WNSF MOTIF
3882, 1yjdC, 0.5542, 3.33, 0.045, 118, 88, CRYSTAL STRUCTURE OF HUMAN CD28 IN COMPLEX WITH THE FAB FRAGMENT OF A MITOGENIC ANTIBODY (5.11A1)
3883, 1dfbH, 0.5542, 3.53, 0.080, 229, 87, STRUCTURE OF A HUMAN MONOCLONAL ANTIBODY FAB FRAGMENT AGAINST GP41 OF HUMAN IMMUNODEFICIENCY VIRUS TYPE I
3884, 6gjqD, 0.5541, 3.44, 0.103, 121, 87, HUMAN NBD1 OF CFTR IN COMPLEX WITH NANOBODY T27 
3885, 5xtzD, 0.5541, 3.02, 0.108, 151, 83, CRYSTAL STRUCTURE OF GAS41 YEATS BOUND TO H3K27AC PEPTIDE 
3886, 5w3mE, 0.5541, 3.38, 0.059, 116, 85, CRYOEM STRUCTURE OF RHINOVIRUS B14 IN COMPLEX WITH C5 FAB (33 DEGREES CELSIUS MOLAR RATIO 1:1 FULL PARTICLE)
3887, 5uk4e, 0.5541, 3.48, 0.103, 125, 87, VESICULAR STOMATITS VIRUS N PROTEIN IN COMPLEX WITH INHIBITORY NANOBODY 1307
3888, 5th2D, 0.5541, 3.66, 0.068, 220, 88, CETUXIMAB FAB IN COMPLEX WITH L5Q MEDITOPE VARIANT
3889, 5ou7A, 0.5541, 2.71, 0.087, 173, 80, CRYSTAL STRUCTURE OF THE GLYCOPROTEIN VI LOOP TRUNCATION MUTANT PAVS- PAPYKN 
3890, 5hi5L, 0.5541, 3.04, 0.082, 213, 85, BINDING SITE ELUCIDATION AND STRUCTURE GUIDED DESIGN OF MACROCYCLIC IL-17A ANTAGONISTS
3891, 5hi4D, 0.5541, 3.16, 0.081, 213, 86, BINDING SITE ELUCIDATION AND STRUCTURE GUIDED DESIGN OF MACROCYCLIC IL-17A ANTAGONISTS
3892, 5e5mA, 0.5541, 3.09, 0.070, 115, 86, CRYSTAL STRUCTURE OF MOUSE CTLA-4 IN COMPLEX WITH NANOBODY
3893, 4xrcH, 0.5541, 3.27, 0.071, 217, 85, ANTIBODY HEMAGGLUTININ COMPLEXES
3894, 4w2pC, 0.5541, 3.37, 0.081, 120, 86, ANTI-MARBURGVIRUS NUCLEOPROTEIN SINGLE DOMAIN ANTIBODY C
3895, 4qhmG, 0.5541, 3.16, 0.047, 217, 85, I3.1 (UNBOUND) FROM CH103 LINEAGE
3896, 4leeA, 0.5541, 3.93, 0.021, 313, 94, STRUCTURE OF THE ALS3 ADHESIN FROM CANDIDA ALBICANS RESIDUES 1-313 (MATURE SEQUENCE) TRIPLE MUTANT IN THE BINDING CAVITY: K59M A116V Y301F
3897, 4imlA, 0.5541, 3.22, 0.047, 234, 85, CROSSFAB BINDING TO HUMAN ANGIOPOIETIN 2
3898, 4duxC, 0.5541, 3.80, 0.063, 1015, 95, E. COLI (LACZ) BETA-GALACTOSIDASE (N460S) IN COMPLEX WITH L-RIBOSE
3899, 3lsoA, 0.5541, 3.22, 0.095, 439, 84, CRYSTAL STRUCTURE OF PUTATIVE MEMBRANE ANCHORED PROTEIN FROM CORYNEBACTERIUM DIPHTHERIAE
3900, 3juaA, 0.5541, 3.29, 0.056, 204, 89, STRUCTURAL BASIS OF YAP RECOGNITION BY TEAD4 IN THE HIPPO PATHWAY
3901, 3isyA, 0.5541, 3.45, 0.070, 115, 86, CRYSTAL STRUCTURE OF AN INTRACELLULAR PROTEINASE INHIBITOR (IPI BSU11130) FROM BACILLUS SUBTILIS AT 2.61 A RESOLUTION
3902, 3cmoH, 0.5541, 3.37, 0.035, 222, 86, HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ18
3903, 5y56B, 0.5540, 3.22, 0.047, 208, 85, FC MUTANT (K392D/K409D/D399K)
3904, 5uk4s, 0.5540, 3.47, 0.103, 125, 87, VESICULAR STOMATITS VIRUS N PROTEIN IN COMPLEX WITH INHIBITORY NANOBODY 1307
3905, 5uk4l, 0.5540, 3.49, 0.103, 125, 87, VESICULAR STOMATITS VIRUS N PROTEIN IN COMPLEX WITH INHIBITORY NANOBODY 1307
3906, 5emvB, 0.5540, 3.31, 0.056, 203, 89, CRYSTAL STRUCTURE OF THE PALMITOYLATED HUMAN TEAD2 TRANSCRIPTION FACTOR
3907, 4weuD, 0.5540, 3.34, 0.071, 121, 85, CO-COMPLEX STRUCTURE OF THE F4 FIMBRIAL ADHESIN FAEG VARIANT AD WITH LLAMA SINGLE DOMAIN ANTIBODY V3
3908, 4rzcH, 0.5540, 3.58, 0.046, 118, 87, FV M6P-1 IN COMPLEX WITH MANNOSE-6-PHOSPHATE
3909, 4n1hB, 0.5540, 3.10, 0.084, 126, 83, STRUCTURE OF A SINGLE-DOMAIN CAMELID ANTIBODY FRAGMENT CAB-F11N IN COMPLEX WITH THE BLAP BETA-LACTAMASE FROM BACILLUS LICHENIFORMIS
3910, 4ibsD, 0.5540, 3.52, 0.087, 194, 92, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R273H (FORM I)
3911, 4at6I, 0.5540, 3.22, 0.057, 212, 87, FAB FRAGMENT OF ANTIPORPHYRIN ANTIBODY 14H7
3912, 3se4C, 0.5540, 3.15, 0.092, 190, 87, HUMAN IFNW-IFNAR TERNARY COMPLEX
3913, 3lh2O, 0.5540, 3.18, 0.035, 110, 85, CRYSTAL STRUCTURE OF HIV EPITOPE-SCAFFOLD 4E10_1VI7A_S0_002_N 4E10 FV COMPLEX
3914, 3iy3B, 0.5540, 3.15, 0.082, 119, 85, VARIABLE DOMAINS OF THE COMPUTER GENERATED MODEL (WAM) OF FAB 8 FITTED INTO THE CRYOEM RECONSTRUCTION OF THE VIRUS- FAB 8 COMPLEX
3915, 3ietB, 0.5540, 3.54, 0.047, 210, 86, CRYSTAL STRUCTURE OF 237MAB WITH ANTIGEN
3916, 3hu6A, 0.5540, 3.13, 0.095, 284, 84, STRUCTURES OF SPOP-SUBSTRATE COMPLEXES: INSIGHTS INTO MOLECULAR ARCHITECTURES OF BTB-CUL3 UBIQUITIN LIGASES: SPOPMATHX/BTB/3-BOX-PUCSBC1
3917, 3fxiD, 0.5540, 4.28, 0.059, 140, 101, CRYSTAL STRUCTURE OF THE HUMAN TLR4-HUMAN MD-2-E.COLI LPS RA COMPLEX
3918, 3fxiC, 0.5540, 4.28, 0.059, 140, 101, CRYSTAL STRUCTURE OF THE HUMAN TLR4-HUMAN MD-2-E.COLI LPS RA COMPLEX
3919, 3fo2B, 0.5540, 3.28, 0.058, 214, 86, CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)GLN MUTANT)
3920, 2vxsL, 0.5540, 3.04, 0.082, 213, 85, STRUCTURE OF IL-17A IN COMPLEX WITH A POTENT FULLY HUMAN NEUTRALISING ANTIBODY
3921, 1to5B, 0.5540, 3.73, 0.065, 156, 92, STRUCTURE OF THE CYTOSOLIC CUZN SOD FROM S. MANSONI
3922, 1ogpB, 0.5540, 3.96, 0.095, 388, 95, THE CRYSTAL STRUCTURE OF PLANT SULFITE OXIDASE PROVIDES INSIGHT INTO SULFITE OXIDATION IN PLANTS AND ANIMALS
3923, 6oyhE, 0.5539, 3.30, 0.083, 124, 84, CRYSTAL STRUCTURE OF MRAY BOUND TO CARBACAPRAZAMYCIN 
3924, 6on9A, 0.5539, 3.23, 0.114, 116, 88, CRYSTAL STRUCTURE OF THE ZIG-8-RIG-5 IG1-IG1 HETERODIMER; TETRAGONAL FORM 
3925, 6h0eC, 0.5539, 3.21, 0.071, 218, 85, FAB DMCBTAU-22.1 IN COMPLEX WITH TAU PEPTIDE V1088-23 
3926, 6bjqA, 0.5539, 2.89, 0.099, 598, 81, EUBACTERIUM ELIGENS BETA-GLUCURONIDASE BOUND TO GLUCURONIC ACID 
3927, 5xwdD, 0.5539, 3.13, 0.082, 108, 85, CRYSTAL STRUCTURE OF THE COMPLEX OF 059-152-FV AND EGFR-ECD
3928, 5th2B, 0.5539, 3.67, 0.068, 216, 88, CETUXIMAB FAB IN COMPLEX WITH L5Q MEDITOPE VARIANT
3929, 5mv4I, 0.5539, 3.44, 0.095, 218, 84, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
3930, 5mubU, 0.5539, 3.42, 0.095, 218, 84, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (CG05)
3931, 5mubL, 0.5539, 3.42, 0.095, 216, 84, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (CG05)
3932, 5k59H, 0.5539, 3.32, 0.047, 212, 86, CRYSTAL STRUCTURE OF LUKGH FROM STAPHYLOCOCCUS AUREUS IN COMPLEX WITH A NEUTRALISING ANTIBODY
3933, 5jp2B, 0.5539, 4.02, 0.092, 270, 98, FCHO1 MU HOMOLOGY DOMAIN (DANIO RERIO) WITH BOUND EPS15 PEPTIDE
3934, 5iczD, 0.5539, 3.66, 0.068, 213, 88, CETUXIMAB FAB IN COMPLEX WITH GQFDLSTRRLKG PEPTIDE
3935, 5hnoB, 0.5539, 3.75, 0.083, 168, 96, THE STRUCTURE OF THE KDO-CAPPED SACCHARIDE BINDING SUBUNIT OF THE O-12 SPECIFIC ABC TRANSPORTER WZT
3936, 5axgA, 0.5539, 3.83, 0.110, 583, 91, CRYSTAL STRUCTURE OF THERMOPHILIC DEXTRANASE FROM THERMOANAEROBACTER PSEUDETHANOLICUS
3937, 2ny1D, 0.5539, 3.66, 0.080, 223, 88, HIV-1 GP120 ENVELOPE GLYCOPROTEIN (I109C T257S S334A S375W Q428C) COMPLEXED WITH CD4 AND ANTIBODY 17B
3938, 2iglD, 0.5539, 3.31, 0.119, 116, 84, CRYSTAL STRUCTURE OF E. COLI YEDX A TRANSTHYRETIN RELATED PROTEIN
3939, 1ow0B, 0.5539, 3.29, 0.072, 209, 83, CRYSTAL STRUCTURE OF HUMAN FCARI BOUND TO IGA1-FC
3940, 1ow0A, 0.5539, 3.29, 0.072, 209, 83, CRYSTAL STRUCTURE OF HUMAN FCARI BOUND TO IGA1-FC
3941, 1g7hB, 0.5539, 3.51, 0.080, 116, 87, CRYSTAL STRUCTURE OF HEN EGG WHITE LYSOZYME (HEL) COMPLEXED WITH THE MUTANT ANTI-HEL MONOCLONAL ANTIBODY D1.3(VLW92A)
3942, 1ft3A, 0.5539, 4.07, 0.044, 129, 91, CRYSTAL STRUCTURE OF TRUNCATED RHOGDI K141A MUTANT
3943, 6ol6H, 0.5538, 3.47, 0.057, 127, 87, STRUCTURE OF IGLB12 SCFV IN COMPLEX WITH ANTI-IDIOTYPE IB2 FAB 
3944, 6fy1H, 0.5538, 3.22, 0.047, 226, 85, CRYSTAL STRUCTURE OF A V2P-REACTIVE RV144 VACCINE-LIKE ANTIBODY; CAP228-16H; IN COMPLEX WITH A SCAFFOLDED AUTOLOGOUS V1V2 
3945, 6fgoB, 0.5538, 3.27, 0.047, 209, 85, FC IN COMPLEX WITH ENGINEERED CALCIUM BINDING DOMAIN Z 
3946, 6dkjA, 0.5538, 3.55, 0.081, 221, 86, HUMAN GIPR ECD AND FAB COMPLEX 
3947, 5wtbB, 0.5538, 4.24, 0.089, 319, 101, COMPLEX STRUCTURE OF STAPHYLOCOCCUS AUREUS SDRE WITH HUMAN COMPLEMENT FACTOR H
3948, 5vlvA, 0.5538, 3.54, 0.080, 125, 87, THE APO FORM OF THE TRICLOCARBAN-BINDING SINGLE DOMAIN CAMELID NANOBODY VHH T9 
3949, 5uk4b, 0.5538, 3.49, 0.103, 125, 87, VESICULAR STOMATITS VIRUS N PROTEIN IN COMPLEX WITH INHIBITORY NANOBODY 1307
3950, 5itfB, 0.5538, 3.66, 0.068, 217, 88, CETUXIMAB FAB IN COMPLEX WITH 2-BROMOPHENYLALANINE MEDITOPE VARIANT
3951, 5e52A, 0.5538, 3.08, 0.070, 294, 86, CRYSTAL STRUCTURE OF HUMAN CNTN5 FN1-FN3 DOMAINS
3952, 5dk0B, 0.5538, 3.25, 0.035, 206, 85, FC HETERODIMER DESIGN 20.8.34 Y349S/T366M/K370Y/K409V + E356G/E357D/S364Q/Y407A
3953, 5djaA, 0.5538, 3.26, 0.047, 208, 85, FC HETERODIMER DESIGN 9.1 Y407M + T366I
3954, 4x4mD, 0.5538, 3.07, 0.024, 214, 83, STRUCTURE OF FCGAMMARI IN COMPLEX WITH FC REVEALS THE IMPORTANCE OF GLYCAN RECOGNITION FOR HIGH AFFINITY IGG BINDING
3955, 4x4mB, 0.5538, 3.07, 0.024, 216, 83, STRUCTURE OF FCGAMMARI IN COMPLEX WITH FC REVEALS THE IMPORTANCE OF GLYCAN RECOGNITION FOR HIGH AFFINITY IGG BINDING
3956, 4tw1E, 0.5538, 3.75, 0.043, 290, 92, CRYSTAL STRUCTURE OF THE OCTAMERIC PORE COMPLEX OF THE STAPHYLOCOCCUS AUREUS BI-COMPONENT TOXIN LUKGH
3957, 4nzdC, 0.5538, 3.21, 0.091, 210, 88, INTERLEUKIN 21 RECEPTOR
3958, 4k3gB, 0.5538, 3.21, 0.069, 109, 87, IMMUNOGLOBULIN LAMBDA VARIABLE DOMAIN L5(L89S) FLUOROGEN ACTIVATING PROTEIN
3959, 4h0gA, 0.5538, 3.37, 0.058, 242, 86, CRYSTAL STRUCTURE OF MIMICRY-RECOGNIZING NATIVE 2D10 SCFV
3960, 4dw2H, 0.5538, 3.27, 0.048, 210, 83, THE CRYSTAL STRUCTURE OF UPA IN COMPLEX WITH THE FAB FRAGMENT OF MAB- 112
3961, 3vdcC, 0.5538, 3.75, 0.074, 1015, 95, E. COLI (LACZ) BETA-GALACTOSIDASE (N460T) IN COMPLEX WITH IPTG
3962, 3sepB, 0.5538, 3.76, 0.074, 1015, 95, E. COLI (LACZ) BETA-GALACTOSIDASE (S796A)
3963, 3ifpC, 0.5538, 3.34, 0.081, 216, 86, X-RAY STRUCTURE OF AMYLOID BETA PEPTIDE:ANTIBODY (ABETA1-7:12B4) COMPLEX
3964, 3ejaD, 0.5538, 3.94, 0.094, 208, 96, MAGNESIUM-BOUND GLYCOSIDE HYDROLASE 61 ISOFORM E FROM THIELAVIA TERRESTRIS
3965, 2fx8K, 0.5538, 3.30, 0.082, 227, 85, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH AN AIB-INDUCED PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41
3966, 2arjH, 0.5538, 3.23, 0.058, 212, 86, CD8ALPHA-ALPHA IN COMPLEX WITH YTS 105.18 FAB
3967, 1vfbB, 0.5538, 3.51, 0.080, 116, 87, BOUND WATER MOLECULES AND CONFORMATIONAL STABILIZATION HELP MEDIATE AN ANTIGEN-ANTIBODY ASSOCIATION
3968, 1ogpF, 0.5538, 3.96, 0.095, 388, 95, THE CRYSTAL STRUCTURE OF PLANT SULFITE OXIDASE PROVIDES INSIGHT INTO SULFITE OXIDATION IN PLANTS AND ANIMALS
3969, 1fdlH, 0.5538, 3.39, 0.070, 218, 86, CRYSTALLOGRAPHIC REFINEMENT OF THE THREE-DIMENSIONAL STRUCTURE OF THE FAB D1.3-LYSOZYME COMPLEX AT 2.5- ANGSTROMS RESOLUTION
3970, 1a7rH, 0.5538, 3.50, 0.080, 116, 87, FV FRAGMENT OF MOUSE MONOCLONAL ANTIBODY D1.3 (BALB/C IGG1 K) VARIANT CHAIN L GLU81->ASP
3971, 6i8sH, 0.5537, 3.45, 0.070, 214, 86, DISCOVERY AND CHARACTERISATION OF AN ANTIBODY THAT SELECTIVELY MODULATES THE INHIBITORY ACTIVITY OF PLASMINOGEN ACTIVATOR INHIBITOR- 1 
3972, 5x3kA, 0.5537, 3.16, 0.084, 708, 83, KFLA1895 D451A MUTANT IN COMPLEX WITH ISOMALTOSE
3973, 5a2kH, 0.5537, 3.58, 0.055, 225, 91, CRYSTAL STRUCTURE OF SCFV-SM3 IN COMPLEX WITH APD-TGALNAC-RP
3974, 4xwoW, 0.5537, 3.47, 0.093, 221, 86, STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF SEC22
3975, 4rgnB, 0.5537, 3.35, 0.082, 213, 85, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO TWO NEUTRALIZING ANTIBODIES 14G8 AND 6D3
3976, 4nhhN, 0.5537, 3.03, 0.024, 206, 83, STRUCTURE OF 2G12 IGG DIMER
3977, 4nhhD, 0.5537, 3.03, 0.024, 206, 83, STRUCTURE OF 2G12 IGG DIMER
3978, 4nhhB, 0.5537, 3.03, 0.024, 206, 83, STRUCTURE OF 2G12 IGG DIMER
3979, 4nhgY, 0.5537, 3.03, 0.024, 206, 83, CRYSTAL STRUCTURE OF 2G12 IGG DIMER
3980, 4nhgP, 0.5537, 3.03, 0.024, 206, 83, CRYSTAL STRUCTURE OF 2G12 IGG DIMER
3981, 4nhgN, 0.5537, 3.03, 0.024, 206, 83, CRYSTAL STRUCTURE OF 2G12 IGG DIMER
3982, 4j3tA, 0.5537, 3.06, 0.087, 870, 80, CRYSTAL STRUCTURE OF BARLEY LIMIT DEXTRINASE CO-CRYSTALLIZED WITH 25MM MALTOTETRAOSE
3983, 4g6fB, 0.5537, 3.70, 0.092, 235, 87, CRYSTAL STRUCTURE OF 10E8 FAB IN COMPLEX WITH AN HIV-1 GP41 PEPTIDE
3984, 3ifpH, 0.5537, 3.34, 0.081, 222, 86, X-RAY STRUCTURE OF AMYLOID BETA PEPTIDE:ANTIBODY (ABETA1-7:12B4) COMPLEX
3985, 3ifpA, 0.5537, 3.34, 0.081, 216, 86, X-RAY STRUCTURE OF AMYLOID BETA PEPTIDE:ANTIBODY (ABETA1-7:12B4) COMPLEX
3986, 2v9uC, 0.5537, 3.85, 0.063, 132, 95, RIM DOMAIN OF MAIN PORIN FROM MYCOBACTERIA SMEGMATIS
3987, 2p9rB, 0.5537, 3.20, 0.141, 97, 85, HUMAN ALPHA2-MACROGLOGULIN IS COMPOSED OF MULTIPLE DOMAINS AS PREDICTED BY HOMOLOGY WITH COMPLEMENT COMPONENT C3
3988, 2jhyA, 0.5537, 4.20, 0.084, 138, 95, CRYSTAL STRUCTURE OF RHOGDI E155H E157H MUTANT
3989, 2edxA, 0.5537, 3.20, 0.080, 134, 88, SOLUTION STRUCTURES OF THE FN3 DOMAIN OF HUMAN RECEPTOR- TYPE TYROSINE-PROTEIN PHOSPHATASE F
3990, 1h3xB, 0.5537, 3.03, 0.024, 206, 83, CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENTGLYCOFORM (G0F)2
3991, 6n9tA, 0.5536, 3.26, 0.047, 207, 85, STRUCTURE OF A PEPTIDE-BASED PHOTO-AFFINITY CROSS-LINKER WITH HERCEPTIN FC 
3992, 6fy2H, 0.5536, 3.41, 0.069, 219, 87, CRYSTAL STRUCTURE OF A V2P-REACTIVE RV144 VACCINE-LIKE ANTIBODY; CAP228-16H; IN COMPLEX WITH A HETEROLOGOUS CAP225 V1V2 
3993, 5uk4o, 0.5536, 3.49, 0.103, 125, 87, VESICULAR STOMATITS VIRUS N PROTEIN IN COMPLEX WITH INHIBITORY NANOBODY 1307
3994, 5t3zD, 0.5536, 3.31, 0.035, 229, 85, 3.5 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074
3995, 5f88B, 0.5536, 3.65, 0.068, 216, 88, CETUXIMAB FAB IN COMPLEX WITH L5Y MEDITOPE VARIANT
3996, 5djxE, 0.5536, 3.26, 0.047, 207, 85, FC HETERODIMER DESIGN 2.9 L368M/K370E + E357A/S364G
3997, 4yhmH, 0.5536, 3.39, 0.093, 222, 86, REVERSAL AGENT FOR DABIGATRAN
3998, 4gw5B, 0.5536, 3.64, 0.068, 216, 88, CQYN MEDITOPE - CETUXIMAB FAB
3999, 4g8aC, 0.5536, 4.43, 0.059, 140, 102, CRYSTAL STRUCTURE OF HUMAN TLR4 POLYMORPHIC VARIANT D299G AND T399I IN COMPLEX WITH MD-2 AND LPS
4000, 4cniH, 0.5536, 3.61, 0.080, 219, 87, CRYSTAL STRUCTURE OF THE FAB PORTION OF OLOKIZUMAB IN COMPLEX WITH IL-6
4001, 3wknM, 0.5536, 3.24, 0.036, 209, 84, CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG
4002, 3pp3I, 0.5536, 3.62, 0.068, 219, 88, EPITOPE CHARACTERIZATION AND CRYSTAL STRUCTURE OF GA101 PROVIDE INSIGHTS INTO THE MOLECULAR BASIS FOR THE TYPE I / TYPE II DISTINCTION OF ANTI- CD20 ANTIBODIES
4003, 3kysA, 0.5536, 3.29, 0.034, 207, 89, CRYSTAL STRUCTURE OF HUMAN YAP AND TEAD COMPLEX
4004, 3if1D, 0.5536, 3.27, 0.048, 210, 84, CRYSTAL STRUCTURE OF 237MAB IN COMPLEX WITH A GALNAC
4005, 3dvgB, 0.5536, 3.20, 0.071, 221, 85, CRYSTAL STRUCTURE OF K63-SPECIFIC FAB APU.3A8 BOUND TO K63-LINKED DI- UBIQUITIN
4006, 2gi7A, 0.5536, 2.72, 0.087, 182, 80, CRYSTAL STRUCTURE OF HUMAN PLATELET GLYCOPROTEIN VI (GPVI)
4007, 1t83B, 0.5536, 3.06, 0.024, 212, 83, CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (ORTHORHOMBIC)
4008, 1rumH, 0.5536, 3.06, 0.070, 222, 86, CRYSTAL STRUCTURE (F) OF H2O2-SOAKED CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 8.5 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 9-1.
4009, 1ospH, 0.5536, 3.20, 0.106, 218, 85, CRYSTAL STRUCTURE OF OUTER SURFACE PROTEIN A OF BORRELIA BURGDORFERI COMPLEXED WITH A MURINE MONOCLONAL ANTIBODY FAB
4010, 1mcpH, 0.5536, 3.43, 0.070, 222, 86, PHOSPHOCHOLINE BINDING IMMUNOGLOBULIN FAB MC/PC603. AN X-RAY DIFFRACTION STUDY AT 2.7 ANGSTROMS
4011, 1jnhB, 0.5536, 3.63, 0.057, 214, 88, CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES
4012, 1gc1H, 0.5536, 3.47, 0.093, 229, 86, HIV-1 GP120 CORE COMPLEXED WITH CD4 AND A NEUTRALIZING HUMAN ANTIBODY
4013, 1ay1H, 0.5536, 3.25, 0.047, 213, 86, ANTI TAQ FAB TP7
4014, 5w3eE, 0.5535, 3.53, 0.057, 116, 87, CRYOEM STRUCTURE OF RHINOVIRUS B14 IN COMPLEX WITH C5 FAB (33 DEGREES CELSIUS MOLAR RATIO 1:3 FULL PARTICLE)
4015, 5k64B, 0.5535, 3.24, 0.047, 213, 85, CRYSTAL STRUCTURE OF VEGF BINDING IGG1-FC (FCAB 448)
4016, 5eiiA, 0.5535, 3.60, 0.116, 220, 86, STRUCTURAL DETERMINATION OF AN PROTEIN COMPLEX OF A FAB WITH INCREASED SOLUBILITY
4017, 5e5mE, 0.5535, 3.10, 0.068, 115, 88, CRYSTAL STRUCTURE OF MOUSE CTLA-4 IN COMPLEX WITH NANOBODY
4018, 5dj2A, 0.5535, 3.26, 0.047, 208, 85, FC HETERODIMER DESIGN 7.4 Y407A + T366V/K409V
4019, 5awnH, 0.5535, 3.61, 0.057, 219, 88, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 BROADLY NEUTRALIZING ANTIBODY 3BC176 FAB
4020, 4q5zO, 0.5535, 3.24, 0.071, 209, 84, CRYSTAL STRUCTURE ANALYSIS OF FAB-BOUND HUMAN INSULIN DEGRADING ENZYME (IDE) IN COMPLEX WITH INSULIN
4021, 4eazB, 0.5535, 3.30, 0.056, 213, 90, VGLL1-TEAD4 STRUCTURE
4022, 3rvtD, 0.5535, 3.08, 0.070, 222, 86, STRUCTURE OF 4C1 FAB IN P212121 SPACE GROUP
4023, 3ifpE, 0.5535, 3.34, 0.081, 216, 86, X-RAY STRUCTURE OF AMYLOID BETA PEPTIDE:ANTIBODY (ABETA1-7:12B4) COMPLEX
4024, 2hczX, 0.5535, 3.40, 0.107, 241, 84, CRYSTAL STRUCTURE OF EXPB1 (ZEA M 1) A BETA-EXPANSIN AND GROUP-1 POLLEN ALLERGEN FROM MAIZE
4025, 2eviA, 0.5535, 4.08, 0.079, 290, 101, STRUCTURE OF A NDT80-DNA COMPLEX (MSE MUTANT MA8T)
4026, 2eizB, 0.5535, 3.23, 0.107, 113, 84, CRYSTAL STRUCTURE OF HUMANIZED HYHEL-10 FV MUTANT(HW47Y)-HEN LYSOZYME COMPLEX
4027, 2cm5A, 0.5535, 3.60, 0.069, 141, 87, CRYSTAL STRUCTURE OF THE C2B DOMAIN OF RABPHILIN
4028, 1vfaB, 0.5535, 3.51, 0.080, 116, 87, BOUND WATER MOLECULES AND CONFORMATIONAL STABILIZATION HELP MEDIATE AN ANTIGEN-ANTIBODY ASSOCIATION
4029, 1to4B, 0.5535, 3.73, 0.065, 156, 92, STRUCTURE OF THE CYTOSOLIC CUZN SOD FROM S. MANSONI
4030, 1nbvH, 0.5535, 3.41, 0.080, 219, 87, AN AUTOANTIBODY TO SINGLE-STRANDED DNA: COMPARISON OF THE THREE-DIMENSIONAL STRUCTURES OF THE UNLIGANDED FAB AND A DEOXYNUCLEOTIDE-FAB COMPLEX
4031, 6quzE, 0.5534, 3.46, 0.069, 124, 87, STRUCTURE OF ATPGS-BOUND OUTWARD-FACING TM287/288 IN COMPLEX WITH SYBODY SB_TM35 
4032, 6n4yF, 0.5534, 3.48, 0.081, 123, 86, METABOTROPIC GLUTAMATE RECEPTOR 5 EXTRACELLULAR DOMAIN WITH NB43 
4033, 6ieaH, 0.5534, 3.15, 0.047, 210, 86, STRUCTURE OF RVFV GN AND HUMAN MONOCLONAL ANTIBODY R13 
4034, 6grqA, 0.5534, 3.09, 0.036, 536, 84, PAIRED IMMUNOGLOBULIN-LIKE RECEPTOR B (PIRB) OR LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR SUBFAMILY B MEMBER 3 (LILRB3) FULL EXTRACELLULAR DOMAIN 
4035, 6ca6H, 0.5534, 3.37, 0.057, 226, 87, CRYSTAL STRUCTURE OF PCT64_35S; A BROADLY NEUTRALIZING ANTI-HIV ANTIBODY. 
4036, 5yaxB, 0.5534, 3.42, 0.058, 230, 86, CRYSTAL STRUCTURE OF A HUMAN NEUTRALIZING ANTIBODY BOUND TO A HBV PRES1 PEPTIDE
4037, 5wavB, 0.5534, 2.95, 0.024, 207, 82, FC ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION-MAKING IN ANTIBODY DRUG DISCOVERY.
4038, 5mv4F, 0.5534, 3.44, 0.095, 213, 84, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
4039, 5mubC, 0.5534, 3.42, 0.095, 216, 84, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (CG05)
4040, 5mubA, 0.5534, 3.43, 0.095, 217, 84, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (CG05)
4041, 5jdrB, 0.5534, 2.61, 0.063, 209, 79, STRUCTURE OF PD-L1
4042, 5iczB, 0.5534, 3.66, 0.068, 216, 88, CETUXIMAB FAB IN COMPLEX WITH GQFDLSTRRLKG PEPTIDE
4043, 5cwsB, 0.5534, 3.38, 0.058, 223, 86, CRYSTAL STRUCTURE OF THE INTACT CHAETOMIUM THERMOPHILUM NSP1-NUP49- NUP57 CHANNEL NUCLEOPORIN HETEROTRIMER BOUND TO ITS NIC96 NUCLEAR PORE COMPLEX ATTACHMENT SITE
4044, 5axhA, 0.5534, 3.71, 0.088, 586, 91, CRYSTAL STRUCTURE OF THERMOPHILIC DEXTRANASE FROM THERMOANAEROBACTER PSEUDETHANOLICUS D312G MUTANT IN COMPLEX WITH ISOMALTOHEXAOSE
4045, 4leeC, 0.5534, 3.94, 0.021, 313, 94, STRUCTURE OF THE ALS3 ADHESIN FROM CANDIDA ALBICANS RESIDUES 1-313 (MATURE SEQUENCE) TRIPLE MUTANT IN THE BINDING CAVITY: K59M A116V Y301F
4046, 4etqA, 0.5534, 3.44, 0.045, 217, 88, VACCINIA VIRUS D8L IMV ENVELOPE PROTEIN IN COMPLEX WITH FAB OF MURINE IGG2A LA5
4047, 3ulvD, 0.5534, 3.30, 0.058, 224, 86, STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM2)
4048, 2etwA, 0.5534, 4.10, 0.079, 297, 101, PRINCIPLES OF PROTEIN-DNA RECOGNITION REVEALED IN THE STRUCTURAL ANALYSIS OF NDT80-MSE DNA COMPLEXES
4049, 2cryA, 0.5534, 3.04, 0.084, 122, 83, SOLUTION STRUCTURE OF THE FIFTH IG-LIKE DOMAIN OF HUMAN KIN OF IRRE LIKE 3
4050, 2ck0H, 0.5534, 3.66, 0.092, 211, 87, ANTI-ANTI-IDIOTYPIC ANTIBODY AGAINST HUMAN ANGIOTENSIN II COMPLEX WITH A SYNTHETIC CYCLIC PEPTIDE
4051, 6qv0E, 0.5533, 3.35, 0.070, 124, 86, STRUCTURE OF ATP-BOUND OUTWARD-FACING TM287/288 IN COMPLEX WITH SYBODY SB_TM35 
4052, 6gk4B, 0.5533, 3.12, 0.036, 121, 84, HUMAN NBD1 OF CFTR IN COMPLEX WITH NANOBODIES D12 AND T8 
4053, 6cmgC, 0.5533, 3.46, 0.059, 226, 85, CRYSTAL STRUCTURE OF THE HENDRA VIRUS ATTACHMENT G GLYCOPROTEIN BOUND TO A POTENT CROSS-REACTIVE NEUTRALIZING HUMAN MONOCLONAL ANTIBODY M102.3 
4054, 5xhgB, 0.5533, 3.53, 0.103, 214, 87, CRYSTAL STRUCTURE OF TRASTUZUMAB FAB FRAGMENT BEARING NE-(O- AZIDOBENZYLOXYCARBONYL)-L-LYSINE
4055, 5vaaA, 0.5533, 3.07, 0.060, 207, 83, CRYSTAL STRUCTURE OF MOUSE IGG2A FC T370K MUTANT
4056, 5urmB, 0.5533, 3.40, 0.057, 1691, 88, CRYSTAL STRUCTURE OF HUMAN BRR2 IN COMPLEX WITH T-1206548
4057, 5no8A, 0.5533, 3.22, 0.036, 669, 83, POLYSACCHARIDE LYASE BACCELL_00875
4058, 5mv4A, 0.5533, 3.45, 0.095, 218, 84, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
4059, 5k59E, 0.5533, 3.46, 0.034, 210, 87, CRYSTAL STRUCTURE OF LUKGH FROM STAPHYLOCOCCUS AUREUS IN COMPLEX WITH A NEUTRALISING ANTIBODY
4060, 5j72B, 0.5533, 3.27, 0.093, 638, 86, CWP6 FROM CLOSTRIDIUM DIFFICILE
4061, 5axhB, 0.5533, 3.67, 0.099, 587, 91, CRYSTAL STRUCTURE OF THERMOPHILIC DEXTRANASE FROM THERMOANAEROBACTER PSEUDETHANOLICUS D312G MUTANT IN COMPLEX WITH ISOMALTOHEXAOSE
4062, 5awtA, 0.5533, 3.59, 0.118, 266, 93, CRYSTAL STRUCTURE OF THE SGIP1 MU HOMOLOGY DOMAIN IN COMPLEX WITH AN EPS15 FRAGMENT CONTAINING TWO DPF MOTIFS (YDPFGGDPFKG)
4063, 4s10A, 0.5533, 3.62, 0.057, 127, 87, GELSOLIN NANOBODY SHIELDING MUTANT PLASMA GELSOLIN FROM FURIN PROTEOLYSIS
4064, 4llaA, 0.5533, 2.79, 0.025, 198, 81, CRYSTAL STRUCTURE OF D3D4 DOMAIN OF THE LILRB2 MOLECULE
4065, 4jg0H, 0.5533, 3.70, 0.080, 224, 87, STRUCTURE OF PHOSPHOSERINE/THREONINE (PSTAB) SCAFFOLD BOUND TO PSER PEPTIDE
4066, 4j3vA, 0.5533, 3.06, 0.087, 872, 80, CRYSTAL STRUCTURE OF BARLEY LIMIT DEXTRINASE IN COMPLEX WITH A BRANCHED THIO-LINKED HEXASACCHARIDE
4067, 3wihI, 0.5533, 3.52, 0.057, 219, 87, CRYSTAL STRUCTURE OF THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1 IN COMPLEX WITH THE FAB FRAGMENT OF MURINE MONOCLONAL ANTIBODY B2212A.
4068, 3wihH, 0.5533, 3.52, 0.057, 219, 87, CRYSTAL STRUCTURE OF THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1 IN COMPLEX WITH THE FAB FRAGMENT OF MURINE MONOCLONAL ANTIBODY B2212A.
4069, 3eyqD, 0.5533, 3.67, 0.080, 208, 87, CRYSTAL STRUCTURE OF MJ5 FAB A GERMLINE ANTIBODY VARIANT OF ANTI-HUMAN CYTOMEGALOVIRUS ANTIBODY 8F9
4070, 2x0uB, 0.5533, 3.64, 0.086, 194, 93, STRUCTURE OF THE P53 CORE DOMAIN MUTANT Y220C BOUND TO A 2- AMINO SUBSTITUTED BENZOTHIAZOLE SCAFFOLD
4071, 6ncpC, 0.5532, 3.69, 0.069, 229, 87, CRYSTAL STRUCTURE OF HIV-1 BROADLY NEUTRALIZING ANTIBODY ACS202 
4072, 6k7oR, 0.5532, 2.78, 0.037, 94, 81, COMPLEX STRUCTURE OF LILRB4 AND H128-3 ANTIBODY 
4073, 6i5pE, 0.5532, 3.07, 0.096, 138, 83, CO-CRYSTAL STRUCTURE OF HUMAN SPOP MATH DOMAIN (E47K) AND HUMAN BRD3 FRAGMENT 
4074, 5y56A, 0.5532, 3.26, 0.047, 208, 85, FC MUTANT (K392D/K409D/D399K)
4075, 5ukqH, 0.5532, 3.40, 0.081, 220, 86, STRUCTURE OF UNLIGANDED ANTI-GP120 CD4BS ANTIBODY DH522.2 FAB
4076, 5uk4m, 0.5532, 3.52, 0.103, 125, 87, VESICULAR STOMATITS VIRUS N PROTEIN IN COMPLEX WITH INHIBITORY NANOBODY 1307
4077, 5uemH, 0.5532, 3.48, 0.034, 230, 87, CRYSTAL STRUCTURE OF 354NC37 FAB IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057 GP120
4078, 5mv4R, 0.5532, 3.45, 0.095, 215, 84, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
4079, 5mv4C, 0.5532, 3.46, 0.095, 218, 84, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
4080, 5lg1B, 0.5532, 3.23, 0.047, 208, 85, ROOM TEMPERATURE STRUCTURE OF HUMAN IGG4-FC FROM CRYSTALS ANALYSED IN SITU
4081, 5jz7G, 0.5532, 3.46, 0.035, 128, 86, NGF IN COMPLEX WITH MEDI578 SCFV
4082, 5hpmD, 0.5532, 3.67, 0.068, 214, 88, CETUXIMAB FAB IN COMPLEX WITH CYCLIC LINKED MEDITOPE
4083, 4rvpB, 0.5532, 3.65, 0.098, 153, 92, CRYSTAL STRUCTURE OF SUPEROXIDE DISMUTASE FROM SEDUM ALFREDII
4084, 4ibtC, 0.5532, 3.52, 0.087, 197, 92, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R273H AND SECOND-SITE SUPPRESSOR MUTATION T284R
4085, 3lh2L, 0.5532, 3.21, 0.035, 110, 85, CRYSTAL STRUCTURE OF HIV EPITOPE-SCAFFOLD 4E10_1VI7A_S0_002_N 4E10 FV COMPLEX
4086, 2y7oA, 0.5532, 4.12, 0.087, 311, 92, STRUCTURE OF N-TERMINAL DOMAIN OF CANDIDA ALBICANS ALS9-2 - G299W MUTANT
4087, 2jhsA, 0.5532, 4.13, 0.074, 137, 95, CRYSTAL STRUCTURE OF RHOGDI K135HK138HK141H MUTANT
4088, 2evjA, 0.5532, 4.09, 0.079, 290, 101, STRUCTURE OF AN NDT80-DNA COMPLEX (MSE MUTANT MA9C)
4089, 1jn6B, 0.5532, 3.66, 0.068, 214, 88, CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES
4090, 6iqhB, 0.5531, 3.23, 0.035, 207, 85, X-RAY CRYSTAL STRUCTURE OF COVALENT-BONDED COMPLEX OF FC AND PEPTIDE 
4091, 5xjfB, 0.5531, 3.24, 0.047, 215, 85, CRYSTAL STRUCTURE OF FUCOSYLATED IGG FC Y296W MUTANT COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA
4092, 5utzH, 0.5531, 3.42, 0.046, 223, 87, HUMAN IL-2/FAB COMPLEX 
4093, 5uk4p, 0.5531, 3.50, 0.103, 125, 87, VESICULAR STOMATITS VIRUS N PROTEIN IN COMPLEX WITH INHIBITORY NANOBODY 1307
4094, 5mubR, 0.5531, 3.45, 0.095, 220, 84, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (CG05)
4095, 5mu0C, 0.5531, 3.14, 0.073, 212, 82, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
4096, 5djxB, 0.5531, 3.19, 0.036, 207, 84, FC HETERODIMER DESIGN 2.9 L368M/K370E + E357A/S364G
4097, 5dj6A, 0.5531, 3.27, 0.047, 208, 85, FC HETERODIMER DESIGN 6.1 F405W/Y407A + T366M
4098, 4yzfK, 0.5531, 3.46, 0.080, 223, 87, CRYSTAL STRUCTURE OF THE ANION EXCHANGER DOMAIN OF HUMAN ERYTHROCYTE BAND 3
4099, 4xbgG, 0.5531, 3.42, 0.070, 219, 86, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION
4100, 4kgjB, 0.5531, 3.40, 0.102, 607, 88, CRYSTAL STRUCTURE OF HUMAN ALPHA-L-IDURONIDASE COMPLEX WITH 5-FLUORO- ALPHA-L-IDOPYRANOSYLURONIC ACID FLUORIDE
4101, 3u9uA, 0.5531, 3.31, 0.047, 219, 86, CRYSTAL STRUCTURE OF EXTRACELLULAR DOMAIN OF HUMAN ERBB4/HER4 IN COMPLEX WITH THE FAB FRAGMENT OF MAB1479
4102, 3ixxG, 0.5531, 3.33, 0.071, 221, 85, THE PSEUDO-ATOMIC STRUCTURE OF WEST NILE IMMATURE VIRUS IN COMPLEX WITH FAB FRAGMENTS OF THE ANTI-FUSION LOOP ANTIBODY E53
4103, 3dv6B, 0.5531, 3.50, 0.080, 121, 87, CRYSTAL STRUCTURE OF SAG506-01 TETRAGONAL CRYSTAL 2
4104, 3durD, 0.5531, 3.50, 0.080, 121, 87, CRYSTAL STRUCTURE OF SAG173-04
4105, 2igfL, 0.5531, 3.09, 0.122, 219, 82, CRYSTAL STRUCTURES OF AN ANTIBODY TO A PEPTIDE AND ITS COMPLEX WITH PEPTIDE ANTIGEN AT 2.8 ANGSTROMS
4106, 2ibzX, 0.5531, 3.55, 0.057, 127, 88, YEAST CYTOCHROME BC1 COMPLEX WITH STIGMATELLIN
4107, 2evhA, 0.5531, 4.09, 0.079, 290, 101, STRUCTURE OF A NDT80-DNA COMPLEX (MSE MUTANT MA7G)
4108, 2d03H, 0.5531, 3.24, 0.071, 212, 85, CRYSTAL STRUCTURE OF THE G91S MUTANT OF THE NNA7 FAB
4109, 1im9D, 0.5531, 2.95, 0.024, 195, 84, CRYSTAL STRUCTURE OF THE HUMAN NATURAL KILLER CELL INHIBITORY RECEPTOR KIR2DL1 BOUND TO ITS MHC LIGAND HLA-CW4
4110, 1ggtB, 0.5531, 3.77, 0.102, 708, 88, THREE-DIMENSIONAL STRUCTURE OF A TRANSGLUTAMINASE: HUMAN BLOOD COAGULATION FACTOR XIII
4111, 1bvkB, 0.5531, 3.38, 0.059, 116, 85, HUMANIZED ANTI-LYSOZYME FV COMPLEXED WITH LYSOZYME
4112, 6iqgB, 0.5530, 3.22, 0.047, 207, 85, X-RAY CRYSTAL STRUCTURE OF FC AND PEPTIDE COMPLEX 
4113, 6geiA, 0.5530, 3.57, 0.074, 215, 94, TEAD4 (216-434);E263A+Y429F COMPLEXED WITH YAP PEPTIDE (60- 100);S94A AND MYRISTOATE (COVALENTLY BOUND TO LYS344; NOT CYS367 ) AT 1.65A (P41212 CRYSTAL FORM); MYRISTOYLATION WAS DONE BY ADDING MYR-COA 
4114, 6ff9B, 0.5530, 3.51, 0.087, 193, 92, MUTANT R280K OF HUMAN P53 
4115, 6cw3C, 0.5530, 3.45, 0.069, 220, 87, CRYSTAL STRUCTURE OF A YEAST SAGA TRANSCRIPTIONAL COACTIVATOR ADA2/GCN5 HAT SUBCOMPLEX; CRYSTAL FORM 2 
4116, 6a6cA, 0.5530, 2.63, 0.089, 84, 79, CRYSTAL STRUCTURE OF CARBOHYDRATE-BINDING MODULE FAMILY 56 BETA-1;3- GLUCAN BINDING DOMAIN 
4117, 5x3jB, 0.5530, 3.35, 0.083, 714, 84, KFLA1895 D451A MUTANT IN COMPLEX WITH CYCLOBIS-(1->6)-ALPHA-NIGEROSYL
4118, 5utzF, 0.5530, 3.42, 0.046, 222, 87, HUMAN IL-2/FAB COMPLEX 
4119, 5i2iB, 0.5530, 3.65, 0.068, 220, 88, STRUCTURE OF CETUXIMAB FAB WITH CYCLIC F3Q VARIANT OF THE MEDITOPE
4120, 5hi3D, 0.5530, 3.35, 0.080, 213, 88, BINDING SITE ELUCIDATION AND STRUCTURE GUIDED DESIGN OF MACROCYCLIC IL-17A ANTAGONISTS
4121, 5cjqH, 0.5530, 3.40, 0.070, 217, 86, CRYSTAL STRUCTURE OF A TRIMERIC INFLUENZA HEMAGGLUTININ STEM IN COMPLEX WITH AN BROADLY NEUTRALIZING ANTIBODY CR9114
4122, 5a16E, 0.5530, 3.65, 0.068, 226, 88, CRYSTAL STRUCTURE OF FAB4201 RAISED AGAINST HUMAN ERYTHROCYTE ANION EXCHANGER 1
4123, 4weuE, 0.5530, 3.36, 0.071, 121, 85, CO-COMPLEX STRUCTURE OF THE F4 FIMBRIAL ADHESIN FAEG VARIANT AD WITH LLAMA SINGLE DOMAIN ANTIBODY V3
4124, 4n1hD, 0.5530, 3.40, 0.093, 126, 86, STRUCTURE OF A SINGLE-DOMAIN CAMELID ANTIBODY FRAGMENT CAB-F11N IN COMPLEX WITH THE BLAP BETA-LACTAMASE FROM BACILLUS LICHENIFORMIS
4125, 4mauH, 0.5530, 3.24, 0.047, 212, 86, CRYSTAL STRUCTURE OF ANTI-ST2L ANTIBODY C2244
4126, 4lsdA, 0.5530, 3.27, 0.080, 96, 87, MYOKINE STRUCTURE
4127, 4jn2H, 0.5530, 3.60, 0.057, 225, 88, AN ANTIDOTE FOR DABIGATRAN
4128, 4gt7D, 0.5530, 3.15, 0.035, 213, 85, AN ENGINEERED DISULFIDE BOND REVERSIBLY TRAPS THE IGE-FC3-4 IN A CLOSED NON-RECEPTOR BINDING CONFORMATION
4129, 4grgD, 0.5530, 3.15, 0.035, 213, 85, CRYSTAL STRUCTURE OF IGE COMPLEXED WITH E2_79 AN ANTI-IGE INHIBITOR
4130, 4aixA, 0.5530, 3.08, 0.107, 106, 84, CRYSTALLOGRAPHIC STRUCTURE OF AN AMYLOIDOGENIC VARIANT 3RC34Y OF THE GERMINAL LINE LAMBDA 3
4131, 3qe5A, 0.5530, 3.30, 0.071, 487, 85, COMPLETE STRUCTURE OF STREPTOCOCCUS MUTANS ANTIGEN I/II CARBOXY- TERMINUS
4132, 3if1B, 0.5530, 3.55, 0.047, 210, 86, CRYSTAL STRUCTURE OF 237MAB IN COMPLEX WITH A GALNAC
4133, 3cfdH, 0.5530, 3.37, 0.047, 220, 86, PURPLE-FLUORESCENT ANTIBODY EP2-25C10 IN COMPLEX WITH ITS STILBENE HAPTEN
4134, 2ajvH, 0.5530, 3.26, 0.047, 219, 86, CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB  IN COMPLEX WITH COCAINE
4135, 1ex0A, 0.5530, 3.73, 0.102, 705, 88, HUMAN FACTOR XIII MUTANT W279F ZYMOGEN
4136, 1ehlH, 0.5530, 3.28, 0.023, 217, 86, 64M-2 ANTIBODY FAB COMPLEXED WITH D(5HT)(6-4)T
4137, 6fczK, 0.5529, 3.29, 0.047, 210, 85, MODEL OF GC1Q-FC COMPLEX BASED ON 7A EM MAP
4138, 6cmiD, 0.5529, 3.62, 0.057, 228, 87, CRYSTAL STRUCTURE OF THE HENDRA VIRUS ATTACHMENT G GLYCOPROTEIN BOUND TO A POTENT CROSS-REACTIVE NEUTRALIZING HUMAN MONOCLONAL ANTIBODY M102.3 
4139, 5werL, 0.5529, 3.65, 0.099, 312, 91, CRYSTAL STRUCTURE OF TAPBPR AND H2-DD COMPLEX
4140, 5uk4c, 0.5529, 3.50, 0.103, 125, 87, VESICULAR STOMATITS VIRUS N PROTEIN IN COMPLEX WITH INHIBITORY NANOBODY 1307
4141, 5f0pB, 0.5529, 3.62, 0.087, 286, 92, STRUCTURE OF RETROMER VPS26-VPS35 SUBUNITS BOUND TO SNX3 AND DMT1(L557M) (SEMET LABELED)
4142, 4yzfE, 0.5529, 3.43, 0.046, 223, 87, CRYSTAL STRUCTURE OF THE ANION EXCHANGER DOMAIN OF HUMAN ERYTHROCYTE BAND 3
4143, 4gw5D, 0.5529, 3.65, 0.068, 215, 88, CQYN MEDITOPE - CETUXIMAB FAB
4144, 4fqyH, 0.5529, 3.57, 0.068, 213, 88, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR9114 BOUND TO H3 INFLUENZA HEMAGGLUTININ
4145, 3fmgH, 0.5529, 3.38, 0.047, 221, 86, STRUCTURE OF ROTAVIRUS OUTER CAPSID PROTEIN VP7 TRIMER IN COMPLEX WITH A NEUTRALIZING FAB
4146, 2iglA, 0.5529, 3.26, 0.107, 116, 84, CRYSTAL STRUCTURE OF E. COLI YEDX A TRANSTHYRETIN RELATED PROTEIN
4147, 2hkfH, 0.5529, 3.30, 0.071, 210, 85, CRYSTAL STRUCTURE OF THE COMPLEX FAB M75- PEPTIDE
4148, 2euxA, 0.5529, 4.10, 0.079, 290, 101, STRUCTURE OF A NDT80-DNA COMPLEX (MSE VARIANT VA4G)
4149, 2arwA, 0.5529, 2.95, 0.107, 103, 84, THE SOLUTION STRUCTURE OF THE MEMBRANE PROXIMAL CYTOKINE RECEPTOR DOMAIN OF THE HUMAN INTERLEUKIN-6 RECEPTOR
4150, 1um4H, 0.5529, 3.15, 0.024, 217, 85, CATALYTIC ANTIBODY 21H3 WITH HAPTEN
4151, 1fieB, 0.5529, 3.60, 0.092, 715, 87, RECOMBINANT HUMAN COAGULATION FACTOR XIII
4152, 6k7oA, 0.5528, 2.80, 0.037, 94, 81, COMPLEX STRUCTURE OF LILRB4 AND H128-3 ANTIBODY 
4153, 6i8sF, 0.5528, 3.50, 0.070, 214, 86, DISCOVERY AND CHARACTERISATION OF AN ANTIBODY THAT SELECTIVELY MODULATES THE INHIBITORY ACTIVITY OF PLASMINOGEN ACTIVATOR INHIBITOR- 1 
4154, 6gegA, 0.5528, 3.40, 0.055, 204, 91, TEAD4 (216-434);Y429F COMPLEXED WITH YAP PEPTIDE (60-100); S94A AND MYRISTOATE (COVALENTLY BOUND) AT 2.23A (P41212 CRYSTAL FORM); MYRISTOYLATION WAS DONE BY ADDING MYR-COA 
4155, 6fonC, 0.5528, 3.71, 0.065, 252, 92, ELONGATED CONFORMER OF THE HUMAN COPPER CHAPERONE FOR SOD1 COMPLEXED WITH HUMAN SOD1 
4156, 6f2wB, 0.5528, 3.43, 0.071, 128, 85, BACTERIAL ASC TRANSPORTER CRYSTAL STRUCTURE IN OPEN TO IN CONFORMATION 
4157, 5vk2D, 0.5528, 3.40, 0.093, 218, 86, STRUCTURAL BASIS FOR ANTIBODY-MEDIATED NEUTRALIZATION OF LASSA VIRUS
4158, 5tdpD, 0.5528, 3.13, 0.059, 214, 85, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-HER2 ANTIBODY 4D5 WITH REDESIGNED HEAVY AND LIGHT CHAIN INTERFACES
4159, 5mv3F, 0.5528, 3.41, 0.095, 216, 84, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
4160, 5lgkA, 0.5528, 3.12, 0.058, 307, 86, CRYSTAL STRUCTURE OF THE HUMAN IGE-FC BOUND TO ITS B CELL RECEPTOR DERCD23
4161, 5k9qX, 0.5528, 3.61, 0.057, 231, 88, CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.A.26 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ
4162, 5itfD, 0.5528, 3.65, 0.068, 215, 88, CETUXIMAB FAB IN COMPLEX WITH 2-BROMOPHENYLALANINE MEDITOPE VARIANT
4163, 5ir1D, 0.5528, 3.67, 0.068, 220, 88, CETUXIMAB FAB IN COMPLEX WITH 3-BROMOPHENYLALANINE MEDITOPE VARIANT
4164, 5hm1A, 0.5528, 3.20, 0.069, 119, 87, LLAMA VHH 2E7 IN COMPLEX WITH GP41
4165, 5hi5D, 0.5528, 3.34, 0.080, 213, 88, BINDING SITE ELUCIDATION AND STRUCTURE GUIDED DESIGN OF MACROCYCLIC IL-17A ANTAGONISTS
4166, 5gs2H, 0.5528, 3.37, 0.095, 231, 84, CRYSTAL STRUCTURE OF DIABODY COMPLEX WITH REPEBODY AND MBP
4167, 5esvC, 0.5528, 3.61, 0.046, 230, 87, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH03 ISOLATED FROM DONOR CH0219 IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE C SUPERINFECTING STRAIN OF DONOR CAP256.
4168, 4ygvA, 0.5528, 3.30, 0.106, 220, 85, REVERSAL AGENT FOR DABIGATRAN
4169, 4qo1B, 0.5528, 3.38, 0.099, 199, 91, P53 DNA BINDING DOMAIN IN COMPLEX WITH NB139
4170, 4lo9C, 0.5528, 3.53, 0.087, 194, 92, HUMAN P53 CORE DOMAIN MUTANT N235K
4171, 4leeD, 0.5528, 3.98, 0.021, 313, 95, STRUCTURE OF THE ALS3 ADHESIN FROM CANDIDA ALBICANS RESIDUES 1-313 (MATURE SEQUENCE) TRIPLE MUTANT IN THE BINDING CAVITY: K59M A116V Y301F
4172, 4j3uB, 0.5528, 3.04, 0.087, 864, 80, CRYSTAL STRUCTURE OF BARLEY LIMIT DEXTRINASE IN COMPLEX WITH MALTOSYL- S-BETACYCLODEXTRIN
4173, 4cdhB, 0.5528, 3.00, 0.024, 208, 83, CRYSTALLOGRAPHIC STRUCTURE OF THE HUMAN IGG1 ALPHA 2-6 SIALILATED FC-FRAGMENT
4174, 3wpnA, 0.5528, 3.87, 0.067, 309, 89, KINESIN SPINDLE PROTEIN EG5 IN COMPLEX WITH ATP-COMPETITIVE INHIBITOR PVZB1194
4175, 3l1oH, 0.5528, 3.56, 0.138, 224, 87, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY MN423 FAB FRAGMENT WITH FREE COMBINING SITE CRYSTALLIZED IN THE PRESENCE OF ZINC
4176, 3eiiC, 0.5528, 3.86, 0.095, 208, 95, ZINC-BOUND GLYCOSIDE HYDROLASE 61 E FROM THIELAVIA TERRESTRIS
4177, 3cfdB, 0.5528, 3.36, 0.047, 219, 86, PURPLE-FLUORESCENT ANTIBODY EP2-25C10 IN COMPLEX WITH ITS STILBENE HAPTEN
4178, 2dl2A, 0.5528, 3.01, 0.024, 197, 84, KILLER IMMUNOGLOBULIN RECEPTOR 2DL2
4179, 1wz1H, 0.5528, 3.51, 0.080, 123, 87, CRYSTAL STRUCTURE OF THE FV FRAGMENT COMPLEXED WITH DANSYL- LYSINE
4180, 1txkB, 0.5528, 4.05, 0.041, 477, 97, CRYSTAL STRUCTURE OF ESCHERICHIA COLI OPGG
4181, 1hysD, 0.5528, 3.51, 0.057, 220, 88, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A POLYPURINE TRACT RNA:DNA
4182, 1g7iB, 0.5528, 3.51, 0.080, 116, 87, CRYSTAL STRUCTURE OF HEN EGG WHITE LYSOZYME (HEL) COMPLEXED WITH THE MUTANT ANTI-HEL MONOCLONAL ANTIBODY D1.3 (VLW92F)
4183, 6n50E, 0.5527, 3.49, 0.071, 123, 85, METABOTROPIC GLUTAMATE RECEPTOR 5 EXTRACELLULAR DOMAIN IN COMPLEX WITH NB43 AND L-QUISQUALIC ACID 
4184, 6k7oQ, 0.5527, 2.79, 0.037, 94, 81, COMPLEX STRUCTURE OF LILRB4 AND H128-3 ANTIBODY 
4185, 6azxC, 0.5527, 3.52, 0.092, 210, 87, CRYSTAL STRUCTURE OF THE NEUTRALIZING ANTI-CIRCUMSPOROZOITE PROTEIN 663 ANTIBODY
4186, 5wobO, 0.5527, 3.25, 0.071, 209, 84, CRYSTAL STRUCTURE ANALYSIS OF FAB1-BOUND HUMAN INSULIN DEGRADING ENZYME (IDE) IN COMPLEX WITH INSULIN 
4187, 5vk2H, 0.5527, 3.29, 0.094, 217, 85, STRUCTURAL BASIS FOR ANTIBODY-MEDIATED NEUTRALIZATION OF LASSA VIRUS
4188, 5vg0A, 0.5527, 3.50, 0.057, 142, 88, ROOM TEMPERATURE X-RAY CRYSTALLOGRAPHIC STRUCTURE OF A JONESIA DENITRIFICANS LYTIC POLYSACCHARIDE MONOOXYGENASE AT 1.1 ANGSTROM RESOLUTION.
4189, 5uk4g, 0.5527, 3.48, 0.103, 125, 87, VESICULAR STOMATITS VIRUS N PROTEIN IN COMPLEX WITH INHIBITORY NANOBODY 1307
4190, 5uk4d, 0.5527, 3.50, 0.103, 125, 87, VESICULAR STOMATITS VIRUS N PROTEIN IN COMPLEX WITH INHIBITORY NANOBODY 1307
4191, 5mv4U, 0.5527, 3.44, 0.095, 212, 84, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
4192, 5iw3A, 0.5527, 3.04, 0.024, 208, 83, ANTI-CD20 MONOCLONAL ANTIBODY FC FRAGMENT
4193, 5iieA, 0.5527, 3.39, 0.057, 210, 87, STRUCTURE OF THE UNLIGANDED ANTI-HIV ANTIBODY DH501 THAT BINDS GP120 V3 GLYCAN AND THE BASE OF V3
4194, 5hyqB, 0.5527, 3.66, 0.068, 220, 88, CETUXIMAB FAB IN COMPLEX WITH AMIDATED MEDITOPE
4195, 5dmjE, 0.5527, 3.52, 0.081, 116, 86, STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE CD40 IN COMPLEX WITH 3H56-5 DAB
4196, 4xnqB, 0.5527, 3.54, 0.092, 217, 87, ANTIBODY HEMAGGLUTININ COMPLEXES
4197, 4xcnE, 0.5527, 3.44, 0.081, 218, 86, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA); 2.9 A RESOLUTION
4198, 4qhnA, 0.5527, 3.33, 0.081, 222, 86, I2 (UNBOUND) FROM CH103 LINEAGE
4199, 4kvpD, 0.5527, 3.51, 0.076, 194, 92, HUMAN P53 CORE DOMAIN MUTANT V157F
4200, 3tx4A, 0.5527, 3.39, 0.100, 267, 90, CRYSTAL STRUCTURE OF MUTANT (C354A) M. TUBERCULOSIS LD-TRANSPEPTIDASE TYPE 2
4201, 3lh2N, 0.5527, 3.21, 0.035, 110, 85, CRYSTAL STRUCTURE OF HIV EPITOPE-SCAFFOLD 4E10_1VI7A_S0_002_N 4E10 FV COMPLEX
4202, 3ixxI, 0.5527, 3.52, 0.047, 221, 86, THE PSEUDO-ATOMIC STRUCTURE OF WEST NILE IMMATURE VIRUS IN COMPLEX WITH FAB FRAGMENTS OF THE ANTI-FUSION LOOP ANTIBODY E53
4203, 3h9zC, 0.5527, 3.22, 0.047, 209, 86, CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS
4204, 2ji0A, 0.5527, 4.15, 0.096, 138, 94, CRYSTAL STRUCTURE OF RHOGDI K138Y K141Y MUTANT
4205, 1ogpC, 0.5527, 3.98, 0.095, 388, 95, THE CRYSTAL STRUCTURE OF PLANT SULFITE OXIDASE PROVIDES INSIGHT INTO SULFITE OXIDATION IN PLANTS AND ANIMALS
4206, 1nmbH, 0.5527, 3.51, 0.034, 122, 88, THE STRUCTURE OF A COMPLEX BETWEEN THE NC10 ANTIBODY AND INFLUENZA VIRUS NEURAMINIDASE AND COMPARISON WITH THE OVERLAPPING BINDING SITE OF THE NC41 ANTIBODY
4207, 1g4rA, 0.5527, 3.80, 0.052, 353, 96, CRYSTAL STRUCTURE OF BOVINE BETA-ARRESTIN 1
4208, 1ft0A, 0.5527, 4.29, 0.074, 129, 94, CRYSTAL STRUCTURE OF TRUNCATED HUMAN RHOGDI K113A MUTANT
4209, 1dvfB, 0.5527, 3.61, 0.080, 116, 88, IDIOTOPIC ANTIBODY D1.3 FV FRAGMENT-ANTIIDIOTOPIC ANTIBODY E5.2 FV FRAGMENT COMPLEX
4210, 1bvkE, 0.5527, 3.25, 0.071, 116, 84, HUMANIZED ANTI-LYSOZYME FV COMPLEXED WITH LYSOZYME
4211, 1a7oH, 0.5527, 3.54, 0.080, 116, 87, FV FRAGMENT OF MOUSE MONOCLONAL ANTIBODY D1.3 (BALB/C IGG1 K) R96L DELETION MUTANT ON VARIANT FOR CHAIN L GLU81->ASP AND CHAIN H LEU312->VAL
4212, 6idgH, 0.5526, 3.15, 0.059, 221, 85, ANTIBODY 64M-5 FAB IN COMPLEX WITH DT(6-4)T 
4213, 6cue3, 0.5526, 3.30, 0.047, 117, 86, CRYO-EM STRUCTURE AT 4.0 A RESOLUTION OF VACCINE-ELICITED ANTIBODY VFP7.04 IN COMPLEX WITH HIV-1 ENV BG505 DS-SOSIP; AND ANTIBODIES VRC03 AND PGT122 
4214, 5t78D, 0.5526, 3.46, 0.059, 209, 85, CRYSTAL STRUCTURE OF THERAPEUTIC MAB AR20.5 IN COMPLEX WITH MUC1 PEPTIDE
4215, 5nmvH, 0.5526, 3.40, 0.047, 221, 86, CRYSTAL STRUCTURE OF 2F22 FAB FRAGMENT AGAINST TFPI1
4216, 5lowH, 0.5526, 3.24, 0.059, 140, 85, STRUCTURE OF THE CA2+-BOUND RABPHILIN 3A C2B DOMAIN SNAP25 COMPLEX (P21 SPACE GROUP)
4217, 5i2iD, 0.5526, 3.67, 0.068, 216, 88, STRUCTURE OF CETUXIMAB FAB WITH CYCLIC F3Q VARIANT OF THE MEDITOPE
4218, 5esqB, 0.5526, 3.66, 0.068, 215, 88, CETUXIMAB FAB IN COMPLEX WITH CYCLIC BETA-ALANINE-LINKED MEDITOPE
4219, 5dj0A, 0.5526, 3.26, 0.047, 208, 85, FC HETERODIMER DESIGN 11.2 Y349S/K370Y + E357D/S364Q
4220, 4zs7H, 0.5526, 3.25, 0.035, 222, 85, STRUCTURAL MIMICRY OF RECEPTOR INTERACTION BY ANTAGONISTIC IL-6 ANTIBODIES
4221, 4yhiH, 0.5526, 3.43, 0.093, 222, 86, REVERSAL AGENT FOR DABIGATRAN
4222, 4rrpO, 0.5526, 3.47, 0.071, 153, 85, CRYSTAL STRUCTURE OF THE FAB COMPLEXED WITH ANTIGEN ASF1P NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET PDR16
4223, 4o9hL, 0.5526, 3.12, 0.047, 211, 86, STRUCTURE OF INTERLEUKIN-6 IN COMPLEX WITH A CAMELID FAB FRAGMENT
4224, 4l4jA, 0.5526, 2.99, 0.036, 208, 84, CRYSTAL STRUCTURE OF FC-FRAGMENT OF HUMAN IGG2-SIGMA ANTIBODY
4225, 4imlH, 0.5526, 3.41, 0.046, 234, 87, CROSSFAB BINDING TO HUMAN ANGIOPOIETIN 2
4226, 4gh7D, 0.5526, 3.40, 0.056, 278, 89, CRYSTAL STRUCTURE OF ANTICALIN N7A IN COMPLEX WITH ONCOFETAL FIBRONECTIN FRAGMENT FN7B8
4227, 1yzzA, 0.5526, 3.48, 0.070, 114, 86, HUMANIZED CABAN33 AT ROOM TEMPERATURE
4228, 1to5C, 0.5526, 3.75, 0.065, 156, 92, STRUCTURE OF THE CYTOSOLIC CUZN SOD FROM S. MANSONI
4229, 1seqH, 0.5526, 3.54, 0.057, 221, 87, FAB MNAC13
4230, 1dvfD, 0.5526, 3.14, 0.071, 121, 85, IDIOTOPIC ANTIBODY D1.3 FV FRAGMENT-ANTIIDIOTOPIC ANTIBODY E5.2 FV FRAGMENT COMPLEX
4231, 1ck0H, 0.5526, 3.69, 0.092, 211, 87, ANTI-ANTI-IDIOTYPIC ANTIBODY AGAINST HUMAN ANGIOTENSIN II UNLIGANDED FORM
4232, 6fysH, 0.5525, 3.22, 0.048, 127, 84, STRUCTURE OF SINGLE DOMAIN ANTIBODY SD83 
4233, 6ewaD, 0.5525, 2.99, 0.048, 169, 84, CRYSTAL STRUCTURE OF HLA-A2 IN COMPLEX WITH LILRB1 
4234, 6c5kH, 0.5525, 3.12, 0.059, 217, 85, S25-23 FAB IN COMPLEX WITH CHLAMYDIACEAE LPS (CRYSTAL FORM 2) 
4235, 6c5kA, 0.5525, 3.31, 0.057, 215, 87, S25-23 FAB IN COMPLEX WITH CHLAMYDIACEAE LPS (CRYSTAL FORM 2) 
4236, 5yoyH, 0.5525, 3.58, 0.057, 126, 87, CRYSTAL STRUCTURE OF THE HUMAN TUMOR NECROSIS FACTOR IN COMPLEX WITH GOLIMUMAB FV 
4237, 5hyqD, 0.5525, 3.67, 0.068, 213, 88, CETUXIMAB FAB IN COMPLEX WITH AMIDATED MEDITOPE
4238, 5awsA, 0.5525, 3.60, 0.118, 275, 93, CRYSTAL STRUCTURE OF THE SGIP1 MU HOMOLOGY DOMAIN IN THE P1 SPACE GROUP
4239, 4yqxN, 0.5525, 3.49, 0.069, 121, 87, MOUSE IL-2 BOUND TO JES6-1 SCFV FRAGMENT
4240, 4xcnC, 0.5525, 3.31, 0.082, 228, 85, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA); 2.9 A RESOLUTION
4241, 4wtwA, 0.5525, 3.25, 0.060, 95, 84, CRYSTAL STRUCTURE OF THE THIRD FNIII DOMAIN OF INTEGRIN BETA4
4242, 4uwqK, 0.5525, 3.27, 0.071, 121, 85, CRYSTAL STRUCTURE OF THE DISULFIDE-LINKED COMPLEX OF THE THIOSULFODYROLASE SOXB WITH THE CARRIER-PROTEIN SOXYZ FROM THERMUS THERMOPHILUS
4243, 4rrpH, 0.5525, 3.69, 0.092, 221, 87, CRYSTAL STRUCTURE OF THE FAB COMPLEXED WITH ANTIGEN ASF1P NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET PDR16
4244, 4rgnH, 0.5525, 3.65, 0.080, 213, 87, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO TWO NEUTRALIZING ANTIBODIES 14G8 AND 6D3
4245, 4m1gH, 0.5525, 3.18, 0.071, 216, 85, STRUCTURE OF MURINE IGG2A A27D7-FAB IN COMPLEX WITH VACCINIA ANTIGEN A33R AT THE RESOLUTION OF 1.6 ANGSTROMS
4246, 4ibzC, 0.5525, 3.52, 0.087, 192, 92, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R273C AND SECOND-SITE SUPPRESSOR MUTATION T284R
4247, 3rkdH, 0.5525, 3.55, 0.068, 218, 88, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY
4248, 3hqmB, 0.5525, 3.10, 0.096, 132, 83, STRUCTURES OF SPOP-SUBSTRATE COMPLEXES: INSIGHTS INTO MOLECULAR ARCHITECTURES OF BTB-CUL3 UBIQUITIN LIGASES: SPOPMATHX-CISBC2
4249, 2ntfB, 0.5525, 3.34, 0.070, 222, 86, CRYSTAL STRUCTURE OF A QUORUM-QUENCHING ANTIBODY IN COMPLEX WITH AN N- ACYL-L-HOMOSERINE LACTONE ANALOG
4250, 1xtlB, 0.5525, 3.58, 0.079, 152, 89, CRYSTAL STRUCTURE OF P104H MUTANT OF SOD-LIKE PROTEIN FROM BACILLUS SUBTILIS.
4251, 1j1oH, 0.5525, 3.11, 0.084, 114, 83, CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT LY50F COMPLEXED WITH HEN EGG WHITE LYSOZYME
4252, 1a6wH, 0.5525, 3.27, 0.035, 120, 86, B1-8 FV FRAGMENT COMPLEXED WITH A (4-HYDROXY-5-IODO-3- NITROPHENYL) ACETATE COMPOUND
4253, 1a6vN, 0.5525, 3.15, 0.058, 109, 86, B1-8 FV FRAGMENT COMPLEXED WITH A (4-HYDROXY-3-NITROPHENYL) ACETATE COMPOUND
4254, 6nb6I, 0.5524, 3.08, 0.036, 124, 84, SARS-COV COMPLEX WITH HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT (STATE 1) 
4255, 6n8dF, 0.5524, 3.52, 0.057, 216, 87, CRYSTAL STRUCTURE OF GII.4 2002 NOROVIRUS P DOMAIN IN COMPLEX WITH NEUTRALIZING HUMAN ANTIBODY A1431 
4256, 5id1B, 0.5524, 3.67, 0.068, 214, 88, CETUXIMAB FAB IN COMPLEX WITH MPT-CYS MEDITOPE
4257, 5ff6D, 0.5524, 3.67, 0.068, 214, 88, CETUXIMAB FAB IN COMPLEX WITH L10Q MEDITOPE VARIANT
4258, 5eukB, 0.5524, 3.68, 0.068, 220, 88, CETUXIMAB FAB IN COMPLEX WITH F3H MEDITOPE VARIANT
4259, 5dvoB, 0.5524, 3.01, 0.024, 205, 84, FC K392D/K409D HOMODIMER
4260, 4y5xJ, 0.5524, 3.47, 0.058, 124, 86, DIABODY 305 COMPLEX WITH EPOR
4261, 4rgoH, 0.5524, 3.64, 0.080, 213, 87, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO THE NEUTRALIZING ANTIBODY 14G8
4262, 4kh2B, 0.5524, 3.41, 0.102, 607, 88, CRYSTAL STRUCTURE OF HUMAN ALPHA-L-IDURONIDASE COMPLEX WITH 2-DEOXY-2- FLUORO-ALPHA-L-IDOPYRANOSYLURONIC ACID FLUORIDE
4263, 4hc1H, 0.5524, 3.15, 0.047, 220, 86, CRYSTAL STRUCTURE OF A LOOP DELETED MUTANT OF HUMAN MADCAM-1 D1D2 COMPLEXED WITH FAB 10G3
4264, 3s7gB, 0.5524, 3.24, 0.047, 207, 85, AGLYCOSYLATED HUMAN IGG1 FC FRAGMENT
4265, 3ietD, 0.5524, 3.54, 0.047, 211, 86, CRYSTAL STRUCTURE OF 237MAB WITH ANTIGEN
4266, 2fjfB, 0.5524, 3.24, 0.118, 218, 85, STRUCTURE OF THE G6 FAB A PHAGE DERIVED VEGF BINDING FAB
4267, 2agjH, 0.5524, 3.36, 0.057, 225, 87, CRYSTAL STRUCTURE OF A GLYCOSYLATED FAB FROM AN IGM CRYOGLOBULIN WITH PROPERTIES OF A NATURAL PROTEOLYTIC ANTIBODY
4268, 1yylH, 0.5524, 3.67, 0.091, 229, 88, CRYSTAL STRUCTURE OF CD4M33 A SCORPION-TOXIN MIMIC OF CD4 IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
4269, 1kshB, 0.5524, 3.20, 0.048, 141, 83, COMPLEX OF ARL2 AND PDE DELTA CRYSTAL FORM 2 (NATIVE)
4270, 1i3vA, 0.5524, 3.49, 0.070, 129, 86, THREE-DIMENSIONAL STRUCTURE OF A LAMA VHH DOMAIN UNLIGANDED
4271, 1ggyA, 0.5524, 3.77, 0.102, 702, 88, HUMAN FACTOR XIII WITH YTTERBIUM BOUND IN THE ION SITE
4272, 6ge3A, 0.5523, 3.43, 0.055, 204, 91, X-RAY STRUCTURE OF TEAD4 (WILDTYPE) COMPLEXED WITH YAP (WILDTYPE): THE ROLE OF RESIDUAL FLEXIBILITY AND WATER MOLECULES IN THE ADAPTATION OF A BOUND INTRINSICALLY DISORDERED PROTEIN TO MUTATIONS AT A BINDING INTERFACE 
4273, 6aeeG, 0.5523, 2.76, 0.061, 369, 82, CRYSTAL STRUCTURE OF THE FOUR IG-LIKE DOMAINS OF LILRB1 COMPLEXED WITH HLA-G 
4274, 5wkoA, 0.5523, 3.36, 0.058, 225, 86, CRYSTAL STRUCTURE OF ANTIBODY 27F3 RECOGNIZING THE HA FROM A/CALIFORNIA/04/2009 (H1N1) INFLUENZA VIRUS
4275, 5opiC, 0.5523, 3.57, 0.121, 332, 91, CRYSTAL STRUCTURE OF THE TAPBPR-MHC I PEPTIDE EDITING COMPLEX
4276, 5mu2M, 0.5523, 3.43, 0.095, 216, 84, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
4277, 5mu2I, 0.5523, 3.44, 0.095, 218, 84, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
4278, 5ir1B, 0.5523, 3.65, 0.068, 220, 88, CETUXIMAB FAB IN COMPLEX WITH 3-BROMOPHENYLALANINE MEDITOPE VARIANT
4279, 5ezoH, 0.5523, 3.32, 0.035, 222, 85, CRYSTAL STRUCTURE OF PFCYRPA IN COMPLEX WITH AN INVASION-INHIBITORY ANTIBODY FAB.
4280, 5bk1C, 0.5523, 3.49, 0.081, 226, 86, CRYSTAL STRUCTURE OF MALTOSE BINDING PROTEIN IN COMPLEX WITH AN ENDOSTERIC SYNTHETIC ANTIBODY
4281, 5a16A, 0.5523, 3.51, 0.080, 226, 87, CRYSTAL STRUCTURE OF FAB4201 RAISED AGAINST HUMAN ERYTHROCYTE ANION EXCHANGER 1
4282, 4yqxH, 0.5523, 3.52, 0.057, 121, 87, MOUSE IL-2 BOUND TO JES6-1 SCFV FRAGMENT
4283, 4y5xG, 0.5523, 3.53, 0.070, 124, 86, DIABODY 305 COMPLEX WITH EPOR
4284, 4wi9B, 0.5523, 3.04, 0.012, 208, 84, STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION I253A/H310A
4285, 4obrB, 0.5523, 3.39, 0.102, 606, 88, CRYSTAL STRUCTURE OF HUMAN ALPHA-L-IDURONIDASE COMPLEX WITH ALPHA-L- IDURONIC ACID
4286, 4k3hH, 0.5523, 3.16, 0.057, 109, 87, IMMUNOGLOBULIN LAMBDA VARIABLE DOMAIN L5(L89S) FLUOROGEN ACTIVATIONG PROTEIN IN COMPLEX WITH MALACHITE GREEN
4287, 3ay4A, 0.5523, 3.19, 0.024, 215, 85, CRYSTAL STRUCTURE OF NONFUCOSYLATED FC COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA
4288, 1oauJ, 0.5523, 3.33, 0.047, 122, 86, FV STRUCTURE OF THE IGE SPE-7 IN COMPLEX WITH DNP-SER (IMMUNISING HAPTEN)
4289, 1oauH, 0.5523, 3.33, 0.047, 122, 86, FV STRUCTURE OF THE IGE SPE-7 IN COMPLEX WITH DNP-SER (IMMUNISING HAPTEN)
4290, 1oarJ, 0.5523, 3.42, 0.047, 122, 86, FV IGE SPE-7 IN COMPLEX WITH ALIZARIN RED
4291, 1oarH, 0.5523, 3.42, 0.047, 122, 86, FV IGE SPE-7 IN COMPLEX WITH ALIZARIN RED
4292, 1gdfA, 0.5523, 4.19, 0.094, 145, 96, STRUCTURE OF RHOGDI: A C-TERMINAL BINDING DOMAIN TARGETS AN N-TERMINAL INHIBITORY PEPTIDE TO GTPASES NMR MINIMIZED AVERAGE STRUCTURE
4293, 1a6vM, 0.5523, 3.13, 0.058, 109, 86, B1-8 FV FRAGMENT COMPLEXED WITH A (4-HYDROXY-3-NITROPHENYL) ACETATE COMPOUND
4294, 6k7oP, 0.5522, 2.82, 0.037, 94, 81, COMPLEX STRUCTURE OF LILRB4 AND H128-3 ANTIBODY 
4295, 6ensA, 0.5522, 3.68, 0.085, 185, 94, STRUCTURE OF MOUSE WILD-TYPE RKIP
4296, 5xj3A, 0.5522, 3.56, 0.080, 117, 87, COMPLEX STRUCTURE OF IPILIMUMAB-SCFV AND CTLA-4 
4297, 5wkoE, 0.5522, 3.35, 0.058, 225, 86, CRYSTAL STRUCTURE OF ANTIBODY 27F3 RECOGNIZING THE HA FROM A/CALIFORNIA/04/2009 (H1N1) INFLUENZA VIRUS
4298, 5v4eH, 0.5522, 3.21, 0.035, 216, 85, ENGINEERED HUMAN IGG FC DOMAIN GLYCO801 (FC801)
4299, 5etuB, 0.5522, 3.67, 0.068, 216, 88, CETUXIMAB FAB IN COMPLEX WITH L5E MEDITOPE VARIANT
4300, 5esqD, 0.5522, 3.72, 0.068, 212, 88, CETUXIMAB FAB IN COMPLEX WITH CYCLIC BETA-ALANINE-LINKED MEDITOPE
4301, 5e5mC, 0.5522, 3.08, 0.080, 116, 87, CRYSTAL STRUCTURE OF MOUSE CTLA-4 IN COMPLEX WITH NANOBODY
4302, 5dk3B, 0.5522, 3.48, 0.069, 441, 87, CRYSTAL STRUCTURE OF PEMBROLIZUMAB A FULL LENGTH IGG4 ANTIBODY
4303, 5djdB, 0.5522, 3.26, 0.047, 207, 85, FC HETERODIMER DESIGN 5.1 T366V + Y407F
4304, 4qnpH, 0.5522, 3.72, 0.045, 224, 88, CRYSTAL STRUCTURE OF THE 2009 PANDEMIC H1N1 INFLUENZA VIRUS NEURAMINIDASE WITH A NEUTRALIZING ANTIBODY
4305, 4nehA, 0.5522, 3.58, 0.102, 1084, 88, AN INTERNAL LIGAND-BOUND METASTABLE STATE OF A LEUKOCYTE INTEGRIN AXB2
4306, 4nbxB, 0.5522, 3.51, 0.094, 123, 85, CRYSTAL STRUCTURE OF CLOSTRIDIUM DIFFICILE TOXIN A FRAGMENT TCDA-A1 BOUND TO A20.1 VHH
4307, 4m8qH, 0.5522, 3.25, 0.059, 125, 85, ONTOGENY OF RECOGNITION SPECIFICITY AND FUNCTIONALITY FOR THE ANTI-HIV NEUTRALIZING ANTIBODY 4E10
4308, 4gt7A, 0.5522, 2.99, 0.036, 212, 84, AN ENGINEERED DISULFIDE BOND REVERSIBLY TRAPS THE IGE-FC3-4 IN A CLOSED NON-RECEPTOR BINDING CONFORMATION
4309, 3wiiI, 0.5522, 3.50, 0.070, 220, 86, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF B2212A A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1.
4310, 3pp4H, 0.5522, 3.55, 0.057, 220, 88, EPITOPE CHARACTERIZATION AND CRYSTAL STRUCTURE OF GA101 PROVIDE INSIGHTS INTO THE MOLECULAR BASIS FOR THE TYPE I / TYPE II DISTINCTION OF ANTI- CD20 ANTIBODIES
4311, 3juaE, 0.5522, 3.30, 0.045, 216, 89, STRUCTURAL BASIS OF YAP RECOGNITION BY TEAD4 IN THE HIPPO PATHWAY
4312, 2y5eA, 0.5522, 3.05, 0.087, 866, 80, BARLEY LIMIT DEXTRINASE IN COMPLEX WITH ALPHA-CYCLODEXTRIN
4313, 2euvA, 0.5522, 4.10, 0.079, 290, 101, PRINCIPLES OF PROTEIN-DNA RECOGNITION REVEALED IN THE STRUCTURAL ANALYSIS OF NDT80-MSE DNA COMPLEXES
4314, 1va9A, 0.5522, 3.46, 0.098, 122, 92, SOLUTION STRUCTURE OF THE SECOND FNIII DOMAIN OF DSCAML1 PROTEIN
4315, 1to5A, 0.5522, 3.74, 0.065, 156, 92, STRUCTURE OF THE CYTOSOLIC CUZN SOD FROM S. MANSONI
4316, 1kb9J, 0.5522, 3.22, 0.047, 127, 86, YEAST CYTOCHROME BC1 COMPLEX
4317, 1h3wM, 0.5522, 3.03, 0.024, 206, 83, STRUCTURAL ANALYSIS OF HUMAN IGG-FC GLYCOFORMS REVEALS A CORRELATION BETWEEN GLYCOSYLATION AND STRUCTURAL INTEGRITY
4318, 6igwA, 0.5521, 3.25, 0.069, 119, 87, MPZL1 MUTANT - S86G; V145G; Q146K;P147T;G148S 
4319, 6icfH, 0.5521, 3.49, 0.058, 219, 86, THE NZ-1 FAB COMPLEXED WITH THE PDZ TANDEM FRAGMENT OF A. AEOLICUS S2P HOMOLOG WITH THE PA12 TAG INSERTED BETWEEN THE RESIDUES 263 AND 266 
4320, 6i53G, 0.5521, 3.55, 0.105, 123, 86, CRYO-EM STRUCTURE OF THE HUMAN SYNAPTIC ALPHA1-BETA3-GAMMA2 GABAA RECEPTOR IN COMPLEX WITH MEGABODY38 IN A LIPID NANODISC 
4321, 5zo9B, 0.5521, 4.04, 0.055, 331, 91, EG5 MOTOR DOMAIN IN COMPLEX WITH STLC-TYPE INHIBITOR PVEI0021 (C2 TYPE) 
4322, 5zo7B, 0.5521, 4.13, 0.054, 332, 92, KINESIN SPINDLE PROTEIN EG5 IN COMPLEX WITH STLC-TYPE INHIBITOR PVEI0138 
4323, 5xj3G, 0.5521, 3.57, 0.080, 117, 87, COMPLEX STRUCTURE OF IPILIMUMAB-SCFV AND CTLA-4 
4324, 5mu2E, 0.5521, 3.44, 0.107, 215, 84, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
4325, 5kn5A, 0.5521, 3.47, 0.070, 214, 86, TGFALPHA/EPIREGULIN COMPLEX WITH NEUTRALIZING ANTIBODY LY3016859
4326, 5jz7C, 0.5521, 3.47, 0.035, 128, 86, NGF IN COMPLEX WITH MEDI578 SCFV
4327, 5iv2D, 0.5521, 3.68, 0.068, 214, 88, CETUXIMAB FAB IN COMPLEX WITH ARG9CIR MEDITOPE VARIANT
4328, 5id1D, 0.5521, 3.68, 0.068, 212, 88, CETUXIMAB FAB IN COMPLEX WITH MPT-CYS MEDITOPE
4329, 5icxB, 0.5521, 3.66, 0.068, 220, 88, CETUXIMAB FAB IN COMPLEX WITH CQFDLSTRRLRCGGSK MEDITOPE
4330, 5hpmB, 0.5521, 3.67, 0.068, 216, 88, CETUXIMAB FAB IN COMPLEX WITH CYCLIC LINKED MEDITOPE
4331, 5ff6B, 0.5521, 3.67, 0.068, 220, 88, CETUXIMAB FAB IN COMPLEX WITH L10Q MEDITOPE VARIANT
4332, 5eukD, 0.5521, 3.68, 0.068, 213, 88, CETUXIMAB FAB IN COMPLEX WITH F3H MEDITOPE VARIANT
4333, 5djdA, 0.5521, 3.27, 0.047, 208, 85, FC HETERODIMER DESIGN 5.1 T366V + Y407F
4334, 5cjxA, 0.5521, 3.48, 0.103, 224, 87, CRYSTAL STRUCTURE OF 8ANC195 FAB IN COMPLEX WITH BG505 SOSIP.664 HIV-1 ENV TRIMER
4335, 4xbgC, 0.5521, 3.44, 0.070, 226, 86, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION
4336, 4krmL, 0.5521, 3.51, 0.081, 124, 86, NANOBODY/VHH DOMAIN 7D12 IN COMPLEX WITH DOMAIN III OF THE EXTRACELLULAR REGION OF EGFR PH 3.5
4337, 4krmF, 0.5521, 3.44, 0.082, 122, 85, NANOBODY/VHH DOMAIN 7D12 IN COMPLEX WITH DOMAIN III OF THE EXTRACELLULAR REGION OF EGFR PH 3.5
4338, 3zknC, 0.5521, 3.31, 0.047, 215, 85, BACE2 FAB INHIBITOR COMPLEX
4339, 2aewB, 0.5521, 3.09, 0.060, 188, 84, A MODEL FOR GROWTH HORMONE RECEPTOR ACTIVATION BASED ON SUBUNIT ROTATION WITHIN A RECEPTOR DIMER
4340, 1jnhF, 0.5521, 3.44, 0.070, 214, 86, CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES
4341, 1cfvH, 0.5521, 3.37, 0.047, 119, 85, MONOCLONAL ANTIBODY FRAGMENT FV4155 FROM E. COLI
4342, 6k7oH, 0.5520, 3.59, 0.057, 225, 88, COMPLEX STRUCTURE OF LILRB4 AND H128-3 ANTIBODY 
4343, 6h3hA, 0.5520, 3.37, 0.035, 222, 86, FAB FRAGMENT OF ANTIBODY AGAINST FULLERENE C60 
4344, 5yawB, 0.5520, 4.11, 0.064, 146, 94, FRAGMENT-BASED DRUG DISCOVERY OF INHIBITORS TO BLOCK PDEDELTA-RAS PROTEIN-PROTEIN INTERACTION 
4345, 5w24H, 0.5520, 3.47, 0.082, 216, 85, CRYSTAL STRUCTURE OF 5C4 FAB
4346, 5mu2O, 0.5520, 3.46, 0.095, 214, 84, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
4347, 5mu2C, 0.5520, 3.43, 0.095, 218, 84, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
4348, 5m2wB, 0.5520, 3.32, 0.093, 119, 86, STRUCTURE OF NANOBODY NB18 RAISED AGAINST TSSK FROM E. COLI T6SS
4349, 5iv2B, 0.5520, 3.66, 0.068, 216, 88, CETUXIMAB FAB IN COMPLEX WITH ARG9CIR MEDITOPE VARIANT
4350, 4ygaD, 0.5520, 3.56, 0.163, 123, 86, CDPK1 FROM TOXOPLASMA GONDII BOUND TO INHIBITORY VHH-1B7
4351, 4xcyE, 0.5520, 3.44, 0.070, 223, 86, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDYLGLYCEROL (06:0 PG)
4352, 4q2zA, 0.5520, 3.71, 0.080, 224, 88, FAB FRAGMENT OF HIV VACCINE-ELICITED CD4BS-DIRECTED ANTIBODY GE356 FROM A NON-HUMAN PRIMATE
4353, 4nkdC, 0.5520, 3.23, 0.047, 121, 86, CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT
4354, 4nkdA, 0.5520, 3.23, 0.047, 121, 86, CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT
4355, 4nc2B, 0.5520, 3.41, 0.082, 122, 85, CRYSTAL STRUCTURE OF TCDB-B1 BOUND TO B39 VHH
4356, 4bqcB, 0.5520, 3.24, 0.094, 176, 85, CRYSTAL STRUCTURE OF THE FN5 AND FN6 DOMAINS OF NEO1 BOUND TO SOS
4357, 4b50A, 0.5520, 3.05, 0.071, 122, 84, CRYSTAL STRUCTURE OF THE HIV-1 GP41 MPER-SPECIFIC LLAMA VHH 2H10
4358, 3zkmC, 0.5520, 3.30, 0.047, 215, 85, BACE2 FAB COMPLEX
4359, 3qcuI, 0.5520, 3.30, 0.023, 219, 86, CRYSTAL STRUCTURE OF THE LT3015 ANTIBODY FAB FRAGMENT IN COMPLEX WITH LYSOPHOSPHATIDIC ACID (14:0)
4360, 3ntcH, 0.5520, 3.31, 0.070, 221, 86, CRYSTAL STRUCTURE OF KD-247 FAB AN ANTI-V3 ANTIBODY THAT INHIBITS HIV-1 ENTRY
4361, 1xtmB, 0.5520, 3.66, 0.067, 153, 90, CRYSTAL STRUCTURE OF THE DOUBLE MUTANT Y88H-P104H OF A SOD-LIKE PROTEIN FROM BACILLUS SUBTILIS.
4362, 1um6H, 0.5520, 3.31, 0.046, 217, 87, CATALYTIC ANTIBODY 21H3
4363, 1tzaA, 0.5520, 3.53, 0.044, 130, 90, X-RAY STRUCTURE OF NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET SOR45
4364, 1kiqB, 0.5520, 3.51, 0.080, 116, 87, FV MUTANT Y(B 101)F (VH DOMAIN) OF MOUSE MONOCLONAL ANTIBODY D1.3 COMPLEXED WITH HEN EGG WHITE LYSOZYME
4365, 1i3vB, 0.5520, 3.50, 0.070, 129, 86, THREE-DIMENSIONAL STRUCTURE OF A LAMA VHH DOMAIN UNLIGANDED
4366, 1g6vK, 0.5520, 3.20, 0.071, 126, 84, COMPLEX OF THE CAMELID HEAVY-CHAIN ANTIBODY FRAGMENT CAB- CA05 WITH BOVINE CARBONIC ANHYDRASE
4367, 6aniH, 0.5519, 3.52, 0.034, 216, 88, COLTUXIMAB FAB IN COMPLEX WITH ANTI-KAPPA VHH DOMAIN
4368, 5zo8A, 0.5519, 4.13, 0.054, 331, 92, EG5 MOTOR DOMAIN IN COMPLEX WITH STLC-TYPE INHIBITOR PVEI0021 (P21 TYPE) 
4369, 5vm0B, 0.5519, 3.54, 0.080, 127, 87, THE HAPTEN TRICLOCARBAN BOUND TO THE SINGLE DOMAIN CAMELID NANOBODY VHH T9 
4370, 5v4eG, 0.5519, 3.25, 0.047, 219, 85, ENGINEERED HUMAN IGG FC DOMAIN GLYCO801 (FC801)
4371, 5t1lD, 0.5519, 3.68, 0.068, 216, 88, CETUXIMAB FAB IN COMPLEX WITH CQA(PH)2DLSTRRLKC PEPTIDE
4372, 5nscA, 0.5519, 3.26, 0.047, 209, 85, FC DEKK HETERODIMER VARIANT
4373, 5iryA, 0.5519, 3.12, 0.035, 539, 85, CRYSTAL STRUCTURE OF HUMAN DESMOCOLLIN-1 ECTODOMAIN
4374, 5hbtD, 0.5519, 3.26, 0.082, 219, 85, COMPLEX STRUCTURE OF FAB35 AND HUMAN NACHR ALPHA1
4375, 5d6dB, 0.5519, 3.29, 0.047, 208, 85, CRYSTAL STRUCTURE OF GASDALIE IGG1 FC IN COMPLEX WITH FCGRIIIA
4376, 3ggwB, 0.5519, 2.97, 0.086, 207, 81, CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A CARBOHYDRATE-MIMETIC PEPTIDE
4377, 3fo2H, 0.5519, 3.29, 0.058, 214, 86, CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)GLN MUTANT)
4378, 1ggyB, 0.5519, 3.63, 0.103, 705, 87, HUMAN FACTOR XIII WITH YTTERBIUM BOUND IN THE ION SITE
4379, 6df2H, 0.5518, 3.72, 0.115, 219, 87, IMPROVED ANTI-PHOSPHOTYROSINE ANTIBODY 4G10-S5-4D5 FAB COMPLEXED WITH PHOSPHOTYROSINE PEPTIDE 
4380, 5wobK, 0.5518, 3.54, 0.070, 207, 86, CRYSTAL STRUCTURE ANALYSIS OF FAB1-BOUND HUMAN INSULIN DEGRADING ENZYME (IDE) IN COMPLEX WITH INSULIN 
4381, 5jsaE, 0.5518, 3.51, 0.102, 224, 88, UNCLEAVED PREFUSION OPTIMIZED GP140 TRIMER WITH AN ENGINEERED 10- RESIDUE HR1 TURN BOUND TO BROADLY NEUTRALIZING ANTIBODIES 8ANC195 AND PGT128
4382, 5aoiB, 0.5518, 3.67, 0.086, 196, 93, STRUCTURE OF THE P53 CANCER MUTANT Y220C IN COMPLEX WITH AN INDOLE-BASED SMALL MOLECULE
4383, 4xbgE, 0.5518, 3.64, 0.091, 218, 88, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION
4384, 4rvpA, 0.5518, 3.53, 0.099, 153, 91, CRYSTAL STRUCTURE OF SUPEROXIDE DISMUTASE FROM SEDUM ALFREDII
4385, 4mj2B, 0.5518, 3.41, 0.102, 607, 88, CRYSTAL STRUCTURE OF APO-IDURONIDASE IN THE R3 FORM
4386, 4lasH, 0.5518, 3.30, 0.011, 117, 87, CRYSTAL STRUCTURES OF A THERAPEUTIC SINGLE CHAIN ANTIBODY IN THE FREE FORM AND IN COMPLEX WITH AMPHETAMINE AND 4-HYDROXYMETHAMPHETAMINE
4387, 4kknA, 0.5518, 3.42, 0.056, 117, 89, CRYSTAL STRUCTURE OF BOVINE CTLA-4 PSI-NYSGRC-012704
4388, 4k7pY, 0.5518, 3.70, 0.102, 219, 88, GENERATION AND CHARACTERIZATION OF A UNIQUE REAGENT THAT RECOGNIZES A PANEL OF RECOMBINANT HUMAN MONOCLONAL ANTIBODY THERAPEUTICS IN THE PRESENCE OF ENDOGENOUS HUMAN IGG
4389, 4k3hD, 0.5518, 3.18, 0.057, 109, 87, IMMUNOGLOBULIN LAMBDA VARIABLE DOMAIN L5(L89S) FLUOROGEN ACTIVATIONG PROTEIN IN COMPLEX WITH MALACHITE GREEN
4390, 4bm7A, 0.5518, 3.29, 0.047, 207, 85, CRYSTAL STRUCTURE OF IGG FC F241A MUTANT WITH NATIVE GLYCOSYLATION
4391, 3wknD, 0.5518, 3.19, 0.036, 209, 84, CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG
4392, 2w59A, 0.5518, 3.09, 0.116, 215, 86, STRUCTURE OF AN AVIAN IGY-FC 3-4 FRAGMENT
4393, 2jhtC, 0.5518, 4.25, 0.062, 138, 96, CRYSTAL STRUCTURE OF RHOGDI K135TK138TK141T MUTANT
4394, 1y07D, 0.5518, 2.64, 0.078, 123, 77, CRYSTAL STRUCTURE OF THE SUPEROXIDE REDUCTASE FROM TREPONEMA PALLIDUM
4395, 1nm4A, 0.5518, 2.99, 0.060, 102, 84, SOLUTION STRUCTURE OF CU(I)-COPC FROM PSEUDOMONAS SYRINGAE
4396, 1kzyA, 0.5518, 3.67, 0.086, 195, 93, CRYSTAL STRUCTURE OF THE 53BP1 BRCT REGION COMPLEXED TO TUMOR SUPPRESSOR P53
4397, 1kmtA, 0.5518, 4.17, 0.074, 138, 95, CRYSTAL STRUCTURE OF RHOGDI GLU(154155)ALA MUTANT
4398, 6ff9A, 0.5517, 3.53, 0.087, 193, 92, MUTANT R280K OF HUMAN P53 
4399, 5vmeA, 0.5517, 3.23, 0.047, 207, 85, CRYSTAL STRUCTURE OF HUMAN IGG1 FC K248E T437R MUTANT
4400, 5mu2K, 0.5517, 3.44, 0.095, 216, 84, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
4401, 5mu2A, 0.5517, 3.44, 0.095, 216, 84, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
4402, 5iopD, 0.5517, 3.67, 0.068, 213, 88, CETUXIMAB FAB IN COMPLEX WITH 4-BROMOPHENYLALANINE MEDITOPE VARIANT
4403, 5bk2H, 0.5517, 3.66, 0.103, 220, 87, CRYSTAL STRUCTURE OF MALTOSE BINDING PROTEIN IN COMPLEX WITH A PERISTERIC SYNTHETIC ANTIBODY
4404, 4n0uE, 0.5517, 3.23, 0.047, 209, 85, TERNARY COMPLEX BETWEEN NEONATAL FC RECEPTOR SERUM ALBUMIN AND FC
4405, 4loeC, 0.5517, 3.53, 0.087, 194, 92, HUMAN P53 CORE DOMAIN MUTANT N239Y
4406, 4g3yH, 0.5517, 3.69, 0.057, 220, 87, CRYSTAL STRUCTURE OF TNF-ALPHA IN COMPLEX WITH INFLIXIMAB FAB FRAGMENT
4407, 4dbfB, 0.5517, 4.02, 0.043, 257, 93, CRYSTAL STRUCTURES OF CG1458
4408, 3umnB, 0.5517, 3.44, 0.067, 116, 89, CRYSTAL STRUCTURE OF LAMIN-B1
4409, 3u30C, 0.5517, 3.56, 0.081, 218, 86, CRYSTAL STRUCTURE OF A LINEAR-SPECIFIC UBIQUITIN FAB BOUND TO LINEAR UBIQUITIN
4410, 3qcvH, 0.5517, 3.28, 0.023, 219, 86, CRYSTAL STRUCTURE OF THE LT3015 ANTIBODY FAB FRAGMENT IN COMPLEX WITH LYSOPHOSPHATIDIC ACID (18:2)
4411, 3qctH, 0.5517, 3.31, 0.035, 219, 86, CRYSTAL STRUCTURE OF THE HUMANIZED APO LT3015 ANTI-LYSOPHOSPHATIDIC ACID ANTIBODY FAB FRAGMENT
4412, 3c6sF, 0.5517, 3.09, 0.073, 209, 82, CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG PENTADECASACCHARIDE
4413, 3bz4H, 0.5517, 3.39, 0.071, 209, 84, CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG DECASACCHARIDE
4414, 2hffH, 0.5517, 3.67, 0.103, 212, 87, CRYSTAL STRUCTURE OF CB2 FAB
4415, 2eksB, 0.5517, 3.25, 0.107, 113, 84, CRYSTAL STRUCTURE OF HUMANIZED HYHEL-10 FV-HEN LYSOZYME COMPLEX
4416, 1yntB, 0.5517, 3.42, 0.058, 218, 86, STRUCTURE OF THE IMMUNODOMINANT EPITOPE DISPLAYED BY THE SURFACE ANTIGEN 1 (SAG1) OF TOXOPLASMA GONDII COMPLEXED TO A MONOCLONAL ANTIBODY
4417, 1l6xA, 0.5517, 3.31, 0.047, 207, 85, FC FRAGMENT OF RITUXIMAB BOUND TO A MINIMIZED VERSION OF THE B-DOMAIN FROM PROTEIN A CALLED Z34C
4418, 1f13B, 0.5517, 3.64, 0.103, 719, 87, RECOMBINANT HUMAN CELLULAR COAGULATION FACTOR XIII
4419, 1cfvL, 0.5517, 3.13, 0.036, 113, 84, MONOCLONAL ANTIBODY FRAGMENT FV4155 FROM E. COLI
4420, 1cc0F, 0.5517, 4.24, 0.084, 180, 95, CRYSTAL STRUCTURE OF THE RHOA.GDP-RHOGDI COMPLEX
4421, 1cc0E, 0.5517, 4.24, 0.084, 180, 95, CRYSTAL STRUCTURE OF THE RHOA.GDP-RHOGDI COMPLEX
4422, 6fhjA, 0.5516, 3.27, 0.071, 979, 85, STRUCTURAL DYNAMICS AND CATALYTIC PROPERTIES OF A MULTI-MODULAR XANTHANASE; NATIVE. 
4423, 6cvkA, 0.5516, 3.71, 0.056, 241, 89, HEPATITIS B E-ANTIGEN IN COMPLEX WITH SCFV E13 
4424, 5yc1F, 0.5516, 3.45, 0.057, 164, 87, TRAF4_GPIB COMPLEX
4425, 5xjfA, 0.5516, 3.23, 0.024, 215, 85, CRYSTAL STRUCTURE OF FUCOSYLATED IGG FC Y296W MUTANT COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA
4426, 5mu0K, 0.5516, 3.44, 0.083, 215, 84, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
4427, 5iopB, 0.5516, 3.66, 0.068, 215, 88, CETUXIMAB FAB IN COMPLEX WITH 4-BROMOPHENYLALANINE MEDITOPE VARIANT
4428, 4zsoB, 0.5516, 3.50, 0.045, 218, 88, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN B7-H6 A TUMOR CELL LIGAND FOR NATURAL CYTOTOXICITY RECEPTOR NKP30 AND AN INHIBITORY ANTIBODY
4429, 4yzfI, 0.5516, 3.43, 0.046, 223, 87, CRYSTAL STRUCTURE OF THE ANION EXCHANGER DOMAIN OF HUMAN ERYTHROCYTE BAND 3
4430, 4nqsB, 0.5516, 3.23, 0.036, 207, 84, KNOB-INTO-HOLE IGG FC
4431, 4krlB, 0.5516, 3.44, 0.082, 122, 85, NANOBODY/VHH DOMAIN 7D12 IN COMPLEX WITH DOMAIN III OF THE EXTRACELLULAR REGION OF EGFR PH 6.0
4432, 4h88H, 0.5516, 3.37, 0.047, 218, 86, STRUCTURE OF POM1 FAB FRAGMENT COMPLEXED WITH MOUSE PRPC FRAGMENT 120- 230
4433, 4fqiH, 0.5516, 3.63, 0.057, 215, 88, CRYSTAL STRUCTURE OF FAB CR9114 IN COMPLEX WITH A H5N1 INFLUENZA VIRUS HEMAGGLUTININ
4434, 4dk6B, 0.5516, 3.71, 0.080, 127, 87, STRUCTURE OF EDITOSOME PROTEIN
4435, 3qxtB, 0.5516, 3.44, 0.059, 124, 85, STRUCTURE OF AN ANTI-METHOTREXATE CDR1-3 GRAFT VHH ANTIBODY IN COMPLEX WITH METHOTREXATE
4436, 3cx5J, 0.5516, 3.56, 0.045, 127, 88, STRUCTURE OF COMPLEX III WITH BOUND CYTOCHROME C IN REDUCED STATE AND DEFINITION OF A MINIMAL CORE INTERFACE FOR ELECTRON TRANSFER.
4437, 3bgfH, 0.5516, 3.22, 0.023, 216, 86, X-RAY CRYSTAL STRUCTURE OF THE SARS CORONAVIRUS SPIKE RECEPTOR BINDING DOMAIN IN COMPLEX WITH F26G19 FAB
4438, 2fjfF, 0.5516, 3.24, 0.118, 218, 85, STRUCTURE OF THE G6 FAB A PHAGE DERIVED VEGF BINDING FAB
4439, 2bxwB, 0.5516, 4.22, 0.084, 138, 95, CRYSTAL STRUCTURE OF RHOGDI LYS(135138141)TYR MUTANT
4440, 1v7nK, 0.5516, 3.50, 0.082, 217, 85, HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB
4441, 1s4iD, 0.5516, 3.60, 0.067, 151, 89, CRYSTAL STRUCTURE OF A SOD-LIKE PROTEIN FROM BACILLUS SUBTILIS
4442, 1g7jB, 0.5516, 3.51, 0.080, 112, 87, CRYSTAL STRUCTURE OF HEN EGG WHITE LYSOZYME (HEL) COMPLEXED WITH THE MUTANT ANTI-HEL MONOCLONAL ANTIBODY D1.3 (VLW92H)
4443, 6ieaL, 0.5515, 3.44, 0.045, 218, 89, STRUCTURE OF RVFV GN AND HUMAN MONOCLONAL ANTIBODY R13 
4444, 6i8sE, 0.5515, 3.41, 0.059, 214, 85, DISCOVERY AND CHARACTERISATION OF AN ANTIBODY THAT SELECTIVELY MODULATES THE INHIBITORY ACTIVITY OF PLASMINOGEN ACTIVATOR INHIBITOR- 1 
4445, 6g6zA, 0.5515, 4.16, 0.054, 333, 92, EG5-INHIBITOR COMPLEX 
4446, 5xjeA, 0.5515, 3.23, 0.024, 213, 85, CRYSTAL STRUCTURE OF FUCOSYLATED IGG1 FC COMPLEXED WITH BIS- GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA
4447, 5utzJ, 0.5515, 3.46, 0.046, 218, 87, HUMAN IL-2/FAB COMPLEX 
4448, 5t5bH, 0.5515, 3.61, 0.081, 206, 86, CRYSTAL STRUCTURE OF THE COMPLEX OF 10E8 FAB LIGHT CHAIN MUTANT5 AND T117V2 HIV-1 MPER SCAFFOLD
4449, 5n0aI, 0.5515, 3.47, 0.035, 131, 86, CRYSTAL STRUCTURE OF A259C COVALENTLY LINKED DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN DIMER IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11
4450, 5n0aH, 0.5515, 3.47, 0.035, 131, 86, CRYSTAL STRUCTURE OF A259C COVALENTLY LINKED DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN DIMER IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11
4451, 5mu0A, 0.5515, 3.48, 0.107, 214, 84, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
4452, 5ivzD, 0.5515, 3.68, 0.068, 213, 88, CETUXIMAB FAB IN COMPLEX WITH ARG8CIR MEDITOPE VARIANT
4453, 5bw7B, 0.5515, 3.23, 0.047, 215, 85, CRYSTAL STRUCTURE OF NONFUCOSYLATED FC Y296W MUTANT COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA
4454, 4wi6A, 0.5515, 3.17, 0.036, 208, 84, STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION N434A
4455, 4tw1G, 0.5515, 3.69, 0.033, 290, 92, CRYSTAL STRUCTURE OF THE OCTAMERIC PORE COMPLEX OF THE STAPHYLOCOCCUS AUREUS BI-COMPONENT TOXIN LUKGH
4456, 4ni6A, 0.5515, 3.56, 0.112, 138, 89, REPEAT DOMAIN 1 OF CLOSTRIDIUM PERFRINGENS CPE0147
4457, 4idjH, 0.5515, 3.63, 0.068, 224, 88, S.AUREUS A-HEMOLYSIN MONOMER IN COMPLEX WITH FAB
4458, 3p2dB, 0.5515, 3.87, 0.073, 352, 96, CRYSTAL STRUCTURE OF ARRESTIN-3 REVEALS THE BASIS OF THE DIFFERENCE IN RECEPTOR BINDING BETWEEN TWO NON-VISUAL SUBTYPES
4459, 3grwH, 0.5515, 3.75, 0.091, 230, 88, FGFR3 IN COMPLEX WITH A FAB
4460, 3duuB, 0.5515, 3.49, 0.080, 121, 87, CRYSTAL STRUCTURE OF SAG506-01 ORTHORHOMBIC TWINNED CRYSTAL 2
4461, 3cfeB, 0.5515, 3.22, 0.047, 219, 85, CRYSTAL STRUCTURE OF PURPLE-FLUORESCENT ANTIBODY EP2-25C10
4462, 3c6sH, 0.5515, 3.08, 0.085, 209, 82, CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG PENTADECASACCHARIDE
4463, 1yntD, 0.5515, 3.42, 0.058, 218, 86, STRUCTURE OF THE IMMUNODOMINANT EPITOPE DISPLAYED BY THE SURFACE ANTIGEN 1 (SAG1) OF TOXOPLASMA GONDII COMPLEXED TO A MONOCLONAL ANTIBODY
4464, 1v7mH, 0.5515, 3.43, 0.082, 217, 85, HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB
4465, 1rocA, 0.5515, 3.37, 0.071, 155, 85, CRYSTAL STRUCTURE OF THE HISTONE DEPOSITION PROTEIN ASF1
4466, 1pzsA, 0.5515, 3.85, 0.033, 171, 91, CRYSTAL STRUCTURE OF A CU-ZN SUPEROXIDE DISMUTASE FROM MYCOBACTERIUM TUBERCULOSIS AT 1.63 RESOLUTION
4467, 1ezvX, 0.5515, 3.23, 0.047, 127, 86, STRUCTURE OF THE YEAST CYTOCHROME BC1 COMPLEX CO- CRYSTALLIZED WITH AN ANTIBODY FV-FRAGMENT
4468, 1evuA, 0.5515, 3.73, 0.102, 707, 88, HUMAN FACTOR XIII WITH CALCIUM BOUND IN THE ION SITE
4469, 6i68E, 0.5514, 3.24, 0.095, 139, 84, CO-CRYSTAL STRUCTURE OF HUMAN SPOP MATH DOMAIN (M117V) AND HUMAN BRD3 FRAGMENT 
4470, 6e0cN, 0.5514, 3.26, 0.035, 229, 85, CRYO-EM STRUCTURE OF THE CENP-A NUCLEOSOME (W601) IN COMPLEX WITH A SINGLE CHAIN ANTIBODY FRAGMENT 
4471, 5yoyR, 0.5514, 3.59, 0.046, 126, 87, CRYSTAL STRUCTURE OF THE HUMAN TUMOR NECROSIS FACTOR IN COMPLEX WITH GOLIMUMAB FV 
4472, 5x08H, 0.5514, 3.57, 0.080, 217, 88, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY 4E10 MUTANT NPRO WITH PEPTIDE BOUND
4473, 5wtbA, 0.5514, 4.30, 0.089, 313, 101, COMPLEX STRUCTURE OF STAPHYLOCOCCUS AUREUS SDRE WITH HUMAN COMPLEMENT FACTOR H
4474, 5werC, 0.5514, 3.74, 0.108, 317, 93, CRYSTAL STRUCTURE OF TAPBPR AND H2-DD COMPLEX
4475, 5u3kH, 0.5514, 3.56, 0.058, 222, 86, CRYSTAL STRUCTURE OF DH511.2 FAB IN COMPLEX WITH HIV-1 GP41 MPER 662- 683 PEPTIDE
4476, 5no8B, 0.5514, 3.20, 0.036, 669, 83, POLYSACCHARIDE LYASE BACCELL_00875
4477, 5mu0E, 0.5514, 3.44, 0.083, 218, 84, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
4478, 5mhlB, 0.5514, 3.72, 0.103, 697, 87, FXIIIA IN COMPLEX WITH THE INHIBITOR MI0621
4479, 5etuD, 0.5514, 3.70, 0.068, 214, 88, CETUXIMAB FAB IN COMPLEX WITH L5E MEDITOPE VARIANT
4480, 5emwB, 0.5514, 3.40, 0.067, 206, 90, CRYSTAL STRUCTURE OF THE PALMITOYLATED HUMAN TEAD3 TRANSCRIPTION FACTOR
4481, 5e7fA, 0.5514, 3.13, 0.095, 126, 84, COMPLEX BETWEEN LACTOCOCCAL PHAGE TUC2009 RBP HEAD DOMAIN AND A NANOBODY (L06)
4482, 5djyA, 0.5514, 3.28, 0.047, 208, 85, FC HETERODIMER DESIGN 20.8 Y349S/T366V/K370Y/K409V + E357D/S364Q/Y407A
4483, 4zsoD, 0.5514, 3.41, 0.046, 219, 87, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN B7-H6 A TUMOR CELL LIGAND FOR NATURAL CYTOTOXICITY RECEPTOR NKP30 AND AN INHIBITORY ANTIBODY
4484, 4yzfG, 0.5514, 3.47, 0.080, 223, 87, CRYSTAL STRUCTURE OF THE ANION EXCHANGER DOMAIN OF HUMAN ERYTHROCYTE BAND 3
4485, 4qgyB, 0.5514, 3.53, 0.093, 126, 86, CAMELID (LLAMA) NANOBODY N25 (VHH) AGAINST TYPE 6 SECRETION SYSTEM TSSM PROTEIN
4486, 4cadB, 0.5514, 3.15, 0.024, 221, 84, MECHANISM OF FARNESYLATED CAAX PROTEIN PROCESSING BY THE INTEGRAL MEMBRANE PROTEASE RCE1
4487, 3wknJ, 0.5514, 3.25, 0.036, 209, 84, CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG
4488, 3t09A, 0.5514, 3.87, 0.083, 1015, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (S796A) GALACTONOLACTONE COMPLEX
4489, 3sgjA, 0.5514, 3.06, 0.024, 219, 84, UNIQUE CARBOHYDRATE-CARBOHYDRATE INTERACTIONS ARE REQUIRED FOR HIGH AFFINITY BINDING BETWEEN FCGIII AND ANTIBODIES LACKING CORE FUCOSE
4490, 3duuD, 0.5514, 3.53, 0.080, 121, 87, CRYSTAL STRUCTURE OF SAG506-01 ORTHORHOMBIC TWINNED CRYSTAL 2
4491, 1qupA, 0.5514, 3.77, 0.043, 219, 94, CRYSTAL STRUCTURE OF THE COPPER CHAPERONE FOR SUPEROXIDE DISMUTASE
4492, 1qbmH, 0.5514, 3.50, 0.068, 219, 88, FAB E8B ANTIBODY X-RAY STRUCTURE AT 2.37 ANGSTROMS RESOLUTION
4493, 1oztL, 0.5514, 3.39, 0.057, 130, 88, CRYSTAL STRUCTURE OF APO-H46R FAMILIAL ALS MUTANT HUMAN CU ZN SUPEROXIDE DISMUTASE (CUZNSOD) TO 2.5A RESOLUTION
4494, 1kyoJ, 0.5514, 3.20, 0.059, 127, 85, YEAST CYTOCHROME BC1 COMPLEX WITH BOUND SUBSTRATE CYTOCHROME C
4495, 1kipB, 0.5514, 3.50, 0.080, 116, 87, FV MUTANT Y(B 32)A (VH DOMAIN) OF MOUSE MONOCLONAL ANTIBODY D1.3 COMPLEXED WITH HEN EGG WHITE LYSOZYME
4496, 6fy0H, 0.5513, 3.43, 0.057, 226, 87, CRYSTAL STRUCTURE OF A V2-DIRECTED; RV144 VACCINE-LIKE ANTIBODY FROM HIV-1 INFECTION; CAP228-16H; BOUND TO A HETEROLOGOUS V2 PEPTIDE 
4497, 5yoyQ, 0.5513, 3.61, 0.057, 126, 87, CRYSTAL STRUCTURE OF THE HUMAN TUMOR NECROSIS FACTOR IN COMPLEX WITH GOLIMUMAB FV 
4498, 5w3oD, 0.5513, 3.47, 0.057, 116, 87, CRYOEM STRUCTURE OF RHINOVIRUS B14 IN COMPLEX WITH C5 FAB (33 DEGREES CELSIUS MOLAR RATIO 1:3 EMPTY PARTICLE)
4499, 5vh4A, 0.5513, 3.44, 0.059, 220, 85, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-TNFA ANTIBODY INFLIXIMAB IN AN I-CENTERED ORTHORHOMBIC CRYSTAL FORM
4500, 5mu0M, 0.5513, 3.47, 0.095, 212, 84, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
4501, 5mu0I, 0.5513, 3.45, 0.083, 216, 84, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
4502, 5ijdC, 0.5513, 4.41, 0.040, 137, 101, THE CRYSTAL STRUCTURE OF MOUSE TLR4/MD-2/LIPID A COMPLEX
4503, 5hvhC, 0.5513, 3.28, 0.058, 118, 86, CRYSTAL STRUCTURE OF THROMBIN-ACTIVATABLE FIBRINOLYSIS INHIBITOR IN COMPLEX WITH TWO INHIBITORY NANOBODIES
4504, 4yxkH, 0.5513, 3.37, 0.047, 218, 86, CRYSTAL STRUCTURE OF ELK PRION PROTEIN COMPLEXED WITH POM1 FAB
4505, 4gw1B, 0.5513, 3.66, 0.068, 221, 88, CQFD MEDITOPE
4506, 3zjbA, 0.5513, 3.32, 0.070, 172, 86, THE STRUCTURE OF THE TRAF DOMAIN OF HUMAN TRAF4
4507, 3rp1B, 0.5513, 2.89, 0.061, 97, 82, CRYSTAL STRUCTURE OF HUMAN LAIR-1 IN C2 SPACE GROUP
4508, 3qxuD, 0.5513, 3.29, 0.071, 123, 85, FREE STRUCTURE OF AN ANTI-METHOTREXATE CDR1-3 GRAFT VHH ANTIBODY
4509, 3qxtA, 0.5513, 3.40, 0.059, 124, 85, STRUCTURE OF AN ANTI-METHOTREXATE CDR1-3 GRAFT VHH ANTIBODY IN COMPLEX WITH METHOTREXATE
4510, 3hqlB, 0.5513, 3.04, 0.098, 132, 82, STRUCTURES OF SPOP-SUBSTRATE COMPLEXES: INSIGHTS INTO MOLECULAR ARCHITECTURES OF BTB-CUL3 UBIQUITIN LIGASES:SPOPMATHX-PUCSBC1_PEP2
4511, 2x0wB, 0.5513, 3.66, 0.086, 194, 93, STRUCTURE OF THE P53 CORE DOMAIN MUTANT Y220C BOUND TO 56- DIMETHOXY-2-METHYLBENZOTHIAZOLE
4512, 2gj7A, 0.5513, 3.26, 0.047, 207, 85, CRYSTAL STRUCTURE OF A GE-GI/FC COMPLEX
4513, 2dqiH, 0.5513, 3.32, 0.082, 114, 85, CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT (LY50A) COMPLEXED WITH HEN EGG LYSOZYME
4514, 1xq4C, 0.5513, 3.45, 0.068, 120, 88, CRYSTAL STRUCTURE OF THE PUTATIVE APAA PROTEIN FROM BORDETELLA PERTUSSIS NORTHEAST STRUCTURAL GENOMICS TARGET BER40
4515, 1nc4C, 0.5513, 3.16, 0.057, 215, 87, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 2D12.5 FAB COMPLEXED WITH GD- DOTA
4516, 1gguA, 0.5513, 3.71, 0.102, 701, 88, HUMAN FACTOR XIII WITH CALCIUM BOUND IN THE ION SITE
4517, 1g7mB, 0.5513, 3.53, 0.080, 116, 87, CRYSTAL STRUCTURE OF HEN EGG WHITE LYSOZYME (HEL) COMPLEXED WITH THE MUTANT ANTI-HEL MONOCLONAL ANTIBODY D1.3 (VLW92V)
4518, 1dn2A, 0.5513, 3.26, 0.047, 207, 85, FC FRAGMENT OF HUMAN IGG1 IN COMPLEX WITH AN ENGINEERED 13 RESIDUE PEPTIDE DCAWHLGELVWCT-NH2
4519, 5xcvA, 0.5512, 3.81, 0.057, 169, 88, CRYSTAL STRUCTURE OF NZ-1 FV-CLASP FRAGMENT WITH ITS ANTIGEN PEPTIDE
4520, 5wnbI, 0.5512, 3.47, 0.046, 216, 87, STRUCTURE OF ANTIBODY 3D3 BOUND TO THE LINEAR EPITOPE OF RSV G
4521, 5werI, 0.5512, 3.65, 0.112, 301, 89, CRYSTAL STRUCTURE OF TAPBPR AND H2-DD COMPLEX
4522, 5urkA, 0.5512, 3.32, 0.057, 1706, 87, CRYSTAL STRUCTURE OF HUMAN BRR2 IN COMPLEX WITH T-3935799
4523, 4zmaT, 0.5512, 3.06, 0.149, 198, 87, CRYSTAL STRUCTURE OF A FVIIA-TRYPSIN CHIMERA (ST) IN COMPLEX WITH SOLUBLE TISSUE FACTOR
4524, 4yhnA, 0.5512, 3.45, 0.093, 220, 86, DABIGATRAN REVERSAL AGENT
4525, 4xvuK, 0.5512, 3.25, 0.059, 216, 85, STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF NYV1
4526, 4xvuC, 0.5512, 3.36, 0.058, 222, 86, STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF NYV1
4527, 4q6yB, 0.5512, 3.09, 0.036, 206, 84, CRYSTAL STRUCTURE OF A CHEMOENZYMATIC GLYCOENGINEERED DISIALYLATED FC (DI-SFC)
4528, 4j3wA, 0.5512, 3.04, 0.087, 862, 80, CRYSTAL STRUCTURE OF BARLEY LIMIT DEXTRINASE (E510A MUTANT) IN COMPLEX WITH A BRANCHED MALTOHEXASACCHARIDE
4529, 4etqH, 0.5512, 3.51, 0.045, 215, 88, VACCINIA VIRUS D8L IMV ENVELOPE PROTEIN IN COMPLEX WITH FAB OF MURINE IGG2A LA5
4530, 4aixC, 0.5512, 3.09, 0.107, 106, 84, CRYSTALLOGRAPHIC STRUCTURE OF AN AMYLOIDOGENIC VARIANT 3RC34Y OF THE GERMINAL LINE LAMBDA 3
4531, 3tt1I, 0.5512, 3.44, 0.058, 212, 86, CRYSTAL STRUCTURE OF LEUT IN THE OUTWARD-OPEN CONFORMATION IN COMPLEX WITH FAB
4532, 3kbfA, 0.5512, 3.75, 0.032, 156, 93, C. ELEGANS CUZN SUPEROXIDE DISMUTASE
4533, 3ay4B, 0.5512, 3.25, 0.047, 216, 85, CRYSTAL STRUCTURE OF NONFUCOSYLATED FC COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA
4534, 2fauA, 0.5512, 3.62, 0.085, 286, 94, CRYSTAL STRUCTURE OF HUMAN VPS26
4535, 2dqgH, 0.5512, 3.11, 0.084, 114, 83, CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT (HY53F) COMPLEXED WITH HEN EGG LYSOZYME
4536, 1wk0A, 0.5512, 3.22, 0.069, 137, 87, SOLUTION STRUCTURE OF FIBRONECTIN TYPE III DOMAIN DERIVED FROM HUMAN KIAA0970 PROTEIN
4537, 1ggcH, 0.5512, 3.24, 0.048, 215, 83, MAJOR ANTIGEN-INDUCED DOMAIN REARRANGEMENTS IN AN ANTIBODY
4538, 1g7lB, 0.5512, 3.47, 0.081, 110, 86, CRYSTAL STRUCTURE OF HEN EGG WHITE LYSOZYME (HEL) COMPLEXED WITH THE MUTANT ANTI-HEL MONOCLONAL ANTIBODY D1.3 (VLW92S)
4539, 1f13A, 0.5512, 3.65, 0.103, 722, 87, RECOMBINANT HUMAN CELLULAR COAGULATION FACTOR XIII
4540, 1a44A, 0.5512, 3.60, 0.064, 185, 94, PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN FROM CALF BRAIN
4541, 6qgyD, 0.5511, 3.46, 0.082, 122, 85, CRYSTAL STRUCTURE OF E.COLI BAMA BETA-BARREL IN COMPLEX WITH NANOBODY B12 
4542, 6pi7C, 0.5511, 3.35, 0.071, 219, 85, CRYSTAL STRUCTURE OF THE TDRD2 EXTENDED TUDOR DOMAIN IN COMPLEX WITH AN ANTIBODY FRAGMENT AND THE PIWIL1 PEPTIDE 
4543, 6e4zH, 0.5511, 3.38, 0.107, 208, 84, ANTI-PCSK9 FAB 6E2 BOUND TO THE MODIFIED N-TERMINAL PEPTIDE FROM PCSK9 
4544, 5zo9A, 0.5511, 4.13, 0.054, 331, 92, EG5 MOTOR DOMAIN IN COMPLEX WITH STLC-TYPE INHIBITOR PVEI0021 (C2 TYPE) 
4545, 5zo7A, 0.5511, 4.13, 0.054, 332, 92, KINESIN SPINDLE PROTEIN EG5 IN COMPLEX WITH STLC-TYPE INHIBITOR PVEI0138 
4546, 5yoyG, 0.5511, 3.59, 0.046, 126, 87, CRYSTAL STRUCTURE OF THE HUMAN TUMOR NECROSIS FACTOR IN COMPLEX WITH GOLIMUMAB FV 
4547, 5x3iB, 0.5511, 3.38, 0.083, 709, 84, KFLA1895 D451A MUTANT
4548, 5w38A, 0.5511, 3.07, 0.024, 209, 83, 1.80A RESOLUTION STRUCTURE OF HUMAN IGG3 FC (N392K)
4549, 5m59C, 0.5511, 3.45, 0.091, 1702, 88, CRYSTAL STRUCTURE OF CHAETOMIUM THERMOPHILUM BRR2 HELICASE CORE IN COMPLEX WITH PRP8 JAB1 DOMAIN
4550, 5kn5D, 0.5511, 3.48, 0.070, 215, 86, TGFALPHA/EPIREGULIN COMPLEX WITH NEUTRALIZING ANTIBODY LY3016859
4551, 5e7fB, 0.5511, 3.12, 0.095, 125, 84, COMPLEX BETWEEN LACTOCOCCAL PHAGE TUC2009 RBP HEAD DOMAIN AND A NANOBODY (L06)
4552, 4xbpE, 0.5511, 3.37, 0.094, 225, 85, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLETHANOLAMINE (06:0 PE)
4553, 4ongH, 0.5511, 3.69, 0.046, 210, 87, FAB FRAGMENT OF 3D6 IN COMPLEX WITH AMYLOID BETA 1-40
4554, 4lkxA, 0.5511, 3.48, 0.070, 214, 86, HUMANIZED ANTIBODY 4B12 FAB COMPLEXED WITH A CEMX SEGMENT
4555, 4k3hE, 0.5511, 3.18, 0.057, 109, 87, IMMUNOGLOBULIN LAMBDA VARIABLE DOMAIN L5(L89S) FLUOROGEN ACTIVATIONG PROTEIN IN COMPLEX WITH MALACHITE GREEN
4556, 4cadE, 0.5511, 3.15, 0.024, 220, 84, MECHANISM OF FARNESYLATED CAAX PROTEIN PROCESSING BY THE INTEGRAL MEMBRANE PROTEASE RCE1
4557, 2uudH, 0.5511, 3.55, 0.080, 121, 87, CRYSTAL STRUCTURE OF THE TEPC15-VK45.1 ANTI-2-PHENYL-5- OXAZOLONE NQ10-1.12 SCFV IN COMPLEX WITH THE HAPTEN
4558, 2d9qB, 0.5511, 3.27, 0.100, 299, 90, CRYSTAL STRUCTURE OF THE HUMAN GCSF-RECEPTOR SIGNALING COMPLEX
4559, 1tziB, 0.5511, 3.54, 0.092, 222, 87, CRYSTAL STRUCTURE OF THE FAB YADS2 COMPLEXED WITH H-VEGF
4560, 1a2yB, 0.5511, 3.27, 0.071, 116, 85, HEN EGG WHITE LYSOZYME D18A MUTANT IN COMPLEX WITH MOUSE MONOCLONAL ANTIBODY D1.3
4561, 6f2gB, 0.5510, 3.50, 0.081, 131, 86, struct.pdbx_descriptor               Putative amino acid/polyamine transport protein; Nanobody 74  
4562, 6cnjF, 0.5510, 3.05, 0.060, 218, 84, STRUCTURE OF THE 2ALPHA3BETA STIOCHIOMETRY OF THE HUMAN ALPHA4BETA2 NICOTINIC RECEPTOR 
4563, 5yaxA, 0.5510, 3.42, 0.070, 228, 86, CRYSTAL STRUCTURE OF A HUMAN NEUTRALIZING ANTIBODY BOUND TO A HBV PRES1 PEPTIDE
4564, 5vl7H, 0.5510, 3.62, 0.080, 219, 87, PCSK9 COMPLEX WITH FAB33
4565, 5ivzB, 0.5510, 3.69, 0.068, 216, 88, CETUXIMAB FAB IN COMPLEX WITH ARG8CIR MEDITOPE VARIANT
4566, 5immB, 0.5510, 3.50, 0.093, 125, 86, NANOBODY TARGETING MOUSE VSIG4 IN SPACEGROUP P212121
4567, 5f3jC, 0.5510, 3.58, 0.057, 228, 87, CRYSTAL STRUCTURE OF DBP IN COMPLEX WITH INHIBITORY MONOCLONAL ANTIBODY 2D10
4568, 5f1oB, 0.5510, 3.47, 0.081, 128, 86, HUMAN CD38 IN COMPLEX WITH NANOBODY MU551
4569, 5awuA, 0.5510, 3.62, 0.106, 265, 94, CRYSTAL STRUCTURE OF THE SGIP1 MU HOMOLOGY DOMAIN IN COMPLEX WITH AN EPS15 FRAGMENT CONTAINING TWO DPF MOTIFS (YDPFKGSDPFA)
4570, 4q5zK, 0.5510, 3.55, 0.070, 207, 86, CRYSTAL STRUCTURE ANALYSIS OF FAB-BOUND HUMAN INSULIN DEGRADING ENZYME (IDE) IN COMPLEX WITH INSULIN
4571, 4oiaB, 0.5510, 3.16, 0.086, 375, 81, CRYSTAL STRUCTURE OF ICAM-5 D1-D4 ECTODOMAIN FRAGMENT SPACE GROUP P4322
4572, 4nkdE, 0.5510, 3.24, 0.047, 121, 86, CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT
4573, 4krmB, 0.5510, 3.45, 0.093, 124, 86, NANOBODY/VHH DOMAIN 7D12 IN COMPLEX WITH DOMAIN III OF THE EXTRACELLULAR REGION OF EGFR PH 3.5
4574, 4fqrs, 0.5510, 3.80, 0.080, 238, 88, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
4575, 4bkfB, 0.5510, 3.26, 0.108, 505, 83, CRYSTAL STRUCTURE OF THE HUMAN EPHA4 ECTODOMAIN IN COMPLEX WITH HUMAN EPHRINB3
4576, 4bkfA, 0.5510, 3.26, 0.108, 505, 83, CRYSTAL STRUCTURE OF THE HUMAN EPHA4 ECTODOMAIN IN COMPLEX WITH HUMAN EPHRINB3
4577, 3r0mA, 0.5510, 3.57, 0.080, 127, 87, CRYSTAL STRUCTURE OF ANTI-HIV LLAMA VHH ANTIBODY A12
4578, 3nn8G, 0.5510, 3.21, 0.047, 121, 86, CRYSTAL STRUCTURE OF ENGINEERED ANTIBODY FRAGMENT BASED ON 3D5
4579, 2ylhA, 0.5510, 4.26, 0.097, 311, 93, STRUCTURE OF N-TERMINAL DOMAIN OF CANDIDA ALBICANS ALS9-2 G299W MUTANT
4580, 2y36H, 0.5510, 3.39, 0.047, 215, 86, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-(4-HYDROXY-3- NITROPHENYL)- ACETYL MURINE GERMLINE ANTIBODY BBE6.12H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE DLWTTAIPTIPS
4581, 2y06H, 0.5510, 3.38, 0.047, 215, 86, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-(4-HYDROXY-3- NITROPHENYL) -ACETYL MURINE GERMLINE ANTIBODY BBE6.12H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE GDPRPSYISHLL
4582, 1srdC, 0.5510, 3.68, 0.076, 154, 92, THREE-DIMENSIONAL STRUCTURE OF CUZN-SUPEROXIDE DISMUTASE FROM SPINACH AT 2.0 ANGSTROMS RESOLUTION
4583, 1m7uB, 0.5510, 4.16, 0.071, 240, 98, CRYSTAL STRUCTURE OF A NOVEL DNA-BINDING DOMAIN FROM NDT80 A TRANSCRIPTIONAL ACTIVATOR REQUIRED FOR MEIOSIS IN YEAST
4584, 1jrhI, 0.5510, 3.23, 0.107, 95, 84, COMPLEX (ANTIBODY/ANTIGEN)
4585, 1fsoA, 0.5510, 4.20, 0.063, 138, 95, CRYSTAL STRUCTURE OF TRUNCATED HUMAN RHOGDI QUADRUPLE MUTANT
4586, 1a6vI, 0.5510, 3.26, 0.047, 119, 86, B1-8 FV FRAGMENT COMPLEXED WITH A (4-HYDROXY-3-NITROPHENYL) ACETATE COMPOUND
4587, 6nggA, 0.5509, 3.34, 0.036, 116, 84, CRYSTAL STRUCTURE OF HUMAN CD160 V58M MUTANT 
4588, 6huoG, 0.5509, 3.51, 0.093, 121, 86, CRYOEM STRUCTURE OF HUMAN FULL-LENGTH HETEROMERIC ALPHA1BETA3GAMMA2L GABA(A)R IN COMPLEX WITH ALPRAZOLAM (XANAX); GABA AND MEGABODY MB38. 
4589, 5t85H, 0.5509, 3.62, 0.081, 232, 86, CRYSTAL STRUCTURE OF 10E8 FAB IN COMPLEX WITH THE MPER EPITOPE SCAFFOLD T117V2 AND PHOSPHATIDYLGLYCEROL (06:0 PG)
4590, 5ml2B, 0.5509, 3.96, 0.098, 144, 92, THE CRYSTAL STRUCTURE OF PDE6D IN COMPLEX WITH INHIBITOR-3
4591, 5kemI, 0.5509, 3.34, 0.057, 121, 87, EBOV SGP IN COMPLEX WITH VARIABLE FAB DOMAINS OF IGGS C13C6 AND BDBV91
4592, 5kemD, 0.5509, 3.34, 0.057, 121, 87, EBOV SGP IN COMPLEX WITH VARIABLE FAB DOMAINS OF IGGS C13C6 AND BDBV91
4593, 5icxD, 0.5509, 3.69, 0.068, 212, 88, CETUXIMAB FAB IN COMPLEX WITH CQFDLSTRRLRCGGSK MEDITOPE
4594, 5gmqB, 0.5509, 3.44, 0.070, 225, 86, STRUCTURE OF MERS-COV RBD IN COMPLEX WITH A FULLY HUMAN ANTIBODY MCA1
4595, 5dk0A, 0.5509, 3.27, 0.047, 207, 85, FC HETERODIMER DESIGN 20.8.34 Y349S/T366M/K370Y/K409V + E356G/E357D/S364Q/Y407A
4596, 4xbpH, 0.5509, 3.51, 0.080, 224, 87, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLETHANOLAMINE (06:0 PE)
4597, 4ibzD, 0.5509, 3.54, 0.087, 192, 92, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R273C AND SECOND-SITE SUPPRESSOR MUTATION T284R
4598, 3tt1H, 0.5509, 3.44, 0.058, 212, 86, CRYSTAL STRUCTURE OF LEUT IN THE OUTWARD-OPEN CONFORMATION IN COMPLEX WITH FAB
4599, 3fkuS, 0.5509, 3.15, 0.048, 233, 83, CRYSTAL STRUCTURE OF INFLUENZA HEMAGGLUTININ (H5) IN COMPLEX WITH A BROADLY NEUTRALIZING ANTIBODY F10
4600, 3bz4D, 0.5509, 3.08, 0.085, 209, 82, CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG DECASACCHARIDE
4601, 2adgB, 0.5509, 3.21, 0.071, 213, 84, CRYSTAL STRUCTURE OF MONOCLONAL ANTI-CD4 ANTIBODY Q425
4602, 1xtlD, 0.5509, 3.69, 0.077, 152, 91, CRYSTAL STRUCTURE OF P104H MUTANT OF SOD-LIKE PROTEIN FROM BACILLUS SUBTILIS.
4603, 1srdD, 0.5509, 3.69, 0.109, 154, 92, THREE-DIMENSIONAL STRUCTURE OF CUZN-SUPEROXIDE DISMUTASE FROM SPINACH AT 2.0 ANGSTROMS RESOLUTION
4604, 1g0xA, 0.5509, 3.12, 0.058, 192, 86, CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF LIR-1 (ILT2)
4605, 1fieA, 0.5509, 3.65, 0.092, 705, 87, RECOMBINANT HUMAN COAGULATION FACTOR XIII
4606, 1bfvL, 0.5509, 3.12, 0.036, 113, 84, MONOCLONAL ANTIBODY FRAGMENT FV4155 FROM E. COLI
4607, 6iekF, 0.5508, 3.19, 0.047, 218, 85, STRUCTURE OF RVFV GN AND HUMAN MONOCLONAL ANTIBODY R12 
4608, 6fn8B, 0.5508, 3.55, 0.065, 152, 92, DOMAIN II OF THE HUMAN COPPER CHAPERONE FOR SUPEROXIDE DISMUTASE AT 1.55 A RESOLUTION 
4609, 6e3fA, 0.5508, 3.47, 0.093, 497, 86, THE STRUCTURE OF THE C-TERMINAL DOMAINS (C123) OF STREPTOCOCCUS INTERMEDIUS ANTIGEN I/II (PAS) 
4610, 5xmhH, 0.5508, 3.53, 0.058, 217, 86, CRYSTAL STRUCTURE OF AN IGM RHEUMATOID FACTOR YES8C IN COMPLEX WITH IGG1 FC
4611, 5wi9F, 0.5508, 3.28, 0.071, 213, 84, CRYSTAL STRUCTURE OF KL WITH AN AGONIST FAB 
4612, 5vh4H, 0.5508, 3.45, 0.071, 222, 85, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-TNFA ANTIBODY INFLIXIMAB IN AN I-CENTERED ORTHORHOMBIC CRYSTAL FORM
4613, 5kelQ, 0.5508, 3.35, 0.046, 120, 87, EBOV GP IN COMPLEX WITH VARIABLE FAB DOMAINS OF IGGS C2G4 AND C13C6
4614, 5kelP, 0.5508, 3.35, 0.046, 120, 87, EBOV GP IN COMPLEX WITH VARIABLE FAB DOMAINS OF IGGS C2G4 AND C13C6
4615, 5kelH, 0.5508, 3.35, 0.046, 120, 87, EBOV GP IN COMPLEX WITH VARIABLE FAB DOMAINS OF IGGS C2G4 AND C13C6
4616, 5di8B, 0.5508, 3.27, 0.047, 207, 85, FC KNOB-HOLE HETERODIMER T366W + T366S/L368A/Y407V
4617, 4w6yB, 0.5508, 3.21, 0.107, 128, 84, CO-COMPLEX STRUCTURE OF THE LECTIN DOMAIN OF F18 FIMBRIAL ADHESIN FEDF WITH INHIBITORY NANOBODY NBFEDF9
4618, 4ma8H, 0.5508, 3.36, 0.047, 218, 86, CRYSTAL STRUCTURE OF MOUSE PRION PROTEIN COMPLEXED WITH CHLORPROMAZINE
4619, 3rp1D, 0.5508, 2.88, 0.061, 97, 82, CRYSTAL STRUCTURE OF HUMAN LAIR-1 IN C2 SPACE GROUP
4620, 3p2tA, 0.5508, 2.81, 0.037, 194, 81, CRYSTAL STRUCTURE OF LEUKOCYTE IG-LIKE RECEPTOR LILRB4 (ILT3/LIR- 5/CD85K)
4621, 3nn8D, 0.5508, 3.30, 0.046, 121, 87, CRYSTAL STRUCTURE OF ENGINEERED ANTIBODY FRAGMENT BASED ON 3D5
4622, 3c6sB, 0.5508, 2.95, 0.086, 209, 81, CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG PENTADECASACCHARIDE
4623, 1q0yH, 0.5508, 3.28, 0.012, 215, 86, ANTI-MORPHINE ANTIBODY 9B1 COMPLEXED WITH MORPHINE
4624, 1fvcB, 0.5508, 3.46, 0.092, 120, 87, X-RAY STRUCTURES OF THE ANTIGEN-BINDING DOMAINS FROM THREE VARIANTS OF HUMANIZED ANTI-P185-HER2 ANTIBODY 4D5 AND COMPARISON WITH MOLECULAR MODELING
4625, 1fnfA, 0.5508, 3.39, 0.105, 368, 86, FRAGMENT OF HUMAN FIBRONECTIN ENCOMPASSING TYPE-III REPEATS 7 THROUGH 10
4626, 6qgwB, 0.5507, 3.22, 0.084, 122, 83, CRYSTAL STRUCTURE OF E.COLI BAMA BETA-BARREL IN COMPLEX WITH NANOBODY E6 
4627, 6mv5H, 0.5507, 3.34, 0.083, 209, 84, ANTI-PCSK9 FAB 6E2 BOUND TO THE N-TERMINAL PEPTIDE FROM PCSK9 (E32K) 
4628, 6cnjJ, 0.5507, 3.06, 0.060, 218, 84, STRUCTURE OF THE 2ALPHA3BETA STIOCHIOMETRY OF THE HUMAN ALPHA4BETA2 NICOTINIC RECEPTOR 
4629, 5u9mC, 0.5507, 3.75, 0.054, 153, 92, COPPER-ZINC SUPEROXIDE DISMUTASE IS ACTIVATED THROUGH A SULFENIC ACID INTERMEDIATE AT A COPPER-ION ENTRY SITE
4630, 5mv3I, 0.5507, 3.42, 0.107, 215, 84, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
4631, 5m6wB, 0.5507, 3.82, 0.088, 913, 91, PROPERDIN IN COMPLEX WITH ALTERNATIVE PATHWAY C3 CONVERTASE
4632, 5fxcH, 0.5507, 3.50, 0.056, 224, 90, CRYSTAL STRUCTURE OF GLYCOPEPTIDE 22 IN COMPLEX WITH SCFV-SM3
4633, 5dj2B, 0.5507, 3.28, 0.035, 207, 85, FC HETERODIMER DESIGN 7.4 Y407A + T366V/K409V
4634, 4ygaB, 0.5507, 3.61, 0.163, 124, 86, CDPK1 FROM TOXOPLASMA GONDII BOUND TO INHIBITORY VHH-1B7
4635, 4nhhE, 0.5507, 3.66, 0.057, 210, 88, STRUCTURE OF 2G12 IGG DIMER
4636, 3n5aA, 0.5507, 3.21, 0.105, 138, 86, SYNAPTOTAGMIN-7 C2B-DOMAIN CALCIUM BOUND
4637, 3ixyG, 0.5507, 3.42, 0.047, 221, 85, THE PSEUDO-ATOMIC STRUCTURE OF DENGUE IMMATURE VIRUS IN COMPLEX WITH FAB FRAGMENTS OF THE ANTI-FUSION LOOP ANTIBODY E53
4638, 3ce1A, 0.5507, 3.53, 0.055, 150, 91, CRYSTAL STRUCTURE OF THE CU/ZN SUPEROXIDE DISMUTASE FROM CRYPTOCOCCUS LIQUEFACIENS STRAIN N6
4639, 2zkhH, 0.5507, 3.40, 0.083, 209, 84, HUMAN THROMBOPOIETIN NEUTRALIZING ANTIBODY TN1 FAB
4640, 2a74E, 0.5507, 3.42, 0.079, 184, 89, HUMAN COMPLEMENT COMPONENT C3C
4641, 1xiwH, 0.5507, 3.37, 0.035, 122, 85, CRYSTAL STRUCTURE OF HUMAN CD3-E/D DIMER IN COMPLEX WITH A UCHT1 SINGLE-CHAIN ANTIBODY FRAGMENT
4642, 1l3nA, 0.5507, 3.69, 0.054, 153, 92, THE SOLUTION STRUCTURE OF REDUCED DIMERIC COPPER ZINC SOD: THE STRUCTURAL EFFECTS OF DIMERIZATION
4643, 1jk9C, 0.5507, 3.86, 0.043, 153, 93, HETERODIMER BETWEEN H48F-YSOD1 AND YCCS
4644, 1evuB, 0.5507, 3.73, 0.102, 708, 88, HUMAN FACTOR XIII WITH CALCIUM BOUND IN THE ION SITE
4645, 6ellH, 0.5506, 3.67, 0.080, 218, 87, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
4646, 5u3lH, 0.5506, 3.59, 0.058, 223, 86, CRYSTAL STRUCTURE OF DH511.2 FAB IN COMPLEX WITH HIV-1 GP41 MPER 670- 683 PEPTIDE
4647, 5t6lH, 0.5506, 3.62, 0.081, 224, 86, CRYSTAL STRUCTURE OF 10E8 FAB IN COMPLEX WITH THE MPER EPITOPE SCAFFOLD T117V2
4648, 5mv4O, 0.5506, 3.48, 0.083, 216, 84, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
4649, 5mv3C, 0.5506, 3.43, 0.095, 213, 84, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
4650, 5e6yC, 0.5506, 3.15, 0.062, 584, 80, CRYSTAL STRUCTURE OF E.COLI BRANCHING ENZYME IN COMPLEX WITH ALPHA CYCLODEXTRIN
4651, 5dt1H, 0.5506, 3.58, 0.105, 243, 86, CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.25 A POTENT V1V2-DIRECTED HIV-1 BROADLY NEUTRALIZING ANTIBODY
4652, 5djxD, 0.5506, 3.27, 0.047, 208, 85, FC HETERODIMER DESIGN 2.9 L368M/K370E + E357A/S364G
4653, 4rvpE, 0.5506, 3.55, 0.110, 153, 91, CRYSTAL STRUCTURE OF SUPEROXIDE DISMUTASE FROM SEDUM ALFREDII
4654, 4q74A, 0.5506, 3.27, 0.047, 214, 85, F241A FC
4655, 4nwtH, 0.5506, 3.34, 0.047, 232, 85, CRYSTAL STRUCTURE OF THE ANTI-HUMAN NGF FAB APE1531
4656, 3wyrB, 0.5506, 3.00, 0.060, 189, 84, CRYSTAL STRUCTURE OF KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR 2DL4
4657, 3w82A, 0.5506, 3.44, 0.090, 616, 89, HUMAN ALPHA-L-IDURONIDASE IN COMPLEX WITH IDURONIC ACID
4658, 2ybgA, 0.5506, 3.54, 0.087, 191, 92, STRUCTURE OF LYS120-ACETYLATED P53 CORE DOMAIN
4659, 2ntfH, 0.5506, 3.54, 0.068, 222, 88, CRYSTAL STRUCTURE OF A QUORUM-QUENCHING ANTIBODY IN COMPLEX WITH AN N- ACYL-L-HOMOSERINE LACTONE ANALOG
4660, 1xq4D, 0.5506, 3.45, 0.068, 120, 88, CRYSTAL STRUCTURE OF THE PUTATIVE APAA PROTEIN FROM BORDETELLA PERTUSSIS NORTHEAST STRUCTURAL GENOMICS TARGET BER40
4661, 1kirB, 0.5506, 3.53, 0.080, 116, 87, FV MUTANT Y(A 50)S (VL DOMAIN) OF MOUSE MONOCLONAL ANTIBODY D1.3 COMPLEXED WITH HEN EGG WHITE LYSOZYME
4662, 5wl2A, 0.5505, 3.61, 0.046, 221, 87, VH1-69 GERMLINE ANTIBODY WITH CDR H3 SEQUENCE OF CR9114 
4663, 5wkoC, 0.5505, 3.41, 0.070, 225, 86, CRYSTAL STRUCTURE OF ANTIBODY 27F3 RECOGNIZING THE HA FROM A/CALIFORNIA/04/2009 (H1N1) INFLUENZA VIRUS
4664, 5kzpH, 0.5505, 3.17, 0.060, 226, 84, STRUCTURE OF THE HCV1-C1 ANTIBODY-ANTIGEN COMPLEX
4665, 2r27A, 0.5505, 3.44, 0.057, 134, 88, CONSTITUTIVELY ZINC-DEFICIENT MUTANT OF HUMAN SUPEROXIDE DISMUTASE (SOD) C6A H80S H83S C111S
4666, 2j1yB, 0.5505, 3.52, 0.087, 193, 92, HUMAN P53 CORE DOMAIN MUTANT M133L-V203A-N239Y-G245S-N268D
4667, 2iwgD, 0.5505, 3.12, 0.024, 207, 83, COMPLEX BETWEEN THE PRYSPRY DOMAIN OF TRIM21 AND IGG FC
4668, 2i60H, 0.5505, 3.61, 0.092, 221, 87, CRYSTAL STRUCTURE OF [PHE23]M47 A SCORPION-TOXIN MIMIC OF CD4 IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
4669, 2dqcH, 0.5505, 3.32, 0.082, 114, 85, CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT(HY33F) COMPLEXED WITH HEN EGG LYSOZYME
4670, 1qrkB, 0.5505, 3.63, 0.103, 705, 87, HUMAN FACTOR XIII WITH STRONTIUM BOUND IN THE ION SITE
4671, 1nc2C, 0.5505, 3.15, 0.057, 215, 87, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 2D12.5 FAB COMPLEXED WITH Y- DOTA
4672, 1k5wA, 0.5505, 3.33, 0.057, 148, 87, THREE-DIMENSIONAL STRUCTURE OF THE SYNAPTOTAGMIN 1 C2B- DOMAIN: SYNAPTOTAGMIN 1 AS A PHOSPHOLIPID BINDING MACHINE
4673, 6o3bB, 0.5504, 3.41, 0.093, 216, 86, CRYSTAL STRUCTURE OF FRIZZLED 7 CRD IN COMPLEX WITH F6 FAB 
4674, 6njnL, 0.5504, 3.37, 0.000, 218, 86, STRUCTURE OF A COMPLEX 
4675, 6mtoH, 0.5504, 3.22, 0.047, 219, 85, CRYSTAL STRUCTURE OF VRC42.01 FAB IN COMPLEX WITH T117-F MPER SCAFFOLD 
4676, 6fxnF, 0.5504, 3.44, 0.057, 220, 88, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
4677, 6dc7H, 0.5504, 3.23, 0.048, 210, 84, APO FAB STRUCTURE OF MOUSE MONOCLONAL ANTIBODY 8B2 
4678, 5zo8B, 0.5504, 4.12, 0.054, 331, 92, EG5 MOTOR DOMAIN IN COMPLEX WITH STLC-TYPE INHIBITOR PVEI0021 (P21 TYPE) 
4679, 5xjeB, 0.5504, 3.27, 0.047, 215, 85, CRYSTAL STRUCTURE OF FUCOSYLATED IGG1 FC COMPLEXED WITH BIS- GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA
4680, 5o05C, 0.5504, 3.29, 0.058, 116, 86, GII.10 VIETNAM 026 NOROVIRUS PROTRUDING DOMAIN IN COMPLEX WITH NANOBODY NANO-42
4681, 5nphH, 0.5504, 3.36, 0.093, 214, 86, STRUCTURE OF THE HEPATITIS C VIRUS STRAIN J4 GLYCOPROTEIN E2 ANTIGENIC REGION 532-540 BOUND TO THE FAB FRAGMENT OF THE NON-NEUTRALIZING ANTIBODY DAO5
4682, 5mv3A, 0.5504, 3.46, 0.083, 216, 84, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
4683, 5lmwA, 0.5504, 3.35, 0.083, 120, 84, LLAMA NANOBODY PORM_02
4684, 5lgjA, 0.5504, 3.21, 0.023, 315, 87, THE CRYSTAL STRUCTURE OF IGE FC MUTANT - P333C
4685, 5f2uA, 0.5504, 4.04, 0.043, 149, 94, STRUCTURE OF FULLY MODIFIED FARNESYLATED INPP5E PEPTIDE IN COMPLEX WITH PDE6D
4686, 5drzB, 0.5504, 3.42, 0.094, 227, 85, CRYSTAL STRUCTURE OF ANTI-HIV-1 ANTIBODY F240 FAB IN COMPLEX WITH GP41 PEPTIDE
4687, 5djyB, 0.5504, 3.28, 0.047, 207, 85, FC HETERODIMER DESIGN 20.8 Y349S/T366V/K370Y/K409V + E357D/S364Q/Y407A
4688, 5dj8B, 0.5504, 3.27, 0.047, 207, 85, FC HETERODIMER DESIGN 7.7 D399M/Y407A + T366V/K409I
4689, 4rrpI, 0.5504, 3.67, 0.080, 220, 87, CRYSTAL STRUCTURE OF THE FAB COMPLEXED WITH ANTIGEN ASF1P NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET PDR16
4690, 4lsdG, 0.5504, 3.16, 0.071, 93, 85, MYOKINE STRUCTURE
4691, 3twcH, 0.5504, 3.41, 0.070, 230, 86, CRYSTAL STRUCTURE OF BROAD AND POTENT HIV-1 NEUTRALIZING ANTIBODY PGT127 IN COMPLEX WITH MAN9
4692, 3bz4F, 0.5504, 3.11, 0.073, 209, 82, CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG DECASACCHARIDE
4693, 3b9vA, 0.5504, 3.27, 0.071, 119, 84, CRYSTAL STRUCTURE OF AN AUTONOMOUS VH DOMAIN
4694, 2ymxH, 0.5504, 3.31, 0.071, 222, 85, CRYSTAL STRUCTURE OF INHIBITORY ANTI-ACHE FAB408
4695, 2g60H, 0.5504, 3.44, 0.023, 208, 86, STRUCTURE OF ANTI-FLAG M2 FAB DOMAIN
4696, 2cjuH, 0.5504, 3.54, 0.069, 121, 87, CRYSTAL STRUCTURE OF THE TEPC15-VK45.1 ANTI-2-PHENYL-5- OXAZOLONE NQ16-113.8 SCFV IN COMPLEX WITH PHOXGABA
4697, 2ac0C, 0.5504, 3.56, 0.087, 195, 92, STRUCTURAL BASIS OF DNA RECOGNITION BY P53 TETRAMERS (COMPLEX I)
4698, 6njlL, 0.5503, 3.22, 0.048, 229, 84, STRUCTURE OF A COMPLEX 
4699, 6n4yE, 0.5503, 3.16, 0.072, 123, 83, METABOTROPIC GLUTAMATE RECEPTOR 5 EXTRACELLULAR DOMAIN WITH NB43 
4700, 6e4yH, 0.5503, 3.39, 0.095, 209, 84, ANTI-PCSK9 FAB 6E2 BOUND TO THE N-TERMINAL PEPTIDE FROM PCSK9; UNMODIFIED 
4701, 6cuf3, 0.5503, 3.25, 0.047, 116, 85, CRYO-EM STRUCTURE AT 4.2 A RESOLUTION OF VACCINE-ELICITED ANTIBODY VFP1.01 IN COMPLEX WITH HIV-1 ENV BG505 DS-SOSIP; AND ANTIBODIES VRC03 AND PGT122 
4702, 6ankA, 0.5503, 3.28, 0.103, 262, 87, SYNAPTOTAGMIN-7 C2A- AND C2B-DOMAINS
4703, 6adqZ, 0.5503, 3.91, 0.032, 216, 93, RESPIRATORY COMPLEX CIII2CIV2SOD2 FROM MYCOBACTERIUM SMEGMATIS 
4704, 6adqY, 0.5503, 3.90, 0.032, 216, 93, RESPIRATORY COMPLEX CIII2CIV2SOD2 FROM MYCOBACTERIUM SMEGMATIS 
4705, 5hyfA, 0.5503, 3.27, 0.036, 209, 84, GLYCOSYLATED KNOB-KNOB FC FRAGMENT (P6122)
4706, 5e7fC, 0.5503, 3.13, 0.095, 129, 84, COMPLEX BETWEEN LACTOCOCCAL PHAGE TUC2009 RBP HEAD DOMAIN AND A NANOBODY (L06)
4707, 4rrpR, 0.5503, 3.24, 0.072, 143, 83, CRYSTAL STRUCTURE OF THE FAB COMPLEXED WITH ANTIGEN ASF1P NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET PDR16
4708, 4kglB, 0.5503, 3.46, 0.090, 612, 89, CRYSTAL STRUCTURE OF HUMAN ALPHA-L-IDURONIDASE COMPLEX WITH [2R3R4R 5S]-2-CARBOXY-345-TRIHYDROXY-PIPERIDINE
4709, 4j2qA, 0.5503, 3.68, 0.074, 340, 94, CRYSTAL STRUCTURE OF C-TERMINALLY TRUNCATED ARRESTIN REVEALS MECHANISM OF ARRESTIN ACTIVATION
4710, 4d2nC, 0.5503, 3.24, 0.036, 205, 84, CRYSTAL STRUCTURE OF DEGLYCOSYLATED SERUM-DERIVED HUMAN IGG4 FC
4711, 3o0rH, 0.5503, 3.52, 0.012, 225, 86, CRYSTAL STRUCTURE OF NITRIC OXIDE REDUCTASE FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH ANTIBODY FRAGMENT
4712, 3mxwH, 0.5503, 3.30, 0.094, 220, 85, CRYSTAL STRUCTURE SONIC HEDGEHOG BOUND TO THE 5E1 FAB FRAGMENT
4713, 3l7fB, 0.5503, 3.48, 0.070, 220, 86, STRUCTURE OF IL-13 ANTIBODY H2L6 A HUMANIZED VARIANT OF C836
4714, 3j3oH, 0.5503, 3.57, 0.057, 220, 88, CONFORMATIONAL SHIFT OF A MAJOR POLIOVIRUS ANTIGEN CONFIRMED BY IMMUNO-CRYOGENIC ELECTRON MICROSCOPY: 160S POLIOVIRUS AND C3-FAB COMPLEX
4715, 3gzqB, 0.5503, 3.31, 0.057, 124, 87, HUMAN SOD1 A4V METAL-FREE VARIANT
4716, 2aqsA, 0.5503, 3.54, 0.078, 160, 90, CU/ZN SUPEROXIDE DISMUTASE FROM NEISSERIA MENINGITIDIS K91E K94E DOUBLE MUTANT
4717, 1m7xC, 0.5503, 3.04, 0.063, 578, 79, THE X-RAY CRYSTALLOGRAPHIC STRUCTURE OF BRANCHING ENZYME
4718, 1dqtD, 0.5503, 3.30, 0.068, 117, 88, THE CRYSTAL STRUCTURE OF MURINE CTLA4 (CD152)
4719, 6chbD, 0.5502, 3.19, 0.035, 125, 85, CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND IOMA 
4720, 5wnbH, 0.5502, 3.42, 0.047, 226, 86, STRUCTURE OF ANTIBODY 3D3 BOUND TO THE LINEAR EPITOPE OF RSV G
4721, 5ubyH, 0.5502, 3.51, 0.103, 228, 87, FAB STRUCTURE OF ANTI-HIV-1 GP120 MAB 1A8
4722, 5tljH, 0.5502, 3.47, 0.082, 217, 85, COMPLEX BETWEEN HUMAN CD27 AND FAB FRAGMENTS OF ANTIBODIES M2177 AND M2191
4723, 5h3vB, 0.5502, 3.12, 0.072, 103, 83, CRYSTAL STRUCTURE OF A TYPE IV SECRETION SYSTEM COMPONENT CAGX IN HELICOBACTER PYLORI
4724, 5drzH, 0.5502, 3.27, 0.071, 227, 84, CRYSTAL STRUCTURE OF ANTI-HIV-1 ANTIBODY F240 FAB IN COMPLEX WITH GP41 PEPTIDE
4725, 4xc3H, 0.5502, 3.58, 0.080, 220, 88, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH ITS PEPTIDE EPITOPE ON HIV-1 GP41; CRYSTALS CRYOPROTECTED WITH RAC-GLYCEROL 1- PHOSPHATE
4726, 4xbgJ, 0.5502, 3.62, 0.080, 217, 88, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION
4727, 4gw1D, 0.5502, 3.68, 0.068, 220, 88, CQFD MEDITOPE
4728, 4gayH, 0.5502, 3.11, 0.059, 212, 85, STRUCTURE OF THE BROADLY NEUTRALIZING ANTIBODY AP33
4729, 4at6B, 0.5502, 3.25, 0.057, 212, 87, FAB FRAGMENT OF ANTIPORPHYRIN ANTIBODY 14H7
4730, 3j93H, 0.5502, 3.43, 0.081, 220, 86, FITTING OF FAB INTO THE CRYOEM DENSITY MAP OF EV71 PROCAPSID IN COMPLEX WITH FAB22A12
4731, 3j3zH, 0.5502, 3.43, 0.081, 220, 86, STRUCTURE OF MA28-7 NEUTRALIZING ANTIBODY FAB FRAGMENT FROM ELECTRON CRYO-MICROSCOPY OF ENTEROVIRUS 71 COMPLEXED WITH A FAB FRAGMENT
4732, 3gk8H, 0.5502, 3.43, 0.081, 220, 86, X-RAY CRYSTAL STRUCTURE OF THE FAB FROM MAB 14 MOUSE ANTIBODY AGAINST CANINE PARVOVIRUS
4733, 3gi9H, 0.5502, 3.38, 0.047, 217, 86, CRYSTAL STRUCTURE OF APCT TRANSPORTER BOUND TO 7F11 MONOCLONAL FAB FRAGMENT
4734, 3c6sD, 0.5502, 3.42, 0.083, 209, 84, CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG PENTADECASACCHARIDE
4735, 2ybgC, 0.5502, 3.54, 0.087, 193, 92, STRUCTURE OF LYS120-ACETYLATED P53 CORE DOMAIN
4736, 2dytA, 0.5502, 3.33, 0.036, 213, 83, THE CRYSTAL STRUCTURE OF SACCHAROMYCES CEREVISIAE ATG3
4737, 2ahiC, 0.5502, 3.57, 0.087, 193, 92, STRUCTURAL BASIS OF DNA RECOGNITION BY P53 TETRAMERS (COMPLEX III)
4738, 1wejH, 0.5502, 3.59, 0.068, 223, 88, IGG1 FAB FRAGMENT (OF E8 ANTIBODY) COMPLEXED WITH HORSE CYTOCHROME C AT 1.8 A RESOLUTION
4739, 1m7xA, 0.5502, 3.11, 0.062, 587, 80, THE X-RAY CRYSTALLOGRAPHIC STRUCTURE OF BRANCHING ENZYME
4740, 1bvlC, 0.5502, 3.38, 0.059, 116, 85, HUMANIZED ANTI-LYSOZYME FV
4741, 6ol7I, 0.5501, 3.63, 0.045, 126, 89, CRYSTAL STRUCTURE OF GLVRC01 SCFV IN COMPLEX WITH ANTI-IDIOTYPE IV8 SCFV 
4742, 5wcaH, 0.5501, 3.37, 0.094, 226, 85, CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING INFLUENZA A ANTIBODY VRC 315 27-1C08 FAB.
4743, 5u3lA, 0.5501, 3.58, 0.070, 224, 86, CRYSTAL STRUCTURE OF DH511.2 FAB IN COMPLEX WITH HIV-1 GP41 MPER 670- 683 PEPTIDE
4744, 5t1kD, 0.5501, 3.67, 0.068, 215, 88, CETUXIMAB FAB IN COMPLEX WITH CQFDA(PH)2STRRLKC
4745, 5mu2G, 0.5501, 3.48, 0.095, 211, 84, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
4746, 4yjzL, 0.5501, 3.61, 0.080, 234, 88, HUMAN ANTIBODY H2526 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 SOLOMON ISLANDS/03/2006
4747, 4xwoD, 0.5501, 3.13, 0.083, 216, 84, STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF SEC22
4748, 4nqsH, 0.5501, 3.32, 0.047, 207, 85, KNOB-INTO-HOLE IGG FC
4749, 4ki5E, 0.5501, 3.17, 0.023, 224, 86, CYSTAL STRUCTURE OF HUMAN FACTOR VIII C2 DOMAIN IN A TERNARY COMPLEX WITH MURINE INHBITORY ANTIBODIES 3E6 AND G99
4750, 4k3hA, 0.5501, 3.22, 0.069, 109, 87, IMMUNOGLOBULIN LAMBDA VARIABLE DOMAIN L5(L89S) FLUOROGEN ACTIVATIONG PROTEIN IN COMPLEX WITH MALACHITE GREEN
4751, 3zkmH, 0.5501, 3.27, 0.035, 215, 85, BACE2 FAB COMPLEX
4752, 3wfcH, 0.5501, 3.53, 0.012, 225, 86, REDUCED AND CARBONMONOXIDE-BOUND CYTOCHROME C-DEPENDENT NITRIC OXIDE REDUCTASE (CNOR) FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH ANTIBODY FRAGMENT
4753, 3iy0H, 0.5501, 3.46, 0.070, 120, 86, VARIABLE DOMAINS OF THE X-RAY STRUCTURE OF FAB 14 FITTED INTO THE CRYOEM RECONSTRUCTION OF THE VIRUS-FAB 14 COMPLEX
4754, 2ywzA, 0.5501, 3.36, 0.116, 111, 86, STRUCTURE OF NEW ANTIGEN RECEPTOR VARIABLE DOMAIN FROM SHARKS
4755, 2vr7F, 0.5501, 3.70, 0.055, 153, 91, CRYSTAL STRUCTURE OF G85R ALS MUTANT OF HUMAN CUZN SUPEROXIDE DISMUTASE (CUZNSOD) AT 1.58 A RESOLUTION
4756, 2r27B, 0.5501, 3.43, 0.057, 134, 88, CONSTITUTIVELY ZINC-DEFICIENT MUTANT OF HUMAN SUPEROXIDE DISMUTASE (SOD) C6A H80S H83S C111S
4757, 2j6eA, 0.5501, 3.26, 0.047, 209, 85, CRYSTAL STRUCTURE OF AN AUTOIMMUNE COMPLEX BETWEEN A HUMAN IGM RHEUMATOID FACTOR AND IGG1 FC REVEALS A NOVEL FC EPITOPE AND EVIDENCE FOR AFFINITY MATURATION
4758, 2gsiD, 0.5501, 3.49, 0.080, 215, 87, CRYSTAL STRUCTURE OF A MURINE FAB IN COMPLEX WITH AN 11 RESIDUE PEPTIDE DERIVED FROM STAPHYLOCOCCAL NUCLEASE
4759, 1tzgH, 0.5501, 3.61, 0.080, 232, 88, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A 13-RESIDUE PEPTIDE CONTAINING THE 4E10 EPITOPE ON GP41
4760, 1mcjB, 0.5501, 3.19, 0.059, 216, 85, PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
4761, 1kmtB, 0.5501, 4.21, 0.074, 138, 95, CRYSTAL STRUCTURE OF RHOGDI GLU(154155)ALA MUTANT
4762, 6mh2D, 0.5500, 3.38, 0.119, 202, 84, STRUCTURE OF HERCEPTIN FAB WITHOUT ANTIGEN 
4763, 6ff9C, 0.5500, 3.55, 0.087, 193, 92, MUTANT R280K OF HUMAN P53 
4764, 6e3lI, 0.5500, 3.34, 0.102, 213, 88, INTERFERON GAMMA SIGNALLING COMPLEX WITH IFNGR1 AND IFNGR2 
4765, 5uslB, 0.5500, 3.36, 0.081, 211, 86, STRUCTURE OF VACCINIA VIRUS D8 PROTEIN BOUND TO HUMAN FAB VV304
4766, 5u3oH, 0.5500, 3.55, 0.058, 235, 86, CRYSTAL STRUCTURE OF DH511.2_K3 FAB IN COMPLEX WITH HIV-1 GP41 MPER PEPTIDE
4767, 5mv4L, 0.5500, 3.50, 0.095, 216, 84, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
4768, 5ijdD, 0.5500, 4.36, 0.050, 137, 100, THE CRYSTAL STRUCTURE OF MOUSE TLR4/MD-2/LIPID A COMPLEX
4769, 5ihbD, 0.5500, 2.67, 0.114, 209, 79, STRUCTURE OF THE IMMUNE RECEPTOR CD33
4770, 5hysK, 0.5500, 3.27, 0.035, 213, 86, STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB
4771, 5djaB, 0.5500, 3.26, 0.047, 207, 85, FC HETERODIMER DESIGN 9.1 Y407M + T366I
4772, 5b6fB, 0.5500, 3.30, 0.106, 211, 85, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF AN ANTI-LEUKOTRIENE C4 MONOCLONAL ANTIBODY COMPLEXED WITH LTC4
4773, 4ttgA, 0.5500, 3.85, 0.085, 1014, 94, BETA-GALACTOSIDASE (E. COLI) IN THE PRESENCE OF POTASSIUM CHLORIDE.
4774, 4krmH, 0.5500, 3.46, 0.093, 124, 86, NANOBODY/VHH DOMAIN 7D12 IN COMPLEX WITH DOMAIN III OF THE EXTRACELLULAR REGION OF EGFR PH 3.5
4775, 4hiiD, 0.5500, 3.17, 0.072, 203, 83, ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102 WITH BOUND RHAMNOSE- GALACTOSE
4776, 4cvwA, 0.5500, 3.03, 0.075, 874, 80, STRUCTURE OF THE BARLEY LIMIT DEXTRINASE-LIMIT DEXTRINASE INHIBITOR COMPLEX
4777, 3vdcA, 0.5500, 3.84, 0.084, 1015, 95, E. COLI (LACZ) BETA-GALACTOSIDASE (N460T) IN COMPLEX WITH IPTG
4778, 3cqpB, 0.5500, 3.44, 0.068, 151, 88, HUMAN SOD1 G85R VARIANT STRUCTURE I
4779, 2vl5C, 0.5500, 3.33, 0.070, 218, 86, STRUCTURE OF ANTI-COLLAGEN TYPE II FAB CIIC1
4780, 2sodB, 0.5500, 3.33, 0.046, 151, 87, DETERMINATION AND ANALYSIS OF THE 2 ANGSTROM STRUCTURE OF COPPER ZINC SUPEROXIDE DISMUTASE
4781, 2oxhD, 0.5500, 3.01, 0.098, 109, 82, THE SOXYZ COMPLEX OF PARACOCCUS PANTOTROPHUS
4782, 2ec9U, 0.5500, 3.17, 0.048, 116, 84, CRYSTAL STRUCTURE ANALYSIS OF HUMAN FACTOR VIIA  SOULUBLE TISSUE FACTOR COMPLEXED WITH BCX-3607
4783, 2bfvL, 0.5500, 3.21, 0.036, 112, 84, MONOCLONAL ANTIBODY FRAGMENT FV4155 FROM E. COLI
4784, 1v7mI, 0.5500, 3.45, 0.094, 217, 85, HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB
4785, 1fptH, 0.5500, 3.56, 0.045, 220, 88, THREE-DIMENSIONAL STRUCTURE OF THE COMPLEX BETWEEN THE FAB FRAGMENT OF AN NEUTRALIZING ANTIBODY FOR TYPE 1 POLIOVIRUS AND ITS VIRAL EPITOPE
4786, 1bfvH, 0.5500, 3.57, 0.046, 119, 87, MONOCLONAL ANTIBODY FRAGMENT FV4155 FROM E. COLI
4787, 6ii8H, 0.5499, 3.46, 0.082, 217, 85, CRYSTAL STRUCTURE OF H7 HEMAGGLUTININ FROM A/ANHUI/1/2013 IN COMPLEX WITH A HUMAN NEUTRALIZING ANTIBODY L4B-18 
4788, 6fg1H, 0.5499, 3.49, 0.091, 218, 88, CRYSTAL STRUCTURE OF FAB OF NATALIZUMAB IN COMPLEX WITH FAB OF NAA32. 
4789, 6e63C, 0.5499, 3.19, 0.082, 212, 85, CRYSTAL STRUCTURE OF MALARIA TRANSMISSION-BLOCKING ANTIGEN PFS48/45 6C IN COMPLEX WITH ANTIBODY TB31F 
4790, 6dc4H, 0.5499, 3.34, 0.081, 222, 86, RSV-NEUTRALIZING HUMAN ANTIBODY AM22 
4791, 5t80H, 0.5499, 3.62, 0.093, 232, 86, CRYSTAL STRUCTURE OF 10E8 FAB IN COMPLEX WITH THE MPER EPITOPE SCAFFOLD T117V2 AND PHOSPHATIDIC ACID (06:0 PA)
4792, 5mu0G, 0.5499, 3.40, 0.107, 215, 84, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
4793, 5ktz7, 0.5499, 3.39, 0.082, 123, 85, EXPANDED POLIOVIRUS IN COMPLEX WITH VHH 12B
4794, 5k64A, 0.5499, 3.28, 0.047, 213, 85, CRYSTAL STRUCTURE OF VEGF BINDING IGG1-FC (FCAB 448)
4795, 5k33A, 0.5499, 3.26, 0.047, 213, 85, CRYSTAL STRUCTURE OF EXTRACELLULAR DOMAIN OF HER2 IN COMPLEX WITH FCAB STAB19
4796, 5j1tC, 0.5499, 3.35, 0.106, 121, 85, TORSINADELTAE-LULL1 COMPLEX H. SAPIENS BOUND TO VHH-BS2
4797, 5imlB, 0.5499, 3.51, 0.093, 125, 86, NANOBODY TARGETING HUMAN VSIG4 IN SPACEGROUP P212121
4798, 5hguA, 0.5499, 3.43, 0.088, 193, 91, CRYSTAL STRUCTURE OF HUMAN TRANSCRIPTION FACTOR TEAD2 IN COMPLEX WITH PALMITATE
4799, 5c7xM, 0.5499, 3.39, 0.095, 213, 84, CRYSTAL STRUCTURE OF MOR04357 A NEUTRALIZING ANTI-HUMAN GM-CSF ANTIBODY FAB FRAGMENT IN COMPLEX WITH HUMAN GM-CSF
4800, 4pd4J, 0.5499, 3.60, 0.045, 127, 88, STRUCTURAL ANALYSIS OF ATOVAQUONE-INHIBITED CYTOCHROME BC1 COMPLEX REVEALS THE MOLECULAR BASIS OF ANTIMALARIAL DRUG ACTION
4801, 4ibyB, 0.5499, 3.52, 0.087, 196, 92, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R273H AND SECOND-SITE SUPPRESSOR MUTATION S240R
4802, 3zmeB, 0.5499, 3.68, 0.086, 197, 93, STRUCTURE OF THE P53 CORE DOMAIN MUTANT Y220C BOUND TO THE SMALL MOLECULE PHIKAN7242
4803, 3u9pH, 0.5499, 3.31, 0.071, 184, 85, CRYSTAL STRUCTURE OF MURINE SIDEROCALIN IN COMPLEX WITH AN FAB FRAGMENT
4804, 3mndB, 0.5499, 3.74, 0.032, 152, 93, CRYSTALLOGRAPHIC ANALYSIS OF THE CYSTOSOLIC CU/ZN SUPEROXIDE DISMUTASE FROM TAENIA SOLIUM
4805, 2oxgF, 0.5499, 3.02, 0.098, 112, 82, THE SOXYZ COMPLEX OF PARACOCCUS PANTOTROPHUS
4806, 2dqeH, 0.5499, 3.05, 0.072, 114, 83, CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT (HY53A) COMPLEXED WITH HEN EGG LYSOZYME
4807, 2aeoB, 0.5499, 3.71, 0.055, 151, 91, CRYSTAL STRUCTURE OF CISPLATINATED BOVINE CUZN SUPEROXIDE DISMUTASE
4808, 1ru9H, 0.5499, 3.30, 0.093, 221, 86, CRYSTAL STRUCTURE (A) OF U.V.-IRRADIATED CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 4.6 WITH A DATA SET COLLECTED IN-HOUSE.
4809, 1oztH, 0.5499, 3.56, 0.067, 135, 89, CRYSTAL STRUCTURE OF APO-H46R FAMILIAL ALS MUTANT HUMAN CU ZN SUPEROXIDE DISMUTASE (CUZNSOD) TO 2.5A RESOLUTION
4810, 1nmcH, 0.5499, 3.54, 0.034, 122, 87, COMPLEX BETWEEN NC10 ANTI-INFLUENZA VIRUS NEURAMINIDASE SINGLE CHAIN ANTIBODY WITH A 15 RESIDUE LINKER AND INFLUENZA VIRUS NEURAMINIDASE
4811, 1nmcB, 0.5499, 3.54, 0.034, 122, 87, COMPLEX BETWEEN NC10 ANTI-INFLUENZA VIRUS NEURAMINIDASE SINGLE CHAIN ANTIBODY WITH A 15 RESIDUE LINKER AND INFLUENZA VIRUS NEURAMINIDASE
4812, 1g4mB, 0.5499, 3.81, 0.062, 357, 96, CRYSTAL STRUCTURE OF BOVINE BETA-ARRESTIN 1
4813, 6r7tA, 0.5498, 3.49, 0.081, 123, 86, CRYSTAL STRUCTURE OF HUMAN MELANOMA-ASSOCIATED ANTIGEN B1 (MAGEB1) IN COMPLEX WITH NANOBODY 
4814, 6qtlE, 0.5498, 3.47, 0.138, 118, 87, CAFFEINE RECOGNIZING NANOBODY 
4815, 6gjuB, 0.5498, 3.45, 0.069, 118, 87, HUMAN NBD1 OF CFTR IN COMPLEX WITH NANOBODIES T2A AND T4 
4816, 6cufH, 0.5498, 3.25, 0.047, 116, 85, CRYO-EM STRUCTURE AT 4.2 A RESOLUTION OF VACCINE-ELICITED ANTIBODY VFP1.01 IN COMPLEX WITH HIV-1 ENV BG505 DS-SOSIP; AND ANTIBODIES VRC03 AND PGT122 
4817, 5xbmB, 0.5498, 3.64, 0.080, 221, 87, STRUCTURE OF SCARB2-JL2 COMPLEX 
4818, 5w23I, 0.5498, 3.35, 0.071, 219, 85, CRYSTAL STRUCTURE OF RSV F IN COMPLEX WITH 5C4 FAB
4819, 5tdoD, 0.5498, 3.21, 0.071, 213, 85, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-HER2 ANTIBODY 4D5 WITH REDESIGNED HEAVY AND LIGHT CHAIN INTERFACES
4820, 5n2kP, 0.5498, 3.37, 0.071, 207, 85, STRUCTURE OF UNBOUND BRIAKINUMAB FAB
4821, 5dj0B, 0.5498, 3.28, 0.047, 207, 85, FC HETERODIMER DESIGN 11.2 Y349S/K370Y + E357D/S364Q
4822, 4xcyF, 0.5498, 3.08, 0.036, 214, 84, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDYLGLYCEROL (06:0 PG)
4823, 4tw1I, 0.5498, 3.77, 0.043, 290, 92, CRYSTAL STRUCTURE OF THE OCTAMERIC PORE COMPLEX OF THE STAPHYLOCOCCUS AUREUS BI-COMPONENT TOXIN LUKGH
4824, 4lmqH, 0.5498, 3.64, 0.115, 220, 87, DEVELOPMENT AND PRECLINICAL CHARACTERIZATION OF A HUMANIZED ANTIBODY TARGETING CXCL12
4825, 4l05A, 0.5498, 3.47, 0.068, 154, 88, CU/ZN SUPEROXIDE DISMUTASE FROM BRUCELLA ABORTUS
4826, 3w5nA, 0.5498, 3.58, 0.067, 1029, 89, CRYSTAL STRUCTURE OF STREPTOMYCES AVERMITILIS ALPHA-L-RHAMNOSIDASE COMPLEXED WITH L-RHAMNOSE
4827, 3w5mA, 0.5498, 3.56, 0.067, 1030, 89, CRYSTAL STRUCTURE OF STREPTOMYCES AVERMITILIS ALPHA-L-RHAMNOSIDASE
4828, 3j3pH, 0.5498, 3.55, 0.045, 220, 88, CONFORMATIONAL SHIFT OF A MAJOR POLIOVIRUS ANTIGEN CONFIRMED BY IMMUNO-CRYOGENIC ELECTRON MICROSCOPY: 135S POLIOVIRUS AND C3-FAB COMPLEX
4829, 3d0aC, 0.5498, 3.56, 0.087, 193, 92, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R249S AND SECOND SITE SUPPRESSOR MUTATION H168R IN SEQUENCE-SPECIFIC COMPLEX WITH DNA
4830, 2jhtD, 0.5498, 4.20, 0.063, 138, 95, CRYSTAL STRUCTURE OF RHOGDI K135TK138TK141T MUTANT
4831, 2jb6A, 0.5498, 3.24, 0.083, 211, 84, FAB FRAGMENT IN COMPLEX WITH SMALL MOLECULE HAPTEN CRYSTAL FORM-2
4832, 2aeqH, 0.5498, 3.19, 0.108, 116, 83, AN EPIDEMIOLOGICALLY SIGNIFICANT EPITOPE OF A 1998 INFLUENZA VIRUS NEURAMINIDASE FORMS A HIGHLY HYDRATED INTERFACE IN THE NA-ANTIBODY COMPLEX.
4833, 6n5dE, 0.5497, 3.22, 0.082, 222, 85, BROADLY PROTECTIVE ANTIBODIES DIRECTED TO A SUBDOMINANT INFLUENZA HEMAGGLUTININ EPITOPE 
4834, 6hugG, 0.5497, 3.36, 0.094, 121, 85, CRYOEM STRUCTURE OF HUMAN FULL-LENGTH ALPHA1BETA3GAMMA2L GABA(A)R IN COMPLEX WITH PICROTOXIN AND MEGABODY MB38. 
4835, 6go1A, 0.5497, 3.24, 0.070, 318, 86, CRYSTAL STRUCTURE OF A BACILLUS ANTHRACIS PEPTIDOGLYCAN DEACETYLASE 
4836, 6folC, 0.5497, 3.78, 0.065, 153, 92, DOMAIN II OF THE HUMAN COPPER CHAPERONE IN COMPLEX WITH HUMAN CU;ZN SUPEROXIDE DISMUTASE 
4837, 6fhnA, 0.5497, 3.28, 0.071, 978, 85, STRUCTURAL DYNAMICS AND CATALYTIC PROPERTIES OF A MULTI-MODULAR XANTHANASE (PT DERIVATIVE) 
4838, 6e0cM, 0.5497, 3.47, 0.034, 229, 87, CRYO-EM STRUCTURE OF THE CENP-A NUCLEOSOME (W601) IN COMPLEX WITH A SINGLE CHAIN ANTIBODY FRAGMENT 
4839, 6d0nD, 0.5497, 2.74, 0.099, 88, 81, CRYSTAL STRUCTURE OF A CLC-TYPE FLUORIDE/PROTON ANTIPORTER; V319G MUTANT 
4840, 5vxlB, 0.5497, 3.43, 0.070, 116, 86, 2.80 A RESOLUTION STRUCTURE OF IPAD FROM SHIGELLA FLEXNERI IN COMPLEX WITH SINGLE-DOMAIN ANTIBODY JPS-G3
4841, 5lwfD, 0.5497, 3.38, 0.108, 118, 83, STRUCTURE OF A SINGLE DOMAIN CAMELID ANTIBODY FRAGMENT CAB-G10S IN COMPLEX WITH THE BLAP BETA-LACTAMASE FROM BACILLUS LICHENIFORMIS
4842, 4mcmF, 0.5497, 3.71, 0.033, 153, 92, HUMAN SOD1 C57S MUTANT AS-ISOLATED
4843, 4iycA, 0.5497, 3.99, 0.043, 277, 94, STRUCTURE OF THE T244A MUTANT OF THE PANTON-VALENTINE LEUCOCIDIN COMPONENT FROM STAPHYLOCOCCUS AUREUS
4844, 4ffyH, 0.5497, 3.56, 0.034, 119, 87, CRYSTAL STRUCTURE OF DENV1-E111 SINGLE CHAIN VARIABLE FRAGMENT BOUND TO DENV-1 DIII STRAIN 16007.
4845, 4d2nA, 0.5497, 3.15, 0.024, 208, 83, CRYSTAL STRUCTURE OF DEGLYCOSYLATED SERUM-DERIVED HUMAN IGG4 FC
4846, 3w2dH, 0.5497, 3.21, 0.047, 223, 85, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL EENTEROTOXIN B IN COMPLEX WITH A NOVEL NEUTRALIZATION MONOCLONAL ANTIBODY FAB FRAGMENT
4847, 2nbpA, 0.5497, 3.22, 0.140, 127, 86, SOLUTION STRUCTURE OF THE T119M VARIANT OF TRANSTHYRETIN IN ITS MONOMERIC STATE
4848, 2fh8A, 0.5497, 3.08, 0.085, 922, 82, CRYSTAL STRUCTURE ANALYSIS OF KLEBSIELLA PNEUMONIAE PULLULANASE COMPLEXED WITH ISOMALTOSE
4849, 2fgwH, 0.5497, 3.53, 0.118, 220, 85, X-RAY STRUCTURES OF FRAGMENTS FROM BINDING AND NONBINDING VERSIONS OF A HUMANIZED ANTI-CD18 ANTIBODY: STRUCTURAL INDICATIONS OF THE KEY ROLE OF VH RESIDUES 59 TO 65
4850, 2ajxH, 0.5497, 3.23, 0.047, 219, 85, CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB  IN COMPLEX WITH TRANSITION STATE ANALOG
4851, 1ozuB, 0.5497, 3.55, 0.067, 126, 89, CRYSTAL STRUCTURE OF FAMILIAL ALS MUTANT S134N OF HUMAN CU ZN SUPEROXIDE DISMUTASE (CUZNSOD) TO 1.3A RESOLUTION
4852, 1oqxB, 0.5497, 3.26, 0.047, 209, 85, G-2 GLYCOVARIANT OF HUMAN IGG FC BOUND TO MINIMIZED VERSION OF PROTEIN A CALLED Z34C
4853, 1jv5B, 0.5497, 3.15, 0.048, 117, 84, ANTI-BLOOD GROUP A FV
4854, 1b7aA, 0.5497, 3.63, 0.064, 186, 94, STRUCTURE OF THE PHOSPHATIDYLETHANOLAMINE-BINDING PROTEIN FROM BOVINE BRAIN
4855, 6j5gH, 0.5496, 3.35, 0.047, 120, 85, COMPLEX STRUCTURE OF MAB 4.2-SCFV WITH TICK-BORNE ENCEPHALITIS VIRUS ENVELOPE PROTEIN 
4856, 6e3lE, 0.5496, 3.34, 0.114, 213, 88, INTERFERON GAMMA SIGNALLING COMPLEX WITH IFNGR1 AND IFNGR2 
4857, 6apdD, 0.5496, 3.30, 0.081, 221, 86, CRYSTAL STRUCTURE OF RSV F BOUND BY AM22 AND THE INFANT ANTIBODY ADI- 19425
4858, 5u65A, 0.5496, 3.54, 0.080, 127, 87, CAMEL NANOBODY VHH-5
4859, 5es4C, 0.5496, 4.00, 0.077, 884, 91, RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION
4860, 4ygaF, 0.5496, 3.61, 0.163, 123, 86, CDPK1 FROM TOXOPLASMA GONDII BOUND TO INHIBITORY VHH-1B7
4861, 4qnpE, 0.5496, 3.74, 0.045, 224, 88, CRYSTAL STRUCTURE OF THE 2009 PANDEMIC H1N1 INFLUENZA VIRUS NEURAMINIDASE WITH A NEUTRALIZING ANTIBODY
4862, 4ibsB, 0.5496, 3.53, 0.087, 194, 92, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R273H (FORM I)
4863, 4f9pB, 0.5496, 3.33, 0.057, 208, 87, CRYSTAL STRUCTURE OF THE HUMAN BTN3A1 ECTODOMAIN IN COMPLEX WITH THE 103.2 SINGLE CHAIN ANTIBODY
4864, 3zknH, 0.5496, 3.28, 0.035, 215, 85, BACE2 FAB INHIBITOR COMPLEX
4865, 3ha0D, 0.5496, 3.12, 0.024, 209, 84, CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS
4866, 2x0vB, 0.5496, 3.57, 0.087, 195, 92, STRUCTURE OF THE P53 CORE DOMAIN MUTANT Y220C BOUND TO 4-( TRIFLUOROMETHYL)BENZENE-12-DIAMINE
4867, 2ok0H, 0.5496, 3.53, 0.068, 216, 88, FAB ED10-DNA COMPLEX
4868, 2eebA, 0.5496, 3.08, 0.137, 106, 80, SOLUTION STRUCTURE OF THE 22TH FILAMIN DOMAIN FROM HUMAN FILAMIN-B
4869, 1bvlA, 0.5496, 3.50, 0.069, 116, 87, HUMANIZED ANTI-LYSOZYME FV
4870, 6onbA, 0.5495, 3.41, 0.112, 116, 89, CRYSTAL STRUCTURE OF THE ZIG-8-RIG-5 IG1-IG1 HETERODIMER; MONOCLINIC FORM 
4871, 6cueH, 0.5495, 3.32, 0.047, 117, 86, CRYO-EM STRUCTURE AT 4.0 A RESOLUTION OF VACCINE-ELICITED ANTIBODY VFP7.04 IN COMPLEX WITH HIV-1 ENV BG505 DS-SOSIP; AND ANTIBODIES VRC03 AND PGT122 
4872, 6ck9D, 0.5495, 3.43, 0.023, 128, 86, CRYSTAL STRUCTURE OF HIV-1 CONC_BASE0 PREFUSION ENV TRIMER IN COMPLEX WITH HUMAN ANTIBODY FRAGMENT 3H109L AND 35O22 VARIANTS AT 3.5 ANGSTROM 
4873, 5xtzB, 0.5495, 3.12, 0.108, 132, 83, CRYSTAL STRUCTURE OF GAS41 YEATS BOUND TO H3K27AC PEPTIDE 
4874, 5wb9H, 0.5495, 3.62, 0.068, 220, 88, CRYSTAL STRUCTURE OF CD4 BINDING SITE ANTIBODY N60P23 IN COMPLEX WITH HIV-1 CLADE A/E STRAIN 93TH057 GP120 CORE 
4875, 5jp2A, 0.5495, 4.07, 0.113, 272, 97, FCHO1 MU HOMOLOGY DOMAIN (DANIO RERIO) WITH BOUND EPS15 PEPTIDE
4876, 5ek5A, 0.5495, 3.45, 0.067, 118, 89, STRUCTURAL CHARACTERIZATION OF IRMA FROM ESCHERICHIA COLI
4877, 5e6zC, 0.5495, 3.06, 0.063, 582, 79, CRYSTAL STRUCTURE OF ECOLI BRANCHING ENZYME WITH BETA CYCLODEXTRIN
4878, 5dj6B, 0.5495, 3.30, 0.047, 207, 85, FC HETERODIMER DESIGN 6.1 F405W/Y407A + T366M
4879, 5c7xH, 0.5495, 3.37, 0.095, 214, 84, CRYSTAL STRUCTURE OF MOR04357 A NEUTRALIZING ANTI-HUMAN GM-CSF ANTIBODY FAB FRAGMENT IN COMPLEX WITH HUMAN GM-CSF
4880, 4nkdG, 0.5495, 3.12, 0.047, 121, 85, CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT
4881, 4kvpC, 0.5495, 3.54, 0.076, 195, 92, HUMAN P53 CORE DOMAIN MUTANT V157F
4882, 4hljA, 0.5495, 3.55, 0.146, 223, 89, AXON GUIDANCE RECEPTOR
4883, 4fqkH, 0.5495, 3.67, 0.069, 221, 87, INFLUENZA B/BRISBANE/60/2008 HEMAGGLUTININ FAB CR8059 COMPLEX
4884, 4fqkE, 0.5495, 3.67, 0.069, 220, 87, INFLUENZA B/BRISBANE/60/2008 HEMAGGLUTININ FAB CR8059 COMPLEX
4885, 3wn5D, 0.5495, 3.32, 0.047, 212, 85, CRYSTAL STRUCTURE OF ASYMMETRICALLY ENGINEERED FC VARIANT IN COMPLEX WITH FCGRIIIA
4886, 3fawA, 0.5495, 3.18, 0.096, 775, 83, CRYSTAL STRUCTURE OF THE GROUP B STREPTOCOCCUS PULLULANASE SAP
4887, 2oxhY, 0.5495, 3.03, 0.098, 110, 82, THE SOXYZ COMPLEX OF PARACOCCUS PANTOTROPHUS
4888, 1zq7A, 0.5495, 3.58, 0.071, 197, 84, X-RAY CRYSTAL STRUCTURE OF PROTEIN Q8PZK8 FROM METHANOSARCINA MAZEI. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET MAR9.
4889, 6iekC, 0.5494, 3.31, 0.047, 218, 86, STRUCTURE OF RVFV GN AND HUMAN MONOCLONAL ANTIBODY R12 
4890, 6hujG, 0.5494, 3.38, 0.094, 121, 85, CRYOEM STRUCTURE OF HUMAN FULL-LENGTH HETEROMERIC ALPHA1BETA3GAMMA2L GABA(A)R IN COMPLEX WITH PICROTOXIN; GABA AND MEGABODY MB38. 
4891, 6dc7I, 0.5494, 3.56, 0.034, 211, 88, APO FAB STRUCTURE OF MOUSE MONOCLONAL ANTIBODY 8B2 
4892, 6cnjH, 0.5494, 3.06, 0.060, 218, 84, STRUCTURE OF THE 2ALPHA3BETA STIOCHIOMETRY OF THE HUMAN ALPHA4BETA2 NICOTINIC RECEPTOR 
4893, 6cjcA, 0.5494, 3.25, 0.047, 207, 85, CRYSTAL STRUCTURE OF A FC FRAGMENT LALA MUTANT (L234A; L235A) OF HUMAN IGG1 (CRYSTAL FORM 3) 
4894, 6ca6B, 0.5494, 3.45, 0.057, 226, 87, CRYSTAL STRUCTURE OF PCT64_35S; A BROADLY NEUTRALIZING ANTI-HIV ANTIBODY. 
4895, 6a79I, 0.5494, 3.63, 0.046, 122, 87, CRYSTAL STRUCTURE OF THE FIFTH IMMUNOGLOBULIN DOMAIN (IG5) OF HUMAN ROBO1 IN COMPLEX WITH THE MUTANT SCFV FRAGMENT (P103A) OF MURINE MONOCLONAL ANTIBODY B5209B 
4896, 5o9zC, 0.5494, 3.23, 0.116, 1693, 86, CRYO-EM STRUCTURE OF A PRE-CATALYTIC HUMAN SPLICEOSOME PRIMED FOR ACTIVATION (B COMPLEX)
4897, 4m8qA, 0.5494, 3.52, 0.069, 125, 87, ONTOGENY OF RECOGNITION SPECIFICITY AND FUNCTIONALITY FOR THE ANTI-HIV NEUTRALIZING ANTIBODY 4E10
4898, 4jg9A, 0.5494, 3.69, 0.077, 135, 91, X-RAY CRYSTAL STRUCTURE OF A PUTATIVE LIPOPROTEIN FROM BACILLUS ANTHRACIS
4899, 3wiiH, 0.5494, 3.52, 0.081, 220, 86, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF B2212A A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1.
4900, 3re0C, 0.5494, 3.45, 0.057, 126, 88, CRYSTAL STRUCTURE OF HUMAN APO CUZN SUPEROXIDE DISMUTASE (SOD1) COMPLEXED WITH CISPLATIN
4901, 3qxvB, 0.5494, 3.36, 0.060, 123, 84, STRUCTURE OF AN ANTI-METHOTREXATE CDR1-4 GRAFT VHH ANTIBODY IN COMPLEX WITH METHOTREXATE
4902, 3qqdB, 0.5494, 3.43, 0.057, 127, 88, HUMAN SOD1 H80R VARIANT P212121 CRYSTAL FORM
4903, 2ndfA, 0.5494, 3.17, 0.082, 141, 85, SOLUTION NMR STRUCTURES OF AF9 YEATS DOMAIN IN COMPLEX WITH HISTON H3 ACETYLATION AT K18
4904, 1xgrB, 0.5494, 3.12, 0.072, 210, 83, STRUCTURE FOR ANTIBODY HYHEL-63 Y33I MUTANT COMPLEXED WITH HEN EGG LYSOZYME
4905, 1nbyB, 0.5494, 3.12, 0.060, 210, 83, CRYSTAL STRUCTURE OF HYHEL-63 COMPLEXED WITH HEL MUTANT K96A
4906, 6k7oG, 0.5493, 3.11, 0.074, 218, 81, COMPLEX STRUCTURE OF LILRB4 AND H128-3 ANTIBODY 
4907, 6cufh, 0.5493, 3.26, 0.047, 116, 85, CRYO-EM STRUCTURE AT 4.2 A RESOLUTION OF VACCINE-ELICITED ANTIBODY VFP1.01 IN COMPLEX WITH HIV-1 ENV BG505 DS-SOSIP; AND ANTIBODIES VRC03 AND PGT122 
4908, 5yoyP, 0.5493, 3.62, 0.046, 126, 87, CRYSTAL STRUCTURE OF THE HUMAN TUMOR NECROSIS FACTOR IN COMPLEX WITH GOLIMUMAB FV 
4909, 5fyjH, 0.5493, 3.38, 0.106, 228, 85, CRYSTAL STRUCTURE AT 3.4 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE G X1193.C1 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 35O22 AND VRC01
4910, 5e70A, 0.5493, 3.17, 0.037, 586, 81, CRYSTAL STRUCTURE OF ECOLI BRANCHING ENZYME WITH GAMMA CYCLODEXTRIN
4911, 4zbjA, 0.5493, 3.61, 0.070, 160, 86, UBN1 PEPTIDE BOUND TO H3.3/H4/ASF1
4912, 4pirH, 0.5493, 3.48, 0.069, 124, 87, X-RAY STRUCTURE OF THE MOUSE SEROTONIN 5-HT3 RECEPTOR
4913, 4lsdB, 0.5493, 3.16, 0.081, 93, 86, MYOKINE STRUCTURE
4914, 4krmJ, 0.5493, 3.53, 0.093, 124, 86, NANOBODY/VHH DOMAIN 7D12 IN COMPLEX WITH DOMAIN III OF THE EXTRACELLULAR REGION OF EGFR PH 3.5
4915, 4jdzA, 0.5493, 4.21, 0.081, 430, 99, STRUCTURES OF SDRD FROM STAPHYLOCOCCUS AUREUS REVEAL THE MOLECULAR MECHANISM OF HOW THE CELL SURFACE RECEPTORS RECOGNIZE THEIR LIGANDS
4916, 3i50H, 0.5493, 3.73, 0.080, 212, 87, CRYSTAL STRUCTURE OF THE WEST NILE VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE E53 ANTIBODY FAB
4917, 1yc8B, 0.5493, 3.54, 0.058, 112, 86, CABAN33- Y37V/E44G/R45L TRIPLE MUTANT
4918, 1tjmA, 0.5493, 3.93, 0.054, 156, 93, CRYSTALLOGRAPHIC IDENTIFICATION OF SR2+ COORDINATION SITE IN SYNAPTOTAGMIN I C2B DOMAIN
4919, 1srdB, 0.5493, 3.71, 0.109, 154, 92, THREE-DIMENSIONAL STRUCTURE OF CUZN-SUPEROXIDE DISMUTASE FROM SPINACH AT 2.0 ANGSTROMS RESOLUTION
4920, 6nb7H, 0.5492, 3.27, 0.036, 123, 84, SARS-COV COMPLEX WITH HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT (STATE 2) 
4921, 6k7oF, 0.5492, 3.45, 0.057, 225, 87, COMPLEX STRUCTURE OF LILRB4 AND H128-3 ANTIBODY 
4922, 6dc5H, 0.5492, 3.30, 0.081, 223, 86, RSV PREFUSION F IN COMPLEX WITH AM22 FAB 
4923, 6cw2A, 0.5492, 3.29, 0.070, 217, 86, CRYSTAL STRUCTURE OF A YEAST SAGA TRANSCRIPTIONAL COACTIVATOR ADA2/GCN5 HAT SUBCOMPLEX; CRYSTAL FORM 1 
4924, 5yoyI, 0.5492, 3.36, 0.059, 125, 85, CRYSTAL STRUCTURE OF THE HUMAN TUMOR NECROSIS FACTOR IN COMPLEX WITH GOLIMUMAB FV 
4925, 5hysI, 0.5492, 3.18, 0.047, 213, 85, STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB
4926, 5emwD, 0.5492, 3.39, 0.067, 206, 90, CRYSTAL STRUCTURE OF THE PALMITOYLATED HUMAN TEAD3 TRANSCRIPTION FACTOR
4927, 4w4oA, 0.5492, 3.32, 0.047, 215, 85, HIGH-RESOLUTION CRYSTAL STRUCTURE OF FC BOUND TO ITS HUMAN RECEPTOR FC-GAMMA-RI
4928, 4odxA, 0.5492, 3.51, 0.069, 127, 87, 4E10 GERMLINE ENCODED PRECURSOR NO.7 IN COMPLEX WITH EPITOPE SCAFFOLD T117
4929, 4lo9A, 0.5492, 3.57, 0.087, 194, 92, HUMAN P53 CORE DOMAIN MUTANT N235K
4930, 2fhbA, 0.5492, 3.11, 0.085, 1052, 82, CRYSTAL STRUCTURE ANALYSIS OF KLEBSIELLA PNEUMONIAE PULLULANASE COMPLEXED WITH MALTOSE
4931, 1igfH, 0.5492, 3.61, 0.057, 218, 87, CRYSTAL STRUCTURES OF AN ANTIBODY TO A PEPTIDE AND ITS COMPLEX WITH PEPTIDE ANTIGEN AT 2.8 ANGSTROMS
4932, 6qtlD, 0.5491, 3.53, 0.138, 118, 87, CAFFEINE RECOGNIZING NANOBODY 
4933, 6ellA, 0.5491, 3.67, 0.093, 211, 86, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
4934, 6eayH, 0.5491, 3.53, 0.058, 202, 86, STRUCTURAL BASIS FOR BROAD NEUTRALIZATION OF EBOLAVIRUSES BY AN ANTIBODY TARGETING THE GLYCOPROTEIN FUSION LOOP 
4935, 6cbpA, 0.5491, 3.61, 0.079, 235, 89, CRYSTAL STRUCTURE OF THE SINGLE CHAIN VARIABLE FRAGMENT OF THE DH270.6 BNAB IN COMPLEX WITH THE MAN9-V3 GLYCOPEPTIDE
4936, 5wkoG, 0.5491, 3.55, 0.057, 225, 88, CRYSTAL STRUCTURE OF ANTIBODY 27F3 RECOGNIZING THE HA FROM A/CALIFORNIA/04/2009 (H1N1) INFLUENZA VIRUS
4937, 5m59E, 0.5491, 3.30, 0.080, 1740, 87, CRYSTAL STRUCTURE OF CHAETOMIUM THERMOPHILUM BRR2 HELICASE CORE IN COMPLEX WITH PRP8 JAB1 DOMAIN
4938, 5ljyH, 0.5491, 3.12, 0.085, 113, 82, STRUCTURE OF HANTAVIRUS ENVELOPE GLYCOPROTEIN GC IN COMPLEX WITH SCFV A5
4939, 5k02U, 0.5491, 3.69, 0.055, 153, 91, STRUCTURE OF HUMAN SOD1 WITH T2D MUTATION
4940, 4pirG, 0.5491, 3.49, 0.069, 124, 87, X-RAY STRUCTURE OF THE MOUSE SEROTONIN 5-HT3 RECEPTOR
4941, 4lsdD, 0.5491, 3.16, 0.081, 93, 86, MYOKINE STRUCTURE
4942, 4k3gA, 0.5491, 3.30, 0.069, 109, 87, IMMUNOGLOBULIN LAMBDA VARIABLE DOMAIN L5(L89S) FLUOROGEN ACTIVATING PROTEIN
4943, 4jo2H, 0.5491, 3.35, 0.073, 204, 82, CRYSTAL STRUCTURE OF RABBIT MAB R56 FAB IN COMPLEX WITH V3 CROWN OF HIV-1 CONSENSUS A GP120
4944, 4ibtB, 0.5491, 3.54, 0.087, 195, 92, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R273H AND SECOND-SITE SUPPRESSOR MUTATION T284R
4945, 4ibqC, 0.5491, 3.56, 0.087, 192, 92, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R273C
4946, 4edwH, 0.5491, 3.34, 0.047, 215, 86, NERVE GROWTH FACTOR IN COMPLEX WITH FAB FROM HUMANIZED VERSION OF MOUSE MAB 911 (TANEZUMAB)
4947, 4aj0B, 0.5491, 3.17, 0.106, 107, 85, CRYSTALLOGRAPHIC STRUCTURE OF AN AMYLOIDOGENIC VARIANT 3RCW OF THE GERMINAL LINE LAMBDA 3
4948, 4aizA, 0.5491, 3.00, 0.060, 107, 83, CRYSTALLOGRAPHIC STRUCTURE OF 3MJL2 FROM THE GERMINAL LINE LAMBDA 3
4949, 3ulaB, 0.5491, 4.10, 0.040, 140, 99, CRYSTAL STRUCTURE OF THE TV3 MUTANT F63W-MD-2-ERITORAN COMPLEX
4950, 3q3gK, 0.5491, 3.62, 0.056, 224, 89, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
4951, 3mxvH, 0.5491, 3.42, 0.094, 220, 85, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-SHH 5E1 CHIMERA
4952, 3mj8B, 0.5491, 3.17, 0.060, 211, 84, CRYSTAL STRUCTURE OF HL4E10 FAB A HAMSTER AB STIMULATORY FOR GAMMADELTA T CELLS
4953, 3h2qD, 0.5491, 3.48, 0.068, 128, 88, HUMAN SOD1 H80R VARIANT P21 CRYSTAL FORM
4954, 3dj9A, 0.5491, 3.13, 0.037, 107, 82, CRYSTAL STRUCTURE OF AN ISOLATED UNGLYCOSYLATED ANTIBODY CH2 DOMAIN
4955, 3cxhJ, 0.5491, 3.57, 0.045, 127, 88, STRUCTURE OF YEAST COMPLEX III WITH ISOFORM-2 CYTOCHROME C BOUND AND DEFINITION OF A MINIMAL CORE INTERFACE FOR ELECTRON TRANSFER.
4956, 2rmnA, 0.5491, 3.65, 0.075, 233, 93, THE SOLUTION STRUCTURE OF THE P63 DNA-BINDING DOMAIN
4957, 2pn5A, 0.5491, 3.47, 0.011, 1283, 92, CRYSTAL STRUCTURE OF TEP1R
4958, 2lllA, 0.5491, 3.38, 0.093, 121, 86, SOLUTION NMR STRUCTURE OF C-TERMINAL GLOBULAR DOMAIN OF HUMAN LAMIN- B2 NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET HR8546A
4959, 1rihH, 0.5491, 3.47, 0.023, 221, 86, CRYSTAL STRUCTURE OF FAB 14F7 A UNIQUE ANTI-TUMOR ANTIBODY SPECIFIC FOR N-GLYCOLYL GM3
4960, 1ollA, 0.5491, 3.06, 0.061, 188, 82, EXTRACELLULAR REGION OF THE HUMAN RECEPTOR NKP46
4961, 1ahwB, 0.5491, 3.40, 0.035, 214, 86, A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9)
4962, 6bzyH, 0.5490, 3.24, 0.080, 214, 87, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE 22D11 BROADLY NEUTRALIZING ANTIBODY 
4963, 5xcvD, 0.5490, 3.62, 0.070, 167, 86, CRYSTAL STRUCTURE OF NZ-1 FV-CLASP FRAGMENT WITH ITS ANTIGEN PEPTIDE
4964, 5u3pH, 0.5490, 3.53, 0.047, 232, 86, CRYSTAL STRUCTURE OF DH511.4 FAB
4965, 5truC, 0.5490, 3.37, 0.079, 114, 89, STRUCTURE OF THE FIRST-IN-CLASS CHECKPOINT INHIBITOR IPILIMUMAB BOUND TO HUMAN CTLA-4
4966, 4ygaH, 0.5490, 3.62, 0.163, 123, 86, CDPK1 FROM TOXOPLASMA GONDII BOUND TO INHIBITORY VHH-1B7
4967, 4rvpF, 0.5490, 3.54, 0.099, 153, 91, CRYSTAL STRUCTURE OF SUPEROXIDE DISMUTASE FROM SEDUM ALFREDII
4968, 4dbhA, 0.5490, 3.96, 0.043, 269, 92, CRYSTAL STRUCTURE OF CG1458 WITH INHIBITOR
4969, 4aizC, 0.5490, 2.99, 0.060, 107, 83, CRYSTALLOGRAPHIC STRUCTURE OF 3MJL2 FROM THE GERMINAL LINE LAMBDA 3
4970, 3wfdH, 0.5490, 3.41, 0.024, 225, 85, REDUCED AND ACETALDOXIME-BOUND CYTOCHROME C-DEPENDENT NITRIC OXIDE REDUCTASE (CNOR) FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH ANTIBODY FRAGMENT
4971, 3dusB, 0.5490, 3.35, 0.082, 121, 85, CRYSTAL STRUCTURE OF SAG506-01 ORTHORHOMBIC TWINNED CRYSTAL 1
4972, 2d7tH, 0.5490, 3.36, 0.071, 116, 84, CRYSTAL STRUCTURE OF HUMAN ANTI POLYHYDROXYBUTYRATE ANTIBODY FV
4973, 1xgqB, 0.5490, 3.11, 0.060, 210, 83, STRUCTURE FOR ANTIBODY HYHEL-63 Y33V MUTANT COMPLEXED WITH HEN EGG LYSOZYME
4974, 1r17A, 0.5490, 3.68, 0.065, 321, 92, CRYSTAL STRUCTURE ANALYSIS OF S.EPIDERMIDIS ADHESIN SDRG BINDING TO FIBRINOGEN (ADHESIN-LIGAND COMPLEX)
4975, 1j1xH, 0.5490, 3.34, 0.082, 114, 85, CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT LS93A COMPLEXED WITH HEN EGG WHITE LYSOZYME
4976, 1ct8D, 0.5490, 3.64, 0.080, 220, 88, CATALYTIC ANTIBODY 7C8 COMPLEX
4977, 12e8P, 0.5490, 3.47, 0.093, 221, 86, 2E8 FAB FRAGMENT
4978, 6fp6O, 0.5489, 3.78, 0.065, 153, 92, COMPLEX OF HUMAN CU;ZN SOD1 WITH THE HUMAN COPPER CHAPERONE FOR SOD1 IN A COMPACT CONFORMATION 
4979, 6cwkA, 0.5489, 3.43, 0.071, 129, 85, ANTI-RTA VHH ANTIBODY 
4980, 5xbmE, 0.5489, 3.64, 0.045, 221, 88, STRUCTURE OF SCARB2-JL2 COMPLEX 
4981, 5uoeH, 0.5489, 3.38, 0.094, 119, 85, CRYSTAL STRUCTURE ANALYSIS OF ELBOW-ENGINEERED-FAB-BOUND HUMAN INSULIN DEGRADING ENZYME (IDE)
4982, 5tpnH, 0.5489, 3.44, 0.081, 217, 86, CRYSTAL STRUCTURE OF RSV F IN COMPLEX WITH HUMAN ANTIBODY HRSV90
4983, 5e6zA, 0.5489, 3.04, 0.037, 587, 80, CRYSTAL STRUCTURE OF ECOLI BRANCHING ENZYME WITH BETA CYCLODEXTRIN
4984, 5awrA, 0.5489, 3.67, 0.106, 262, 94, CRYSTAL STRUCTURE OF THE SGIP1 MU HOMOLOGY DOMAIN IN THE P4212 SPACE GROUP
4985, 5abaB, 0.5489, 3.69, 0.086, 197, 93, STRUCTURE OF THE P53 CANCER MUTANT Y220C WITH BOUND SMALL- MOLECULE STABILIZER PHIKAN5149
4986, 3r0mB, 0.5489, 3.59, 0.080, 127, 87, CRYSTAL STRUCTURE OF ANTI-HIV LLAMA VHH ANTIBODY A12
4987, 3qe5B, 0.5489, 3.48, 0.070, 487, 86, COMPLETE STRUCTURE OF STREPTOCOCCUS MUTANS ANTIGEN I/II CARBOXY- TERMINUS
4988, 3igkA, 0.5489, 3.59, 0.087, 197, 92, DIVERSITY IN DNA RECOGNITION BY P53 REVEALED BY CRYSTAL STRUCTURES WITH HOOGSTEEN BASE PAIRS (P53-DNA COMPLEX 2)
4989, 3h9zD, 0.5489, 3.29, 0.047, 209, 86, CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS
4990, 3h9zB, 0.5489, 3.12, 0.024, 209, 85, CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS
4991, 3eo1K, 0.5489, 3.49, 0.071, 216, 85, STRUCTURE OF THE FAB FRAGMENT OF GC-1008 IN COMPLEX WITH TRANSFORMING GROWTH FACTOR-BETA 3
4992, 3eo1E, 0.5489, 3.49, 0.071, 216, 85, STRUCTURE OF THE FAB FRAGMENT OF GC-1008 IN COMPLEX WITH TRANSFORMING GROWTH FACTOR-BETA 3
4993, 3cfkO, 0.5489, 3.12, 0.047, 215, 86, CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4 TRICLINIC CRYSTAL FORM
4994, 1p6fA, 0.5489, 3.05, 0.061, 188, 82, STRUCTURE OF THE HUMAN NATURAL CYTOTOXICITY RECEPTOR NKP46
4995, 1kzyB, 0.5489, 3.70, 0.086, 195, 93, CRYSTAL STRUCTURE OF THE 53BP1 BRCT REGION COMPLEXED TO TUMOR SUPPRESSOR P53
4996, 6i9iH, 0.5488, 3.35, 0.035, 213, 86, RIFT VALLEY FEVER VIRUS GN IN COMPLEX WITH A NEUTRALIZING ANTIBODY FRAGMENT 
4997, 6fysG, 0.5488, 3.59, 0.058, 127, 86, STRUCTURE OF SINGLE DOMAIN ANTIBODY SD83 
4998, 6df0H, 0.5488, 3.74, 0.103, 211, 87, ANTI-PHOSPHOTYROSINE ANTIBODY 4G10-4D5 FAB COMPLEXED WITH SULFATE 
4999, 6c9wB, 0.5488, 3.52, 0.059, 125, 85, CRYSTAL STRUCTURE OF A LIGAND BOUND LACY/NANOBODY COMPLEX 
5000, 5vf2A, 0.5488, 3.67, 0.067, 237, 89, SCFV 2D10 COMPLEXED WITH ALPHA 16 MANNOBIOSE RE-REFINEMENT
5001, 5sy8H, 0.5488, 3.63, 0.081, 234, 86, CRYSTAL STRUCTURE OF THE COMPLEX OF 10E8 FAB LIGHT CHAIN MUTANT1 AND T117V2 HIV-1 MPER SCAFFOLD
